Citrus Sinensis ID: 006545
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 641 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.825 | 0.634 | 0.665 | 0.0 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.790 | 0.629 | 0.447 | 1e-122 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.753 | 0.932 | 0.402 | 1e-101 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.717 | 0.544 | 0.406 | 1e-100 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.720 | 0.553 | 0.404 | 1e-99 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.620 | 0.5 | 0.455 | 1e-98 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.641 | 0.501 | 0.430 | 9e-97 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.567 | 0.454 | 0.424 | 2e-86 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.717 | 0.601 | 0.322 | 4e-63 | |
| O80623 | 815 | Probable receptor-like pr | no | no | 0.410 | 0.322 | 0.385 | 3e-51 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/538 (66%), Positives = 436/538 (81%), Gaps = 9/538 (1%)
Query: 104 DGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR 163
DG VDD+ ++ +A +EA +S++EAF E LRR KAEK+A+++IRRAK SES Y+EELKR
Sbjct: 305 DG-VDDSFNVKIRKATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKR 363
Query: 164 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 223
RK+ E A+A K +K + + +MEELQ A+ QK++LESQIA+SD T ++L QK+ A
Sbjct: 364 RKDTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIA 423
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 283
V+LLQ + E++ELQ ERD+A++EAEELR + +S+ +PQ+F+DFSFSEIE AT++F
Sbjct: 424 VKLLQKLRDEREELQTERDRALREAEELRSHAE--TSTLQLPQYFTDFSFSEIEEATNHF 481
Query: 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
D +LKIGEGGYGSIY GLLRH QVAIKML+P+S QGP E+QQE+D+LSK+RHPN++TL+G
Sbjct: 482 DSTLKIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIG 541
Query: 344 ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
ACPE W+LVYEYLP GSLEDRL+CKDNSPPLSWQ R+RIATE+C+ L+FLHS K HS+VH
Sbjct: 542 ACPEGWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVH 601
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
GDLKPANILLD+N VSKLSDFG L N S RTD GT AY+DPE +SG
Sbjct: 602 GDLKPANILLDSNLVSKLSDFGTCSLLHPNGSKS------VRTDVTGTVAYLDPEASSSG 655
Query: 464 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 523
ELTPKSDVYSFGIILLRLLTGRPAL I+ EV+YALD G L +LLDPLAGDWPFVQAEQLA
Sbjct: 656 ELTPKSDVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLA 715
Query: 524 NLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEV 583
LA+RCCE ++RP+LG +VWRVLEPMRAS GGS+S+ LG E PPYF CPIFQEV
Sbjct: 716 RLALRCCETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEV 775
Query: 584 MQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
MQDPHVAADGFTYEAEA++ WLDS H+TSPMTN+ L+H +L+ N ALRSAIQEWLQ H
Sbjct: 776 MQDPHVAADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWLQHH 833
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 236/527 (44%), Positives = 357/527 (67%), Gaps = 20/527 (3%)
Query: 117 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 176
+AM + S R + EA ++ + + E++ +AKA E L +E +RK EE L KL
Sbjct: 295 KAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKL 354
Query: 177 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 236
E++ + +Q++ M+ELQ+ + LESQ+ + KE +K +A+ELL+++++++DE
Sbjct: 355 EVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDE 414
Query: 237 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 296
++++ + AVKE LR+ K + S + D+SF EI AT+ FDPS K+GEG YGS
Sbjct: 415 IRIDHENAVKEVNALRRLVKGETGESSGSEML-DYSFMEINEATNEFDPSWKLGEGKYGS 473
Query: 297 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 356
+YKG L+H+QVA+KML + EF++ ++ILS++RHPNLVTL+GACPE +L+Y+Y+
Sbjct: 474 VYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYI 533
Query: 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 416
PNGSLED S ++N P LSW++RIRIA+E+CS L+FLHS P I+HG+LKP+ ILLD+N
Sbjct: 534 PNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSN 592
Query: 417 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 476
V+K++D+GIS+ + + + ++DP ++DP + S E+T +SD+Y+FGI
Sbjct: 593 LVTKINDYGISQLIPIDGLD--------KSDP-----HVDPHYFVSREMTLESDIYAFGI 639
Query: 477 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 536
ILL+LLT RP GI ++V+ AL+ + +LD AGDWP + ++LAN+A+RCC+ + +
Sbjct: 640 ILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMN 699
Query: 537 RPELGKDVWRVLEPMRA---SCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 593
RP+L V R ++ M+A ++SY + R PP ++ CPIFQEVM+DP +AADG
Sbjct: 700 RPDLAV-VLRFIDRMKAPEVPSSETSSYANQNVPR-RPPSHYLCPIFQEVMKDPLIAADG 757
Query: 594 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
FTYEAEA++ WL +GH+TSPMTNL + NL+PN AL AIQ+W Q
Sbjct: 758 FTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (950), Expect = e-101, Method: Compositional matrix adjust.
Identities = 214/532 (40%), Positives = 303/532 (56%), Gaps = 49/532 (9%)
Query: 124 NSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE--EALANGKLELERM 181
NSR +F ++ K I K S++ E + F E + + +++
Sbjct: 7 NSRMNSFISSVLVLHFNKQEI------KFEPSVWCEAIDIHNTFSAGEIITGDIICFQKI 60
Query: 182 KK-----QHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY--KKEQ 234
K ++ V LQ D+K+ E + LE++I++ Y +KE+
Sbjct: 61 LKPPDIPKYPSVASFLQHVCDRKTY------EEVRKVHILEEEIVTLKHQADTYLVQKEK 114
Query: 235 -----DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKI 289
D+L+ ERD AV++ ELR S+H+ DFS ++E AT +F + ++
Sbjct: 115 AVTAYDQLKHERDNAVQQVNELR------DQSTHI---ILDFSRKDMEQATEHFKNAREV 165
Query: 290 GEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW 349
G+ YG YKG++ +M+V IK+ L FQQE+ IL + RHPN++T +G C EV
Sbjct: 166 GDTEYGHTYKGMIHNMKVLIKLSSSQKL-----FQQEVSILRQWRHPNIITFIGVCSEVS 220
Query: 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 409
LVYE+LPNG+LEDR+ C +NS PLSW R +I E+C L+FLHS K ++VHGDL+P
Sbjct: 221 ALVYEWLPNGNLEDRIICTNNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPC 280
Query: 410 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
NIL+DAN+ SK+ +FG+S Q N T YMDPEF +GELT S
Sbjct: 281 NILIDANYRSKICNFGMSNLFLQLGTFPPNLT--------ARLPYMDPEFNTTGELTTLS 332
Query: 470 DVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRC 529
DVYS G+I+LRLLTG P L ++++V AL + L L+D AGDWP+++A+QLA + + C
Sbjct: 333 DVYSLGVIILRLLTGMPPLTLSEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSC 392
Query: 530 CEMSRKSRPELGKDVWRVLEPM-RASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPH 588
M+RK RP+L +VW V+EP+ R + Y + P F CPI E+M+DP
Sbjct: 393 TGMTRKKRPDLLNEVWIVIEPLTRKPPAATWPYLQSASGDSSVPAAFICPISMEIMKDPQ 452
Query: 589 VAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
VA+DGFTYEAEA++ W D G SPMTNL L + NLVPN LRS I +LQQ
Sbjct: 453 VASDGFTYEAEAIRCWFDRGISRSPMTNLALPNLNLVPNRVLRSFIHGYLQQ 504
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (936), Expect = e-100, Method: Compositional matrix adjust.
Identities = 199/490 (40%), Positives = 290/490 (59%), Gaps = 30/490 (6%)
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
N E+E+++ + V E +A + ++ E +Q E +K++ E + K
Sbjct: 357 VNLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAK 416
Query: 232 KEQDELQMERDKAVKEAEELR-----------------------KSRKEASSSSHMPQFF 268
+ + ++A+KEAE+++ K + +AS S Q+
Sbjct: 417 DTASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQY- 475
Query: 269 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEID 328
+++ EI AT +F +LKIG G YGS+YK L H A+K+LH Q +F QE++
Sbjct: 476 QHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELE 535
Query: 329 ILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 388
ILSKIRHP+LV L+GACPE LVYEY+ NGSL+DRL +++PP+ W R RIA E+ S
Sbjct: 536 ILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVAS 595
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
L+FLH KP I+H DLKP NILLD NFVSKL D G+S ++Q+++SS T+ +T P
Sbjct: 596 ALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSR--TIFKQTSP 653
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLL 507
GT Y+DPE+ +G ++PKSDVYS G+++L+L+T +PA+ IT V+ A+ D + +L
Sbjct: 654 VGTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAIL 713
Query: 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 567
D AG WP +LA L + C EM R+ RP+L + LE +R + + L S
Sbjct: 714 DKKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQN--LLSRT 771
Query: 568 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 627
PP +F CP+ + VM +P VAADG+TY+ EA++ WL +TSP+TNLPL +KNL+ N
Sbjct: 772 PSGPPSHFICPLLKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIAN 830
Query: 628 LALRSAIQEW 637
L SAI EW
Sbjct: 831 YTLYSAIMEW 840
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 198/489 (40%), Positives = 293/489 (59%), Gaps = 27/489 (5%)
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQ-------TAKELEQKIISAV 224
N E+E+++ + V E +A + ++ E +Q +EL+ K A
Sbjct: 347 VNLNFEVEKLRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEAR 406
Query: 225 ELL----QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH----------MPQF-FS 269
EL QN++K + + + R++A +E + R++ ++++ + PQ +
Sbjct: 407 ELAEKEKQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQ 466
Query: 270 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 329
F++ EI AT +F LKIG G YG++YK L H +K+L Q +FQQE++I
Sbjct: 467 HFAWEEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEI 526
Query: 330 LSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
LSKIRHP+LV L+GACPE LVYEY+ NGSLEDRL +NSPPL W R RIA E+ +
Sbjct: 527 LSKIRHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAA 586
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L+FLH KP I+H DLKPANILLD NFVSK+ D G+S + + +S+ T+ +T P
Sbjct: 587 LVFLHKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLST-KFTIYKQTSPV 645
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-KLKNLLD 508
GT Y+DPE+ +G ++ KSD+YSFG+ILL+LLT +PA+ +T V+ A+D+ + +LD
Sbjct: 646 GTLCYIDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILD 705
Query: 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEER 568
AG+WP + +LA LA+ C E+ K RP+L + LE ++ + + G
Sbjct: 706 QKAGNWPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVS-- 763
Query: 569 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 628
+PP +F CP+ ++VM +P VAADG+TY+ A++ WL H TSPMT+ PL KNL+PN
Sbjct: 764 TQPPTHFICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNY 822
Query: 629 ALRSAIQEW 637
L +AI EW
Sbjct: 823 TLYTAIMEW 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 360 bits (925), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 189/415 (45%), Positives = 264/415 (63%), Gaps = 17/415 (4%)
Query: 240 ERDKAVKEAEELRKSRKEASSSSH----MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 295
ER +A AEE+RK ++ + Q + F + EI AT +F LKIG GGYG
Sbjct: 382 ERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYG 441
Query: 296 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEY 355
S+Y+ L H VA+K+LH +F QE++ILSKIRHP+L+ L+GACPE +LVYEY
Sbjct: 442 SVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEY 501
Query: 356 LPNGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 409
+ NGSLE+RL + PPL W R RIA E+ S L FLH+ +P IVH DLKPA
Sbjct: 502 MHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPA 561
Query: 410 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
NILLD N VSK+ D G+S+ + N S+ +T+ T P GTF Y+DPE+ +G +TP+S
Sbjct: 562 NILLDRNNVSKIGDVGLSKMV--NLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPES 619
Query: 470 DVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDPLAGDWPFVQAEQLANLAM 527
D+Y+FGIILL+L+T R A+G+ ++ AL TGK +LD AGDWP +A+++ + +
Sbjct: 620 DIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGL 679
Query: 528 RCCEMSRKSRPELGKDVWRVLEPMR--ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQ 585
RC EM ++ RP+LGK++ VLE ++ AS + + P +F CPI ++VM+
Sbjct: 680 RCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVME 739
Query: 586 DPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
+P VA+DG+TYE A+K WL H+ SPMT+LP +L+PN +L SAI+EW Q
Sbjct: 740 NPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 9e-97, Method: Compositional matrix adjust.
Identities = 180/418 (43%), Positives = 264/418 (63%), Gaps = 7/418 (1%)
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHN 282
E + ++E+ E R+ +K E ++ K SS P+ + +F++ EI AT +
Sbjct: 400 TEKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSS 459
Query: 283 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
F LKIG G YG +YK L H A+K+LH +F QE++ILSKIRHP+LV L+
Sbjct: 460 FSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLL 519
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
GACP+ LVYEY+ NGSLEDRL ++S P+ W R+RIA E+ S L+FLH KP I+
Sbjct: 520 GACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPII 579
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H DLKPANILL+ NFVSK+ D G+S + + S T+ +T P GT Y+DPE+ +
Sbjct: 580 HRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRT 639
Query: 463 GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---KLKNLLDPLAGDWPFVQA 519
G ++PKSDVY+FG+I+L+LLTG+ A+ +T V+ A++ +L +LD AG+WP +
Sbjct: 640 GRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEET 699
Query: 520 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 579
QLA LA++C E+ K RP+L + VLE ++ + + S +PP +F CP+
Sbjct: 700 RQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSL--SAAPSQPPSHFFCPL 757
Query: 580 FQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 637
++VM++P +AADG+TY+ A++ W++ H TSP+TN PL + NL+PN L +AI EW
Sbjct: 758 LKDVMKEPCIAADGYTYDRRAIEEWME-NHRTSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 157/370 (42%), Positives = 231/370 (62%), Gaps = 6/370 (1%)
Query: 268 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEI 327
+ ++ EI AT F P IGEGGYG +Y+ L A+K++ + + EF +E+
Sbjct: 427 YRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEV 486
Query: 328 DILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 387
++LS++RHP++V L+GACPE LVYEYL NGSLE+ + + N PPL W R R+ E+
Sbjct: 487 EVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVA 546
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
L FLHS KP IVH DLKP NILL+ N+VSK++D G+++ ++ +++ +N T+ +
Sbjct: 547 CGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVT--DVAPDNVTMYRNSV 604
Query: 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507
GT Y+DPE+ +G + PKSD+Y+FGII+L+LLT R GI V+ A+ G L +L
Sbjct: 605 LAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEML 664
Query: 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEE 567
D DWP + E+LA + ++C E + RP+L +V VL+ + S + GS
Sbjct: 665 DKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRL-VETANSKVKKEGSNL 723
Query: 568 RCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 627
R P ++ CPI +E+M++P +AADGFTYE +A+ WL+ H SP+T L H L PN
Sbjct: 724 RA--PSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFKLTPN 780
Query: 628 LALRSAIQEW 637
LRSAI++W
Sbjct: 781 HTLRSAIRDW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 177/549 (32%), Positives = 272/549 (49%), Gaps = 89/549 (16%)
Query: 142 DAIESIRRAKASESLYAEELKR----------RKEFEEALANGKL-ELERMKKQHDEVME 190
+ +E +RR L +E R R E+ +L N ++ E E K+ E E
Sbjct: 243 EKLEYVRRKVNEAKLMIDEKSREVKVNAERSNRAEWAISLCNSRIGEFEAWIKEESERRE 302
Query: 191 ELQIALDQ-KSLLE--SQIAESDQTA----KELEQKIISAVELLQNYKK----EQDELQM 239
+LQ LD K +E E +T EL++ + S V+ + K E + + +
Sbjct: 303 KLQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEVELERVVL 362
Query: 240 ERDKAVKEAEELRKSR----------KE-----ASSSSHMPQFFSDFSFSEIEGATHNFD 284
+R + + E E+LR R KE + S + + ++ +I AT +
Sbjct: 363 QRGEMITEIEKLRSQRDVFNRRIEFCKEREVIGSVSKEEVKCGYREYVAEDIRLATETYS 422
Query: 285 PSLKIGEGG-YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
L++ GG + ++Y+G ++H VA+K++ SL + F ++ +L++IRHPNLV + G
Sbjct: 423 DRLRLKSGGNWTNVYRGRIKHTTVAVKVI-GDSLSDEA-FGAKVKLLNEIRHPNLVAIAG 480
Query: 344 ACPEV-WTLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKP 398
C + L++EY+ NG+L D L S L W RIRIA ++CS L FLHS KP
Sbjct: 481 FCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIRIAHQVCSGLGFLHSVKP 540
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
IVHG L P+ ILLD N V K++ FG+
Sbjct: 541 KPIVHGRLTPSKILLDRNLVPKITGFGL-------------------------------- 568
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
+ S + K DV +FG++LL LLTGR G+ K + +++ + LD AG WP
Sbjct: 569 IMHSDQSDTKPDVMAFGVLLLHLLTGRNWHGLLKAM--SMNQTSILRDLDQTAGKWPLEL 626
Query: 519 AEQLANLAMRCCEMSRKSRPELG-KDVWRVLEPMRASC------GG---STSYRLGSEER 568
A++ LA++C ++R + K++ L +R GG +T+ + +
Sbjct: 627 AKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTKGGYEEATNSNMDEGDP 686
Query: 569 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNL 628
+ P F CPI QEVM++PHVAADGF+YE EA++ WL GH+TSPMTNL L ++ L PN
Sbjct: 687 NDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTSPMTNLRLDYQMLTPNH 746
Query: 629 ALRSAIQEW 637
LRS IQ+W
Sbjct: 747 TLRSLIQDW 755
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 111/288 (38%), Positives = 176/288 (61%), Gaps = 25/288 (8%)
Query: 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 334
I+ AT +FD SL IG GG+G +YKG+LR +VA+K P S QG +EF+ E+++L++ R
Sbjct: 480 IKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFR 539
Query: 335 HPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
H +LV+L+G C E +VYEY+ G+L+D L D+ P LSW+ R+ I L +
Sbjct: 540 HRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHY 599
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF---LSQNEISSNNTTLCCRTDPK 449
LH+ +I+H D+K ANILLD NF++K++DFG+S+ L Q +S T K
Sbjct: 600 LHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVS---------TAVK 650
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKE----VQYAL---DT 500
G+F Y+DPE+L +LT KSDVYSFG+++L ++ GRP + + +E +++A+
Sbjct: 651 GSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKK 710
Query: 501 GKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 547
GKL++++DP L G + ++ + +C + RP +G +W +
Sbjct: 711 GKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNL 758
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 641 | ||||||
| 359489801 | 881 | PREDICTED: U-box domain-containing prote | 0.971 | 0.707 | 0.684 | 0.0 | |
| 224064033 | 809 | predicted protein [Populus trichocarpa] | 0.917 | 0.726 | 0.698 | 0.0 | |
| 147772798 | 881 | hypothetical protein VITISV_015820 [Viti | 0.973 | 0.708 | 0.683 | 0.0 | |
| 356568394 | 883 | PREDICTED: U-box domain-containing prote | 0.992 | 0.720 | 0.679 | 0.0 | |
| 357507363 | 896 | U-box domain-containing protein [Medicag | 0.984 | 0.704 | 0.684 | 0.0 | |
| 87240964 | 884 | Protein kinase; U box [Medicago truncatu | 0.984 | 0.713 | 0.684 | 0.0 | |
| 356531997 | 883 | PREDICTED: U-box domain-containing prote | 0.992 | 0.720 | 0.671 | 0.0 | |
| 118487785 | 521 | unknown [Populus trichocarpa] | 0.812 | 1.0 | 0.787 | 0.0 | |
| 224127680 | 810 | predicted protein [Populus trichocarpa] | 0.900 | 0.712 | 0.663 | 0.0 | |
| 356522608 | 879 | PREDICTED: U-box domain-containing prote | 0.968 | 0.706 | 0.643 | 0.0 |
| >gi|359489801|ref|XP_002274993.2| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] gi|297745303|emb|CBI40383.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/646 (68%), Positives = 523/646 (80%), Gaps = 23/646 (3%)
Query: 2 KLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSD--ECTTGRSTS 59
KL NP QDL R+M+ + V++S D GG+S+P SR E SSD + + RS S
Sbjct: 251 KLVNPGQDL---PRTMSVPVRI-TVLSSPDGTGGVSAPWSRMGREGSSDYWDGISKRSPS 306
Query: 60 QGS-LSSCSSRGVIDVAMIPLIRTEGVSTL--PPSKEDLQ-SSPPSVLDGSVDDNLYDQL 115
Q S S+CSS M + +G+ + P +K+ L SSPPSVL+ +N+YDQL
Sbjct: 307 QASGFSTCSSGD-----MAGEVNEDGLESRASPVAKQALHHSSPPSVLE----ENIYDQL 357
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
QAM EAENSRREAF+E+LRR KAEKDAIE+IRRAK +E ++EELK R++ EEAL
Sbjct: 358 EQAMVEAENSRREAFQESLRRSKAEKDAIEAIRRAKEAERSFSEELKLRRDIEEALQAQG 417
Query: 176 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 235
ELE ++ + E+MEEL+I+L+ KSLLE+QIA+S+Q KELE+KII+AVELLQNYKKE+D
Sbjct: 418 KELESLRNKQQEIMEELKISLNHKSLLENQIADSEQVVKELEEKIIAAVELLQNYKKERD 477
Query: 236 ELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYG 295
ELQ+ERD A+K AEEL+K + +S+SH PQ+F++FSF+EIE AT NFDPS+KIGEGGYG
Sbjct: 478 ELQIERDNAIKTAEELKK---KGASTSHTPQYFAEFSFAEIEKATQNFDPSVKIGEGGYG 534
Query: 296 SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEY 355
SIYKG LRH QVAIKMLH S QGP+EFQQE+DILSK+RHPNLVTL+GACPE W L+YEY
Sbjct: 535 SIYKGCLRHTQVAIKMLHSDSFQGPTEFQQEVDILSKLRHPNLVTLIGACPEAWALIYEY 594
Query: 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415
LPNGSLEDRL+C+DN+PPLSWQ RIRIA ELCSVLIFLHS P SIVHGDLKP+NILLDA
Sbjct: 595 LPNGSLEDRLNCRDNTPPLSWQARIRIAAELCSVLIFLHSNNPDSIVHGDLKPSNILLDA 654
Query: 416 NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 475
NF SKLSDFGI R +S + SSN+ T+CCRT PKGTFAYMDPEFL+SGELT KSDVYSFG
Sbjct: 655 NFGSKLSDFGICRVISHDGNSSNSATMCCRTGPKGTFAYMDPEFLSSGELTVKSDVYSFG 714
Query: 476 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRK 535
IILLRLLTG+PA+GITKEVQ+ALD G L LLDPLAGDWPFVQA+QLA +A+RCCEM+RK
Sbjct: 715 IILLRLLTGKPAIGITKEVQHALDQGNLNTLLDPLAGDWPFVQAKQLALMALRCCEMNRK 774
Query: 536 SRPELGKDVWRVLEPMRASCGG-STSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGF 594
SRP+L +VWRVLEPM+ SCG S+S+R+GSEER + PPYF CPIFQE+MQDP VAADGF
Sbjct: 775 SRPDLVSEVWRVLEPMKVSCGASSSSFRVGSEERGQIPPYFICPIFQEIMQDPCVAADGF 834
Query: 595 TYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
TYEAEAL+GWLD GH TSPMTNL L H NLVPN ALRSAIQEWLQQ
Sbjct: 835 TYEAEALRGWLDGGHSTSPMTNLKLGHLNLVPNRALRSAIQEWLQQ 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064033|ref|XP_002301358.1| predicted protein [Populus trichocarpa] gi|222843084|gb|EEE80631.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2260), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/640 (69%), Positives = 503/640 (78%), Gaps = 52/640 (8%)
Query: 1 MKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQ 60
+KLTNP QDL RVRSMN + G LS+PAS
Sbjct: 221 VKLTNPAQDLVRRVRSMNVNGRGGR----------LSTPAS------------------- 251
Query: 61 GSLSSCSSRGVIDVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMA 120
+G + P S+ D S DGS +D LYDQL +AM+
Sbjct: 252 ---------------------PDGGPSTPSSRSDADGSSDEYDDGSTEDPLYDQLEKAMS 290
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 180
+AENSRREAFEEA+RR KAEK A E+ R+AKASE+LY EE KRRKE EE LA K ELER
Sbjct: 291 DAENSRREAFEEAVRRAKAEKYAFEATRKAKASENLYTEESKRRKEVEEELAKEKEELER 350
Query: 181 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 240
+ ++ DEVMEEL+IA DQKSLLE QI ESDQ KELEQKIISAV LLQNYKKEQDELQ E
Sbjct: 351 INRECDEVMEELRIAEDQKSLLEKQIKESDQMVKELEQKIISAVGLLQNYKKEQDELQKE 410
Query: 241 RDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG 300
RD A+KE EELR+S+ EAS + HM QFFS+FS SEIE AT +FDPSLKIGEGGYGSIYKG
Sbjct: 411 RDNALKEVEELRRSQTEASGT-HMSQFFSEFSLSEIEEATQHFDPSLKIGEGGYGSIYKG 469
Query: 301 LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGS 360
+LR QVA+KMLH +SLQGP+EFQQE+D+LSK+RHPNL+TL+GACPE WTL+YEYLPNGS
Sbjct: 470 VLRQTQVAVKMLHSNSLQGPAEFQQEVDVLSKMRHPNLITLIGACPEAWTLIYEYLPNGS 529
Query: 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
LEDRLSC+DNSPPLSWQTRIRIA ELCSVLIFLHS K HSIVHGDLKPANILLD NFV+K
Sbjct: 530 LEDRLSCRDNSPPLSWQTRIRIAAELCSVLIFLHSSKQHSIVHGDLKPANILLDENFVTK 589
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
LSDFGI R L E SSNNT +C RTDPKGTF+YMDPEFL++GELTPKSDVYSFGIILLR
Sbjct: 590 LSDFGICRLLHHKEGSSNNTAIC-RTDPKGTFSYMDPEFLSTGELTPKSDVYSFGIILLR 648
Query: 481 LLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540
LLT R LGITKEVQ LD G LK LLDPLAGDWPFVQAEQLA+LA+RCCEMSRK+RP+L
Sbjct: 649 LLTARQPLGITKEVQCELDKGNLKTLLDPLAGDWPFVQAEQLAHLALRCCEMSRKNRPDL 708
Query: 541 GKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEA 600
+VWRVLEPM+ASCGGS+ ++LGSEE +PP YF CPIFQEVM+DPHVAADG+TYEAEA
Sbjct: 709 LSEVWRVLEPMKASCGGSSFFQLGSEEHFQPPSYFICPIFQEVMRDPHVAADGYTYEAEA 768
Query: 601 LKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
LKGWLDSGH+TSPMTNL LAH++L+PN ALRSAIQEWLQQ
Sbjct: 769 LKGWLDSGHDTSPMTNLKLAHRDLIPNRALRSAIQEWLQQ 808
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772798|emb|CAN67166.1| hypothetical protein VITISV_015820 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2245), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/645 (68%), Positives = 519/645 (80%), Gaps = 21/645 (3%)
Query: 2 KLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSD--ECTTGRSTS 59
KL NP QDL R+M+ + V++S D GG+S+P SR E SSD + + RS S
Sbjct: 251 KLVNPGQDL---PRTMSVPVRI-TVLSSPDGTGGVSAPWSRMGREGSSDYWDGISKRSPS 306
Query: 60 QGSLSSCSSRGVIDVAMIPLIRTEGVSTL--PPSKEDLQ-SSPPSVLDGSVDDNLYDQLA 116
Q S S S G M + +G+ + P +K+ L SSPPSVL+ +N+YDQL
Sbjct: 307 QXSGFSXCSSG----DMAGEVNEDGLESRASPXAKQALHHSSPPSVLE----ENIYDQLE 358
Query: 117 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 176
QAM EAENSRREAF+E+LRR KAEK AIE+IRRAK +E ++EELK R++ EEAL
Sbjct: 359 QAMVEAENSRREAFQESLRRSKAEKXAIEAIRRAKEAERSFSEELKLRRDIEEALQAQGK 418
Query: 177 ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDE 236
ELE ++ + E+MEEL+I+L+ KSLLE+QIA+S+Q KELE+KIISAVELLQNYKKE+DE
Sbjct: 419 ELESLRNKQQEIMEELKISLNHKSLLENQIADSEQVVKELEEKIISAVELLQNYKKERDE 478
Query: 237 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 296
LQ+ERD A+K AEEL+K + +S+SH PQ+F++FSF+EIE AT NFDPS+KIGEGGYGS
Sbjct: 479 LQIERDNAIKTAEELKK---KGASTSHTPQYFAEFSFAEIEKATQNFDPSVKIGEGGYGS 535
Query: 297 IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 356
IYKG LRH QVAIKMLH S QGPSEFQQE+DILSK+RHPNLVTL+GACPE W L+YEYL
Sbjct: 536 IYKGCLRHTQVAIKMLHSDSFQGPSEFQQEVDILSKLRHPNLVTLIGACPEAWALIYEYL 595
Query: 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN 416
PNGSLEDRL+C+DN+PPLSWQ RIRIA ELCSVLIFLHS P SIVHGDLKP+NILLDAN
Sbjct: 596 PNGSLEDRLNCRDNTPPLSWQARIRIAAELCSVLIFLHSNNPDSIVHGDLKPSNILLDAN 655
Query: 417 FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 476
F SKLSDFGI R +S + SSN+ T+CCRT PKGTFAYMDPEFL+SGELT KSDVYSFGI
Sbjct: 656 FGSKLSDFGICRVISHDGNSSNSATMCCRTGPKGTFAYMDPEFLSSGELTVKSDVYSFGI 715
Query: 477 ILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 536
ILLRLLTG+PA+GITKEVQ+ALD G L LLDPLAGDWPFVQA+QLA +A+RC EM+RKS
Sbjct: 716 ILLRLLTGKPAIGITKEVQHALDQGNLNTLLDPLAGDWPFVQAKQLALMALRCXEMNRKS 775
Query: 537 RPELGKDVWRVLEPMRASCGG-STSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFT 595
RP+L +VWRVLEPM+ SCG S+S+R+GSEER + PPYF CPIFQE+MQDP VAADGFT
Sbjct: 776 RPDLVSEVWRVLEPMKVSCGASSSSFRVGSEERGQIPPYFICPIFQEIMQDPCVAADGFT 835
Query: 596 YEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640
YEAEAL+GWLD GH TSPMTNL L H NLVPN ALRSAIQEWLQQ
Sbjct: 836 YEAEALRGWLDGGHSTSPMTNLKLGHLNLVPNRALRSAIQEWLQQ 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568394|ref|XP_003552396.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2216), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/648 (67%), Positives = 510/648 (78%), Gaps = 12/648 (1%)
Query: 3 LTNPVQDLFHRVRSMNFDRNVGNVMT--SQDSIGGLSSPASRSDAEVSSDECTTGRSTSQ 60
LTNP +LF RVRS N D + + MT S + G S+P R EVSSDE S
Sbjct: 239 LTNPALELFRRVRSAN-DGHGASFMTVSSPEDTEGFSTPHDRMGTEVSSDESDRLSRMSP 297
Query: 61 GSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPSK---EDLQ-SSPPSVLDGSVDDNLYD 113
LS+CS V ++A P + +E L S+ EDL SSPPS LDG +DD +Y+
Sbjct: 298 SGLSTCSDSAV-ELAFTPSLINESSENALELTLSRRIIEDLHYSSPPSTLDGGMDDTIYE 356
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
QL QA AEAEN+ A++E +RR KAEKDA E+IR+ KASESLY EEL RK EE L
Sbjct: 357 QLEQARAEAENATLNAYQETVRRRKAEKDAFEAIRKVKASESLYTEELNLRKMTEEKLRK 416
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
K ELE MK D+V EEL +ALDQK LESQIA S+ KELEQKI+SAV+LLQ+YK E
Sbjct: 417 EKEELESMKSLRDKVKEELCLALDQKESLESQIASSELMVKELEQKILSAVDLLQSYKNE 476
Query: 234 QDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGG 293
+DELQM+RD A++EAEELRK + EAS + ++PQ FS+FSFSEI+ AT NF+PS KIGEGG
Sbjct: 477 RDELQMQRDNALREAEELRKKQGEASGT-NVPQLFSEFSFSEIKEATSNFNPSSKIGEGG 535
Query: 294 YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY 353
YGSI+KG+LRH +VAIKML+ S+QGP EFQQE+D+LSK+RHPNL+TL+GACP+ W LVY
Sbjct: 536 YGSIFKGVLRHTEVAIKMLNSDSMQGPLEFQQEVDVLSKLRHPNLITLIGACPDSWALVY 595
Query: 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413
EYLPNGSLEDRL+CK+N+PPLSWQ RIRIA ELCS LIFLHS KPHS+VHGDLKP+NILL
Sbjct: 596 EYLPNGSLEDRLACKNNTPPLSWQARIRIAAELCSALIFLHSSKPHSVVHGDLKPSNILL 655
Query: 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS 473
DAN +SKLSDFGI R LS E SS+NTT RTDPKGTF YMDPEFLASGELTPKSDVYS
Sbjct: 656 DANLISKLSDFGICRILSNCESSSSNTTEFWRTDPKGTFVYMDPEFLASGELTPKSDVYS 715
Query: 474 FGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS 533
FGIILLRLLTGRPALGITKEV+YALDTGKLK+LLDPLAGDWPFVQAEQLA LA+RCC+M+
Sbjct: 716 FGIILLRLLTGRPALGITKEVKYALDTGKLKSLLDPLAGDWPFVQAEQLARLALRCCDMN 775
Query: 534 RKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 593
RKSRP+L DVWRVL+ MR S GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADG
Sbjct: 776 RKSRPDLYSDVWRVLDAMRVSSGGANSFGLSSEGLLQPPSYFICPIFQEVMRDPHVAADG 835
Query: 594 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
FTYEAEA++GWLD GH+ SPMTN LAH NLVPN ALRSAIQ+WLQ H
Sbjct: 836 FTYEAEAIRGWLDGGHDNSPMTNSKLAHHNLVPNRALRSAIQDWLQNH 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507363|ref|XP_003623970.1| U-box domain-containing protein [Medicago truncatula] gi|355498985|gb|AES80188.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/644 (68%), Positives = 512/644 (79%), Gaps = 13/644 (2%)
Query: 8 QDLFHRVRSMNFDRNVGNVMTSQDSIG--GLSSPASRSDAEVSSDECTTGRSTSQGSLSS 65
Q+LF RVRS N D ++ T+ + G S+P +R EVSSDE TS LS+
Sbjct: 256 QELFRRVRSAN-DGMTASITTNSSPVDNEGFSTPRNRRGTEVSSDESDRLSRTSPSGLST 314
Query: 66 CSSRGVIDVAMIPLI---RTEGVSTLPPSK----EDLQS-SPPSVLDGSVDDNLYDQLAQ 117
S ID + P E S L S EDL+ SPPSVLDG V+D LYDQL Q
Sbjct: 315 FSD-STIDPTLTPYSVAESCENASDLTLSHLIKDEDLRHLSPPSVLDGGVNDTLYDQLEQ 373
Query: 118 AMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLE 177
AM+EA N+ R A++E RRGKAEKDAIE+IRRAKASESLY +EL RK EE L K E
Sbjct: 374 AMSEANNATRHAYQETFRRGKAEKDAIEAIRRAKASESLYTDELNLRKMAEEELRKEKEE 433
Query: 178 LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 237
LE + Q D+V EEL++A+D KS LESQ+A S+ +ELEQKIISAVELLQ+YK E+DEL
Sbjct: 434 LESVTSQRDKVNEELRLAVDLKSSLESQLASSEVMIQELEQKIISAVELLQSYKNERDEL 493
Query: 238 QMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSI 297
Q++RD A++EAE+LRK + E SS+ H+PQ FS+FSFSEIE AT NF+PSLKIGEGGYG+I
Sbjct: 494 QIQRDNALREAEDLRKKQGEGSST-HVPQLFSEFSFSEIEEATSNFNPSLKIGEGGYGNI 552
Query: 298 YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLP 357
YKGLLRH +VAIK+LH +S+QGP EFQQE+D+LSK+RHPNL+TL+GACPE W+LVYEYLP
Sbjct: 553 YKGLLRHTEVAIKILHANSMQGPLEFQQEVDVLSKLRHPNLITLIGACPESWSLVYEYLP 612
Query: 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417
NGSLEDRL+CKDN+ PLSWQTRIRIA ELCS LIFLHS KPHSIVHGDLKP+NI+LD N
Sbjct: 613 NGSLEDRLACKDNTHPLSWQTRIRIAAELCSALIFLHSSKPHSIVHGDLKPSNIILDGNL 672
Query: 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 477
VSKLSDFGI R LS E SSNN T +TDPKGTF YMDPEFLASGELTPKSDVYSFGII
Sbjct: 673 VSKLSDFGICRVLSNYENSSNNNTQFWKTDPKGTFVYMDPEFLASGELTPKSDVYSFGII 732
Query: 478 LLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 537
LLRLLTGRPALGITKEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA LA+RCCEM+RKSR
Sbjct: 733 LLRLLTGRPALGITKEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLARLALRCCEMNRKSR 792
Query: 538 PELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYE 597
P+L DVWR+L+ MRAS GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADGFTYE
Sbjct: 793 PDLHSDVWRILDAMRASSGGTNSFGLSSEGPHQPPSYFICPIFQEVMRDPHVAADGFTYE 852
Query: 598 AEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
AEA++GWLDSGH+ SPMTN L+H+NLVPN ALRSAIQ+WLQ H
Sbjct: 853 AEAIRGWLDSGHDASPMTNSTLSHQNLVPNRALRSAIQDWLQSH 896
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|87240964|gb|ABD32822.1| Protein kinase; U box [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2207), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/644 (68%), Positives = 512/644 (79%), Gaps = 13/644 (2%)
Query: 8 QDLFHRVRSMNFDRNVGNVMTSQDSIG--GLSSPASRSDAEVSSDECTTGRSTSQGSLSS 65
Q+LF RVRS N D ++ T+ + G S+P +R EVSSDE TS LS+
Sbjct: 244 QELFRRVRSAN-DGMTASITTNSSPVDNEGFSTPRNRRGTEVSSDESDRLSRTSPSGLST 302
Query: 66 CSSRGVIDVAMIPLI---RTEGVSTLPPSK----EDLQS-SPPSVLDGSVDDNLYDQLAQ 117
S ID + P E S L S EDL+ SPPSVLDG V+D LYDQL Q
Sbjct: 303 FSD-STIDPTLTPYSVAESCENASDLTLSHLIKDEDLRHLSPPSVLDGGVNDTLYDQLEQ 361
Query: 118 AMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLE 177
AM+EA N+ R A++E RRGKAEKDAIE+IRRAKASESLY +EL RK EE L K E
Sbjct: 362 AMSEANNATRHAYQETFRRGKAEKDAIEAIRRAKASESLYTDELNLRKMAEEELRKEKEE 421
Query: 178 LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 237
LE + Q D+V EEL++A+D KS LESQ+A S+ +ELEQKIISAVELLQ+YK E+DEL
Sbjct: 422 LESVTSQRDKVNEELRLAVDLKSSLESQLASSEVMIQELEQKIISAVELLQSYKNERDEL 481
Query: 238 QMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSI 297
Q++RD A++EAE+LRK + E SS+ H+PQ FS+FSFSEIE AT NF+PSLKIGEGGYG+I
Sbjct: 482 QIQRDNALREAEDLRKKQGEGSST-HVPQLFSEFSFSEIEEATSNFNPSLKIGEGGYGNI 540
Query: 298 YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLP 357
YKGLLRH +VAIK+LH +S+QGP EFQQE+D+LSK+RHPNL+TL+GACPE W+LVYEYLP
Sbjct: 541 YKGLLRHTEVAIKILHANSMQGPLEFQQEVDVLSKLRHPNLITLIGACPESWSLVYEYLP 600
Query: 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417
NGSLEDRL+CKDN+ PLSWQTRIRIA ELCS LIFLHS KPHSIVHGDLKP+NI+LD N
Sbjct: 601 NGSLEDRLACKDNTHPLSWQTRIRIAAELCSALIFLHSSKPHSIVHGDLKPSNIILDGNL 660
Query: 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 477
VSKLSDFGI R LS E SSNN T +TDPKGTF YMDPEFLASGELTPKSDVYSFGII
Sbjct: 661 VSKLSDFGICRVLSNYENSSNNNTQFWKTDPKGTFVYMDPEFLASGELTPKSDVYSFGII 720
Query: 478 LLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 537
LLRLLTGRPALGITKEV+YA+DTGKL +LLDPLAGDWPFVQAEQLA LA+RCCEM+RKSR
Sbjct: 721 LLRLLTGRPALGITKEVKYAVDTGKLTSLLDPLAGDWPFVQAEQLARLALRCCEMNRKSR 780
Query: 538 PELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYE 597
P+L DVWR+L+ MRAS GG+ S+ L SE +PP YF CPIFQEVM+DPHVAADGFTYE
Sbjct: 781 PDLHSDVWRILDAMRASSGGTNSFGLSSEGPHQPPSYFICPIFQEVMRDPHVAADGFTYE 840
Query: 598 AEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
AEA++GWLDSGH+ SPMTN L+H+NLVPN ALRSAIQ+WLQ H
Sbjct: 841 AEAIRGWLDSGHDASPMTNSTLSHQNLVPNRALRSAIQDWLQSH 884
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531997|ref|XP_003534561.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/648 (67%), Positives = 507/648 (78%), Gaps = 12/648 (1%)
Query: 3 LTNPVQDLFHRVRSMNFDRNVGNVM--TSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQ 60
+TNP +LF RVRS N D + + M +S + GLS+P R EVSSDE S
Sbjct: 239 ITNPALELFRRVRSAN-DGHGASFMAVSSPEDTEGLSTPRDRMGTEVSSDESDRLSRMSP 297
Query: 61 GSLSSCSSRGVIDVAMIPLI---RTEGVSTLPPSK---EDLQ-SSPPSVLDGSVDDNLYD 113
LS+CS V ++A+ P + +E L S EDL SSPPS LDG +DD +YD
Sbjct: 298 SGLSTCSDSAV-ELALTPSLINESSENALELTLSHLIIEDLHHSSPPSTLDGGMDDTIYD 356
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
QL QA AEAEN+ A++E +RR KAEKDA E+IR+ KASESLYAEEL +RK EE L
Sbjct: 357 QLEQARAEAENATLNAYQETVRRMKAEKDAFEAIRKIKASESLYAEELNQRKMAEEKLRK 416
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
K ELE MK D V EEL++ALDQK+ LESQIA ++ KELEQKI+SAV LLQ+YK E
Sbjct: 417 EKEELENMKSLRDTVKEELRLALDQKASLESQIASTELMIKELEQKILSAVGLLQSYKNE 476
Query: 234 QDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGG 293
+DELQM+ D A++EAEELRK + EAS + H+PQ S+FSFSEI+ AT NF+PS KIGEGG
Sbjct: 477 RDELQMQCDNALREAEELRKKQGEASGT-HVPQLCSEFSFSEIKEATSNFNPSSKIGEGG 535
Query: 294 YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY 353
YGSI+KG+L H +VAIKML+ S+QGP EFQQE+D+LSK+RHPNL+TL+GACP+ W LVY
Sbjct: 536 YGSIFKGVLHHTEVAIKMLNSDSMQGPLEFQQEVDVLSKLRHPNLITLIGACPDSWALVY 595
Query: 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413
EYLPNGSLEDRL+CKDN+PPLSWQ RIRIA ELCS LIFLHS KPHS+VHGDLKP+NILL
Sbjct: 596 EYLPNGSLEDRLACKDNTPPLSWQARIRIAAELCSALIFLHSSKPHSVVHGDLKPSNILL 655
Query: 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS 473
DAN +SKLSDFGI R LS E S +NTT RTDPKGTF YMDPEFLASGELTPKSDVYS
Sbjct: 656 DANLISKLSDFGICRILSNCESSGSNTTEFWRTDPKGTFVYMDPEFLASGELTPKSDVYS 715
Query: 474 FGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS 533
FGIILLRLLTGRPALGIT EV+YALDTGKLK+LLDPLAGDWPFVQAEQLA LA+RCC+M+
Sbjct: 716 FGIILLRLLTGRPALGITMEVKYALDTGKLKSLLDPLAGDWPFVQAEQLARLALRCCDMN 775
Query: 534 RKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 593
RKSRP+L DVWR+L+ MR S GG+ S+ L SE + P YF CPIFQEVM+DPHVAADG
Sbjct: 776 RKSRPDLYSDVWRILDAMRVSSGGANSFGLSSEGLLQSPSYFICPIFQEVMRDPHVAADG 835
Query: 594 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
FTYEAEA++GWLD GH+ SPMTN LAH NLVPN ALRSAIQ+WLQ H
Sbjct: 836 FTYEAEAIRGWLDGGHDNSPMTNSKLAHHNLVPNRALRSAIQDWLQNH 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118487785|gb|ABK95716.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/523 (78%), Positives = 460/523 (87%), Gaps = 2/523 (0%)
Query: 119 MAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLEL 178
M++AENSRREAFEEA+RR KAEK A E+ R+AKASE+LY EE KRRKE EE LA K EL
Sbjct: 1 MSDAENSRREAFEEAVRRAKAEKYAFEATRKAKASENLYTEESKRRKEVEEELAKEKEEL 60
Query: 179 ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQ 238
ER+ ++ DEVMEEL+IA DQKSLLE QI ESDQ KELEQKIISAV LLQNYKKEQDELQ
Sbjct: 61 ERINRECDEVMEELRIAEDQKSLLEKQIKESDQMVKELEQKIISAVGLLQNYKKEQDELQ 120
Query: 239 MERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIY 298
ERD A+KE EELR+S+ EAS + HM QFFS+FS SEIE AT +FDPSLKIGEGGYGSIY
Sbjct: 121 KERDNALKEVEELRRSQTEASGT-HMSQFFSEFSLSEIEEATQHFDPSLKIGEGGYGSIY 179
Query: 299 KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPN 358
KG+LR QVA+KMLH +SLQGP+EFQQE+D+LSK+RHPNL+TL+GACPE WTL+YEYLPN
Sbjct: 180 KGVLRQTQVAVKMLHSNSLQGPAEFQQEVDVLSKMRHPNLITLIGACPEAWTLIYEYLPN 239
Query: 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418
GSLEDRLSC+DNSPPLSWQTRIRIA ELCSVLIFLHS K HSIVHGDLKPANILLD NFV
Sbjct: 240 GSLEDRLSCRDNSPPLSWQTRIRIAAELCSVLIFLHSSKQHSIVHGDLKPANILLDENFV 299
Query: 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478
+KLSDFGI R L E SSNNT +C RTDPKGTF+YMDPEFL++GELTPKSDVYSFGIIL
Sbjct: 300 TKLSDFGICRLLHHKEGSSNNTAIC-RTDPKGTFSYMDPEFLSTGELTPKSDVYSFGIIL 358
Query: 479 LRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
LRLLT R LGITKEVQ LD G LK LLDPLAGDWPFVQAEQLA+LA+RCCEMSRK+RP
Sbjct: 359 LRLLTARQPLGITKEVQCELDKGNLKTLLDPLAGDWPFVQAEQLAHLALRCCEMSRKNRP 418
Query: 539 ELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEA 598
+L +VWRVLEPM+ASCGGS+ ++LGSEE +PP YF CPIFQEVM+DPHVAADG+TYEA
Sbjct: 419 DLLSEVWRVLEPMKASCGGSSFFQLGSEEHFQPPSYFICPIFQEVMRDPHVAADGYTYEA 478
Query: 599 EALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
EALKGWLDSGH+TSPMTNL LAH++L+PN ALRSAIQEWLQQ
Sbjct: 479 EALKGWLDSGHDTSPMTNLKLAHRDLIPNRALRSAIQEWLQQQ 521
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127680|ref|XP_002320134.1| predicted protein [Populus trichocarpa] gi|222860907|gb|EEE98449.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/642 (66%), Positives = 491/642 (76%), Gaps = 65/642 (10%)
Query: 1 MKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQ 60
+KLTNP QDLF ++ + R G + T
Sbjct: 224 VKLTNPAQDLFRKMEGLQLHR--GQMQTG------------------------------- 250
Query: 61 GSLSSCSSRGVIDVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMA 120
+I ++R +GV LP +Q S DGS++D LYDQL QAMA
Sbjct: 251 --------------VLINMMRYQGV--LP----KIQFSHH---DGSIEDPLYDQLEQAMA 287
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-------KEFEEALAN 173
EAENSR EA EEA+R K E+D +E+IR+AKASESLY EE KRR + +E L
Sbjct: 288 EAENSRFEASEEAVRCAKEERDVVEAIRKAKASESLYTEESKRRTVVEEELAKEKEELEK 347
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
ELE++ K+ DEVM EL IA D KSLLE QI ESD+ KELEQKIISAV LLQNYKKE
Sbjct: 348 INKELEKINKEQDEVMGELCIAQDHKSLLEKQIEESDEMVKELEQKIISAVGLLQNYKKE 407
Query: 234 QDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGG 293
+D L RD A+KEAEELR+++ EASS+ HMP+FFSDFSFSEIE ATH+FDPS KIGEGG
Sbjct: 408 RDHLHKGRDYALKEAEELRRNQTEASST-HMPRFFSDFSFSEIEEATHHFDPSRKIGEGG 466
Query: 294 YGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY 353
YG+IYKG+LR QVA+KML +S+QGP+EFQQE+++LSK+RHPNL+TLVGACPE WTL+Y
Sbjct: 467 YGNIYKGVLRQTQVAVKMLDSNSMQGPAEFQQEVNVLSKMRHPNLITLVGACPEAWTLIY 526
Query: 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413
EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS KPHSIVHGDLKPANILL
Sbjct: 527 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSSKPHSIVHGDLKPANILL 586
Query: 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYS 473
D NFV+KLSDFGI R L E SSNNTT+C RTDPKGTF YMDPEF+++GEL+PKSDVYS
Sbjct: 587 DENFVTKLSDFGICRLLDHKEGSSNNTTIC-RTDPKGTFVYMDPEFVSTGELSPKSDVYS 645
Query: 474 FGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS 533
FGIILLRLLT R ALGITKEV+YALD G LK LLDPLAGDWPFVQAE LA++A+RCCEM+
Sbjct: 646 FGIILLRLLTARQALGITKEVRYALDKGTLKTLLDPLAGDWPFVQAEMLAHMALRCCEMN 705
Query: 534 RKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADG 593
RK+RP+L +VWRVLEPM+ASCG S+ +LGSEE +PP YFTCPIFQEVM+DPHVAADG
Sbjct: 706 RKNRPDLASEVWRVLEPMKASCGTSSFSQLGSEEHFQPPSYFTCPIFQEVMRDPHVAADG 765
Query: 594 FTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQ 635
FTYEAEALKGWLDSGH+TSPMTN LAH +L+PN ALRSAIQ
Sbjct: 766 FTYEAEALKGWLDSGHDTSPMTNFKLAHCDLIPNRALRSAIQ 807
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522608|ref|XP_003529938.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2143), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/651 (64%), Positives = 497/651 (76%), Gaps = 30/651 (4%)
Query: 1 MKLTNPVQDLFHRVRSMNFDRNVGNVMTSQDSIGGLSSPASRSDAEVSSDECTTGRSTSQ 60
+KLTNP Q+LF RVRS+N G S AS SD +GRS S
Sbjct: 249 IKLTNPAQELFRRVRSVN--------------DGHRRSLASVSDESYGQ----SGRSPS- 289
Query: 61 GSLSSCSSRGVIDVAMIPLIRTEGVST---------LPPSKEDLQSSPPSVLDGSVDDNL 111
S CS ++ + P + ++G +K S+ PS +DG +DD L
Sbjct: 290 -VFSMCSHSISVEPGLTPNLISDGSENELDLTLNGPFLINKNLHHSASPSEMDGGMDDAL 348
Query: 112 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 171
YDQL QAMAEA NS+R+A++E +RRG AEK+AI++IRRAK +E+LY EELK RKE EEA+
Sbjct: 349 YDQLEQAMAEAVNSKRDAYQETVRRGNAEKNAIDAIRRAKTTENLYKEELKLRKEQEEAV 408
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
+L MK Q D+V EEL++AL Q S LE+QIA ++ KELEQKIISA LLQNYK
Sbjct: 409 EKANEKLNNMKSQTDKVNEELRLALFQNSSLENQIASTELMIKELEQKIISAENLLQNYK 468
Query: 232 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGE 291
E D+LQ++RD AV EAEE R+ + EASSS+H Q FS+FSF EI+ AT NF+PS KIGE
Sbjct: 469 DELDDLQIQRDIAVGEAEEFRRKQWEASSSAHKLQCFSEFSFQEIKEATSNFNPSQKIGE 528
Query: 292 GGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL 351
GGYGSI+KG+LRH +VAIKML+ S QGP EFQQE+++LSK+RHPN++TL+GACPE WTL
Sbjct: 529 GGYGSIFKGILRHAEVAIKMLNRDSTQGPEEFQQEVEVLSKLRHPNIITLIGACPESWTL 588
Query: 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411
VYEYLPNGSLEDRL+CKDNSPPLSWQTRIRIATELCS LIFLHS KPHSI HGDLKPANI
Sbjct: 589 VYEYLPNGSLEDRLNCKDNSPPLSWQTRIRIATELCSALIFLHSNKPHSIAHGDLKPANI 648
Query: 412 LLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 470
LLDAN VSKLSDFGI R LS + SSN+TT RTDPKGTF Y+DPEFLASGELTPKSD
Sbjct: 649 LLDANLVSKLSDFGICRILLSCQDSSSNSTTQFWRTDPKGTFVYLDPEFLASGELTPKSD 708
Query: 471 VYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCC 530
VYSFGIILLRL+TG+PALGI KEVQYALD GKLK++LDP AGDWPF+ AE+L LA+RCC
Sbjct: 709 VYSFGIILLRLMTGKPALGIIKEVQYALDAGKLKSILDPFAGDWPFMLAEELVRLALRCC 768
Query: 531 EMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVA 590
EM+RKSRP+L DVWR+LEPMRAS G + +++LGS+ C+PPPYF CPIF EVMQDPHVA
Sbjct: 769 EMNRKSRPDLYPDVWRILEPMRASSGVTNTFQLGSQGLCQPPPYFICPIFLEVMQDPHVA 828
Query: 591 ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
ADGFTYEAEA++ WL+SGH+TSP TN LAH++LVPN LR AIQ WLQ H
Sbjct: 829 ADGFTYEAEAIREWLESGHDTSPRTNSKLAHRHLVPNHTLRHAIQNWLQSH 879
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GUH1 | PUB33_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6654 | 0.8252 | 0.6342 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 641 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-22 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 6e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-09 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 9e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-08 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 9e-07 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 2e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 3e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 6e-06 | |
| COG1579 | 239 | COG1579, COG1579, Zn-ribbon protein, possibly nucl | 6e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-06 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 1e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| COG1340 | 294 | COG1340, COG1340, Uncharacterized archaeal coiled- | 1e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 2e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-05 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 3e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 5e-05 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 5e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 5e-05 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 5e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-05 | |
| PRK12704 | 520 | PRK12704, PRK12704, phosphodiesterase; Provisional | 5e-05 | |
| COG1842 | 225 | COG1842, PspA, Phage shock protein A (IM30), suppr | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 7e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 7e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| pfam04012 | 220 | pfam04012, PspA_IM30, PspA/IM30 family | 7e-05 | |
| pfam13868 | 349 | pfam13868, Trichoplein, Tumour suppressor, Mitosta | 7e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-05 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-05 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 1e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| pfam12128 | 1198 | pfam12128, DUF3584, Protein of unknown function (D | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| pfam09731 | 493 | pfam09731, Mitofilin, Mitochondrial inner membrane | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| TIGR03319 | 514 | TIGR03319, RNase_Y, ribonuclease Y | 3e-04 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 4e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 4e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| COG4487 | 438 | COG4487, COG4487, Uncharacterized protein conserve | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| pfam13863 | 126 | pfam13863, DUF4200, Domain of unknown function (DU | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 6e-04 | |
| PRK03918 | 880 | PRK03918, PRK03918, chromosome segregation protein | 6e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 7e-04 | |
| pfam13949 | 292 | pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain bi | 7e-04 | |
| pfam00430 | 132 | pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | 7e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 8e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 8e-04 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.001 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.001 | |
| pfam13514 | 1118 | pfam13514, AAA_27, AAA domain | 0.001 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| COG4477 | 570 | COG4477, EzrA, Negative regulator of septation rin | 0.001 | |
| PRK12705 | 508 | PRK12705, PRK12705, hypothetical protein; Provisio | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| pfam02463 | 1162 | pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | 0.002 | |
| pfam00769 | 244 | pfam00769, ERM, Ezrin/radixin/moesin family | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| PRK14139 | 185 | PRK14139, PRK14139, heat shock protein GrpE; Provi | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| COG4372 | 499 | COG4372, COG4372, Uncharacterized protein conserve | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.003 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.003 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.003 | |
| PRK12704 | 520 | PRK12704, PRK12704, phosphodiesterase; Provisional | 0.003 | |
| pfam01576 | 859 | pfam01576, Myosin_tail_1, Myosin tail | 0.003 | |
| pfam12037 | 276 | pfam12037, DUF3523, Domain of unknown function (DU | 0.003 | |
| PRK02224 | 880 | PRK02224, PRK02224, chromosome segregation protein | 0.003 | |
| COG0711 | 161 | COG0711, AtpF, F0F1-type ATP synthase, subunit b [ | 0.003 | |
| COG4026 | 290 | COG4026, COG4026, Uncharacterized protein containi | 0.003 | |
| COG0419 | 908 | COG0419, SbcC, ATPase involved in DNA repair [DNA | 0.004 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.004 | |
| COG3096 | 1480 | COG3096, MukB, Uncharacterized protein involved in | 0.004 | |
| COG2433 | 652 | COG2433, COG2433, Uncharacterized conserved protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 7e-52
Identities = 79/200 (39%), Positives = 110/200 (55%), Gaps = 20/200 (10%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC 345
+GEGG+G++Y + +VAIK++ E +EI+IL K+ HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
LV EY GSL+D L K+N LS +RI ++ L +LHS + I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 404 GDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 461
DLKP NILLD+ N KL+DFG+S+ L+ + S T+ GT AYM PE L
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIV------GTPAYMAPEVLLG 167
Query: 462 SGELTPKSDVYSFGIILLRL 481
G + KSD++S G+IL L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 83/268 (30%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
K+GEG +G +Y + VAIK++ + +EI IL K++HPN+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 345 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+++ LV EY G L D L LS ++ S L +LHS I
Sbjct: 66 FEDEDKLY-LVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGI 118
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
VH DLKP NILLD + KL+DFG++R L E TT GT YM PE L
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFV------GTPEYMAPEVLL 169
Query: 462 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 520
D++S G+IL LLTG+ P G + ++ GK K P D
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDIS----P 225
Query: 521 QLANLAMRCCEMSRKSRP---ELGKDVW 545
+ +L + + R E + +
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 98/273 (35%), Positives = 137/273 (50%), Gaps = 34/273 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 342
K+G G +G++YK + VA+K+L S + + Q EI IL ++ HPN+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 343 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
A ++ LV EY G L D LS PLS +IA ++ L +LHS +
Sbjct: 65 DAFEDKDHLY-LVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
I+H DLKP NILLD N V K++DFG+++ L ++ SS+ TT GT YM PE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFV------GTPWYMAPEV 169
Query: 460 LASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFV 517
L G PK DV+S G+IL LLTG+P G Q L + L PL D P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---RRILGPPLEFDEPKW 226
Query: 518 --QAEQLANLAMRCCEMSRKSRP---ELGKDVW 545
+E+ +L +C RP E+ + W
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 32/263 (12%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 340
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G C E +V EY+ G L L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESKN- 122
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+H DL N L+ N V K+SDFG+SR L ++ + K +M PE
Sbjct: 123 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-------YRKRGGKLPIRWMAPE 173
Query: 459 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 515
L G+ T KSDV+SFG++L + T +P G++ +EV L G L P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG---YRLPQ-----P 225
Query: 516 FVQAEQLANLAMRCCEMSRKSRP 538
+L +L ++C + RP
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 6e-44
Identities = 87/264 (32%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 340
K+GEG +G +YKG L+ ++VA+K L S Q EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTRIRIATELCSVLIFLHSCK 397
L+G C E +V EY+P G L D L + N P LS + A ++ + +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+H DL N L+ N V K+SDFG+SR L ++ K +M P
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-------VKGGKLPIRWMAP 173
Query: 458 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDW 514
E L G+ T KSDV+SFG++L + T P G++ EV L G L
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG---YRLPK----- 225
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP 538
P +L L ++C + RP
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 35/265 (13%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 340
K+GEG +G +YKG L+ +VA+K L S + EF +E I+ K+ HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G C E +V EY+P G L D L + + L+ + +++A ++ + +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 456
+ VH DL N L+ N V K+SDFG+SR + +++ R G +M
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY--------RKRGGGKLPIKWMA 172
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGD 513
PE L G+ T KSDV+SFG++L + T +P G++ +EV L+ G L
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPENC 229
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP 538
+L L ++C + RP
Sbjct: 230 PD-----ELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 7e-41
Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
K+GEG +G +YKG L+ +VA+K L S + +F +E ++ K+ HPN+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 342 VGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATELCSVLIFL 393
+G C E LV EY+ G L D L LS + + A ++ + +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
S K VH DL N L+ + V K+SDFG+SR + ++ P
Sbjct: 122 ASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD---YYRKKTGGKLP---IR 172
Query: 454 YMDPEFLASGELTPKSDVYSFGIIL 478
+M PE L G T KSDV+SFG++L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
F+ KIG+GG+G +YK + VAIK++ S + + EI IL K +HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 341 LVGA--CP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G+ E+W +V E+ GSL+D L K + L+ + EL L +LHS
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS-- 116
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ I+H D+K ANILL ++ KL DFG+S LS + + NT + GT +M P
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMV-------GTPYWMAP 166
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E + K+D++S GI + L G+P
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 288 KIGEGGYGSIYKGLLRHM--QVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
+G G +GS+Y L + +A+K L S + ++EI ILS ++HPN+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 344 AC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ + EY+ GSL L L + ++ L +LHS +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS---N 120
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
IVH D+K ANIL+D++ V KL+DFG ++ L E ++ +GT +M PE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV------RGTPYWMAPEV 174
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
+ E +D++S G ++ + TG+P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-34
Identities = 88/269 (32%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP-NLVTL-- 341
K+GEG +G +Y VA+K+L E F +EI IL+ + HP N+V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 342 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
LV EY+ GSLED L PLS + I ++ S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 402 VHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+H D+KP NILLD + V KL DFG+++ L +S+ L + GT YM PE L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP--STSVGTPGYMAPEVL 180
Query: 461 ASGEL---TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------LKNLLDPLA 511
L + SD++S GI L LLTG P K T K +L PL+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 512 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 540
P + ++ ++L + K+R
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+IG+G +G +Y L+R +K L S + + E+ IL K+ HPN++
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 342 VGACPEVWT------LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLH 394
E + +V EY G L ++ K P + + +LC L +LH
Sbjct: 65 Y----ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S K I+H D+KP NI L +N + KL DFGIS+ LS + T+ GT Y
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVV------GTPYY 169
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487
+ PE + KSD++S G +L L T +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
+G+G G +YK + A+K +H + + +E+ L P +V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 345 C--PEVWTLVYEYLPNGSLEDRL--SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
++V EY+ GSL D L K P L+ IA ++ L +LH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKRH 120
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
I+H D+KP+N+L+++ K++DFGIS+ L NT C T GT YM PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLE-------NTLDQCNTF-VGTVTYMSPERI 172
Query: 461 ASGELTPKSDVYSFGIILLRLLTGR 485
+ +D++S G+ LL G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 343
IG G +G +YKGL VAIK + ++ + QEID+L ++HPN+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 344 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ +L + EY NGSL + P ++ L +LH +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHE---QGV 120
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H D+K ANIL + V KL+DFG++ L+ GT +M PE +
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--------DASVVGTPYWMAPEVIE 172
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
+ SD++S G ++ LLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 345
K+G G +G ++ G +VA+K L P ++ P F QE I+ K+RH LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 346 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E +V EY+ GSL D L L + +A ++ + +L S + +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL NIL+ N V K++DFG++R + +E R K + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDE-------YTAREGAKFPIKWTAPEAANYGR 180
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 501
T KSDV+SFGI+L ++T GR P G+T EV ++ G
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKI-R 334
+F IGEG + ++ + + AIK+L + + E ++L+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 335 HPNLVTLVGACPEVWT--------LVYEYLPNGSLED---RLSCKDNSPPLSWQTRIR-I 382
HP ++ L +T V EY PNG L + D + R
Sbjct: 61 HPGIIKLY------YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-------EKCTRFY 107
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L +LHS I+H DLKP NILLD + K++DFG ++ L N +N
Sbjct: 108 AAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 443 CCRTDPK------------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
D + GT Y+ PE L SD+++ G I+ ++LTG+P
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 73/208 (35%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 289 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G +G + L+R A+K+L + E + E +ILS+I HP +V L
Sbjct: 1 LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 342 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKP 398
A E LV EY P G L LS S + R R A E+ L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLHS--- 111
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
I++ DLKP NILLDA+ KL+DFG+++ LS S T C GT Y+ PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC------GTPEYLAPE 163
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L D +S G++L +LTG+P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 288 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G +++GL + VA+K L P ++ P +F E I+ K+RHP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 347 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E +V E + GSL + L L I +A ++ S + +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL N+L+ N + K++DFG++R + ++ + R K + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA-------REGAKFPIKWTAPEAALYNR 180
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTG 501
+ KSDV+SFGI+L ++T GR P G+T EV +D G
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 18/192 (9%)
Query: 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEV 348
IG+G +G + G R +VA+K L S + F E +++ +RHPNLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 349 WTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406
L V EY+ GSL D L + + ++ ++ A ++C + +L VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHRDL 128
Query: 407 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 466
N+L+ + V+K+SDFG+++ SQ + S K + PE L + +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQGQDSG-----------KLPVKWTAPEALREKKFS 177
Query: 467 PKSDVYSFGIIL 478
KSDV+SFGI+L
Sbjct: 178 TKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 50/222 (22%)
Query: 289 IGEGGYGSIYKGLL------RHMQ-VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 340
+GEG +G +YKG L VAIK L + EF+QE +++S ++HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSP---------------PLSWQTRIRIA 383
L+G C + +++EYL +G L + L NSP L + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLV--RNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS------ 437
++ + + +L S H VH DL N L+ K+SDFG+SR +I S
Sbjct: 131 IQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR-----DIYSADYYRV 182
Query: 438 -NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478
+ + L R +M PE + G+ T +SD++SFG++L
Sbjct: 183 QSKSLLPVR--------WMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVG 343
KIG G +G +Y L +A+K + + E E+ +L ++HPNLV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 344 ACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKP 398
EV + EY G+LE+ L + IR+ T +L L +LHS
Sbjct: 67 V--EVHREKVYIFMEYCSGGTLEELLEHGRILD----EHVIRVYTLQLLEGLAYLHSHG- 119
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT--DPKGTFAYMD 456
IVH D+KPANI LD N V KL DFG + NNTT GT AYM
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 457 PEFLASGELTPK---SDVYSFGIILLRLLTGRP 486
PE + G+ +D++S G ++L + TG+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ----QEIDILSKIRHPNLVTL 341
++G G G + K L R +A+K + L+ Q +E+DIL K P +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 342 VGAC---PEVWTLVYEYLPNGSLEDRL-SCKDNSP--PLSWQTRIRIATELCSVLIFLHS 395
GA ++ + EY+ GSL+ L + P L +IA + L +LH
Sbjct: 65 YGAFYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H I+H D+KP+NIL+++ KL DFG+S L N ++ GT +YM
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-NSLAKTFV---------GTSSYM 166
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGR 485
PE + + + KSD++S G+ L+ L TGR
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
I +G YG ++ L + AIK++ + ++ Q E DILS+ + P +V L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 342 VGACPEVWTL--VYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
+ L V EYLP G SL + + D RI IA E+ L +LHS
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIA-EIVLALEYLHS- 111
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCCRTDPKGTFAY 454
+ I+H DLKP NIL+D+N KL+DFG+S+ +++ R GT Y
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI--VGTPDY 167
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ PE + + D +S G IL L G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 51/249 (20%)
Query: 289 IGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVT 340
+GEG +G ++ G H VA+K L + + F++E ++L+ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRIATE 385
G C E +V+EY+ +G L L + + P L+ ++IA +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL--RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN------ 439
+ S +++L S VH DL N L+ + V K+ DFG+SR ++ + +
Sbjct: 131 IASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGG 182
Query: 440 -TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQ 495
T L R +M PE + + T +SDV+SFG++L + T G+ P G++ +EV
Sbjct: 183 HTMLPIR--------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234
Query: 496 YALDTGKLK 504
+ G+L
Sbjct: 235 ECITQGRLL 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 288 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
K+G+G +G + +G + + VA+K L L +F +E I+ + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 342 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G V T +V E P GSL DRL KD T A ++ + + +L S
Sbjct: 62 YGV---VLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE---ISSNNTTLCCRTDPKGTFAY 454
+H DL NILL ++ K+ DFG+ R L QNE + + K FA+
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL--------KVPFAW 166
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLT 483
PE L + + SDV+ FG+ L + T
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 30/215 (13%)
Query: 288 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNL 338
++GEG +G + R+ QVA+K L+ Q S+F++EI+IL + H N+
Sbjct: 11 QLGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 339 VTLVGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
V G C + L+ EYLP+GSL D L + + ++ + + ++++C + +L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 452
S + +H DL NIL+++ + K+SDFG+++ L +++ P F
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP----GESP--IF 177
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 486
Y PE L + + + SDV+SFG+ L L T G P
Sbjct: 178 WYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
K+GEG YG +YK R + VA+K + + +G PS +EI +L +++HPN+V L
Sbjct: 6 KLGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V LV+EY L+ L PLS I +L L + HS H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE- 458
I+H DLKP NIL++ + V KL+DFG++R T T T Y PE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA-----FGIPLRTY---THEVVTLWYRAPEI 169
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L S + D++S G I ++TG+P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 25/256 (9%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G ++ G H +VAIK L S+ P F E +++ +++HP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 347 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 405
E ++ EY+ NGSL D L + L+ I +A ++ + F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 406 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 465
L+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTF 180
Query: 466 TPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQL 522
T KSDV+SFGI+L ++T GR P G+T EV L+ G P + P E+L
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----PRPDNCP----EEL 232
Query: 523 ANLAMRCCEMSRKSRP 538
L C + + RP
Sbjct: 233 YELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 289 IGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 347
+G G +G ++ G R + VAIKM+ ++ +F +E ++ K+ HPNLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 348 VWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 405
+ V EY+ NG L + L ++ L + + + +++C + +L S + +H D
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRD 125
Query: 406 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 465
L N L+ + V K+SDFG++R++ ++ +S+ T K + PE
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT-------KFPVKWAPPEVFDYSRF 178
Query: 466 TPKSDVYSFGIILLRLLTG 484
+ KSDV+SFG+++ + +
Sbjct: 179 SSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 31/265 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVT 340
IG+G +G++ K +R + K + ++ E QQ E++IL +++HPN+V
Sbjct: 7 TIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVR 63
Query: 341 ----LVGACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLH- 394
++ + +V EY G L + CK + + RI T+L L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 395 -SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
S ++++H DLKPANI LDAN KL DFG+++ L S+ GT
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYV-----GTPY 175
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513
YM PE L KSD++S G ++ L P ++Q A K+K
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIKEGKFR---R 229
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP 538
P+ + +L + + RP
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 289 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
+G G +GS+ KG+ ++VA+K L H G EF +E +++++ HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 343 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
G C E LV E P G L L K + +A ++ + +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYL--KKR-REIPVSDLKELAHQVAMGMAYLESKH---F 116
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
VH DL N+LL +K+SDFG+SR L + + T + + PE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 462 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 502
G+ + KSDV+S+G+ L + +P + EV L++G+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-23
Identities = 82/257 (31%), Positives = 125/257 (48%), Gaps = 25/257 (9%)
Query: 287 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 346 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 126
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521
T KSDV+SFGI+L L T GR P G + +EV ++ G P + P E
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----PCPPECP----ES 231
Query: 522 LANLAMRCCEMSRKSRP 538
L +L +C + RP
Sbjct: 232 LHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G +++GL + ++VAIK+L L +FQ+E+ L ++RH +L++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 347 E---VWTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V+ ++ E + GSL L + L I +A ++ + +L
Sbjct: 73 VGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE---Q 123
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+ +H DL NIL+ + V K++DFG++R + ++ S++ K + + PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--------KIPYKWTAPEA 175
Query: 460 LASGELTPKSDVYSFGIILLRLLT 483
+ G + KSDV+SFGI+L + T
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-22
Identities = 36/64 (56%), Positives = 45/64 (70%), Gaps = 1/64 (1%)
Query: 574 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSA 633
F CPI EVM+DP + G TYE A++ WL S H T P+T PL H++L+PNLAL+SA
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSA 59
Query: 634 IQEW 637
IQEW
Sbjct: 60 IQEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
KIGEG G +YK R +VAIK + L+ ++ EI I+ +HPN+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 344 AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI-RIATELCSVLIFLHSCKPH 399
+ E+W +V EY+ GSL D ++ N ++ + +I + E+ L +LHS
Sbjct: 83 SYLVGDELW-VVMEYMDGGSLTDIITQ--NFVRMN-EPQIAYVCREVLQGLEYLHS---Q 135
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+++H D+K NILL + KL+DFG + L++ E S N+ + GT +M PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-EKSKRNSVV-------GTPYWMAPEV 187
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
+ + PK D++S GI+ + + G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 50/271 (18%)
Query: 289 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
IG G +G + +G L+ + VAIK L S + +F E I+ + HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 343 GACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G + + + EY+ NGSL+ L ++N + + + + S + +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSE---MN 126
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD---- 456
VH DL NIL+++N V K+SDFG+SR L D + T+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---------------DSEATYTTKGGKIP 171
Query: 457 -----PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 507
PE +A + T SDV+SFGI++ +++ RP ++ ++V A++ G +L
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---- 227
Query: 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
P D P + L + C + R RP
Sbjct: 228 -PPPMDCPSALYQ----LMLDCWQKDRNERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 341
+IGEG +G ++K + + VA+K + L+G P++ +EI L +HP +V L
Sbjct: 7 RIGEGAHGIVFKA--KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 342 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ + LV EY+P L + L +D PL L + ++H+ +
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
I+H DLKPAN+L+ A+ V K++DFG++R S+ E + T Y PE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL-------YSHQVATRWYRAPEL 171
Query: 460 L-ASGELTPKSDVYSFGIILLRLLTGRP 486
L + + P D+++ G I LL G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 43/314 (13%)
Query: 266 QFF-SDFSFS-EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS 321
QFF S S S I + I G G+ YKG + MQ +K ++ + S
Sbjct: 673 QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS 732
Query: 322 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 379
E + K++HPN+V L+G C + L++EY+ +L + L LSW+ R
Sbjct: 733 EIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782
Query: 380 IRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438
+IA + L FLH C P ++V G+L P I++D L S
Sbjct: 783 RKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHL-------------RLSL 828
Query: 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR----PALG----I 490
LC T + AY+ PE + ++T KSD+Y FG+IL+ LLTG+ G I
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 491 TKEVQYALDTGKLKNLLDP-LAGDWPFVQAE--QLANLAMRCCEMSRKSRPELGKDVWRV 547
+ +Y L +DP + GD Q E ++ NLA+ C +RP DV +
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKT 947
Query: 548 LEPMRASCGGSTSY 561
LE S +
Sbjct: 948 LESASRSSSSCVTG 961
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 35/216 (16%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 338
FD K+GEG YGS+YK + H + VAIK++ E +EI IL + P +
Sbjct: 5 FDILEKLGEGSYGSVYKAI--HKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 339 VTLVGAC---PEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIATELCSV---L 390
V G+ ++W +V EY GS+ D +++ K L+ + IA L L
Sbjct: 61 VKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNK----TLTEE---EIAAILYQTLKGL 112
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+LHS + +H D+K NILL+ +KL+DFG+S L + ++ NT + G
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVI-------G 161
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T +M PE + K+D++S GI + + G+P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-22
Identities = 73/220 (33%), Positives = 113/220 (51%), Gaps = 17/220 (7%)
Query: 287 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+K+G+G +G ++ G +VAIK L P ++ P F QE I+ K+RH LV L
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 346 PE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E +V E++ GSL D L D L + +A ++ + ++ + +H
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 179
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALG-ITKEVQYALDTG 501
T KSDV+SFGI+L L+T GR P G + +EV ++ G
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 27/229 (11%)
Query: 289 IGEGGYGSIYKG-------LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+G G +GS+Y+G +V++ + + +QEI +LSK++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 342 VGACPEVWTL-VY-EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE-LCSVLIFLHSCKP 398
+G E L ++ E +P GSL L + P + IR+ T + L +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQILLGLEYLHD--- 120
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ VH D+K ANIL+D N V KL+DFG+++ ++ + KG+ +M PE
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSF----KGSPYWMAPE 171
Query: 459 FLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 506
+A G +D++S G +L + TG+P + V G+ K L
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 64/211 (30%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIK-MLHPHSLQGPSEF-QQEIDILSKIRHPNLVTLVG 343
+GEG YG + K + VAIK + + +E+ +L ++RH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPP-----LSWQTRIRIATELCSVLIFLHSC 396
A LV+EY+ LE + PP WQ L + + HS
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS- 118
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
H+I+H D+KP NIL+ + V KL DFG +R L + L TD T Y
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR----PASPL---TDYVATRWYRA 169
Query: 457 PEFL-ASGELTPKSDVYSFGIILLRLLTGRP 486
PE L DV++ G I+ LL G P
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLH----PHSLQGPSEFQQEIDILSKIRHPNLVT- 340
IG G +Y L + +VAIK + S+ E ++E+ +S+ HPN+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCNHPNVVKY 64
Query: 341 ----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL---IFL 393
+VG E+W LV YL GSL D + +S P IAT L VL +L
Sbjct: 65 YTSFVVGD--ELW-LVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
HS + +H D+K NILL + K++DFG+S L+ + R GT
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----RKTFVGTPC 171
Query: 454 YMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRP 486
+M PE + K+D++SFGI + L TG
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 73/224 (32%), Positives = 99/224 (44%), Gaps = 41/224 (18%)
Query: 289 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 345
IGEG YG +YK + VAIK++ E ++E +IL K HPN+ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 346 ---------PEVWTLVYEYLPNGSLED---RLSCKDNSPPLSWQTRIRIA---TELCSVL 390
++W LV E GS+ D L K W IA E L
Sbjct: 73 IKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+LH + ++H D+K NILL N KL DFG+S L + + NT + G
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI-------G 175
Query: 451 TFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 489
T +M PE +A E +SDV+S GI + L G+P L
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 16/196 (8%)
Query: 286 SLKIGEGGYGSIYKGL-LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
+IG G +G ++ G L +VAIK + ++ +F +E ++ K+ HP LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 345 CPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
C E LV+E++ +G L D L + S +T + + ++C + +L S +++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLES---SNVI 122
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWSSPEVFSF 175
Query: 463 GELTPKSDVYSFGIIL 478
+ + KSDV+SFG+++
Sbjct: 176 SKYSSKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 59/203 (29%), Positives = 107/203 (52%), Gaps = 22/203 (10%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNS--PPLSWQTRIRIATELCSVLIFLHSCKPHS 400
P + ++ E++ G+L D L + + + +AT++ S + +L +
Sbjct: 72 TREPPFY-IITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KN 124
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+H DL N L+ N + K++DFG+SR ++ + T K + PE L
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAKFPIKWTAPESL 177
Query: 461 ASGELTPKSDVYSFGIILLRLLT 483
A + + KSDV++FG++L + T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIK-MLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVG 343
KIGEG YG +YK L VAIK + +G P +EI +L ++ HPN++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL- 64
Query: 344 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSC 396
+V+ LV+E++ + L + KD L ++ I+ +L L F HS
Sbjct: 65 ---DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLP-ESLIKSYLYQLLQGLAFCHS- 116
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
H I+H DLKP N+L++ V KL+DFG++R S T T Y
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLAR-----SFGSPVRPY---THYVVTRWYRA 166
Query: 457 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
PE L + D++S G I LL+ RP
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 288 KIGEGGYGSIYKGL-LRHMQ-VAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVG 343
+IGEG YG +YK + + VA+K + + + P +EI +L K+RHPN+V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK- 64
Query: 344 ACPEVWT--------LVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFL 393
E+ T +V+EY+ + L L + + Q + +L L +L
Sbjct: 65 ---EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES---QIK-CYMKQLLEGLQYL 116
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
HS I+H D+K +NIL++ + V KL+DFG++R + S++ T T
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVI------TLW 166
Query: 454 YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPAL 488
Y PE L + P+ D++S G IL L G+P
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 78/256 (30%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G ++ G + +VA+K L P ++ P F +E I+ K+RH LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 347 E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 405
E +V EY+ GSL D L + L + +A ++ + + ++ + +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 406 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 465
L+ ANIL+ V K++DFG++R + NE ++ R K + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 180
Query: 466 TPKSDVYSFGIILLRLLT-GR-PALGI-TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 522
T KSDV+SFGI+L L+T GR P G+ +EV ++ G P D P L
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----SL 232
Query: 523 ANLAMRCCEMSRKSRP 538
L ++C + + RP
Sbjct: 233 HELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
IG+G +G +YK + + VAIK++ + + QQEI LS+ R P + G+
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 345 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ L + EY GS D L L I E+ L +LH +
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+K ANILL KL+DFG+S L+ +S NT + GT +M PE +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTST-MSKRNTFV-------GTPFWMAPEVIKQ 172
Query: 463 GELTPKSDVYSFGIILLRLLTGRPAL 488
K+D++S GI + L G P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 289 IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 345
+G+G +G +YK + + A K++ S + +F EIDILS+ +HPN+V L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
++W L+ E+ G+L D + + Q R + ++ L FLHS H ++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-- 461
DLK NILL + KL+DFG+S + N +TL R GT +M PE +A
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS--------AKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 462 ---SGELTPKSDVYSFGIILLRLLTGRP 486
K+D++S GI L+ L P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
KIG+G +G +YKG+L+ + +VA+K P L+ +F QE +IL + HPN+V L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIG 59
Query: 344 ACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
C + + V E +P GSL L K N + ++ + + + + +L S +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLES---KNC 114
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H DL N L+ N V K+SDFG+SR + ++ + P + PE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL---KQIP---IKWTAPEALN 168
Query: 462 SGELTPKSDVYSFGIILLRLLTG 484
G T +SDV+S+GI+L +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ------EIDILSKIRHPNL 338
+G G +G + L+RH A+K+L + + +Q E IL IRHP L
Sbjct: 9 LGTGSFGRVM--LVRHKGSGKYYALKILSKAKI---VKLKQVEHVLNEKRILQSIRHPFL 63
Query: 339 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
V L G+ + L V EY+P G L L K P R A ++ L +LHS
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEP-VARFYAA-QVVLALEYLHSL 120
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYM 455
IV+ DLKP N+LLD++ K++DFG ++ + T TLC GT Y+
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRV------KGRTYTLC------GTPEYL 165
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE + S D ++ GI++ +L G P
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 47/275 (17%)
Query: 289 IGEGGYGSIYKGLLRH-------MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 340
+G+G +G +Y+GL + +VAIK ++ + S++ EF E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 341 LVGAC----PEVWTLVYEYLPNGSLEDRL-SCK------DNSPPLSWQTRIRIATELCSV 389
L+G P + +V E + G L+ L S + P + Q I++A E+
Sbjct: 74 LLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
+ +L + K VH DL N ++ + K+ DFG++R + + + R K
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY--------RKGGK 180
Query: 450 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE--VQYALDTGKL 503
G +M PE L G T KSDV+SFG++L + T +P G++ E +++ +D G L
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 504 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
D P ++L L C + + K RP
Sbjct: 241 ---------DLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 289 IGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
IG G +G + +G L+ + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 343 G----ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G + P + ++ E++ NG+L+ L D T I++ L + +
Sbjct: 72 GVVTKSRPVM--IITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLSE 124
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ VH DL NIL+++N V K+SDFG+SRFL + +++ T K + PE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPTYTSSLGGKIPIRWTAPE 181
Query: 459 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWP 515
+A + T SDV+S+GI++ +++ RP ++ ++V A++ ++ P D P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYRLPPPMDCP 237
Query: 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544
L L + C + R +RP+ G+ V
Sbjct: 238 TA----LHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 29/266 (10%)
Query: 289 IGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQGPSEFQQ--------EIDILSKIRHP 336
IG+G YG +Y L M V L Q+ EI+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 337 NLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
N+V +G E ++ EY+P GS+ SC Q ++ L +LH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIG---SCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S I+H DLK N+L+DA+ + K+SDFGIS+ + N ++ +G+ +
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM------QGSVFW 176
Query: 455 MDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512
M PE + S + K D++S G ++L + GR + + G ++ P+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-APPIPP 235
Query: 513 DWPFVQAEQLANLAMRCCEMSRKSRP 538
D + + C ++ +RP
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 306 QVAIKMLHP----HSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNG 359
VA+K+L P ++ + +F +E+ ILS++ PN+ L+G C ++ EY+ NG
Sbjct: 48 LVAVKVLRPDASDNARE---DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 360 SLEDRLS--------CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411
L L NS LS+ T + +AT++ S + +L S + VH DL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161
Query: 412 LLDANFVSKLSDFGISRFLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
L+ N+ K++DFG+SR L ++ L R +M E + G+ T KS
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKS 213
Query: 470 DVYSFGIILLRLLT 483
DV++FG+ L +LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 56/299 (18%)
Query: 289 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNL 338
+GEG +G + K ++ VA+KML ++ SE + E ++L ++ HP++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHV 65
Query: 339 VTLVGACP--EVWTLVYEYLPNGSLE------------------DRLSCKDNSP---PLS 375
+ L GAC L+ EY GSL +R S ++P L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 376 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435
I A ++ + +L K +VH DL N+L+ K+SDFG+SR + + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED- 181
Query: 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKE 493
+ R+ + +M E L T +SDV+SFG++L ++T G P GI E
Sbjct: 182 -----SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 494 VQYALDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
+L NLL + P +E++ NL + C + RP D+ + LE M
Sbjct: 237 --------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF-ADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 81/297 (27%), Positives = 137/297 (46%), Gaps = 58/297 (19%)
Query: 289 IGEGGYGSIYK----GLLRH---MQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 340
IG+G +G +++ GLL + VA+KML S ++FQ+E ++++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 341 LVGACP--EVWTLVYEYLPNGSLEDRL-------------------SCKDNSPPLSWQTR 379
L+G C + L++EY+ G L + L C N PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FLSQNEISS 437
+ IA ++ + + +L K VH DL N L+ N V K++DFG+SR + + +S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEV 494
N + R +M PE + T +SDV+++G++L + + +P G+ +EV
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 495 QYALDTGKLKNLLD--PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549
Y + G + + D PL +L NL C RP + R+L+
Sbjct: 242 IYYVRDGNVLSCPDNCPL----------ELYNLMRLCWSKLPSDRPSFA-SINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 16/192 (8%)
Query: 306 QVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV--GACPEVWTL-VYEYLPNG 359
+VAIK+L P + F++E + +++ HPN+V L+ G P V+EY+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV- 418
+L + L+ L R+ ++ L H+ IVH DLKP NI++ V
Sbjct: 65 TLREVLA---ADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118
Query: 419 --SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGI 476
+K+ DFGI L ++ TL T+ GT Y PE L +TP SD+Y++G+
Sbjct: 119 PHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 477 ILLRLLTGRPAL 488
I L LTG+ +
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--ID---ILSKIRHP 336
+F+ KIG+G +G ++K ++R + + L + ++E ID +L+K+
Sbjct: 1 DFEILNKIGKGSFGVVFK-VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 337 NLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP---PLSWQTRIRIATELCSVLI 391
++ + + L V EY NG L L + P W+ I+I L
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
LHS K I+H D+K N+ LDA K+ D G+++ LS N +N GT
Sbjct: 116 HLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GT 164
Query: 452 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511
Y+ PE KSDV++ G++L TG+ Q AL ++ + P++
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPVS 222
Query: 512 GDWPFVQAEQLANLAMRCCEMSRKSRPE 539
+ Q QLA L +C + RP+
Sbjct: 223 Q--MYSQ--QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 50/284 (17%)
Query: 289 IGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
IG G +G +++G+L+ + VAIK L P ++ + +F E I+ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 343 GACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G + ++ EY+ NG+L+ L D + ++ L + + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------- 453
VH DL NIL+++N K+SDFG+SR L DP+GT+
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED--------------DPEGTYTTSGGKIP 173
Query: 454 --YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG-KLKNLL 507
+ PE +A + T SDV+SFGI++ +++ RP ++ EV A++ G +L
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---- 229
Query: 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
P D P + L ++C + R RP D+ +L+ +
Sbjct: 230 -PAPMDCP----SAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 26/278 (9%)
Query: 280 THNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIR 334
NF KIG+G + +YK LL VA+K + + Q +EID+L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 335 HPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLI 391
HPN++ + + E L V E G L + K + +T + +LCS L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
+HS I+H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GT 169
Query: 452 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511
YM PE + KSD++S G +L + + K Y+L K PL
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549
D +E+L +L RC + RP D+ VL+
Sbjct: 230 AD---HYSEELRDLVSRCINPDPEKRP----DISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 36/213 (16%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGP----SEFQQEIDILSKIRH---PN 337
IG G YG++Y+G H+ VA+K++ +L P S+ Q+E+ +LS++R PN
Sbjct: 9 IGRGAYGAVYRGK--HVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 338 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
+ G+ P +W ++ EY GS+ + + P++ + I E+ L ++H
Sbjct: 64 ITKYYGSYLKGPRLW-IIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
++H D+K ANIL+ KL DFG++ L+QN SS +T GT +
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFV------GTPYW 167
Query: 455 MDPEFLASG-ELTPKSDVYSFGIILLRLLTGRP 486
M PE + G K+D++S GI + + TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 27/257 (10%)
Query: 288 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G ++ +H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 347 -EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E ++ E++ GSL D L + + PL I + ++ + F+ + +H
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ A+ V K++DFG++R + NE ++ R K + PE + G
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 179
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521
T KSDV+SFGI+L+ ++T GR P G++ EV AL+ G + E+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENC--------PEE 231
Query: 522 LANLAMRCCEMSRKSRP 538
L N+ MRC + + RP
Sbjct: 232 LYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-19
Identities = 27/70 (38%), Positives = 38/70 (54%)
Query: 572 PPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALR 631
P F PI E+M+DP + G TY+ ++ L S T P T PL H L+PNL L+
Sbjct: 2 PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61
Query: 632 SAIQEWLQQH 641
I WL+++
Sbjct: 62 EKIDAWLEEN 71
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 289 IGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
+G GG+G + ++ +K H E +IL + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 344 -------------ACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 388
C E+WT++ + G ++ + R IA C
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE------------YTARFYIA---CV 102
Query: 389 VLIF--LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCR 445
VL F LH+ I++ DLKP N+LLD+N KL DFG ++ L S T T C
Sbjct: 103 VLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK----SGQKTWTFC-- 153
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 496
GT Y+ PE + + D +S GI+L LLTGRP G E
Sbjct: 154 ----GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 289 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+G+G +G +Y L QV P + + + + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 342 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
G E ++ EY+P GS++D+L L+ + ++ + +LHS +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---N 123
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GTFAYM 455
IVH D+K ANIL D+ KL DFG S+ L T+C GT +M
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMKSVTGTPYWM 174
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE ++ K+DV+S G ++ +LT +P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 28/210 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVTLV 342
+IG G YG +YK VAIK++ L+ +F QQEI +L + RHPN+V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 343 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
G+ ++W +V EY GSL+D + PLS + E L +LH
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+H D+K ANILL + KL+DFG+S L+ I+ + + GT +M PE
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFI-------GTPYWMAPEV 172
Query: 460 LA---SGELTPKSDVYSFGIILLRLLTGRP 486
A G K D+++ GI + L +P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
++G G +G + G R VAIKM+ S+ EF +E ++ K+ H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 347 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+ + V EY+ NG L + L +++ + + ++C + +L S +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
DL N L+D K+SDFG+SR++ +E SS + R P PE L
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP--------PEVLLYS 176
Query: 464 ELTPKSDVYSFGIILLRLLT 483
+ + KSDV++FG+++ + +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 66/299 (22%)
Query: 288 KIGEGGYGSIY----KGLLRHMQ------------VAIKMLHPHSLQGP-SEFQQEIDIL 330
K+GEG +G ++ +GL + VA+KML + ++F +EI I+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 331 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL---------EDRLSCKDNSPPLSWQTR 379
S++++PN++ L+G C + ++ EY+ NG L E + +N P +S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS--S 437
+ +A ++ S + +L S + VH DL N L+ ++ K++DFG+SR L +
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 497
L R +M E + G+ T SDV++FG+ L + T + KE Y+
Sbjct: 189 GRAVLPIR--------WMAWESILLGKFTTASDVWAFGVTLWEMFT------LCKEQPYS 234
Query: 498 L--DTGKLKNLLDPLAGDWPFVQAEQ------------LANLAMRCCEMSRKSRPELGK 542
L D ++N G++ Q Q + L MRC K RP K
Sbjct: 235 LLSDEQVIEN-----TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 289 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPN 337
IG G +GS+Y G+ +A+K + S+ S+ +EI +L +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 338 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+V +G+ + + EY+P GS+ L+ + +R ++ L +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
I+H D+K ANIL+D K+SDFGIS+ L N +S+ R +G+ +M
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG--ARPSLQGSVFWM 179
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGR 485
PE + T K+D++S G +++ +LTG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 289 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPNLVTLVGA 344
+G G +G ++ + V IK + + Q E +L + HPN++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 345 CPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
E L V EY P G+L + + + NS L T + + +L+ LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQ---ILLALHHVHTKLIL 123
Query: 403 HGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
H DLK NILLD + V K+ DFGIS+ LS S T + GT Y+ PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSK--SKAYTVV-------GTPCYISPELCE 174
Query: 462 SGELTPKSDVYSFGIILLRLLT 483
KSD+++ G +L L +
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)
Query: 289 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
IG G +G + G L R + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 343 GA---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
G V +V EY+ NGSL+ L D T I++ L + +
Sbjct: 72 GVVTKSKPV-MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
VH DL NIL+++N V K+SDFG+SR L + ++ T K + PE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-----RGGKIPIRWTAPEA 180
Query: 460 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 516
+A + T SDV+S+GI++ +++ RP ++ ++V A++ G L P+ D P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--YRLPAPM--DCPA 236
Query: 517 VQAEQLANLAMRCCEMSRKSRPELGKDV 544
L L + C + R RP+ + V
Sbjct: 237 A----LHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 289 IGEGGYGSIYKGLLRHMQ-VAIKM--LHPHS-LQGPSEF---QQEIDILSKIRHPNLVTL 341
+G+G YG++Y GL Q +A+K L + L E+ Q+E+D+L ++H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 342 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G C + T+ E++P GS+ L + PL + ++ + +LH+ +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHN---N 121
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+VH D+K N++L N + KL DFG +R L+ + ++ + GT +M PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAPEV 179
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519
+ KSD++S G + + TG+P L + G + L+ L P +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL----PDSFS 235
Query: 520 EQLANLAMRCCEMSRKSRP 538
+ C + RP
Sbjct: 236 AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 82/260 (31%), Positives = 121/260 (46%), Gaps = 30/260 (11%)
Query: 288 KIGEGGYGSIYK-GLLRHMQV-AIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343
K+G+G YGS+YK L Q A+K + S+ + + EI IL+ + HPN+++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 344 ACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
A + L V EY P G L +S K + Q RI +L L LH K
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
I+H DLK ANILL AN + K+ D GIS+ L +N T + GT YM PE
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-------GTPHYMAPEVW 173
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRPALG--ITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
+ KSD++S G +L + T P ++++Y + GK P+ P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----YPPI----PPIY 225
Query: 519 AEQLANLAMRCCEMSRKSRP 538
++ L N ++ K RP
Sbjct: 226 SQDLQNFIRSMLQVKPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
++GEG +G ++ + M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 341 LVGAC--PEVWTLVYEYLPNGSLE--------DRLSCKDNSP-----PLSWQTRIRIATE 385
G C + +V+EY+ +G L D + D P L + IA++
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLC 443
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + +T L
Sbjct: 132 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
R +M PE + + T +SDV+SFG+IL + T
Sbjct: 189 IR--------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 341
IGEG +G +Y+G+ + VA+K + E F QE I+ + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G E VW +V E P G L L S L+ + I + +L + L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
VH D+ N+L+ + KL DFG+SR+L + K +M PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLPIKWMAPES 179
Query: 460 LASGELTPKSDVYSFGIILLRLL 482
+ T SDV+ FG+ + +L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 56/224 (25%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 289 IGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLVTL 341
+G G +G++YKG+ + VAIK+L + + E E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 342 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KR 129
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH------AEGGKVPIKWMALESI 183
Query: 461 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTG 501
T KSDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 344
KIG+G G++Y + +VAIK ++ EI ++ + +HPN+V + +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 345 --CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
E+W +V EYL GSL D ++ C D + + E L FLHS +
Sbjct: 86 LVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS---NQ 135
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVV 187
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
PK D++S GI+ + ++ G P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 46/284 (16%)
Query: 288 KIGEGGYGSIYKGLL-----RHMQ-VAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVT 340
++GE +G IYKG L H Q VAIK L + Q EFQQE +++++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 341 LVGACPEVW--TLVYEYLPNGSLEDRL---------SCKDNS-----PPLSWQTRIRIAT 384
L+G + +++EYL G L + L C + L + IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 444
++ + + +L S H VH DL NIL+ K+SD G+SR EI S +
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYY--- 180
Query: 445 RTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDT 500
R PK +M PE + G+ + SD++SFG++L + + +P G + Q ++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEM 238
Query: 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544
+ + LL P + D P ++ +L C + RP KD+
Sbjct: 239 VRKRQLL-PCSEDCP----PRMYSLMTECWQEGPSRRPRF-KDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 338
NF K+GEG Y ++YKG R VA+K +H + +G PS +EI ++ +++H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 339 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
V L V LV+EY+ + L+ + L T +L + F C
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF---C 116
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRF--LSQNEISSNNTTLCCRTDPKGTFAY 454
+ ++H DLKP N+L++ KL+DFG++R + N S+ TL Y
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW----------Y 166
Query: 455 MDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
P+ L S + D++S G I+ ++TGRP
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)
Query: 288 KIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSE---FQ--QEIDILSKIRHPNLVT 340
K+GEG Y +YK + VAIK + + + F +EI +L +++HPN++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 341 LVGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFL 393
L+ +V+ LV+E++ LE + KD S L+ I+ L +L
Sbjct: 67 LL----DVFGHKSNINLVFEFME-TDLEKVI--KDKSIVLT-PADIKSYMLMTLRGLEYL 118
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDPKGTF 452
HS + I+H DLKP N+L+ ++ V KL+DFG++R F S N ++ T
Sbjct: 119 HS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV---------TR 166
Query: 453 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 488
Y PE + D++S G I LL P L
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 289 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 342
IGEG +G + + +++ M AIKML + + +F E+++L K+ HPN++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 343 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 387
GAC L EY P G+L D L + L+ Q ++ A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+ + +L +H DL N+L+ N SK++DFG+SR +T
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---------GEEVYVKKTM 177
Query: 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 491
+ +M E L T KSDV+SFG++L + L G P G+T
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 22/267 (8%)
Query: 282 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 336
NF KIG G + +Y+ LL + VA+K + L +EID+L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 337 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 393
N++ + E +V E G L + K + +T + +LCS L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513
YM PE + KSD++S G +L + + K Y+L + PL D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRPEL 540
+E+L L C + RP++
Sbjct: 232 H---YSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 22/194 (11%)
Query: 289 IGEGGYGSIYKGLLRHMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 347
IG+G +G + G R +VA+K + + + Q F E +++++RH NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 348 ---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+V EY+ GSL D L + S L ++ + ++C + +L + ++ VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL N+L+ + V+K+SDFG+++ E SS T K + PE L +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT------GKLPVKWTAPEALREKK 175
Query: 465 LTPKSDVYSFGIIL 478
+ KSDV+SFGI+L
Sbjct: 176 FSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 344
+IG+G +G +YKG+ + VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 345 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
++W ++ EYL GS D L PL I E+ L +LHS +
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
K+D++S GI + L G P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 288 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--VGA 344
K+G G +G ++ G + +VA+K L P ++ + F +E +++ ++H LV L V
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 345 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E ++ EY+ GSL D L D + I + ++ + ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ AN+L+ + + K++DFG++R + NE ++ R K + PE + G
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGS 180
Query: 465 LTPKSDVYSFGIILLRLLT-GR-PALGITK-EVQYALDTG 501
T KSDV+SFGI+L ++T G+ P G++ +V AL G
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 46/270 (17%)
Query: 288 KIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTL 341
KIGEG +G L++ Q IK ++ + E ++E+ +LS ++HPN+V
Sbjct: 7 KIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 342 VGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP-----PLSWQTRIRIATELCSVLIFLH 394
+ E L V +Y G L +++ + L W ++C L +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVH 118
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
K I+H D+K NI L + KL DFGI+R L N+T RT GT Y
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELART-CIGTPYY 167
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL-LDPLAGD 513
+ PE + KSD+++ G +L + T +++A + G +KNL L + G
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGS 217
Query: 514 WPFVQAE---QLANLAMRCCEMSRKSRPEL 540
+P V + L NL + + + + RP +
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSV 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 42/227 (18%)
Query: 288 KIGEGGYGSIY----KGLLRHMQ--------------VAIKMLHPHSLQGP-SEFQQEID 328
K+GEG +G ++ +G+ + M VA+KML + + ++F +EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 329 ILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS--------CKDNSPPLSWQT 378
I+S+++ PN++ L+ C L + EY+ NG L LS K + +S+ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 379 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS-- 436
I +AT++ S + +L S + VH DL N L+ N+ K++DFG+SR L +
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
L R +M E + G+ T SDV++FG+ L +LT
Sbjct: 189 QGRAVLPIR--------WMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 30/237 (12%)
Query: 275 EIEGATHNFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 332
E E + +G+G YG +Y L +++AIK + + +EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 333 IRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATE 385
++H N+V +G+ E + + E +P GSL L K DN + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQ-NEISSNNTTLC 443
+ L +LH + IVH D+K N+L++ + V K+SDFG S+ L+ N + T
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--- 170
Query: 444 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 498
GT YM PE + G +D++S G ++ + TG+P E Q A+
Sbjct: 171 ------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 8e-17
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 344
KIG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 345 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
++W ++ EYL GS D L PL I E+ L +LHS K
Sbjct: 71 YLKDTKLW-IIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H D+K AN+LL + KL+DFG++ L+ +I N GT +M PE +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPEVIK 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
K+D++S GI + L G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 84/248 (33%), Positives = 116/248 (46%), Gaps = 44/248 (17%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---HPNLV 339
IGEG YG++YK R + VA+K + P S +G P +EI +L ++ HPN+V
Sbjct: 7 IGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 340 TLVGAC--PEVW-----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
L+ C P TLV+E++ + L LS K P L +T + +L + F
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
LHS H IVH DLKP NIL+ ++ K++DFG++R I S L T T
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMAL---TSVVVTL 170
Query: 453 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD--- 508
Y PE L S TP D++S G I L RP T E +L + D
Sbjct: 171 WYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEAD------QLDKIFDVIG 223
Query: 509 -PLAGDWP 515
P +WP
Sbjct: 224 LPSEEEWP 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ------QEIDILSKIRHPN 337
+GEG YG + K +H + VAIK L+ + +EI +L ++RH N
Sbjct: 8 LVGEGSYGMVMK--CKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 338 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
LV L+ + LV+E++ + L+D L N L + ++ + F HS
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNG--LDESRVRKYLFQILRGIEFCHS 118
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRTDPKGTFAY 454
H+I+H D+KP NIL+ + V KL DFG +R L + E+ TD T Y
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---------TDYVATRWY 166
Query: 455 MDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 486
PE L ++ D+++ G ++ +LTG P
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 289 IGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
IG+G +G +Y G L + + A+K L+ L+ +F +E I+ HPN+++L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 343 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
G C P V V Y+ +G L + + + ++P + + I ++ + +L S
Sbjct: 63 GICLPSEGSPLV---VLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK 117
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
K VH DL N +LD +F K++DFG++R + E S + T K +M
Sbjct: 118 K---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN----HTGAKLPVKWMA 170
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT 483
E L + + T KSDV+SFG++L L+T
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 37/218 (16%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 339
D +KIGEG G + + QVA+K + Q E+ I+ +HPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 340 T-----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVL- 390
LVG E+W +V E+L G+L D ++ TR+ +IAT +VL
Sbjct: 80 EMYSSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLAVLK 126
Query: 391 --IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
FLH+ ++H D+K +ILL ++ KLSDFG F +Q +S + R
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQ--VSKE---VPRRKSL 175
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT +M PE ++ + D++S GI+++ ++ G P
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 282 NFDPSLKIGEGGYGS--IYKGLLRHMQVAIKMLHPHSLQGPSEF--QQEIDILSKIRHPN 337
++ P +G+G +G +Y+ V K ++ L EI ILS ++HPN
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 338 LVTLVGACPEVWTLV--YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
++ + TL+ EY G+L D++ + + + ++ S + ++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK 119
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
I+H D+K NI L + KL DFGIS+ L +E S T + GT YM
Sbjct: 120 ---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-------GTPYYM 168
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLT 483
PE + KSD+++ G +L LLT
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 289 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 342
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 343 GACPEVWTL--VYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELC 387
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 170
Query: 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 491
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 42/279 (15%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGP-SEFQQEIDILSKI 333
N +G G +G ++ + ++ V +K L + SEF++E+D+ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 334 RHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRL------SCKDNSPPLSWQTRIRIATE 385
H N+V L+G C E ++ EY G L+ L K PPLS + ++ + T+
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 444
+ + L + VH DL N L+ + K+S +S+ + N +
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 501
R ++ PE + + + KSDV+SFG+++ + T P G++ +EV L G
Sbjct: 183 R--------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 502 KLKNLLDPLAGDWPFVQA--EQLANLAMRCCEMSRKSRP 538
KL+ P + +L L RC ++ K RP
Sbjct: 235 KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 325 QEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 382
E IL ++ HP LV L + E LV + L G L LS K S + +++
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFS-EEQVKF 104
Query: 383 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
E+ L +LHS I+H D+KP NILLD ++DF I+ ++ + T+
Sbjct: 105 WICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
GT YM PE L + D +S G+ L G+
Sbjct: 159 TS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-P 346
IGEG +G++ +G +VA+K + F +E +++K+ H NLV L+G
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406
+V E + G+L + L + + +S ++ + ++ + +L S K +VH DL
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 407 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 466
NIL+ + V+K+SDFG++R + +N+ L + + PE L + +
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVK--------WTAPEALKHKKFS 175
Query: 467 PKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 522
KSDV+S+G++L + + GR P + + KEV+ ++ G ++P G V
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY---RMEPPEGCPADVYV--- 228
Query: 523 ANLAMRCCEMSRKSRPELGK 542
L C E K RP K
Sbjct: 229 --LMTSCWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSC-----------KDNSP-PLSWQTRIRIATEL 386
G C E +V+EY+ +G L L +D +P L+ + IA+++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNNTTLCC 444
S +++L S VH DL N L+ V K+ DFG+SR + + T L
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
R +M PE + + T +SD++SFG++L + T
Sbjct: 189 R--------WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 289 IGEGGYGSIYKGLLRH--------MQVAIKMLHPHSLQGPS-EFQQEIDILSKIRHPNLV 339
+GEG +G + L R+ QVA+K L P S + ++EI+IL + H N+V
Sbjct: 12 LGEGHFGKVE--LCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 340 TLVGACPEVW----TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
G C E L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP--RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
VH DL N+L+++ K+ DFG+++ I ++ + D +
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSPVFWY 179
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLT 483
PE L + SDV+SFG+ L LLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 42/274 (15%)
Query: 289 IGEGGYGSIYKGLLRHM--------QVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLV 339
+G G +G +Y+G + +VA+K L + Q EF +E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 340 TLVGAC--PEVWTLVYEYLPNGSL----EDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
L+G C E ++ E + G L D + P L+ + + I ++ ++L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 394 HSCKPHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
+ H +H DL N L+ DA+ V K+ DFG++R + +++ +
Sbjct: 123 E--QMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK------EGEG 173
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQYALDTGKLK 504
+M PE L G+ T +SDV+SFG+++ +LT G+ PAL + +Q+ G+L+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
P +++ L C RP
Sbjct: 234 K---------PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 282 NFDPSLKIGEGGYGSIY--KGLLRHMQVAIKM--LHPHSLQGPSEFQQEIDILSKIRHPN 337
++ KIGEG +G IY K IK L ++ ++E+ +L+K++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 338 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSPPLSWQTRIRIATELCSVL 390
+VT + E L V EY G L R++ + LSW +I + L
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG------L 114
Query: 391 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
+H K I+H D+K NI L N V+KL DFGI+R L N++ T
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-------NDSMELAYT-CV 163
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
GT Y+ PE + K+D++S G +L L T
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 289 IGEGGYGSIYKGLLRHMQ------VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
+G+G +GS+ +Q VA+K L + + +F++EI+IL ++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 343 GACPEV----WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G C LV EYLP GSL D L + L + + A+++C + +L S +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ--KHRERLDHRKLLLYASQICKGMEYLGSKR- 128
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DL NIL+++ K+ DFG+++ L Q++ R + + PE
Sbjct: 129 --YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-----EYYKVREPGESPIFWYAPE 181
Query: 459 FLASGELTPKSDVYSFGIILLRLLT 483
L + + SDV+SFG++L L T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 26/203 (12%)
Query: 290 GEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLVGAC 345
G GG S K + +A K++H + S ++ E+ I+ + R P +V+ GA
Sbjct: 16 GNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ + E++ GSL DR+ K P+ + +IA + L +L++ H I+
Sbjct: 73 LNENNI-CMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV--HRIM 126
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+KP+NIL+++ KL DFG+S L I+S T GT YM PE +
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFV------GTSTYMSPERIQG 176
Query: 463 GELTPKSDVYSFGIILLRLLTGR 485
G+ T KSDV+S GI ++ L G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 322 EFQQEIDILSKIRHPNLVTLVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 379
++EI +++++ HP+++ ++GA E + L E++ GS+ LS
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGAFKEAVI 105
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSN 438
I +L L +LH + I+H D+K AN+L+D+ +++DFG + L
Sbjct: 106 INYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL-------- 154
Query: 439 NTTLCCRTDPKG----TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV 494
+ +G T A+M PE L + DV+S G +++ + T +P K
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214
Query: 495 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+ K+ + P + L ++ +RC E+ + RP
Sbjct: 215 NHLALIFKIASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
++G G +G ++ G R ++VAIK ++ ++ +F +E ++ K+ HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 347 EVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+ L V E++ NG L + L + LS + + ++C + +L +S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHR 124
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL N L+ + V K+SDFG++R++ +E +S+ + K + PE +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS-------SGAKFPVKWSPPEVFNFSK 177
Query: 465 LTPKSDVYSFGIILLRLLT 483
+ KSDV+SFG+++ + T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGPSEFQQEIDILSKI 333
HN ++GEG +G ++ ++ VA+K L S +F +E ++L+ +
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 334 RHPNLVTLVGACPE--VWTLVYEYLPNGSLE--------DRLSCKDNSPP--LSWQTRIR 381
+H ++V G C E +V+EY+ +G L D + + + P L+ +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI--SSNN 439
IA ++ + +++L S VH DL N L+ N + K+ DFG+SR + + +
Sbjct: 125 IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
T L R +M PE + + T +SDV+S G++L + T
Sbjct: 182 TMLPIR--------WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPN 337
F ++G+GGYG ++ + VA+K + L +E + E DIL+ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 338 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELCSVLIFLH 394
LV L+ A E L EY+P G L+ N LS R +A +V
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAV----D 115
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
+ +H DLKP N L+DA+ KL+DFG LS+ ++ N+ + G+ Y
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVV-------GSPDY 164
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
M PE L D +S G +L L G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 54/236 (22%)
Query: 288 KIGEGGYGSIY--------------------KGLLRHMQVAIKMLHPHSLQGP-SEFQQE 326
K+GEG +G ++ KG R + VA+K+L P + + ++F +E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG--RPLLVAVKILRPDANKNARNDFLKE 69
Query: 327 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK----------DNSPP- 373
+ ILS+++ PN++ L+G C + ++ EY+ NG L LS D PP
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 374 -----LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428
+S+ + + +A ++ S + +L S + VH DL N L+ N K++DFG+SR
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 429 FLSQNEIS--SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 482
L + L R +M E + G+ T SDV++FG+ L +L
Sbjct: 187 NLYAGDYYRIQGRAVLPIR--------WMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 69/229 (30%), Positives = 118/229 (51%), Gaps = 30/229 (13%)
Query: 289 IGEGGYGSIYKGL------LRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 339
+G G +G++YKG+ + VAIK+L+ + GP EF E I++ + HP+LV
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLV 72
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
L+G C P + LV + +P+G L D + KDN + Q + ++ +++L
Sbjct: 73 RLLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE- 127
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+VH DL N+L+ + K++DFG++R L +E N K +M
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN------ADGGKMPIKWMA 179
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 502
E + + T +SDV+S+G+ + L+T G+P GI T+E+ L+ G+
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPH---SLQGPSEFQQEIDILSKIR 334
+ + +G G +G ++ L+R A+K++ L+ E +L ++
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 335 HPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL 386
HP ++ L WT ++ EY+P G L L NS S T + A+E+
Sbjct: 60 HPFIIRLF------WTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEI 110
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
L +LHS IV+ DLKP NILLD KL+DFG ++ ++ TLC
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLC--- 159
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE + S D ++ GI++ +L G P
Sbjct: 160 ---GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 47/242 (19%)
Query: 289 IGEGGYGSIYKGLLR-------HMQVAIKML----HPHSLQGPSEFQQEIDILSKI-RHP 336
+GEG +G + K VA+KML L S+ E++++ I +H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGKHK 76
Query: 337 NLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPP---------------LSWQT 378
N++ L+G C + ++ +V EY +G+L D L + PP L+ +
Sbjct: 77 NIINLLGVCTQEGPLYVVV-EYAAHGNLRDFL--RARRPPGEYASPDDPRPPEETLTQKD 133
Query: 379 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438
+ A ++ + FL S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 134 LVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQY 496
T+ + +M PE L T +SDV+SFG++L + T G P GI E +
Sbjct: 191 ------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 497 AL 498
L
Sbjct: 245 KL 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLV 342
++GEG GS+ K L++ M A+K + P +Q E++I + P +V
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 343 GACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
GA + + + EY GSL+ K + + +IA + L +LHS K
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
I+H D+KP+NILL KL DFG+S L ++S T GT YM P
Sbjct: 126 ---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFT------GTSFYMAP 172
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGR 485
E + + SDV+S G+ LL + R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 47/260 (18%)
Query: 254 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQV----AI 309
S +SSS+ + S SE+E +IG G G++YK + H A+
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVN-------RIGSGAGGTVYK--VIHRPTGRLYAL 104
Query: 310 KMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVW------TLVYEYLPNGSLE 362
K+++ H + +EI+IL + HPN+V C +++ ++ E++ GSLE
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLE 160
Query: 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422
+ L+ +A ++ S + +LH IVH D+KP+N+L+++ K++
Sbjct: 161 GTHIADE--QFLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210
Query: 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF----LASGELTPKS-DVYSFGII 477
DFG+SR L+Q N++ GT AYM PE L G + D++S G+
Sbjct: 211 DFGVSRILAQTMDPCNSSV--------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 478 LLRLLTGRPALGITKEVQYA 497
+L GR G+ ++ +A
Sbjct: 263 ILEFYLGRFPFGVGRQGDWA 282
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 344
+IG+G +G ++KG+ Q VAIK++ + E QQEI +LS+ P + G+
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 345 C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 398
++W ++ EYL GS D L + P +IAT E+ L +LHS K
Sbjct: 71 YLKGTKLW-IIMEYLGGGSALDLL----RAGPFD---EFQIATMLKEILKGLDYLHSEKK 122
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+H D+K AN+LL KL+DFG++ L+ +I N GT +M PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--------GTPFWMAPE 171
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ K+D++S GI + L G P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL-- 341
KIGEG YG +YKG + VA+K + S + PS +EI +L +++HPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 342 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
V L++E+L + L+ L D+ P + + + L +L + C +
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FL 460
+H DLKP N+L+D V KL+DFG++R + + T T Y PE L
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
S + D++S G I + T +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 282 NFDPSLKIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHP 336
NF KIG G + +Y+ LL VA+K + + Q +EID+L ++ HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 337 NLVTLVGACPE--VWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFL 393
N++ + + E +V E G L + K + +T + +LCS + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
HS ++H D+KPAN+ + A V KL D G+ RF S ++++ GT
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--------GTPY 171
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRL 481
YM PE + KSD++S G +L +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 43/274 (15%)
Query: 288 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 339
++G+G +G +Y+G R + +VA+K ++ SL+ EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 340 TLVGACP--EVWTLVYEYLPNGSLEDRLSC-------KDNSPPLSWQTRIRIATELCSVL 390
L+G + +V E + +G L+ L PP + Q I++A E+ +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 451 TF--AYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 504
+M PE L G T SD++SFG++L + L +P G++ E +++ +D G L
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL- 240
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
D P E++ +L C + + K RP
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 69/231 (29%), Positives = 98/231 (42%), Gaps = 71/231 (30%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIK---------MLHPHSLQGPSEFQQEIDILSKIR 334
KIGEG YG ++K R+ + VAIK ++ +L+ EI +L +++
Sbjct: 8 KIGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALR-------EIRMLKQLK 58
Query: 335 HPNLVTLVGACPEVWT------LVYEYL-----------PNGSLEDRLSCKDNSPPLSWQ 377
HPNLV L+ EV+ LV+EY P G K + WQ
Sbjct: 59 HPNLVNLI----EVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKK----IIWQ 108
Query: 378 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437
T L ++ C H+ +H D+KP NIL+ KL DFG +R L+
Sbjct: 109 T-----------LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156
Query: 438 NNTTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 486
TD T Y PE L G+ P DV++ G + LLTG+P
Sbjct: 157 -------YTDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 17/182 (9%)
Query: 307 VAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVYEYLPNGSL 361
VA+K L Q S +++EI+IL + H N+V G C E L+ EY+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421
D L K L+ + A ++C + +LHS +H DL N+LLD + + K+
Sbjct: 96 RDYLP-KHK---LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL 481
DFG+++ + + R D + E L + + SDV+SFG+ L L
Sbjct: 149 GDFGLAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 482 LT 483
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 289 IGEGGYGSIYKGLLRH-------MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVT 340
+G G +G +Y+GL R +QVA+K L S Q S+F E I+SK H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 341 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSP------PLSWQTRIRIATELCSVLIF 392
L+G E ++ E + G L+ L ++N P L+ + + A V
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCA---RDVAKG 128
Query: 393 LHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD-- 447
+ + +H D+ N LL V+K++DFG++R +I R
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIY--------RASYY 175
Query: 448 PKGTFA-----YMDPEFLASGELTPKSDVYSFGIIL 478
KG A +M PE G T K+DV+SFG++L
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 289 IGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLV 342
IGEG +G + K ++ M AIK + ++ + +F E+++L K+ HPN++ L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 343 GACPE--VWTLVYEYLPNGSLEDRLS-------------CKDNSPPLSWQTRIRIATELC 387
GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+ +L +H DL NIL+ N+V+K++DFG+SR +T
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTM 182
Query: 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGIT 491
+ +M E L T SDV+S+G++L + L G P G+T
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 47/225 (20%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKM-LHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
KIG+G +G ++K RH + VA+K L + +G P +EI IL ++H N+V L
Sbjct: 19 KIGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 342 VGACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--------RIA 383
+ C T LV+E+ C+ + L + ++
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEF-----------CEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443
L + L ++H K I+H D+K ANIL+ + + KL+DFG++R S ++ S N
Sbjct: 126 KMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN---- 178
Query: 444 CRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRP 486
T+ T Y PE L GE P D++ G I+ + T P
Sbjct: 179 RYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 342
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
TLV+EYL + L+ L DN L ++I + +L L C I+
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIF--MFQLLRGLSYCHKRKIL 125
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 461
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 177
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
S E + D++ G IL + TGRP
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 39/221 (17%)
Query: 289 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 343
+G G YG +YKG RH++ AIK++ + E + EI++L K H N+ T G
Sbjct: 24 VGNGTYGQVYKG--RHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 344 A----CP-----EVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 393
A P ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 81 AFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHL 137
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H+ H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 138 HA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 186
Query: 454 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 488
+M PE +A E P +SD++S GI + + G P L
Sbjct: 187 WMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 289 IGEGGYGSIYKGLLR-HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
+G+G +G ++KG L+ VA+K P L+ +F E IL + HPN+V L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKLIGV 60
Query: 345 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
C + +V E +P G L K + L + ++ A + + + +L S + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLES---KNCI 115
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H DL N L+ N V K+SDFG+SR SS+ + + PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK-------QIPIKWTAPEALNY 168
Query: 463 GELTPKSDVYSFGIIL 478
G + +SDV+S+GI+L
Sbjct: 169 GRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKM--LHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 341
KIGEG YG +YK R +A+K L PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 342 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
V + LV+EYL + L+ + D+SP + R+ I T L +L + C H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRL-IKTYLYQILRGIAYCHSHRV 123
Query: 402 VHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 459
+H DLKP N+L+D KL+DFG++R + T T Y PE
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG--------IPVRTFTHEVVTLWYRAPEIL 175
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
L S + D++S G I ++ +P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 289 IGEGGYGSIYK----GLLRH---MQVAIKMLHPHSLQGPSE-FQQEIDILSKI-RHPNLV 339
+G G +G + + GL + M+VA+KML P + E E+ I+S + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 340 TLVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
L+GAC P + ++ EY G L + L K S L+ + + + ++ + FL S
Sbjct: 103 NLLGACTIGGPIL--VITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFLAS 159
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFA 453
+ +H DL N+LL + K+ DFG++R + N + N L +
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-------- 208
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513
+M PE + + T +SDV+S+GI+L + + LG +D+ K + +
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP 538
P ++ ++ C + RP
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 340
KIG+G G++Y + +VAIK ++ EI ++ + ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 341 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 86 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALDFLHS--- 133
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ ++H D+K NILL + KL+DFG ++ + S +T+ GT +M PE
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPE 185
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ PK D++S GI+ + ++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 30/211 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
KIGEG YG +YK R VA+K + +G PS +EI +L ++ HPN+V L
Sbjct: 6 KIGEGTYGVVYKA--RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSCK 397
V LV+E+L + L+ + D+SP + +L + + HS
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCHS-- 117
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
H ++H DLKP N+L+D KL+DFG++R + + T T Y P
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 168
Query: 458 EFLASGEL--TPKSDVYSFGIILLRLLTGRP 486
E L TP D++S G I ++ RP
Sbjct: 169 EILLGSRQYSTP-VDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 13/91 (14%)
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
H ++H D+KP+NILLDA+ KL DFGIS L ++ +T G AYM PE
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---------AKTRSAGCAAYMAPE 184
Query: 459 FLASGELTPK----SDVYSFGIILLRLLTGR 485
+ + PK +DV+S GI L+ L TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 72/221 (32%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 289 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVG 343
+G G YG +YKG RH++ AIK++ + E +QEI++L K H N+ T G
Sbjct: 14 VGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70
Query: 344 AC---------PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFL 393
A ++W LV E+ GS+ D + + K N+ W I E+ L L
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHL 127
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H H ++H D+K N+LL N KL DFG+S L + + NT + GT
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFI-------GTPY 176
Query: 454 YMDPEFLASGELTP------KSDVYSFGIILLRLLTGRPAL 488
+M PE +A E P KSD++S GI + + G P L
Sbjct: 177 WMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR-HPNLVTL 341
K+G+G YG ++K + R VA+K + + + ++ Q+ EI L ++ HPN+V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIF-DAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 342 VGACPEV----WTLVYEYLPN--------GSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
+ LV+EY+ LED + I +L
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------------VHKRYIMYQLLKA 119
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L ++HS +++H DLKP+NILL+++ KL+DFG++R LS+ E + N L TD
Sbjct: 120 LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDYV 173
Query: 450 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 486
T Y PE L S T D++S G IL +L G+P
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT----- 340
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 341 LVGACPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
LVG E+W +V EYL GSL D ++ C D + + E L FLHS
Sbjct: 87 LVG--DELW-VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLHS--- 134
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ ++H D+K NILL + KL+DFG F +Q I+ + R+ GT +M PE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQ--ITPEQSK---RSTMVGTPYWMAPE 186
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ PK D++S GI+ + ++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 24/235 (10%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 342
K+GEG Y ++YKG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ TLV+EYL + L+ L NS + + L +L L+ C ++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-----NVKLFLFQLLRGLNYCHRRKVL 126
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 461
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--------TLWYRPPDILLG 178
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 515
S + + + D++ G I + TGRP G T E Q + L P WP
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQG--PSEFQQEIDILSKIRH 335
F+ +IGEG YG +Y+ R VA+K + + + P +EI +L +RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 336 PNLVTL----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVL 390
PN+V L VG + LV EY +D S DN P P S + +L L
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDP 448
+LH + I+H DLK +N+LL K++DFG++R ++ TL
Sbjct: 122 QYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW----- 173
Query: 449 KGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495
Y PE L T D+++ G IL LL +P L E++
Sbjct: 174 -----YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKM--LHPHSLQGPSEFQQEIDILSKIRH 335
NF KIGEG YG +YK R+ VA+K L + PS +EI +L ++ H
Sbjct: 1 NFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 336 PNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
PN+V L V LV+E+L +D D SP + I + L +L L
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPL-IKSYLFQLLQGL 113
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
C H ++H DLKP N+L++ KL+DFG++R + T T
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--------VPVRTYTHEVVTLW 165
Query: 454 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 488
Y PE L + D++S G I ++T R AL
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 52/278 (18%)
Query: 289 IGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTL 341
+GEG +GS+ +G L ++VA+K + H+ EF E + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 342 VGACPEVWTL--------VYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 390
+G C E +L + ++ +G L L L QT ++ ++ +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCC 444
+L + + +H DL N +L + ++DFG+S+ + Q I+
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-------- 175
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDT 500
K ++ E LA T KSDV++FG+ I R T P + + Y
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231
Query: 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+LK D L ++L +L C K RP
Sbjct: 232 NRLKQPEDCL---------DELYDLMYSCWRADPKDRP 260
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 31/264 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLH---PHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
+IG G +G ++ G LR + VA+K P L+ ++F QE IL + HPN+V L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLI 59
Query: 343 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G C + +V E + G L + P L + I++ + + +L S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KH 114
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+H DL N L+ V K+SDFG+SR + E +T + P + PE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP---VKWTAPEAL 168
Query: 461 ASGELTPKSDVYSFGIILLRL--LTGRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 517
G + +SDV+SFGI+L L P ++ ++ + A++ G L P +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPC-----PEL 220
Query: 518 QAEQLANLAMRCCEMSRKSRPELG 541
+ + L RC E RP
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 69/260 (26%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 289 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQ-GPSEFQQ-------------EIDILSK 332
+GEG YG + K L VAIK + + ++ +Q E+ I+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 333 IRHPNLVTLVGA-CPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
I+H N++ LV + LV + + L+ + D L+ I ++ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS---SNNTTLCCR-- 445
LH +H DL PANI +++ + K++DFG++R S S + T+ R
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 446 -TDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 503
T T Y PE L + + D++S G I LLTG+P E+ G++
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRI 246
Query: 504 KNLL-DPLAGDWPFVQAEQL 522
LL P +WP QA++L
Sbjct: 247 FELLGTPNEDNWP--QAKKL 264
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+I EG YG +Y+ R + VA+K L P +EI+IL K++HPN+VT+
Sbjct: 12 RIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 342 ----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
VG+ + +V EY+ + L+ + + P + +L S + LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD-- 124
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ I+H DLK +N+LL+ + K+ DFG++R E S T T Y P
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAR-----EYGSPLKPY---TQLVVTLWYRAP 175
Query: 458 E-FLASGELTPKSDVYSFGIILLRLLTGRP 486
E L + E + D++S G I LLT +P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 287 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
+++G G +G + KG+ + + VAIK+L + + E +E +I+ ++ +P +V +
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 342 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C E LV E G L LS K + +S + + V + + + +
Sbjct: 61 IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
VH DL N+LL +K+SDFG+S+ L ++++ R+ K + PE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKAL-----GADDSYYKARSAGKWPLKWYAPECI 170
Query: 461 ASGELTPKSDVYSFGIIL 478
+ + +SDV+S+GI +
Sbjct: 171 NFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGA 344
++G+G YGS+YK L R V + M S+F Q E+DIL K P +V GA
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 345 CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ VY EY+ GSL+ + + + RI + L FL + H+I
Sbjct: 68 F-FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNI 124
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H D+KP N+L++ N KL DFG+S S T + C++ YM PE +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQS-------YMAPERIK 174
Query: 462 SGEL------TPKSDVYSFGIILLRLLTGR 485
SG T +SDV+S G+ +L + GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 24/239 (10%)
Query: 288 KIGEGGYGSIYKGL--LRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTL--V 342
K+GEG Y +++KG L VA+K + H P +E+ +L ++H N+VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ TLV+EYL +D D+ + ++I L +L L C ++
Sbjct: 73 VHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRRKVL 126
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 461
H DLKP N+L++ KL+DFG++R S + +N + T Y P+ L
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--------TLWYRPPDVLLG 178
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519
S E + + D++ G I + +GRP G T E + L + L P WP + +
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 38/232 (16%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPN 337
+++ K+GEG +G +YK VA+K + H+ + P +EI IL K++HPN
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 338 LVTLVGACPEVWTLVYEYLPNGSLEDRLS--------CKDNSPPLSWQTRIR-------- 381
+V L+ + E P+ S R S D S L ++
Sbjct: 69 VVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKC 119
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+L + +LH I+H D+K ANIL+D + K++DFG++R +
Sbjct: 120 YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 442 LCCRTDPKG---TFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPAL 488
T Y PE L GE T D++ G + + T RP L
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
++G+G +G +YK + A K++ S + ++ EI+IL+ HP +V L+GA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSI 401
++W ++ E+ P G+++ + D + +I+ I ++ L +LHS K I
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHSMK---I 131
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H DLK N+LL + KL+DFG+S + N TL R GT +M PE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 462 SGEL--TP---KSDVYSFGIILLRLLTGRP 486
+ TP K+D++S GI L+ + P
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
+ +KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 341 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 392
LVG E+W L+ E+L G+L D +S QTR+ +IAT SVL
Sbjct: 83 MYKSYLVGE--ELWVLM-EFLQGGALTDIVS----------QTRLNEEQIATVCESVLQA 129
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
L ++H D+K +ILL + KLSDFG +S++ + R GT
Sbjct: 130 LCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTP 181
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ--EIDILSKI-RHPNLVTLV 342
++G+G +GS+Y + VAIK + E E+ L K+ HPN+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 343 GACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCSVLIFLHS 395
EV+ V+EY+ G+L L P S ++ IR I ++ L +H
Sbjct: 65 ----EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFS-ESVIRSIIYQILQGLAHIHK 117
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H H DLKP N+L+ V K++DFG++R EI S TD T Y
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPY----TDYVSTRWYR 165
Query: 456 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
PE L S + D+++ G I+ L T RP
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLH-PHSLQG-PSEFQQEIDILSKIR---H 335
++P +IG G YG++YK H VA+K + + G P +E+ +L ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 336 PNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 388
PN+V L+ C T LV+E++ + L L K P L +T + +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFLR 119
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
L FLH+ + IVH DLKP NIL+ + KL+DFG++R I S L T
Sbjct: 120 GLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMAL---TPV 167
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508
T Y PE L D++S G I + +P E A GK+ +L+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIG 224
Query: 509 -PLAGDWP 515
P DWP
Sbjct: 225 LPPEDDWP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
++G+G +G +YK + V A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+W L+ E+ G++ D + + P Q R+ + + L +LH K I+
Sbjct: 72 YYENNLWILI-EFCAGGAV-DAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---II 125
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-- 460
H DLK NIL + KL+DFG+S + N T+ R GT +M PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 461 ASGELTP---KSDVYSFGIILLRLLTGRP 486
+ + P K+DV+S GI L+ + P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDILSKI 333
++ +IGEG YG ++K R ++ VA+K + + + P +E+ +L +
Sbjct: 1 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 334 R---HPNLVTLVGACP-------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 383
HPN+V L C TLV+E++ + L L K P + +T +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLD-KVPEPGVPTETIKDMM 116
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S ++
Sbjct: 117 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 171
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 503
T Y PE L D++S G I + +P + +V GK+
Sbjct: 172 -------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKI 221
Query: 504 KNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKDV 544
+++ P DWP A + + K ELGKD+
Sbjct: 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 289 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVTLV 342
+G G G++YK LL +A+K++ L E Q+ E++IL K P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI---PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 343 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
GA ++ E++ GSL D + RIA + L +L S K
Sbjct: 66 GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLK--- 115
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
I+H D+KP+N+L++ KL DFG+S L ++S T GT AYM PE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYV------GTNAYMAPERI 165
Query: 461 ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLD---PLAGDWPF 516
+ + SDV+S GI + L GR P I K + L+ ++D P+ F
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 517 VQAEQLANLAMRCCEMSRKSRP 538
+E+ + +C K RP
Sbjct: 226 --SEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 289 IGEGGYGSIYKGL-------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+G+G +G +Y L QV P + + S + EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 342 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G + T+ EY+P GS++D+L L+ + ++ + +LHS
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHS-- 124
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT--ICMSGTGIRSVT---GTPYWMSP 178
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E ++ K+DV+S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHPN 337
+F+ +IG G YG +YK R++ AIK++ + + QQEI ++ +H N
Sbjct: 10 DFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 338 LVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
+V G+ ++W + E+ GSL+D + PLS ++ E L +LH
Sbjct: 68 IVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH 123
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S +H D+K ANILL N KL+DFG+S ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRKSFIGTPYW 172
Query: 455 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 488
M PE A G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 43/276 (15%)
Query: 288 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLV 339
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 340 TLVGACPEVW-TLV-YEYLPNGSLEDRL----SCKDNSP---PLSWQTRIRIATELCSVL 390
L+G + TLV E + G L+ L +N+P P S + I++A E+ +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L++ K VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--------RKGGKG 181
Query: 451 TFA--YMDPEFLASGELTPKSDVYSFGIILLRL--LTGRPALGITKE--VQYALDTGKLK 504
+M PE L G T SDV+SFG++L + L +P G++ E +++ ++ G L
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL- 240
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540
D P + L L C + + K RP
Sbjct: 241 --------DKPDNCPDMLFELMRMCWQYNPKMRPSF 268
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 25/217 (11%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRHP 336
H+++ ++G G YG +YK R++ A+K++ S QQEI ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66
Query: 337 NLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
N+V G+ E + EY GSL+D + PLS + E L +LH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH 123
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S +H D+K ANILL N KL+DFG++ ++ T+ R GT +
Sbjct: 124 S---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--------ATIAKRKSFIGTPYW 172
Query: 455 MDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPAL 488
M PE A +G D+++ GI + L +P +
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 51/289 (17%)
Query: 288 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVT 340
+IG G +G + G + +V +K L + P E F QE+ ++ HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 341 LVGACPEV--WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 396
+G C E + LV E+ P G L++ L Q + R+A E+ S L++LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCRTDPKGTFAY 454
+H DL N L A+ K+ D+G+ ++ I+ + + R +
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--------W 168
Query: 455 MDPEFLAS-------GELTPKSDVYSFGIILLRLLTGR----PALGITKEVQYALDTGKL 503
+ PE + + T KS+++S G+ + L T P L + ++ + +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 504 K----NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548
K L + W V M+ C + ++RP ++V +L
Sbjct: 229 KLPKPQLDLKYSDRWYEV---------MQFCWLDPETRPTA-EEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 344
KIG+G G+++ + +VAIK ++ EI ++ ++++PN+V + +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 345 -CPEVWTLVYEYLPNGSLEDRLS--CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ +V EYL GSL D ++ C D + + + E L FLH+ + +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA------VCRECLQALEFLHA---NQV 136
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H D+K N+LL + KL+DFG ++ + S +T+ GT +M PE +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV------GTPYWMAPEVVT 188
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
PK D++S GI+ + ++ G P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 340
++G G +G++ KG+ + + VA+K+L + P+ E +E +++ ++ +P +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVR 60
Query: 341 LVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC-SVLIFLHSCKP 398
++G C E W LV E G L L + + TEL V + + +
Sbjct: 61 MIGICEAESWMLVMELAELGPLNKFLQKNKH-------VTEKNITELVHQVSMGMKYLEE 113
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ VH DL N+LL +K+SDFG+S+ L +E +T K + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-----NYYKAKTHGKWPVKWYAPE 168
Query: 459 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 502
+ + + KSDV+SFG+++ + +P G+ EV +++G+
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 26/206 (12%)
Query: 289 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ----QEIDILSKIRHPNLVTLV 342
I +G +GS+Y K AIK+L + ++ + ++ + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 343 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+ + LV EYL G S L + E+ + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCA---SLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RG 117
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
I+H D+KP N+L+D KL+DFG+SR +N+ GT Y+ PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------------KFVGTPDYLAPETI 165
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
SD +S G ++ L G P
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 39/245 (15%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL--V 342
K+GEG Y ++YKG + VA+K + +G P +E +L ++H N+VTL +
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------- 395
+ TLV+EYL D + + +V +FL
Sbjct: 72 IHTKKTLTLVFEYLD----------TDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAY 118
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFA 453
C ++H DLKP N+L+ KL+DFG++R S S+ TL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW---------- 168
Query: 454 YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512
Y P+ L S E + D++ G I + TGRP + +V+ L + L P
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK-IFRVLGTPTEE 227
Query: 513 DWPFV 517
WP V
Sbjct: 228 TWPGV 232
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 29/214 (13%)
Query: 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKML-HPH--SLQGPSEFQQEIDILSKIRHPNLVT 340
S+ I E SIYKG+ + +V I+ H + EI L +I N++
Sbjct: 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82
Query: 341 LVG-------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
+ G P + +L+ EY G L + L D LS++T++ +A + C L L
Sbjct: 83 IYGFIIDIVDDLPRL-SLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNL 138
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
+ K + + +L + L+ N+ K+ G+ + LS + N
Sbjct: 139 Y--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----------MV 185
Query: 454 YMDPEFLAS--GELTPKSDVYSFGIILLRLLTGR 485
Y + L E T K D+YS G++L + TG+
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 340
+GEG YG + K RH + VAIK + E ++ E+ +L ++ N+V
Sbjct: 9 VGEGAYGVVLK--CRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVE 64
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L A LV+EY+ LE + PP ++ + + ++ +H C
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP------EKVRSYIYQLIKAIHWCHK 118
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ IVH D+KP N+L+ N V KL DFG +R LS+ ++ T+ T Y PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN-------YTEYVATRWYRSPE 171
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L D++S G IL L G+P
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 49/221 (22%)
Query: 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH-PNLVTLVGA 344
IG G +G++ K L + + + S E ++ ++D++ + P +V GA
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 345 ---------CPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 387
C E+ + VYE L K P I +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVL-----------KSVIP-----EEILGKIAVA 115
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+V + + I+H D+KP+NILLD N KL DFGIS L + I+ +T
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIA--------KTR 166
Query: 448 PKGTFAYMDPEFLASGELTP---KSDVYSFGIILLRLLTGR 485
G YM PE + +SDV+S GI L + TG+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 288 KIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNL 338
++GE +G +YKG L + VAIK L + +GP EF+ E + S+++HPN+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 339 VTLVGACP--EVWTLVYEYLPN----------------GSLEDRLSCKDNSPPLSWQTRI 380
V L+G + ++++ Y + GS +D + K P + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---V 127
Query: 381 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS--N 438
I T++ + + FL S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 128 HIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
N+ L R +M PE + G+ + SD++S+G++L + +
Sbjct: 185 NSLLPIR--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 289 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 341
+G+G +G +Y R + V P S + E + EI +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 342 VGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G + ++ E++P GS++D+L + L+ + ++ + +LHS
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHS-- 124
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ IVH D+K ANIL D+ KL DFG S+ L I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT--ICLSGTGMKSVT---GTPYWMSP 178
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E ++ K+D++S G ++ +LT +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 289 IGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEID---ILSKIRHPNLV 339
+G G +G+++KG+ + VAIK + S G FQ+ D + + H +V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 340 TLVGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G CP LV + P GSL D + + + L Q + ++ + +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEE--- 127
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
H +VH +L NILL ++ + +++DFG++ L ++ ++ K +M E
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY------FYSEHKTPIKWMALE 181
Query: 459 FLASGELTPKSDVYSFGIILLRLLT 483
+ G T +SDV+S+G+ + +++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 288 KIGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSEF---QQEIDILSKIRHPNLVT 340
++G+G +G++Y K + ++ + P P+E QE +LSK+ HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+ E + ++ EY L+ +L K LS ++ +L+ +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS---ENQVCEWFIQLLLGVHYMH 123
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
I+H DLK NI L N + K+ DFG+SR L + TT GT YM P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS--CDLATTF------TGTPYYMSP 174
Query: 458 EFLASGELTPKSDVYSFGIIL 478
E L KSD++S G IL
Sbjct: 175 EALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 45/218 (20%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKML--HPHSLQGPSEFQQEIDILSKIR-HPNLVT 340
KIGEG + + K + + AIK + H SL+ + + EI L ++ HPN++
Sbjct: 6 KIGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILR 62
Query: 341 LVGACPEV--------WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
L+ EV LV+E L + +L + + K PL + +L L
Sbjct: 63 LI----EVLFDRKTGRLALVFE-LMDMNLYELI--KGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR---TDPK 449
+H + I H D+KP NIL+ + + KL+DFG R + + T+
Sbjct: 116 MHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR------------GIYSKPPYTEYI 159
Query: 450 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
T Y PE L G PK D+++ G + +L+ P
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL-QG-PSEFQQEIDILSKIRHPN 337
++ KIGEG YG+++K R VA+K + +G PS +EI +L +++H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 338 LVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+V L V + TLV+EY + SC + P ++ +L L F HS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS---FMFQLLKGLAFCHS 117
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H+++H DLKP N+L++ N KL+DFG++R + + C + T Y
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYR 166
Query: 456 DPEFLASGELTPKS-DVYSFGIILLRLLT-GRP 486
P+ L +L S D++S G I L GRP
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP--HSLQGPSEFQQ----EIDILSK 332
+ IGEG YG + + ++VAIK + P H F Q EI IL +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----FCQRTLREIKILRR 59
Query: 333 IRHPNLVTL--------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS--------W 376
+H N++ + + +V+ +V E + L + + LS +
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVY-IVQELMET-DLYKLIK----TQHLSNDHIQYFLY 113
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
Q +R L ++HS +++H DLKP+N+LL+ N K+ DFG++R
Sbjct: 114 QI-LR-------GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 437 SNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ T+ T Y PE L S T D++S G IL +L+ RP
Sbjct: 163 TGFL-----TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSK-IRHPNLVT 340
IG+G +G + L +H A+K+L ++ E + E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 341 LVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 397
L + + V +Y+ G L L + + P + R R A E+ S L +LHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN 116
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
I++ DLKP NILLD+ L+DFG+ + E S +T C GT Y+ P
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFC------GTPEYLAP 165
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L D + G +L +L G P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
D +KIGEG G + ++ VA+K + Q E+ I+ +H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 341 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 392
LVG E+W +V E+L G+L D ++ TR+ +IA +VL
Sbjct: 82 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLKA 128
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
L ++H D+K +ILL + KLSDFG +S+ E+ + + GT
Sbjct: 129 LSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLV-------GTP 180
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+M PE ++ P+ D++S GI+++ ++ G P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 48/238 (20%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLH-PHSLQG-PSEFQQEIDILSKIRHPNL 338
FD +IGEG YG +YK + VA+K + + +G P +EI IL ++ H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 339 VTLVGACPEVWT----------------LVYEYLPN---GSLEDRLS--CKDNSPPLSWQ 377
V L E+ T LV+EY+ + G LE L +D+
Sbjct: 69 VNLK----EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------- 117
Query: 378 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437
I + + +L L+ C + +H D+K +NILL+ KL+DFG++R + E
Sbjct: 118 ----IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 438 NNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEV 494
T+ T Y PE L E P DV+S G IL L T +P +E+
Sbjct: 174 -------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
D +KIGEG G + +H QVA+K + Q E+ I+ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 341 -----LVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI---RIATELCSVLIF 392
LVG E+W +V E+L G+L D ++ TR+ +IAT SVL
Sbjct: 84 MYNSYLVG--DELW-VVMEFLEGGALTDIVT----------HTRMNEEQIATVCLSVLRA 130
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
L ++H D+K +ILL ++ KLSDFG +S+ E+ + + GT
Sbjct: 131 LSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLV-------GTP 182
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+M PE ++ + D++S GI+++ ++ G P
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 59/276 (21%)
Query: 289 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLV 339
+G+G YG + L+RH Q IK L +L+ S +QE +LS+++HPN+V
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKL---NLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 340 TLVGACPEVWT-------LVYEYLPNGSLEDRLSCKD-----NSPPLSWQTRIRIATELC 387
E W +V + G L +L + + + W +I +A
Sbjct: 63 AY----RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL-SQNEISSNNTTLCCRT 446
L +LH I+H DLK N+ L + K+ D GI+R L +Q +++S TL
Sbjct: 115 --LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS---TLI--- 163
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI--TKEVQYALDTGKLK 504
GT YM PE ++ KSDV++ G + + T + A + Y + GKL
Sbjct: 164 ---GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540
P+ D+ + +L L + RP +
Sbjct: 221 ----PMPKDY----SPELGELIATMLSKRPEKRPSV 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 307 VAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPNLVTLVGACPEVWTL--VYEYLPNGSLE 362
VA+KML + + S+ E++++ I +H N++ L+GAC + L + EY G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 363 DRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 409
+ L + ++++ + ++ + +L S K +H DL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166
Query: 410 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
N+L+ N V K++DFG++R + N I T T+ + +M PE L T +S
Sbjct: 167 NVLVTENNVMKIADFGLARDV--NNIDYYKKT----TNGRLPVKWMAPEALFDRVYTHQS 220
Query: 470 DVYSFGIILLRLLT--GRPALGITKEVQYAL 498
DV+SFG+++ + T G P GI E + L
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 68/249 (27%), Positives = 113/249 (45%), Gaps = 23/249 (9%)
Query: 278 GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIR 334
G +++ K+GEG Y ++YKG + VA+K++ +G P +E +L ++
Sbjct: 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 335 HPNLVTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLI 391
H N+V L + E TLV+EY+ D D P +++ +L L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
++H I+H DLKP N+L+ KL+DFG++R S + +N + T
Sbjct: 118 YIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--------T 166
Query: 452 FAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510
Y P+ L S E + D++ G I + ++ G A K++Q L+ L L P
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV-LGTPN 225
Query: 511 AGDWPFVQA 519
WP V +
Sbjct: 226 EDTWPGVHS 234
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 289 IGEGGYGSIY----KGLLRHMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 341
+G G +G +Y R + V P S + E + EI +L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 342 VGAC--PE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G PE ++ EY+P GS++D+L L+ R ++ + +LHS
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHS-- 124
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ IVH D+K ANIL D+ KL DFG S+ + I + T + T GT +M P
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT--ICMSGTGIKSVT---GTPYWMSP 178
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E ++ K+DV+S ++ +LT +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 41/217 (18%)
Query: 289 IGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 339
+G+GGYG ++ G + M+V K + + + + E +IL ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 340 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE------LCSVLI 391
L+ A L+ EYL G L L R I E L + +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE------------REGIFMEDTACFYLSEISL 111
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 449
L I++ DLKP NILLDA KL+DFG L + I T C
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG----LCKESIHEGTVTHTFC------ 161
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT YM PE L D +S G ++ +LTG P
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 291 EGGYGSIYKGLLRHM------QVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRHPNLV 339
EG +G I+ G+L +V +K + H+ SE Q QE +L + H N++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----SEIQVTLLLQESCLLYGLSHQNIL 71
Query: 340 TLVGACPEVWT---LVYEYLPNGSLED-----RLSCKDNSPPLSWQTRIRIATELCSVLI 391
++ C E ++Y Y+ G+L+ RL +N LS Q + +A ++ +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
+LH ++H D+ N ++D K++D +SR L + C +
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------CLGDNENRP 182
Query: 452 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
+M E L + E + SDV+SFG++L L+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQ---EIDILSKIRHPNLVTLV 342
+G G G + K L R + +A K++H L+ P+ Q E+ +L + P +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIH---LEIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 343 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
GA E+ ++ E++ GSL D++ K P + +I IA + L +L + H
Sbjct: 66 GAFYSDGEI-SICMEHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLR--EKH 119
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM PE
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYMSPER 169
Query: 460 LASGELTPKSDVYSFGIILLRLLTGR 485
L T +SD++S G+ L+ + GR
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 288 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL-- 341
K+GEG Y ++YKG+ R + VA+K++ + +G P +E +L ++H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQL-VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 342 VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT-ELCSVLIFLHSCKPHS 400
+ E T V+EY+ D P +R+ +L L ++H
Sbjct: 71 IIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QH 123
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPE 458
I+H DLKP N+L+ KL+DFG++R S SS TL Y P+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW----------YRPPD 173
Query: 459 -FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDWPF 516
L + + + D++ G I + +L G+PA +V L+ K+ +L P WP
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE--KIWTVLGVPTEDTWP- 230
Query: 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548
++ L E +P+ + VW+ L
Sbjct: 231 ----GVSKLPNYKPEWFLPCKPQQLRVVWKRL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 64/238 (26%), Positives = 94/238 (39%), Gaps = 58/238 (24%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKML-------HPHSLQGPSEFQQEIDILSKIRHPN 337
IG G +G ++ L+R A+K+L + + E DIL+ P
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQI----AHVRAERDILADADSPW 62
Query: 338 LVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
+V L ++ LV EY+P G L + L KD P R IA EL
Sbjct: 63 IVKLY------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ET-ARFYIA-ELVLA 113
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS----------RFLSQNEISSNN 439
L +H +H D+KP NIL+DA+ KL+DFG+ +L+ +
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 440 TTLCCRTDPK-----------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ R GT Y+ PE L + D +S G+IL +L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 35/270 (12%)
Query: 289 IGEGGYGSIYK-------GLLRHMQVAIKMLHPHSLQGPSEFQQEID--------ILSKI 333
+G G +G +YK L ++ I + +P + E + I I ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALK-EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 334 RHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVL 390
RHPN+V E L V + + L + S K+ + + I ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+LH K IVH DL P NI+L + ++DFG+++ T G
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---------LTSVVG 175
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510
T Y PE + + K+DV++FG IL ++ T +P T + A T ++ + +PL
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--TKIVEAVYEPL 233
Query: 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540
+ +E + ++ C ++RP++
Sbjct: 234 PEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRH---MQV-AIKMLHPHSLQGPSE---FQQEIDILSKI 333
+FD IG G +G + L+RH QV A+K+L + S+ F +E DI++
Sbjct: 43 EDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 334 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 391
+V L A + +V EY+P G L + +S D P W R A E+ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKW-ARFYTA-EVVLALD 156
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
+HS +H D+KP N+LLD + KL+DFG + N + +T + GT
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-------GT 206
Query: 452 FAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRP 486
Y+ PE L S G + D +S G+ L +L G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLV----T 340
IG+G YG + + H +VAIK ++ + + +EI +L +RHP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 341 LVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
++ + +V+E L L + D+ P Q + +L L ++H+
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---YQLLRALKYIHTA- 122
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-TLCCRTDPKGTFAYMD 456
++ H DLKP NIL +A+ K+ DFG++R ++ N+T T TD T Y
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVATRWYRA 174
Query: 457 PEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 499
PE S + TP D++S G I +LTG+P L K V + LD
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQ-------VAIKMLHPHSLQGPSEFQ--QEIDILSKIRHPNLV 339
+G+G +G ++ L+R + A+K+L +L+ + E DIL+++ HP +V
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSC 396
L A L+ ++L G L RLS + + ++ EL L LHS
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
I++ DLKP NILLD KL+DFG+S+ +E + C GT YM
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC------GTVEYMA 166
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTG 484
PE + T +D +SFG+++ +LTG
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 57/232 (24%)
Query: 288 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 340
IG G YG +YK ++ + AIK Q Q +EI +L +++H N+V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 341 LVGACPE-----VWTLVYEYLPNGSLEDRLS-CKDNS-------PP-----LSWQTRIRI 382
LV E V+ L+++Y + D K + PP L WQ
Sbjct: 67 LVEVFLEHADKSVY-LLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFL---SQNEI 435
+ + + +LHS + ++H DLKPANIL+ V K+ D G++R +
Sbjct: 117 ---ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 436 SSNNTTLCCRTDPKGTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 486
+ + T Y PE L + T D+++ G I LLT P
Sbjct: 171 DLDPVVV--------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 342
+IG G +G++Y VAIK + Q ++Q +E+ L ++RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 343 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G T LV EY GS D L + PL I L +LHS H
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-F 459
+H D+K NILL KL+DFG S + +S N+ + GT +M PE
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSFV-------GTPYWMAPEVI 183
Query: 460 LA--SGELTPKSDVYSFGIILLRLLTGRPAL 488
LA G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 51/277 (18%)
Query: 289 IGEGGYGSIYKGLLRH----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLV 342
+GEG +GS+ +G L ++VA+K + + +F E + + HPN++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 343 GACPEVW--------TLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVLI 391
G C + ++ ++ +G L L D L Q ++ T++ S +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR------FLSQNEISSNNTTLCCR 445
+L S S +H DL N +L+ N ++DFG+S+ + Q I+
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--------- 174
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGI----ILLRLLTGRPALGITKEVQYALDTG 501
K ++ E LA T KSDV+SFG+ I R T P + ++ Y
Sbjct: 175 ---KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+LK D L G L +L C ++ K RP
Sbjct: 232 RLKQPPDCLDG---------LYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 288 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 342
+IG G +G++Y + + VAIK + Q ++Q +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 343 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G T LV EY GS D L + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
++H D+K NILL + KL DFG S + ++ N + GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFV-------GTPYWMAPEVI 183
Query: 461 AS---GELTPKSDVYSFGIILLRLLTGRPAL 488
+ G+ K DV+S GI + L +P L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 46/221 (20%)
Query: 289 IGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQ---------QEIDILSKIRHPN 337
IG G YG + + +VAIK + F +EI +L +RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 338 LVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR-IATELCS 388
++ L+ +V+ +V E + L + PL+ I+ ++
Sbjct: 61 IIGLLDILRPPSPEDFNDVY-IVTELMET-DLHKVIKSPQ---PLTDD-HIQYFLYQILR 114
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT--LCCRT 446
L +LHS ++H DLKP+NIL+++N K+ DFG++R + +E T + R
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 447 DPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
Y PE L+S T D++S G I LLT +P
Sbjct: 172 -------YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 342
+IG G +G++Y H VA+K + Q ++Q +E+ L +++HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 343 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G + T LV EY GS D L + PL I L +LHS H+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 141
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
++H D+K NILL KL+DFG S ++ S N+ + GT +M PE +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFV-------GTPYWMAPEVI 189
Query: 461 AS---GELTPKSDVYSFGIILLRLLTGRPAL 488
+ G+ K DV+S GI + L +P L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 35/214 (16%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ--QEIDILSKIRH-PNLVTL 341
+G G YG + K +RH+ +A+K + ++ + + ++DI + P VT
Sbjct: 9 LGRGAYGVVDK--MRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 342 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 396
GA +VW + + + SL D+ K L+ I +IA + L +LHS
Sbjct: 66 YGALFREGDVW--ICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
S++H D+KP+N+L++ N KL DFGIS +L + ++ +T G YM
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVA--------KTIDAGCKPYMA 171
Query: 457 PEFLASGELTP-----KSDVYSFGIILLRLLTGR 485
PE + + EL KSDV+S GI ++ L TGR
Sbjct: 172 PERI-NPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 280 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHP 336
T ++ IG+G YG +YK + A+K+L P S E + E +IL + HP
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79
Query: 337 NLVTLVG--------ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR---IATE 385
N+V G ++W LV E GS+ + + L R+ I+
Sbjct: 80 NVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMISYI 133
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 445
L L+ L + I+H D+K NILL KL DFG+S L+ + N +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 189
Query: 446 TDPKGTFAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPAL 488
GT +M PE +A + + DV+S GI + L G P L
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLH I++ DLK N+LLD+ K++DFG+ + + + T+
Sbjct: 102 AAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE L+ P D ++ G++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 49/273 (17%)
Query: 289 IGEGGYGSIYKGLLRH------------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP 336
+G+G + +IYKG+LR + V +K+L + F + ++S++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 337 NLVTLVGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+LV L G C + +V EY+ G L+ L + N+ L W ++ +A +L S L +L
Sbjct: 62 HLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 396 CKPHSIVHGDLKPANILL---DAN-----FVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
K +VHG++ NIL+ N F+ KLSD GI T+ R +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPI------------TVLSREE 163
Query: 448 PKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505
++ PE + +G+ LT +D +SFG LL + + T + ++
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
L D +LANL +C RP
Sbjct: 224 RLPMP--DCA-----ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 41/240 (17%)
Query: 289 IGEGGYGSIYKGLL---------RHMQVAIKMLHPHSLQGP-SEFQQEIDILSKI-RHPN 337
+GEG +G + R +VA+KML + + S+ E++++ I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 338 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP---------------LSWQTRI 380
++ L+GAC + L + EY G+L + L + PP LS++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR--RPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 381 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 440
A ++ + +L S K +H DL N+L+ + V K++DFG++R + + I
Sbjct: 144 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 198
Query: 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 498
T T+ + +M PE L T +SDV+SFG++L + T G P G+ E + L
Sbjct: 199 T----TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 305 MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACPE---VWTLVYEYLPNG 359
+ VA+KML + + S+ E++++ I +H N++ L+GAC + ++ LV EY G
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKG 103
Query: 360 SLEDRL-------------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406
+L + L +CK L+++ + A ++ + +L S K +H DL
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160
Query: 407 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 466
N+L+ + V K++DFG++R + + T + + +M PE L T
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT------NGRLPVKWMAPEALFDRVYT 214
Query: 467 PKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 498
+SDV+SFG++L + T G P GI E + L
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 37/238 (15%)
Query: 289 IGEGGYGSIYK----GLLRHMQ-----VAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPN 337
+GEG +G + + G+ + VA+KML ++ + ++ E++++ I +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 338 LVTLVGACPEVWTL--VYEYLPNGSLEDRLSCK-----DNSP--------PLSWQTRIRI 382
++ L+G C + L + EY G+L + L + D + LS++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A ++ + +L S + +H DL N+L+ + V K++DFG++R + I T
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKTS 194
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYAL 498
R K +M PE L T +SDV+SFGI++ + T G P GI E + L
Sbjct: 195 NGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIR 334
++D IG G +G + L+RH A+K+L + S+ F +E DI++
Sbjct: 44 DYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 335 HPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
P +V L A + +V EY+P G L + +S D P W + T V++
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---KFYT--AEVVLA 154
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
L + ++H D+KP N+LLD + KL+DFG + + + +T + GT
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-------GTP 207
Query: 453 AYMDPEFLAS----GELTPKSDVYSFGIILLRLLTG 484
Y+ PE L S G + D +S G+ L +L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 288 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLV 342
+IG G +G++Y + + + VAIK + Q ++Q +E+ L +I+HPN +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 343 GACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G T LV EY GS D L + PL I L +LHS H+
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HN 145
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
++H D+K NILL KL+DFG S + S N+ + GT +M PE +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFV-------GTPYWMAPEVI 193
Query: 461 AS---GELTPKSDVYSFGIILLRLLTGRPAL 488
+ G+ K DV+S GI + L +P L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 36/104 (34%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L+FLH H +++ DLK NILLDA KL+DFG+ + + ++ TT
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE L E P D ++ G+++ ++ G+P
Sbjct: 156 FC-----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 289 IGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 341
+G G +G++YKG+ + VAIK+L + S + E E +++ + P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 342 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C LV + +P G L D + ++N + Q + ++ + +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+VH DL N+L+ + K++DFG++R L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH------ADGGKVPIKWMALESI 183
Query: 461 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 502
T +SDV+S+G+ + L+T +P GI +E+ L+ G+
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 289 IGEGGYGS--IYKGLLRHMQVAIKMLH-PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+GEG +G + + + + A+K + P S + ++E +L+K++HPN+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 346 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPL-SWQTRIRIATELCSVLIFLHSCKPHSIV 402
L V EY G L ++ K L T ++ ++C + +H + ++
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+K NI L N KL DFG +R L ++ C GT Y+ PE +
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLL------TSPGAYACTY--VGTPYYVPPEIWEN 174
Query: 463 GELTPKSDVYSFGIILLRLLT 483
KSD++S G IL L T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVG 343
+G+GG+G + ++ A K L L +G E IL K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 344 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV + G L+ + P I A ++ L LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 402 VHGDLKPANILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
V+ DLKP N+LLD + ++SD G++ +I GT YM PE L
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----------AGTPGYMAPEVL 166
Query: 461 ASGELTPKSDVYSFGIILLRLLTGR 485
D ++ G L ++ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTL 341
IG G +G + L+RH A+K+L + S+ F +E DI++ P +V L
Sbjct: 51 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
A + +V EY+P G L + +S D P W R T V++ L +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWA---RFYT--AEVVLALDAIHSM 161
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+H D+KP N+LLD + KL+DFG +++ + +T + GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-------GTPDYISPEV 214
Query: 460 LAS----GELTPKSDVYSFGIILLRLLTG 484
L S G + D +S G+ L +L G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 40/275 (14%)
Query: 289 IGEGGYGSIYKGLLRH-----MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTL 341
+G+G +GS+ + L+ +VA+KML S EF +E + + HPN++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 342 VGACPE--------VWTLVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 390
+G + ++ ++ +G L L + L QT +R ++ S +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L S + +H DL N +L+ N ++DFG+S+ + + C P
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG---CASKLPVK 180
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEV-QYALDTGKLKNL 506
A E LA T SDV++FG+ + ++T P G+ E+ Y + +LK
Sbjct: 181 WLAL---ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 541
D L E + L +C K RP
Sbjct: 238 PDCL---------EDVYELMCQCWSPEPKCRPSFQ 263
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 289 IGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 344
IG+G YG ++K L + + A+K+L P H + E + E +IL + HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGM 83
Query: 345 C--------PEVWTLVYEYLPNGSLEDRLSC-----KDNSPPLSWQTRIRIATELCSVLI 391
++W LV E GS+ D + + P+ IA L L+
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
L + +H D+K NILL KL DFG+S L+ + N + GT
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--------GT 187
Query: 452 FAYMDPEFLASGE-----LTPKSDVYSFGIILLRLLTGRPALG 489
+M PE +A + + DV+S GI + L G P L
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHP 336
+F+ ++G G G + K ++H + +A K++H ++ +E+ +L + P
Sbjct: 6 DFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 337 NLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
+V GA E+ ++ E++ GSL+ L P + +++ + L +L
Sbjct: 64 YIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYL 119
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +
Sbjct: 120 R--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRS 167
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
YM PE L + +SD++S G+ L+ L GR
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 289 IGEGGYGSIYKGLLR------HMQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
+G G +G++YKGL + VAIK L S + E E +++ + +P++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 342 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEE---RR 129
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
+VH DL N+L+ K++DFG+++ L +E + K +M E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH------AEGGKVPIKWMALESI 183
Query: 461 ASGELTPKSDVYSFGIILLRLLT--GRPALGI-TKEVQYALDTGK 502
T +SDV+S+G+ + L+T +P GI E+ L+ G+
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 70/239 (29%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 334
+F+ I G YG++Y L+RH + A+K ++ +L ++ QQ E DIL+
Sbjct: 2 DFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE 59
Query: 335 HPNLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 387
+P +V++ + C +V EY+ G D + N L E
Sbjct: 60 NPFVVSMFCSFETKRHLC-----MVMEYVEGG---DCATLLKNIGALPVDMARMYFAETV 111
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
L +LH+ + IVH DLKP N+L+ + KL+DFG LS+ + S T L
Sbjct: 112 LALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG----LSKIGLMSLTTNLYEGHI 164
Query: 448 PKGTFAYMD------PEFLA------SGELTPKSDVYSFGIILLRLLTG-RPALGITKE 493
K T ++D PE++A G P D ++ GIIL L G P G T E
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 57/250 (22%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRH--------MQVAIK--MLHPHSLQGPSEFQQEIDIL 330
+F+ IG G +G + L++ M+ K ML + + + E DIL
Sbjct: 1 DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQV---AHVRAERDIL 55
Query: 331 SKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSW-QTRIRIATELC 387
++ +P +V L + L+ EYLP G + L KD + +TR IA
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIA---- 108
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS------------RFLSQNEI 435
++ + S +H D+KP N+LLDA KLSDFG+ R LS
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 436 SSNNTTLCCRTDPK------------------GTFAYMDPE-FLASGELTPKSDVYSFGI 476
S+ + K GT Y+ PE FL +G + D +S G+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGV 227
Query: 477 ILLRLLTGRP 486
I+ +L G P
Sbjct: 228 IMYEMLVGYP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLV 339
IG+GG G +Y L + +VA+K + + P F +E I + + HP +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 340 TLVGACPEVWTLVYE--YLPNGSLEDRL----SCKDNSPPLSWQTRI----RIATELCSV 389
+ C + + Y Y+ +L+ L + S L+ +T + I ++C+
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE-----ISSNNTTLCC 444
+ ++HS ++H DLKP NILL + D+G + F E I + +C
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 445 R--TDPK---GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
T P GT YM PE L + +D+Y+ G+IL ++LT
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 281 HNFDPSLKIGEGGYGSI----YKGLLRHMQVAIKMLHPHSLQGPSEFQ---QEIDILSKI 333
+F+ +G G +G + +KG + AIK L + + Q QE IL ++
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 334 RHPNLVTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
HP +V ++ + + V+ + E++ G L L P +A + L
Sbjct: 76 SHPFIVNMMCSFQDENRVY-FLLEFVVGGELFTHLRKAGRFPN-------DVAKFYHAEL 127
Query: 391 I----FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
+ +LHS I++ DLKP N+LLD K++DFG ++ ++ TLC
Sbjct: 128 VLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC--- 176
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE + S D ++ G++L + G P
Sbjct: 177 ---GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 288 KIGEGGYGSIYKGL----LRHMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLV 342
+IG G +G + G QV +K L S+Q +F +E ++H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 343 GACPEV--WTLVYEYLPNGSLEDRL-SCK--DNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G C EV + LV E+ P G L+ L SC+ + P T R+A E+ L+ LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK-- 118
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGIS 427
++ +H DL N LL A+ K+ D+G+S
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 289 IGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLVTL 341
IG+G +G + K L A+K+L + E Q+ I +L ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 342 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 398
+ E V +++ G L L ++ S P + R R A E+ S L +LHS
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFP---EPRARFYAAEIASALGYLHSIN- 116
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
IV+ DLKP NILLD+ L+DFG+ + S TT C GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFC------GTPEYLAPE 166
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ D + G +L +L G P
Sbjct: 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSK-IRHPNLVT 340
IG+G +G + L RH A+K+L ++ E E ++L K ++HP LV
Sbjct: 3 IGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 341 LVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCK 397
L + L V +Y+ G L L + R R A E+ S L +LHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+IV+ DLKP NILLD+ L+DFG+ + E + +T C GT Y+ P
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFC------GTPEYLAP 165
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L D + G +L +L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 282 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 332
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 333 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
+R P LVTL A L+ +Y+ G L L +++ + R+ IA E+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVYIA-EIVLA 117
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTDP 448
L LH I++ D+K NILLD+ L+DFG+S+ FL++ E + + C
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFC----- 167
Query: 449 KGTFAYMDPEFLASGELTPKS--DVYSFGIILLRLLTG 484
GT YM PE + G D +S G++ LLTG
Sbjct: 168 -GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 289 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 343
IG+G +G + + R Q A+K + + SE E +L+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 344 A--CPEVWTLVYEYLPNGSLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
+ PE LV ++ G L L D S + R A LC+ L LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-----RARFYTAELLCA-LENLHK--- 111
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
++++ DLKP NILLD L DFG+ + +++ +N T C GT Y+ PE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN--TFC------GTPEYLAPE 163
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL--KNLLDPL 510
L T D ++ G++L +LTG P Y + ++ K L +PL
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPF-------YDENVNEMYRKILQEPL 210
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGP---SEFQQEIDILSKIR 334
+FD +G G +G + ++R A+K++ L S F++E DILS
Sbjct: 2 DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 335 HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
P + L A + LV EY P G L L+ ++ + + L +++
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFD-EDMAQFY--LAELVLA 114
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
+HS VH D+KP N+L+D KL+DFG S +++N P GT
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-----SAARLTANKMVNS--KLPVGTP 167
Query: 453 AYMDPEFLASGELTPKS------DVYSFGIILLRLLTGR 485
Y+ PE L + K D +S G+I ++ GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 52/274 (18%)
Query: 289 IGEGGYGSIYKGL---------LRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 339
+G+G + I+KG+ L +V +K+L F + ++S++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G C + +V EY+ GSL+ L N +SW ++ +A +L L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED-- 118
Query: 398 PHSIVHGDLKPANILL----DANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
+ HG++ N+LL D + KLSD GIS + EI L R
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLER---- 167
Query: 450 GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG--RP--ALGITKEVQYALDTGKLK 504
++ PE + L+ +D +SFG L + +G +P AL K++Q+ D +L
Sbjct: 168 --IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP 225
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
A W +LANL +C + RP
Sbjct: 226 ------APKW-----TELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
VL+ +H ++H D+K ANILL +N + KL DFG S+ + T C
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----- 206
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 486
GT Y+ PE + K+D++S G++L LLT RP
Sbjct: 207 -GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-09
Identities = 32/165 (19%), Positives = 68/165 (41%), Gaps = 19/165 (11%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIES--------IRRAKASESLYAEELK-- 162
+L + + E E E ++ G+ E+ ++ I + S + EL+
Sbjct: 261 SELEKRLEEIEQLLEELNKKIKDLGEEEQLRVKEKIGELEAEIASLERSIAEKERELEDA 320
Query: 163 --RRKEFEEALANGKLE-------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 213
R + E + E +E +K+ D++ EE ++ L +++ E D+
Sbjct: 321 EERLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEF 380
Query: 214 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E ++ E L+ K+E +EL+ E D+ +E + L + +
Sbjct: 381 AETRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADL 425
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 338
+F+ ++G G G ++K + + +A K++H ++ +E+ +L + P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 339 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
V GA E+ ++ E++ GSL+ L P Q +++ + L +L
Sbjct: 66 VGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLR- 120
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
+ H I+H D+KP+NIL+++ KL DFG+S L I S + GT +YM
Sbjct: 121 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV------GTRSYM 169
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGR 485
PE L + +SD++S G+ L+ + GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 42/216 (19%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEID-----ILSKIRHPNLV 339
IG+G +G + L + A+K+L ++ E Q I +L ++HP LV
Sbjct: 3 IGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLV 59
Query: 340 TLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVL 390
L + E V +Y+ G L E + R R A E+ S +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----------EPRARFYAAEVASAI 109
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+LHS +I++ DLKP NILLD+ L+DFG+ + E +T C G
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFC------G 158
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T Y+ PE L D + G +L +L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 65/246 (26%), Positives = 96/246 (39%), Gaps = 30/246 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
KIGEG YG +YK ++ VA+K L P +EI +L + + +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 344 ACPEVWT--------LVYEYLPNG--SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
V LV+EYL + D + + PL +T +L +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 394 HSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
H H ++H DLKP N+L+D + K++D G+ R S + T T
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--------IPVKSYTHEIVTL 175
Query: 453 AYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511
Y PE L S + D++S G I + +P E+Q L KL L P
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL--LGTPTE 233
Query: 512 GDWPFV 517
WP V
Sbjct: 234 QVWPGV 239
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
+L +A E E EE +A ++ + + A EELKR E E
Sbjct: 354 AELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEE-- 411
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
LER+ ++ +++ EEL+ + L++++ E ++ +ELE+++ + L+ ++
Sbjct: 412 ----RLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKELER 467
Query: 233 EQDELQMERDKAVKEAEELRK 253
E ELQ E + KE L
Sbjct: 468 ELAELQEELQRLEKELSSLEA 488
|
Length = 1163 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 289 IGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGPSEFQQ-----EIDILSKIRHPNL 338
+G G +G + +G L R + VAI L G S+ Q+ E L + H N+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLR----AGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 339 VTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
V L G T+ V EY+ NG+L+ L + + L + + L S + +L
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
VH L +L++++ V K+S F R L +++ + TT+ K +
Sbjct: 127 ---GYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTM----SGKSPVLWAA 176
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT 483
PE + + SDV+SFGI++ +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 282 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 332
NF+ +G G YG ++ G L M+V K + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 333 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
IR P LVTL A L+ +Y+ G L LS ++ Q E+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS---GEIVLA 117
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L LH I++ D+K NILLD+N L+DFG+S+ ++E+ + C
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFC------ 167
Query: 450 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTG 484
GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 32/246 (13%)
Query: 249 EELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ-- 306
+ L+ +K+ S S+ P+ + + + NF +L G G +G + ++
Sbjct: 5 KNLQLHKKKDSDSTKEPKRKNKMKYEDF-----NFIRTL--GTGSFGRVILATYKNEDFP 57
Query: 307 -VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGS 360
VAIK + + E IL+ I HP V L G+ + LV E++ G
Sbjct: 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGE 117
Query: 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
L P A ++ + +L S +IV+ DLKP N+LLD + K
Sbjct: 118 FFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIK 171
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
++DFG ++ + + TLC GT Y+ PE L + +D ++ GI +
Sbjct: 172 MTDFGFAKV-----VDTRTYTLC------GTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220
Query: 481 LLTGRP 486
+L G P
Sbjct: 221 ILVGCP 226
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 17/145 (11%)
Query: 351 LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPA 409
V EYL G L + SC P + A E+ L FLHS IV+ DLK
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHS---KGIVYRDLKLD 125
Query: 410 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
NILLD + K++DFG+ + +N + T C GT Y+ PE L +
Sbjct: 126 NILLDTDGHIKIADFGMCK---ENMLGDAKTCTFC-----GTPDYIAPEILLGQKYNTSV 177
Query: 470 DVYSFGIILLRLLTGR-PALGITKE 493
D +SFG++L +L G+ P G +E
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 282 NFDPSLKIGEGGYGSIY---------KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 332
NF+ +G G YG ++ G L M+V K + + E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 333 IRH-PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCS 388
+R P LVTL A L+ +Y+ G + L +DN + +R + E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRTD 447
L LH IV+ D+K NILLD+ L+DFG+S+ FLS+ + + C
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--ERTYSFC---- 167
Query: 448 PKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTG 484
GT YM PE + K+ D +S GI++ LLTG
Sbjct: 168 --GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 31/165 (18%)
Query: 331 SKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL-----EDRLSCKDNSPPLSWQTRIRI 382
+ RHP LV L AC + V EY G L D S + R
Sbjct: 57 NSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----------EPRAVF 105
Query: 383 -ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
A + L +LH + IV+ DLK N+LLD K++DFG+ + +T
Sbjct: 106 YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160
Query: 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT ++ PE L T D + G+++ +L G
Sbjct: 161 FC------GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 109 DNLYDQLAQAMAEAE--NSRREAFEEALRRGKAEKD-----------AIESIRRAKAS-E 154
+ L +LA E E SR E EE L + E + +ES+ A A +
Sbjct: 719 EELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAKLK 778
Query: 155 SLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAK 214
E ++R+ +E L + ELE +++ D + EL+ ++ LE +I E ++ +
Sbjct: 779 EEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEEIE 838
Query: 215 ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
ELE+K+ E L+ +KE +EL+ E ++ E EEL KE
Sbjct: 839 ELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKEL 882
|
Length = 1163 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 326 EIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRI 382
E +L RHP L L + L V EY G L LS + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYG 101
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 440
A E+ S L +LHSC +V+ DLK N++LD + K++DFG L + IS T
Sbjct: 102 A-EIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG----LCKEGISDGATMK 153
Query: 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 154 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 40/111 (36%), Positives = 54/111 (48%), Gaps = 17/111 (15%)
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
+ + IA EL L LH + IV+ DLKP NILLDA L DFG LS+ ++
Sbjct: 97 RAKFYIA-ELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFG----LSKANLT 148
Query: 437 SNNT--TLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTG 484
N T T C GT Y+ PE L + T D +S G+++ + G
Sbjct: 149 DNKTTNTFC------GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 289 IGEGGYGSI--YKGLLRHMQVAIK-MLHPHSLQGPSEFQ-QEIDILSKIRHPNLVTL--V 342
+G G +G + + L VAIK ++ P S ++ +E+ +L +RH N+++L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 343 GACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
P E V E L G+ RL S PL Q ++ L ++HS +
Sbjct: 78 FISPLEDIYFVTELL--GTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSA---GV 129
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK-----GTFAYMD 456
VH DLKP+NIL++ N K+ DFG++R DP+ T Y
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARI----------------QDPQMTGYVSTRYYRA 173
Query: 457 PE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
PE L + + D++S G I +L G+P
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L ++HS +++H DLKP+N+LL+AN K+ DFG++R + + T+
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTEYV 169
Query: 450 GTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
T Y PE L E T DV+S G I LL +P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 32/226 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 341
K+G G YG +YK + + A+K + + + +EI +L +++HPN+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 342 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
A +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQILDGIHY 123
Query: 396 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 448
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 449 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 493
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 289 IGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----V 342
IG G +G +Y+ + +VAIK + LQ P +E+ I+ + H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 343 GACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
C + +V E++P + N+ L + +LC L ++HS
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188
Query: 397 KPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
I H DLKP N+L+D N KL DFG ++ L + S + +C R Y
Sbjct: 189 --KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-------YR 237
Query: 456 DPEF-LASGELTPKSDVYSFGIILLRLLTGRP 486
PE L + T D++S G I+ ++ G P
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 11/103 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLH I++ DLK N+LLD + K++DFG+ + +N +
Sbjct: 102 AAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST 155
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
C GT Y+ PE L + D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL-- 341
K+G G YG +YK + + A+K + + + +EI +L +++HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQK 65
Query: 342 ---VGACPEVWTLVYEYLPNG---SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+ +VW L+++Y + ++ + K N P+ R + + L +L +H
Sbjct: 66 VFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQILDGIHY 123
Query: 396 CKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTL--CCRTDP- 448
+ ++H DLKPANIL+ K++D G +R N+ L DP
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--------NSPLKPLADLDPV 175
Query: 449 KGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRPALGITKE 493
TF Y PE L K+ D+++ G I LLT P +E
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 289 IGEGGYGSIY------KGLLRHMQV----AIKMLHPHSLQGPSEFQQEIDILSKIRH--- 335
IG GG+G +Y G + M+ IKM QG + E +LS +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDC 56
Query: 336 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
P +V + A P+ + + + + G L LS S A E+ L +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHM 113
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H+ +V+ DLKPANILLD + ++SD G++ S+ + ++ GT
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHG 160
Query: 454 YMDPEFLASGELTPKS-DVYSFGIILLRLLTGR-PALGITKEVQYALDTGKL 503
YM PE L G S D +S G +L +LL G P + ++ +D L
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ S L+FLH I++ DLK N+LLD KL+DFG+ + N ++ +T
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STF 156
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 484
C GT Y+ PE L P D ++ G++L +L G
Sbjct: 157 C------GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLHS I++ DLK N++LD + K++DFG+ + +N N +
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST 155
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
C GT Y+ PE L + T D +SFG++L +L G+
Sbjct: 156 FC-----GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 288 KIGEGGYG-----SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
+IG G +G IY V ++ S + +EF Q+ D ++HPN++ +
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 343 GACPEV--WTLVYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSC 396
G C E + LV+EY G L+ LS + NS L Q R+A E+ + + +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK- 117
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGI--SRFLSQNEISSNNTTLCCR-TDPKGTFA 453
H+ +H DL N L ++ K+ D+GI SR+ + ++ + R P+
Sbjct: 118 --HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLL 482
+ L + E T S+V++ G+ L L
Sbjct: 176 FHGG--LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 49/225 (21%)
Query: 288 KIGEGGYGSI----YKGLLRHMQVAIK---------MLHPHSLQGPSEFQQEIDILSKIR 334
++G+G YG + VAIK +L +L+ E+ +L R
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-------ELKLLRHFR 59
Query: 335 -HPNLVTLV-------GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLS---WQTRI-RI 382
H N+ L G E++ +YE L L + + PL+ +Q+ I +I
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR---SGQPLTDAHFQSFIYQI 114
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
LC L ++HS +++H DLKP N+L++A+ K+ DFG++R S+N +
Sbjct: 115 ---LCG-LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM- 166
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 486
T+ T Y PE + S + K+ DV+S G IL LL +P
Sbjct: 167 ---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 75/239 (31%)
Query: 289 IGEGGYGSIYKGLLRH--MQVAIK---MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
+G G G ++ + +VA+K + P S++ +EI I+ ++ H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVK--- 66
Query: 344 ACPEVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIA--------TELCSV----- 389
VYE L P+GS D + + T + T+L +V
Sbjct: 67 --------VYEVLGPSGS--------DLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110
Query: 390 ----------------LIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFL-- 430
L ++HS +++H DLKPAN+ ++ + V K+ DFG++R +
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 431 --SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRP 486
S S T Y P L S T D+++ G I +LTG+P
Sbjct: 168 HYSHKGYLSEGLV---------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLHS I++ DLK N++LDA K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE +A D ++FG++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 50/174 (28%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 326 EIDILSKIRHPNLVTLVGACPEVW-TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 384
EIDIL I H ++ L+ A W + V +P D + D S PL + I I
Sbjct: 136 EIDILKTISHRAIINLIHAYR--WKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQR 192
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 444
L L +LH I+H D+K NI LD + L DFG + C
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA----------------C 233
Query: 445 RTD-----PK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 488
+ D P+ GT PE LA K+D++S G++L + L
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-07
Identities = 33/148 (22%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIE-SIRRAK----ASESLYAEELKRRKEFEEA 170
+ E EE + + E + +E + A+ A E +RR+ E+
Sbjct: 770 LEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQE 829
Query: 171 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 230
+ + E+E ++++ DE+ EEL+ + L+ ++ E + +ELE ++ E +
Sbjct: 830 IEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELEEEKEEL 889
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEA 258
++E EL+ E + +E E+LR+ +E
Sbjct: 890 EEELRELESELAELKEEIEKLRERLEEL 917
|
Length = 1163 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 289 IGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G +G + L+R A+K+L + E E +L RHP L L
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 342 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 398
A + V EY G L LS + + R R E+ S L +LHS
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS--- 113
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 456
+V+ D+K N++LD + K++DFG L + IS T T C GT Y+
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC------GTPEYLA 163
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGR 485
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 289 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 343
IG G +G + ++H + A+K+L+ + +E F++E ++L + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 344 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV +Y G L LS ++ P R IA +++ +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYIA----EMVLAIHSIHQLHY 123
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
VH D+KP N+LLD N +L+DFG ++Q+ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 462 S-----GELTPKSDVYSFGIILLRLLTG 484
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
++L + + E E E + K E + +E R+A E EE E E L
Sbjct: 754 EELQERLEELEEELESLEEALAKL-KEEIEELEEKRQALQEELEELEEELE--EAERRLD 810
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ ELE ++++ + + +E++ ++ LE ++ E ++ +ELE+++ E L+ +
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 233 EQDEL-------QMERDKAVKEAEELRKSRKEASS 260
E++EL + E+++ +E EL E
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKE 905
|
Length = 1163 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G +G + L+R A+K+L + E E +L RHP L +L
Sbjct: 3 LGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 342 VGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKP 398
+ + V EY+ G L LS + + R R E+ S L +LHS K
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPKGTFAYMD 456
IV+ DLK N++LD + K++DFG L + I+ T T C GT Y+
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFG----LCKEGITDAATMKTFC------GTPEYLA 163
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGR 485
PE L + D + G+++ ++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
+++ L ++H DLK ANI L + KL DFG S+ S + ++ C
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----- 232
Query: 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG-----ITKEVQYA-LD-- 499
GT Y+ PE + K+D++S G+IL LLT RP G I ++V Y D
Sbjct: 233 -GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 500 ----TGKLKNLLDPLAGDWP 515
+ +K LLDPL P
Sbjct: 292 PCPVSSGMKALLDPLLSKNP 311
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L +LHS I+H D+KP N+L+++N V K+ DFG++R +E T
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-------SKHMTQEV 165
Query: 450 GTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGR 485
T Y PE L S T D++S G I LL R
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 281 HNFDPSLKIGEGGYGSIYKGLLRHMQV-----AIKMLHPHSLQGPSEFQQ---EIDILSK 332
+F +G+G G ++ L ++ A+K+L + ++ ++ E +IL+
Sbjct: 1 KHFKKIKLLGKGDVGRVF---LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 333 IRHPNLVTLVG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
+ HP L TL LV +Y P G L L + LS + A E+ L
Sbjct: 58 LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLAL 116
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS----------------QNE 434
+LH IV+ DLKP NILL + LSDF +S+ +
Sbjct: 117 EYLH-LL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 435 ISSNNTTLCCRTDPK-----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
S + T + GT Y+ PE ++ D ++ GI+L +L G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 33/148 (22%), Positives = 68/148 (45%)
Query: 111 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 170
L ++L E + E + + E+ E R A E + R +E EE
Sbjct: 686 LEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEE 745
Query: 171 LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 230
L + ELE ++++ +E+ EEL+ + + L+ +I E ++ + L++++ E L+
Sbjct: 746 LEELEEELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEA 805
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEA 258
++ D L+ E + + E L + +E
Sbjct: 806 ERRLDALERELESLEQRRERLEQEIEEL 833
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 35/139 (25%), Positives = 69/139 (49%), Gaps = 7/139 (5%)
Query: 124 NSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK-RRKEFEEALANGKLELERMK 182
E EE L R + E + ++ +A + + EELK +E E L + EL +K
Sbjct: 238 RKELEELEEELSRLEEELEELQE-ELEEAEKEI--EELKSELEELREELEELQEELLELK 294
Query: 183 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 242
++ +E+ E+ + ++ LE+++ E ++ +EL++KI + E L+ + +EL+
Sbjct: 295 EEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLA 354
Query: 243 ---KAVKEAEELRKSRKEA 258
+A +E EE + E
Sbjct: 355 ELEEAKEELEEKLSALLEE 373
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 92 KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAK 151
+E+L+S ++ + ++ QA+ E E EEA RR A + +ES+ + +
Sbjct: 764 EEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRR 823
Query: 152 ASESLYAEELK-RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 210
EEL+ +E EE L + ELE ++K+ +E+ EEL+ +K LE ++
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDEL---- 879
Query: 211 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
KELE++ E L+ + E EL+ E +K + EEL +
Sbjct: 880 ---KELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 343
+G+GG+G + +R A K L ++ G S E IL K+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 344 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV + G L+ + N P + + A E+ L LH +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR---ENT 123
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
V+ DLKP NILLD ++SD G++ + + E GT YM PE L
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---------GTVGYMAPEVLN 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 493
+ T D + G ++ ++ G+ KE
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 16/141 (11%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIFLHSCKPHSIVHGDLKPA 409
LV EY+ G L + + P + R A E+C L FLH I++ DLK
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLP----EEHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 410 NILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS 469
N+LLDA+ KL+D+G+ + + + T+ C GT Y+ PE L E
Sbjct: 126 NVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFC-----GTPNYIAPEILRGEEYGFSV 177
Query: 470 DVYSFGIILLRLLTGRPALGI 490
D ++ G+++ ++ GR I
Sbjct: 178 DWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 60/225 (26%)
Query: 289 IGEGGYGSIYKGLLRH--MQVAIK-MLHPHSLQGPSEFQQEID---------ILSKIRHP 336
+G G YG + +VAIK + P FQ I +L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP--------FQSAIHAKRTYRELRLLKHMDHE 74
Query: 337 NLVTLVGACPEVWTLVYEYLPNGSLED-------------RLSCKDNSPPLSWQTRIR-I 382
N++ L+ +V+T P SLED L+ LS I+ +
Sbjct: 75 NVIGLL----DVFT------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFL 123
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
++ L ++HS I+H DLKP+NI ++ + K+ DFG++R
Sbjct: 124 VYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------- 171
Query: 443 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
T T Y PE L D++S G I+ LLTG+
Sbjct: 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLHS I++ DLK N++LD+ K++DFG+ + +N T
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 282 NFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP 336
+ P IG G YG + + +VAIK + PH+ P+ ++ E+ IL +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 337 NLVTL-------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
N++ + +V+ +V + L L + PL+ + +L
Sbjct: 65 NIIAIRDILRPPGADFKDVY-VVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRG 119
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L ++HS ++H DLKP+N+L++ + ++ DFG++R LS + T+
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM----TEYV 172
Query: 450 GTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPAL 488
T Y PE L S E T D++S G I +L GR L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 24/112 (21%), Positives = 49/112 (43%), Gaps = 16/112 (14%)
Query: 323 FQQEIDILSKIRH-----PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQ 377
++E+ IL + P ++ + + L+ E++ +L+ +S +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSY-LLMEWIEGETLD----------EVSEE 86
Query: 378 TRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429
+ IA +L +L LH + HGDL P NIL+D + + D+ + +
Sbjct: 87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 289 IGEGGYGSIY---KGLLRHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRH---PNLV 339
IG GG+G +Y K M A+K L + QG + E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+ A P+ + + + G L LS S + ATE+ L +H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+V+ DLKPANILLD + ++SD G++ S+ + ++ GT YM P
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----------VGTHGYMAP 164
Query: 458 EFLASGELTPKS-DVYSFGIILLRLLTG 484
E L G S D +S G +L +LL G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 20/212 (9%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 343
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 344 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV + G L+ + N P Q I A ELC L L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR---ERI 123
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
V+ DLKP NILLD ++SD G++ + + E GT YM PE +
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---------GTVGYMAPEVIN 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 493
+ + T D + G ++ ++ G+ KE
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 4/142 (2%)
Query: 116 AQAMAEAENSRRE--AFEEAL--RRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 171
Q E+ A EE L + E + + E L +E +E L
Sbjct: 192 GQLSELLEDIEDLLEALEEELKELKKLEEIQEEQEEEELEQEIEALEERLAELEEEKERL 251
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
K L ++ E ++ + L + L ++ E + +ELE++I E L+ +
Sbjct: 252 EELKARLLEIESLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLR 311
Query: 232 KEQDELQMERDKAVKEAEELRK 253
+EL+ +K E L K
Sbjct: 312 ALLEELEELLEKLKSLEERLEK 333
|
Length = 908 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 9/146 (6%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALA 172
+L + E + E+ K+ K+ + S+ EEL+R+ E + LA
Sbjct: 668 ELKELEEELAELEAQ-LEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ ELE+++ + +E+ EEL+ ++ L+ ++ ELE+++ S E L K+
Sbjct: 727 ALEEELEQLQSRLEELEEELEELEEELEELQERLE-------ELEEELESLEEALAKLKE 779
Query: 233 EQDELQMERDKAVKEAEELRKSRKEA 258
E +EL+ +R +E EEL + +EA
Sbjct: 780 EIEELEEKRQALQEELEELEEELEEA 805
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 39/173 (22%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 114 QLAQAMAEAENSRR------EAFEEALRRGKAEKDAIESIRR--AKASESLYAEELK--- 162
+L + E E EEA + + K +E +R + E L + +
Sbjct: 240 ELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELREELEELQEELLELKEEIEE 299
Query: 163 ----------RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT 212
R +E E L + LE +K++ + + EEL+ LE +AE ++
Sbjct: 300 LEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEA 359
Query: 213 AKELEQK----IISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 261
+ELE+K + EL + ++E EL+ E + E EEL++ +
Sbjct: 360 KEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEER 412
|
Length = 1163 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 289 IGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVG 343
IG G +G + L++ A+K+L+ + +E F++E D+L + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 344 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV +Y G L LS ++ P R +A ++I + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVIAIDSVHQLHY 123
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
VH D+KP NIL+D N +L+DFG L ++ ++ + GT Y+ PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------GTPDYISPEILQ 176
Query: 462 S-----GELTPKSDVYSFGIILLRLLTG 484
+ G+ P+ D +S G+ + +L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 28/155 (18%), Positives = 61/155 (39%), Gaps = 11/155 (7%)
Query: 114 QLAQAMAEAEN--SRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKE 166
+LA+ AE + + E E + + +D + E + E K E
Sbjct: 323 RLAKLEAEIDKLLAEIEELEREIEEERKRRDKLTEEYAELKEELEDLRAELEEVDKEFAE 382
Query: 167 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKI---ISA 223
+ L + + +LE++K++ +E+ EL ++ L ++A+ + +E KI
Sbjct: 383 TRDELKDYREKLEKLKREINELKRELDRLQEELQRLSEELADLNAAIAGIEAKINELEEE 442
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E + ++ E ++E+ A E +
Sbjct: 443 KEDKA-LEIKKQEWKLEQLAADLSKYEQELYDLKE 476
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|224495 COG1579, COG1579, Zn-ribbon protein, possibly nucleic acid-binding [General function prediction only] | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 126 RREAFEEALRRGKAEKDAI----ESIRRAKAS--------ESLYAEELKRRKEFEEALAN 173
R + +AL++ KAE +A+ E++ ES E +R K EE L+
Sbjct: 25 RIKEIRKALKKAKAELEALNKALEALEIELEDLENQVSQLESEIQEIRERIKRAEEKLSA 84
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
K E E E+QIA ++ + LE ++AE + ++LE++I E L+ +K
Sbjct: 85 VKDERELRALNI-----EIQIAKERINSLEDELAELMEEIEKLEKEIEDLKERLERLEKN 139
Query: 234 QDELQMERDKAVKEAEELRK--SRKEASSSSHMPQ 266
E + ++ V E E + S K +
Sbjct: 140 LAEAEARLEEEVAEIREEGQELSSKREELKEKLDP 174
|
Length = 239 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVG 343
+G+GG+G + +R A K L ++ G + E IL K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 344 A--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
A + LV + G L+ + N P + + A E+ L LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR---ERI 123
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
V+ DLKP NILLD ++SD G++ + + E GT YM PE +
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---------GTVGYMAPEVVK 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPALGITKE 493
+ T D + G ++ ++ G+ KE
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 335 HPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 390
HP LV L +C V E++ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
FLH I++ DLK N+LLDA KL+D+G+ + + + T+ C G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFC-----G 158
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 490
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 8/149 (5%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
+L + + E E E ++ E + K EEL+ R+ E
Sbjct: 292 ELKEEIEELEGEISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLE---- 347
Query: 174 GKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
ELE++ + +E EEL+ L LE + ELE ++ L+ K+
Sbjct: 348 ---ELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKR 404
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSS 261
E + L+ ++ + E+L++ KE +
Sbjct: 405 EIESLEERLERLSERLEDLKEELKELEAE 433
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 36/151 (23%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 110 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR----AKASESLYAEELKRRK 165
L ++LA+ A+ E E + ++ +D +E +RR + EL +
Sbjct: 671 ELEEELAELEAQLE-KLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELAALE 729
Query: 166 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 225
E E L + ELE ++ +E +EELQ L++ LE ++ ++ +L+++I E
Sbjct: 730 EELEQLQSRLEELEEELEELEEELEELQERLEE---LEEELESLEEALAKLKEEIEELEE 786
Query: 226 LLQNYKKEQDELQMERDKAVKEAEELRKSRK 256
Q ++E +EL+ E ++A + + L + +
Sbjct: 787 KRQALQEELEELEEELEEAERRLDALERELE 817
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 121 EAENSRREAFEEALRRGKAEKDAI---ESIRRAKASESLYAEELKRRKEF---EEALANG 174
+ E RE E L + AE + + + E L R+E E LA
Sbjct: 336 KEELEERETLLEELEQLLAELEEAKEELEEKLSALLEELEELFEALREELAELEAELAEI 395
Query: 175 KLELERMKKQHDEV-------MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 227
+ ELE +K++ + + E L+ ++ LE+++ E +EL +++ E L
Sbjct: 396 RNELEELKREIESLEERLERLSERLEDLKEELKELEAELEELQTELEELNEELEELEEQL 455
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+ + EL+ E + EEL++ KE SS
Sbjct: 456 EELRDRLKELERELAEL---QEELQRLEKELSS 485
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 34/156 (21%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 110 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 169
+L + + E EE + + ++ I + L+ +E E
Sbjct: 263 SLELEALKIREEELRELERLLEELEEKIERLEELEREIEELEEELEGLRALLEELEELLE 322
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQK----SLLESQIAESDQTAKELEQKIISAVE 225
L + + LE+++++ +++ EL+ ++K LLE ++ E ++ +ELE+++ A+E
Sbjct: 323 KLKSLEERLEKLEEKLEKLESELEELAEEKNELAKLLEERLKELEERLEELEKELEKALE 382
Query: 226 LLQNYKKEQDEL---QMERDKAVKEA-EELRKSRKE 257
L+ ++ EL E A++E EEL + KE
Sbjct: 383 RLKQLEEAIQELKEELAELSAALEEIQEELEELEKE 418
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 35/135 (25%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
A+ +AE ++A EAL++ E E +++ +A E AEELK+ +E K
Sbjct: 1677 AEEAKKAEEDEKKA-AEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEEN------K 1729
Query: 176 LELERMKKQHDE---VMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
++ E KK+ +E EE + ++K + E ++ A+E+ ++ + +E + +
Sbjct: 1730 IKAEEAKKEAEEDKKKAEEAKKDEEEKKKIAHLKKEEEKKAEEIRKEKEAVIE--EELDE 1787
Query: 233 EQDELQMERDKAVKE 247
E ++ +ME DK +K+
Sbjct: 1788 EDEKRRMEVDKKIKD 1802
|
Length = 2084 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422
R + + SP LS+ + + ++ + + FL S + VH DL N+L+ + K+
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKIC 281
Query: 423 DFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
DFG++R + N IS +T L +M PE + + T SDV+SFGI+L
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--------PLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 481 LLT 483
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+ L FLH I++ DLK N++LD+ K++DFG+ + ++ + T
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE +A D +++G++L +L G+P
Sbjct: 161 FC-----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|224259 COG1340, COG1340, Uncharacterized archaeal coiled-coil protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 29/158 (18%), Positives = 65/158 (41%), Gaps = 5/158 (3%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRG--KAEKDAIESIRRAKASESLYAEELKRRKE 166
D + +L + E + + E L K+ + IE + + + + L EE + +
Sbjct: 79 DEINAKLQELRKEYRELKEKRNEFNLGGRSIKSLEREIERLEKKQQTSVLTPEEERELVQ 138
Query: 167 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLES---QIAESDQTAKELEQKIISA 223
+ L + ++ ++++++ E + K +I E A+E +++I
Sbjct: 139 KIKELRKELEDAKKALEENEKLKELKAEIDELKKKAREIHEKIQELANEAQEYHEEMIKL 198
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSS 261
E +KE DEL E + K+ +EL + + +
Sbjct: 199 FEEADELRKEADELHEEFVELSKKIDELHEEFRNLQNE 236
|
Length = 294 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 33/157 (21%), Positives = 63/157 (40%), Gaps = 7/157 (4%)
Query: 109 DNLYDQLAQAMAEAEN-SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR---- 163
L LA+ AE E R A + R +A E L E +
Sbjct: 729 SALRKDLARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELE 788
Query: 164 --RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 221
++ +E L + L+ ++ + + EE ++ LE +IA +++ ++LE++I
Sbjct: 789 AQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIE 848
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E +++ E +EL+ ++ E E L R
Sbjct: 849 ELSEDIESLAAEIEELEELIEELESELEALLNERASL 885
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 36/179 (20%), Positives = 75/179 (41%), Gaps = 34/179 (18%)
Query: 113 DQLAQAMAEAENSRREAFEE------ALRRGKAEKDA----IESIRRAKAS-ESLYAEEL 161
++L Q + E E E E+ L + E + +E + K E E
Sbjct: 824 ERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELEDELKELE 883
Query: 162 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA-------- 213
+ ++E EE L + EL +K++ +++ E L+ + LE ++ E ++
Sbjct: 884 EEKEELEEELRELESELAELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTL 943
Query: 214 -KELEQKI--------------ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
ELE++I + A+E + ++ +EL+ +R+ + E+L + +E
Sbjct: 944 ETELEREIERLEEEIEALGPVNLRAIEEYEEVEERYEELKSQREDLEEAKEKLLEVIEE 1002
|
Length = 1163 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 28/181 (15%)
Query: 109 DNLYDQLAQAMAEAENSRRE------AFEEALRRGKAEKDAIESIRRAKASESLYAEEL- 161
+L D L + + E R+ + + +E + EEL
Sbjct: 698 RSLEDLLEELRRQLEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQ 757
Query: 162 KRRKEFEEAL-------ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAE------ 208
+R +E EE L A K E+E ++++ + EEL+ ++ E ++
Sbjct: 758 ERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELE 817
Query: 209 --------SDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+Q +ELE++I E L ++E +EL+ E ++ +E EEL ++E
Sbjct: 818 SLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEAEKEELED 877
Query: 261 S 261
Sbjct: 878 E 878
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 43/205 (20%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 93 EDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESI----- 147
ED +L+ + + + E ++ +E R ++ ++S+
Sbjct: 565 EDRLQELKELLEELRLLRTRKEELEELRERLKELKKKLKELEERLSQLEELLQSLELSEA 624
Query: 148 -RRAKASESLYAEELKRRKE---FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLL 202
+ +E EL++ EE L ELE ++ E+ ELQ +++ L
Sbjct: 625 ENELEEAEEELESELEKLNLQAELEELLQAALEELEEKVEELEAEIRRELQRIENEEQLE 684
Query: 203 ESQIAESDQTAKELEQ-------------KIISAVELLQNYKKEQDELQMERD---KAVK 246
E ++ E +Q +ELEQ +I +E L++ K E +EL+ E + KA++
Sbjct: 685 E-KLEELEQLEEELEQLREELEELLKKLGEIEQLIEELESRKAELEELKKELEKLEKALE 743
Query: 247 EAEELRKSRKEASSSSHMPQFFSDF 271
EELR+ +A + + +
Sbjct: 744 LLEELREKLGKAGLRADILRNLLAQ 768
|
Length = 908 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 22/136 (16%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
L + AE EA R E+ + RR + E E + + +
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 174 GKLELERMKKQHDEVMEE-------LQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 226
+ +E ++ + + ++ E L + + L ++ E + EL +++ E
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELESKRSELRRELEELREK 923
Query: 227 LQNYKKEQDELQMERD 242
L + + L++ D
Sbjct: 924 LAQLELRLEGLEVRID 939
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEA------LAN 173
E + E+ L + E + ES+ EEL+ R KE E L +
Sbjct: 552 EELKKKLAELEKKLDELEEELAELLKELEELGFESV--EELEERLKELEPFYNEYLELKD 609
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ ELER +K+ ++ EEL A ++ + E ++ E + +ELE+K + E + ++E
Sbjct: 610 AEKELEREEKELKKLEEELDKAFEELAETEKRLEELRKELEELEKKY--SEEEYEELREE 667
Query: 234 QDELQMERDKAVKEAEELRKSRKEASSS 261
EL E E EEL K R+E +
Sbjct: 668 YLELSRELAGLRAELEELEKRREEIKKT 695
|
Length = 880 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 19/136 (13%)
Query: 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414
+ R+ CK N + I ++ + L ++H H I HGD+KP NI++D
Sbjct: 110 VENTKEIFKRIKCK-NKKLIK-----NIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160
Query: 415 ANFVSKLSDFGISRFLSQN----EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 470
N + D+GI+ + E S L +GT Y + +T + D
Sbjct: 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL-----HRGTLYYAGLDAHNGACVTRRGD 215
Query: 471 VYSFGIILLRLLTGRP 486
+ S G +L+ G
Sbjct: 216 LESLGYCMLK-WAGIK 230
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 12/114 (10%)
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
I + ++ ++ LHS IV+ D+KP N+LLD +LSD G++ E+
Sbjct: 98 IHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGK 149
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 493
T T GT YM PE L + D ++ G + ++ GR KE
Sbjct: 150 TI----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
A E+C L LH IV+ DLKP NILLD + ++SD G++ + + + T+
Sbjct: 108 AAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TI 158
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
R GT YM PE + + T D ++ G +L ++ G+
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411
+Y ++ + + + KD PL QTR I +L + ++H K ++H D+K NI
Sbjct: 249 LYSFMYDEAFD----WKDR--PLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298
Query: 412 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDV 471
L+ + L DFG + + + + + GT A PE LA +D+
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-------GTVATNSPEILAGDGYCEITDI 351
Query: 472 YSFGIILLRLLT 483
+S G+ILL +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 17/166 (10%)
Query: 109 DNLYDQLAQAMAEAENS------RREAFEEALRRGKAE----KDAIESIRRAKASESLYA 158
+N D+L+Q +++A E E+ + K ++ + S+ + +
Sbjct: 701 ENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELEEDLSSLEQEIENVKSEL 760
Query: 159 EEL-KRRKEFEEALANGKLEL---ERMKKQH--DEVMEELQIALDQKSLLESQIAESDQT 212
+EL R +E EE L + L E E+ EL ++ S +E+++ E +Q
Sbjct: 761 KELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQK 820
Query: 213 AKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
L + + +Q ++++ +L+ E+ K++++ E +KE
Sbjct: 821 LNRLTLEKEYLEKEIQELQEQRIDLK-EQIKSIEKEIENLNGKKEE 865
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 34/154 (22%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 113 DQLAQAMAE-----AENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF 167
++L + E AE EA E L E + + L + E
Sbjct: 344 EKLEELKEELESLEAELEELEAELEELESRLEELEE-QLETLRSKVAQLELQIASLNNEI 402
Query: 168 EEALANGKLE-LERMKKQHDEVMEELQIALD--QKSLLESQIAESDQTAKELEQKIISAV 224
E A +LE LE +++ + +EEL L+ + L++++ E ++ +EL++++
Sbjct: 403 ERLEA--RLERLEDRRERLQQEIEELLKKLEEAELKELQAELEELEEELEELQEELERLE 460
Query: 225 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E L+ ++E +E + D A +E +L+ +R ++
Sbjct: 461 EALEELREELEEAEQALDAAERELAQLQ-ARLDS 493
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 19/140 (13%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410
LV +Y G L LS ++ P R +A +++ + S VH D+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA----EMVLAIDSVHQLGYVHRDIKPDN 132
Query: 411 ILLDANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL-----ASGE 464
+LLD N +L+DFG R L+ + SN GT Y+ PE L G
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAV--------GTPDYISPEILQAMEDGKGR 184
Query: 465 LTPKSDVYSFGIILLRLLTG 484
P+ D +S G+ + +L G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 49/186 (26%)
Query: 113 DQLAQAMAEAENSRREAFEEAL-------RRGKAEK--------------------DAIE 145
+++ A E RR+ EEA R+ +AE+ +E
Sbjct: 147 EEIINAKPEE---RRKLIEEAAGVSKYKERKEEAERKLERTEENLERLEDLLEELEKQLE 203
Query: 146 SIRRAKASESLYAEELKRRKEFEEALANGKL------------ELERMKKQHDEVMEELQ 193
+ R Y E +E E AL KL EL R++++ +E+ EEL+
Sbjct: 204 KLERQAEKAERYQELKAELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELE 263
Query: 194 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 253
A + L+S++ +EL +++ E L K+E +EL+ E + EEL
Sbjct: 264 EAEKEIEELKSEL-------EELREELEELQEELLELKEEIEELEGEISLLRERLEELEN 316
Query: 254 SRKEAS 259
+E
Sbjct: 317 ELEELE 322
|
Length = 1163 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 31/145 (21%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
+ L + +AE E + E R + E +E+++ + L+ +E
Sbjct: 235 EALEERLAELEEEKERLEELKARLLEIESLELEALKIREEELRELERLLEELEE------ 288
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
++ER+++ E+ E + ++LLE ++ K LE+++ E L+ +
Sbjct: 289 ----KIERLEELEREIEELEEELEGLRALLEELEELLEKL-KSLEERLEKLEEKLEKLES 343
Query: 233 EQDELQMERDKAVKEAEELRKSRKE 257
E +EL E+++ K EE K +E
Sbjct: 344 ELEELAEEKNELAKLLEERLKELEE 368
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 5e-05
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 17/172 (9%)
Query: 103 LDGSVDDNLYDQLAQAMA-EAENSRREAFEEALR----RGKAEKDAIESIRRA----KAS 153
L S D +D A EA EEA + + + + A E+ ++A KA
Sbjct: 1072 LKPSYKDFDFDAKEDNRADEATEEAFGKAEEAKKTETGKAEEARKAEEAKKKAEDARKAE 1131
Query: 154 ESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 213
E+ AE+ ++ +E +A ++E+ R K + EE + A D K ++ AE + A
Sbjct: 1132 EARKAEDARKAEEARKAEDAKRVEIAR-KAEDARKAEEARKAEDAKKAEAARKAEEVRKA 1190
Query: 214 KEL----EQKIISAVELLQNYKKEQDELQMERDK---AVKEAEELRKSRKEA 258
+EL + + A + +K ++ + E K AVK+AEE +K +EA
Sbjct: 1191 EELRKAEDARKAEAARKAEEERKAEEARKAEDAKKAEAVKKAEEAKKDAEEA 1242
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 30/134 (22%), Positives = 57/134 (42%), Gaps = 9/134 (6%)
Query: 126 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 185
R E E L + E E +E +E EE L +LE+ ++++
Sbjct: 233 RLEELREELEELQEELKEAEEELEELTAEL---------QELEEKLEELRLEVSELEEEI 283
Query: 186 DEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV 245
+E+ +EL ++ S LE Q + LE+++ L+ + + DEL E +
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELE 343
Query: 246 KEAEELRKSRKEAS 259
++ EEL++ +
Sbjct: 344 EKLEELKEELESLE 357
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 289 IGEGGYGSIYKGLLRHM--QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVG 343
+G+GG+G + +R A K L+ L+ ++ E IL+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 344 ACPEVWT---LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
A + T LV + G L + + + +P ++ S L LH
Sbjct: 61 AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
I++ DLKP N+LLD + ++SD G++ L + + GT +M PE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--------GTPGFMAPEL 168
Query: 460 LASGELTPKSDVYSFGIILLRLLTGR 485
L E D ++ G+ L ++ R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (110), Expect = 5e-05
Identities = 27/117 (23%), Positives = 60/117 (51%), Gaps = 7/117 (5%)
Query: 138 KAEKDAIESIRRAKASESLYAEELKRRKEFE--EALANGKLELERMKKQHDEVMEELQIA 195
+AE++A + AK AE +K+ E E + + E E+ ++ +++L+
Sbjct: 35 EAEEEAKRILEEAKKE----AEAIKKEALLEAKEEIHKLRNEFEKELRERRNELQKLEKR 90
Query: 196 LDQK-SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 251
L QK L+ ++ ++ +ELE+K + Q +K+++EL+ ++ ++E E +
Sbjct: 91 LLQKEENLDRKLELLEKREEELEKKEKELEQKQQELEKKEEELEELIEEQLQELERI 147
|
Length = 520 |
| >gnl|CDD|224755 COG1842, PspA, Phage shock protein A (IM30), suppresses sigma54-dependent transcription [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
+LA+A R+A +A+ R K + +E + AE+L+ + E AL
Sbjct: 38 SELAKA--------RQALAQAIARQKQLERKLEEAQA-------RAEKLEEKA--ELALQ 80
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
G +L R E +EE Q D LE+++ ++++ ++L++++ + + + +
Sbjct: 81 AGNEDLAR------EALEEKQSLEDLAKALEAELQQAEEQVEKLKKQLAALEQKIAELRA 134
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 267
+++ L R A K E++ +S SSSS M F
Sbjct: 135 KKEAL-KARKAAAKAQEKVNRSLGGGSSSSAMAAF 168
|
Length = 225 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
FL S K +H DL NILL N V K+ DFG++R + ++ D +
Sbjct: 188 FLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------GDARLP 238
Query: 452 FAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
+M PE + T +SDV+SFG++L + +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-05
Identities = 31/149 (20%), Positives = 67/149 (44%), Gaps = 4/149 (2%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
+++ E E E R + ++ + E+L E + E EEA
Sbjct: 303 EISLLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEE 362
Query: 174 GKLELERMKKQHDEVMEELQIALD----QKSLLESQIAESDQTAKELEQKIISAVELLQN 229
+ +L + ++ +E+ E L+ L + + + +++ E + + LE+++ E L++
Sbjct: 363 LEEKLSALLEELEELFEALREELAELEAELAEIRNELEELKREIESLEERLERLSERLED 422
Query: 230 YKKEQDELQMERDKAVKEAEELRKSRKEA 258
K+E EL+ E ++ E EEL + +E
Sbjct: 423 LKEELKELEAELEELQTELEELNEELEEL 451
|
Length = 1163 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 117 QAMAEAENSRR-EAFEEALRRGKAEK-DAIESIRRA-----KASESLYAEELKRRKEFEE 169
QA +AE +R+ + ++A + KA++ E ++A KA E+ A+E K++ E +
Sbjct: 1269 QAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAK 1328
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
A+ + K+ E + A ++ + AE+ + KE +K A +
Sbjct: 1329 KKADAAKKKAEEAKKAAEAAKAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAE 1388
Query: 230 YKKEQDELQMERDKAVKEAEELRKSRKE 257
KK+ DE + + ++ K+A+EL+K+
Sbjct: 1389 EKKKADEAKKKAEEDKKKADELKKAAAA 1416
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 21/152 (13%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRA-----KASESLYAEELKRRKE---F 167
A+A +AE R+ EEA + A+K E++++A A E+ AEE + +E F
Sbjct: 1202 AEAARKAEEERK--AEEARKAEDAKK--AEAVKKAEEAKKDAEEAKKAEEERNNEEIRKF 1257
Query: 168 EEA-LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 226
EEA +A+ +K + +EL+ A ++K E++ AE + A E ++K A E
Sbjct: 1258 EEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEEKKKADEAKKK---AEE- 1313
Query: 227 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
K+ DE + + ++A K+A+ +K +EA
Sbjct: 1314 ----AKKADEAKKKAEEAKKKADAAKKKAEEA 1341
|
Length = 2084 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 7e-05
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 39/211 (18%)
Query: 285 PSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HP 336
LK+ +G +G + +L+H +Q IK + +++ E + ++ +P
Sbjct: 20 KKLKLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNP 69
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
N + L + + L+ +Y+ +G L D L LS +I +L L LH
Sbjct: 70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 395 SCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H+I+H D+K N+L D A L D+G L + T C GT
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKII----GTPSCYD----GTLD 171
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTG 484
Y PE + D ++ G++ LLTG
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 32/173 (18%)
Query: 326 EIDILSKIRHPNLVTLVGA-------C---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLS 375
E IL I HP+++ L G C P T +Y YL + + ++ D
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---AAKRNIAICD------ 183
Query: 376 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435
+ I + + +LH + I+H D+K NI ++ L DFG + F +I
Sbjct: 184 ---ILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDI 235
Query: 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 488
++N GT A PE LA P D++S GI+L + T +L
Sbjct: 236 NANKYY-----GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|217843 pfam04012, PspA_IM30, PspA/IM30 family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 31/155 (20%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
LAQ +A + R+ E+ + K E A ++ K +E L E L E+
Sbjct: 44 QALAQVIARQKQLERKLEEQKEQAKKLENKARAALT--KGNEELAREALAEIATLEKQAE 101
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ + + + A++Q L Q+A LE KI Q K
Sbjct: 102 -----------ALETQLTQQRSAVEQ---LRKQLA-------ALETKI-------QQLKA 133
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF 267
++ L+ R KA K E + S AS+ S F
Sbjct: 134 KKTALKA-RLKAAKAQEAVNTSLGSASTESATDSF 167
|
This family includes PspA a protein that suppresses sigma54-dependent transcription. The PspA protein, a negative regulator of the Escherichia coli phage shock psp operon, is produced when virulence factors are exported through secretins in many Gram-negative pathogenic bacteria and its homologue in plants, VIPP1, plays a critical role in thylakoid biogenesis, essential for photosynthesis. Activation of transcription by the enhancer-dependent bacterial sigma(54) containing RNA polymerase occurs through ATP hydrolysis-driven protein conformational changes enabled by activator proteins that belong to the large AAA(+) mechanochemical protein family. It has been shown that PspA directly and specifically acts upon and binds to the AAA(+) domain of the PspF transcription activator. Length = 220 |
| >gnl|CDD|206039 pfam13868, Trichoplein, Tumour suppressor, Mitostatin | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 7e-05
Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 20/161 (12%)
Query: 111 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRRK---- 165
L + + E E R+E +EE L+ E++ + E I R + + A+E + ++
Sbjct: 72 GRAVLQEQIEEREKRRQEEYEERLQ----EREQMDEIIERIQEEDEAEAQEKREKQKKLR 127
Query: 166 -EFEEALANGKLELERMKKQHDEVMEELQIA------LDQKSLLESQIAESDQTAKELEQ 218
E +E ++E + +K+ + EEL+I +++ E++ E + KE E
Sbjct: 128 EEIDEFNEE-RIERKEEEKERER-EEELKILEYQREKAEREEEREAERRERKE-EKEREV 184
Query: 219 KIISA-VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
+ A E ++ ++E DEL+ + + E +E +K ++EA
Sbjct: 185 ARLRAQQEEAEDEREELDELRADLYQEEYERKERQKEKEEA 225
|
Trichoplein or mitostatin, was first defined as a meiosis-specific nuclear structural protein. It has since been linked with mitochondrial movement. It is associated with the mitochondrial outer membrane, and over-expression leads to reduction in mitochondrial motility whereas lack of it enhances mitochondrial movement. The activity appears to be mediated through binding the mitochondria to the actin intermediate filaments (IFs). Length = 349 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 8e-05
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 5/154 (3%)
Query: 108 DDNLYDQLAQAMAEAENSRRE---AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 164
D N+ + A+ +AE +R E E ++ KAE+ + KA E AEE K++
Sbjct: 1575 DKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEEKKK 1634
Query: 165 KE-FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA 223
E ++ A K + E +KK +E + +K+ + + AE + A+E E+K A
Sbjct: 1635 VEQLKKKEAEEKKKAEELKKAEEENKIKAA-EEAKKAEEDKKKAEEAKKAEEDEKKAAEA 1693
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
++ K+ +EL+ + + K+AEEL+K+ +E
Sbjct: 1694 LKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEE 1727
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 8e-05
Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
A+ + +AE +++ E+ ++ EK E +++A+ + A E ++ E ++ A
Sbjct: 1622 AEELKKAEEEKKKV-EQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEA 1680
Query: 176 LELERMKKQHDEVM----EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
+ E +K+ E + EE + A + K + ++++ K E+ I A E K
Sbjct: 1681 KKAEEDEKKAAEALKKEAEEAKKAEELKKKEAEEKKKAEELKKAEEENKIKAEEA----K 1736
Query: 232 KEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 266
KE +E DK K+AEE +K +E +H+ +
Sbjct: 1737 KEAEE-----DK--KKAEEAKKDEEEKKKIAHLKK 1764
|
Length = 2084 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 326 EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI- 382
E +L RHP L L + + V EY G L LS ++ + + R R
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RER---VFSEDRARFY 100
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT-- 440
E+ S L +LHS K ++V+ DLK N++LD + K++DFG L + I T
Sbjct: 101 GAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGATMK 154
Query: 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 155 TFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 30/138 (21%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 126 RREAFEEALRRGKAE--KDAIESIRRAKAS-ESLYAEELKRRKEFEEALANGKLELERMK 182
E AL K + + +E + + E E + +E E+ + K ELE ++
Sbjct: 221 ELRELELALLLAKLKELRKELEELEEELSRLEEELEELQEELEEAEKEIEELKSELEELR 280
Query: 183 KQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERD 242
++ +E+ EEL ++ LE +I+ + +ELE + L+ ++ +EL+ + +
Sbjct: 281 EELEELQEELLELKEEIEELEGEISLLRERLEELENE-------LEELEERLEELKEKIE 333
Query: 243 KAVKEAEELRKSRKEASS 260
+E EE +E
Sbjct: 334 ALKEELEERETLLEELEQ 351
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 33/143 (23%), Positives = 60/143 (41%), Gaps = 2/143 (1%)
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 180
E E +E L+ + E + + + E E E EE + + EL
Sbjct: 235 EELREELEELQEELKEAEEELEELT--AELQELEEKLEELRLEVSELEEEIEELQKELYA 292
Query: 181 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 240
+ + + ++ QI ++ + LE Q+ E + +ELE K+ E L +++ +EL+ E
Sbjct: 293 LANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEE 352
Query: 241 RDKAVKEAEELRKSRKEASSSSH 263
+ E EEL +E S
Sbjct: 353 LESLEAELEELEAELEELESRLE 375
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 412
Y+ + +++ LS D S L+ + ++ + FL S + VH DL N+L
Sbjct: 214 YKGSNDSEVKNLLS-DDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 413 LDANFVSKLSDFGISRFL--SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 470
L + K+ DFG++R + N +S +T L + +M PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK--------WMAPESIFDNLYTTLSD 321
Query: 471 VYSFGIILLRL--LTGRPALGI 490
V+S+GI+L + L G P G+
Sbjct: 322 VWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 44/163 (26%), Positives = 63/163 (38%), Gaps = 33/163 (20%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410
L+ E+LP G + L KD +T+ IA + ++ S +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLT--EEETQFYIAETVLAI----DSIHQLGFIHRDIKPDN 131
Query: 411 ILLDANFVSKLSDFGI---------------------SRFLSQNEISSNNTTLCCRTDPK 449
+LLD+ KLSDFG+ S F QN S R +
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 450 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 33/164 (20%)
Query: 329 ILSKIRHPNLV----TLVG---AC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQT 378
+L + HP+++ TLV C P + +Y YL S PL
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK-----------RSRPLPIDQ 158
Query: 379 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438
+ I ++ L +LH+ I+H D+K NI ++ + D G ++F ++
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPA 212
Query: 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 482
L GT PE LA + K+D++S GI+L +L
Sbjct: 213 FLGLA------GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 23/167 (13%)
Query: 321 SEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLS--CKDNSPPLS 375
QQEI +++HPN++ V + E++ +V + GS ED L + P
Sbjct: 44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP--- 99
Query: 376 WQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434
+ I I ++ + L ++HS +H +K ++ILL + LS S +
Sbjct: 100 -ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---- 151
Query: 435 ISSNNTTLCCRTDPKGT---FAYMDPEFLASGEL--TPKSDVYSFGI 476
I PK + ++ PE L KSD+YS GI
Sbjct: 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 31/118 (26%), Positives = 58/118 (49%), Gaps = 11/118 (9%)
Query: 363 DRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
D +D PL +R ++++ + FL S + +H D+ N+LL V+K
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAK 252
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478
+ DFG++R + N++ + + + +M PE + T +SDV+S+GI+L
Sbjct: 253 ICDFGLARDI------MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 24/130 (18%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 135 RRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALANGKLELERMKKQHDEVMEELQ 193
R K ++ + + + LK + E+ L + +LE +++Q +E+ EL
Sbjct: 667 RELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQLEELERQLEELKRELA 726
Query: 194 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 253
++ L+S++ +ELE+++ E L+ ++ +EL+ E + + +L++
Sbjct: 727 ALEEELEQLQSRL-------EELEEELEELEEELEELQERLEELEEELESLEEALAKLKE 779
Query: 254 SRKEASSSSH 263
+E
Sbjct: 780 EIEELEEKRQ 789
|
Length = 1163 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 33/165 (20%), Positives = 69/165 (41%), Gaps = 14/165 (8%)
Query: 110 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 169
L +++AQ E E E R +AE++ E+ + E+ + + K E
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALRE 803
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
AL + EL + ++ + E L+ + + E ++ + ++ +EL + I S ++
Sbjct: 804 ALDELRAELTLLNEEAANLRERLESLERRIAATERRLEDLEEQIEELSEDIESLAAEIEE 863
Query: 230 YKKEQDELQMERDKAVKE--------------AEELRKSRKEASS 260
++ +EL+ E + + E EEL + +E S
Sbjct: 864 LEELIEELESELEALLNERASLEEALALLRSELEELSEELRELES 908
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 12/117 (10%)
Query: 367 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426
K L+ + I + ++ + FL S K +H DL NILL N V K+ DFG+
Sbjct: 172 YKK---VLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 225
Query: 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
+R + + + + D + +M PE + T +SDV+SFG++L + +
Sbjct: 226 ARDIYK------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|221432 pfam12128, DUF3584, Protein of unknown function (DUF3584) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 43/184 (23%)
Query: 94 DLQSSPPSVLDGSVDDNLYD-QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKA 152
DL P +++GS D LY L + + A E LR R +A
Sbjct: 569 DLD---PQLVEGSDSDTLYGVSLDLQRLDVPDY--AANETELRE-----------RLQQA 612
Query: 153 SESLYAEELKRRKEFEEALA---------------------NGKLELERMKKQHDEVMEE 191
E+L + ++K+ EE L +L+L+R++ + + ++
Sbjct: 613 EEALQSAV-AKQKQAEEQLVQANAELEEQKRAEAEARTALKQARLDLQRLQNEQQSLKDK 671
Query: 192 LQIAL-DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEE 250
L++A+ ++K E+Q+ + D K+L ++ + L+ K + EL+ ER + E
Sbjct: 672 LELAIAERKQQAETQLRQLDAQLKQLLEQQQAF---LEALKDDFRELRTERLAKWQVVEG 728
Query: 251 LRKS 254
+
Sbjct: 729 ELDN 732
|
This protein is found in bacteria and eukaryotes. Proteins in this family are typically between 943 to 1234 amino acids in length. This family contains a P-loop motif suggesting it is a nucleotide binding protein. It may be involved in replication. Length = 1198 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 13/113 (11%)
Query: 373 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR--FL 430
PL+ + I + ++ + FL S K +H DL NILL N V K+ DFG++R +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
+ + + L +M PE + T +SDV+SFG++L + +
Sbjct: 227 DPDYVRKGSARL--------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 48/221 (21%)
Query: 287 LKIGEGGYGSIYKGLLRHM--QVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
++G G YG++ L R +VAIK L+ S +E+ +L ++H N++ L+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 343 GACPEVWT------------LVYEYLPN--GSL--EDRLSCKDNSPPLSWQTRIR-IATE 385
+V+T LV ++ G L ++LS + RI+ + +
Sbjct: 81 ----DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----------EDRIQFLVYQ 126
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 445
+ L ++H+ I+H DLKP N+ ++ + K+ DFG++R + +E++ T R
Sbjct: 127 MLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVVTRWYR 182
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
P+ +M T D++S G I+ +LTG+P
Sbjct: 183 A-PEVILNWM--------HYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 1/140 (0%)
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELER 180
N R + L R + E+ K E L A+ LK KE E+ + EL+
Sbjct: 233 LKLNEERIDLLQELLRDEQEEIESSKQELEKEEEIL-AQVLKENKEEEKEKKLQEEELKL 291
Query: 181 MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 240
+ K+ +E+ EL +K E ++ ES++ K+LE+++ E ++ +KE EL+++
Sbjct: 292 LAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELEIK 351
Query: 241 RDKAVKEAEELRKSRKEASS 260
R+ +E E+L K +++
Sbjct: 352 REAEEEEEEQLEKLQEKLEQ 371
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 275 EIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAIKMLHP--HSLQGPSEFQQEIDIL 330
E+ N P +G G YGS+ ++VA+K L S+ +E+ +L
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 331 SKIRHPNLVTLVGACPEVWTL-----VY--EYLPNGSLEDRLSCK----DNSPPLSWQTR 379
++H N++ L+ +L VY +L L + + C+ D+ L +Q
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 128
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
+ L ++HS I+H DLKP+N+ ++ + K+ DFG++R
Sbjct: 129 ------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 173
Query: 440 TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGR 485
T T Y PE + + D++S G I+ LLTGR
Sbjct: 174 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|220369 pfam09731, Mitofilin, Mitochondrial inner membrane protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 28/192 (14%)
Query: 90 PSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRR 149
P ++L S ++D +DNL D L +A A+ + ++ E++ +E +
Sbjct: 136 PVVQELVSIFNDLIDSIKEDNLKDDLESLIASAKEELDQLSKKLAELKAEEEEELERALK 195
Query: 150 AKASESL--YAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIA 207
K E L EEL R E +EA ++++ + + EEL+ ++K L ++
Sbjct: 196 EKREELLSKLEEELLARLESKEAA-----LEKQLRLEFEREKEELRKKYEEK--LRQELE 248
Query: 208 E-----SDQTAKELEQKIISAVELLQNYKKEQDE-LQMERD----------KAVKEAEEL 251
+ EL + A+EL + + KE E ++ ER+ +K E+
Sbjct: 249 RQAEAHEQKLKNELALQ---AIELQREFNKEIKEKVEEERNGRLAKLAELNSRLKGLEKA 305
Query: 252 RKSRKEASSSSH 263
SR EA +H
Sbjct: 306 LDSRSEAEDENH 317
|
Mitofilin controls mitochondrial cristae morphology. Mitofilin is enriched in the narrow space between the inner boundary and the outer membranes, where it forms a homotypic interaction and assembles into a large multimeric protein complex. The first 78 amino acids contain a typical amino-terminal-cleavable mitochondrial presequence rich in positive-charged and hydroxylated residues and a membrane anchor domain. In addition, it has three centrally located coiled coil domains. Length = 493 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 25/97 (25%), Positives = 47/97 (48%)
Query: 162 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 221
++ +E EE +A + L ++K+ +E+ EEL+ + L QI+ + LE ++
Sbjct: 684 EKIEELEEKIAELEKALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVE 743
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E + KE EL+ E ++ + EE + EA
Sbjct: 744 QLEERIAQLSKELTELEAEIEELEERLEEAEEELAEA 780
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 24/82 (29%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H DL NILL ++K+ DFG++R + N++ + + + +M PE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI------RNDSNYVVKGNARLPVKWMAPESIF 289
Query: 462 SGELTPKSDVYSFGIILLRLLT 483
+ T +SDV+S+GI+L + +
Sbjct: 290 NCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|188306 TIGR03319, RNase_Y, ribonuclease Y | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 32/142 (22%), Positives = 66/142 (46%), Gaps = 11/142 (7%)
Query: 115 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 174
+ +A EAE ++EA EA + +E + + +E L E +R + EE L
Sbjct: 38 IEEAKKEAETLKKEALLEAKEEVHKLRAELERELKERRNE-LQRLE-RRLLQREETLDR- 94
Query: 175 KLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE- 233
++E + K+ + + ++ + +++ L+ + E ++ E +++ L Q KE
Sbjct: 95 --KMESLDKKEENLEKKEKELSNKEKNLDEKEEELEELIAEQREELERISGLTQEEAKEI 152
Query: 234 -----QDELQMERDKAVKEAEE 250
++E + E K +KE EE
Sbjct: 153 LLEEVEEEARHEAAKLIKEIEE 174
|
Members of this family are RNase Y, an endoribonuclease. The member from Bacillus subtilis, YmdA, has been shown to be involved in turnover of yitJ riboswitch [Transcription, Degradation of RNA]. Length = 514 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 7/153 (4%)
Query: 112 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 171
+++ + + E E E E L + E +E S+ L EL E + +
Sbjct: 405 LEEIQEELEELEKELEEL-ERELEELEEEIKKLEEQINQLESKELMIAELAGAGE-KCPV 462
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISA----VELL 227
+L E K+ + EL+ L+++ E + AE + +ELE+++ +ELL
Sbjct: 463 CGQELPEEHEKELLELYELELE-ELEEELSREKEEAELREEIEELEKELRELEEELIELL 521
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+ + ++EL+ + +K EEL + +++
Sbjct: 522 ELEEALKEELEEKLEKLENLLEELEELKEKLQL 554
|
Length = 908 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 35/146 (23%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
A+ +AE +++ ++ + KAE+ R + LY EE K + E + K
Sbjct: 1560 AEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIEEVMKLYEEEKKMKAEEAKKAEEAK 1619
Query: 176 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL---QNYKK 232
++ E +KK +E + Q+ K + ++++ K E+ I A E + KK
Sbjct: 1620 IKAEELKKAEEEKKKVEQL----KKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKK 1675
Query: 233 EQDELQMERDKAVKEAEELRKSRKEA 258
+ +E + + K AE L+K +EA
Sbjct: 1676 KAEEAKKAEEDEKKAAEALKKEAEEA 1701
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 41/166 (24%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIR----RAKASESLYAEELKRRKEFEEAL 171
A+ +A+ ++++A EEA + +A+K A E+ + + KA E+ A+E K++ E +
Sbjct: 1427 AEEKKKADEAKKKA-EEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADEAKKKAEEAKKA 1485
Query: 172 ANGKLELERMKKQHDEV---------MEELQIALDQKSLLESQIAESDQTAKEL----EQ 218
K + E KK+ DE +E + A + K E++ AE + A E E+
Sbjct: 1486 DEAKKKAEEAKKKADEAKKAAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEK 1545
Query: 219 KIISAVELLQNYKKEQDELQME--------RDKAVKEAEELRKSRK 256
K ++ + KK +++ + E ++ A+++AEE +K+ +
Sbjct: 1546 KKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEE 1591
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 126 RREAFEEA-------LRRGKAEK-------------DAIESIRRAKASESLYAEELKRRK 165
RR FEEA RR + E+ D + + R S AE+ +R K
Sbjct: 157 RRAIFEEAAGISKYKERRKETERKLERTRENLDRLEDILNELERQLKSLERQAEKAERYK 216
Query: 166 EFEEALANGKL-----ELERMKKQHDEVMEELQIALDQKSLLESQIAESD---QTAK--- 214
E + L +L LE ++++ +E+ EEL+ A ++ L +++ E + + +
Sbjct: 217 ELKAELRELELALLVLRLEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEV 276
Query: 215 -ELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 259
ELE++I + L E L+ ++ + L + +E
Sbjct: 277 SELEEEIEELQKELYALANEISRLEQQKQILRERLANLERQLEELE 322
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 28/145 (19%), Positives = 57/145 (39%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
Q N R+ E + + E E E E + + E L
Sbjct: 303 QKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEAELEE 362
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ ELE ++ + +E+ E+L+ + + LE QIA + + LE ++ + + ++E
Sbjct: 363 LEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNEIERLEARLERLEDRRERLQQE 422
Query: 234 QDELQMERDKAVKEAEELRKSRKEA 258
+EL + ++A + + E
Sbjct: 423 IEELLKKLEEAELKELQAELEELEE 447
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-04
Identities = 31/123 (25%), Positives = 60/123 (48%), Gaps = 3/123 (2%)
Query: 138 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 197
A K+ E I+ K + +KR + EE + + ELE + ++ +E+ EL +
Sbjct: 162 NAYKNLGEVIKEIKRRIERLEKFIKRTENIEELIKEKEKELEEVLREINEISSELPELRE 221
Query: 198 QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKS 254
+ LE ++ E ++ +E+E+ L + +K ++ EL+ ++ KE EEL +
Sbjct: 222 ELEKLEKEVKELEELKEEIEELEKELESLEGSKRKLEEKIRELEERIEELKKEIEELEEK 281
Query: 255 RKE 257
KE
Sbjct: 282 VKE 284
|
Length = 880 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 289 IGEGGYGSIYKGLL--------------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR 334
+G G IY G+L + ++V +K+L P F + ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 335 HPNLVTLVGACPEVW--TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF 392
H ++V L G C +V E++ G L+ L S L+ + ++A +L S L +
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 393 LHSCKPHSIVHGDLKPANILL-------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCC 444
L +VHG++ NILL + KLSD GI LS+ E C
Sbjct: 121 LEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE--------CV 169
Query: 445 RTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIIL 478
P ++ PE + S L+ +D +SFG L
Sbjct: 170 ERIP-----WIAPECVEDSKNLSIAADKWSFGTTL 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|226889 COG4487, COG4487, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 32/158 (20%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 109 DNLYDQLAQAMAEAENSR---REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRK 165
+ + L + EA R R A ++ L + + + + ++ +E + EL +
Sbjct: 38 SRILNTLEEFEKEANEKRAQYRSAKKKELSQLEEQLINQKKEQKNLFNEQIKQFELALQD 97
Query: 166 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQ-TAKELEQKIISAV 224
E LE + + D+ +E L+ LD+ S ++ + Q TA+ +E+K +
Sbjct: 98 E-----IAKLEALELLNLEKDKELELLEKELDELSK---ELQKQLQNTAEIIEKKRENNK 149
Query: 225 EL----LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
+N KK ++ L++ER+K ++ E +
Sbjct: 150 NEERLKFENEKKLEESLELEREKFEEQLHEANLDLEFK 187
|
Length = 438 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410
L+ E+LP G + L KD + Q I ++ + + +H D+KP N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYI------AETVLAIDAIHQLGFIHRDIKPDN 131
Query: 411 ILLDANFVSKLSDFGIS------------RFLSQNEIS-----SNNTTLCCRTDPK---- 449
+LLDA KLSDFG+ R L+ N S + N+ T K
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 450 ------GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE D +S G+I+ +L G P
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|206034 pfam13863, DUF4200, Domain of unknown function (DUF4200) | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 25/100 (25%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 162 KRRKEFEEALANGKLELERMKKQHDEVMEELQ---IALDQK-SLLESQIAESDQTAKELE 217
KRR+ E +L L+ +++ + E L+ L++K L+ + + D+ KE E
Sbjct: 5 KRREMEEV-----QLALDAKREEFERREELLKQREEELEKKEEELQESLIKFDKFLKENE 59
Query: 218 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
K A + + KK + E + E + E EEL+ ++
Sbjct: 60 AKRRRAEKKAEEEKKLRKEKEEEIKELKAELEELKAEIEK 99
|
This family is found in eukaryotes. It is a coiled-coil domain of unknwon function. Length = 126 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 42/170 (24%), Positives = 62/170 (36%), Gaps = 41/170 (24%)
Query: 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411
V +Y+P G + L R IA C++ S +H D+KP NI
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFE--EDLARFYIAELTCAI----ESVHKMGFIHRDIKPDNI 132
Query: 412 LLDANFVSKLSDFGI---------SRFLSQN------------EISSNNT---------- 440
L+D + KL+DFG+ S++ + E S +
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 441 ----TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE L T D +S G+IL +L G+P
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
+ Q A + E+ + + +E + + L E + E E LA
Sbjct: 284 EELQKELYALANEISRLEQQKQILRERLANLER-QLEELEAQL-EELESKLDELAEELAE 341
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE-------L 226
+ +LE +K++ + + EL+ + LES++ E ++ + L K+
Sbjct: 342 LEEKLEELKEELESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNNE 401
Query: 227 LQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
++ + + L+ R++ +E EEL K +EA
Sbjct: 402 IERLEARLERLEDRRERLQQEIEELLKKLEEA 433
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|235175 PRK03918, PRK03918, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 29/141 (20%), Positives = 63/141 (44%), Gaps = 11/141 (7%)
Query: 126 RREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQH 185
E EE + + ++ ++ ++ K Y + + +E+ + L + L R++++
Sbjct: 264 LEERIEELKKEIEELEEKVKELKELKEKAEEYIKLSEFYEEYLDELREIEKRLSRLEEEI 323
Query: 186 DEVMEELQIALDQKSLLESQIAESDQTAKELE---------QKIISAVELLQNYKKEQDE 236
+ + E ++ +++ LE + + K LE ++ + E L+ KK
Sbjct: 324 NGIEERIKELEEKEERLEELKKKLKELEKRLEELEERHELYEEAKAKKEELERLKKRLTG 383
Query: 237 LQMERDKAVKEAEELRKSRKE 257
L E K KE EEL K+++E
Sbjct: 384 LTPE--KLEKELEELEKAKEE 402
|
Length = 880 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 335 HPNLVTLVGACPEVWT---LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVL 390
HP LV L +C + + V EY+ G L + + P + R + E+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----EEHARFYSAEISLAL 109
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+LH I++ DLK N+LLD+ KL+D+G+ + + + T+ C G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC-----G 158
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGI 490
T Y+ PE L + D ++ G+++ ++ GR I
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-04
Identities = 32/149 (21%), Positives = 65/149 (43%), Gaps = 5/149 (3%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEAL 171
++L + + E E E E+AL + E + +E E EEL R+ + L
Sbjct: 680 EELEEKIEELEEKIAEL-EKALAELRKELEELEEELEQLRKE---LEELSRQISALRKDL 735
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
A + E+E+++++ ++ +EL + LE ++ E+++ E E +I ++ K
Sbjct: 736 ARLEAEVEQLEERIAQLSKELTELEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLK 795
Query: 232 KEQDELQMERDKAVKEAEELRKSRKEASS 260
+E L+ D+ E L +
Sbjct: 796 EELKALREALDELRAELTLLNEEAANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|222469 pfam13949, ALIX_LYPXL_bnd, ALIX V-shaped domain binding to HIV | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 24/185 (12%)
Query: 82 TEGVSTLPPS-----KEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRR 136
EG LPPS +E L+ S+DD +L+Q E +E
Sbjct: 1 LEGPLGLPPSLLEKAEEIRSEGGIERLERSLDD--LPELSQRN-------EEILDEIKEL 51
Query: 137 GKAEKDAIESIRRA-------KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 189
E+ E +R S L AE + +++ L +++ + +E
Sbjct: 52 LDEEESEDEQLRAKYGERWTRPPSSELTAELREELRKYRGYLEQASESDAQLRSKLEEHE 111
Query: 190 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 249
E L++ + LE+ + S + ++ + L+ + +EL+ ER+K ++E +
Sbjct: 112 ENLELLSGPEEELEALLPSSSPS---KTPEVSEQISRLRELLNKLNELKAEREKLLEELK 168
Query: 250 ELRKS 254
E +
Sbjct: 169 EKAQD 173
|
The binding of the LYPxL motif of late HIV p6Gag and EIAV p9Gag to this domain is necessary for viral budding.This domain is generally central between an N-terminal Bro1 domain, pfam03097 and a C-terminal proline-rich domain. The retroviruses thus used this domain to hijack the ESCRT system of the cell. Length = 292 |
| >gnl|CDD|109486 pfam00430, ATP-synt_B, ATP synthase B/B' CF(0) | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 22/112 (19%)
Query: 113 DQLAQAMAEAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 166
+++A + EAE ++A E+ L +A +A E I AK A++LK
Sbjct: 33 EKIANNIKEAEERLKQAAALLAEAEQQLA--QARAEASEIINNAKKE----AQKLK---- 82
Query: 167 FEEALANGKLELERMKKQ-HDEVMEELQIALDQKSLLESQIAE-SDQTAKEL 216
EE LA + + ER+ + E+ +E + AL + L Q+A + Q A++L
Sbjct: 83 -EEILAEAQKDAERLLESARAEIEQEKEQALAE---LRQQVAALAVQIAEKL 130
|
Part of the CF(0) (base unit) of the ATP synthase. The base unit is thought to translocate protons through membrane (inner membrane in mitochondria, thylakoid membrane in plants, cytoplasmic membrane in bacteria). The B subunits are thought to interact with the stalk of the CF(1) subunits. This domain should not be confused with the ab CF(1) proteins (in the head of the ATP synthase) which are found in pfam00006. Length = 132 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 37/145 (25%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 116 AQAMAEAENSRR-EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 174
A + +AE ++ E ++A KAE+D ++R+A+ E+ AEE + + +
Sbjct: 1548 ADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAE--EAKKAEEARIEEVMKLYEEEK 1605
Query: 175 KLELERMKKQHDEVM--EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
K++ E KK + + EEL+ A ++K +E + + K+ E+ + E K
Sbjct: 1606 KMKAEEAKKAEEAKIKAEELKKAEEEKKKVEQLKKKEAEEKKKAEE--LKKAEEENKIKA 1663
Query: 233 EQDELQMERDKAVKEAEELRKSRKE 257
++ + E DK K+AEE +K+ ++
Sbjct: 1664 AEEAKKAEEDK--KKAEEAKKAEED 1686
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 6/151 (3%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE-----SLYAEELKRRKEF 167
++ + +AEAE + E E + + K E A+ +E A +R +
Sbjct: 771 EEAEEELAEAE-AEIEELEAQIEQLKEELKALREALDELRAELTLLNEEAANLRERLESL 829
Query: 168 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 227
E +A + LE +++Q +E+ E+++ + LE I E + + L + S E L
Sbjct: 830 ERRIAATERRLEDLEEQIEELSEDIESLAAEIEELEELIEELESELEALLNERASLEEAL 889
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
+ E +EL E + + ELR+ +E
Sbjct: 890 ALLRSELEELSEELRELESKRSELRRELEEL 920
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 32/162 (19%), Positives = 67/162 (41%), Gaps = 12/162 (7%)
Query: 109 DNLYDQLAQAMAEAENSRREAFE--EALRRGKAEKDAIES-IRRAKASESLYAEELKRRK 165
+ L +L+ +E E + L + IE I + + E E L+ +
Sbjct: 684 EGLKRELSSLQSELRRIENRLDELSQELSDASRKIGEIEKEIEQLEQEEEKLKERLEELE 743
Query: 166 EFEEALANGKLELERMKKQHDEVMEELQIALDQ---------KSLLESQIAESDQTAKEL 216
E +L ++ K+ + +EEL+ L + L S+I E +L
Sbjct: 744 EDLSSLEQEIENVKSELKELEARIEELEEDLHKLEEALNDLEARLSHSRIPEIQAELSKL 803
Query: 217 EQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
E+++ L+ +++ + L +E++ KE +EL++ R +
Sbjct: 804 EEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQRIDL 845
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 27/126 (21%), Positives = 61/126 (48%), Gaps = 1/126 (0%)
Query: 133 ALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF-EEALANGKLELERMKKQHDEVMEE 191
++ G K + + +R EL+ + E EE L + K EL ++ +E+ +
Sbjct: 651 SITGGSRNKRSSLAQKRELKELEEELAELEAQLEKLEEELKSLKNELRSLEDLLEELRRQ 710
Query: 192 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 251
L+ Q L+ ++A ++ ++L+ ++ E L+ ++E +ELQ ++ +E E L
Sbjct: 711 LEELERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESL 770
Query: 252 RKSRKE 257
++ +
Sbjct: 771 EEALAK 776
|
Length = 1163 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 0.001
Identities = 36/154 (23%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
D+ A +AE + ++ EEA ++ A K E ++A ++ AEE K++ + + A
Sbjct: 1357 DEAEAAEEKAEAAEKKK-EEAKKKADAAKKKAEEKKKADEAKK-KAEEDKKKADELKKAA 1414
Query: 173 NGKLELERMKKQHDEV--MEELQIALDQKSLLES--QIAESDQTAKELEQKIISAVELLQ 228
K + + KK+ +E +E + ++ + + AE + A+E ++K A + +
Sbjct: 1415 AAKKKADEAKKKAEEKKKADEAKKKAEEAKKADEAKKKAEEAKKAEEAKKKAEEAKKADE 1474
Query: 229 NYKKEQ-----DELQMERDKAVKEAEELRKSRKE 257
KK + DE + + ++A K+A+E +K+ +
Sbjct: 1475 AKKKAEEAKKADEAKKKAEEAKKKADEAKKAAEA 1508
|
Length = 2084 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 0.001
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 17/156 (10%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEF---EEALA 172
A+ +A+ ++++A EEA ++ K A E+ + KA E+ AEE K+ E EEA
Sbjct: 1479 AEEAKKADEAKKKA-EEAKKKADEAKKAAEA--KKKADEAKKAEEAKKADEAKKAEEAKK 1535
Query: 173 NGKLELERMKKQHDEV--MEELQIALDQKSLLESQIAESDQT--------AKELEQKIIS 222
+ + KK+ DE+ EEL+ A ++K E++ AE D+ AK+ E+ I
Sbjct: 1536 ADEAKKAEEKKKADELKKAEELKKAEEKKKAEEAKKAEEDKNMALRKAEEAKKAEEARIE 1595
Query: 223 AV-ELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
V +L + KK + E + ++A +AEEL+K+ +E
Sbjct: 1596 EVMKLYEEEKKMKAEEAKKAEEAKIKAEELKKAEEE 1631
|
Length = 2084 |
| >gnl|CDD|205692 pfam13514, AAA_27, AAA domain | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 13/156 (8%)
Query: 105 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 164
GSV D L + + R+ AL K K+ IR + + + +K
Sbjct: 129 GSVRDELEKEADELWKP--RGRKPEINVAL---KELKELEAEIREVQLKTRTWKDLVKAL 183
Query: 165 KEFEEALANGKLELERMKKQHDEVMEELQIALDQ---KSLLESQIAESDQTAKELEQKII 221
E EE LAN + EL +++K+ +E L+ L + LE Q+A E+
Sbjct: 184 DEAEEELANLRKELRQLEKEKQR-LERLRRLLPLLAERKALEQQLAA----LGEVIDLPP 238
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
AVE + + E + + + E L+ E
Sbjct: 239 DAVERYEEARAELRAARRNLELLTERLEALQAELDE 274
|
This domain is found in a number of double-strand DNA break proteins. This domain contains a P-loop motif. Length = 1118 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 33/174 (18%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR----- 163
+L DQL + E+A RR +AEKD +++ +A +L EE K
Sbjct: 443 HDLTDQLGEG-----GRNVHELEKARRRLEAEKDELQAALE-EAEAALELEESKVLRAQV 496
Query: 164 -----RKEFEEALANGKLELERMKKQHDEVMEELQIALDQ-----------KSLLESQIA 207
R E E LA + E E +K H +E LQ L+ K LE I
Sbjct: 497 ELSQIRSEIERRLAEKEEEFENTRKNHQRAIESLQATLEAEAKGKAEASRLKKKLEGDIN 556
Query: 208 ESDQTAKELEQKIISAVELLQNYKKEQD---ELQMERDKAVKEAEELRKSRKEA 258
E + L+ + E +N KK Q ELQ + ++ + E+ R+ A
Sbjct: 557 ELEIA---LDHANKANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVA 607
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 41/135 (30%), Positives = 54/135 (40%), Gaps = 17/135 (12%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410
LV ++ G L +S N P + R A E+ L LH IV DL P N
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDALHR---EGIVCRDLNPNN 115
Query: 411 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSD 470
ILLD +L+ F +E+ + C + Y PE E T D
Sbjct: 116 ILLDDRGHIQLTYFS-----RWSEVEDS----CDGEAVENM--YCAPEVGGISEETEACD 164
Query: 471 VYSFGIILLRLLTGR 485
+S G IL LLTG+
Sbjct: 165 WWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|226883 COG4477, EzrA, Negative regulator of septation ring formation [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 109 DNLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAI-ESIRRAKASESLYAEELKRR 164
++LYD L + EA+N + L + K + + E I R K S L EL
Sbjct: 291 ESLYDLLERE-VEAKNVVEENLPILPDYLEKAKENNEHLKEEIERVKESYRLAETELGSV 349
Query: 165 KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 224
++FE+ EL+ ++ DE++E ++ S L+ + E ++ ++E +
Sbjct: 350 RKFEK-------ELKELESVLDEILENIEAQEVAYSELQDNLEEIEKALTDIEDEQEKVQ 402
Query: 225 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFF 268
E L + +K++ E + ++ + E+ K E S+ +P+ F
Sbjct: 403 EHLTSLRKDELEARENLERLKSKLHEI-KRYMEKSNLPGLPETF 445
|
Length = 570 |
| >gnl|CDD|237178 PRK12705, PRK12705, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 5/134 (3%)
Query: 115 LAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEE-LKRRKEFEEALAN 173
L +A EAE A EA E++ R + E EE L +++E +A A
Sbjct: 39 LQEAQKEAEEKLEAALLEAKELLLRERNQQRQEARREREELQREEERLVQKEEQLDARAE 98
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+L+ ++ Q +E + L + LE Q+ L + LL+ E
Sbjct: 99 ---KLDNLENQLEEREKALSARELELEELEKQLDNELYRVAGLTPEQARK-LLLKLLDAE 154
Query: 234 QDELQMERDKAVKE 247
+E + +R K ++E
Sbjct: 155 LEEEKAQRVKKIEE 168
|
Length = 508 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 33/142 (23%), Positives = 67/142 (47%), Gaps = 4/142 (2%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
A +AE ++ +EA ++ + K A E+ ++A+ ++ A+ K++ E + A
Sbjct: 1292 ADEAKKAEEKKK--ADEAKKKAEEAKKADEAKKKAEEAKK-KADAAKKKAEEAKKAAEAA 1348
Query: 176 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 235
E EE A ++K + A++ + E ++K A + + KK+ D
Sbjct: 1349 KAEAEAAADEAEAAEEKAEAAEKKKEEAKKKADAAKKKAEEKKKADEAKKKAEEDKKKAD 1408
Query: 236 ELQMERDKAVKEAEELRKSRKE 257
EL+ + A K+A+E +K +E
Sbjct: 1409 ELK-KAAAAKKKADEAKKKAEE 1429
|
Length = 2084 |
| >gnl|CDD|217051 pfam02463, SMC_N, RecF/RecN/SMC N terminal domain | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 3/139 (2%)
Query: 120 AEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 179
E E L+ + + D E ++ ++ +ELK+ KE E L ELE
Sbjct: 290 KLLAKEEEELKSELLKLERRKVDDEEKLKESEKELKKLEKELKKEKEEIEELEKELKELE 349
Query: 180 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQM 239
++ +E E+L + LE E K +++ SA +L + + ++E +
Sbjct: 350 IKREAEEEEEEQL---EKLQEKLEQLEEELLAKKKLESERLSSAAKLKEEELELKNEEEK 406
Query: 240 ERDKAVKEAEELRKSRKEA 258
E ++ +E+ KE
Sbjct: 407 EAKLLLELSEQEEDLLKEE 425
|
This domain is found at the N terminus of SMC proteins. The SMC (structural maintenance of chromosomes) superfamily proteins have ATP-binding domains at the N- and C-termini, and two extended coiled-coil domains separated by a hinge in the middle. The eukaryotic SMC proteins form two kind of heterodimers: the SMC1/SMC3 and the SMC2/SMC4 types. These heterodimers constitute an essential part of higher order complexes, which are involved in chromatin and DNA dynamics. This family also includes the RecF and RecN proteins that are involved in DNA metabolism and recombination. Length = 1162 |
| >gnl|CDD|216108 pfam00769, ERM, Ezrin/radixin/moesin family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 26/154 (16%)
Query: 121 EAENSRREA------FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG 174
EAE ++E EE +RR A+K+ E A E+LK+ +E + L
Sbjct: 2 EAEREQQELEERMEQMEEDMRR--AQKELEEYEETAL----ELEEKLKQEEEEAQLLEKK 55
Query: 175 KLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
ELE ++ +EE A + ++ LE+++ E+ +LE+ E + ++
Sbjct: 56 ADELEEENRR----LEEEAAASEEERERLEAEVDEATAEVAKLEE----EREKKEAETRQ 107
Query: 234 -QDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 266
Q EL+ ++ + +EL EA+++ P
Sbjct: 108 LQQELREAQEAHERARQEL----LEAAAAPTAPP 137
|
This family of proteins contain a band 4.1 domain (pfam00373), at their amino terminus. This family represents the rest of these proteins. Length = 244 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 39/131 (29%)
Query: 129 AFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEV 188
AFE A R G E I AK L E+ K +L +
Sbjct: 490 AFEIAKRLGLPE----NIIEEAKK---LIGED--------------KEKLNEL------- 521
Query: 189 MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEA 248
IA SL E + E +Q A+E E + A +L + ++++++LQ E DK ++EA
Sbjct: 522 -----IA----SLEELER-ELEQKAEEAEALLKEAEKLKEELEEKKEKLQEEEDKLLEEA 571
Query: 249 E-ELRKSRKEA 258
E E +++ KEA
Sbjct: 572 EKEAQQAIKEA 582
|
Length = 782 |
| >gnl|CDD|237621 PRK14139, PRK14139, heat shock protein GrpE; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 111 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE-FEE 169
L D +A AE EN RR A E+ KA K AIES +AE L K+ E
Sbjct: 51 LQDSFLRAKAETENVRRRAQEDV---AKAHKFAIES----------FAESLLPVKDSLEA 97
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLE 203
ALA+ +LE++++ + +++L A ++ ++E
Sbjct: 98 ALADESGDLEKLREGVELTLKQLTSAFEKGRVVE 131
|
Length = 185 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 6/78 (7%)
Query: 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410
LV EYL G ++ L + ++ +E+ L +LH H I+H DLKP N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDN 134
Query: 411 ILLDANFVSKLSDFGISR 428
+L+ KL+DFG+S+
Sbjct: 135 MLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 69/310 (22%), Positives = 129/310 (41%), Gaps = 59/310 (19%)
Query: 288 KIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 341
KIG G +G ++ L++H + K + L+ S+ E++++ +++H N+V
Sbjct: 20 KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 342 VG-----ACPEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+ A +++ L+ E+ G L + C + + I +L L + H+
Sbjct: 78 IDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 396 CKP----HSIVHGDLKPANILLDANF-----------------VSKLSDFGISRFLSQNE 434
K ++H DLKP NI L ++K+ DFG+S+ +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 435 ISSNNTTLCCRTDPKGTFAYMDPEFL--ASGELTPKSDVYSFGIILLRLLTGRPALGITK 492
++ + C GT Y PE L + KSD+++ G I+ L +G+ K
Sbjct: 197 MAHS----CV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF--HK 245
Query: 493 EVQYALDTGKLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPE----LGKDVWRV 547
++ +LK D P+ G ++++L L +S K RP LG + +
Sbjct: 246 ANNFSQLISELKRGPDLPIKG-----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
Query: 548 LEPMRASCGG 557
+ P + GG
Sbjct: 301 VGPPVGAAGG 310
|
Length = 1021 |
| >gnl|CDD|226809 COG4372, COG4372, Uncharacterized protein conserved in bacteria with the myosin-like domain [Function unknown] | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 29/133 (21%), Positives = 57/133 (42%), Gaps = 2/133 (1%)
Query: 130 FEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 189
LR G + D I RA +E A+ KR E E A +L+ R +++ V
Sbjct: 65 LNRNLRSGVFQLDDIRPQLRALRTELGTAQGEKRAAETEREAARSELQKARQERE--AVR 122
Query: 190 EELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAE 249
+EL A + + ++A + A++L+ ++ + E + + + LQ + + A
Sbjct: 123 QELAAARQNLAKAQQELARLTKQAQDLQTRLKTLAEQRRQLEAQAQSLQASQKQLQASAT 182
Query: 250 ELRKSRKEASSSS 262
+L+ + S
Sbjct: 183 QLKSQVLDLKLRS 195
|
Length = 499 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
LHS I+H DLKP+NI++ ++ K+ DFG++R N + + T
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV---------TR 186
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTG 484
Y PE + D++S G I+ L+ G
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 27/143 (18%), Positives = 54/143 (37%), Gaps = 3/143 (2%)
Query: 112 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 171
+ L + E + E +E + + I K EEL+R E L
Sbjct: 366 LEDLRAELEEVDKEFAETRDELKDYREKLEKLKREINELKRELDRLQEELQRL---SEEL 422
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYK 231
A+ + ++ + +E+ EE + + E ++ + + EQ++ E +
Sbjct: 423 ADLNAAIAGIEAKINELEEEKEDKALEIKKQEWKLEQLAADLSKYEQELYDLKEEYDRVE 482
Query: 232 KEQDELQMERDKAVKEAEELRKS 254
KE +LQ E +A +A +
Sbjct: 483 KELSKLQRELAEAEAQARASEER 505
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 32/163 (19%), Positives = 64/163 (39%), Gaps = 26/163 (15%)
Query: 110 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELK------- 162
+L +L+ + + EE + R +A IE E Y E+
Sbjct: 783 DLEARLSHSRIPEIQAELSKLEEEVSRIEARLREIEQKLNRLTLEKEYLEKEIQELQEQR 842
Query: 163 -----RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 217
+ K E+ + N + E + +E +EEL+ AL LES++ +L+
Sbjct: 843 IDLKEQIKSIEKEIENLNGKKEEL----EEELEELEAALRD---LESRL-------GDLK 888
Query: 218 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
++ L+ +++ +EL+ + +K K EL+ +
Sbjct: 889 KERDELEAQLRELERKIEELEAQIEKKRKRLSELKAKLEALEE 931
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 35/136 (25%), Positives = 64/136 (47%), Gaps = 4/136 (2%)
Query: 121 EAENSRREAFEEALRRGKAEKDAIESIRRA--KASESLYAEELKRRKEFEEALANGKLEL 178
EA+ + E E +R+ + + A + R+A KA E+ A+ELK+ +E ++A K E
Sbjct: 1241 EAKKAEEERNNEEIRKFEEARMAHFARRQAAIKAEEARKADELKKAEEKKKADEAKKAEE 1300
Query: 179 ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQ 238
++ + + EE + A + K E ++D K+ E+ +A + DE +
Sbjct: 1301 KKKADEAKKKAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAE 1360
Query: 239 MERDKAVKEAEELRKS 254
+K EA E +K
Sbjct: 1361 AAEEK--AEAAEKKKE 1374
|
Length = 2084 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 32/167 (19%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 112 YDQLAQAMAEAENSRREAFEE--ALRRGKAEKDA-IESIRRAKAS------------ESL 156
++L + + E + +EA EE L E + +E +R + +L
Sbjct: 234 LEELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYAL 293
Query: 157 YAE--ELKRRKEF-EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTA 213
E L+++K+ E LAN + +LE ++ Q +E+ +L ++ + LE ++ E +
Sbjct: 294 ANEISRLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEEL 353
Query: 214 KELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+ LE ++ L+ + +EL+ + + + +L ++
Sbjct: 354 ESLEAELEELEAELEELESRLEELEEQLETLRSKVAQLELQIASLNN 400
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|237177 PRK12704, PRK12704, phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (96), Expect = 0.003
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 31/159 (19%)
Query: 115 LAQAMAEAENSRREAF----EEALR-RGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 169
L +A EAE ++EA EE + R + EK+ E RR + + KR + EE
Sbjct: 44 LEEAKKEAEAIKKEALLEAKEEIHKLRNEFEKELRE--RRNE-----LQKLEKRLLQKEE 96
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
L +LE ++K+ +E+ ++ + ++ LE + E +EL ++ + +E +
Sbjct: 97 NLDR---KLELLEKREEELEKKEKELEQKQQELEKKEEE----LEELIEEQLQELERISG 149
Query: 230 YKKEQ----------DELQMERDKAVKEAEELRKSRKEA 258
E+ +E + E +KE EE ++++EA
Sbjct: 150 LTAEEAKEILLEKVEEEARHEAAVLIKEIEE--EAKEEA 186
|
Length = 520 |
| >gnl|CDD|144972 pfam01576, Myosin_tail_1, Myosin tail | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 48/152 (31%), Positives = 72/152 (47%), Gaps = 26/152 (17%)
Query: 112 YDQLAQAMAEAENSRREAFEEALRRGKAEKDAI----ESIRRAKASESLYAEELKRRK-- 165
D L + + E ++ E E L + AE ES +A E EELK++
Sbjct: 273 LDSLREQLEEESEAKAEL-ERQLSKANAEIQQWRSKFESEGALRAEE---LEELKKKLNQ 328
Query: 166 ---EFEEAL--ANGKL-ELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQK 219
E EEA AN K LE+ K + +E+LQI L++ ++ A ELE+K
Sbjct: 329 KISELEEAAEAANAKCDSLEKTKSRLQSELEDLQIELER----------ANAAASELEKK 378
Query: 220 IISAVELLQNYKKEQDELQMERDKAVKEAEEL 251
+ ++L +K++ DELQ E D A +EA L
Sbjct: 379 QKNFDKILAEWKRKVDELQAELDTAQREARNL 410
|
The myosin molecule is a multi-subunit complex made up of two heavy chains and four light chains it is a fundamental contractile protein found in all eukaryote cell types. This family consists of the coiled-coil myosin heavy chain tail region. The coiled-coil is composed of the tail from two molecules of myosin. These can then assemble into the macromolecular thick filament. The coiled-coil region provides the structural backbone the thick filament. Length = 859 |
| >gnl|CDD|221389 pfam12037, DUF3523, Domain of unknown function (DUF3523) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 132 EALRRG-KAEKDAIESIRRA-KASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVM 189
AL RG KA ++ +ES A KA E +E R+ E E + + + + K + V
Sbjct: 32 TALERGAKALRE-LESSPHAKKAFELSKMQEKTRQAELEAKIKEYEAQQAQAKLERARVE 90
Query: 190 EELQIALDQKSLLESQIAESDQTAK---ELEQKIISAVELLQNYKKEQDELQMERDKAVK 246
E +++ L+ Q + Q A+ EL +K EL Q ++ ++ L+M+ + ++
Sbjct: 91 AE-----ERRKTLQEQTQQEQQRAQYQDELARKRYQK-ELEQQRRQNEELLKMQEESVLR 144
Query: 247 EAEELRKSRKE 257
+ E +R++ +E
Sbjct: 145 Q-EAMRRATEE 154
|
This presumed domain is functionally uncharacterized. This domain is found in eukaryotes. This domain is typically between 257 to 277 amino acids in length. This domain is found associated with pfam00004. This domain has a conserved LER sequence motif. Length = 276 |
| >gnl|CDD|179385 PRK02224, PRK02224, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDA---IESIR-RAKASESLYAEELKRRKEFE 168
++L + + E E EE L R + +A IE + R + E L AE + +E
Sbjct: 478 EELEAELEDLE-EEVEEVEERLERAEDLVEAEDRIERLEERREDLEELIAERRETIEEKR 536
Query: 169 EALAN-----GKLELERMKKQHD--EVMEELQIALDQKSLLESQIAESDQTAKELEQKII 221
E +LE E +K+ E EE + A ++ + L S++AE + + LE +I
Sbjct: 537 ERAEELRERAAELEAEAEEKREAAAEAEEEAEEAREEVAELNSKLAELKERIESLE-RIR 595
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSR 255
+ + + + + E + L+ E+ +A+ E + R+ R
Sbjct: 596 TLLAAIADAEDEIERLR-EKREALAELNDERRER 628
|
Length = 880 |
| >gnl|CDD|223783 COG0711, AtpF, F0F1-type ATP synthase, subunit b [Energy production and conversion] | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 138 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 197
K A++ R+AK ++ L E + ++E + LA + ELE ++Q E++E+
Sbjct: 29 KPILKALDE-RQAKIADDLAEAE-RLKEEAQALLAEYEQELEEAREQASEIIEQA----- 81
Query: 198 QKSLLESQIAE-SDQTAKELEQKIISAVELLQNYKKE-QDELQME-RDKAVKEAEELRKS 254
K E E + +ELE+ +A ++ K+ +EL+ E + AV AE+L
Sbjct: 82 -KKEAEQIAEEIKAEAEEELERIKEAAEAEIEAEKERALEELRAEVAELAVAIAEKL--L 138
Query: 255 RKEASSSSHM 264
K+ ++
Sbjct: 139 GKKVDEAAQK 148
|
Length = 161 |
| >gnl|CDD|226513 COG4026, COG4026, Uncharacterized protein containing TOPRIM domain, potential nuclease [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 9/132 (6%)
Query: 164 RKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQ---KI 220
RKE + AL L+ + ++ ++ E+ + K LE E ++ KELE+ +
Sbjct: 109 RKELKNALVRAGLKTLQRVPEYMDLKEDY---EELKEKLEELQKEKEELLKELEELEAEY 165
Query: 221 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 280
E L+ + E L+ K E +L+K E +P+ + S++ T
Sbjct: 166 EEVQERLKRLEVENSRLEEMLKKLPGEVYDLKKRWDELEPGVELPE---EELISDLVKET 222
Query: 281 HNFDPSLKIGEG 292
N P G+G
Sbjct: 223 LNLAPKDIEGQG 234
|
Length = 290 |
| >gnl|CDD|223496 COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 30/157 (19%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 110 NLYDQLAQAMAEAEN---SRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKE 166
L + + E S E E+ + + + +E + K L +R KE
Sbjct: 308 EGLRALLEELEELLEKLKSLEERLEKLEEKLEKLESELEELAEEK--NELAKLLEERLKE 365
Query: 167 FEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL 226
EE L + ELE+ ++ ++ E +Q ++ + L + + E + +ELE++ +E
Sbjct: 366 LEERLEELEKELEKALERLKQLEEAIQELKEELAELSAALEEIQEELEELEKE----LEE 421
Query: 227 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 263
L+ +E +E + ++ + + E E + +
Sbjct: 422 LERELEELEEEIKKLEEQINQLESKELMIAELAGAGE 458
|
Length = 908 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 289 IGEGGYGSI---YKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLV- 342
+G G YGS+ Y LR +VA+K L SL +E+ +L ++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ-KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 343 ----GACPEVWTLVY--EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
E + VY L L + + C+ LS + + +L L ++HS
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHSA 137
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
I+H DLKP+N+ ++ + ++ DFG++R + +E+ T T Y
Sbjct: 138 ---GIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM----------TGYVATRWYRA 183
Query: 457 PEFLASG-ELTPKSDVYSFGIILLRLLTGR 485
PE + + D++S G I+ LL G+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|225638 COG3096, MukB, Uncharacterized protein involved in chromosome partitioning [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 28/176 (15%)
Query: 80 IRTEGV--STLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRG 137
I+ G S L P LQS P ++QL + A+A+ +R+A ++A
Sbjct: 912 IQQHGNTLSKLEPIASVLQSDPEQ----------FEQLKEDYAQAQQMQRQARQQAF--- 958
Query: 138 KAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALD 197
A + ++ RRA S S AE L + E L + LE+ + + E+L+
Sbjct: 959 -ALTEVVQ--RRAHFSYSDSAEMLSENSDLNEKL---RQRLEQAEAERTRAREQLRQH-- 1010
Query: 198 QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 253
++Q+++ +Q L+ + ELL ++E ++ + D +E +R+
Sbjct: 1011 -----QAQLSQYNQVLASLKSSYDTKKELLNELQQELQDIGVRADSGAEERARIRR 1061
|
Length = 1480 |
| >gnl|CDD|225288 COG2433, COG2433, Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 25/160 (15%)
Query: 131 EEALRRGKAEKDAIES---IRRAKASESLYAEELKRR----KEFEEALANGKLELERMKK 183
EAL + K E+ E + ++Y + +K+ + EE + K ELE +K+
Sbjct: 391 AEALSKVKEEERPREKEGTEEEERREITVYEKRIKKLEETVERLEEENSELKRELEELKR 450
Query: 184 QHDEV---MEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQME 240
+ +++ +E + + K + +I D+ + LE++ L+ KK +EL+
Sbjct: 451 EIEKLESELERFRREVRDKVRKDREIRARDRRIERLEKE-------LEEKKKRVEELE-- 501
Query: 241 RDKAVKEAEELRKSRKEASSSSHMP-QFFSDFSFSEIEGA 279
++ ELRK RK S P + + IE A
Sbjct: 502 -----RKLAELRKMRKLELSGKGTPVKVVEKLTLEAIEEA 536
|
Length = 652 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 641 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| TIGR00599 | 397 | rad18 DNA repair protein rad18. This family is bas | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| KOG2042 | 943 | consensus Ubiquitin fusion degradation protein-2 [ | 97.9 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.84 | |
| PLN03208 | 193 | E3 ubiquitin-protein ligase RMA2; Provisional | 97.82 | |
| COG5113 | 929 | UFD2 Ubiquitin fusion degradation protein 2 [Postt | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.76 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.71 | |
| PF11789 | 57 | zf-Nse: Zinc-finger of the MIZ type in Nse subunit | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.98 | |
| PLN02236 | 344 | choline kinase | 96.97 | |
| PF15227 | 42 | zf-C3HC4_4: zinc finger of C3HC4-type, RING; PDB: | 96.88 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.77 | |
| KOG0823 | 230 | consensus Predicted E3 ubiquitin ligase [Posttrans | 96.65 | |
| KOG0287 | 442 | consensus Postreplication repair protein RAD18 [Re | 96.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.49 | |
| PF13923 | 39 | zf-C3HC4_2: Zinc finger, C3HC4 type (RING finger); | 96.45 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.16 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=407.23 Aligned_cols=275 Identities=45% Similarity=0.796 Sum_probs=234.1
Q ss_pred cCCCCChhhHhhhcCCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc
Q 006545 267 FFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345 (641)
Q Consensus 267 ~~~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 345 (641)
....|++.++..+|++|.....||+|+||.||+|...+ ..||||++.........+|.+|+.+|.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999975 89999988765543144699999999999999999999999
Q ss_pred c--C-ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccc
Q 006545 346 P--E-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422 (641)
Q Consensus 346 ~--~-~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~ 422 (641)
. + ..+|||||+++|+|.++|...... +++|..+++|+.++|.||.|||...+.+||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 4 3 379999999999999999765444 89999999999999999999999766689999999999999999999999
Q ss_pred cccccccccc-ccccCCCccccccCCC-CCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---------
Q 006545 423 DFGISRFLSQ-NEISSNNTTLCCRTDP-KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT--------- 491 (641)
Q Consensus 423 DFGla~~~~~-~~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~--------- 491 (641)
|||+|+.... .... ... .||.+|+|||++..+..+.++|||||||+|+||+||++|.+..
T Consensus 220 DFGLa~~~~~~~~~~---------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV---------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CccCcccCCccccce---------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999966543 2110 011 5999999999999999999999999999999999999888642
Q ss_pred HHHHHHHhhcccccccCCCC--CCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 492 KEVQYALDTGKLKNLLDPLA--GDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 492 ~~~~~~~~~~~~~~~~d~~~--~~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
.+....+..+.+..++|+.. +.++. .....+..++.+|++.+|.+||+|.+ |.+.|+.+.
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKELEGIL 353 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHHHhhc
Confidence 23334556678899999885 45554 56778999999999999999999999 566665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=395.51 Aligned_cols=255 Identities=35% Similarity=0.549 Sum_probs=213.4
Q ss_pred CCccceeeccCceEEEEEEECCeE-EEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccccC---ceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE---VWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~~~-vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~~lV~Ey~ 356 (641)
+.....||+|+||+||+|.++|.. ||||++....... ...|.+|+.+|.+++|||||+++|+|.+ ..+|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344556999999999999999988 9999998755433 3489999999999999999999999954 378999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeeccCCCCceEeccCC-ccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 434 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g-IiHrDIkp~NILld~~~-~vKL~DFGla~~~~~~~ 434 (641)
++|+|..+|... ....+++..++.|+.|||.||.|||+ ++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999754 45679999999999999999999999 66 99999999999999998 99999999998766432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLA--SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
. ..+...||+.|||||++. ...|+.++|||||||+||||+||+.||........+.... .....+
T Consensus 199 ~--------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-----~~~~Rp 265 (362)
T KOG0192|consen 199 T--------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-----VGGLRP 265 (362)
T ss_pred c--------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hcCCCC
Confidence 1 123356999999999999 5689999999999999999999999998777543322221 011223
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhc
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~ 555 (641)
..|..++..+..|+.+||..||..||++.+ +...|+.+....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e-i~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLE-IVSRLESIMSHI 307 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHH-HHHHHHHHHHhh
Confidence 345557889999999999999999999999 778888887653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=396.77 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=209.7
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccccC--ceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~ 353 (641)
..|...+.||+|||+.||.+++ +|..||+|++.+.... ..+.+.+||+|.+.|+|||||+++++|++ +.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999988 5889999999875443 35678999999999999999999999965 689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|+|..++|..++. ...++++..++.++.||+.||.|||+ ++|||||||..||||+.+.+|||+|||||..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 55779999999999999999999999 89999999999999999999999999999988755
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
+ ... ...+|||.|+|||++....++..+||||+|||||.||+|+|||...+--...... +... -.
T Consensus 172 ~--Erk------~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I-k~~~------Y~ 236 (592)
T KOG0575|consen 172 G--ERK------KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI-KLNE------YS 236 (592)
T ss_pred c--ccc------ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-HhcC------cc
Confidence 3 112 3446999999999999999999999999999999999999999765433222211 1111 12
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
.|...+.++.+||.++|+.||.+|||+.+++.
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 35677889999999999999999999999653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=383.98 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=205.0
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccccC--ceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV 352 (641)
..+|+.++.||+|+||.||++.- +|..+|+|++++..... ...+..|.++|...++|+||+||.+|++ ++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 45789999999999999999976 57899999999875533 4668899999999999999999999954 79999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+|||++..+|. ....|++..+..++.+++.|+..||. .|||||||||+|+|||..|++||+|||||..+..
T Consensus 220 MEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999995 44579999999999999999999999 8999999999999999999999999999975543
Q ss_pred ccccC---------------CCccc------------------------cccCCCCCCcccCChhhhccCCCCchhhHHH
Q 006545 433 NEISS---------------NNTTL------------------------CCRTDPKGTFAYMDPEFLASGELTPKSDVYS 473 (641)
Q Consensus 433 ~~~~~---------------~~~~~------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwS 473 (641)
..... ..... ......+|||.|||||++.+.+|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 11100 00000 0112457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 474 FGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 474 lGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
||||+||||.|.|||...+.....-....+...+.... ....+.++.+||.+||. ||.+|...
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---EVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999988776655444433333322111 12345889999999999 99999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=375.62 Aligned_cols=246 Identities=31% Similarity=0.483 Sum_probs=204.5
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
..+|...+.||+|+||+||+|+++ +..||||.+.+... ...+-+..|+.+|+.++|||||.+++++ ++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888899999999999999984 68899999987642 2345678999999999999999999998 56799999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC------Ccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN------FVSKLSDFGIS 427 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~------~~vKL~DFGla 427 (641)
|||.||+|.+++.. .+.+++.++..++.||+.||++||+ ++||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 3469999999999999999999999 899999999999999764 56899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 507 (641)
+.+..... ....+|++.|||||++..++|+.|+|+||+|+|||+|++|++||...+..+......+-...+
T Consensus 163 R~L~~~~~---------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~ 233 (429)
T KOG0595|consen 163 RFLQPGSM---------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV 233 (429)
T ss_pred hhCCchhH---------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc
Confidence 98875432 233459999999999999999999999999999999999999998766655444332222222
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+|+...+..+|.+|-+..+-+
T Consensus 234 ----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 234 ----PVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ----CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 222344455677899999999999998887733
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=365.28 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=209.3
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEec-ccc---CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG-ACP---EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g-~~~---~~~~lV 352 (641)
.+|.+.++||+|+||+||++.. ++..||.|.++...... ...+..|+.+|++|+|||||++++ .|. ..++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3688899999999999999976 58899999988543332 346889999999999999999999 442 237899
Q ss_pred EEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeeccCCCCceEeccCCccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
||||.+|+|...+... .....+++..+|+++.|++.||..+|+.-++ -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998643 3456799999999999999999999994333 3899999999999999999999999999988
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh--hcccccccC
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLD 508 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--~~~~~~~~d 508 (641)
..... ...+.+|||.||+||.+...+|+++|||||+||++|||+.-++||.+.+-...... .+..
T Consensus 179 ~s~~t--------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~----- 245 (375)
T KOG0591|consen 179 SSKTT--------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY----- 245 (375)
T ss_pred cchhH--------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----
Confidence 76542 23556799999999999999999999999999999999999999988765443322 2211
Q ss_pred CCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 509 PLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 509 ~~~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
+..| ..++..+..||..|+..||..||+....|.++..
T Consensus 246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1123 6789999999999999999999997654544443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=371.25 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cC-ceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PE-VWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~-~~~lV~Ey 355 (641)
+.+..+.||+|..|+||++.++ ++.+|+|++...... ...++.+|+++++..+|||||.+||+| +. ..+|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4566788999999999999996 788999999654332 246789999999999999999999998 33 38999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
|.||||.+++. ..+.+++....+|+.++++||.|||.. ++||||||||+||||+..|.|||+|||.++.+....
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~- 233 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI- 233 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh-
Confidence 99999999994 336699999999999999999999963 689999999999999999999999999998776541
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----HHHHHHHhhcccccccCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-----KEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~-----~~~~~~~~~~~~~~~~d~~ 510 (641)
..+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ..+... ..+++..
T Consensus 234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------~~Iv~~p 298 (364)
T KOG0581|consen 234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------CAIVDEP 298 (364)
T ss_pred ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------HHHhcCC
Confidence 24557999999999999999999999999999999999999999764 222211 1222222
Q ss_pred CCCCChh-hHHHHHHHHHHHhhhccCCCCChHH
Q 006545 511 AGDWPFV-QAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 511 ~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.+..|.. .++++..++..||++||.+||++.+
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 3344554 7899999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=375.98 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=198.8
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC-------chhHHHHHHHHhcCCCCceeeEeccc--cCce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG-------PSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 349 (641)
..|-+.+.||+|+||.|-+|.. +++.||||++++..... ...+.+|++||++|+|||||+++++| ++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4578889999999999999987 47899999998753322 22357999999999999999999999 4567
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC---Cccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGI 426 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~---~~vKL~DFGl 426 (641)
|+||||+.||+|.+.+. .++.+.+..-..++.|++.||.|||+ +||+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999994 44557788889999999999999999 999999999999999765 7899999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcHH---HHHHHhh
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITKE---VQYALDT 500 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~~sDVwSlGviL~eLltG~~Pf~~~~~---~~~~~~~ 500 (641)
|+...... .+...+||+.|.|||++.+.. +..++|+||+|||||-+|+|.+||..... ....+..
T Consensus 326 AK~~g~~s---------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGEGS---------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred hhccccce---------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 99876432 234456999999999998765 33488999999999999999999964322 3333333
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+++... +......+.+..+||.+||..||++||++.+++
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 332211 122346788999999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=365.05 Aligned_cols=238 Identities=29% Similarity=0.373 Sum_probs=202.1
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
..+|++.++||+|+||.||.+.. +++.+|+|++++.... ......+|..||..++||.||+++..|+ +.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45799999999999999999876 4688999999876433 3467889999999999999999999995 479999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|+.||.|..+|. ....|++..+..++.+|+.||.|||+ +|||||||||+|||||..|+++|+|||+|+....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999994 45669999999999999999999999 9999999999999999999999999999985544
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH--HhhcccccccCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPL 510 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~ 510 (641)
.... ....+||+.|||||++.+.+|+.++|+|||||++|+|++|.+||...+..... +..++
T Consensus 178 ~~~~--------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDA--------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------- 241 (357)
T ss_pred CCCc--------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------
Confidence 3211 12356999999999999999999999999999999999999999876543322 22222
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
....|...+....+|+.++|..||.+|..
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 12234557889999999999999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=376.79 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=213.9
Q ss_pred CCCCccceeeccCceEEEEEEECCe-EEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 357 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~~-~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 357 (641)
..+...+.||+|-||.||.|.+++. .||+|.++... ...+.|.+|+.+|++|+|+|||+++|+|. +.+|||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3456778899999999999999876 89999998763 34578999999999999999999999994 35899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
.|+|.++|.. .....+...+.+.++.|||+|++||++ +++|||||.+.||||+++..+||+|||+|+...++....
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 345678999999999999999999999 899999999999999999999999999999655443222
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH--HHhhcccccccCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~ 514 (641)
.....-...|.|||.+..+.++.+||||||||+||||+| |+.||......+. .+..|. . -..
T Consensus 361 -------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy--R------lp~ 425 (468)
T KOG0197|consen 361 -------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY--R------LPR 425 (468)
T ss_pred -------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC--c------CCC
Confidence 122334678999999999999999999999999999999 9999987655443 333332 2 234
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
|..++..+.+|+..||..+|++|||+.. +...|+.+...
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~-L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFET-LREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHH-HHHHHHHhhhc
Confidence 7778999999999999999999999997 87888776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=369.07 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=212.7
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcC-CCCceeeEeccccC--ce
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VW 349 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~--~~ 349 (641)
....+|.+++.||.|+|++|++|+.. ++.||||++.+.-. ....-+..|-++|.+| .||.|++||..|.| .+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999874 68899999976532 2234577899999999 89999999999965 68
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
|+|+||+++|+|.++|.+ .+.|++.-.+.++.+|+.||+|||+ +|||||||||+|||||.+|++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999954 3569999999999999999999999 8999999999999999999999999999999
Q ss_pred cccccccC-----CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc
Q 006545 430 LSQNEISS-----NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 430 ~~~~~~~~-----~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
+....... ...........+||..|.+||++..+..++.+|||+||||||+|+.|.|||...++.........+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l- 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL- 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-
Confidence 87665441 111111235578999999999999999999999999999999999999999888775543333222
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.-.||...++.+.+||.+.|..||.+|++..+
T Consensus 303 ------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q 334 (604)
T KOG0592|consen 303 ------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQ 334 (604)
T ss_pred ------cccCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence 23456677789999999999999999999966
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.31 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=203.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cC--ceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PE--VWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~--~~~lV~E 354 (641)
.+|...+.||+|+||.||++.+. +...|||.+........+.+.+|+.+|.+|+|||||+++|.. .+ .++|+||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46778889999999999999986 588999998766333355689999999999999999999963 33 4889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCcccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~~~~~~ 433 (641)
|+++|+|.+++..... .|++..+..++.|++.||.|||+ +|||||||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999964433 69999999999999999999999 99999999999999999 799999999999876641
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC-cHHHHHHHhhcccccccCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI-TKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~-~~~~~~~~~~~~~~~~~d~~~ 511 (641)
... ........||+.|||||++.++ ...+++|||||||++.||+||.+||.. .......+..+.-. ..
T Consensus 172 ~~~-----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTK-----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SL 241 (313)
T ss_pred ccc-----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CC
Confidence 111 1112345699999999999864 344699999999999999999999976 23333333332222 22
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.+|...+..+.+++.+|+..+|.+|||+.+.+
T Consensus 242 P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL 274 (313)
T KOG0198|consen 242 PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELL 274 (313)
T ss_pred CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 366777899999999999999999999999943
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=356.68 Aligned_cols=251 Identities=28% Similarity=0.379 Sum_probs=204.7
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc----cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV 352 (641)
..|+.+.+||+|.||.||+|++ +|+.||+|++..... .......+||.||++|+||||++|.+.. ...+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4678888999999999999988 478899999987653 3355678999999999999999999976 2368999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
+|||+. +|..++. .....|++.++..++.|++.||.|+|. +||+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999975 8888884 344579999999999999999999999 9999999999999999999999999999998876
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc--------
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-------- 503 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~-------- 503 (641)
..... .+..+-|.+|.|||++.+. .|++++|+||.||||.||++|+|.|.+.+++......-++
T Consensus 271 ~~~~~-------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 271 SGSAP-------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCcc-------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 54221 3556679999999999886 6999999999999999999999999988887655432111
Q ss_pred -c--cc-----cCCCC------CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -K--NL-----LDPLA------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -~--~~-----~d~~~------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .+ +.+.. .+.....+....+|+..+|..||.+|.|+.+++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 1 00 00000 001123456789999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=339.40 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=198.9
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
.|+.+.++|+|+||+||++++ +|+.||||++....... .+-..+|+.+|++|+|||+|.++.+| ...++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 578888999999999999987 47889999997654322 24478999999999999999999999 4578999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
|+..-|.+ |.. ....++...+.+++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+...+.
T Consensus 83 ~dhTvL~e-Le~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHE-LER--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHH-HHh--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 97654444 432 23348889999999999999999999 8999999999999999999999999999998874321
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc-ccccC-----
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-KNLLD----- 508 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~-~~~~d----- 508 (641)
..+..+.|.+|.|||.+.+ .+|++.+||||+||++.||++|.|.|.+.++++......+. ..++.
T Consensus 157 --------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 157 --------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred --------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 1345568999999999988 68999999999999999999999999988877765433211 11110
Q ss_pred ------------C-------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 509 ------------P-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 509 ------------~-------~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
| +...+| ..+.-+.+|+..||..||.+|++-++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHH
Confidence 0 011122 344578999999999999999998873
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.01 Aligned_cols=233 Identities=26% Similarity=0.367 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccccC--ceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~ 353 (641)
.+|+..+.||.|+||.|.+++.+ +..+|+|++.+..... .+...+|..+|+.+.||+++++++.|.+ ..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 36888999999999999999874 6789999998764332 4567899999999999999999999854 689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||.|..+|. ..++|++..++.++.+|+.||+|||+ ++|++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999994 44579999999999999999999999 89999999999999999999999999999987644
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
. ...+|||.|+|||++...+|+.++|+|||||++|||+.|.+||...+.....-..- ...-.
T Consensus 198 T-----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~-------~~~v~ 259 (355)
T KOG0616|consen 198 T-----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL-------EGKVK 259 (355)
T ss_pred E-----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH-------hCccc
Confidence 2 33459999999999999999999999999999999999999998877654322211 11224
Q ss_pred CChhhHHHHHHHHHHHhhhccCCC
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSR 537 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~R 537 (641)
+|...+..+.+|+..+|+.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 577888999999999999999999
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=355.83 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=202.3
Q ss_pred cCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEecccc---C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~---~ 347 (641)
..+|.+.++||.|+||.||+|.+. +..||||++...... ....+.+|+.+|..+ +||||++++|+|. .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457899999999999999999752 357999998754322 235688999999999 8999999999874 3
Q ss_pred ceEEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDN--------------------------------------------------------- 370 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~--------------------------------------------------------- 370 (641)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 47899999999999999864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCC
Q 006545 371 --SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448 (641)
Q Consensus 371 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~ 448 (641)
..++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......... .....
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~~~~~ 236 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGSA 236 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh------cccCC
Confidence 2358889999999999999999999 899999999999999999999999999998654321110 11223
Q ss_pred CCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH---HHHhhcccccccCCCCCCCChhhHHHHHH
Q 006545 449 KGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ---YALDTGKLKNLLDPLAGDWPFVQAEQLAN 524 (641)
Q Consensus 449 ~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~---~~~~~~~~~~~~d~~~~~~~~~~~~~l~~ 524 (641)
.+++.|+|||++.+..++.++|||||||+||+|++ |.+||....... ..+..+. ....+...+..+.+
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~ 308 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATPEIYR 308 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC--------CCCCCCCCCHHHHH
Confidence 46788999999999999999999999999999997 999997543211 1111111 11123455678999
Q ss_pred HHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 525 LAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 525 Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
|+.+||..||.+||++.+ +++.|+.+..
T Consensus 309 li~~cl~~dp~~RPs~~e-l~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSA-LVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHH-HHHHHHHHHh
Confidence 999999999999999999 7778877653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.12 Aligned_cols=244 Identities=28% Similarity=0.372 Sum_probs=204.1
Q ss_pred hcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCC----CC-CCchhHHHHHHHHhcCC-CCceeeEeccc--cCc
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPH----SL-QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEV 348 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~----~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~ 348 (641)
..++|.+.+.||+|+||.|+.|.+ ++..||+|++... .. .....+.+|+.+++.++ ||||++++.++ ...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999987 4789999987764 11 22456778999999999 99999999988 456
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-Ccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 427 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFGla 427 (641)
+++|||||.||+|.+++.. .+++.+..+..++.|++.|+.|+|+ +||+||||||+|||++.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999953 5678999999999999999999999 899999999999999999 99999999999
Q ss_pred cccc-cccccCCCccccccCCCCCCcccCChhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc
Q 006545 428 RFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 428 ~~~~-~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
.... ... .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.........
T Consensus 169 ~~~~~~~~---------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~--- 236 (370)
T KOG0583|consen 169 AISPGEDG---------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR--- 236 (370)
T ss_pred cccCCCCC---------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh---
Confidence 9774 221 123456999999999999977 86 78999999999999999999998755443332211
Q ss_pred cccCCCCCCCChhh-HHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NLLDPLAGDWPFVQ-AEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~~d~~~~~~~~~~-~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...-.+|... +.++..|+.+||..||..|+++.+++
T Consensus 237 ----~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 237 ----KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1122334555 88999999999999999999999944
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.16 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=204.3
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|...++||+|.||.||+|.+ +|+.||||+++.....+ .....+|++.|+.++|+||+.++++|. +...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 577788999999999999998 47899999998764432 345789999999999999999999995 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++ .+|...+. +....++...+..++.+++.||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 58999985 556679999999999999999999999 8999999999999999999999999999998876543
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc------------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 502 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~------------ 502 (641)
.. +..+-|.+|.|||.+.|. .|+..+|+||.|||+.||+-|.|.|.+.++++.....-.
T Consensus 157 ~~--------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 157 IQ--------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cc--------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 22 223579999999999875 699999999999999999999999988877765432210
Q ss_pred ---------cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ---------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ---------~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.....+.........+..+.+|+..||.+||.+|+++.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 010111111122234566789999999999999999999944
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.85 Aligned_cols=243 Identities=22% Similarity=0.330 Sum_probs=200.4
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccccC------ceEEEEEec
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYL 356 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lV~Ey~ 356 (641)
...||+|++|.||+|.+++..||||++....... ...|.+|+.+|.+++||||++++|++.+ ..++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3579999999999999999999999998654333 3567899999999999999999998743 578999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+||+|.+++.. ...+++.....++.+++.||.|||.. .+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999953 34688999999999999999999973 378899999999999999999999999988654321
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh--hcccccccCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDPLAG 512 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--~~~~~~~~d~~~~ 512 (641)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+....... .... ..
T Consensus 178 ---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~-------~~ 241 (283)
T PHA02988 178 ---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN-------SL 241 (283)
T ss_pred ---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-------CC
Confidence 12357899999999976 6899999999999999999999999986643322111 1111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
..+...+..+.+|+.+||+.||.+||++.+ ++..|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-ll~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKE-ILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHH-HHHHHHHHH
Confidence 233456788999999999999999999999 778887765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.83 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=212.9
Q ss_pred hHhhhcCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc-cCceEE
Q 006545 275 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTL 351 (641)
Q Consensus 275 ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~l 351 (641)
++....+.+.+...||+|.||+||+|.+.| .||||+++...... .+.|++|+.++++-+|.||+-+.|+| .+.+.|
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AI 464 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAI 464 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceee
Confidence 333444556778899999999999999987 49999998765543 46799999999999999999999999 456689
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
|+.+|.|-+|+.+|+-. ...|...+.+.|+.||++|+.|||. ++|||||||..|||+.+++.|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999999643 3568899999999999999999999 999999999999999999999999999997544
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
...... ......|...|||||++.. .+|++.+|||||||++|||+||..||......+..+..++.....+
T Consensus 540 ~w~g~~------q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 540 RWSGEQ------QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eecccc------ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 331111 1233458999999999975 4799999999999999999999999986555554444444433333
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
... ....++.++.+|+..||.+++++||.+.+ |+..|+.+..
T Consensus 614 ~s~--~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~-il~~l~~l~~ 655 (678)
T KOG0193|consen 614 LSK--IRSNCPKAMKRLLSDCWKFDREERPLFPQ-LLSKLEELLP 655 (678)
T ss_pred chh--hhccCHHHHHHHHHHHHhcCcccCccHHH-HHHHHHHhhh
Confidence 322 23456789999999999999999999999 5554554443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.90 Aligned_cols=240 Identities=26% Similarity=0.400 Sum_probs=208.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.|....+||+|+.|.||.+... +..||||.+........+-+.+|+.+|+.++|+|||.+++.| .+..++||||++
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 4666678999999999999874 678999999988777777899999999999999999999987 678999999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
||+|.|.+. ...+++.++..|+.+++.||+|||. +||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999984 3348999999999999999999999 8999999999999999999999999999998776542
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh--cccccccCCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLDPLAGDWP 515 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~--~~~~~~~d~~~~~~~ 515 (641)
.+...+|||+|||||+.....|++++||||||++++||+-|.|||-..+.+...+.. ..... -..+
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~------lk~~ 492 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK------LKNP 492 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC------cCCc
Confidence 245678999999999999999999999999999999999999999766555443322 11111 1235
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
...+..+.+++.+||..|+.+||++.+
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 667889999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.75 Aligned_cols=242 Identities=30% Similarity=0.412 Sum_probs=205.7
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
++|.+...||+|+||.||||+.+ ...||+|.+.+.... ....+.+|++|++.++|||||.++++|+ ..+++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 36777888999999999999875 578999999875433 2456899999999999999999999995 46899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
||.| +|..+|. ....++++.+..|+.+++.||.|||+ ++|+|||+||.|||++.+|.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999994 45679999999999999999999999 899999999999999999999999999999876543
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
...+.+.|||.|||||++.+++|+..+|.||+|||+|||++|+|||-...-.... ..+-.....|
T Consensus 155 --------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv-------~~I~~d~v~~ 219 (808)
T KOG0597|consen 155 --------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV-------KSILKDPVKP 219 (808)
T ss_pred --------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH-------HHHhcCCCCC
Confidence 2235677999999999999999999999999999999999999999544332211 1122223456
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
|...+..+..++...|.+||..|.++.+.+
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 778889999999999999999999998843
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=341.85 Aligned_cols=259 Identities=25% Similarity=0.324 Sum_probs=211.0
Q ss_pred hhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEeccc--cCceEEE
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
.....|.+...||.|..++||+|++ ++..||||+++...... .+.+.+|+..|+.++||||++++.+| +..+++|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3456799999999999999999988 47899999998765544 47899999999999999999999988 5679999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|.||.+||+.+++...-.. .+++..+..|+.++++||.|||. +|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999765443 39999999999999999999999 9999999999999999999999999999987766
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc--cccccc-
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG--KLKNLL- 507 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~--~~~~~~- 507 (641)
.+ ....... ...+||++|||||++.. .+|+.|+||||||++..||.+|..||.........+..- ......
T Consensus 179 ~G---~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 179 SG---DRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred cC---ceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 54 1111122 66789999999999654 479999999999999999999999998776665444321 111000
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+-....+..+.+++..||..||.+||++.+.+
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0001111223456899999999999999999999844
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=342.17 Aligned_cols=250 Identities=28% Similarity=0.352 Sum_probs=199.6
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--------------CchhHHHHHHHHhcCCCCceeeEe
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------GPSEFQQEIDILSKIRHPNLVTLV 342 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--------------~~~~~~~Ei~iL~~l~HpnIv~l~ 342 (641)
..+.|.+.+.||+|.||.|-+|... ++.||||++.+.... ..+.+.+||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3568999999999999999999884 788999999764221 124688999999999999999999
Q ss_pred cccc----CceEEEEEecCCCChhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC
Q 006545 343 GACP----EVWTLVYEYLPNGSLEDRLSCKDNSPP-LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 343 g~~~----~~~~lV~Ey~~ggsL~~~L~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~ 417 (641)
.+.+ +.+|||+|||..|.+...- ...+ +++.++++|+.++..||.|||. +|||||||||+|+||+.+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCC
Confidence 9874 4699999999998876542 3344 9999999999999999999999 8999999999999999999
Q ss_pred cccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcHH
Q 006545 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKE 493 (641)
Q Consensus 418 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~~sDVwSlGviL~eLltG~~Pf~~~~~ 493 (641)
++||+|||.+..+.......... .....+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~---~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDD---QLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred cEEeeccceeeecccCCccccHH---HHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999998775442211111 123367999999999998743 34688999999999999999999977665
Q ss_pred HHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.........- ++.-.......+.+.+||.+||.+||..|.++.++
T Consensus 325 ~~l~~KIvn~-----pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 325 LELFDKIVND-----PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred HHHHHHHhcC-----cccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 5543322111 11111112457889999999999999999999884
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.69 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=207.0
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
+-|..++.||.|+.|.|-+|++ +|+.+|||++.+... .....+.+|+-||+-+.||||+++|+++. ..+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999988 589999999987632 23557899999999999999999999984 4689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||.|.++|. ..+++++..+.+++.||+.|+.|+|. .+|+||||||+|+|||..+.+||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999994 55679999999999999999999999 78999999999999999999999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.. ..+.+|++.|.|||++.+.+|. .++||||.|||||.||||+.||+.++-........+. .-
T Consensus 166 kl---------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------~f 229 (786)
T KOG0588|consen 166 KL---------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------VF 229 (786)
T ss_pred cc---------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------cc
Confidence 32 2334699999999999999986 7899999999999999999999866544433322111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.|...+.++.+||.+||..||..|.++.+++
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 34677889999999999999999999999954
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=340.42 Aligned_cols=234 Identities=25% Similarity=0.336 Sum_probs=194.9
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888999999999999999985 78899999875422 22456889999999999999999999874 46889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999853 3468999999999999999999999 899999999999999999999999999987654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ....+
T Consensus 156 -----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~~~ 217 (291)
T cd05612 156 -----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-------GKLEF 217 (291)
T ss_pred -----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCcCC
Confidence 123589999999999999999999999999999999999999976654332211110 01123
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
+...+..+.+||.+||..||.+||+
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccC
Confidence 4455778999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.04 Aligned_cols=241 Identities=23% Similarity=0.289 Sum_probs=203.3
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCC-CCceeeEeccc--cCce
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVW 349 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~ 349 (641)
....+|.+.++||+|+||+|+++..+ +..+|||++++...- +.+....|..|+.... ||.++.++.+| .+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999885 578999999987543 3456788999988875 99999999999 5689
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
|+||||+.||++..+. ....|++..+..++..|+.||.|||+ +||||||||.+|||||..|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954443 34569999999999999999999999 9999999999999999999999999999985
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
.-..+. ...+.+|||.|||||++.+..|+.++|+|||||+|||||+|.+||.+.++.......- .
T Consensus 518 ~m~~g~--------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-------~ 582 (694)
T KOG0694|consen 518 GMGQGD--------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-------N 582 (694)
T ss_pred cCCCCC--------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------c
Confidence 432221 1244569999999999999999999999999999999999999998877654322211 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
-...+|...+.+...++.++|..+|.+|--+
T Consensus 583 d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1234677889999999999999999999877
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.50 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=203.6
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCch-hHHHHHHHHhcCC-CCceeeEecccc--C-ceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPS-EFQQEIDILSKIR-HPNLVTLVGACP--E-VWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~-~~~~Ei~iL~~l~-HpnIv~l~g~~~--~-~~~lV~ 353 (641)
.+|.+.++||.|.||.||+|.. .+..||||.++.......+ .-.+|+..|++|+ |||||+|..++- + .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4789999999999999999987 4788999998865433222 2468999999998 999999999883 3 689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|||. .+|.+++..+ +.+|++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus 90 E~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence 9995 6999999644 6789999999999999999999999 99999999999999999999999999999976544
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC----
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD---- 508 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d---- 508 (641)
. ..+..+.|.+|.|||++.. +-|+.+.|+||+|||++|+.+-+|.|.+.++++.......+....+
T Consensus 164 p---------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 164 P---------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred C---------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 2 2355668999999998864 6799999999999999999999999999888776654321111000
Q ss_pred ---------------C----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 509 ---------------P----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 509 ---------------~----~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .....-...+.++.+||.+||..||.+||++.+.+
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 0 01111123677899999999999999999999944
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.62 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 341 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~------------------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l 341 (641)
++|.+.++||+|+||.||+|.+. +..||+|++...... ....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 47888899999999999999752 246999998764322 23468899999999999999999
Q ss_pred eccc--cCceEEEEEecCCCChhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 006545 342 VGAC--PEVWTLVYEYLPNGSLEDRLSCKD----------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403 (641)
Q Consensus 342 ~g~~--~~~~~lV~Ey~~ggsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiH 403 (641)
++++ .+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9988 356899999999999999885421 12347888999999999999999999 89999
Q ss_pred ccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh
Q 006545 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483 (641)
Q Consensus 404 rDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt 483 (641)
|||||+|||++.++.+||+|||+++.+...... .......++..|+|||++.++.++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999765432211 11123346789999999998899999999999999999987
Q ss_pred --CCCCCCCcHHHHHHHhhcc-cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 484 --GRPALGITKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 484 --G~~Pf~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
|..||...+.......... +...........+..++..+.+|+.+||..+|.+||++.+ +...|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~-i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD-IHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH-HHHHHh
Confidence 5678865433222111110 0000001111223455678999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.44 Aligned_cols=241 Identities=25% Similarity=0.338 Sum_probs=194.3
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.|+..+.||+|+||.||+|.+ .+..||+|.+...... ....+.+|+.++..++|+||+++++++ .+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999987 4789999998754322 234578999999999999999999987 456889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887532 23468999999999999999999999 899999999999999999999999999997654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH--HHHhhcccccccCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAG 512 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~ 512 (641)
. .....||..|+|||++.+..++.++|||||||++|+|++|++||...+... ..+... +.....
T Consensus 157 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~ 222 (285)
T cd05631 157 T---------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-----VKEDQE 222 (285)
T ss_pred e---------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-----hhcccc
Confidence 1 123458999999999999999999999999999999999999997543211 111110 011112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
.++...+..+.+|+.+||..||.+||+.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 3445567889999999999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=344.43 Aligned_cols=236 Identities=22% Similarity=0.303 Sum_probs=196.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
.+|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++ .+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 47888999999999999999884 68899999875422 2245688999999999999999999988 45689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999853 3468899999999999999999999 89999999999999999999999999999865432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
. ....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......... ....
T Consensus 172 ~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------~~~~ 233 (329)
T PTZ00263 172 T-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------GRLK 233 (329)
T ss_pred c-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------CCcC
Confidence 1 123589999999999999999999999999999999999999976554332211110 0112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
+|...+..+.+||.+||..||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 344467789999999999999999984
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.19 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=200.0
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++..++||||+++++++ .+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999984 68899999975432 2235688999999999999999999988 44689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 99999999999943 3468999999999999999999999 89999999999999999999999999998765431
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC-CCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d-~~~~ 512 (641)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..............+. +...
T Consensus 155 -----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 155 -----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred -----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 1234589999999999999999999999999999999999999976654332222111111111 1111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+..+.+|+.+||..+|.+||++.+++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 11124577899999999999999999998844
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.68 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=201.1
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecc----ccCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGA----CPEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~----~~~~~~lV 352 (641)
..|+.++.|++|+||.||+|.++ +..||+|.++...... +-.-.+||.+|.+++|||||.+-.+ --+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35888899999999999999985 5789999998765332 3456899999999999999998554 45679999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
||||+. +|..++... ..+|...++.-+..|++.||+|||. +.|+||||||+|+|++..|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999964 888888533 3679999999999999999999999 8999999999999999999999999999998876
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccc----c
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL----L 507 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~----~ 507 (641)
.. ...+..+-|.+|.|||++.+. .|+.+.|+||+|||+.||++++|.|.+..+.+.....-.+... +
T Consensus 230 p~--------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 230 PL--------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred Cc--------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 52 123555679999999999876 6999999999999999999999999887766544322111000 0
Q ss_pred --------------------CCCCCCCChh-hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 --------------------DPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 --------------------d~~~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+...++.. .+..-.+|+..+|.+||.+|.|+.+.+
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 0011112222 457789999999999999999999843
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.06 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=204.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..|.....||+|+||.||+|.+. ++.||+|++......+ .+.+.+|+.+|..++++||.++||.+ ...++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666788999999999999985 6789999998765443 57899999999999999999999987 5578899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
|.||++.+.|. ....+.+..+.-|+.+++.||.|||. .+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999993 44456888889999999999999999 8999999999999999999999999999987765432
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC-CCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD-PLAGDW 514 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d-~~~~~~ 514 (641)
.....+||+.|||||++....|+.++||||||++.+||++|.|||....+... ..++. ...+..
T Consensus 167 --------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lflIpk~~PP~L 231 (467)
T KOG0201|consen 167 --------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LFLIPKSAPPRL 231 (467)
T ss_pred --------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EEeccCCCCCcc
Confidence 22456799999999999988999999999999999999999999976655322 11221 112233
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....++.+.+++..||+.||+.||++.+.+
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 346688899999999999999999999844
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.51 Aligned_cols=232 Identities=22% Similarity=0.256 Sum_probs=189.2
Q ss_pred ceeeccCceEEEEEEE--CCeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
+.||+|+||.||++.. .+..||||++..... .....+.+|+.+++.++||||+++++++ .+..++||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 468899999975432 1234577899999999999999999987 45689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---- 150 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----
Confidence 99998853 3568999999999999999999999 8999999999999999999999999999875322110
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... .....+|...+
T Consensus 151 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~p~~~~ 219 (323)
T cd05571 151 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEIRFPRTLS 219 (323)
T ss_pred ----cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCC
Confidence 1123458999999999999999999999999999999999999997654332211110 01123455667
Q ss_pred HHHHHHHHHHhhhccCCCCC
Q 006545 520 EQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs 539 (641)
..+.+||.+||..||.+||+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHHccCCHHHcCC
Confidence 88999999999999999993
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=331.20 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=196.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
++|.+.+.||+|+||.||+|.++ +..||||++..... .....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999985 57899999876432 2245688999999999999999999988 346899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++++++..+.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 23468999999999999999999999 899999999999999999999999999998764322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc----------
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~---------- 504 (641)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+............
T Consensus 155 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 155 NA-------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cc-------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 11 1123458999999999999899999999999999999999999997654332221111000
Q ss_pred --------cccCCC-------CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 --------NLLDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 --------~~~d~~-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+. ...+....+..+.+|+.+||+.||.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000 0011123567899999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.64 Aligned_cols=257 Identities=28% Similarity=0.522 Sum_probs=215.8
Q ss_pred cCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 349 (641)
.++....+.||+|+||+||+|...+ ..||||.++..... ...+|++|+++|..|+|||||+|+|+| .+..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667889999999999998743 56999999877655 467899999999999999999999999 5578
Q ss_pred EEEEEecCCCChhhhhhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 350 TLVYEYLPNGSLEDRLSCKD-------N----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
++|+|||..|+|.++|.... . .++|+..+.+.|+.|||.|+.||-+ +.+|||||-..|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999995321 1 3358999999999999999999999 78999999999999999999
Q ss_pred ccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCc--HHHH
Q 006545 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT--KEVQ 495 (641)
Q Consensus 419 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~--~~~~ 495 (641)
|||+|||+++.....+..... ....-..+|||||.+..+.|+.+||||||||+|||+++ |..||.+. .++.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVR------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred EEecccccchhhhhhhhhccc------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999977655433221 12234679999999999999999999999999999998 99898654 3455
Q ss_pred HHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 496 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 496 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
..+..+++. ..|..++..+..|+..||+.+|.+||++.+ |-..|..+...
T Consensus 716 e~i~~g~lL--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e-I~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 ECIRAGQLL--------SCPENCPTEVYSLMLECWNENPKRRPSFKE-IHSRLQAWAQA 765 (774)
T ss_pred HHHHcCCcc--------cCCCCCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHHHHHhc
Confidence 555555553 347788999999999999999999999999 77788776554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=345.90 Aligned_cols=232 Identities=28% Similarity=0.485 Sum_probs=196.3
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCChhh
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 363 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~~ 363 (641)
+.-||.|+.|-||+|.+.+..||||+++... ..+|+-|++|+||||+.|.|+|. ..+|||||||+.|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 3459999999999999999999999876422 35788899999999999999994 46889999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcccc
Q 006545 364 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443 (641)
Q Consensus 364 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 443 (641)
+|. ...+++......|..+||.|+.|||. +.|||||||.-||||+.+..|||+|||.++......
T Consensus 202 VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--------- 266 (904)
T KOG4721|consen 202 VLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--------- 266 (904)
T ss_pred HHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---------
Confidence 994 44568888999999999999999999 789999999999999999999999999998765442
Q ss_pred ccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHH
Q 006545 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 523 (641)
Q Consensus 444 ~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 523 (641)
......||..|||||++.+.+.+.|+|||||||||||||||..||...+.....+..+.- .+.-..|..+++.+.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN-----sL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN-----SLHLPVPSTCPDGFK 341 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC-----cccccCcccCchHHH
Confidence 123456999999999999999999999999999999999999999765544333222211 112234677889999
Q ss_pred HHHHHHhhhccCCCCChHHHH
Q 006545 524 NLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 524 ~Li~~cL~~dP~~RPs~~evv 544 (641)
-|+++||...|.+||++.+++
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHH
Confidence 999999999999999999954
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.95 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=199.8
Q ss_pred cCCCCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
..+|++.+.||+|+||.||+|.+. +..||+|+++..... ....|.+|+.++.+++||||++++|++ .+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346888999999999999999763 467999998865322 234688999999999999999999987 456899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ .|++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998543 3468999999999999999999999 899999999999999999999999999876532
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
.... .......++..|+|||.+.+..++.++|||||||++|++++ |.+||................
T Consensus 159 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------ 225 (266)
T cd05064 159 SEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------ 225 (266)
T ss_pred ccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------
Confidence 2110 01112235678999999999999999999999999999875 999997654433221111110
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
....+...+..+.+++.+||+.+|.+||++.+ +.+.|..
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~-i~~~l~~ 264 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQ-IHSILSK 264 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHH-HHHHHHh
Confidence 11124456778999999999999999999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.99 Aligned_cols=233 Identities=23% Similarity=0.293 Sum_probs=190.2
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL 361 (641)
||+|+||.||+|.+. +..||+|++.... ......+.+|+.++.+++||||+++++++ .+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999884 6789999987532 22345678899999999999999999987 4468999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 999853 3468999999999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 521 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...+......... . ....++...+..
T Consensus 149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~-----~~~~~~~~~~~~ 219 (312)
T cd05585 149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--Q-----EPLRFPDGFDRD 219 (312)
T ss_pred --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--c-----CCCCCCCcCCHH
Confidence 1123458999999999999999999999999999999999999997654332221110 0 112334556788
Q ss_pred HHHHHHHHhhhccCCCCChHH
Q 006545 522 LANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 522 l~~Li~~cL~~dP~~RPs~~e 542 (641)
+.+|+.+||..||.+||++..
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~ 240 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNG 240 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCC
Confidence 999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.85 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=199.0
Q ss_pred cCCCCccceeeccCceEEEEEEE-------CCeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--Cc
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EV 348 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~-------~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~ 348 (641)
.++|++.+.||+|+||.||+|.+ .+..||||+++.... .....+.+|+.+|..+ +||||++++|+|. +.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34789999999999999999974 245799999875432 2245688999999999 8999999999983 46
Q ss_pred eEEEEEecCCCChhhhhhcCCC----------------------------------------------------------
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 370 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 370 (641)
.++|||||+||+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 8899999999999998853211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 371 --------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 371 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1257889999999999999999999 89999999999999999999999999999865433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH---HHHhhcccccccCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ---YALDTGKLKNLLDPLAG 512 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~---~~~~~~~~~~~~d~~~~ 512 (641)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||....... ..+..+. ..
T Consensus 271 ~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~ 336 (375)
T cd05104 271 V------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------RM 336 (375)
T ss_pred c------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--------cC
Confidence 0 0122335678999999999999999999999999999998 899996543221 1111111 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
..+...+..+.+|+.+||+.||.+||++.+ +++.|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-il~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQ-IVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHh
Confidence 123344678999999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.30 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=201.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--C----eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc-cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV 352 (641)
.+|+..+.||+|+||.||+|.+. + ..||+|++..... .....+.+|+.+++.++||||++++|+| .+..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46889999999999999999863 3 3489999875432 2345788999999999999999999988 4467899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|+++|+|.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999998643 3458889999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||............... ..
T Consensus 162 ~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~------~~ 229 (316)
T cd05108 162 DEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ER 229 (316)
T ss_pred CCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC------CC
Confidence 32111 0112234678999999999999999999999999999998 99999765433211111100 01
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
...+..++..+.+++.+||..+|.+||++.+ ++..|..+..
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-l~~~l~~~~~ 270 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHHc
Confidence 1123345678999999999999999999999 5556666654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.09 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=200.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCCC-chhHHHHHHHHhcC-CCCceeeEecccc--Cc
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNLVTLVGACP--EV 348 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~ 348 (641)
..+|++.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.+ +||||++++++|. +.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457899999999999999998852 2479999997643322 34688999999999 8999999999884 46
Q ss_pred eEEEEEecCCCChhhhhhcCC-----------------------------------------------------------
Q 006545 349 WTLVYEYLPNGSLEDRLSCKD----------------------------------------------------------- 369 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~----------------------------------------------------------- 369 (641)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 899999999999999885321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 370 --------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 370 --------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
...++++..+++|+.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-----
Confidence 11357889999999999999999999 89999999999999999999999999999765432111
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 520 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 520 (641)
.......++..|+|||++.+..++.++|||||||++|+|++ |++||............. ... .....+...+.
T Consensus 269 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--~~~---~~~~~~~~~~~ 342 (374)
T cd05106 269 -VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--KRG---YQMSRPDFAPP 342 (374)
T ss_pred -eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH--Hcc---cCccCCCCCCH
Confidence 01122335678999999998899999999999999999997 999996543221111110 000 01112334567
Q ss_pred HHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 521 QLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 521 ~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.+.+++.+||+.+|.+||++.+ |++.|+.+
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~-l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQ-ISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHH-HHHHHHHH
Confidence 8999999999999999999999 77777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.02 Aligned_cols=231 Identities=22% Similarity=0.267 Sum_probs=188.2
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||++++++| .+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999874 68899999976422 2234577899999999999999999987 45689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 150 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----
Confidence 99988843 3468999999999999999999999 8999999999999999999999999999875322211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... .....+|...+
T Consensus 151 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-------~~~~~~p~~~~ 219 (323)
T cd05595 151 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLS 219 (323)
T ss_pred ----ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCCCCCCCCC
Confidence 0123458999999999999999999999999999999999999997654332211110 00112345567
Q ss_pred HHHHHHHHHHhhhccCCCC
Q 006545 520 EQLANLAMRCCEMSRKSRP 538 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RP 538 (641)
..+.+|+.+||..||.+||
T Consensus 220 ~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHHccCCHHHhC
Confidence 8899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=341.87 Aligned_cols=235 Identities=23% Similarity=0.314 Sum_probs=193.9
Q ss_pred cCCCCccceeeccCceEEEEEEECC---eEEEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~---~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
..+|.+.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++||||+++++++. +..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468899999999999999998642 579999986532 223456889999999999999999999984 46889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 3468999999999999999999999 899999999999999999999999999998653
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......... ..
T Consensus 183 ~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-------~~ 244 (340)
T PTZ00426 183 TRT-----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-------GI 244 (340)
T ss_pred CCc-----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-------CC
Confidence 221 223589999999999998999999999999999999999999987654332211111 01
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCC
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRP 538 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RP 538 (641)
..+|...+..+.+++.+||+.+|.+|+
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 123445567899999999999999996
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=343.86 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=196.8
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|++.+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|..++||||+++++++ .+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999884 68899999975422 2234578899999999999999999988 44689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999853 3468999999999999999999999 89999999999999999999999999999765432
Q ss_pred cccCCCcc------------------------------ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh
Q 006545 434 EISSNNTT------------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483 (641)
Q Consensus 434 ~~~~~~~~------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt 483 (641)
........ .......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11100000 000113469999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC---hHH
Q 006545 484 GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE---LGK 542 (641)
Q Consensus 484 G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~e 542 (641)
|.+||...+..............+. .......+..+.+||.+|+. +|.+|++ +.+
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQ---FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccC---CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 9999987654433222211111110 01112346789999999996 9999998 666
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.63 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=193.4
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
.+|.+.++||.|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46889999999999999999874 67899999875432 23456789999999999999999999874 457899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++ +|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 898888532 3357889999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc------------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 502 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~------------ 502 (641)
......|++.|+|||++.+ ..++.++|||||||++|+|+||++||...+..........
T Consensus 159 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 159 --------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred --------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 1123457999999999875 5689999999999999999999999976543222111000
Q ss_pred ------cccccCCCC-----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ------LKNLLDPLA-----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ------~~~~~d~~~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.....+.. .......+..+.+||.+||..||.+|||+.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 000000000 000123456789999999999999999999843
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.35 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=192.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc-------CceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-------~~~~ 350 (641)
+|++.++||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999874 68899999875322 23346889999999999999999998762 1378
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988884 33468999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh---------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--------- 499 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--------- 499 (641)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||...+.......
T Consensus 154 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 154 FNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred ccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 3321111 11133468999999999876 6789999999999999999999999975443221100
Q ss_pred --------hcccc----cccCCCC---CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 500 --------TGKLK----NLLDPLA---GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 500 --------~~~~~----~~~d~~~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... .+..... .......+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 00000 0000000 000112356789999999999999999999844
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.48 Aligned_cols=235 Identities=22% Similarity=0.259 Sum_probs=191.5
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++ .+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 68899999976432 2235678899999999999999999887 45689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 150 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---- 150 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----
Confidence 99988843 3468999999999999999999999 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... .....+|...+
T Consensus 151 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-------~~~~~~p~~~~ 219 (328)
T cd05593 151 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEDIKFPRTLS 219 (328)
T ss_pred ----ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-------cCCccCCCCCC
Confidence 1123458999999999999999999999999999999999999997654433221110 01123455667
Q ss_pred HHHHHHHHHHhhhccCCCC-----ChHH
Q 006545 520 EQLANLAMRCCEMSRKSRP-----ELGK 542 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RP-----s~~e 542 (641)
..+.+|+.+||..||.+|| ++.+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ 247 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKE 247 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 8899999999999999997 6666
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=328.61 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=192.6
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
..+|.+.+.||.|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999984 688999998754332 234678999999999999999999988 456889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++ ++|.+++.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 678777743 23458889999999999999999999 899999999999999999999999999987543221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc-----c-----c
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-----K-----L 503 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~-----~-----~ 503 (641)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........+... . +
T Consensus 158 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 158 H--------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred c--------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 1 1123458999999999875 458899999999999999999999997654322211100 0 0
Q ss_pred cc-----ccCCC--CCCCC---------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 KN-----LLDPL--AGDWP---------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ~~-----~~d~~--~~~~~---------~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ...+. ....+ ...+..+.+|+.+||+.||.+|||+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00 00000 00000 01235788999999999999999998843
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.42 Aligned_cols=249 Identities=20% Similarity=0.222 Sum_probs=201.7
Q ss_pred CCCccceeeccCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.|.+.+.||+|+||.||+|... +..||+|.+..........+.+|+.+|+.++||||++++++| .+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999763 467899977554433345678899999999999999999988 45789999999
Q ss_pred CCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 357 PNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 357 ~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+||+|.+++... ....++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888532 334578999999999999999999999 8999999999999999999999999999987643321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......... . ......+
T Consensus 225 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~--~----~~~~~~~ 292 (478)
T PTZ00267 225 L------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL--Y----GKYDPFP 292 (478)
T ss_pred c------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h----CCCCCCC
Confidence 1 11234469999999999999999999999999999999999999997654432211110 0 0111234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
...+..+.+||.+||..+|.+||++.+++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 456678999999999999999999998653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=333.92 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.++|++.+.||+|+||.||++.+. +..||+|++...... ....+.+|+.+|++++||||+++++++ .+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357999999999999999999985 678999998764321 235689999999999999999999987 456899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999853 34588999999999999999999982 369999999999999999999999999987653321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc----------
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~---------- 504 (641)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........+...
T Consensus 159 ----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 159 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 123358999999999999999999999999999999999999996544322111100000
Q ss_pred ------------------------------cccCCCCCCC-ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 ------------------------------NLLDPLAGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ------------------------------~~~d~~~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+........ ....+..+.+|+.+||..||++||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 113567899999999999999999999843
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.33 Aligned_cols=254 Identities=25% Similarity=0.298 Sum_probs=200.8
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
++|.+.+.||+|+||.||+|.+. +..||||++..... .....+..|+.++..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999986 78999999975422 23456889999999999999999999883 4689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 568999999999999999999999 89999999999999999999999999999866543
Q ss_pred cccC---------------------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH
Q 006545 434 EISS---------------------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 492 (641)
Q Consensus 434 ~~~~---------------------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~ 492 (641)
.... ............||+.|+|||++.+..++.++|||||||+||+|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2000 0000011234569999999999999999999999999999999999999997765
Q ss_pred HHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC-hHHHH
Q 006545 493 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE-LGKDV 544 (641)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evv 544 (641)
..............+. .+ .....+..+.+||.+||. +|.+||+ +.+++
T Consensus 235 ~~~~~~~i~~~~~~~~--~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 235 LQETYNKIINWKESLR--FP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred HHHHHHHHhccCCccc--CC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 4433222211111110 00 111257889999999997 9999999 87743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.26 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=192.6
Q ss_pred CCCccceeeccCceEEEEEEEC---CeEEEEEEecCCCCCC--chhHHHHHHHHhcC---CCCceeeEecccc-------
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP------- 346 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l---~HpnIv~l~g~~~------- 346 (641)
+|.+.+.||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888999999999999999873 5779999987543222 34567788887766 6999999999872
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
...++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 35789999996 68988885432 3458999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc--
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-- 504 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~-- 504 (641)
+....... ......||+.|+|||.+.+..++.++|||||||++|+|++|.+||................
T Consensus 157 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 157 ARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred eEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 97654321 1123458999999999998899999999999999999999999998665433221110000
Q ss_pred --------------cccCCCC----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 --------------NLLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 --------------~~~d~~~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.... ..+....+..+.+|+.+||..||++||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0000000 011123456789999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=340.11 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=212.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCc-eEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEV-WTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~-~~lV~ 353 (641)
.+|..++++|+|+||.++...++ ++.+++|.+....... .....+|+.+++++.|||||.+.+.| ++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999987765 5789999998765444 33578999999999999999999998 334 78999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
+||+||+|.+.+.+.. ...|++..+..|+.|++.|+.|||+ +.|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 5679999999999999999999998 89999999999999999999999999999988765
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.. .....+||+.||.||++.+.+|+.++|||||||++|||++-+++|...+............ . ..
T Consensus 160 ~~--------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~--~----~P 225 (426)
T KOG0589|consen 160 DS--------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL--Y----SP 225 (426)
T ss_pred hh--------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc--C----CC
Confidence 41 1234569999999999999999999999999999999999999998877665544432222 2 23
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 546 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~ 546 (641)
.|..++.++..||..||..+|..||++.+++.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 456678899999999999999999999996544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=310.91 Aligned_cols=244 Identities=26% Similarity=0.415 Sum_probs=205.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccccC--ceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV 352 (641)
.++|++++.||+|-||.||.|..+ +-.||+|++.+... ....++.+|++|-+.|+||||+++|++|.+ ..||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457899999999999999999885 46799999987543 235679999999999999999999999954 68999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
+||.++|+|...|... ....+++.....++.|+|.||.|+|. ++||||||||+|+|++..+.+||+|||-+.....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999533 34568899999999999999999999 8999999999999999999999999998865432
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
+ . +...+||..|.|||...+..++..+|+|++|++.||++.|.+||.............+. .-
T Consensus 177 ~----k------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------~~ 239 (281)
T KOG0580|consen 177 N----K------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------DL 239 (281)
T ss_pred C----C------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------cc
Confidence 1 1 23445999999999999999999999999999999999999999766533322222221 22
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+|...+..+.+||.+|+..+|.+|....+++
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHh
Confidence 34677888999999999999999999999843
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.63 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=206.8
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEEC-C-eEEEEEEecCCCCCCchhHHHHHHHHhcCC-CCceeeEeccc------c
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR-H-MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC------P 346 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~-~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~------~ 346 (641)
+.....++++.+.|.+|||+.||+|.+. + ..||+|++...+......+.+|+++|+.|. |+|||.+++.. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 3345567888999999999999999885 3 789999988776666778999999999996 99999999943 1
Q ss_pred ---CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccc
Q 006545 347 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 423 (641)
Q Consensus 347 ---~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~D 423 (641)
-.++|.||||.||+|-|++..+.... |++.++++|+.++++|+.+||.+. .+|||||||-+||||+.+|..||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 13679999999999999997654444 999999999999999999999976 4799999999999999999999999
Q ss_pred cccccccccccccCCCc-cccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh
Q 006545 424 FGISRFLSQNEISSNNT-TLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 499 (641)
Q Consensus 424 FGla~~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~ 499 (641)
||.+............. .+...-....|+.|+|||++. +.+++.|+|||+|||+||-|+....||+...... +.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--Il 267 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--IL 267 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--EE
Confidence 99987543332111100 000000112589999999874 6689999999999999999999999997653322 11
Q ss_pred hcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 500 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 500 ~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
.+++.- +. ...++..+.+||..||+.||.+||++.+++ ..+-.++
T Consensus 268 ng~Y~~------P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~-~~~~~l~ 312 (738)
T KOG1989|consen 268 NGNYSF------PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVL-EEIFELA 312 (738)
T ss_pred eccccC------CC-CccHHHHHHHHHHHHhccCcccCCCHHHHH-HHHHHHh
Confidence 111111 11 246889999999999999999999999944 4444444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.73 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=200.3
Q ss_pred CCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
+|++.+.||+|+||.||+|...+ ..||+|.+...... ....|.+|+.++..++||||+++++++. ...++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 67888999999999999998743 46999998754322 2346889999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 352 VYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999864321 1458899999999999999999999 89999999999999999999
Q ss_pred ccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHH
Q 006545 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 497 (641)
Q Consensus 419 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~ 497 (641)
++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 163 ~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999765432211 11123346889999999998899999999999999999998 99999754432221
Q ss_pred --HhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 498 --LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 498 --~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
+..+ .....+...+..+.+|+.+||+.||.+||++.+ |.+.|+
T Consensus 237 ~~i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~-i~~~l~ 281 (283)
T cd05048 237 EMIRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKD-IHTRLR 281 (283)
T ss_pred HHHHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHh
Confidence 1111 112234566789999999999999999999999 656554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.14 Aligned_cols=237 Identities=25% Similarity=0.304 Sum_probs=190.5
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||+++.... .....+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 57899999975421 2234456677777654 899999999987 4568899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--- 151 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--- 151 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---
Confidence 999998843 3468999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ....++...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~ 219 (316)
T cd05592 152 -----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------DRPHFPRWI 219 (316)
T ss_pred -----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCCCCCCC
Confidence 11234589999999999999999999999999999999999999976654332221111 112334556
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+..+.+|+.+||..+|.+||++.+.+
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 78899999999999999999986534
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.43 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=204.3
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
..+|++.+.||+|.||.|-+|.. .|+.||||.+++....+ .-.+.+|++||+.|+||||+.+|.+|. +...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788999999999999999976 47999999998876554 345889999999999999999999995 568899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||..+|.|.|++. ..+.|++.....++.||..|+.|+|. ++++|||||.+|||+|.|+++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999995 44569999999999999999999999 8999999999999999999999999999998876
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcHHHHHH--HhhcccccccCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~--~~~~~~~~~~d~ 509 (641)
... .+..+|++.|.+||++++.+|. +.+|-|||||+||.|+.|.-||++.+..... +..|....
T Consensus 206 ~kf---------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---- 272 (668)
T KOG0611|consen 206 KKF---------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---- 272 (668)
T ss_pred ccH---------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----
Confidence 532 2345699999999999999985 8999999999999999999999887654332 22222221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+..+....-||++||..||..|.++.++.
T Consensus 273 ------P~~PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 273 ------PETPSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred ------CCCCchHHHHHHHHHhcCcccchhHHHHh
Confidence 22345678899999999999999998843
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=318.58 Aligned_cols=247 Identities=24% Similarity=0.449 Sum_probs=197.7
Q ss_pred CCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 357 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 357 (641)
.+|++.+.||+|+||.||+|.+.. ..+|+|.+.... .....+.+|+.+|++++||||+++++++. +..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357788899999999999998864 579999876432 33567899999999999999999999884 46899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988533 2358999999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......++..|+|||.+.+..++.++||||||+++|+|++ |++||...+............. ...+.
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------~~~~~ 224 (256)
T cd05114 157 ------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------LYRPK 224 (256)
T ss_pred ------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------CCCCC
Confidence 1122235678999999998889999999999999999999 9999976554332222111111 11233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRV 547 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~ 547 (641)
..+..+.+++.+||..+|.+||++.+ +++.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~-l~~~ 254 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAE-LLRA 254 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHH-HHHh
Confidence 34678999999999999999999999 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.99 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=195.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.|...+.||+|+||+||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999884 678999999764322 234688999999999999999999998 456899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||+|.+++.. ...+++..+..++.||+.||.|||. .||+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999853 3458899999999999999999999 899999999999999999999999999986442111
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 006545 435 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 475 (641)
Q Consensus 435 ~~~~---------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlG 475 (641)
.... ....+......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 0000011235699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHh--hhccCCCCChHHHH
Q 006545 476 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCC--EMSRKSRPELGKDV 544 (641)
Q Consensus 476 viL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL--~~dP~~RPs~~evv 544 (641)
|++|+|+||.+||...+..............+ ........+..+.+||.+|+ ..+|..||++.+++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999997655433222211111110 00111235678999998844 55666799998843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.73 Aligned_cols=232 Identities=27% Similarity=0.349 Sum_probs=188.5
Q ss_pred ceeeccCceEEEEEEE-----CCeEEEEEEecCCC----CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 287 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~-----~~~~vAvK~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+.||+|+||.||++.. .+..||||++.... ......+..|+.+|+.++||||+++++++ .+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 35789999987532 12234578899999999999999999988 3468999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999843 3468888999999999999999999 8999999999999999999999999999875332211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......... .....+
T Consensus 156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-------~~~~~~ 220 (323)
T cd05584 156 V--------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------GKLNLP 220 (323)
T ss_pred c--------ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCCCCC
Confidence 1 1234589999999999998899999999999999999999999976654332221111 011234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCC
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
...+..+.+||.+||..+|.+||+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCC
Confidence 556788999999999999999993
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.71 Aligned_cols=238 Identities=23% Similarity=0.283 Sum_probs=190.7
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHH---hcCCCCceeeEeccc--cCceEEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDIL---SKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL---~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
|.+.+.||+|+||.||+|.+. +..||||++..... .....+..|+.++ +.++||||+++++++ .+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999884 68899999975421 2234566776665 566899999999988 4568999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||++||+|..++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998873 2458999999999999999999999 8999999999999999999999999999874322
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ...
T Consensus 154 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~~~ 218 (324)
T cd05589 154 FGD--------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEV 218 (324)
T ss_pred CCC--------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC
Confidence 111 11234589999999999999999999999999999999999999976654332211110 011
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.+|...+..+.++|.+||..||.+||+..+
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234456788999999999999999997554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.49 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=193.4
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcCCCC-ceeeEeccc--cCceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHP-NLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~--~~~~~lV~ 353 (641)
+|.+.+.||+|+||.||+|... +..||||++.... ......+..|+.++..+.|+ +|+++++++ .+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999885 4689999987542 22345678899999999765 578888877 45689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998843 3468999999999999999999999 89999999999999999999999999998643211
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.......... ....
T Consensus 155 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~~ 219 (324)
T cd05587 155 GK--------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNVS 219 (324)
T ss_pred CC--------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCC
Confidence 10 01234589999999999999999999999999999999999999976654332222111 1123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
+|...+..+.+++.+||..||.+||+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 3455678899999999999999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.30 Aligned_cols=252 Identities=27% Similarity=0.474 Sum_probs=202.5
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.+|.+.+.||.|+||.||+|.+. +..||+|++.... .....+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778889999999999999884 6889999987432 3346788999999999999999999988 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.... ...+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999985432 3458999999999999999999999 89999999999999999999999999999866543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......... ......+
T Consensus 161 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------~~~~~~~ 227 (263)
T cd05052 161 A-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------GYRMERP 227 (263)
T ss_pred c-------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------CCCCCCC
Confidence 1 111234678999999999999999999999999999998 9999975443222111110 0112334
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
...+..+.+++.+||..+|.+||++.+ +.+.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~-l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAE-IHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHH-HHHHHHhh
Confidence 556788999999999999999999999 66777653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.56 Aligned_cols=256 Identities=23% Similarity=0.461 Sum_probs=205.0
Q ss_pred CCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
.+|.+.+.||+|+||.||++... +..+|+|.+..........+.+|+.++++++||||+++++++ .+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 47888899999999999999752 356899988765433455789999999999999999999988 456899
Q ss_pred EEEecCCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccc
Q 006545 352 VYEYLPNGSLEDRLSCKD----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL 421 (641)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+ +|++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999985332 12358999999999999999999999 89999999999999999999999
Q ss_pred cccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH--HHH
Q 006545 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YAL 498 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~--~~~ 498 (641)
+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||....... ..+
T Consensus 162 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred ccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999998865432211 11122346788999999998899999999999999999998 999997554322 122
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
..+... ..+...+..+.+|+.+||+.+|.+||++.+ +...|+.+...
T Consensus 236 ~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~-v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKE-IHSLLQNLAKA 282 (288)
T ss_pred HcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHHHHHh
Confidence 222111 122345678999999999999999999999 77888887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.50 Aligned_cols=244 Identities=40% Similarity=0.641 Sum_probs=190.5
Q ss_pred ccceeeccCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 285 PSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 285 ~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
..+.||.|.||.||+|.+. +..|+||++...... ....|.+|+.++++++||||++++|+|. +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3567999999999999987 578999999653322 2567999999999999999999999984 458999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++|+|.++|... ....+++..+..|+.|++.||.|||+ ++++|+||+|+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999754 23568999999999999999999999 8999999999999999999999999999987632211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH--HHhhcccccccCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAG 512 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~ 512 (641)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||...+.... .+..+.. .
T Consensus 159 ~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------~ 224 (259)
T PF07714_consen 159 Y------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------L 224 (259)
T ss_dssp E------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------T
T ss_pred c------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------c
Confidence 1 11122346789999999999999999999999999999999 7899976544332 2222211 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 547 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~ 547 (641)
..+...+..+.+++..||..+|.+||++.+ +++.
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~-i~~~ 258 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQE-ILQE 258 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHH-HHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHH-HHhc
Confidence 234456788999999999999999999999 4443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.52 Aligned_cols=252 Identities=23% Similarity=0.411 Sum_probs=200.0
Q ss_pred CCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWT 350 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~ 350 (641)
.+|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+++|+.++||||+++++++ ....+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46788889999999999999763 367999998765433 245789999999999999999999988 45689
Q ss_pred EEEEecCCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 351 LVYEYLPNGSLEDRLSCKD-----------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
+||||+++|+|.+++.... ....+++..+..++.+++.||.|||+ +|++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999986432 23458899999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 498 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 498 (641)
||+|||++.......... ......+++.|+|||++.+..+++++|||||||++|+|++ |..||..........
T Consensus 162 kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred EECCcccceecccCccee------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999987553322110 1122346789999999999999999999999999999998 999986544332211
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
... .......+...+..+.+++.+||..||.+||++.+ +++.|
T Consensus 236 ~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e-il~~l 278 (280)
T cd05049 236 CIT------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKD-IHERL 278 (280)
T ss_pred HHH------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence 111 00111123345678999999999999999999998 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=325.66 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=201.0
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecC--CCCCCchhHHHHHHHHhcCCCCceeeEeccccC-------
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE------- 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 347 (641)
....|...+.||.|+||.|+.+.++ |..||||++.. .......+..+|+.+|+.++|+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777889999999999999884 78999999873 333445678899999999999999999998732
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..|+|+|+| +.+|...+. .+..++...+..++.|++.||.|+|+ .+|+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence 479999999 678999984 34459999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh------
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------ 500 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~------ 500 (641)
+...... .....+..+.|.+|.|||++.. ..|+.+.||||+||||.||++|++.|.+.+.+......
T Consensus 173 R~~~~~~------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 173 RYLDKFF------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred eeccccC------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 9876541 1122456678999999998865 57999999999999999999999999776554332111
Q ss_pred -----------cccccccCCC--------CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 -----------GKLKNLLDPL--------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 -----------~~~~~~~d~~--------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+... ...+ +..++...+|+.+||..||.+|+|+.+++
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 0011111100 1112 24567899999999999999999999955
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=322.91 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=198.5
Q ss_pred hcCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--Cc
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 348 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~ 348 (641)
..++|++.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999864 25699999864322 12346889999999999999999999884 46
Q ss_pred eEEEEEecCCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL 421 (641)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ .|++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 8899999999999999854321 2346788999999999999999999 89999999999999999999999
Q ss_pred cccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH--
Q 006545 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL-- 498 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~-- 498 (641)
+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||..........
T Consensus 161 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999987654322111 0112345788999999999899999999999999999999 789997554332211
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
..+.. ...+...+..+.+++.+||+.+|.+||++.+ ++..|
T Consensus 235 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~l 275 (277)
T cd05062 235 MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSI 275 (277)
T ss_pred HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHh
Confidence 11111 1223445678999999999999999999999 54444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.24 Aligned_cols=251 Identities=24% Similarity=0.435 Sum_probs=201.2
Q ss_pred CCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.+|++.++||+|+||.||+|... +..||+|.+.... .....+.+|+.+++.++||||+++++.+ .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46888999999999999999875 4679999876533 2356789999999999999999999887 346789999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++... ....+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99999998543 23468899999999999999999999 89999999999999999999999999999876432211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......++..|+|||.+.+..++.++|||||||++|+|+| |..||............... .. ...+.
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--~~----~~~~~ 227 (261)
T cd05072 160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG--YR----MPRME 227 (261)
T ss_pred ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC--CC----CCCCC
Confidence 1122346778999999998899999999999999999998 99999754432221111111 00 11122
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
..+..+.+++.+||..+|.+||++.+ +.++|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDY-LQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHH-HHHHHhc
Confidence 35678999999999999999999998 7777764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=319.62 Aligned_cols=253 Identities=26% Similarity=0.485 Sum_probs=206.2
Q ss_pred hcCCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
...+|.+.++||.|+||.||+|.+. +..+|+|++..........+..|+.+++.++||||+++++++ .+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457888999999999999999885 578999998876655567799999999999999999999987 4468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++|+|.+++.... ...+++..+..++.+++.||.|||+ +||+|+||+|+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996432 3468999999999999999999999 8999999999999999999999999999976643221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......
T Consensus 160 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~~~ 225 (261)
T cd05148 160 L--------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT------AGYRMPC 225 (261)
T ss_pred c--------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH------hCCcCCC
Confidence 1 112336778999999998899999999999999999998 899997654322211111 1111123
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
+...+..+.+++.+||..+|.+||++.+ +.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKA-LREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHhc
Confidence 4456788999999999999999999999 7677654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=350.19 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=205.1
Q ss_pred hHhhhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccccC---
Q 006545 275 EIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--- 347 (641)
Q Consensus 275 ei~~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--- 347 (641)
++.....+|.+.+.||+|+||+||+|.. .+..||||++...... ....+.+|+.++..++|+||+++++.+..
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445567999999999999999999987 4789999998765332 23467889999999999999999876521
Q ss_pred -------ceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 348 -------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 348 -------~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 257999999999999998643 234578999999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 499 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~ 499 (641)
||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 183 kL~DFGls~~~~~~~~~~------~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDD------VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256 (496)
T ss_pred EEEecccCeecccccccc------ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999998664332111 11234689999999999999999999999999999999999999976554322111
Q ss_pred hcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 500 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 500 ~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. ... .....+...+..+.+|+.+||..+|.+||++.+++
T Consensus 257 ~--~~~----~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 257 T--LAG----RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred H--hcC----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 1 111 11123455678899999999999999999999854
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.35 Aligned_cols=242 Identities=25% Similarity=0.450 Sum_probs=194.0
Q ss_pred eeeccCceEEEEEEE----CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLL----RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~----~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~ggs 360 (641)
.||+|+||.||+|.+ .+..||+|++...... ....+.+|+.+++.++||||++++|++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999976 3578999998754322 2356889999999999999999999884 46789999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCc
Q 006545 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 440 (641)
Q Consensus 361 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 440 (641)
|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||.|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 82 LNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 9999843 3468999999999999999999999 8999999999999999999999999999986643321110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH--HHhhcccccccCCCCCCCChh
Q 006545 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 441 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......++..|+|||.+....++.++|||||||++|+|++ |.+||........ .+..+. ....|..
T Consensus 154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--------~~~~~~~ 222 (257)
T cd05116 154 ---AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--------RMECPQR 222 (257)
T ss_pred ---ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------CCCCCCC
Confidence 0112235679999999988889999999999999999998 9999975543222 122111 1223455
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
.+..+.+||.+||..||.+||++.+ |...|+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~-i~~~l~ 253 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAV-VELRLR 253 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHH-HHHHHh
Confidence 6788999999999999999999998 555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.29 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=193.5
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|.+.+.||+|+||.||++.. .+..||||++..... .....+.+|+.+++.++||||+++++++. +..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 688899999999999999987 468899999865321 12346788999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999853 3568899999999999999999999 899999999999999999999999999996432211
Q ss_pred ccC----------CCcc-----------------------------ccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 006545 435 ISS----------NNTT-----------------------------LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 475 (641)
Q Consensus 435 ~~~----------~~~~-----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlG 475 (641)
... .... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 0000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCC---CChHHHH
Q 006545 476 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR---PELGKDV 544 (641)
Q Consensus 476 viL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~R---Ps~~evv 544 (641)
|++|+|++|.+||..................+. .+ .....+..+.+||.+||. +|.+| +++.+++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLY--FP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC--CC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999976554332221111111110 00 112356789999999997 77765 5777743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.04 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=202.7
Q ss_pred hcCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCC-CCceeeEecccc--C
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP--E 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~ 347 (641)
....|.+.++||+|+||.||+|.+.+ ..||||++...... ....+.+|+.+|+++. ||||++++|+|. +
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678899999999999999998632 46999999754332 2456899999999996 999999999984 4
Q ss_pred ceEEEEEecCCCChhhhhhcCC----------------------------------------------------------
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD---------------------------------------------------------- 369 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~---------------------------------------------------------- 369 (641)
..+||||||++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 6899999999999998885421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec
Q 006545 370 -----------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414 (641)
Q Consensus 370 -----------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld 414 (641)
....+++..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01347888999999999999999999 8999999999999999
Q ss_pred cCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH
Q 006545 415 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 493 (641)
Q Consensus 415 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~ 493 (641)
.++.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999865432211 01122346788999999999999999999999999999997 9999965322
Q ss_pred HHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
........ .. ......+...+..+.+++.+||..+|.+||++.+ |.++|+.+.
T Consensus 346 ~~~~~~~~--~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~-l~~~l~~l~ 398 (400)
T cd05105 346 DSTFYNKI--KS---GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH-LSDIVESLL 398 (400)
T ss_pred hHHHHHHH--hc---CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH-HHHHHHHHc
Confidence 11111110 00 0011223455678999999999999999999999 778887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.25 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=193.4
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~ 353 (641)
+|.+.+.||+|+||.||+|.+. +..||||++..... .....+..|..++..+ .||+|+++++++ .+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999885 57899999876432 1233567788888877 589999999887 45688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998843 3458999999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...+.......... ....
T Consensus 155 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------~~~~ 219 (323)
T cd05616 155 GV--------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNVA 219 (323)
T ss_pred CC--------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC
Confidence 11 11234589999999999999999999999999999999999999986654332211111 1123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
+|...+..+.+|+.+||+.+|.+|++..
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 4556678899999999999999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.29 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc----cC---ceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PE---VWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~---~~~l 351 (641)
-.|...+++|+|+||.||+|... +..||||.+-.+.. --.+|+.+|+.++|||||+|..+| +. ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35778889999999999999985 57899998765432 235899999999999999998877 22 3458
Q ss_pred EEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-Ccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRF 429 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFGla~~ 429 (641)
||||+| .+|..++... ..+..++.-.+.-+.+||++||.|||+ .||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999997 4888888532 234568888899999999999999999 899999999999999976 9999999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc-----
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----- 503 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~----- 503 (641)
+..+..+ ... ..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+.....-++
T Consensus 176 L~~~epn--iSY-------icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 176 LVKGEPN--ISY-------ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eccCCCc--eeE-------EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 8776533 222 248899999999875 6999999999999999999999999877665544322111
Q ss_pred ----------------ccccCCCCC-CCChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 504 ----------------KNLLDPLAG-DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 504 ----------------~~~~d~~~~-~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
..+...... -+....++++.+|+.++|.++|.+|.++.+++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111110111 134456789999999999999999999998554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=318.89 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=200.5
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCc-eeeEecccc--C------c
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPN-LVTLVGACP--E------V 348 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~--~------~ 348 (641)
.|....+||+|+||+||+|+. +|..||+|++...... -+....+|+.+|+.|+|+| ||.+++++. + .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 466677899999999999987 4788999999876542 4667899999999999999 999999883 2 5
Q ss_pred eEEEEEecCCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
.++|+||+. .+|..++...... ..++...+..++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 789999994 6899998654321 357778999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
+.+.-.. ...+..++|.+|.|||++.+. .|++..||||+|||++||+++++.|.+..+.+...........
T Consensus 168 ra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 168 RAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred HHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9655322 113456789999999999987 7999999999999999999999999988776655433211111
Q ss_pred cC--------------CCCCCCC--h-------hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 507 LD--------------PLAGDWP--F-------VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ~d--------------~~~~~~~--~-------~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. .....|. . .......+++.+||+++|.+|.|+..++
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 10 0001111 1 1124789999999999999999999854
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=330.43 Aligned_cols=237 Identities=25% Similarity=0.318 Sum_probs=189.6
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999985 5789999997642 12234567788888764 899999999988 4468899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--- 151 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---
Confidence 999999853 3468899999999999999999999 8999999999999999999999999999874322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......... ....++...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~~~~~~~~~ 219 (316)
T cd05619 152 -----KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------DNPCYPRWL 219 (316)
T ss_pred -----ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCCCCccC
Confidence 01234589999999999999999999999999999999999999976554322211110 011233446
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+..+.+|+.+||..+|.+||++.+.+
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHH
Confidence 67899999999999999999997434
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=332.03 Aligned_cols=235 Identities=24% Similarity=0.285 Sum_probs=190.1
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 6789999987542 22345577888888876 699999999988 4468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--- 151 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--- 151 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---
Confidence 999998853 3468999999999999999999999 8999999999999999999999999999875322211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ....++...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~ 219 (320)
T cd05590 152 -----TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------DEVVYPTWL 219 (320)
T ss_pred -----cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-------CCCCCCCCC
Confidence 11234589999999999999999999999999999999999999976654332211110 111234456
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+..+.+|+.+||..||.+||++.+
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCC
Confidence 788999999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.63 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=199.0
Q ss_pred CCCCccceeeccCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc-CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~----~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 352 (641)
.+|...+.||+|+||.||+|.+. +. .|++|.+...... ....+..|+.+++.++||||++++|++. ...++|
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35778889999999999999873 33 4788887543222 2346778888999999999999999884 457899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
+||+++|+|.+++... ...+++..+..|+.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999533 3468999999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH--HHHhhcccccccCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~--~~~~~~~~~~~~d~ 509 (641)
..... ......++..|+|||.+.++.++.++|||||||++|+|++ |..||....... ..+..+...
T Consensus 162 ~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----- 230 (279)
T cd05111 162 DDKKY------FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL----- 230 (279)
T ss_pred CCccc------ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-----
Confidence 32111 1123346789999999998899999999999999999998 999997654322 122211111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
..+...+..+..++.+||..+|..||++.+ +...|..+..
T Consensus 231 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~e-l~~~l~~~~~ 270 (279)
T cd05111 231 ---AQPQICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMAR 270 (279)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHHh
Confidence 112234567899999999999999999999 6667766553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.99 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=202.1
Q ss_pred cCCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEec
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 356 (641)
..+|++.+.||+|+||.||+|.+. +..||+|.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356888999999999999999874 4679999987543 23567899999999999999999999883 4688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.... ...+++..+..++.+++.||.|||+ +||+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985433 3468999999999999999999999 89999999999999999999999999999876532111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....++..|+|||.+.+..++.++|||||||++|+|+| |+.||................. ...+
T Consensus 160 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------~~~~ 226 (261)
T cd05068 160 A-------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------MPCP 226 (261)
T ss_pred c-------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------CCCC
Confidence 0 011223468999999998899999999999999999999 9999976544322211111100 1123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
...+..+.+++.+||..+|.+||++.+ +...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~-l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFET-LQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHhc
Confidence 345678999999999999999999999 6666653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=336.16 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=192.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|++.+.||+|+||+||++... +..||||++..... .....+..|+.++..++||||+++++.+. ...++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6888999999999999999874 68899999975422 12346788999999999999999999884 46889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 82 FLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999853 3568999999999999999999999 899999999999999999999999999997654321
Q ss_pred ccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 006545 435 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487 (641)
Q Consensus 435 ~~~~~---------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~P 487 (641)
..... ..........||+.|+|||++.+..++.++|||||||++|+|++|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 10000 000001234699999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhh--hccCCCCChHHH
Q 006545 488 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCE--MSRKSRPELGKD 543 (641)
Q Consensus 488 f~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~--~dP~~RPs~~ev 543 (641)
|...+..............+. .+. ....+..+.++|.+++. .++..||++.++
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~--~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei 290 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLI--FPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEI 290 (363)
T ss_pred CCCCCHHHHHHHHHcCcCccc--CCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHH
Confidence 976554432222211111100 000 11246778889988664 233356888874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.57 Aligned_cols=236 Identities=22% Similarity=0.256 Sum_probs=190.1
Q ss_pred ceeeccCceEEEEEEE--CCeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
+.||+|+||.||++.. .+..||+|++..... .....+..|+.++..++||||+++++++ .+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987 468899999976432 2234577899999999999999999887 45689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|..++. ....+++..+..++.||+.||.|||+. .||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 9998884 334689999999999999999999962 5899999999999999999999999999875332211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
......||+.|+|||++.+..++.++|||||||++|+|+||..||...+......... .....+|...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~-------~~~~~~p~~~~ 220 (325)
T cd05594 152 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEIRFPRTLS 220 (325)
T ss_pred ----ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh-------cCCCCCCCCCC
Confidence 0123458999999999999999999999999999999999999997654432211111 01112345567
Q ss_pred HHHHHHHHHHhhhccCCCC-----ChHH
Q 006545 520 EQLANLAMRCCEMSRKSRP-----ELGK 542 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RP-----s~~e 542 (641)
..+.+|+.+||..||.+|+ ++.+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ 248 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKE 248 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHH
Confidence 8899999999999999997 6666
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.51 Aligned_cols=255 Identities=25% Similarity=0.494 Sum_probs=204.3
Q ss_pred CCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
.+|.+.+.||+|+||.||+|... +..+++|.+..........+.+|+.++++++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778889999999999999752 3458999887655444567899999999999999999999884 46899
Q ss_pred EEEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 352 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
||||+++++|.+++.... ....+++..++.++.+++.||.|||+ +||+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 12348999999999999999999999 89999999999999999999
Q ss_pred ccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH-
Q 006545 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY- 496 (641)
Q Consensus 419 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~- 496 (641)
++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|+| |.+||........
T Consensus 162 ~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred EEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999765433211 11123346889999999999999999999999999999999 9999865443221
Q ss_pred -HHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 497 -ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 497 -~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
....+. ....+...+..+.+++.+||..+|.+||++.+ |.+.|+.+..
T Consensus 236 ~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~-v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGR--------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKE-IYKILHALGK 284 (291)
T ss_pred HHHhCCC--------CCCCCccCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHHh
Confidence 111111 11123345678999999999999999999999 7888887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=331.67 Aligned_cols=232 Identities=25% Similarity=0.344 Sum_probs=187.8
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||++..... .....+..|..++..+ +||||+++++++ .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999885 57899999876422 2234577899999876 799999999988 3468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 151 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--- 151 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---
Confidence 999988843 3468999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...+........... ...+|...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------~~~~p~~~ 219 (321)
T cd05591 152 -----TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------DVLYPVWL 219 (321)
T ss_pred -----cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CCCCCCCC
Confidence 112345899999999999999999999999999999999999999876544322211110 11234445
Q ss_pred HHHHHHHHHHHhhhccCCCCC
Q 006545 519 AEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs 539 (641)
+..+.+|+.+||..||.+||+
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCC
Confidence 778999999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.82 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=192.3
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
.|...++||+|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999884 67899999875432 12346889999999999999999999984 46899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
||+||+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999853 3458899999999999999999999 899999999999999999999999999986432110
Q ss_pred ccCC---------------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHH
Q 006545 435 ISSN---------------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFG 475 (641)
Q Consensus 435 ~~~~---------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlG 475 (641)
.... ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 0000011234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 476 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 476 viL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
|+||+|++|++||...+..............+ ........++.+.++|.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999998765544332221111111 01112235678889998876 59999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=330.40 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=190.0
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999884 6789999997642 12334567788888764 899999999988 4468899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--- 151 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---
Confidence 999998843 3468999999999999999999999 8999999999999999999999999999864321110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+......... .....++...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~ 219 (316)
T cd05620 152 -----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-------VDTPHYPRWI 219 (316)
T ss_pred -----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCCCCCCC
Confidence 1123458999999999999999999999999999999999999997655432211110 0112234456
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+..+.+|+.+||..||.+||++.+.+
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 77899999999999999999986533
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.01 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=195.5
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||+|... +..||||++..... .....+.+|+.+|+.++||||+++++.+ .+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999874 68899999865321 2245688999999999999999999988 45689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999853 3468899999999999999999999 89999999999999999999999999998543211
Q ss_pred cccCC-----------------------------------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHH
Q 006545 434 EISSN-----------------------------------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478 (641)
Q Consensus 434 ~~~~~-----------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL 478 (641)
..... ....+......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00000 0000111234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC---ChHHH
Q 006545 479 LRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKD 543 (641)
Q Consensus 479 ~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RP---s~~ev 543 (641)
|+|++|++||................... ........+..+.++|.+|+ .+|.+|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTL---HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccc---cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999998765443322221111111 01112245678899999977 5999999 66663
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.51 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=201.9
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||+|.. .+..||||.+....... ...+.+|+.+++.++||||+++++++ .+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999987 47899999886543222 24578999999999999999999987 45688999
Q ss_pred EecCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
||+++|+|.+++.... ....+++..+..++.+++.||.|||+ ++++|+||||+|||++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885332 23458899999999999999999999 8999999999999999999999999999887643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH--HHHHHhhcccccccCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPL 510 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~ 510 (641)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .....
T Consensus 159 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-- 225 (267)
T cd08228 159 KTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI---EQCDY-- 225 (267)
T ss_pred hhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH---hcCCC--
Confidence 321 11233588999999999988899999999999999999999999954321 1111111 00000
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
....+...+..+.+++.+||..+|.+||++.+ +++.++.+
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-vl~~~~~~ 265 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGY-VHQIAKQM 265 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHH-HHHHHHHh
Confidence 01112245678999999999999999999999 77777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.81 Aligned_cols=241 Identities=23% Similarity=0.290 Sum_probs=189.4
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHH-HHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||+||+|.+. +..||||++...... ....+..|.. +++.++||||+++++.+ .+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999984 788999998754221 2234555555 46789999999999987 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 151 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--- 151 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---
Confidence 999998853 3468999999999999999999999 8999999999999999999999999999875322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......... . ....+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~-----~~~~~~~~ 219 (323)
T cd05575 152 -----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--K-----PLRLKPNI 219 (323)
T ss_pred -----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--C-----CCCCCCCC
Confidence 11234589999999999999999999999999999999999999976543332111100 0 01123345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+..+.+++.+||+.||.+||++...+.+++
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 778999999999999999999975343333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.11 Aligned_cols=244 Identities=25% Similarity=0.442 Sum_probs=196.2
Q ss_pred CCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 358 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~g 358 (641)
+|.+.+.||+|+||.||+|.+.+ ..||||.+.... .....+.+|+.++++++||||+++++++. +..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 57888899999999999998865 459999887543 33567899999999999999999999883 457899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++... ...+++..++.++.+++.||.|||+ .|++|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-- 156 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence 9999998543 2368999999999999999999999 89999999999999999999999999998765432211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+............ ....+..
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 225 (256)
T cd05113 157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL------RLYRPHL 225 (256)
T ss_pred -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC------CCCCCCC
Confidence 1112235678999999998889999999999999999998 999997554332211111100 1112333
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll 252 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLL 252 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 467899999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.48 Aligned_cols=234 Identities=22% Similarity=0.295 Sum_probs=187.1
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcC-CCCceeeEecccc--CceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||+++..... ....+..|..++..+ +||||++++++|. +..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999884 678999999864322 234578899999998 7999999999883 468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--- 151 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--- 151 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---
Confidence 999988843 3569999999999999999999999 8999999999999999999999999999874322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH--------HHHHHhhcccccccCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------VQYALDTGKLKNLLDPL 510 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~--------~~~~~~~~~~~~~~d~~ 510 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... .+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~ 220 (329)
T cd05588 152 -----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ------VILEK 220 (329)
T ss_pred -----ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH------HHHcC
Confidence 11234589999999999999999999999999999999999999963211 000000 00011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
....|...+..+.+|+.+||..||.+||+.
T Consensus 221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 221 QIRIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 122345567789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.70 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=201.3
Q ss_pred CCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 358 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~g 358 (641)
.+|++.++||+|+||.||+|... +..||+|.+..... ....+.+|+.++++++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46888999999999999999875 46799999876443 4567999999999999999999999874 457899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
++|.+++... ....+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.++|+|||++..+.......
T Consensus 85 ~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05070 85 GSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-
Confidence 9999998543 23458999999999999999999999 899999999999999999999999999998664432111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.....++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+.......... ......+..
T Consensus 160 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 227 (260)
T cd05070 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER------GYRMPCPQD 227 (260)
T ss_pred ------ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCCCCCCCc
Confidence 112235678999999988899999999999999999999 8999976543322211110 011123445
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
.+..+.+|+.+||..+|.+||++.+ +.+.|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l~ 258 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEY-LQSFLE 258 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHH-HHHHHh
Confidence 5678999999999999999999998 656665
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.18 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=201.0
Q ss_pred CCCCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
++|.+.+.||+|+||.||+|.+. ...||||++...... ....|.+|+.+++.++||||+++++++ .+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888999999999999999874 247999998754322 235688999999999999999999987 3468899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++++|.+++... ...+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998543 2368999999999999999999999 8999999999999999999999999999987752
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||............... ..
T Consensus 159 ~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------~~ 226 (266)
T cd05033 159 SEATY------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG------YR 226 (266)
T ss_pred cccce------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC------CC
Confidence 11110 0112235678999999998899999999999999999998 99999654433221111110 01
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
...+...+..+.+|+.+||+.+|.+||++.+ +++.|+.+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e-i~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQ-IVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHhh
Confidence 1123445678999999999999999999999 66666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=317.17 Aligned_cols=249 Identities=27% Similarity=0.338 Sum_probs=197.1
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|.+.+.||+|+||.||+|.. .+..||+|++..........+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999987 4688999999765544456788999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++.. ..++++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 3468999999999999999999999 8999999999999999999999999999986543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
......|++.|+|||.+. ...++.++|||||||++|+|++|.+||.............. ..+.+...
T Consensus 162 --------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 231 (267)
T cd06646 162 --------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKL 231 (267)
T ss_pred --------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCC
Confidence 112235889999999885 34578899999999999999999999964433222111100 00111111
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+..+.+|+.+||..+|.+||++.+++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 263 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 11223467899999999999999999999843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=322.55 Aligned_cols=251 Identities=26% Similarity=0.281 Sum_probs=202.9
Q ss_pred CCCCccceeeccCceEEEEEEECC--eEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
+.|+.++.||.|.-|+||++..++ ..+|+|++.+..... ..+...|-+||+.++||.++.||..| ++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467888999999999999999976 789999998865443 34577899999999999999999999 45689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|||+||+|..++++ +....|++..++.++.+++.||+|||- .|||+|||||+||||-++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988754 455679999999999999999999999 89999999999999999999999999998644211
Q ss_pred ccc-----------------------------C-C------------------CccccccCCCCCCcccCChhhhccCCC
Q 006545 434 EIS-----------------------------S-N------------------NTTLCCRTDPKGTFAYMDPEFLASGEL 465 (641)
Q Consensus 434 ~~~-----------------------------~-~------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~ 465 (641)
... . . ..+.......+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 0 0 000112335689999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 466 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 466 s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
+.++|+|+|||+|||||.|..||.+.+......+.-... ...+..+ ..+..+.+||+++|.+||.+|...
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~----l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP----LKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC----CcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999998776554433321111 1112222 567889999999999999999983
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=335.22 Aligned_cols=241 Identities=25% Similarity=0.381 Sum_probs=189.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
.+|...++||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++|+||+++++++. +.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45778889999999999999884 689999998654322 2356889999999999999999999884 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+.+|+|.+.. ..++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986543 25677888999999999999999 8999999999999999999999999999986643211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH--HHHhhcccccccC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLD 508 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~d 508 (641)
......||..|+|||++.. ...+.++|||||||++|+|++|+.||....... ........
T Consensus 224 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----- 290 (353)
T PLN00034 224 --------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----- 290 (353)
T ss_pred --------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----
Confidence 0123468999999998843 234568999999999999999999997332111 11111000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+...+..+.+||.+||..||.+||++.+++
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 011223345677899999999999999999999844
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.05 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=198.2
Q ss_pred CCCCccceeeccCceEEEEEEE------CCeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~------~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
.+|++.+.||+|+||.||+|.+ .+..||+|.+...... ....+.+|+.+++.++||||+++++++ .+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577888999999999999985 2467999998754322 235688999999999999999999987 456899
Q ss_pred EEEecCCCChhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC
Q 006545 352 VYEYLPNGSLEDRLSCKD--------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~ 417 (641)
||||+++|+|.+++.... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 12357889999999999999999999 8999999999999999999
Q ss_pred cccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH-
Q 006545 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ- 495 (641)
Q Consensus 418 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~- 495 (641)
.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cEEeccccccccccCCccee------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999998664332111 1122335778999999998889999999999999999998 999996544322
Q ss_pred -HHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 496 -YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 496 -~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
........ ...+...+..+.+++.+||+.+|.+||++.+ +.+.|.
T Consensus 236 ~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l~ 281 (283)
T cd05090 236 IEMVRKRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKD-IHTRLR 281 (283)
T ss_pred HHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHhh
Confidence 21221111 1123445678999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.55 Aligned_cols=236 Identities=28% Similarity=0.336 Sum_probs=192.3
Q ss_pred ceeeccCceEEEEEEE-----CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 287 LKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~-----~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
+.||+|+||.||++.. .+..||+|++...... ....+..|+.+|++++||||+++++++ .+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 4688999999754322 234577899999999999999999988 446889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999999843 3468999999999999999999999 8999999999999999999999999999876533211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... .....|..
T Consensus 154 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-------~~~~~p~~ 220 (318)
T cd05582 154 ------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-------AKLGMPQF 220 (318)
T ss_pred ------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-------CCCCCCCC
Confidence 11234589999999999988899999999999999999999999976654332221110 11123445
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.+..+.+|+.+||+.||.+||++.+.
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~ 246 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPD 246 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 67889999999999999999997653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.43 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=194.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|+..++||+|+||.||++.+. +..||||++...... ....+.+|+.+++.++||||+++++.+. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999874 688999998754322 2245778999999999999999999873 56899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888543 23468999999999999999999999 899999999999999999999999999987654221
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....... +...+......+
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~ 224 (285)
T cd05605 157 T---------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKEDQEEY 224 (285)
T ss_pred c---------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhccccc
Confidence 1 1223589999999999988999999999999999999999999976433211100 000111112233
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
+...+..+.+|+.+||..||.+||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcC
Confidence 4456788999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.01 Aligned_cols=233 Identities=22% Similarity=0.290 Sum_probs=189.3
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 5789999997542 22344577899999888 699999999987 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 999988843 3469999999999999999999999 89999999999999999999999999998643221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ....++...
T Consensus 153 ------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------~~~~~~~~~ 219 (318)
T cd05570 153 ------TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------DEVRYPRWL 219 (318)
T ss_pred ------ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCCCCCcC
Confidence 1223589999999999999999999999999999999999999976554332211110 011234456
Q ss_pred HHHHHHHHHHHhhhccCCCCCh
Q 006545 519 AEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
+..+.+||.+||..||.+||++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCC
Confidence 7889999999999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.58 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=201.1
Q ss_pred cCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEecccc---C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~---~ 347 (641)
..+|.+.+.||.|+||.||+|... ++.||+|++...... ....+..|+.++.++ +||||++++++|. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 347899999999999999999653 367999998754322 134577899999999 8999999999873 3
Q ss_pred ceEEEEEecCCCChhhhhhcCCC---------------------------------------------------------
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDN--------------------------------------------------------- 370 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~--------------------------------------------------------- 370 (641)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 57899999999999998853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCC
Q 006545 371 -SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449 (641)
Q Consensus 371 -~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 449 (641)
..++++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..+....... ......
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~~~~~ 236 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RKGDAR 236 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hccCCC
Confidence 1368999999999999999999999 899999999999999999999999999998764332111 112234
Q ss_pred CCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH---HHHHHhhcccccccCCCCCCCChhhHHHHHHH
Q 006545 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 525 (641)
Q Consensus 450 Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~L 525 (641)
++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+.. ...+...+..+.++
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l 308 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------MRAPEYATPEIYSI 308 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------CCCCccCCHHHHHH
Confidence 6778999999999999999999999999999998 9999965322 1111111111 11233456789999
Q ss_pred HHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 526 AMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 526 i~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
+.+||+.+|.+||++.+ +++.|+.+..
T Consensus 309 ~~~cl~~~p~~RPs~~e-ll~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSE-LVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHH-HHHHHHHHHh
Confidence 99999999999999998 7778776643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.25 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=199.3
Q ss_pred CCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc---cCceEEEEEecC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLP 357 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lV~Ey~~ 357 (641)
.+|.+.+.||+|+||.||+|...+..||+|.+.... ....+.+|+.++++++|+|++++++++ ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 368888999999999999999999999999986432 345788999999999999999999875 245889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++.... ...+++..+..++.+++.||.|||+ +||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999986432 2358899999999999999999999 899999999999999999999999999987543321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||............... .....+.
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~ 222 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------YKMDAPD 222 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC------CCCCCCC
Confidence 11224678999999998899999999999999999997 99999754432221111100 1112334
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
..+..+.+++.+||..+|.+||++.+ +.+.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQ-LREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHH-HHHHHhc
Confidence 56788999999999999999999999 6566653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.58 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=201.3
Q ss_pred CCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
+|.+.+.||+|+||.||+|.... ..+++|.+...... ....+.+|+.+++.++||||+++++.| .+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998742 46899988754321 235688999999999999999999987 456889
Q ss_pred EEEecCCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 006545 352 VYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~N 410 (641)
||||+++|+|.+++.... ...++++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 999999999999875321 12358899999999999999999999 899999999999
Q ss_pred eEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 006545 411 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 489 (641)
Q Consensus 411 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~ 489 (641)
||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYV------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchh------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999987654332111 0122235778999999988889999999999999999998 999997
Q ss_pred CcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 490 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
.............. .....+...+..+.+++..||+.+|.+||++.+ +...|+.+..
T Consensus 232 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~-i~~~l~~~~~ 288 (290)
T cd05045 232 GIAPERLFNLLKTG------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD-ISKELEKMMV 288 (290)
T ss_pred CCCHHHHHHHHhCC------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH-HHHHHHHHHh
Confidence 65433321111110 111223455678999999999999999999999 7777777643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=313.98 Aligned_cols=246 Identities=25% Similarity=0.437 Sum_probs=194.9
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCCCCh
Q 006545 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGSL 361 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~ggsL 361 (641)
.||+|+||.||+|.+. +..||+|++....... ...+.+|+.++++++||||+++++++. +..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999874 3569999987653322 356889999999999999999999884 467899999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++... ...+++..++.++.+++.||.|||+ +|++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 9998532 3468999999999999999999999 8999999999999999999999999999986543321110
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 520 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 520 (641)
......++..|+|||.+.+..++.++|||||||++|+|++ |.+||............... .....+...+.
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 225 (257)
T cd05115 154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG------KRLDCPAECPP 225 (257)
T ss_pred --ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------CCCCCCCCCCH
Confidence 1122234678999999998889999999999999999996 99999755433221111111 11223455678
Q ss_pred HHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 521 QLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 521 ~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
.+.+++.+||..+|++||++.+ |.+.|+.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~-i~~~l~~ 254 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAK-VEERMRT 254 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHH-HHHHHhh
Confidence 9999999999999999999999 6565543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.11 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=195.4
Q ss_pred CCccceeeccCceEEEEEEECC----eEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--------Cc
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------EV 348 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~----~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~~ 348 (641)
|.+.+.||+|+||.||+|.+.. ..||+|.+..... .....+..|+.+++.++||||+++++++. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466789999999999998753 3699998875432 22456889999999999999999998751 13
Q ss_pred eEEEEEecCCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFG 425 (641)
.++||||+++|+|.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887422 123458999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH--HHhhcc
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGK 502 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~--~~~~~~ 502 (641)
+++.+....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||........ .+..+.
T Consensus 158 ~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYR------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred cccccCccccee------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 998764432110 0112236778999999999999999999999999999999 8999975443221 111111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 503 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 503 ~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
. ...+...+..+.++|.+||..+|.+||++.+ +++.|+.
T Consensus 232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l~~ 270 (272)
T cd05075 232 R--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFET-LRCELEK 270 (272)
T ss_pred C--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHh
Confidence 1 1123345678999999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=333.08 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=190.7
Q ss_pred CCCccceeeccCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHhcC-CCCceeeEecccc--Cce
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 349 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~-----~~~~vAvK~~~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 349 (641)
+|++.+.||+|+||.||++.. .+..||+|++..... .....+..|+.++..+ +||||+++++++. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999876 467899999875321 2234678899999999 5999999998873 468
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 899999999999999853 3458999999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHH--HHHHhhcccccc
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNL 506 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~~~~~~~~ 506 (641)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||..||...... ...+... ..
T Consensus 155 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~-- 224 (332)
T cd05614 155 FLSEEKE-------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-IL-- 224 (332)
T ss_pred ccccCCC-------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-Hh--
Confidence 5332211 11234589999999999865 4789999999999999999999999632210 0001100 00
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
.....++...+..+.+++.+||..||.+||++.
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 225 --KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 111233445678899999999999999999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.16 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=199.0
Q ss_pred CCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecccc--C------
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--E------ 347 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~------ 347 (641)
|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.+++.++||||+++++++. +
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567788999999999999863 2679999987643322 356889999999999999999999762 1
Q ss_pred ceEEEEEecCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
..++||||+++|+|..++.... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 2689999999999999885432 23468999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhccc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~ 503 (641)
|+++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.............
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-- 229 (273)
T cd05035 158 GLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-- 229 (273)
T ss_pred cceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 9998664332111 0112235678999999988899999999999999999999 999997654433221111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 504 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 504 ~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.......+...+..+.+++.+||..||.+||++.+ +.+.|+.+
T Consensus 230 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e-~~~~l~~~ 272 (273)
T cd05035 230 ----HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTK-LREVLENI 272 (273)
T ss_pred ----cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHhh
Confidence 11112234456788999999999999999999999 66666543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.31 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=196.2
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.++|++.++||.|+||.||++.+. +..+|+|++...... ....+.+|+.+++.++||||++++++| .+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 357999999999999999999885 678999988754321 235688999999999999999999988 456899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999999853 34588999999999999999999972 379999999999999999999999999987553321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc-----ccc-----
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-----KLK----- 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~-----~~~----- 504 (641)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||............+ ...
T Consensus 159 ----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 159 ----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred ----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 122358999999999998899999999999999999999999997543322111000 000
Q ss_pred ----------------------------cccCCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 ----------------------------NLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ----------------------------~~~d~~~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..........+ ...+.++.+|+.+||+.||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 00000000001 12356789999999999999999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.07 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=189.7
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL 361 (641)
||+|+||+||++.+. +..||+|.+...... ....+..|+.+++.++||||+++++++. ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999874 688999998754322 2245778999999999999999998873 468899999999999
Q ss_pred hhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCc
Q 006545 362 EDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 440 (641)
Q Consensus 362 ~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 440 (641)
.+++... .....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence 9887432 234569999999999999999999999 89999999999999999999999999998765433211
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH--HHHhhcccccccCCCCCCCChhh
Q 006545 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 441 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........ . ....++...
T Consensus 154 ----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----~-~~~~~~~~~ 224 (280)
T cd05608 154 ----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL----N-DSVTYPDKF 224 (280)
T ss_pred ----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----c-cCCCCcccC
Confidence 123458999999999999999999999999999999999999997543211 11111101 0 112334556
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+..+.+++.+||+.||.+||++.+
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCC
Confidence 788999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.36 Aligned_cols=253 Identities=31% Similarity=0.474 Sum_probs=202.2
Q ss_pred cCCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc-cCceEEEEEecC
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLP 357 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV~Ey~~ 357 (641)
..+|.+.++||+|+||.||+|.+.+ ..||+|++.... .....+.+|+.+++.++||||+++++.+ .+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 3468999999999999999998754 579999987533 2346789999999999999999999977 456789999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++... ....+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999999543 23457899999999999999999999 899999999999999999999999999998665432111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
.....++..|+|||.+.+..++.++|||||||++|+|+| |.+||............... .....+.
T Consensus 160 -------~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~------~~~~~~~ 226 (262)
T cd05071 160 -------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------YRMPCPP 226 (262)
T ss_pred -------ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC------CCCCCcc
Confidence 112346778999999998899999999999999999999 88999755432221111000 0111233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
..+..+.+|+.+||+.+|.+||++.+ +...|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~-~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHH-HHHHHHHh
Confidence 45678999999999999999999999 76777643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=312.93 Aligned_cols=244 Identities=25% Similarity=0.462 Sum_probs=196.0
Q ss_pred CCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 358 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~g 358 (641)
+|++.+.||+|+||.||+|.+.+ ..+|+|++.... .....+.+|+.+++.++||||+++++++. +..++||||++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 57788899999999999998854 579999986433 23457889999999999999999999873 467899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999998543 2368999999999999999999999 899999999999999999999999999987654321110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.....++..|+|||.+.+..++.++|||||||++|+|++ |.+||............... .....+..
T Consensus 158 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~ 225 (256)
T cd05059 158 ------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------YRLYRPKL 225 (256)
T ss_pred ------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC------CcCCCCCC
Confidence 112224568999999999999999999999999999999 89999755443322211111 01123445
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l 252 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLL 252 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 678899999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=312.69 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=203.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|++.+.||.|+||.||+|... +..||+|.++..... ....+.+|+.++++++|+||+++++++ .+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999985 788999988753322 245788999999999999999999987 44688999
Q ss_pred EecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
||+++|+|.+++... .....+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 234568999999999999999999999 8999999999999999999999999999876543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.................. ..
T Consensus 159 ~~~~--------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 226 (267)
T cd08224 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----YP 226 (267)
T ss_pred CCcc--------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----CC
Confidence 2211 12234788999999999889999999999999999999999999543311111100000001 11
Q ss_pred CCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 513 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 513 ~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
..+. ..+..+.++|.+||..+|.+||++.+ +++.|..+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~-il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISY-VLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHH-HHHHHHHhc
Confidence 1122 45668999999999999999999999 777777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.98 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=190.8
Q ss_pred hcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--------C-
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E- 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~- 347 (641)
...+|.+.+.||+|+||.||+|.+ .+..||||++.... ....+|+.+|+.++||||+++++++. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345799999999999999999988 46889999885432 34568999999999999999987651 1
Q ss_pred -ceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-ccccccc
Q 006545 348 -VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDF 424 (641)
Q Consensus 348 -~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-~vKL~DF 424 (641)
.+++||||+++ +|.+++... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 35689999975 676666432 334578999999999999999999999 8999999999999998654 7999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~ 503 (641)
|+|+.+..... .....||+.|+|||++.+. .++.++|||||||+||+|++|.+||...............
T Consensus 216 Gla~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 216 GSAKNLLAGQR---------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccchhccCCCC---------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99986643221 1223589999999998764 6999999999999999999999999765443322111000
Q ss_pred ----------------ccc-cCC-----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ----------------KNL-LDP-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ----------------~~~-~d~-----~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
... +.. ....+|...+..+.+||.+||..||.+||++.+++
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 000 00112334567899999999999999999999954
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.39 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=202.9
Q ss_pred hcCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--C
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~ 347 (641)
..++|++.+.||+|+||.||+|...+ ..+|+|.+..... .....+.+|+.++.++ +||||+++++++. .
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44578889999999999999998642 5799999875422 2234588999999999 8999999999873 4
Q ss_pred ceEEEEEecCCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec
Q 006545 348 VWTLVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld 414 (641)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 688999999999999998542 224568999999999999999999999 8999999999999999
Q ss_pred cCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH
Q 006545 415 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 493 (641)
Q Consensus 415 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~ 493 (641)
.++.+||+|||+++.+........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred CCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999987654321111 112235678999999998899999999999999999997 9999976543
Q ss_pred HHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
........ .......+...+..+.+|+.+||..+|.+||++.+ +++.|+.+
T Consensus 241 ~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-il~~l~~~ 291 (293)
T cd05053 241 EELFKLLK------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ-LVEDLDRM 291 (293)
T ss_pred HHHHHHHH------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHHHHh
Confidence 32211110 01111234455778999999999999999999999 66666654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.72 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=191.6
Q ss_pred eeeccCceEEEEEEE--CCeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCChh
Q 006545 288 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLE 362 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL~ 362 (641)
.||+|+||.||+|.+ .++.||+|.+...... ....+.+|+.+++.++||||++++++| ....++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 599999999999987 4788999987643321 235689999999999999999999988 34688999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccc
Q 006545 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442 (641)
Q Consensus 363 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 442 (641)
+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccc-----
Confidence 998532 3468999999999999999999999 899999999999999999999999999987544221100
Q ss_pred cccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHH
Q 006545 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521 (641)
Q Consensus 443 ~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 521 (641)
......++..|+|||.+.++.++.++|||||||++|+|++ |.+||............... .....+...+..
T Consensus 152 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 224 (252)
T cd05084 152 -TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG------VRLPCPELCPDA 224 (252)
T ss_pred -cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC------CCCCCcccCCHH
Confidence 0011123567999999999999999999999999999998 99999654332211111110 111234455778
Q ss_pred HHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 522 LANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 522 l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+.+|+.+||..+|.+||++.+ +.+.|
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~-~~~~l 250 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFST-VHQEL 250 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHH-HHHHH
Confidence 999999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.82 Aligned_cols=240 Identities=21% Similarity=0.308 Sum_probs=193.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCC-CCceeeEeccc--cCceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lV~ 353 (641)
+|+..+.||+|+||.||+|... +..||||++..... .....+..|..++..+. |++|+++++++ .+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999874 67899999875422 22345778999998886 57788888877 34689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998843 3469999999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||.............. ....
T Consensus 155 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~~ 219 (323)
T cd05615 155 GV--------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNVS 219 (323)
T ss_pred Cc--------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC
Confidence 11 11234589999999999999999999999999999999999999976654322211110 1122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+|...+..+.+++.+||..+|.+|++..+
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGP 248 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCC
Confidence 34556778999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.45 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=198.8
Q ss_pred CCCCccceeeccCceEEEEEEE------CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc----CceE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 350 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 350 (641)
.+|.+.+.||+|+||.||+|.. .+..||+|.+..........+.+|+.+++.++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688889999999999999874 35789999987655444567899999999999999999999762 3578
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH-HHHhhcc-------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGK------- 502 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~~~~------- 502 (641)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..|+....... .......
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 159 PQDKEYY-----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cCCCcce-----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 4432110 01112234567999999998899999999999999999999987764332111 0000000
Q ss_pred -cccccC-CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 503 -LKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 503 -~~~~~d-~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
+...+. ......+...+..+.+|+.+||..+|.+||++.+ |...|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-i~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE-LALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHHhc
Confidence 000000 0011123345678999999999999999999999 66667654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=313.23 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=196.9
Q ss_pred ceeeccCceEEEEEEEC--C---eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~---~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~gg 359 (641)
++||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+++.++||||+++++++. +..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 36999999999999873 2 57999998865543 3456889999999999999999999874 4678999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++... ..+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 81 PLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 999999533 368999999999999999999999 899999999999999999999999999998664332111
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+............ ....+...
T Consensus 153 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~ 223 (257)
T cd05060 153 ---RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------RLPRPEEC 223 (257)
T ss_pred ---ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------cCCCCCCC
Confidence 11112234578999999998899999999999999999998 999997654432211111111 11234455
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
+..+.++|.+||..+|.+||++.+ +...|+.+
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~-l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSE-LESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHH-HHHHHHhc
Confidence 678999999999999999999999 77777653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.67 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=202.8
Q ss_pred cCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
..+|.+.+.||.|+||.||+|...+..||||.+..... ....+.+|+.+++.++|+||+++++++ .+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 34788889999999999999999999999999976543 456789999999999999999999987 457899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999854322 368999999999999999999999 8999999999999999999999999999986633211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
...++..|+|||.+....++.++||||||+++|+|++ |..||............... .....+.
T Consensus 158 ---------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~ 222 (256)
T cd05039 158 ---------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG------YRMEAPE 222 (256)
T ss_pred ---------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC------CCCCCcc
Confidence 1224678999999988899999999999999999997 99999765433221111110 0112234
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
..+..+.++|.+||..+|.+||++.+ ++..|.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l~ 254 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQ-LREQLA 254 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHH-HHHHHh
Confidence 45688999999999999999999988 666654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.11 Aligned_cols=234 Identities=22% Similarity=0.298 Sum_probs=186.9
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||+|++...... ....+..|+.++.++ +||||+++++++ .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999884 578999999864322 234577899988877 799999999987 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--- 151 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 151 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---
Confidence 999988843 3468999999999999999999999 8999999999999999999999999999875322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH--------HHHHHHhhcccccccCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--------EVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~--------~~~~~~~~~~~~~~~d~~ 510 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....... .+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~------~i~~~ 220 (329)
T cd05618 152 -----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------VILEK 220 (329)
T ss_pred -----ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH------HHhcC
Confidence 1123458999999999999999999999999999999999999995211 0011100 00011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
....|...+..+.+|+.+||..||.+||+.
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 123455667889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.25 Aligned_cols=248 Identities=25% Similarity=0.283 Sum_probs=195.7
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
...+|.+.+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+++++++. +..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999884 67899999865321 22345788999999999999999999884 45889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||++||+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998842 347888999999999999999999 899999999999999999999999999997654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccccc
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 507 (641)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...+..............+
T Consensus 194 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 194 ANGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred CCCcc-------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 32211 11234699999999998653 47899999999999999999999998665433222111100000
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCC--CCChHHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGKD 543 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~ev 543 (641)
........+..+.+||.+||..+|.+ ||++.++
T Consensus 267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred ---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 00011235788999999999999987 9999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.30 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=198.1
Q ss_pred CCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
+|.+.+.||.|+||.||+|.+. +..||||++....... ...+.+|+.++..++||||+++++++. +..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677788999999999999863 3679999987543221 346889999999999999999999883 46889
Q ss_pred EEEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 352 VYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999984221 12358889999999999999999999 89999999999999999999
Q ss_pred ccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHH
Q 006545 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYA 497 (641)
Q Consensus 419 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~ 497 (641)
+||+|||+++........ .......+++.|+|||.+.++.++.++|||||||++|+|++ |.+||.........
T Consensus 163 ~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred eEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999998865433211 11123346789999999998899999999999999999998 88898755433221
Q ss_pred HhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 498 LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 498 ~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
.... .......+...+..+.+|+.+||+.+|.+||++.+ ++..|+
T Consensus 237 ~~i~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~-i~~~l~ 281 (283)
T cd05091 237 EMIR------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD-IHSRLR 281 (283)
T ss_pred HHHH------cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHhh
Confidence 1111 11112234556788999999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=316.55 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=200.8
Q ss_pred CCCCccceeeccCceEEEEEEEC--Ce----EEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc-CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HM----QVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~----~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV 352 (641)
.+|...++||.|+||+||+|.+. +. .||+|++...... ....+.+|+.++..++||||+++++++. ...+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46788899999999999999863 33 5899998754332 2456889999999999999999999884 467899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|+|+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 9999999999998532 3468999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHH--HHHhhcccccccCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQ--YALDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~--~~~~~~~~~~~~d~ 509 (641)
..... ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||....... ..+..+.
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------- 228 (279)
T cd05109 162 DETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE------- 228 (279)
T ss_pred cccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------
Confidence 32110 0112235678999999998899999999999999999998 999997543322 1111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
....+...+..+.+++.+||..||.+||++.+ ++..|..+..
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~-l~~~l~~~~~ 270 (279)
T cd05109 229 -RLPQPPICTIDVYMIMVKCWMIDSECRPRFRE-LVDEFSRMAR 270 (279)
T ss_pred -cCCCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHhhc
Confidence 11123345678999999999999999999999 5577766653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.63 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=198.3
Q ss_pred CCccceeeccCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc----CceEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 351 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~l 351 (641)
|...+.||+|+||+||++.+ .+..||+|++..... .....+.+|+.+|+.++||||+++++++. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37888999999999988754 356799999876432 23456889999999999999999999873 24789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++|+|.+++.. ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 348999999999999999999999 899999999999999999999999999998665
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH-HHHHhh-------ccc
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDT-------GKL 503 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~-~~~~~~-------~~~ 503 (641)
...... .......++..|+|||.+.+..++.++|||||||++|+|+||..||...... ...... ..+
T Consensus 159 ~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 159 EGHEYY-----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred Ccchhh-----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 332110 0011223567899999999889999999999999999999999998643211 111100 000
Q ss_pred ccccCC-CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 504 KNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 504 ~~~~d~-~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
....+. .....+...+..+.+++.+||..+|++||++.+ ++..|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS-LIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHH-HHHHHHHhh
Confidence 000100 111234456789999999999999999999999 667777653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.41 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=198.8
Q ss_pred CCCCccceeeccCceEEEEEEE-------CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~-------~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
.+|....+||+|+||.||++.. .+..+|+|.+..........+.+|+.+++.++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677788999999999999964 24579999887655444567999999999999999999999874 46889
Q ss_pred EEEecCCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 352 VYEYLPNGSLEDRLSCKDN------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ +||+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1358899999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 498 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 498 (641)
||+|||++......... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..........
T Consensus 162 kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred EECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 99999998765432111 01122235788999999999999999999999999999998 999996543332211
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
...... ....+...+..+.+|+.+||..+|.+||++.+ |...|
T Consensus 236 ~~~~~~------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~-l~~~l 278 (280)
T cd05092 236 CITQGR------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKD-IHSRL 278 (280)
T ss_pred HHHcCc------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHH
Confidence 111111 11123345678999999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.69 Aligned_cols=241 Identities=24% Similarity=0.274 Sum_probs=189.5
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999874 78899999875422 12234556655 46778999999999887 4578999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 151 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--- 151 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---
Confidence 99998884 34568999999999999999999999 8999999999999999999999999999875322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+............ ...+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-------~~~~~~~ 219 (325)
T cd05604 152 -----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-------LVLRPGA 219 (325)
T ss_pred -----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-------ccCCCCC
Confidence 1123458999999999999999999999999999999999999997654433221111100 1122345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+..+.+++.+||..+|.+||++.+.+.+++
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 678999999999999999999875443433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.86 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=204.2
Q ss_pred cCCCCccceeeccCceEEEEEEEC------CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc---cCce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~---~~~~ 349 (641)
..+|.+.+.||+|+||.||+|.+. +..|++|++..... .....+.+|+.++++++||||+++++++ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 457888999999999999999875 37799998864322 2245688999999999999999999986 2468
Q ss_pred EEEEEecCCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNS-----PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+ ++++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998644322 568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhccc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~ 503 (641)
|+++.+........ .....++..|+|||.+.+..++.++|||||||++|++++ |++||...+...........
T Consensus 162 g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 99986543321110 112236778999999998899999999999999999999 99999765543322211110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 504 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 504 ~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
. ....+...+..+.+++.+||..+|++||++.+ +...|..+.
T Consensus 236 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-~~~~l~~~~ 277 (280)
T cd05043 236 Y------RLAQPINCPDELFAVMACCWALDPEERPSFSQ-LVQCLTDFH 277 (280)
T ss_pred C------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHH
Confidence 0 11123345678999999999999999999999 777777664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=338.14 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=205.7
Q ss_pred cCCCCccceeeccCceEEEEEEECC-----eE-EEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEeccc--cCc
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-----MQ-VAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 348 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----~~-vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~ 348 (641)
..+....++||+|+||.||+|.++- .. ||||..+... .....+|.+|+++|+.++|||||++||++ ...
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3344556899999999999998741 23 8999988533 22346799999999999999999999987 457
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
++||||+|+||+|.++|.+... .++..++..++.++|.||+|||+ +++|||||-..|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 8999999999999999964432 59999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhccccccc
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 507 (641)
.-....... ....-...|+|||.+..+.|++++|||||||++||+++ |..||.+....+...... .
T Consensus 311 ~~~~~~~~~--------~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-----~ 377 (474)
T KOG0194|consen 311 AGSQYVMKK--------FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-----K 377 (474)
T ss_pred CCcceeecc--------ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-----h
Confidence 654211111 01124679999999999999999999999999999998 899998776544322220 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
.......|...+..+..++.+||..+|.+||+|.+ +.+.|+.+...
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~-i~~~l~~~~~~ 423 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMST-IKKKLEALEKK 423 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHH-HHHHHHHHHhc
Confidence 11112234567889999999999999999999999 77788777654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=332.43 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
++|.+.+.||+|+||.||++... +..||||++..... .....+..|+.+++.++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999874 68899999986432 22356889999999999999999999873 4689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 2468999999999999999999999 89999999999999999999999999999866433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccccc
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 507 (641)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..................+
T Consensus 156 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred Cce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 211 112345899999999987 4567899999999999999999999997655433222111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .......+..+.+|+..||. +|.+||++.+++
T Consensus 229 ~---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 229 K---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred C---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 0 01112356789999999998 999999998843
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=312.59 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=202.2
Q ss_pred CCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc-cCceEEEEEecCC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPN 358 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV~Ey~~g 358 (641)
.+|.+.++||+|+||.||+|... +..||+|.+.... .....+.+|+.+++.++||||+++++++ .+..++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 46888999999999999999874 5789999987543 3456789999999999999999999987 4468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.... ...+++..+..++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05067 85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc--
Confidence 99999885433 3468999999999999999999999 89999999999999999999999999999766532211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......++..|+|||++.+..++.++|||||||++|+|++ |++||...+........... .....+..
T Consensus 159 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~ 227 (260)
T cd05067 159 -----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG------YRMPRPDN 227 (260)
T ss_pred -----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC------CCCCCCCC
Confidence 1122346778999999998999999999999999999999 99999755433222111110 01112334
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
.+..+.+++.+||..+|.+||++.+ +...|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l~ 258 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEY-LRSVLE 258 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHH-HHHHhh
Confidence 5678999999999999999999998 666665
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.56 Aligned_cols=240 Identities=24% Similarity=0.306 Sum_probs=188.9
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999984 67899999875422 12234555554 57889999999999987 4468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--- 151 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--- 151 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---
Confidence 999988843 3468889999999999999999999 8999999999999999999999999999875322111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+......... .. ....+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~-----~~~~~~~~ 219 (321)
T cd05603 152 -----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HK-----PLQLPGGK 219 (321)
T ss_pred -----ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cC-----CCCCCCCC
Confidence 1123458999999999999899999999999999999999999997654332211110 00 11234456
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRV 547 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~ 547 (641)
+..+.+++.+||+.+|.+||+....+.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 248 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKADFLEI 248 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCCCHHHH
Confidence 77899999999999999999986544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.19 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
.+|.+.+.||.|+||.||+|.. .+..||||.+....... ...+.+|+.+++.++||||+++++++ .+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3678888999999999999986 57889999886543222 34688999999999999999999987 45688999
Q ss_pred EecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
||+++++|.+++... .....+++..++.++.+++.||.|||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 234568999999999999999999999 8999999999999999999999999999876643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............ .+..... ..
T Consensus 159 ~~~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~--~~ 227 (267)
T cd08229 159 KTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQCDY--PP 227 (267)
T ss_pred CCcc--------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcCCC--CC
Confidence 3211 12235889999999999889999999999999999999999999643321111111 0111000 01
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
..+...+..+.+++.+||..+|.+||++.+ |.+++..+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITY-VYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHH-HHHHHhhh
Confidence 112345678999999999999999999998 77777655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.98 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=189.3
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHH-HHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEID-ILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++ .+..++||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999885 57799999875321 11223444444 56788999999999987 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--- 151 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--- 151 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---
Confidence 999998853 3458888999999999999999999 8999999999999999999999999999875432211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......... . ....+...
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~-----~~~~~~~~ 219 (325)
T cd05602 152 -----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--K-----PLQLKPNI 219 (325)
T ss_pred -----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--C-----CcCCCCCC
Confidence 11234589999999999999999999999999999999999999976554332211100 0 11223356
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+..+.+++.+||+.+|.+||++.+.+.+++
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 778999999999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.60 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=199.9
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|.+.+.||+|+||.||+|.. .+..|++|.+..... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477788999999999999988 468899999875432 23456889999999999999999999884 468999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++|++|.+++... ....+++..++.++.+++.||.|||+ .||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998643 23568999999999999999999999 8999999999999999999999999999886654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+........ .... ....+
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~----~~~~~ 222 (256)
T cd08529 157 F--------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGV----FPPVS 222 (256)
T ss_pred h--------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCC----CCCCc
Confidence 1 12235789999999999999999999999999999999999999766543322111 1111 11223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+++.+||..+|++||++.+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 34567899999999999999999999844
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=354.20 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=206.9
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
++|.+.++||+|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++. +..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999884 6889999997643322 346889999999999999999999883 4688999
Q ss_pred EecCCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccc
Q 006545 354 EYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFG 425 (641)
||++||+|.+++.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 12346677889999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCC----------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH
Q 006545 426 ISRFLSQNEISSN----------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495 (641)
Q Consensus 426 la~~~~~~~~~~~----------~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~ 495 (641)
++........... ...........||+.|+|||++.+..++.++|||||||++|+|+||.+||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987622110000 000011123569999999999999999999999999999999999999997543322
Q ss_pred HHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 496 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 496 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
..... ....+.........+..+.+++.+||..||.+||+..+++...|+.....
T Consensus 239 i~~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111 11111110011245677999999999999999999888898888887653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=321.66 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=204.0
Q ss_pred cCCCCccceeeccCceEEEEEEECC---------eEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEeccc--c
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--P 346 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~---------~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~ 346 (641)
..+|.+.+.||+|+||.||++.+.+ ..+|+|.+..... .....+..|+.+++.+ +||||++++++| .
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999997632 4699999876432 2235688899999999 799999999988 3
Q ss_pred CceEEEEEecCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl 413 (641)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ +|++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 468899999999999999964321 2358899999999999999999999 899999999999999
Q ss_pred ccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcH
Q 006545 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 492 (641)
Q Consensus 414 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~ 492 (641)
+.++.+||+|||++........... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhc------cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999876543211100 111234578999999999899999999999999999998 889997654
Q ss_pred HHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 493 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
........... .....+...+..+.+|+.+||..+|.+||++.+ +++.|+.+...
T Consensus 248 ~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-vl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHcC------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHHHH
Confidence 32221111100 011234455778999999999999999999999 77888877765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=316.59 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=200.1
Q ss_pred cCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 349 (641)
.++|.+.+.||+|+||.||+|...+ ..||+|.+..... .....+.+|+.+++.++||||+++++++ ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3478889999999999999998742 5799999865432 2234688999999999999999999987 4468
Q ss_pred EEEEEecCCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDN-------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~ 422 (641)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 2347889999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhc
Q 006545 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 501 (641)
Q Consensus 423 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~ 501 (641)
|||+++.+....... ......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...+.........
T Consensus 162 dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CcccchhhccCcccc------cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 999988654432111 1122346789999999988889999999999999999998 999996544332211111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 502 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.......|...+..+.+++.+||..+|.+||++.+ +...|
T Consensus 236 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l 275 (277)
T cd05032 236 ------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE-IVSSL 275 (277)
T ss_pred ------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHh
Confidence 11111234445788999999999999999999999 55444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=315.39 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=195.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|.+.+.||.|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++ ++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999884 688999998754322 235688999999999999999999998 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++ ++|.+++........+++..+..++.|++.||.|||+ ++|+||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6888888654444679999999999999999999999 8999999999999999999999999999875532211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc------------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------ 502 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~------------ 502 (641)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||..............
T Consensus 157 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 157 --------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred --------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 11233578999999998764 578999999999999999999999976544332221100
Q ss_pred ------ccccc----CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ------LKNLL----DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ------~~~~~----d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... ...........+.++.++|.+||..||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 00000 0000011223567889999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=317.67 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=199.4
Q ss_pred hcCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCc
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 348 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~ 348 (641)
...+|++.+.||+|+||.||+|..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++ .+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 347999987644321 223578899999999999999999987 346
Q ss_pred eEEEEEecCCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKD-------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL 421 (641)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 899999999999999996432 12456778899999999999999999 89999999999999999999999
Q ss_pred cccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhh
Q 006545 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT 500 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~ 500 (641)
+|||+++......... ......++..|+|||.+.++.++.++|||||||++|+|++ |.+||............
T Consensus 161 ~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999988654322111 0122235778999999999899999999999999999998 78999754433221111
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.+......+...+..+.+++.+||+.+|.+||++.+ +++.|...
T Consensus 235 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~~ 278 (288)
T cd05061 235 ------MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLKDD 278 (288)
T ss_pred ------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHhh
Confidence 011111223344678999999999999999999998 55555543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=356.40 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=209.8
Q ss_pred CCCccceeeccCceEEEEEEECC-------eEEEEEEecCCC-CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
+......||+|+||.||.|.+.+ ..||||.+.... .....+|.+|..+|++++|||||+++|+| ....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 45667889999999999998842 348999988653 34467899999999999999999999998 346889
Q ss_pred EEEecCCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
++|||.||+|..+|.... ....++....+.++.|||+|+.||++ +++|||||...|+||+....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999996542 14468999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH--hhcccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL--DTGKLK 504 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~--~~~~~~ 504 (641)
+.+......... ....-...|||||.+..+.++.++|||||||+|||++| |..||...+..+... ..+.
T Consensus 850 rDiy~~~yyr~~------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKH------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-- 921 (1025)
T ss_pred Hhhhhchheecc------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence 955444322111 11123568999999999999999999999999999999 999998776654332 2221
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhc
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~ 555 (641)
.-+.|..++..+.+|+..||+.+|++||++.. +++.+..+....
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~-i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRT-IVEQDPAISNAA 965 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHH-HHhhhhhhhhhh
Confidence 12347788999999999999999999999999 666666666543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.80 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC-----CchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
.+|...+.||.|+||.||+|.. .+..||+|.+...... ....+.+|+.++++++||||+++++++ .+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999987 4689999998754322 124688899999999999999999988 457899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998853 3458899999999999999999999 899999999999999999999999999987654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|++||...+.......... ....
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~ 225 (263)
T cd06625 156 TICSSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTN 225 (263)
T ss_pred cccccc-----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCC
Confidence 321110 001233578899999999998899999999999999999999999976544332222111 1112
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 234555677899999999999999999998843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=316.09 Aligned_cols=249 Identities=27% Similarity=0.370 Sum_probs=191.3
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcC---CCCceeeEecccc-------C
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP-------E 347 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l---~HpnIv~l~g~~~-------~ 347 (641)
+|.+.+.||+|+||.||+|.+. +..||+|.+....... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999884 6889999987643222 33566788887766 7999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 3689999997 58888875432 3458999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-----
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 502 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~----- 502 (641)
........ .....||..|+|||++.+..++.++|||||||++|+|++|++||..............
T Consensus 156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 156 RIYSCQMA---------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred ccccCccc---------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCC
Confidence 86543211 1223579999999999988999999999999999999999999976543322111100
Q ss_pred ----cccc-------cCCC----CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ----LKNL-------LDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ----~~~~-------~d~~----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+... +.+. ........+..+.+|+.+||..||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 0000 0011123456789999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.10 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=188.6
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL 361 (641)
||+|+||.||++... +..||+|.+...... ....+..|+.++++++||||+++++++. ...++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999874 789999998653221 2234567999999999999999999884 468899999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++... ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 9887533 23458899999999999999999999 8999999999999999999999999999876543211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH--HHHHhhcccccccCCCCCCCChhhH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+........+.. .....+
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 223 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFT 223 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCC
Confidence 12235899999999999989999999999999999999999999653221 111111111111110 112356
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.+|+.+||+.||.+||++.+++
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccch
Confidence 7899999999999999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.75 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=200.1
Q ss_pred cCCCCccceeeccCceEEEEEEECC------------------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceee
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH------------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVT 340 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~------------------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~ 340 (641)
..+|.+.+.||+|+||.||+|.+.. ..||+|++...... ....+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987642 45899998765332 2456889999999999999999
Q ss_pred Eecccc--CceEEEEEecCCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 006545 341 LVGACP--EVWTLVYEYLPNGSLEDRLSCKD--------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410 (641)
Q Consensus 341 l~g~~~--~~~~lV~Ey~~ggsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~N 410 (641)
++++|. +..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+ ++|+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 999884 56899999999999999985432 12368999999999999999999999 899999999999
Q ss_pred eEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 006545 411 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPAL 488 (641)
Q Consensus 411 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt--G~~Pf 488 (641)
|+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred eeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 999999999999999987654332111 1123346789999999998889999999999999999998 77888
Q ss_pred CCcHHHHHHHhhccc-ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 489 GITKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 489 ~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
............... ...........+...+..+.+|+.+||+.+|.+||++.+ |.+.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e-l~~~L 294 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE-IHLFL 294 (296)
T ss_pred CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHH-HHHHh
Confidence 654332221111111 000001111223445678999999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=313.71 Aligned_cols=249 Identities=28% Similarity=0.379 Sum_probs=197.8
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEecccc--------
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-------- 346 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-------- 346 (641)
.+++.|+..+.||+|+||.||+|... +..||+|++.... .....+..|+.++.++ +||||++++++|.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999874 6789999987543 3345788999999998 7999999999873
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 3478999999999999998643 23468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 501 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~ 501 (641)
+........ ......|++.|+|||++. +..++.++|||||||++|+|++|.+||.............
T Consensus 158 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 158 SAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred ceecccccc--------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 876543211 112345899999999986 3458889999999999999999999996544332222111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .......+...+..+.+|+.+||..+|.+||++.+++
T Consensus 230 ~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 230 R-----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred c-----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1 0011111223457899999999999999999998843
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.55 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=188.4
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.+|.+.+.||+|+||.||++.+. +..||||.... ..+.+|+.+|++++||||+++++++ ....++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999884 68899997532 3578999999999999999999987 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
. ++|..++.. ...+++..++.|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 688888743 3458899999999999999999999 89999999999999999999999999998754322111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH----------HHHHHHhh-ccc--
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----------EVQYALDT-GKL-- 503 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~----------~~~~~~~~-~~~-- 503 (641)
......||+.|+|||++.+..+++++|||||||++|+|++|..||.... .....+.. +..
T Consensus 239 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 239 -------KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred -------ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 1123469999999999999999999999999999999999998763211 00000000 000
Q ss_pred ----------cc---------ccCC-CCCCCC--hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ----------KN---------LLDP-LAGDWP--FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ----------~~---------~~d~-~~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ...+ ....|. ...+..+.+||.+||..||.+|||+.+++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 00 0000 000110 12356799999999999999999999844
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.85 Aligned_cols=246 Identities=31% Similarity=0.507 Sum_probs=199.9
Q ss_pred ceeeccCceEEEEEEEC-----CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|... +..|++|++....... ...+.+|+.++..++|+||+++++++. ...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999885 6789999998765433 567889999999999999999999874 468899999999
Q ss_pred CChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 359 GSLEDRLSCKDN------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 359 gsL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|.+++..... ...+++..++.++.+++.||.|||+ ++|+||||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999964421 3679999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
.... .......+++.|+|||.+....++.++|||||||++|+|++ |..||.............. ...
T Consensus 158 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~~~ 225 (262)
T cd00192 158 DDYY------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK------GYR 225 (262)
T ss_pred cccc------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc------CCC
Confidence 4210 11223457889999999998899999999999999999999 6999976644332211111 111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
...+...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l 261 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSE-LVERL 261 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHH-HHHhh
Confidence 2234455789999999999999999999998 54443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.77 Aligned_cols=249 Identities=26% Similarity=0.452 Sum_probs=200.1
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCc---------hhHHHHHHHHhcCCCCceeeEeccc--cCc
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIRHPNLVTLVGAC--PEV 348 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~---------~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~ 348 (641)
+|.+...||.|+||.||+|.+ .+..||+|.+........ ..+.+|+.++++++||||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367778999999999999987 468899998876543322 4578899999999999999999987 456
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 8899999999999999943 3568899999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
............ .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+..........
T Consensus 155 ~~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 226 (267)
T cd06628 155 KLEANSLSTKTN--GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------ 226 (267)
T ss_pred ccccccccCCcc--ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------
Confidence 765322111111 111234588999999999988899999999999999999999999976554433222111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+...+..+.+++.+||+.+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 112233445678899999999999999999998843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=328.66 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=191.2
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--------C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~ 347 (641)
..+|.+.+.||+|+||.||++.+. +..||||++..... .....+.+|+.+++.++||||+++++++. .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468999999999999999999874 68899999875422 22456789999999999999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..|+||||+.+ +|...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 36899999965 5666552 247888999999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc------
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------ 501 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~------ 501 (641)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.........
T Consensus 171 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 171 RTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred cccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 7543221 1123458999999999999999999999999999999999999997554321110000
Q ss_pred ----------cccc-------------------ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 ----------KLKN-------------------LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ----------~~~~-------------------~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.... ...+.........+..+.+||.+||..||.+||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 000000011112356789999999999999999999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=331.59 Aligned_cols=235 Identities=24% Similarity=0.304 Sum_probs=187.5
Q ss_pred ceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
+.||+|+||.||+|... +..||+|++...... ....+..|+.++.++ +||||+.+++++ .+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 578999999864322 234578899999888 699999999987 3568999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 151 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--- 151 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---
Confidence 999988843 3469999999999999999999999 8999999999999999999999999999874322110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH------HHHHHHhhcccccccCCCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK------EVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~------~~~~~~~~~~~~~~~d~~~~ 512 (641)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......... .....
T Consensus 152 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------~~~~~ 220 (327)
T cd05617 152 -----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------LEKPI 220 (327)
T ss_pred -----ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------HhCCC
Confidence 0123458999999999999999999999999999999999999995321 111111110 00112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
..|...+..+.+++.+||..||.+||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23555678899999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=318.71 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=200.8
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|...+.||+|+||.||+|.. .+..||+|.+..........+.+|+.+++.++||||+++++.+ ....++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 34788999999999999999987 4688999998876555567789999999999999999999987 4578999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++. ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999884 2358899999999999999999999 8999999999999999999999999999876543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|++||................. + ....+
T Consensus 172 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~---~-~~~~~ 239 (296)
T cd06654 172 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---P-ELQNP 239 (296)
T ss_pred c--------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC---C-CCCCc
Confidence 1 1223588999999999988899999999999999999999999976554322221111000 0 11123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+|+.+||..+|.+||++.+++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil 268 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHh
Confidence 34567899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.76 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=197.4
Q ss_pred cCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~ 349 (641)
+++|.+.+.||+|+||.||+|.+.+ ..||+|.+...... ....|.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578899999999999999998843 67899987654322 234688999999999999999999987 3468
Q ss_pred EEEEEecCCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC---ccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDN----SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLS 422 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~---~vKL~ 422 (641)
++||||++|++|.+++..... ...+++..++.++.||+.||.|||+ ++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 899999999999999864421 2358999999999999999999999 8999999999999998654 68999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhc
Q 006545 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTG 501 (641)
Q Consensus 423 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~ 501 (641)
|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYR------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred cCccccccCCcccee------cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999998763322110 0112234578999999999999999999999999999997 999997644322111110
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 502 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
. .....++...+..+.+++.+||..+|.+||++.+ |++.|
T Consensus 236 ~------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l 275 (277)
T cd05036 236 G------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI 275 (277)
T ss_pred c------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence 0 0112234556788999999999999999999999 44443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.23 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=206.8
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CC------chhHHHHHHHHhcCCCCceeeEeccc-
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QG------PSEFQQEIDILSKIRHPNLVTLVGAC- 345 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~------~~~~~~Ei~iL~~l~HpnIv~l~g~~- 345 (641)
-.....+|-.+.+||+|||+.||+|.+ ..+.||||+-..... .+ .+...+|..|.+.|+||.||++|++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 334456788999999999999999987 468899998764322 11 23467899999999999999999998
Q ss_pred --cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec---cCCccc
Q 006545 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSK 420 (641)
Q Consensus 346 --~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld---~~~~vK 420 (641)
.+.+|-|+|||+|.+|.-+|. ....+++..+..|+.||+.||.||.... .+|||-||||.||||- .-|.+|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 567999999999999999994 4456899999999999999999999976 4899999999999995 348999
Q ss_pred ccccccccccccccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHH
Q 006545 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 496 (641)
Q Consensus 421 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~ 496 (641)
|+|||+++.+........ ..........||.+|++||.+.-+ .++.++||||+|||+|.++.|+.||+.....+.
T Consensus 614 ITDFGLSKIMdddSy~~v-dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSV-DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred eeecchhhhccCCccCcc-cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 999999999876654322 122334556799999999988543 478899999999999999999999987665555
Q ss_pred HHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 497 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 497 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.+..+.+........+. .+..+.+..++|++||++.-.+|.+..+
T Consensus 693 ILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred HHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 44444333222221222 2345678999999999999999988776
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.66 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=193.3
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|+..+.||+|+||.||++... +..||||++..... .....+..|+.++..++||||+++++.+. +..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888999999999999999884 68899999975321 22456788999999999999999999884 46899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999853 3468999999999999999999999 899999999999999999999999999987553221
Q ss_pred ccCCC---------------------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 006545 435 ISSNN---------------------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487 (641)
Q Consensus 435 ~~~~~---------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~P 487 (641)
..... ..........||+.|+|||++.+..++.++|||||||++|+|+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 10000 000001234699999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 488 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 488 f~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
|...+..............+. .+ .....+..+.+||.+|+ .+|.+|++..
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~--~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~ 285 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLV--FP-PEVPISEKAKDLILRFC-TDSENRIGSN 285 (360)
T ss_pred CCCCCHHHHHHHHHcCCCcee--cC-CCCCCCHHHHHHHHHhc-cChhhcCCCC
Confidence 976654332222111111110 00 01124678999999987 4999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=313.70 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=202.9
Q ss_pred CCCCccceeeccCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~-----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~ 353 (641)
.+|.+.+.||.|+||.||+|.+.. ..||||....... ...+.+.+|+.+++.++||||+++++++. +..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457888999999999999998742 3689998875542 23457899999999999999999999874 4678999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++... ...+++..++.++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999543 2358999999999999999999999 89999999999999999999999999998866443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.... .....++..|+|||.+....++.++|||||||++|+|++ |.+||................. .
T Consensus 161 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------~ 227 (270)
T cd05056 161 SYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------L 227 (270)
T ss_pred ccee-------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------C
Confidence 2111 112235678999999988889999999999999999986 9999976554332222111111 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
..+...+..+.+++.+||..+|.+||++.+ +...|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~-~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTE-LKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHh
Confidence 123455678999999999999999999999 7777777654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=318.52 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=198.1
Q ss_pred CCCCccceeeccCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 352 (641)
++|++.+.||+|+||.||+|.... ..+++|.++.... .....+.+|+.++.++ +||||+++++++. ...++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999998742 3478888764322 2235688999999999 7999999999884 458899
Q ss_pred EEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 353 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999985432 12358899999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 498 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 498 (641)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 159 kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred EECCcCCCcccccee---------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999986432110 0011123567999999998899999999999999999997 999997554332211
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
.. ........+...+..+.+|+.+||..+|.+||++.+ +.+.|+.+...
T Consensus 230 ~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~~~~ 278 (297)
T cd05089 230 KL------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ-ISVQLSRMLEA 278 (297)
T ss_pred HH------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHHh
Confidence 11 001111223446678999999999999999999999 55666666543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=319.08 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=197.1
Q ss_pred CCCCccceeeccCceEEEEEEECC----------------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH----------------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVG 343 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~----------------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g 343 (641)
++|.+.+.||+|+||.||++...+ ..||+|.+...... ....|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999987632 34899998764322 2346889999999999999999999
Q ss_pred cc--cCceEEEEEecCCCChhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceE
Q 006545 344 AC--PEVWTLVYEYLPNGSLEDRLSCKD---------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 412 (641)
Q Consensus 344 ~~--~~~~~lV~Ey~~ggsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NIL 412 (641)
++ .+..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 88 456889999999999999885432 11347889999999999999999999 89999999999999
Q ss_pred eccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 006545 413 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGI 490 (641)
Q Consensus 413 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt--G~~Pf~~ 490 (641)
++.++.+||+|||++......... .......++..|+|||.+.++.++.++|||||||++|+|++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999998765432110 11122345789999999998899999999999999999998 6678865
Q ss_pred cHHHHHHHhhcc-cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 491 TKEVQYALDTGK-LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 491 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
............ ............+...+..+.+|+.+||..+|.+||++.+ +.+.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~-i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK-IHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHh
Confidence 433221111110 0000000111123345678999999999999999999998 555553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=314.10 Aligned_cols=247 Identities=27% Similarity=0.349 Sum_probs=195.6
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
++|.+.+.||+|+||.||+|.. .+..||+|++..........+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4788888999999999999987 4688999998766544455688999999999999999999987 45789999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.. ...+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998843 3468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
......|+..|+|||++. ...++.++|||||||++|+|++|.+||............... . ..+....
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~-~~~~~~~ 232 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-N-FQPPKLK 232 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-C-CCCCccc
Confidence 112345899999999984 456889999999999999999999998644332211111100 0 0010001
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.....+..+.++|.+||..+|.+||++.++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~l 262 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 111345679999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.21 Aligned_cols=284 Identities=24% Similarity=0.417 Sum_probs=214.5
Q ss_pred CCCCccceeeccCceEEEEEEEC--C----eEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEeccc-cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~----~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV 352 (641)
.+|+..+.||+|+||.||+|.+. + ..||+|.+....... ...+.+|+.+++.++||||++++|+| ....+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 46778889999999999999873 3 357999887543322 23688999999999999999999987 3457799
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999998532 3358899999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH--HHHHHhhcccccccCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~ 509 (641)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .......+..
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------ 229 (303)
T cd05110 162 DEKEY------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER------ 229 (303)
T ss_pred ccccc------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------
Confidence 32110 0122345778999999998999999999999999999997 9999965432 2222211110
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCCcCCCccccccCC
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQD 586 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~~~~~~~~~~~~~r~~~p~~~~cPi~~evm~d 586 (641)
...+...+..+.+++..||..+|.+||++.+ +...|..+...... .....+..+...|....-|++++.|.+
T Consensus 230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-l~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (303)
T cd05110 230 --LPQPPICTIDVYMVMVKCWMIDADSRPKFKE-LAAEFSRMARDPQR--YLVIQGDDRMKLPSPNDSKFFQNLLDE 301 (303)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhchhh--heeeccCCcCCCCCCchhhHHhccccc
Confidence 0112334568999999999999999999999 66777776543221 122233344455666666777776654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.95 Aligned_cols=244 Identities=29% Similarity=0.460 Sum_probs=207.3
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCC-CCceeeEecccc--CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~l 351 (641)
...|.+.+.||+|.||.||++..+ |..+|+|++.+..... ...+.+|+.+|+++. |||||.++++|. +..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457899999999999999999884 6889999998876544 358999999999998 999999999995 46799
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc----CCcccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFGIS 427 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~----~~~vKL~DFGla 427 (641)
|||+|.||.|.+.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+.. ++.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999655 39999999999999999999999 89999999999999953 358999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHH--hhccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKN 505 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~--~~~~~~~ 505 (641)
....... .....+||+.|+|||++...+|+..+||||+||++|.|++|.+||.......... ..+.+
T Consensus 187 ~~~~~~~---------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKPGE---------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-- 255 (382)
T ss_pred eEccCCc---------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--
Confidence 9876521 1245679999999999999999999999999999999999999998776544333 22222
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+.|+ ..+..+.++|..|+..||..|+++.+++
T Consensus 256 --~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 256 --DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred --CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 22334444 4588999999999999999999999944
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.19 Aligned_cols=250 Identities=31% Similarity=0.478 Sum_probs=199.9
Q ss_pred CCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPN 358 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~g 358 (641)
.+|.+...||+|+||.||+|.+.+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 358888999999999999998854 579999876543 23457889999999999999999999874 467899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++.... ...+++..+..++.+++.||.|||+ .|++|+||||+||+++.++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~- 159 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA- 159 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc-
Confidence 99999986432 3458899999999999999999999 899999999999999999999999999997664332111
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.....++..|+|||.+.+..++.++|||||||++|+|+| |..||............... . ....+..
T Consensus 160 ------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~---~~~~~~~ 227 (260)
T cd05069 160 ------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG---Y---RMPCPQG 227 (260)
T ss_pred ------cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---C---CCCCCcc
Confidence 112236778999999998899999999999999999999 99999765433221111110 0 1122344
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
.+..+.+++.+||..+|.+||++.+ +.+.|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~ 258 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEY-IQSFLE 258 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHH-HHHHHh
Confidence 5678999999999999999999998 666665
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=336.26 Aligned_cols=240 Identities=30% Similarity=0.478 Sum_probs=200.9
Q ss_pred eeeccCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccccC--ceEEEEEecCCCChhh
Q 006545 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED 363 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ggsL~~ 363 (641)
+||+|.||+||-|++.. ..+|||-+.........-+..|+.+.+.|+|.|||+++|+|.+ .+-|.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999864 5689999887766666778999999999999999999999944 4568999999999999
Q ss_pred hhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec-cCCcccccccccccccccccccCCCc
Q 006545 364 RLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNT 440 (641)
Q Consensus 364 ~L~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld-~~~~vKL~DFGla~~~~~~~~~~~~~ 440 (641)
+|..+ .+|+ .+.++-.+..||++||.|||. +.|||||||-+||||+ -.|.+||+|||.++.+....
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 99643 4556 788999999999999999999 8899999999999995 67999999999998765432
Q ss_pred cccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH-HhhcccccccCCCCCCCChh
Q 006545 441 TLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 441 ~~~~~~~~~Gt~~Y~APE~l~~~--~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~ 517 (641)
.+.....||..|||||++..+ +|++++|||||||++.||.||+|||......+.+ +..|.+. ..++.|..
T Consensus 731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPee 803 (1226)
T KOG4279|consen 731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEE 803 (1226)
T ss_pred --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHH
Confidence 233456699999999999876 5999999999999999999999999644333333 2333222 23567888
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
.+.+...+|.+|+.++|.+||++.+.+.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8999999999999999999999999543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.45 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=192.6
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
..+|++.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.+++.++||||+++++++. +..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 457999999999999999999885 67899999864321 22345789999999999999999999884 468999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||++||+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999842 348889999999999999999999 8999999999999999999999999999986643
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...+.............
T Consensus 195 ~~~~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05621 195 TGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred CCce-------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Confidence 2211 11234699999999999764 378899999999999999999999976654332211110000
Q ss_pred CCCCCCC--hhhHHHHHHHHHHHhhhccC--CCCChHHH
Q 006545 509 PLAGDWP--FVQAEQLANLAMRCCEMSRK--SRPELGKD 543 (641)
Q Consensus 509 ~~~~~~~--~~~~~~l~~Li~~cL~~dP~--~RPs~~ev 543 (641)
...+| ...+..+.+++..||..++. .||++.++
T Consensus 265 --~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~ 301 (370)
T cd05621 265 --SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI 301 (370)
T ss_pred --ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHH
Confidence 01112 23467899999999985554 38888873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.57 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=204.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP-- 346 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~---------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-- 346 (641)
..+|.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888999999999999999752 24699998875422 2345688999999999 8999999999884
Q ss_pred CceEEEEEecCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDN-------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl 413 (641)
...++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ +||+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 467899999999999999864321 2357889999999999999999999 899999999999999
Q ss_pred ccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcH
Q 006545 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 492 (641)
Q Consensus 414 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~ 492 (641)
+.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999998664332111 1122335678999999998889999999999999999998 888886554
Q ss_pred HHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhc
Q 006545 493 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 493 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~ 555 (641)
.......... ......+...+..+.+|+.+||..+|.+||++.+ +++.|+.+....
T Consensus 245 ~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e-~l~~l~~~~~~~ 300 (304)
T cd05101 245 VEELFKLLKE------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQ-LVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHHc------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHH-HHHHHHHHHHhh
Confidence 3322111110 0111223456788999999999999999999999 778888777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.59 Aligned_cols=247 Identities=20% Similarity=0.262 Sum_probs=192.3
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--------C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~ 347 (641)
.++|.+.+.||+|+||.||++.+. +..||||++..... .....+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999874 67899999875432 22356789999999999999999998762 2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 36899999964 6777663 247888999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-----
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 502 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~----- 502 (641)
+...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........-.
T Consensus 174 ~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (364)
T cd07875 174 RTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244 (364)
T ss_pred cccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 7653321 11234589999999999999999999999999999999999999976543221111000
Q ss_pred ---------------------c---------ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ---------------------L---------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ---------------------~---------~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .....+.........+..+.+||.+||..||.+|||+.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0 00000001111122345789999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.98 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=195.8
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
|++.+.||.|+||.||+|.+. +..+++|.+..........+.+|+.+++.++||||+++++++ ....++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999985 577899998765444456788999999999999999999987 4568899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
++|..++.. ...++++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 999988753 23468999999999999999999999 8999999999999999999999999999875533211
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
......|++.|+|||++. +..++.++|||||||++|+|++|.+||...+............. + ...
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~-~~~ 229 (282)
T cd06643 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---P-TLA 229 (282)
T ss_pred -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---C-CCC
Confidence 112345899999999984 34578899999999999999999999976554433222211110 0 111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+...+..+.+||.+||..+|.+||++.+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 2334567899999999999999999998843
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.89 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=196.3
Q ss_pred eeeccCceEEEEEEECC-----eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~-----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~ggs 360 (641)
.||+|+||.||+|.+.. ..||||.+..... .....+.+|+.++++++||||+++++.+. ...++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 68999999999998732 3699999987655 34567899999999999999999999874 46789999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCc
Q 006545 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 440 (641)
Q Consensus 361 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~ 440 (641)
|.+++..... ..+++..++.++.|++.||.|||. ++++|+||+|+||+++.++.+||+|||++..+.......
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999865432 568999999999999999999999 899999999999999999999999999998765432110
Q ss_pred cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 441 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+............ .....+...+
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 227 (257)
T cd05040 155 --VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-----ERLERPEACP 227 (257)
T ss_pred --ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----CcCCCCccCC
Confidence 11123457889999999999999999999999999999998 999996554433222111111 1111233456
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
..+.+++.+||..+|.+||++.+ +.+.|
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~-~~~~l 255 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAA-LREFL 255 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHH-HHHHh
Confidence 78999999999999999999999 44443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.24 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=199.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|++.+.||.|+||.||++.+. +..||+|.++... ......+.+|+.+++.++||||+++++.+ .+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999874 6889999986432 23346788999999999999999999988 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++... ....+++..+..++.+++.||.|||+ +||+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988533 23458899999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
.....|++.|+|||++.+..++.++||||||+++|+|++|.+||...+.......... ... ...+.
T Consensus 157 --------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~~----~~~~~ 222 (255)
T cd08219 157 --------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GSY----KPLPS 222 (255)
T ss_pred --------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CCC----CCCCc
Confidence 1234588999999999988999999999999999999999999976554332221110 111 11233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
..+..+.+|+.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 45678999999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.43 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=202.5
Q ss_pred hhcCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCCC-chhHHHHHHHHhcCC-CCceeeEecccc--
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIR-HPNLVTLVGACP-- 346 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~-HpnIv~l~g~~~-- 346 (641)
....+|.+.++||+|+||.||+|.+.+ ..||||+++...... ...+.+|+.+|.++. ||||++++|+|.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 344578888999999999999998643 579999997643222 346889999999997 999999999984
Q ss_pred CceEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKD--------------------------------------------------------- 369 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~--------------------------------------------------------- 369 (641)
+..++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 46899999999999999985431
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCce
Q 006545 370 --------------------------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411 (641)
Q Consensus 370 --------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NI 411 (641)
....+++..+..|+.|++.||.|||+ .+|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 11247788899999999999999999 8999999999999
Q ss_pred EeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 006545 412 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 490 (641)
Q Consensus 412 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~ 490 (641)
|++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYI------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccc------cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999998654322110 0122346789999999998889999999999999999998 8999965
Q ss_pred cHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 491 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
..........- .. ......|...+..+.+|+.+||..+|.+||++.+ |+..|+.+
T Consensus 345 ~~~~~~~~~~~--~~---~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e-ll~~L~~~ 399 (401)
T cd05107 345 LPMNEQFYNAI--KR---GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ-LVHLVGDL 399 (401)
T ss_pred CCchHHHHHHH--Hc---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHHH
Confidence 43222111110 00 0011224456788999999999999999999999 76777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.33 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=196.4
Q ss_pred CCCCccceeeccCceEEEEEEEC--Ce--EEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~--~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 352 (641)
++|++.+.||+|+||.||+|.+. +. .+|+|.+..... .....+.+|+.++.++ +||||+++++++. +..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999874 33 467777664322 2234688999999999 8999999999883 468999
Q ss_pred EEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 353 YEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 12368999999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 498 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~ 498 (641)
||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...+......
T Consensus 164 kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred EeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 999999986322110 0111224678999999988889999999999999999998 999996544332211
Q ss_pred hhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 499 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
.. ........+...+..+.+|+.+||..+|.+||++.+ ++..|..+..
T Consensus 235 ~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-il~~l~~~~~ 282 (303)
T cd05088 235 KL------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLE 282 (303)
T ss_pred HH------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHH
Confidence 11 011111223345678999999999999999999999 5555555543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=329.25 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=192.4
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccccC-------ceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 350 (641)
+|++.+.||+|+||.||+|.+ .+..||||++..... .....+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999987 478999999865322 223568899999999999999999998732 578
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||+. ++|.+.+. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57877773 34568999999999999999999999 89999999999999999999999999999865
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------ 503 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~------ 503 (641)
...... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+...........
T Consensus 154 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 154 EPDESK-------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccCccc-------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 432211 11234578999999999874 5789999999999999999999999765433221110000
Q ss_pred ---------------ccccCC-C---CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ---------------KNLLDP-L---AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ---------------~~~~d~-~---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+ . ........+..+.+||.+||..||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 000000 0 0011223467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.79 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=201.9
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|++.+.||.|+||.||+|.. .+..||||.+..........+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34689999999999999999986 4788999998765555566788999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|..++. ...+++..+..++.+++.||.|||+ .|++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999884 2358999999999999999999999 8999999999999999999999999999876543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|.+||...+............ ......+
T Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 238 (296)
T cd06655 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPELQNP 238 (296)
T ss_pred c--------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----CcccCCc
Confidence 1 122358899999999998889999999999999999999999997765443322111100 0011123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.++|.+||..+|.+||++.+++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 44567899999999999999999999855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.72 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=192.6
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
.+|.+.+.||+|+||.||+|.+. +..||+|.+...... ....+.+|+.++++++||||+++++++ .+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46889999999999999999874 678999998754332 234678999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++ +|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 788877432 3458889999999999999999999 8999999999999999999999999999875433211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---------ccc
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN 505 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~---------~~~ 505 (641)
. .....+++.|+|||.+.+ ..++.++|||||||++|+|+||++||...+.......... +..
T Consensus 160 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 160 T--------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred c--------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 1 122357899999999865 4688999999999999999999999975543221111000 000
Q ss_pred c--------cC-CC-C----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 L--------LD-PL-A----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~--------~d-~~-~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+ .+ +. . .......+..+.+|+.+||..||.+||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 0 00 00 0 001123466789999999999999999999844
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.93 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=189.1
Q ss_pred hHhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCC------CceeeEecccc
Q 006545 275 EIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH------PNLVTLVGACP 346 (641)
Q Consensus 275 ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~g~~~ 346 (641)
++...+++|.+.++||+|+||+||+|.+. +..||||+++... .....+..|+.++..++| +++++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34456788999999999999999999874 6789999986432 223456678888877754 45888888773
Q ss_pred ---CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC------
Q 006545 347 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------ 417 (641)
Q Consensus 347 ---~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~------ 417 (641)
...++||+++ |++|.+++.. ...+++..+..|+.||+.||.|||+. .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence 3578999988 7788888853 34699999999999999999999971 3899999999999998665
Q ss_pred ----------cccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 006545 418 ----------VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487 (641)
Q Consensus 418 ----------~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~P 487 (641)
.+||+|||++...... .....||+.|+|||++.+..|+.++|||||||++|||++|++|
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~~-----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERHS-----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccCCCCceEEECCCCccccCccc-----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4999999987543211 1334689999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHhhcc----cc-------------cccCC---CCCC---------------CChhhHHHHHHHHHHHhhh
Q 006545 488 LGITKEVQYALDTGK----LK-------------NLLDP---LAGD---------------WPFVQAEQLANLAMRCCEM 532 (641)
Q Consensus 488 f~~~~~~~~~~~~~~----~~-------------~~~d~---~~~~---------------~~~~~~~~l~~Li~~cL~~ 532 (641)
|...+.......... +. .++.. .... ........+.+||.+||.+
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 976554322111100 00 00000 0000 0001235678999999999
Q ss_pred ccCCCCChHHHH
Q 006545 533 SRKSRPELGKDV 544 (641)
Q Consensus 533 dP~~RPs~~evv 544 (641)
||.+||++.+++
T Consensus 425 dP~~R~ta~e~L 436 (467)
T PTZ00284 425 DRQKRLNARQMT 436 (467)
T ss_pred ChhhCCCHHHHh
Confidence 999999999944
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.67 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=206.6
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
.+-|++.+.||+|.|+.|-+|.+ +|..||||++.+..... ...+.+|+..|+-++|||||+||.+.+ ..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34688899999999999998865 79999999998875544 457889999999999999999999984 5799999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec-cCCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld-~~~~vKL~DFGla~~~~~ 432 (641)
|+-.+|+|.+++.+.. ..+.+....+++.||+.|+.|+|+ ..+|||||||+||.+. +-|-|||.|||++..+..
T Consensus 97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999997554 358999999999999999999999 6699999999999875 568999999999987765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
... .+..+|+..|.|||++.+..|+ +++||||||||||.|++|++||...++.........-.
T Consensus 172 G~k---------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK------- 235 (864)
T KOG4717|consen 172 GKK---------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK------- 235 (864)
T ss_pred cch---------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-------
Confidence 531 2344699999999999999998 78999999999999999999997665544332221111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
-..|...+.+..+||..||..||.+|.+..+++
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 234788999999999999999999999998854
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=326.86 Aligned_cols=248 Identities=20% Similarity=0.266 Sum_probs=192.4
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc--------
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-------- 346 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-------- 346 (641)
..++|.+.+.||+|+||.||++.+. +..||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999874 688999998754322 2356778999999999999999999872
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 236899999965 6666663 247889999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh----c-
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT----G- 501 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~----~- 501 (641)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........ +
T Consensus 166 ~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 166 ARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred cccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 97653321 112345899999999999999999999999999999999999999765432211100 0
Q ss_pred -----------cccccc-------------------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 -----------KLKNLL-------------------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 -----------~~~~~~-------------------d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...... -+.....+...+..+.+||.+||..||.+|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 000000 0001111223456789999999999999999999944
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.09 Aligned_cols=249 Identities=29% Similarity=0.359 Sum_probs=201.4
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.+|.+.+.||.|+||.||+|... +..+++|++..........+.+|+.+++.++||||+++++++ .+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 47888999999999999999874 578999999876555567899999999999999999999987 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++... ...+++..+..++.|++.||.|||+ ++|+|+||+|+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999988532 2568999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
......++..|+|||.+.+. .++.++|||||||++|+|+||.+||...+........... .+.+....
T Consensus 157 -------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~ 227 (262)
T cd06613 157 -------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS--NFPPPKLK 227 (262)
T ss_pred -------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCcccc
Confidence 11233578899999999876 7899999999999999999999999765433322221111 01111111
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+...+..+.+++.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 2334567899999999999999999998844
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=304.11 Aligned_cols=267 Identities=23% Similarity=0.280 Sum_probs=206.8
Q ss_pred hhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc-------cCc
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEV 348 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-------~~~ 348 (641)
...++|.+.+.||.|||+-||++.. ++..+|+|++......+.+...+|++..++++||||++++++. ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3456899999999999999999874 5788999999988877788899999999999999999999886 224
Q ss_pred eEEEEEecCCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDN-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
.||+++|...|+|.+.+..... +..+++.+++.|+.++++||.+||...+ +++||||||.|||++..+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999976543 3479999999999999999999999553 6999999999999999999999999998
Q ss_pred cccccccccCC-CccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc
Q 006545 428 RFLSQNEISSN-NTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 428 ~~~~~~~~~~~-~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~ 503 (641)
....-...... ............|..|.|||.+. +...+.++|||||||+||.|+.|..||+..-. .-+.+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSl 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSL 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeE
Confidence 76543321111 01111122334699999999996 34678999999999999999999999952211 01111
Q ss_pred ccccCCCCCCC--ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 504 KNLLDPLAGDW--PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 504 ~~~~d~~~~~~--~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.-.+....-.+ ...+++.+.+||..||+.||.+||++.+ ++..++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~-ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE-LLSKLDDL 300 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH-HHHHHHhh
Confidence 11111100011 1237889999999999999999999999 55555443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.73 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=197.9
Q ss_pred CCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc-cCceEEEEEecCCC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLVYEYLPNG 359 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV~Ey~~gg 359 (641)
.+|.+.+.||+|+||.||+|...+..||+|.+.... ....+.+|+.+++.++||||+++++++ .+..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 357888999999999999999999999999986532 345789999999999999999999987 45688999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.... ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999986432 3458899999999999999999999 899999999999999999999999999987543211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
.....+..|+|||.+.+..++.++|||||||++|+|++ |++||................ ....+...
T Consensus 155 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~ 222 (254)
T cd05083 155 ------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY------RMEPPEGC 222 (254)
T ss_pred ------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC------CCCCCCcC
Confidence 11224578999999998899999999999999999997 999997654332211111100 11123345
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+..+.+++.+||..+|.+||++.+ +...|
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~-l~~~l 251 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHK-LREKL 251 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHH-HHHHH
Confidence 678999999999999999999998 54444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.26 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=198.8
Q ss_pred CCCCccceeeccCceEEEEEEE-------CCeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEecccc---Cc
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL-------RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP---EV 348 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~-------~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~---~~ 348 (641)
.+|.+.+.||+|+||.||+|.+ .++.||||+++..... ....+.+|+.+|.++ +||||++++++|. ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4789999999999999999974 2478999999754322 234688999999999 6899999999873 35
Q ss_pred eEEEEEecCCCChhhhhhcCCC----------------------------------------------------------
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDN---------------------------------------------------------- 370 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 370 (641)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998854210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccc
Q 006545 371 ------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 444 (641)
Q Consensus 371 ------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~ 444 (641)
...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------~~ 237 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VR 237 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------hh
Confidence 1247888899999999999999999 89999999999999999999999999999865332111 01
Q ss_pred cCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH---HHHHHhhcccccccCCCCCCCChhhHH
Q 006545 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAE 520 (641)
Q Consensus 445 ~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~~~~~ 520 (641)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |..||..... .......+. ....+...+.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 309 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTP 309 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC--------CCCCCCCCCH
Confidence 122335678999999998899999999999999999997 9999965322 111111111 1112233456
Q ss_pred HHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 521 QLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 521 ~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
.+.+++.+||..+|.+||++.+ |++.|+.+..
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~e-il~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHH-HHHHHHHHHh
Confidence 8999999999999999999999 6667776653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.11 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=200.0
Q ss_pred cCCCCccceeeccCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~---~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
.++|+..+.||+|+||.||+|... + ..+|+|.+..... .....+..|+.+++.++||||+++++++. +..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 347888899999999999999874 2 3699998875432 22456889999999999999999999884 46889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++++|.+++... ...+++..+..++.+++.||.|||+ .|++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998532 3568999999999999999999999 899999999999999999999999999987664
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
....... .......+..|+|||++.+..++.++|||||||++|+|++ |+.||...+........... .
T Consensus 159 ~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~------~ 227 (268)
T cd05063 159 DDPEGTY-----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG------F 227 (268)
T ss_pred cccccce-----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC------C
Confidence 3321110 0111223567999999998889999999999999999997 99999654432222111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
....+...+..+.+++.+||..+|.+||++.+ +...|+.+
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVD-IVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHhh
Confidence 11223345678999999999999999999999 66666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.97 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=191.1
Q ss_pred eeeccCceEEEEEEEC-----CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc---cCceEEEEEecCC
Q 006545 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPN 358 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~---~~~~~lV~Ey~~g 358 (641)
.||+|+||.||+|.+. +..||||.+..... .....+.+|+.+++.++||||+++++++ ....++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 25699998754322 2245788999999999999999999976 3357899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++... ...+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999998533 2346778889999999999999999 8999999999999999999999999999976543221110
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+.......... ......+..
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 226 (262)
T cd05058 157 ----HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ------GRRLLQPEY 226 (262)
T ss_pred ----cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc------CCCCCCCCc
Confidence 00122346778999999988899999999999999999999 5677765443322211110 011112333
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
.+..+.+++.+||..+|.+||++.+ ++..|+.+.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~-il~~l~~~~ 260 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSE-LVSRIEQIF 260 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHh
Confidence 4678999999999999999999999 666666553
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.26 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=203.2
Q ss_pred CChhhHhhhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccc--
Q 006545 271 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC-- 345 (641)
Q Consensus 271 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~-- 345 (641)
+.++.+.....+|++.+.||+|+||.||+|.. .+..+|+|++.... .....+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34566677888999999999999999999988 46789999876532 2235688999999999 699999999976
Q ss_pred -----cCceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 346 -----PEVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 346 -----~~~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
.+..++||||++|++|.+++... .....+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 23579999999999999987532 234568899999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEV 494 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~ 494 (641)
||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 164 kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred EEccCCceeecccCCC--------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 9999999876543211 1123358999999999853 45788999999999999999999999765543
Q ss_pred HHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 495 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 495 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......... .+ ....+...+..+.+|+.+||..+|.+||++.+++
T Consensus 236 ~~~~~~~~~~---~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 236 RALFKIPRNP---PP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred HHHhhccccC---CC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 3322211110 00 1112333456899999999999999999999854
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.15 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=200.6
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
++|+..+.||.|+||.||+|... +..|++|.+..... ...+.+|+.+++.++||||+++++.+ ....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888999999999999999985 58899999875432 56899999999999999999999987 44688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998532 3568999999999999999999999 8999999999999999999999999999887654321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......|+..|+|||++.+..++.++|||||||++|+|++|++||................ ......+.
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 223 (256)
T cd06612 155 -------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP----PPTLSDPE 223 (256)
T ss_pred -------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC----CCCCCchh
Confidence 1122347889999999999899999999999999999999999997654433322211100 00111233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 4567899999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=316.71 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=200.0
Q ss_pred hcCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEeccc--cC
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGAC--PE 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~ 347 (641)
..++|.+.+.||+|+||.||+|... +..||||++...... ....+.+|+.+++++ +||||+++++++ .+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457889999999999999999752 357999998754322 234688999999999 799999999988 34
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence 6899999999999999985432 2348999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
......... .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||............- ..
T Consensus 189 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~--~~- 259 (302)
T cd05055 189 RDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI--KE- 259 (302)
T ss_pred ccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH--Hc-
Confidence 865433211 01122346788999999999999999999999999999998 999996543222111100 00
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
......+...+..+.+++.+||..+|.+||++.+ ++..|+.
T Consensus 260 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-ll~~l~~ 300 (302)
T cd05055 260 --GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ-IVQLIGK 300 (302)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH-HHHHHHh
Confidence 0011123344678999999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.06 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=198.2
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
++.++.++.....||+|+||.||+|.+. +..||+|.+..........+.+|+.+++.++|+||+++++++ .+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999874 567999998766544556789999999999999999999987 456889
Q ss_pred EEEecCCCChhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPL--SWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 428 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~ 428 (641)
||||+++++|.+++.... .++ ++..+..++.|++.||.|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999986432 234 788899999999999999999 89999999999999976 6799999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccc
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
........ .....|++.|+|||++.+.. ++.++||||||+++|+|++|.+||..............
T Consensus 158 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~---- 225 (268)
T cd06624 158 RLAGINPC--------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG---- 225 (268)
T ss_pred ecccCCCc--------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----
Confidence 65432111 11234789999999987643 78999999999999999999999964332111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......++...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 00112234555678899999999999999999999844
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.67 Aligned_cols=250 Identities=24% Similarity=0.263 Sum_probs=191.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||++... +..||||++..... .....+.+|+.++..++||||+++++++ .+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999874 67899999875321 2234588999999999999999999988 44689999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998532 3458999999999999999999999 89999999999999999999999999998765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
.... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..............+.
T Consensus 156 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GTVQ-------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCcc-------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc
Confidence 2110 122358999999999963 4578899999999999999999999976544332211111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccC--CCCChHHHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRK--SRPELGKDV 544 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~--~RPs~~evv 544 (641)
........+..+.+++.+||..++. .||++.+++
T Consensus 229 --~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l 264 (331)
T cd05597 229 --FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFK 264 (331)
T ss_pred --CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 0111123567899999998865333 377877733
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.13 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=200.8
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|.+.+.||.|+||.||+|.. .+..||+|.+..........+.+|+.+++.++||||++++++| .+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35789999999999999999987 4788999999766555556788999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++.. ..+++..+..++.+++.||.|||+ .||+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998842 357889999999999999999999 8999999999999999999999999999876543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|.+||...+........... .......+
T Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~ 238 (297)
T cd06656 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNP 238 (297)
T ss_pred C--------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----CCCCCCCc
Confidence 1 12235889999999999988999999999999999999999999765433221111100 00011223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+|+.+||..+|.+||++.+++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 44567789999999999999999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.96 Aligned_cols=248 Identities=24% Similarity=0.262 Sum_probs=191.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
+|.+.++||+|+||.||++.+. +..||+|++.... ......+..|+.++..++|+||+++++++ .+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6888999999999999999885 5779999986422 11233578899999999999999999988 446899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999532 3458999999999999999999999 899999999999999999999999999987553322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..............+
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-- 227 (332)
T cd05623 157 TV-------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-- 227 (332)
T ss_pred cc-------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc--
Confidence 11 112345899999999986 3468899999999999999999999997655433222111100000
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCC--CCChHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGKD 543 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~ev 543 (641)
.........+..+.+|+.+|+..++.. ||++.++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH
Confidence 011112345778999999998654443 6777773
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.30 Aligned_cols=258 Identities=23% Similarity=0.390 Sum_probs=202.2
Q ss_pred CCCCccceeeccCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--C
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 347 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~---------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~ 347 (641)
.+|.+.+.||+|+||.||+|... ...||+|.+..... .....+..|+.+++.+ +||||++++++|. .
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888999999999999999752 34699999875432 2235688999999999 6999999999884 4
Q ss_pred ceEEEEEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld 414 (641)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 5889999999999999986432 12458999999999999999999999 8999999999999999
Q ss_pred cCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH
Q 006545 415 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 493 (641)
Q Consensus 415 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~ 493 (641)
.++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKK------TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred CCCcEEEccccccccccccccccc------cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999986643221110 111224568999999998899999999999999999999 8999976543
Q ss_pred HHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
......... ......+...+..+.+|+.+||..+|.+||++.+ ++..|..+...
T Consensus 243 ~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLRE------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ-LVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHc------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHHHH
Confidence 221111110 0111224455678999999999999999999999 77888877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.83 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=199.2
Q ss_pred CCCCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
.+|.+.+.||+|+||.||+|.+. +..+|+|.+...... ....+.+|+.+++.++||||+++++++ .+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999873 246999988754322 235688999999999999999999987 4568899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++++|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998643 2458999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
..... .......++..|+|||.+.+..++.++|||||||++|++++ |..||................ .
T Consensus 159 ~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------~ 227 (267)
T cd05066 159 DPEAA-----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------R 227 (267)
T ss_pred cccee-----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC------c
Confidence 32111 00112234678999999998899999999999999999886 999996544322211111110 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
...+...+..+.+++.+||+.+|.+||++.+ +.+.|+.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~ 265 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQ-IVSILDK 265 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHHH-HHHHHHh
Confidence 1123345678999999999999999999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=330.22 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=193.5
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEecccc--Cc
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACP--EV 348 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~ 348 (641)
+.....+|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.+++.++||||+++++++. +.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3444578999999999999999999885 67899999864321 22345788999999999999999999884 46
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.++||||++||+|.+++.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 8899999999999999842 347888999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+............
T Consensus 191 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 191 KMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred EcCcCCcc-------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 66432211 11234699999999999754 37899999999999999999999998765433222111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCC---CCChHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS---RPELGK 542 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~---RPs~~e 542 (641)
..+. ...+...+..+.+||..||. +|.. ||++.+
T Consensus 264 ~~~~---~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~e 300 (371)
T cd05622 264 NSLT---FPDDNDISKEAKNLICAFLT-DREVRLGRNGVEE 300 (371)
T ss_pred Cccc---CCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHH
Confidence 1110 01122467789999999998 4444 677776
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.13 Aligned_cols=251 Identities=24% Similarity=0.438 Sum_probs=199.2
Q ss_pred CCCccceeeccCceEEEEEEE-CCeEEEEEEecCCCCCC------chhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG------PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~~------~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
+|...+.||.|+||.||+|.. .+..+|||.+....... ...+.+|+.+++.++|+||++++++|. +..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999999999987 56789999887543211 245889999999999999999999984 468899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++++|.+++.. ..++++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999853 2458899999999999999999999 8999999999999999999999999999886543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...+.............. ..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~ 228 (265)
T cd06631 155 VGLHGTHS--NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----MP 228 (265)
T ss_pred cccccccc--ccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----CC
Confidence 21111100 1112345899999999999888999999999999999999999999765544332222111111 12
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+...+..+.++|.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 23445678899999999999999999999843
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.37 Aligned_cols=252 Identities=27% Similarity=0.484 Sum_probs=198.2
Q ss_pred cCCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--Cce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 349 (641)
.++|++...||+|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++++. +..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457889999999999999999863 467999998754321 2356889999999999999999999884 468
Q ss_pred EEEEEecCCCChhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCc
Q 006545 350 TLVYEYLPNGSLEDRLSCKD-------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPAN 410 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~N 410 (641)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||. ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999985321 12357889999999999999999999 899999999999
Q ss_pred eEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 006545 411 ILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALG 489 (641)
Q Consensus 411 ILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~ 489 (641)
||++.++.++|+|||++........... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA------SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccc------cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999876543221100 112234678999999998899999999999999999997 888885
Q ss_pred CcHHHHH--HHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 490 ITKEVQY--ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 490 ~~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
....... .+..+.. ...+...+..+.+|+.+||..+|.+||++.+ +...|+
T Consensus 235 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e-l~~~l~ 287 (288)
T cd05050 235 GMAHEEVIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFAS-INRILQ 287 (288)
T ss_pred CCCHHHHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHH-HHHHhh
Confidence 4433221 1111111 1123345678999999999999999999999 655554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=327.39 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=207.5
Q ss_pred CccceeeccCceEEEEEEECC------eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccccC-ceEEEEEe
Q 006545 284 DPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE-VWTLVYEY 355 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~~------~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~lV~Ey 355 (641)
...++||.|.||.||+|++.. -.||||.-+.+.. .+.+.|..|..+|+.++|||||+++|+|.+ ..+||||.
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL 471 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL 471 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence 345679999999999999853 3489998877543 346789999999999999999999999954 67899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++.|.|..+|... ...++......++.||+.||.|||+ ..+|||||-..|||+.....|||+|||+++.+.....
T Consensus 472 ~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 472 APLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999643 4458888999999999999999999 8999999999999999999999999999998877643
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
... +...-..-|||||-++...++.++|||.|||++||++. |..||.+....+. +..+-.......
T Consensus 547 Yka-------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~iEnGeRlP~ 613 (974)
T KOG4257|consen 547 YKA-------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGHIENGERLPC 613 (974)
T ss_pred hhc-------cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEEecCCCCCCC
Confidence 322 22234678999999999999999999999999999986 9999976543221 111112234456
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
|..+++.|..|+.+||+++|.+||.+.+ +...|..+..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrfte-i~~~lsdv~q 651 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTE-IKAILSDVLQ 651 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHH-HHHHHHHHHH
Confidence 8889999999999999999999999998 6666665554
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.98 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=197.9
Q ss_pred hhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc----Cc
Q 006545 277 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EV 348 (641)
Q Consensus 277 ~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~ 348 (641)
.....+|.+.+.||.|+||+||+|.+. +..||+|++...... ....|..|+.+|+.|+|||||+++++|. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 334568999999999999999999885 578999998764332 2356889999999999999999999872 35
Q ss_pred eEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CceeeccCCCCceEecc--------
Q 006545 349 WTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKP----HSIVHGDLKPANILLDA-------- 415 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~gIiHrDIkp~NILld~-------- 415 (641)
+||||||+++|+|.++|... .....+++..++.|+.||+.||.|||...+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 88999999999999998643 223569999999999999999999998431 45999999999999964
Q ss_pred ---------CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhC
Q 006545 416 ---------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTG 484 (641)
Q Consensus 416 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG 484 (641)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|+||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 24589999999986543211 123458999999999864 4588999999999999999999
Q ss_pred CCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 485 RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 485 ~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+||.........+....... .. .....+..+.+||..||..+|.+||++.+++
T Consensus 240 k~PF~~~~~~~qli~~lk~~p--~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGP--DL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCC--CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 999976544333222211100 00 0123467899999999999999999999955
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.09 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=201.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEec
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 356 (641)
..+|.+.+.||+|+||.||+|.+. +..||||.+.... .....+.+|+.++++++||||+++++++. ...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457889999999999999999875 4679999987543 34567999999999999999999999874 4689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.... ...+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999986432 2468999999999999999999999 89999999999999999999999999998866432111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
......++..|+|||.+.+..++.++|||||||++|+|++ |+.||............... .....+
T Consensus 160 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------~~~~~~ 226 (261)
T cd05034 160 -------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG------YRMPRP 226 (261)
T ss_pred -------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------CCCCCC
Confidence 1112234678999999998899999999999999999998 99999765433222111110 011123
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
...+..+.+++.+||..+|.+||++.+ +...|+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~-l~~~l~ 259 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEY-LQSFLE 259 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHH-HHHHHh
Confidence 334678999999999999999999998 666665
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.46 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=197.9
Q ss_pred CCCccceeeccCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~---~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
.|.+.+.||+|+||.||+|.+. + ..||||++..... .....|..|+.+++.++||||+++++++. ...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 5778899999999999999874 2 3699999875422 22457899999999999999999999873 4578999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++... ...+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999998543 3458999999999999999999999 89999999999999999999999999998766443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
...... ........+..|+|||.+.+..++.++|||||||++|||++ |.+||...+............ ..
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------~~ 230 (269)
T cd05065 160 TSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------RL 230 (269)
T ss_pred cccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------cC
Confidence 211110 00111123467999999999999999999999999999886 999997554332221111110 11
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
..+...+..+.+++.+||..+|.+||++.+ +...|+.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~ 267 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQ-IVSTLDK 267 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHh
Confidence 123345678999999999999999999998 6566654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.85 Aligned_cols=246 Identities=35% Similarity=0.519 Sum_probs=193.8
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCch--hHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~--~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
|++.+.||+|+||+||++... +..||+|++......... ...+|+.++++++||||+++++++ ....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999995 467999999876433222 234699999999999999999988 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++. ....+++..+..++.|++.||.+||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc--
Confidence 9999999995 34568999999999999999999999 899999999999999999999999999987641111
Q ss_pred CCCccccccCCCCCCcccCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH--HHHHHhhcccccccCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 513 (641)
.......++..|+|||++. +..++.++||||||+++|+|++|..||..... ................ ..
T Consensus 153 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 224 (260)
T PF00069_consen 153 ------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS--SQ 224 (260)
T ss_dssp ------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--TT
T ss_pred ------cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--cc
Confidence 1123445899999999998 78899999999999999999999999987621 1111111110000000 00
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
........+.+++.+||+.||.+||++.+++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1111247899999999999999999999843
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.73 Aligned_cols=194 Identities=26% Similarity=0.408 Sum_probs=157.5
Q ss_pred cceeeccCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc----cCceEEEEEecC
Q 006545 286 SLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVYEYLP 357 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV~Ey~~ 357 (641)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|++++||||+++++++ ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999863 4679999987543 234578999999999999999999987 235789999985
Q ss_pred CCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe----ccCCcccccccccc
Q 006545 358 NGSLEDRLSCKD------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGIS 427 (641)
Q Consensus 358 ggsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl----d~~~~vKL~DFGla 427 (641)
++|.+++.... ....+++..+..++.|++.||.|||+ +||+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877764221 22358999999999999999999999 899999999999999 45689999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 490 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~ 490 (641)
+.+...... ........||+.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 160 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCcc-----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876433211 1112334689999999999774 589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.65 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=196.5
Q ss_pred CCCCccceeeccCceEEEEEEEC------------------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR------------------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTL 341 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~------------------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l 341 (641)
++|++.+.||+|+||.||++.+. +..||+|++...... ....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998542 235899998754322 23578899999999999999999
Q ss_pred eccc--cCceEEEEEecCCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCce
Q 006545 342 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDN--------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANI 411 (641)
Q Consensus 342 ~g~~--~~~~~lV~Ey~~ggsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NI 411 (641)
++++ .+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+ .||+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9987 4568999999999999999864321 1347788999999999999999999 8999999999999
Q ss_pred EeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 006545 412 LLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALG 489 (641)
Q Consensus 412 Lld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt--G~~Pf~ 489 (641)
|++.++.++|+|||++..+...... .......+++.|+|||...++.++.++|||||||++|+|++ |..||.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999998865432211 01122235678999999988899999999999999999998 778886
Q ss_pred CcHHHHHHHhhccc-ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 490 ITKEVQYALDTGKL-KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 490 ~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
...........+.. ...........+...+..+.+|+.+||..||.+||++.+ |.+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l 294 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE-IHATL 294 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHH
Confidence 54332221111110 000000011123345678999999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.93 Aligned_cols=242 Identities=28% Similarity=0.435 Sum_probs=191.9
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCChhh
Q 006545 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLED 363 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~~ 363 (641)
+||+|+||.||+|... +..||+|++....... ...+.+|+.+++.++||||+++++++. +..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999874 5789999987543221 236889999999999999999999883 46889999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcccc
Q 006545 364 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443 (641)
Q Consensus 364 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 443 (641)
++... ...+++..+..++.+++.||.|||+ +|++||||+|+||+++.++.+||+|||++..........
T Consensus 82 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------ 150 (250)
T cd05085 82 FLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------ 150 (250)
T ss_pred HHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc------
Confidence 88533 3458899999999999999999999 899999999999999999999999999987543321110
Q ss_pred ccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHH
Q 006545 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQL 522 (641)
Q Consensus 444 ~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 522 (641)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||............... .....+...+..+
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 223 (250)
T cd05085 151 -SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------YRMSCPQKCPDDV 223 (250)
T ss_pred -CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCCHHH
Confidence 111234678999999998899999999999999999998 99999765433322111111 1112234457889
Q ss_pred HHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 523 ANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 523 ~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.+++.+||..+|.+||++.+ +.+.|
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~-l~~~l 248 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSE-LQKEL 248 (250)
T ss_pred HHHHHHHcccCcccCCCHHH-HHHHh
Confidence 99999999999999999999 44443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=306.10 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=199.1
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
..|++...||+|.|+.||+... +|+.+|+|+++... ..+.+.+.+|+.|-+.|+||||+++.+... ...|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3677788899999999999876 47889999887543 235678999999999999999999999874 45789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec---cCCcccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 431 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld---~~~~vKL~DFGla~~~~ 431 (641)
++.|++|..-+-.. ..+++..+-.++.||+.+|.|+|. ++|||||+||.|+|+. ..--+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999997666322 457888899999999999999999 9999999999999994 44578999999999877
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
... .....+|||.|||||++...+|+..+|||+.|||||-||.|++||.+.+.....-.. ....++...
T Consensus 165 ~g~---------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I--~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI--KAGAYDYPS 233 (355)
T ss_pred Ccc---------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH--hccccCCCC
Confidence 321 124567999999999999999999999999999999999999999774332221111 122223223
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.|+ ..+++..+|+++||..||.+|.|+.+++
T Consensus 234 ~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 234 PEWD-TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cccC-cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 3443 5678899999999999999999998855
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.00 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=191.8
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
|+..+.||+|+||.||++.+. ++.||||.+....... ...+.+|+.+++.++|+||+.+++.+ .+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999885 6789999987543322 23577899999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++||+|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999885432 2458999999999999999999999 8999999999999999999999999999876533211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
.....|+..|+|||++.+..++.++|||||||++|+|++|++||........... ...........++
T Consensus 158 ---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~ 225 (285)
T cd05630 158 ---------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVQEEYS 225 (285)
T ss_pred ---------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhhhhhcC
Confidence 1223589999999999999999999999999999999999999975321100000 0000011111233
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
...+..+.+|+.+||..||.+||++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCC
Confidence 4456789999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.06 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=196.7
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+.|++.++||.|+||.||+|... +..|++|++..........+.+|+.+++.++||||+++++.+ ....++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999884 688999998765544456788999999999999999999987 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|..++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998877432 3458999999999999999999999 8999999999999999999999999998865432211
Q ss_pred CCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
......+++.|+|||++. ...++.++|||||||++|+|++|.+||...+............ .+ .
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~ 234 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PP-T 234 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC---Cc-c
Confidence 112334788999999985 3457889999999999999999999997654433222211110 00 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+++.+||..+|.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 112334567899999999999999999998843
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.82 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=190.2
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|++.++||+|+||.||+|.+ .+..||+|++...... ....+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577888999999999999987 4688999998754322 234688999999999999999999987 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|..+. .+++..+..++.|++.||.|||+ .||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 37788999999999999999999 899999999999999999999999999987654321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHH-hhcccccccCCCCCCC-
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLLDPLAGDW- 514 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~d~~~~~~- 514 (641)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .........+......
T Consensus 150 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (279)
T cd06619 150 --------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221 (279)
T ss_pred --------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCC
Confidence 123458999999999999899999999999999999999999995422110000 0000000001111111
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+..+.+++.+||..+|.+||++.+++
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil 251 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 123456899999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.20 Aligned_cols=231 Identities=26% Similarity=0.394 Sum_probs=182.5
Q ss_pred eeeccCceEEEEEEEC--------------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 288 KIGEGGYGSIYKGLLR--------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~--------------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
.||+|+||.||+|... ...|++|++..........+..|+.++..++||||+++++++. ...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999999752 2358999887654444457888999999999999999999873 46889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc-------cccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV-------SKLSDF 424 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~-------vKL~DF 424 (641)
||||+++|+|..++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999998887532 3468999999999999999999999 89999999999999987654 899999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCcHHHHHHH-hhc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLL-TGRPALGITKEVQYAL-DTG 501 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~~sDVwSlGviL~eLl-tG~~Pf~~~~~~~~~~-~~~ 501 (641)
|++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.......... ..+
T Consensus 157 g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 224 (262)
T cd05077 157 GIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224 (262)
T ss_pred CCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc
Confidence 988654321 1234788999999987 467899999999999999998 5888886543222111 111
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ......+..+.+|+.+||+.||.+||++.+++
T Consensus 225 ~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il 258 (262)
T cd05077 225 QC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258 (262)
T ss_pred Cc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 00 01122356799999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.00 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=190.7
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--------C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~ 347 (641)
..+|.+.+.||.|+||.||+|.+. +..||||++..... .....+.+|+.+|+.++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 457899999999999999999874 67899999875422 22345778999999999999999998773 2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..+++++++ +++|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence 368999988 789988773 3459999999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc----
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---- 502 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~---- 502 (641)
....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..........
T Consensus 166 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 166 RQADDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred eecCCCc-----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 8654321 23358999999999977 5689999999999999999999999976543221111000
Q ss_pred -------------cccccCCCCCCCC--------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 -------------LKNLLDPLAGDWP--------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 -------------~~~~~d~~~~~~~--------~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+.. ....+ ...++.+.+|+.+||..||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 00001 12344678999999999999999999844
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.76 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=198.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|.+.+.||.|+||.||+|.+. +..||+|++..........+..|+.++++++||||+++++.+ ....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 346888999999999999999884 688999998765444456788999999999999999999987 4468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++... ..++++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999998532 3468999999999999999999999 8999999999999999999999999998875433211
Q ss_pred cCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
......|++.|+|||.+. +..++.++|||||||++|+|++|++||...+............ +.
T Consensus 159 --------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~ 226 (280)
T cd06611 159 --------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE----PP 226 (280)
T ss_pred --------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC----CC
Confidence 112335899999999985 3457789999999999999999999997665443322221110 00
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+...+..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 1112334567899999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.51 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=185.9
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggs 360 (641)
.||+|+||.||+|... ...+|+|.+...... ....+.+|+.+++.++||||+++++.|. ...++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999753 356888887644322 2346789999999999999999999874 46899999999999
Q ss_pred hhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 361 LEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 361 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|.+++..... ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 9999865432 2335678889999999999999999 899999999999999999999999999986543221110
Q ss_pred CccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
......+++.|+|||++.. ..++.++|||||||++|+|++ |.+||............. ........
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 231 (269)
T cd05042 158 -----TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV-REQDIKLP 231 (269)
T ss_pred -----ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-hccCccCC
Confidence 0122346778999999753 356789999999999999999 888987554332211110 01111111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
....+...+..+.+++..|| .||.+||++.+ |.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~-v~~~l 267 (269)
T cd05042 232 KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE-VHELL 267 (269)
T ss_pred CCcccccCCHHHHHHHHHHh-cCcccccCHHH-HHHHh
Confidence 22334456778888999998 59999999998 55544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=304.77 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=198.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--C-ceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--E-VWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~-~~~lV~E 354 (641)
+|++.+.||+|+||.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+. + ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999874 57899999875432 22356889999999999999999998763 2 4689999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++++|.+++... ....+++.++..++.+++.||.+||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998643 23458999999999999999999999 899999999999999999999999999998664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH--HhhcccccccCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLKNLLDPLAG 512 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~~~ 512 (641)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..... ...+.. .
T Consensus 157 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~ 220 (257)
T cd08223 157 D--------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------P 220 (257)
T ss_pred C--------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------C
Confidence 1 112345889999999999999999999999999999999999999765433221 111111 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+...+..+.+++.+||..+|.+||++.+++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 22345667899999999999999999999844
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=307.32 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=187.0
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggs 360 (641)
.||+|+||.||+|... +..+|+|.+...... ....+.+|+.+++.++||||+++++++. ...++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5999999999999864 356999988765432 2346889999999999999999999884 45789999999999
Q ss_pred hhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 361 LEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 361 L~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999986432 22346777888999999999999999 89999999999999999999999999998754322111
Q ss_pred CccccccCCCCCCcccCChhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASG-------ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
.......|+..|+|||++.+. .++.++|||||||++|+|++ |.+||.............. .......
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 231 (269)
T cd05087 157 ----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR-EQQLKLP 231 (269)
T ss_pred ----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh-cccCCCC
Confidence 111234578899999998642 35789999999999999996 9999975543332111100 0001111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.+......+..+.+++..|+ .+|.+||++.+ |+..|
T Consensus 232 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~-l~~~l 267 (269)
T cd05087 232 KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE-VHLLL 267 (269)
T ss_pred CCccCCCCChHHHHHHHHHh-cCcccCCCHHH-HHHHh
Confidence 12222345667899999999 68999999999 54444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=312.17 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=193.9
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
|+..+.||.|+||+||+|.+. ++.||+|.+...... ....+.+|+.+|+.++|+||+.+++++ .+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999884 688999998754322 234577899999999999999998877 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888543 23469999999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh-hcccccccCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TGKLKNLLDPLAGDW 514 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~-~~~~~~~~d~~~~~~ 514 (641)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||........... ...... ....+
T Consensus 158 ---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05632 158 ---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE----TEEVY 224 (285)
T ss_pred ---------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----ccccc
Confidence 1223589999999999988999999999999999999999999976543221111 111111 11123
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+...+..+.+|+..||..||.+||++.+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 3445678999999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.04 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=189.8
Q ss_pred eeeccCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--CceEEEEEecCCC
Q 006545 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNG 359 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV~Ey~~gg 359 (641)
.||+|+||.||+|.+.+ ..+++|.+..... .....+.+|+.++.++ +||||++++++|. ...++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999998743 3578888874332 2245688999999999 7999999999884 4588999999999
Q ss_pred ChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 360 SLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 360 sL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
+|.+++.... ....+++..+..++.+++.||.|||+ +|++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999985432 12358899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhccccc
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
+....... .......+..|+|||++....++.++|||||||++|+|++ |..||...+.........
T Consensus 159 ~~~~~~~~---------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---- 225 (270)
T cd05047 159 SRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---- 225 (270)
T ss_pred ccccchhh---------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh----
Confidence 86322110 0011224667999999988899999999999999999997 999996543322111110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.......+...+..+.+|+.+||..+|.+||++.+ ++..|..+
T Consensus 226 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l~~~ 268 (270)
T cd05047 226 --QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRM 268 (270)
T ss_pred --CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHH-HHHHHHHh
Confidence 00011123345678999999999999999999999 66666554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=303.92 Aligned_cols=245 Identities=26% Similarity=0.487 Sum_probs=195.7
Q ss_pred CCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecC
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 357 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 357 (641)
.+|++.+.||.|+||.||+|.+. +..+|+|.+.... .....+.+|+.++++++||||+++++++. ...++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778889999999999999875 6789999886443 23457899999999999999999999883 46889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999998532 3458899999999999999999999 89999999999999999999999999998765432111
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......++..|+|||.+.++.++.++|||||||++|+|++ |..||.................. ..+.
T Consensus 157 ------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~ 224 (256)
T cd05112 157 ------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL------YKPR 224 (256)
T ss_pred ------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC------CCCC
Confidence 0112235678999999998899999999999999999998 99999755432221111111111 1123
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+..+.+|+.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l 252 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLL 252 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 3467899999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=308.75 Aligned_cols=242 Identities=28% Similarity=0.353 Sum_probs=197.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC-CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|.+.+.||.|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++ ....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 6788889999999999999874 6889999987543 22345688999999999999999999987 34688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.. .++++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999999843 278999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......|++.|+|||.+.+..++.++|||||||++|+|+||.+||...+........... . ....+.
T Consensus 154 -------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~---~~~~~~ 220 (274)
T cd06609 154 -------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN---N---PPSLEG 220 (274)
T ss_pred -------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---C---CCCCcc
Confidence 112345888999999999888999999999999999999999999765433222111110 1 111112
Q ss_pred h-hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 517 V-QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 517 ~-~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .+..+.+++.+||..+|.+||++.+++
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 2 567899999999999999999999843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.81 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=203.2
Q ss_pred CCCCccceeeccCceEEEEEEEC---------CeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEecccc--C
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 347 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~---------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~ 347 (641)
.+|.+.+.||+|+||.||+|.+. ...||+|++..... .....+.+|+.+++++ +||||++++++|. +
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999752 13689998875432 2245788999999999 7999999999883 4
Q ss_pred ceEEEEEecCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld 414 (641)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||. +||+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 6889999999999999986432 12358889999999999999999999 8999999999999999
Q ss_pred cCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH
Q 006545 415 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE 493 (641)
Q Consensus 415 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~ 493 (641)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred CCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999998654322110 0122234678999999999999999999999999999998 8899976543
Q ss_pred HHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhc
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~ 555 (641)
........ .......+...+..+.+|+.+||+.+|.+||++.+ ++..|+.+....
T Consensus 243 ~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e-ll~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLK------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQ-LVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHH------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH-HHHHHHHHhhhc
Confidence 33211111 01111223445678999999999999999999999 777788777554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.63 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=191.0
Q ss_pred cCCCCccceeeccCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
..+|.+.+.||.|+||.||++... +..||+|.+... ..+.+|+.+|+.++||||+++++++. ...++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 347999999999999999998763 367999987643 24578999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+. ++|.+++. ....+++..++.|+.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 68888883 34569999999999999999999999 89999999999999999999999999999765443
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH------HHHHHhhccc----
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALDTGKL---- 503 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~------~~~~~~~~~~---- 503 (641)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..........
T Consensus 239 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 239 PDTP------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccc------cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 2111 11234689999999999999999999999999999999999999954321 1111100000
Q ss_pred -------------ccccCCCCCCCC-------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -------------KNLLDPLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -------------~~~~d~~~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..........+. ...+..+.++|.+||..||.+||++.+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 000000000010 12356788999999999999999999954
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.51 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=197.5
Q ss_pred CCCCccceeeccCceEEEEEEE------CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc----Cce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL------RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 349 (641)
..|.+.+.||+|+||.||++.+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999874 357899999875532 22457899999999999999999999873 347
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||++|++|.+++... ...+++..+..++.+++.||.|||+ +||+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998533 2358999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH-Hh--------h
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA-LD--------T 500 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~-~~--------~ 500 (641)
+....... .......++..|+|||.+.+..++.++|||||||++|+|+|++.|+......... .. .
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 159 IETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233 (284)
T ss_pred cccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence 65332110 1112344778899999998888999999999999999999987765321110000 00 0
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
..............+...+..+.+|+.+||+.+|.+||++.+ +++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN-LIEGFEAI 283 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHH-HHHHHHhh
Confidence 000000000111123346778999999999999999999999 66665543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.56 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=193.1
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
.+|.+.+.||.|+||.||+|.+. +..||+|.+...... ....+.+|+.+++.++||||+++++++ .+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999874 688999998754322 234678999999999999999999998 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++ ++|.+++... ...+++..+..++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887533 3458899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc---------cccc
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG---------KLKN 505 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~---------~~~~ 505 (641)
. .....+++.|+|||.+.+. .++.++|||||||++|+|+||++||...+......... .+..
T Consensus 160 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 160 T--------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred c--------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 0 1223478999999998764 58889999999999999999999997654322111000 0000
Q ss_pred ccC------CCCC--------CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 LLD------PLAG--------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~~d------~~~~--------~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
... .... ......+..+.+||.+||..||.+|||+.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000 0000 11123466789999999999999999998843
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.22 Aligned_cols=248 Identities=23% Similarity=0.283 Sum_probs=190.9
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||++... +..||+|++..... .....+..|+.++..++|+||+++++++ .+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999874 57899999875321 1234578899999999999999999988 45688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 3468899999999999999999999 89999999999999999999999999999765433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
... ......||+.|+|||++.+ +.++.++|||||||++|+|++|+.||...+..............+.
T Consensus 156 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05624 156 GTV-------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ 228 (331)
T ss_pred Cce-------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc
Confidence 211 1122458999999999876 4688899999999999999999999976554332211111000000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCC--CCChHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKS--RPELGK 542 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~e 542 (641)
.+......+..+.+|+.+||..++.+ |+++.+
T Consensus 229 --~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~ 262 (331)
T cd05624 229 --FPSHITDVSEEAKDLIQRLICSRERRLGQNGIED 262 (331)
T ss_pred --CCCccccCCHHHHHHHHHHccCchhhcCCCCHHH
Confidence 01111234678999999999865543 356655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.75 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=196.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|++.+.||+|+||.||++.+. +..||+|.+..... .....+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999985 78899998875422 1235688999999999999999999987 45788999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|..++........+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999885433344789999999999999999999962 489999999999999999999999999987653221
Q ss_pred CCCccccccCCCCCCcccCChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~------~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
.....|++.|+|||.+.+. .++.++|||||||++|+|++|..||........... +.......
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~ 226 (286)
T cd06622 158 --------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSAIVDGD 226 (286)
T ss_pred --------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHHHhhcC
Confidence 1223478899999998654 357899999999999999999999965432211110 11111111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+...+..+.+|+.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 2233445678899999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=305.03 Aligned_cols=250 Identities=29% Similarity=0.511 Sum_probs=200.5
Q ss_pred cCCCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEEecC
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 357 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~Ey~~ 357 (641)
..+|.+.++||+|+||.||+|.+. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 357889999999999999999874 4679999887532 23457889999999999999999998874 45789999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++.... ...+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999986432 3458889999999999999999999 89999999999999999999999999999765432211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH--HHhhcccccccCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY--ALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~ 514 (641)
......++..|+|||++....++.++|||||||++|+|+| |.+||...+.... .+..+. ....
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 224 (260)
T cd05073 159 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------RMPR 224 (260)
T ss_pred ------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------CCCC
Confidence 1122345678999999998889999999999999999999 9999976543222 111111 0112
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
+...+..+.+++.+||..+|.+||++.+ +...|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~-l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEY-IQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHH-HHHHHhc
Confidence 2345678999999999999999999998 7666653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=307.90 Aligned_cols=255 Identities=23% Similarity=0.385 Sum_probs=202.5
Q ss_pred CCCCccceeeccCceEEEEEEEC--C----eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc-cCceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC-PEVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~----~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~-~~~~~lV 352 (641)
.+|.+.+.||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+++.++||||++++++| ....++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 46788899999999999999863 2 36899988765432 235688999999999999999999987 4578899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999998533 3458999999999999999999999 8999999999999999999999999999987653
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
..... ......++..|+|||.+....++.++|||||||++|+|++ |.+||................ .
T Consensus 162 ~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------~ 229 (279)
T cd05057 162 DEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE------R 229 (279)
T ss_pred cccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC------C
Confidence 22110 0112224678999999988899999999999999999998 999997654332221111110 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
...+...+..+.+++.+||..+|..||++.+ +...|..+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~-l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKE-LINEFSKMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHHHHHHh
Confidence 1123345678999999999999999999999 7777777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=314.38 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=194.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|++.+.||+|+||.||++.+. +..+|+|.+...... ....+.+|+.++.+++||||++++++| .+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888999999999999999874 577999988754221 234588999999999999999999988 45789999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+|++|.+++.. ...+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 82 DGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999853 35689999999999999999999972 489999999999999999999999999987543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccccc---------
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL--------- 507 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 507 (641)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+...............
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 122358899999999988889999999999999999999999996543222111110000000
Q ss_pred ---------------------CCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 ---------------------DPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 ---------------------d~~~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+..+ ...+..+.+|+.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00000001 12456799999999999999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.01 Aligned_cols=246 Identities=25% Similarity=0.455 Sum_probs=193.9
Q ss_pred eeeccCceEEEEEEECC--------eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 288 KIGEGGYGSIYKGLLRH--------MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~--------~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.||+|+||.||+|.... ..||||.+..... .....+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998742 5699998865432 2355788999999999999999999987 44689999999
Q ss_pred CCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-----cccccccccc
Q 006545 357 PNGSLEDRLSCKD----NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-----VSKLSDFGIS 427 (641)
Q Consensus 357 ~ggsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-----~vKL~DFGla 427 (641)
++|+|.+++.... ....+++..+..++.+++.||.|||+ .+++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999986432 22458899999999999999999999 8999999999999999877 8999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
.......... ......++..|+|||.+.++.++.++|||||||++|+|+| |..||...+..........
T Consensus 159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---- 228 (269)
T cd05044 159 RDIYKSDYYR------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA---- 228 (269)
T ss_pred cccccccccc------cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc----
Confidence 7654332111 1122345788999999999999999999999999999998 9999975544332211110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
......+...+..+.++|.+||..+|.+||++.+ +.+.|.
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~ 268 (269)
T cd05044 229 --GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR-IQEILQ 268 (269)
T ss_pred --CCccCCcccchHHHHHHHHHHcCCCcccCCCHHH-HHHHHh
Confidence 0111223456788999999999999999999999 555543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.36 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=196.1
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC-----chhHHHHHHHHhcCCCCceeeEecccc----Cce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP----EVW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~-----~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 349 (641)
.+|...+.||+|+||.||+|.. .+..||+|.+....... ...+.+|+.+++.++||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999987 46889999887543221 235788999999999999999999873 357
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 3458899999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
......... ......++..|+|||.+.+..++.++|||||||++|+|++|++||............. ...
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----~~~ 225 (266)
T cd06651 156 LQTICMSGT-----GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP 225 (266)
T ss_pred cccccccCC-----ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----cCC
Confidence 543211100 1122347899999999998889999999999999999999999997654333222111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+...+..+..++ +||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 12334555667788888 78889999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.68 Aligned_cols=243 Identities=27% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.|+..+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566678999999999999874 67899999875432 2235688999999999999999999988 44689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++. ...+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999884 2468999999999999999999999 8999999999999999999999999999876543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ........+.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~ 223 (277)
T cd06642 157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------PKNSPPTLEG 223 (277)
T ss_pred -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------hcCCCCCCCc
Confidence 112235789999999999889999999999999999999999999654332211111 0111122233
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
..+..+.+++.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 45678999999999999999999999653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.10 Aligned_cols=232 Identities=26% Similarity=0.396 Sum_probs=180.5
Q ss_pred eeeccCceEEEEEEEC--------------------------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeE
Q 006545 288 KIGEGGYGSIYKGLLR--------------------------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 341 (641)
.||+|+||.||+|... ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998741 13589998875433334568889999999999999999
Q ss_pred eccc--cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC--
Q 006545 342 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-- 417 (641)
Q Consensus 342 ~g~~--~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-- 417 (641)
+|+| ....++||||+++|+|..++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9998 3467899999999999998853 23468899999999999999999999 8999999999999997643
Q ss_pred -----cccccccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCC
Q 006545 418 -----VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLL-TGRPALGI 490 (641)
Q Consensus 418 -----~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLl-tG~~Pf~~ 490 (641)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|.+||..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4799999987543221 11246888999998875 56899999999999999995 79999965
Q ss_pred cHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 491 TKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 491 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
............. ...+......+.++|.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 225 RTPSEKERFYEKK--------HRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred cChHHHHHHHHhc--------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 4332211110000 011222345799999999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.05 Aligned_cols=233 Identities=25% Similarity=0.305 Sum_probs=182.3
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcC---CCCceeeEeccc--cCceEEEEEecCC
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKI---RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l---~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
||+|+||+||+|.+. +..||||++...... ....+..|..++..+ +||||+++++++ .+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999874 688999998653221 123455677777665 699999999987 4468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++. ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.........
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 99998885 34568999999999999999999999 89999999999999999999999999998754322111
Q ss_pred CccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC-h
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP-F 516 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~-~ 516 (641)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+............. .++ .
T Consensus 153 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------~~~~~ 219 (330)
T cd05586 153 ------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-------RFPKN 219 (330)
T ss_pred ------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-------CCCCc
Confidence 1234589999999998765 589999999999999999999999976544332111110000 111 1
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+..+.+|+.+||..||.+||+...
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 34678899999999999999997544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=313.17 Aligned_cols=193 Identities=25% Similarity=0.401 Sum_probs=156.9
Q ss_pred ceeeccCceEEEEEEEC----CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc----cCceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC----PEVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV~Ey~~g 358 (641)
.+||+|+||.||+|... +..||+|.+.... ....+.+|+.+++.++||||+++++++ ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999864 3679999887543 234678999999999999999999987 335789999986
Q ss_pred CChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe----ccCCccccccccccc
Q 006545 359 GSLEDRLSCK------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL----DANFVSKLSDFGISR 428 (641)
Q Consensus 359 gsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl----d~~~~vKL~DFGla~ 428 (641)
++|.+++... .....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5777766321 122358899999999999999999999 899999999999999 566899999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 490 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~ 490 (641)
......... .......||+.|+|||++.+. .++.++|||||||++|+|+||.+||..
T Consensus 161 ~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccc-----cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 765432111 112334689999999999764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.58 Aligned_cols=252 Identities=24% Similarity=0.283 Sum_probs=198.4
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
+|+..+.||+|+||.||+|... +..||||.+...... ....+..|+.+++.++||||+++++.+. +..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888899999999999999884 688999999765433 2356889999999999999999999873 46889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+.|++|.+++... ....+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 99999999988533 33568999999999999999999999 899999999999999999999999999987654321
Q ss_pred ccCCCc---------------------cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH
Q 006545 435 ISSNNT---------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE 493 (641)
Q Consensus 435 ~~~~~~---------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~ 493 (641)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110000 00011234689999999999988899999999999999999999999976554
Q ss_pred HHHHHhhcccccccCCCCCCCCh--hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 494 VQYALDTGKLKNLLDPLAGDWPF--VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 494 ~~~~~~~~~~~~~~d~~~~~~~~--~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......... . ...++. ..+..+.+++.+||..+|.+||+....+
T Consensus 238 ~~~~~~~~~--~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 238 DETFSNILK--K-----EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred HHHHHHHhc--C-----CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 332221110 0 001111 2578899999999999999999954433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.04 Aligned_cols=258 Identities=27% Similarity=0.356 Sum_probs=203.5
Q ss_pred CChhhHhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEecccc-
Q 006545 271 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP- 346 (641)
Q Consensus 271 ~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~- 346 (641)
+.+.++..++++|.+...||.|+||.||+|... +..+|+|++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445667778899999999999999999999884 6889999986532 2245678899999999 8999999999873
Q ss_pred ------CceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 347 ------EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 347 ------~~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
...++||||+++|+|.+++... .....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 2478999999999999988532 234568999999999999999999999 899999999999999999999
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEV 494 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~ 494 (641)
||+|||++......... .....|+..|+|||.+... .++.++|||||||++|+|++|++||......
T Consensus 168 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred EEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999998865432211 1223588999999998653 3688999999999999999999999765543
Q ss_pred HHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 495 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 495 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......... .+ .-..+......+.+||.+||..+|.+||++.+++
T Consensus 240 ~~~~~~~~~~---~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 240 KTLFKIPRNP---PP-TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HHHHHHhcCC---CC-CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 3322211100 00 0011223456799999999999999999999844
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.78 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=189.8
Q ss_pred ccceeecc--CceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 285 PSLKIGEG--GYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 285 ~~~~LG~G--~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+..+||+| +||+||++..+ +..||||++....... ...+.+|+.+++.++||||++++++| ++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 78999999874 6889999987653322 34577899999999999999999988 45789999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 2358999999999999999999999 89999999999999999999999999876543221111
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh--hcccccccCC---
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--TGKLKNLLDP--- 509 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~--~~~~~~~~d~--- 509 (641)
.. ..........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+.....++.
T Consensus 158 ~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cc-ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 00 00001122347788999999976 4689999999999999999999999975433221111 1111100000
Q ss_pred ----------------------------------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 ----------------------------------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ----------------------------------~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+....+..+.+|+.+||..||.+|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 00011123456899999999999999999999843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=299.43 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=201.5
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC----c----hhHHHHHHHHhcC-CCCceeeEeccccC-
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG----P----SEFQQEIDILSKI-RHPNLVTLVGACPE- 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~----~----~~~~~Ei~iL~~l-~HpnIv~l~g~~~~- 347 (641)
..+|...+.||.|..++|-++.. ++..+|+|++....... . +.-.+|+.||+++ .||||+.+.++++.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34678888899999999998876 46889999987543221 1 2356899999998 69999999999954
Q ss_pred -ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 348 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 348 -~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
.+++|++.|+.|.|.|+|. ....+++....+|+.|+..|+.|||. ++||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 5779999999999999994 44569999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~ 500 (641)
|+.+..... ....+|||+|+|||.+. ..+|+..+|+|++|||||.||.|.+||.........-..
T Consensus 170 a~~l~~Gek---------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGEK---------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred eeccCCchh---------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 998876532 23456999999999884 246889999999999999999999999766554332211
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
+...+....++| .+.+....+||.+||+.||.+|.|+.+.+.
T Consensus 241 --meGkyqF~speW-adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 241 --MEGKYQFRSPEW-ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --HhcccccCCcch-hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 122222233444 356778999999999999999999999664
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.84 Aligned_cols=250 Identities=28% Similarity=0.359 Sum_probs=194.5
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
++|+....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++ ....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999885 68899999865432 1234678999999999999999999988 346889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+++++|..++. ....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887763 23458999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-ccc-------
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-LKN------- 505 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~-~~~------- 505 (641)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.............. ...
T Consensus 155 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 155 DD--------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred cc--------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 10 122347889999999876 4588999999999999999999999976544322211100 000
Q ss_pred ----------ccCCCCC------CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 ----------LLDPLAG------DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ----------~~d~~~~------~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+... ......+..+.+|+.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 0000000 00112357789999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.43 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=197.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 356 (641)
.|+..+.||.|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. ...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777888999999999999874 68899999875432 22456889999999999999999999884 5689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+||+|.+++.. .++++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998842 358899999999999999999999 8999999999999999999999999999976543221
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......++..|+|||.+.+..++.++|||||||++|+|+||.+||............. .......+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~ 223 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------KNNPPTLTG 223 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh------cCCCCCCch
Confidence 1122357889999999998889999999999999999999999997554332221110 011122344
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHH
Confidence 5678899999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=303.75 Aligned_cols=231 Identities=28% Similarity=0.448 Sum_probs=183.9
Q ss_pred eeeccCceEEEEEEECCe------------EEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEE
Q 006545 288 KIGEGGYGSIYKGLLRHM------------QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 354 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~~------------~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~E 354 (641)
.||+|+||.||+|.+... .|++|++...... ...+.+|+.+++.++||||+++++++. +..++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 599999999999998532 3788887654432 567899999999999999999999873 56789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-------cccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-------VSKLSDFGIS 427 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-------~vKL~DFGla 427 (641)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999985432 268999999999999999999999 8999999999999999887 7999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 504 (641)
...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..........
T Consensus 156 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-- 221 (259)
T cd05037 156 ITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-- 221 (259)
T ss_pred cccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc--
Confidence 765431 122367789999999876 78999999999999999999 5788865432211111000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+......+.+++.+||..+|.+||++.+++
T Consensus 222 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 255 (259)
T cd05037 222 ------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255 (259)
T ss_pred ------CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHH
Confidence 0111222237899999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.28 Aligned_cols=254 Identities=27% Similarity=0.357 Sum_probs=200.1
Q ss_pred ChhhHhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccc---
Q 006545 272 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--- 345 (641)
Q Consensus 272 ~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--- 345 (641)
+..++....+.|++...||.|+||.||+|.+. +..||+|++.... .....+..|+.++.++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44556667789999999999999999999984 6789999986543 2335688899999998 799999999987
Q ss_pred -----cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccc
Q 006545 346 -----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420 (641)
Q Consensus 346 -----~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vK 420 (641)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 235789999999999999885432 3458888999999999999999999 8999999999999999999999
Q ss_pred ccccccccccccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH
Q 006545 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495 (641)
Q Consensus 421 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~ 495 (641)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|++|.+||.......
T Consensus 162 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999876532211 112345899999999986 3468889999999999999999999996544332
Q ss_pred HHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 496 YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 496 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
........ .. ........+..+.+||.+||..||.+||++.++
T Consensus 234 ~~~~~~~~---~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 234 ALFLIPRN---PP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred hhhhHhhC---CC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 22211110 00 011122356789999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.02 Aligned_cols=245 Identities=23% Similarity=0.328 Sum_probs=198.7
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|+..+.||.|+||.||.+.. .+..+++|.+..... .....+.+|+.++++++|+||+++++++ .+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999988776 468899999875432 2345688999999999999999999988 3467899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++|+|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986432 3568999999999999999999999 8999999999999999999999999999986644321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||.............. . .....+
T Consensus 157 --------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~----~~~~~~ 222 (256)
T cd08221 157 --------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G----NYTPVV 222 (256)
T ss_pred --------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C----CCCCCc
Confidence 11234589999999999888899999999999999999999999976544332221110 0 011122
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+++.+||..+|.+||++.+++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 34567899999999999999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.55 Aligned_cols=232 Identities=25% Similarity=0.385 Sum_probs=183.3
Q ss_pred eeeccCceEEEEEEECC---------eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 288 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~---------~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
.||.|+||.||+|.... ..||+|.+........+.+..|+.+++.++||||+++++++ .+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999997632 34888887654433446788999999999999999999988 35788999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc--------cccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--------SKLSDFGISR 428 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~--------vKL~DFGla~ 428 (641)
++|+|.+++... ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999998543 2368999999999999999999999 89999999999999987765 5899999876
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhC-CCCCCCcHHHHHHHhhcccccc
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG-~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
..... ....++..|+|||.+.+. .++.++|||||||++|+|++| .+||...+..........
T Consensus 157 ~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~---- 220 (258)
T cd05078 157 TVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED---- 220 (258)
T ss_pred ccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc----
Confidence 44321 123478899999999864 588999999999999999998 467654433221111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....|......+.+|+.+||+.+|.+||++.+++
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 254 (258)
T cd05078 221 ----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254 (258)
T ss_pred ----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHH
Confidence 1123334457899999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.44 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=195.6
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
++|++.+.||+|+||+||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++ .+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999885 78899998875432 2346788999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++.. ..++++..+..++.+++.||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999998843 34689999999999999999999973 479999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHH----HH-hhcccccccCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY----AL-DTGKLKNLLDPL 510 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~----~~-~~~~~~~~~d~~ 510 (641)
.....|+..|+|||++.+..++.++|||||||++|+|+||..||........ .. ....+.......
T Consensus 159 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 159 ---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred ---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1223589999999999888999999999999999999999999975432100 00 000001111111
Q ss_pred CCCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+. ..+..+.+|+.+||..||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~ 264 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 111111 2557899999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=309.91 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=204.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
-|+++.+||+|+||.||+++++ |..||||.+... .+..++.+|+.||++++.|++|++||.+ ...++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4788899999999999999885 788999988754 3567899999999999999999999976 456899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
.|++.+++. ..+.+|++..+..++...+.||.|||. ..-||||||..|||++-+|++||+|||.|..+....
T Consensus 112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 999999995 445689999999999999999999999 678999999999999999999999999998765543
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
..+....||+.|||||++..-.|+.++||||||++..||..|+|||.........+.. ..-.|..-.-|..
T Consensus 184 -----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 184 -----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTFKKPEE 254 (502)
T ss_pred -----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCCCChHh
Confidence 2234567999999999999999999999999999999999999999765554322111 1111111223556
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.+.++.++++.||-.+|++|-++.+
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHH
Confidence 6789999999999999999999877
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.47 Aligned_cols=244 Identities=29% Similarity=0.448 Sum_probs=193.4
Q ss_pred ceeeccCceEEEEEEEC-CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCChh
Q 006545 287 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLE 362 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~ 362 (641)
++||.|+||.||++.+. ++.||+|.+...... ....+.+|++++++++||||+++++++. ...++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999886 788999988765433 3457899999999999999999999874 4688999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccc
Q 006545 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442 (641)
Q Consensus 363 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~ 442 (641)
+++... ...+++..+..++.+++.||.|||+ ++++||||+|+|||++.++.+||+|||++..........
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-----
Confidence 998543 2358899999999999999999999 899999999999999999999999999987654221110
Q ss_pred cccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHH
Q 006545 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521 (641)
Q Consensus 443 ~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 521 (641)
......++..|+|||.+.++.++.++|||||||++|+|+| |..||................ ....+...+..
T Consensus 151 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 223 (251)
T cd05041 151 -SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------RMPAPQLCPEE 223 (251)
T ss_pred -ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------CCCCCccCCHH
Confidence 0011224667999999998899999999999999999999 889996554322211111100 11123445678
Q ss_pred HHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 522 LANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 522 l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
+.+++.+||..+|.+||++.+ +++.|
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~e-ll~~l 249 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSE-IYNEL 249 (251)
T ss_pred HHHHHHHHhccChhhCcCHHH-HHHHh
Confidence 999999999999999999998 55554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=309.26 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=200.3
Q ss_pred CCCCccceeeccCceEEEEEEEC------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccccC----ce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~ 349 (641)
..|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999864 578999999865443 35679999999999999999999998743 57
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++++|.+++... ...+++..+..++.+++.||.|||+ +||+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 8999999999999999533 2358999999999999999999999 8999999999999999999999999999987
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH--------Hhhc
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--------LDTG 501 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~--------~~~~ 501 (641)
........ .......++..|+|||.+.+..++.++|||||||++|+|+||..||......... ....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 159 LPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred cccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 65332110 1111223566799999998889999999999999999999999998543211100 0000
Q ss_pred ccccccC-CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 502 KLKNLLD-PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 502 ~~~~~~d-~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
.+...+. ......+...+..+.+|+.+||..+|.+||++.+ |+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e-i~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD-LILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHH-HHHHHhhc
Confidence 0000000 0011113344578999999999999999999999 77777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.52 Aligned_cols=243 Identities=27% Similarity=0.419 Sum_probs=198.6
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
+|+..+.||+|+||.||+|... +..|++|.+...... ....+.+|+.+++.++||||+++++++. ...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667788999999999999884 788999998754321 2356889999999999999999999884 468899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++++|.+++.. ...+++..+..++.+++.||.|||+ .||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 3458899999999999999999999 8999999999999999999999999999876543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
.. ......|+..|+|||.+.... ++.++|+|||||++|+|++|++||................. .
T Consensus 155 ~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~ 220 (258)
T cd06632 155 FS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----L 220 (258)
T ss_pred cc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----C
Confidence 32 112345889999999998776 89999999999999999999999976654443333222111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+++.+||..+|.+||++.+++
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 223445678899999999999999999999843
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.10 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=196.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHhcCCCCceeeEeccccC----ce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACPE----VW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~ 349 (641)
.+|.+.+.||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999874 688999988643221 12467889999999999999999998743 47
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++++|.+++... ..+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999998532 457888999999999999999999 8999999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|++||............. ..+
T Consensus 156 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~ 225 (265)
T cd06652 156 LQTICLSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQP 225 (265)
T ss_pred cccccccc-----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----cCC
Confidence 54321111 01122358899999999988889999999999999999999999997554333221111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+..|...+..+.+++.+|+. +|.+||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence 2233455667789999999995 999999998843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.21 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=199.2
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc----CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV~ 353 (641)
+|++.+.||.|+||.||++.+ .+..||+|++...... ....+..|+.+++.++||||+++++++. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477888999999999999987 4678999998754332 2346888999999999999999998762 3478999
Q ss_pred EecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeccCCCCceEeccCCccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
||+++++|.+++... ....++++..++.++.+++.||.|||..+ ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998543 23457999999999999999999999221 189999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+......... ...
T Consensus 161 ~~~~~~--------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~ 226 (265)
T cd08217 161 GHDSSF--------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK------EGK 226 (265)
T ss_pred cCCccc--------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh------cCC
Confidence 543210 122358999999999998889999999999999999999999997654322111110 111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+...+..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1233455678899999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.28 Aligned_cols=251 Identities=30% Similarity=0.395 Sum_probs=198.3
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEecccc--------
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP-------- 346 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-------- 346 (641)
..+++|++.+.||.|+||.||+|... +..+++|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999984 57899999875442 346789999999999 7999999999872
Q ss_pred CceEEEEEecCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFG 425 (641)
+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 23689999999999999885432 24568999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~ 500 (641)
++........ ......|+..|+|||++.. ..++.++|||||||+||+|++|.+||............
T Consensus 159 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 159 VSAQLDSTLG--------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred cceecccchh--------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 9876543211 1123458999999998854 34678999999999999999999999754433222211
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. .. .+ ....+...+..+.+|+.+||..||.+||++.+++
T Consensus 231 ~~--~~-~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 231 PR--NP-PP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred hc--cC-CC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 10 00 00 1111223567899999999999999999999844
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.20 Aligned_cols=244 Identities=31% Similarity=0.499 Sum_probs=195.8
Q ss_pred CCccceeeccCceEEEEEEECC------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
|++.+.||.|+||.||++.... ..||+|++...... ....+..|+.++..++||||+++++++. +..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566789999999999998864 77999999765443 4567899999999999999999999884 4688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 128999999999999999999999 89999999999999999999999999999876544
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
..... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+............. .
T Consensus 157 ~~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------~ 223 (258)
T smart00219 157 DYYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR------L 223 (258)
T ss_pred ccccc-------ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------C
Confidence 21111 11236789999999988889999999999999999998 8999975443322211111111 1
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
..+...+..+.+++.+||..+|.+||++.++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 1233367789999999999999999999983
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.77 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=214.0
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
++-...+.....+||-|.||.||.|.|+. ..||||.++.+. ...++|..|+.+|+.++|||+|+|+|+| +..+||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33334456777899999999999999974 679999988544 3567899999999999999999999999 457999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
|+|||..|+|.++|...+. ..++.-..+.++.||+.|+.||.. +++|||||-..|.|+.++..||++|||+++++.
T Consensus 341 iTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999976543 346777888999999999999999 899999999999999999999999999999987
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHH--HHHHhhcccccccC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLD 508 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~--~~~~~~~~~~~~~d 508 (641)
.+...... ...-.+-|.|||-+....++.++|||+|||+|||+.| |-.||.+.+.. ...+..+.
T Consensus 417 gDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------ 483 (1157)
T KOG4278|consen 417 GDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------ 483 (1157)
T ss_pred CCceeccc-------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------
Confidence 76543322 2224678999999999999999999999999999998 99999766533 22333321
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
.-+-|..+++.+.+|++.||+.+|.+||++.+ +-+.++.|-.
T Consensus 484 --RM~~PeGCPpkVYeLMraCW~WsPsDRPsFae-iHqafEtmf~ 525 (1157)
T KOG4278|consen 484 --RMDGPEGCPPKVYELMRACWNWSPSDRPSFAE-IHQAFETMFS 525 (1157)
T ss_pred --cccCCCCCCHHHHHHHHHHhcCCcccCccHHH-HHHHHHHHhc
Confidence 12346778999999999999999999999999 7788877654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.47 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=201.7
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
++|++.+.||.|+||+||+|.. .+..+|+|++..... .....+.+|+.+++.++|+||+++++.+ .+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3688899999999999999987 467899999875432 2456789999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++........+++..+..++.|++.||.|||+ .||+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999654334568999999999999999999999 8999999999999999999999999999987654432
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC-C
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG-D 513 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~-~ 513 (641)
... .......|+..|+|||.+... .++.++|||||||++|+|++|+.||...+........... ....... .
T Consensus 158 ~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (267)
T cd06610 158 RTR----KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPSLETGA 231 (267)
T ss_pred ccc----cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCCCcCCcc
Confidence 110 111233588999999999877 7899999999999999999999999765443322221111 0000000 0
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+..+.+++.+||..||.+||++.+++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 1124567899999999999999999998843
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.64 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=197.7
Q ss_pred CCCCccceeeccCceEEEEEEEC-------CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 350 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~-------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 350 (641)
.+|.....||.|+||.||+|... ...|++|.+...... ....+.+|+.++++++||||+++++++. +..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999863 356999988654433 2357899999999999999999999984 4689
Q ss_pred EEEEecCCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNS------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999644322 268999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhh--c
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDT--G 501 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~--~ 501 (641)
|++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||............ +
T Consensus 162 ~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred ccccccCccccc-------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 998754322111 1122346778999999988889999999999999999998 88899654332221111 1
Q ss_pred ccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 502 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
... ...+...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 235 ~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~-~l~~l 273 (275)
T cd05046 235 KLE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE-LVSAL 273 (275)
T ss_pred CcC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence 111 1113345678999999999999999999999 54443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.99 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=195.6
Q ss_pred CCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 283 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
|.....||.|+||.||+|.. .+..||+|++..........+.+|+.++..++||||+++++++ .+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 34445799999999999987 4788999998765544556788999999999999999999987 4578999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
++|..++. ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++........
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--- 172 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--- 172 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc---
Confidence 99998873 2458999999999999999999999 8999999999999999999999999999875543211
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
......|+..|+|||++.+..++.++|||||||++|+|++|.+||................ .. ....+...
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~-~~~~~~~~ 243 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PP-KLKNAHKI 243 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CC-CccccCCC
Confidence 1122358899999999998899999999999999999999999997554433222111100 00 11112234
Q ss_pred HHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+..+.+++.+||..+|.+||++.+++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 56799999999999999999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.23 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=195.2
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC----------chhHHHHHHHHhcCCCCceeeEeccc--cC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG----------PSEFQQEIDILSKIRHPNLVTLVGAC--PE 347 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~----------~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~ 347 (641)
+|...+.||.|+||.||+|.. .+..||||.+....... .+.+..|+.+++.++||||+++++++ .+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999986 46889999886432111 13577899999999999999999987 45
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..++||||+++++|.+++... ..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 688999999999999998533 568999999999999999999999 89999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
......... .......|+..|+|||.+.... ++.++||||||+++|+|++|..||.................
T Consensus 156 ~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (272)
T cd06629 156 KKSDDIYDN------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229 (272)
T ss_pred ccccccccc------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc
Confidence 765432111 0112345889999999987654 88999999999999999999999975544333222111110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
............+..+.+++.+||..+|.+||++.+++
T Consensus 230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 230 -APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred -CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 00111112234567899999999999999999998844
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.46 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=197.3
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC------CchhHHHHHHHHhcCCCCceeeEecccc--CceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~l 351 (641)
+|+..+.||+|+||.||+|.. ++..||+|++...... ....+.+|+.+++.++||||+++++++. +..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999987 4688999998754321 1346889999999999999999999984 46889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-ccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 430 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-~vKL~DFGla~~~ 430 (641)
||||+++++|.+++.. ..++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 3468999999999999999999999 8999999999999998775 6999999998876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH---HHHHhhccccccc
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV---QYALDTGKLKNLL 507 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~---~~~~~~~~~~~~~ 507 (641)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ........
T Consensus 155 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 225 (268)
T cd06630 155 AAKGTGAG----EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS----- 225 (268)
T ss_pred ccccccCC----ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-----
Confidence 54321111 1112345889999999998888999999999999999999999999643221 11111100
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......+...+..+.+++.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 0112334556678899999999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=311.49 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=195.4
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.|.....||.|+||.||++.. .+..||||.+..........+.+|+.+++.++||||+++++.+ .+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344556799999999999987 4688999998765444456788999999999999999999987 457899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++. ...+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999999873 2358899999999999999999999 8999999999999999999999999999875533211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||............. ..+.+.. .....
T Consensus 174 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~ 243 (292)
T cd06658 174 ------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR---DNLPPRV-KDSHK 243 (292)
T ss_pred ------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCcc-ccccc
Confidence 1122348899999999988899999999999999999999999997654433221111 1111111 11223
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.+++.+||..+|.+||++.+++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 466899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.04 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=196.3
Q ss_pred CCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccccC--------
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 347 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 347 (641)
|.+.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556778999999999999863 478999998764322 24568899999999999999999997621
Q ss_pred ceEEEEEecCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD---NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
..+++++|+++|+|.+++.... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2468999999999988874321 22357899999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhccc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~ 503 (641)
|+++......... ......+++.|++||.+.+..++.++|||||||++|+|++ |++||...+...........
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYR------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred cccccccCCccee------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 9988654322111 1112235678999999999999999999999999999999 89999765443221111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 504 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 504 ~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
. ....+...+..+.+++.+||..+|.+||++.+ ++..|+.+
T Consensus 232 ~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~-~~~~l~~~ 272 (273)
T cd05074 232 N------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQH-LRDQLELI 272 (273)
T ss_pred C------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHhh
Confidence 1 01122345678999999999999999999999 66666643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.82 Aligned_cols=247 Identities=24% Similarity=0.290 Sum_probs=191.9
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~E 354 (641)
-|..++.||-|+||+|.++.. +...+|+|.+.+.+.. ....++.|.+||...++++||+||..|. +.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 466678899999999998854 4567999999876432 2356789999999999999999999994 57999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||++..+|.+ .+.|.+..++.++.++.+|+++.|. .|+|||||||+|||||.+|++||+|||||.-+...+
T Consensus 710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999953 3568899999999999999999999 899999999999999999999999999997664332
Q ss_pred ccCCCc----------------------------------cccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHH
Q 006545 435 ISSNNT----------------------------------TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480 (641)
Q Consensus 435 ~~~~~~----------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~e 480 (641)
....+. ..+.....+||+.|+|||++....|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 0012224579999999999999999999999999999999
Q ss_pred HHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCC
Q 006545 481 LLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538 (641)
Q Consensus 481 LltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RP 538 (641)
|+.|++||..............+...++ -.+....+.+..+||.+++. +++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~---~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLH---IPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccc---cccccccCHHHHHHHHHHhc-Chhhhh
Confidence 9999999976655444333333333333 22233456677777766543 444453
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=325.86 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=204.3
Q ss_pred CCccceeeccCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
|.++..||.|+||.||+|..+. -..|.|++...+....+.|.-||+||..++||+||+|++.| .+.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4556679999999999998864 34678988877777778899999999999999999999864 7789999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|-...++.. -..+|++.++.-++++++.||.|||+ ++|||||||..|||++-+|.++|+|||.+.....
T Consensus 114 GAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------ 182 (1187)
T KOG0579|consen 114 GAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------ 182 (1187)
T ss_pred chHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh------
Confidence 999887753 34579999999999999999999999 8999999999999999999999999998764322
Q ss_pred CccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
+........|||+|||||+.. ..+|+.++||||||++|.||..+.||....+.....+...+-. |..--
T Consensus 183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe----PPTLl 256 (1187)
T KOG0579|consen 183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE----PPTLL 256 (1187)
T ss_pred --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC----CCccc
Confidence 223345667999999999874 4689999999999999999999999998877776655443221 11112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.|...+..+.+++.+||..||..||++++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 3566688999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.63 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=211.0
Q ss_pred CCCccceeeccCceEEEEEEEC--C---eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~---~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
...+.++||.|.||.||+|.++ + ..||||.++.... ....+|..|+.||.+++||||++|.|+.. ....||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999885 2 5699999987543 33567999999999999999999999973 4578999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|||++|+|+.+|..++ +.|++.+...+++.|+.|+.||-+ .++|||||...||||+.+..+|++|||+++.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999997554 459999999999999999999999 89999999999999999999999999999987655
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHH--HHHHHhhcccccccCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKE--VQYALDTGKLKNLLDPL 510 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~ 510 (641)
. ..... .....-...|.|||.+...+++.+||||||||+|||.++ |..||..... +..++..+.
T Consensus 785 ~-~~~yt----t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy-------- 851 (996)
T KOG0196|consen 785 P-EAAYT----TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY-------- 851 (996)
T ss_pred C-Ccccc----ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc--------
Confidence 3 11111 122334679999999999999999999999999999886 9989865443 333333331
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
.-.-|.+++..|.+|+..||++|...||.+.+ ++..|+.+...
T Consensus 852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~q-iV~~lDklIrn 894 (996)
T KOG0196|consen 852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQ-IVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHH-HHHHHHHHhcC
Confidence 12237788999999999999999999999999 77888887754
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.15 Aligned_cols=239 Identities=28% Similarity=0.376 Sum_probs=197.3
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
-|.-++.||.|+||-||-|.+. ...||||.+.....+. ...+.+|+..|.+++|||++.+-|+| +...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4677788999999999999884 5789999988765544 34688999999999999999999998 456789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|| -||-.|++. ....++-+..+..|+.+.+.||.|||+ ++.||||||..|||+++.|.|||+|||.|......
T Consensus 107 YC-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 467777774 234678999999999999999999999 89999999999999999999999999998766443
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
...+|||.|||||++. .+.|+-++||||||++..||.-.+||+-..+.....+....-. .|..
T Consensus 180 -----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe---sPtL 245 (948)
T KOG0577|consen 180 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---SPTL 245 (948)
T ss_pred -----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC---CCCC
Confidence 4567999999999985 4789999999999999999999999987766655443321111 0111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.....+..+..++..||+.-|.+|||..+.
T Consensus 246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred --CCchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 123457889999999999999999998773
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.32 Aligned_cols=249 Identities=27% Similarity=0.360 Sum_probs=194.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|+..++||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++++. ...++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 6888899999999999999984 688999988654322 2456889999999999999999999984 468999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|..+... ...+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999998887632 2348999999999999999999999 8999999999999999999999999999876543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc----cc------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----LK------ 504 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~----~~------ 504 (641)
. .....++..|+|||++.+. .++.++|||||||++|+|++|++||.............. +.
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 156 V--------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred c--------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 1 1223578999999998764 578899999999999999999999975543322111100 00
Q ss_pred --------cccCCCC------CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 --------NLLDPLA------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 --------~~~d~~~------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+.. .......+..+.+|+.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 0000000 001123467899999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.11 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=195.5
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|.+.+.||.|+||.||+|.+ .+..||+|++..... .....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999987 468899999876542 2246789999999999999999999987 4468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+ +++|.+++.... .++++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999885332 569999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-c----------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-L---------- 503 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~-~---------- 503 (641)
. ......|+..|+|||.+.+. .++.++|||||||++|+|++|.+||.............. +
T Consensus 155 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 R-------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred C-------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 0 11234589999999998654 468999999999999999999999865543221111000 0
Q ss_pred -------ccccCCCC-----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -------KNLLDPLA-----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -------~~~~d~~~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+.. .......+..+.+||.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 00000000 011123457899999999999999999999844
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.89 Aligned_cols=248 Identities=26% Similarity=0.331 Sum_probs=195.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc----CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV~E 354 (641)
+|...+.||.|++|.||+|.+. +..||+|.+...... ....+.+|+++++.++||||++++++|. ..+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5788899999999999999984 688999998754332 2456899999999999999999999873 25789999
Q ss_pred ecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 355 y~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|++|++|.+++... .....+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887532 234568899999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH-----HH--HHHhhcccccc
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-----VQ--YALDTGKLKNL 506 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~-----~~--~~~~~~~~~~~ 506 (641)
.. ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .. ..........+
T Consensus 159 ~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 159 LA----------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc----------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 11 123478899999999989999999999999999999999999975421 11 11111011110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+ ........+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 229 KD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred cc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 00 0010123467899999999999999999998844
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.09 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|+..+.||+|+||.||++.. .+..||+|.+..... .....+.+|+.++++++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999987 468899999875432 22357889999999999999999999884 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988532 22357899999999999999999999 8999999999999999999999999999976543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+......... . ......+
T Consensus 157 ~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~----~~~~~~~ 222 (256)
T cd08218 157 L--------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--R----GSYPPVS 222 (256)
T ss_pred h--------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh--c----CCCCCCc
Confidence 1 112347889999999998889999999999999999999999997554332221110 1 1111223
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.++|.+||+.+|.+||++.+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 45577899999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.26 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=211.4
Q ss_pred CCCccceeeccCceEEEEEEEC---C--eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR---H--MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~---~--~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~E 354 (641)
.....++||+|.||.|++|.|+ | -.||||.++..... ....|.+|+.+|.+|+|||+++|||+.- ....+|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~E 190 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFE 190 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhh
Confidence 3455678999999999999995 2 46999999877655 4678999999999999999999999985 46779999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
+++.|||.+.|.+ .....|.......++.|||.|+.||.+ +++|||||-..||||.....|||+||||.+.+....
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999986 566778889999999999999999999 899999999999999999999999999999887654
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
..- .......-.+.|+|||.+....++.++|||+|||+||||+| |..||.+....+........ ..-.
T Consensus 267 d~Y-----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------erLp 335 (1039)
T KOG0199|consen 267 DMY-----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------ERLP 335 (1039)
T ss_pred cce-----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc------ccCC
Confidence 221 11223345789999999999999999999999999999998 88999877766544333211 1223
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le 549 (641)
-|..++..+.+++..||..+|.+||++..+..+.+.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 477889999999999999999999999995544443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.59 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=189.3
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|.+.+.||+|+||.||+|.+ .|..||+|.+...... ....+.+|+.+++.++||||+++++++. ...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477888999999999999998 4788999998754322 2356788999999999999999999983 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+. ++|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5787777432 3468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh-c------------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-G------------ 501 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~-~------------ 501 (641)
......+++.|+|||.+.+. .++.++|||||||++|+|+||..||............ .
T Consensus 155 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 --------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred --------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 11233578999999998775 4789999999999999999988875322211111000 0
Q ss_pred ccccc-----cCCCC-----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 KLKNL-----LDPLA-----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ~~~~~-----~d~~~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... ..... .......+..+.+|+.+||..||.+|||+.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 00000 00000 011123467889999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=305.71 Aligned_cols=249 Identities=25% Similarity=0.311 Sum_probs=193.4
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-----CchhHHHHHHHHhcCCCCceeeEecccc--CceEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-----GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV 352 (641)
+|+..+.||.|+||.||+|.+. +..||||.+...... ....+..|+.+++.++|+||+++++++. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999874 689999999765433 1235678999999999999999999884 468899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+ +||+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985332 369999999999999999999999 8999999999999999999999999999986644
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---------
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--------- 502 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~--------- 502 (641)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||..............
T Consensus 155 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 155 PNRK--------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred CCcc--------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 3211 122346889999999865 4678999999999999999999988865443221111100
Q ss_pred ------cccccCC------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ------LKNLLDP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ------~~~~~d~------~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....... .........+..+.++|.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0000000 00011233467899999999999999999999954
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.26 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=199.4
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
.++|.+.+.||.|+||.||+|.. .+..||+|.+..........+.+|+.+++.++||||+++++.| .+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 35789999999999999999986 4688999998755444456788999999999999999999988 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++.. ..+++..+..++.+++.||.|||+ +|++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999842 347889999999999999999999 8999999999999999999999999999876543321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|++||...+............ .+ ....+
T Consensus 171 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~---~~-~~~~~ 238 (293)
T cd06647 171 K--------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TP-ELQNP 238 (293)
T ss_pred c--------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC---CC-CCCCc
Confidence 1 122358899999999988889999999999999999999999997654432211111000 00 01112
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+++.+||..+|.+||++.+++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 33466799999999999999999999855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.20 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=190.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
.+|+..+.||.|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999874 688999998754322 2345778999999999999999999884 468999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++ +|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 899888533 2368999999999999999999999 8999999999999999999999999999875432211
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh-hc---------ccc
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-TG---------KLK 504 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~-~~---------~~~ 504 (641)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.........+. .. .+.
T Consensus 159 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 T--------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred c--------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 0 112246889999999876 4588999999999999999999999965442111110 00 000
Q ss_pred cc------cCCC---------CCCC-ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NL------LDPL---------AGDW-PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~------~d~~---------~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. .... .... .......+.+++.+||..+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 00 0000 0000 011126788999999999999999998843
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.74 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=194.4
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
++|...+.||+|+||.||++... +..||+|.+...... ....+.+|+.+++.++||||+++++.+. +..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999885 578999998765321 2346789999999999999999999884 4578999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++|++|.+++.. ...+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999953 3468999999999999999999999 89999999999999999999999999998742211
Q ss_pred cccC-------CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccc
Q 006545 434 EISS-------NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 434 ~~~~-------~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
.... ............|+..|+|||.+.+..++.++|||||||++|+|++|..||............. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~-~~~~ 233 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-SDDI 233 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccc
Confidence 1000 0000011122457889999999988889999999999999999999999997554332111110 0000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+. .+...+..+.+++.+||..+|.+||+...
T Consensus 234 ~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 266 (305)
T cd05609 234 EWPE---GDEALPADAQDLISRLLRQNPLERLGTGG 266 (305)
T ss_pred CCCC---ccccCCHHHHHHHHHHhccChhhccCccC
Confidence 0011 11245678999999999999999999765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.34 Aligned_cols=236 Identities=26% Similarity=0.351 Sum_probs=194.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
++|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.++++++||||+++++++ .+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999884 68899999875432 2245688999999999999999999987 44688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998533 568999999999999999999999 89999999999999999999999999998765433
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............. ....
T Consensus 155 -----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~ 216 (290)
T cd05580 155 -----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-------GKVR 216 (290)
T ss_pred -----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCcc
Confidence 1223488999999999888899999999999999999999999976553322111110 0112
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
.+...+..+.+++.+||..+|.+||+.
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCc
Confidence 344457889999999999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.93 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=197.4
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|+..+.||+|+||.||++.. .+..+|||.+...... ....+.+|+.+++.++||||+++++.+ .+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999887 4688999998765322 245688999999999999999999987 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-Cccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFGla~~~~~~~ 434 (641)
+++++|.+++.... ...+++..+..++.+++.||.|||+ +||+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996432 3458999999999999999999999 899999999999999854 568999999998764332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......... ......
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 221 (256)
T cd08220 157 K---------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS------GTFAPI 221 (256)
T ss_pred c---------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh------cCCCCC
Confidence 1 1223578999999999988899999999999999999999999976544332222110 111122
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 334577899999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.55 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=192.7
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|+..+.||.|+||.||+|.+ .+..||||.+...... ....+.+|+.++++++||||+++++++ .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999988 4688999988754322 235688999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+. ++|..++.... ...+++..+..++.+++.||.|||. .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 68888875432 3468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc-----------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----------- 503 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~----------- 503 (641)
. .....+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||...+...........
T Consensus 156 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 156 T--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred c--------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1 12234688999999887654 688999999999999999999999765443322111000
Q ss_pred -----------ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -----------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -----------~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...............+..+.++|.+||..||.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 00000000011123456788999999999999999998844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.68 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=202.6
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
..+..|.....||.|+||.||+|.+. +..|++|++..... ....+.+|+.+++.++|+||+++++++ .+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888999999999999999986 78899999976543 456788999999999999999999987 45789999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++++|.+++.... ..+++..+..++.+++.||.|||+ .||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996432 369999999999999999999999 89999999999999999999999999998755432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+........... ... ...
T Consensus 170 ~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--~~~ 237 (286)
T cd06614 170 KSK--------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIP--PLK 237 (286)
T ss_pred hhh--------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCC--CCc
Confidence 211 12234788999999998888999999999999999999999999766544332221110 000 011
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+...+..+.++|.+||+.+|.+||++.+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 1222567899999999999999999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.43 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=196.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|++.+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.+++.++|+||+++++++ .+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888999999999999999885 67899999875432 2245789999999999999999999998 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
++++.+..++. ....+++..+..++.+++.||.|||. .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766553 23458999999999999999999999 8999999999999999999999999999887654421
Q ss_pred cCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc----------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK---------- 504 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~---------- 504 (641)
. ......++..|+|||++.+. .++.++||||||+++|+|++|++||................
T Consensus 156 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 156 S-------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred c-------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 0 11234578899999999888 88999999999999999999999997654433222111000
Q ss_pred ----------cccCCC-----CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 ----------NLLDPL-----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ----------~~~d~~-----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...... ...++...+..+.+||.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 000000 0012333478899999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.11 Aligned_cols=247 Identities=30% Similarity=0.436 Sum_probs=197.5
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|...+.||+|+||.||+|.. .+..|++|.+...... ....+..|+.+++.++|+||+++++.+ .+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999987 4688999998866543 356789999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 3458889999999999999999999 8999999999999999999999999999987654432
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcH-HHHHHHhhcccccccCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGE---LTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~~sDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~d~~~ 511 (641)
.... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.... .......... .. .
T Consensus 155 ~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~---~ 224 (264)
T cd06626 155 TMGE----EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GH---K 224 (264)
T ss_pred cccc----cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CC---C
Confidence 1111 012345789999999998766 8899999999999999999999996542 2222111111 00 1
Q ss_pred CCCCh--hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPF--VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~--~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...|. ..+..+.+++.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11122 2367889999999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=301.38 Aligned_cols=242 Identities=26% Similarity=0.413 Sum_probs=195.1
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCC---CCceeeEecccc--CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIR---HPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~--~~~~lV~ 353 (641)
.|+..+.||.|+||.||+|.+ .+..||+|.+..... .....+.+|+.+++.+. |||++++++++. +..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999997 468899999875432 23456889999999996 999999999873 4688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++|++|.+++.. ..+++..++.++.+++.||.|||+ .||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998842 368999999999999999999999 89999999999999999999999999999876543
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
... .....|+..|+|||.+.++ .++.++|||||||++|+|++|.+||............... . ..
T Consensus 155 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~---~~ 220 (277)
T cd06917 155 SSK--------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---K---PP 220 (277)
T ss_pred ccc--------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---C---CC
Confidence 211 1223588999999998754 5789999999999999999999999766543322111111 0 11
Q ss_pred CCCh-hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPF-VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.++. ..+..+.+++.+||..||.+||++.+++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 1111 2567899999999999999999999854
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.06 Aligned_cols=242 Identities=28% Similarity=0.403 Sum_probs=196.0
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
-|+..+.||.|+||.||+|.+ .+..||||++..... .....+.+|+.++.+++||||+++++++ .+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999987 467899998864432 2235688999999999999999999988 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++. ...+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999884 2458999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.............. ......+.
T Consensus 157 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~ 223 (277)
T cd06641 157 -------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------NNPPTLEG 223 (277)
T ss_pred -------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc------CCCCCCCc
Confidence 11223578899999999888899999999999999999999999975543322211110 01112234
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 251 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELL 251 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 4567899999999999999999999944
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.01 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=184.7
Q ss_pred eeeccCceEEEEEEEC-C---eEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLLR-H---MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~-~---~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggs 360 (641)
.||+|+||.||+|... + ..+++|.+..... .....+.+|+.+++.++||||+++++.|. ...++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999753 2 3466777665432 23467899999999999999999999884 46799999999999
Q ss_pred hhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 361 LEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 361 L~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 155 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI--- 155 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence 999986432 23356777888999999999999999 89999999999999999999999999987643221100
Q ss_pred ccccccCCCCCCcccCChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHH--hhcccccccCC
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLAS-------GELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL--DTGKLKNLLDP 509 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~--~~~~~~~~~d~ 509 (641)
.......|+..|+|||++.. ..++.++|||||||++|+|++ |.+||.......... ..+......
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-- 230 (268)
T cd05086 156 ---ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF-- 230 (268)
T ss_pred ---hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC--
Confidence 01123457889999998853 245789999999999999997 577886544332211 111111112
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.+..+...+..+.+++..|| .+|.+||++.+ +.+.|
T Consensus 231 -~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~-i~~~l 266 (268)
T cd05086 231 -KPQLELPYSERWYEVLQFCW-LSPEKRATAEE-VHRLL 266 (268)
T ss_pred -CCccCCCCcHHHHHHHHHHh-hCcccCCCHHH-HHHHh
Confidence 22333446778999999999 68999999999 55544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.17 Aligned_cols=247 Identities=19% Similarity=0.308 Sum_probs=188.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
...|.+.+.||+|+||.||+|.+. +..||||... ...+.+|+.+|++++|||||++++++ .+..++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999985 5789999632 23567999999999999999999987 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+. ++|.+++... ...+++..++.|+.|++.||.|||+ +||+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 6888887532 3469999999999999999999999 8999999999999999999999999999986543221
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC-CCc---------HHHHHHHhhcccc-
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GIT---------KEVQYALDTGKLK- 504 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf-~~~---------~~~~~~~~~~~~~- 504 (641)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+ ... ..+...+......
T Consensus 316 ~------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 316 T------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred c------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 1 0112346999999999999999999999999999999999987654 211 1111111111100
Q ss_pred cccCC----------------------CCCCCC--hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NLLDP----------------------LAGDWP--FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~~d~----------------------~~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.. ....|. ...+..+.+||.+||..||.+||++.+++
T Consensus 390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 00000 001111 12345789999999999999999999944
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.07 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=194.8
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 356 (641)
+|+..+.||.|++|.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999984 788999998765432 2456788999999999999999999984 4689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++ +|.+++........+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 888888654444579999999999999999999999 8999999999999999999999999999975543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---------ccc-
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKN- 505 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~---------~~~- 505 (641)
......++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......... +..
T Consensus 156 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 156 -------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred -------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 11223478899999998664 578999999999999999999999975543221111000 000
Q ss_pred -ccCCCC-----------CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 -LLDPLA-----------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 -~~d~~~-----------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...... ..+....+..+.+++.+||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 000000 011123456789999999999999999998843
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.36 Aligned_cols=245 Identities=30% Similarity=0.469 Sum_probs=200.3
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
+|...+.||+|++|.||++... +..+++|++..........+.+|+.+++.++||||+++++++ ....++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999985 788999999876554556799999999999999999999987 456889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++.... ..+++..+..++.+++.||.+||. +|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999985432 568999999999999999999999 8999999999999999999999999999876654321
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.....|+..|+|||.+.+..++.++||||||+++|+|++|++||...+.......... ........+..
T Consensus 154 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 222 (253)
T cd05122 154 -------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEK 222 (253)
T ss_pred -------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cCCCCcCcccc
Confidence 1223478999999999988899999999999999999999999976543332222211 00001111222
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.++|.+||..||.+||++.+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l 249 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLL 249 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 367899999999999999999998843
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.86 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=191.5
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc--CceEEEE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~ 353 (641)
++.+|.+.+.||+|+||.||+|... +..||+|++....... ...+.+|+.+++.++|+||+++++++. +..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999874 7889999987654322 346789999999999999999999873 4688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 6776666422 3457888899999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc-----------
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG----------- 501 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~----------- 501 (641)
... .....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||.........+...
T Consensus 157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 157 SQT--------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCC--------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 111 1223478999999998764 58889999999999999999999997554322211110
Q ss_pred -----ccccccCCCCCC---------C-ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 -----KLKNLLDPLAGD---------W-PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 -----~~~~~~d~~~~~---------~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
............ + ....+..+.+++.+|+..||.+|||+.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 000000000000 0 011246789999999999999999999844
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=302.88 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=195.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.|...+.||.|++|.||+|... +..|++|++..........+.+|+.+++.++||||+++++++ .+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445578999999999999874 678999998755444455688999999999999999999987 467899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
|++|.+++.. ..+++..+..++.+++.||.|||+ +||+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999853 458899999999999999999999 8999999999999999999999999998875433211
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+........... ..+ ....+..
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~-~~~~~~~ 240 (285)
T cd06648 171 ------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPP-KLKNLHK 240 (285)
T ss_pred ------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCC-CCccccc
Confidence 112235889999999999888999999999999999999999999765443322111111 111 1111223
Q ss_pred hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.+++.+||..+|.+||++.+++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 567899999999999999999998844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.59 Aligned_cols=249 Identities=25% Similarity=0.336 Sum_probs=193.0
Q ss_pred CCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
|++.+.||.|++|.||+|.+ .+..||+|++...... ....+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999987 4789999998765322 235688999999999999999999988 35688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+ ++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68998885332 1368999999999999999999999 89999999999999999999999999998755332111
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-------------
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 502 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~------------- 502 (641)
.....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..........
T Consensus 156 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 156 --------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred --------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1223468899999988764 578999999999999999999999976554332211100
Q ss_pred ---------cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ---------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ---------~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...............+..+.++|.+||+.+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 000000011112234457899999999999999999998844
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.70 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=206.7
Q ss_pred CCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCCCCc-hhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~~~~-~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
....+.++||+|-||.|.++...+ ..||||+++.....+. ..|.+|+++|.+|+|||||.++|+| ++.+++|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345677899999999999998876 8999999998776554 7899999999999999999999999 67899999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|..+|...... .+......+|+.||+.|++||.+ .++|||||.+.|+|+|.++++||+|||+++.+......
T Consensus 618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999755322 14555677899999999999999 78999999999999999999999999999966544322
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCcHHHHHHHhhcccccccCC-CCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGITKEVQYALDTGKLKNLLDP-LAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt--G~~Pf~~~~~~~~~~~~~~~~~~~d~-~~~~ 513 (641)
. .....+-...|||||.+..++++.++|||+||+++||+++ ...||......+..-+.+.+..-... .-..
T Consensus 694 ~------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 694 R------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred e------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 1 1223345789999999999999999999999999999865 78899765544433333222211111 1123
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.|..++..+.+|+.+||..+-.+||++.+ +...|
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~-lh~~l 801 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQ-LHLFL 801 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHH-HHHHH
Confidence 46677889999999999999999999999 44443
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.80 Aligned_cols=250 Identities=23% Similarity=0.409 Sum_probs=195.4
Q ss_pred CCCccceeeccCceEEEEEEEC---CeEEEEEEecCCCCC----------CchhHHHHHHHHhc-CCCCceeeEeccc--
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQ----------GPSEFQQEIDILSK-IRHPNLVTLVGAC-- 345 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~~----------~~~~~~~Ei~iL~~-l~HpnIv~l~g~~-- 345 (641)
+|++.+.||+|+||.||+|.+. +..+|+|.+...... ....+..|+.++.+ ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999985 477999988643211 12346778888875 7999999999987
Q ss_pred cCceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 346 PEVWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 346 ~~~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
.+..++||||++|++|.+++... .....+++..++.++.|++.||.|||.. .+++|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 45688999999999999887532 2345689999999999999999999952 57999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
|++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|.+||..............
T Consensus 159 g~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-- 227 (269)
T cd08528 159 GLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE-- 227 (269)
T ss_pred cceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--
Confidence 9998654432 11234588999999999988899999999999999999999999976544332211110
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
....+.. ....+..+.+++.+||..||.+||++.+ +..++
T Consensus 228 ~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e-~~~~~ 267 (269)
T cd08528 228 AVYEPLP---EGMYSEDVTDVITSCLTPDAEARPDIIQ-VSAMI 267 (269)
T ss_pred ccCCcCC---cccCCHHHHHHHHHHCCCCCccCCCHHH-HHHHh
Confidence 0011111 1134678999999999999999999999 44443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.32 Aligned_cols=190 Identities=22% Similarity=0.325 Sum_probs=159.6
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
...+|.+.+.||+|+||.||+|... +..||+|+.... ....|+.++++++||||+++++++ ....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999985 468999975432 346799999999999999999988 446789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+. ++|.+++.. ...++++..+..|+.||+.||.|||. +||+||||||+|||++.++.+||+|||++.......
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 688888753 33568999999999999999999999 899999999999999999999999999987533211
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALG 489 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~-~Pf~ 489 (641)
......||+.|+|||++.+..++.++|||||||++|+|+++. ++|.
T Consensus 212 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 ---------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ---------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 012345899999999999999999999999999999999854 4443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.65 Aligned_cols=238 Identities=25% Similarity=0.313 Sum_probs=196.5
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
+|++.+.||.|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++.+ .+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999885 788999999764322 346788999999999999999999987 446899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+.|++|.+++... .++++..+..++.+++.||.|||. ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998532 578999999999999999999999 899999999999999999999999999987654332
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH--HHHHHhhcccccccCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--VQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 512 (641)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .......... ...
T Consensus 155 ~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~ 219 (258)
T cd05578 155 L---------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADV 219 (258)
T ss_pred c---------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccc
Confidence 1 1223478899999999988899999999999999999999999976542 1111111110 112
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
..+...+..+.++|.+||..+|.+||++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 2344556899999999999999999999
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.76 Aligned_cols=247 Identities=26% Similarity=0.291 Sum_probs=202.5
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccccC--c
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGACPE--V 348 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~ 348 (641)
+.-...+|.++++||+|+||.|..+..+ ++.||+|++++-.. ....-|..|.+||..-+.++|+.++.+|.| +
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3334558999999999999999999885 57799999987322 234569999999999999999999999955 6
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
+|+||+|++||+|..+|.+.. ++++..+..++..|..||.-||+ .|+|||||||+|||||..|++||+|||.|-
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHH
Confidence 899999999999999996443 69999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL 503 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~ 503 (641)
.+..++... ....+|||.|++||++.. +.|++.+|+||+||++|||+.|..||...+-+...-.....
T Consensus 224 km~~dG~V~-------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 224 KMDADGTVR-------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred hcCCCCcEE-------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 887665332 244579999999999952 56999999999999999999999999777666554444333
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 504 KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 504 ~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
...+... -....+..+.+||.+.+. +|..|..
T Consensus 297 k~~l~FP---~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 297 KESLSFP---DETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred hhhcCCC---cccccCHHHHHHHHHHhc-Chhhhcc
Confidence 3333211 013478899999998775 6777766
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=302.79 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=192.0
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCC-CCceeeEecccc--Cc-----e
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIR-HPNLVTLVGACP--EV-----W 349 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~~-----~ 349 (641)
+|+..+.||.|+||.||+|.+. +..||||.+...... ....+.+|+.+++.+. ||||+++++++. +. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6888999999999999999884 688999988754322 2356889999999995 699999999873 22 6
Q ss_pred EEEEEecCCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDN--SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGI 426 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGl 426 (641)
++||||+++ +|.+++..... ...+++..++.++.||+.||.|||. ++|+||||+|+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 899999985 78888754322 3468999999999999999999999 89999999999999998 89999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccc
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
+..+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.............
T Consensus 158 ~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 158 GRAFSIPVKS--------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred ceecCCCccc--------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 8765332111 122346889999998865 4578999999999999999999999976554433221110000
Q ss_pred -----cc------------C----CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 -----LL------------D----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 -----~~------------d----~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. . ..........+..+.++|.+||..+|.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00 0 000001123567799999999999999999998844
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=297.37 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|++.+.||.|+||.||+|.+. +..|+||++..... .....+.+|+.++.+++||||+++++++ ....++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6788899999999999999885 78899999877644 2356789999999999999999999987 34689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++... .++++..++.++.+++.||.|||+. .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999533 5689999999999999999999983 58999999999999999999999999998876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH--HHHHHHhhcccccccCCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. ....++..|+|||.+.+..++.++||||||+++|+|+||.+||.... ......... ........
T Consensus 157 ~--------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 223 (264)
T cd06623 157 C--------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSL 223 (264)
T ss_pred c--------cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----hcCCCCCC
Confidence 1 12347899999999999999999999999999999999999997653 111111111 11111222
Q ss_pred Chh-hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFV-QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~-~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.. .+..+.++|.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 333 678899999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.43 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=194.0
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--c--CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--P--EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~--~~~~lV 352 (641)
.+|+..+.||.|+||.||+|.+. +..||+|.+....... ...+.+|+.++.+++||||+++++++ . ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999985 6789999987543322 23567899999999999999999987 3 578999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988885432 368999999999999999999999 8999999999999999999999999999886654
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---------
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK--------- 502 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~--------- 502 (641)
.... .....+++.|+|||.+.+. .++.++|||||||++|+|++|.+||..............
T Consensus 159 ~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 159 PLKP--------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred Cccc--------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 3211 1223478899999998765 468999999999999999999999975543221111000
Q ss_pred ------cc--------c-ccCCCCCCCChh-hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 ------LK--------N-LLDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ------~~--------~-~~d~~~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+. . ........++.. .+..+.++|.+||..+|++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 00 0 000011122222 477899999999999999999999844
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.90 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=196.6
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
+|.+.+.||.|+||.||+|..+ +..||+|.+..... .....+.+|+.+++.++||||+++++.+. ...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999884 67899999876432 23456889999999999999999999873 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-ccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNE 434 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-~vKL~DFGla~~~~~~~ 434 (641)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999985432 2358999999999999999999999 8999999999999998875 56999999987664322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
.. .....|++.|+|||.+.+..++.++|||||||++|+|++|..||...+........ ..... ...
T Consensus 157 ~~--------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~----~~~ 222 (257)
T cd08225 157 EL--------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI--CQGYF----API 222 (257)
T ss_pred cc--------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--hcccC----CCC
Confidence 11 12234889999999998888999999999999999999999999765443322211 11111 112
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSIL 252 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 234567899999999999999999999844
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=310.89 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=202.3
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
+.|..-++||+||||.||-+.. +|+-+|.|.+.+.... ......+|-.||.+++.+.||.+-.+| .+.+|+||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577888999999999997755 5788999988765332 234578999999999999999998887 57899999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
..|+||+|.-+|....+ +.|++..+..++.+|+.||.+||. .+||+|||||+|||+|+.|+++|+|.|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999976543 679999999999999999999999 89999999999999999999999999999987765
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
... ...+||.+|||||++.++.|+...|+|||||+||+|+.|+.||.....-... ..+...+......
T Consensus 341 ~~~---------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 341 KPI---------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLEDPEE 408 (591)
T ss_pred Ccc---------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhcchhh
Confidence 421 3447999999999999999999999999999999999999999644321110 0111111112345
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
++...++++.+|....|..||.+|..-.
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 6777889999999999999999997654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.95 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=191.2
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc-------Cce
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-------EVW 349 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-------~~~ 349 (641)
+++|.+.+.||+|+||.||+|.+ ++..||||++..... .....+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999987 468899999865322 22356788999999999999999998762 236
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++|+||+. ++|..++. ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 58877773 3468999999999999999999999 8999999999999999999999999999886
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc-------
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------- 501 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~------- 501 (641)
......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.........
T Consensus 156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccC-----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 543321111 1123458999999998755 568999999999999999999999996543221110000
Q ss_pred --ccccccC----------CCCCC-----CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 --KLKNLLD----------PLAGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 --~~~~~~d----------~~~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+..+.. +.... .....+..+.+++.+||+.+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000000 00000 0112356789999999999999999999844
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=300.26 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=188.7
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHH-HhcCCCCceeeEeccc--cCceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDI-LSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~i-L~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
++|++.+.||+|+||.||+|.+. +..||||.+...... ....+..|+.+ ++.++||||+++++++ .+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999884 789999998765322 23455667665 5667899999999988 456899999
Q ss_pred ecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeeccCCCCceEeccCCccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPH-SIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 355 y~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|++ |+|.+++... .....+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888777542 234579999999999999999999998 6 899999999999999999999999999876543
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHH-HHHHHhhccccccc
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLL 507 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~ 507 (641)
... .+...|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ....... .
T Consensus 157 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~ 221 (283)
T cd06617 157 SVA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------V 221 (283)
T ss_pred ccc---------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH------H
Confidence 211 122347889999998865 4578899999999999999999999964321 1111110 0
Q ss_pred CCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 DPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d~~~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......+ ...+..+.++|.+||..+|.+||++.+++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00011111 23467899999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.04 Aligned_cols=202 Identities=29% Similarity=0.377 Sum_probs=171.3
Q ss_pred hhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCC-C-----CceeeEeccc--cC
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-H-----PNLVTLVGAC--PE 347 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~g~~--~~ 347 (641)
....+|.+.+.||+|+||.|.+|.+. +..||||++++... -..+...|+.+|..|+ | -|+|+++++| .+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 33447899999999999999999984 68899999986532 2345678999999996 3 4799999987 67
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc--CCcccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NFVSKLSDFG 425 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~--~~~vKL~DFG 425 (641)
+.|||+|.+ ..+|.++|.... ...|+...++.|+.||+.||.+||. .+|||+||||+||||.. ...+||+|||
T Consensus 262 HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 899999999 579999996543 4569999999999999999999999 89999999999999954 3489999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHH
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 496 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~ 496 (641)
.|........ ....+..|.|||++.+.+|+.+.||||||||++||++|.|.|.+.++.+.
T Consensus 337 SSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 337 SSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred cccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 9987765431 23468899999999999999999999999999999999999987766543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.30 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=196.1
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|+..+.||.|+||.||++.+. +..||+|.+...... ....+.+|+.+++.++||||+++++.+ ....++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999985 688999998765432 345688999999999999999999987 45688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++++|.+++.... ..+++..+..++.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999985432 5789999999999999999999983 5899999999999999999999999999876543211
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH----HHHHHHhhcccccccCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK----EVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~----~~~~~~~~~~~~~~~d~~~~ 512 (641)
....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ........ .......
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPP 222 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCC
Confidence 11347889999999999999999999999999999999999996542 11111111 1111111
Q ss_pred CCChh-hHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFV-QAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.. .+..+.++|.+||..+|.+||++.+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 11222 567899999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.83 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=201.6
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc----CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV~ 353 (641)
+|...+.||+|++|.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999986 78899999876543 23567899999999999999999999873 4588999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++++|.+++... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998533 379999999999999999999999 89999999999999999999999999999877654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH-HHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~d~~~~ 512 (641)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ......... .....
T Consensus 155 ~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~ 223 (260)
T cd06606 155 ETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPP 223 (260)
T ss_pred ccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCc
Confidence 321 011234588999999999888899999999999999999999999976542 221111111 11122
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+...+..+.++|.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 34455578999999999999999999999844
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=300.66 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=188.9
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL 361 (641)
||+|+||+||++... +..||+|.+..... .....+..|+.+|+.++||||+++++++ .+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999874 78899999875432 1234567899999999999999999887 4568999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++..... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 999864332 468999999999999999999999 8999999999999999999999999999876543211
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH--HHHHhhcccccccCCCCCCCChhhH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+..... ......+...+
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 222 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFS 222 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCC
Confidence 12234788999999998888999999999999999999999999654321 111111111 11222344557
Q ss_pred HHHHHHHHHHhhhccCCCCChHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+.++|.+||+.+|.+||++.+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 88999999999999999996655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.17 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=190.8
Q ss_pred CCCccceeeccCceEEEEEEE----CCeEEEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEecccc----CceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL----RHMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~----~~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~ 350 (641)
.|++.+.||+|+||.||+|.. .+..||||.+.... ......+.+|+.+++.++||||+++++++. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999999999998 45889999998743 223456788999999999999999999883 4589
Q ss_pred EEEEecCCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc----CCccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDF 424 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~----~~~vKL~DF 424 (641)
+||||+++ +|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6766664221 22368999999999999999999999 89999999999999999 999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH--------
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-------- 495 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~-------- 495 (641)
|++......... ........+++.|+|||.+.+. .++.++|||||||++|+|++|++||.......
T Consensus 157 g~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 157 GLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred ccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 999876443211 0111234578999999988764 58899999999999999999999996432211
Q ss_pred ----HHHhh---------------ccccccc-CCCCCCCC-----------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 496 ----YALDT---------------GKLKNLL-DPLAGDWP-----------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 496 ----~~~~~---------------~~~~~~~-d~~~~~~~-----------~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.. ....... ......++ ...+..+.+++.+||..||.+||++.+++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 00000 0000000 00000111 13456789999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.23 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=192.9
Q ss_pred CccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 284 DPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
....+||+|+||.||+|.. ++..||||.+..........+.+|+.+++.++||||+++++.+ .+..++||||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3346799999999999988 4688999998654434455688999999999999999999987 56789999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++........
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---- 171 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 171 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc----
Confidence 9999873 2358899999999999999999999 8999999999999999999999999998875543211
Q ss_pred ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhH
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
......|++.|+|||.+.+..++.++|||||||++|+|++|.+||............. ........ .....+
T Consensus 172 ----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~ 243 (292)
T cd06657 172 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNLPPKLK-NLHKVS 243 (292)
T ss_pred ----cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhCCcccC-CcccCC
Confidence 1122357899999999988889999999999999999999999997654432211110 00111110 112345
Q ss_pred HHHHHHHHHHhhhccCCCCChHHHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..+.+++.+||..+|.+||++.+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHh
Confidence 6789999999999999999999944
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.71 Aligned_cols=239 Identities=25% Similarity=0.299 Sum_probs=199.2
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCc---hhHHHHHHHHhcCCCCceeeEeccc--cCceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---SEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
-++|+.+++||+|.||.|.++.- .++.+|||++++...... ..-..|-.+|+..+||.+..+-..| .+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35789999999999999998876 478999999998754433 3456789999999999999998877 5689999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||..||.|.-+|. ....+++.....+..+|+.||.|||+ ++||.||||.+|+|+|.+|++||+|||+|+--..
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999995 34568999999999999999999999 8999999999999999999999999999985332
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.+ . .....+|||.|+|||++....|+.++|+|.+||++|||++|+.||...+... +..++-...-
T Consensus 321 ~g--~------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-------LFeLIl~ed~ 385 (516)
T KOG0690|consen 321 YG--D------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-------LFELILMEDL 385 (516)
T ss_pred cc--c------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-------HHHHHHhhhc
Confidence 22 1 1244569999999999999999999999999999999999999996543321 1222222223
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
.+|...+++...|+..+|..||.+|..
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 467778899999999999999999954
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.57 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=197.1
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-----CCchhHHHHHHHHhcCCCCceeeEecccc----Cce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGACP----EVW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~ 349 (641)
.+|.+.+.||+|+||.||+|.+ .+..||+|.+..... .....+.+|+.++++++||||+++++++. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999987 468899998754321 12346889999999999999999999873 247
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 3458899999999999999999999 8999999999999999999999999999986
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|++||............. ..+
T Consensus 156 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~ 225 (264)
T cd06653 156 IQTICMSG-----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQP 225 (264)
T ss_pred cccccccC-----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCC
Confidence 53221100 01123458899999999998889999999999999999999999997654443322211 111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.....|...+..+.+++.+||. +|..||+..++
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~ 258 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFL 258 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence 2233456677889999999999 57999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.86 Aligned_cols=250 Identities=25% Similarity=0.304 Sum_probs=189.9
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCC-CCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|.....||+|+||.||++.+. +..||+|.+...... ....+.+|+.++.++. ||||+++++++ ....+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999884 688999998754332 2346889999999996 99999999987 4467899999
Q ss_pred cCCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 356 LPNGSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 356 ~~ggsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
+. ++|.++... ......+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 465554321 12235689999999999999999999972 48999999999999999999999999999765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
.. .....|++.|+|||.+.+. .++.++|||||||++|+|++|++||............. ........
T Consensus 162 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 231 (288)
T cd06616 162 IA---------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKGDPPIL 231 (288)
T ss_pred Cc---------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCCCCCcC
Confidence 11 1223478999999999776 68999999999999999999999997554222221111 00000011
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+...+..+.+|+.+||..+|.+||++.+++
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1122234677899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.87 Aligned_cols=258 Identities=16% Similarity=0.183 Sum_probs=182.5
Q ss_pred cCCCCccceeeccCceEEEEEEECC-----eEEEEEEecCCCCCCch-----------hHHHHHHHHhcCCCCceeeEec
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPS-----------EFQQEIDILSKIRHPNLVTLVG 343 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~-----~~vAvK~~~~~~~~~~~-----------~~~~Ei~iL~~l~HpnIv~l~g 343 (641)
...|.+.++||+|+||.||+|.+.+ ..+|+|+.......... ....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998754 35677764433221100 1123334556678999999998
Q ss_pred cccC------ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC
Q 006545 344 ACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 344 ~~~~------~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~ 417 (641)
++.. ..+++++++. .++.+.+.. ....++..+..|+.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 7522 2367888774 466666632 2335788899999999999999999 8999999999999999999
Q ss_pred cccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHH
Q 006545 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA 497 (641)
Q Consensus 418 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~ 497 (641)
.++|+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|+|++|.+||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCccccc-ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999876433211110 001122346999999999999999999999999999999999999999755221111
Q ss_pred ---HhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 498 ---LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 498 ---~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
........+.... . .....+..+.+++..|+..+|.+||++.+ +.+.|
T Consensus 243 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~-l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK-I-KIKNANKFIYDFIECVTKLSYEEKPDYDA-LIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhh-h-ccCCCCHHHHHHHHHHHhCCCCCCCCHHH-HHHhh
Confidence 1111111111110 0 12234678999999999999999999998 54443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=290.36 Aligned_cols=243 Identities=28% Similarity=0.429 Sum_probs=200.5
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|.+.+.||+|++|.||+|... +..|++|.+..... .....+.+|++++++++|||++++++++ ....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999874 57899999987654 2345789999999999999999999987 3468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++++|.+++... ..+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998533 568999999999999999999999 8999999999999999999999999999987654321
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 515 (641)
. .....++..|+|||.+.+..++.++||||||+++|+|++|.+||...+.......... ......+
T Consensus 155 ~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~ 220 (254)
T cd06627 155 D--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLP 220 (254)
T ss_pred c--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCC
Confidence 1 1223478999999999888889999999999999999999999976554333222211 1112234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+..+.+++.+||..+|++||++.+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 45678899999999999999999998843
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.65 Aligned_cols=247 Identities=20% Similarity=0.264 Sum_probs=192.1
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEecccc--------C
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--------E 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------~ 347 (641)
..+|+..+.||+|+||.||+|.+ .+..||||.+.... ......+.+|+.+++.++||||++++++|. .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999987 47889999986432 122346778999999999999999999873 2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..++||||+. ++|.+.+.. .++...+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 3689999995 588887732 28889999999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc------
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG------ 501 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~------ 501 (641)
........ .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.........
T Consensus 166 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 166 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred eeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 86543211 122357899999999999999999999999999999999999997544321110000
Q ss_pred -------------------c------cccccCC-----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 -------------------K------LKNLLDP-----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 -------------------~------~~~~~d~-----~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. +...+.. .....+...+..+.++|.+||..||.+||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 0000000 00011223466789999999999999999999955
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.34 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=192.9
Q ss_pred CccceeeccCceEEEEEEECCeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
.+.+.+|.|+++.||++..++..||||++.... ......+.+|+.+++.++||||+++++++ .+..+++|||+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344456667777777777788999999987652 22346789999999999999999999987 44689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.+.......... .
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-~ 159 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-R 159 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc-c
Confidence 9999986432 2358899999999999999999999 899999999999999999999999999987654332111 1
Q ss_pred ccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh--cccccccC-------
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLD------- 508 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~--~~~~~~~d------- 508 (641)
..........++..|+|||++.. ..++.++|||||||++|+|++|..||............ +.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11111233457889999999976 35889999999999999999999999755433322211 11110000
Q ss_pred ------------------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 509 ------------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 509 ------------------~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+...+..+.+|+.+||..||.+||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 001112233456889999999999999999999844
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.10 Aligned_cols=241 Identities=28% Similarity=0.378 Sum_probs=191.9
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
..|...+.||+|+||.||+|.. .+..||+|.+....... ...+.+|+.+++.++||||++++++| .+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4688889999999999999987 47889999986543322 24588999999999999999999988 45688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++ |+|.+++... ..++++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766432 3458999999999999999999999 89999999999999999999999999998754322
Q ss_pred cccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
....|++.|+|||++. ...++.++||||||+++|+|+||.+||...+........... . .+
T Consensus 169 ------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~--~~- 232 (307)
T cd06607 169 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--SP- 232 (307)
T ss_pred ------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-C--CC-
Confidence 1234788999999874 356889999999999999999999999765544332221110 0 00
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+++.+||..+|.+||++.+++
T Consensus 233 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 233 -TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred -CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 001223466899999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.67 Aligned_cols=251 Identities=27% Similarity=0.311 Sum_probs=193.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecccc----CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~l 351 (641)
..+|++.+.||.|+||.||+|.+. +..||+|++....... ...+.+|+.++++++|+||+++++++. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357899999999999999999984 7889999987543222 335678999999999999999999873 34789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+. ++|.+++... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 5888887532 3568999999999999999999999 899999999999999999999999999998765
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc-----c
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-----N 505 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~-----~ 505 (641)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+............ .
T Consensus 160 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 160 LPAKP--------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred CccCC--------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 33211 122235788999999875 468899999999999999999999997665443221111000 0
Q ss_pred ------------ccCCCCCCC------ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 ------------LLDPLAGDW------PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ------------~~d~~~~~~------~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+......+ ....+..+.++|.+||..||.+||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 000000000 012367789999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.17 Aligned_cols=241 Identities=27% Similarity=0.350 Sum_probs=190.7
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL 361 (641)
||.|+||.||++.+. +..|++|++..... .....+.+|+.++++++||||+++++.+ ....++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999985 78999999876543 2345688999999999999999999887 3468999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++... ..+++..+..++.|++.||.|||. .+++||||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9998543 368999999999999999999999 8999999999999999999999999999876543311100000
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh--hH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV--QA 519 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~--~~ 519 (641)
........++..|+|||.+....++.++||||||+++|+|++|..||.............. . ...++.. .+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--G-----KIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-----CcCCCccccCC
Confidence 0112234578899999999888899999999999999999999999976554332211111 0 0112222 36
Q ss_pred HHHHHHHHHHhhhccCCCCChHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+.+++.+||+.+|.+||++..
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~ 250 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKS 250 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCcc
Confidence 88999999999999999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=290.17 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=201.8
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|.+.+.||.|+||.||++.+. +..|++|++..... .....+.+|+.+++.++|||++++++.+ .+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999986 78899999876543 3345688999999999999999999887 4568899999
Q ss_pred cCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 356 ~~ggsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
+++++|.+++.... ....+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986432 23679999999999999999999999 899999999999999999999999999998664432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+........ ... .....
T Consensus 158 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~----~~~~~ 223 (258)
T cd08215 158 D--------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LKG----QYPPI 223 (258)
T ss_pred c--------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hcC----CCCCC
Confidence 1 112235889999999999888999999999999999999999999766533222111 111 11223
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 445678899999999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.20 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=191.2
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEecccc----------
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP---------- 346 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~---------- 346 (641)
++|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999884 688999988654322 2235678999999999999999999862
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
...++||||+. ++|.+.+... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 23589999996 5788877432 2368999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccc
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
+..+........ .......++..|+|||.+.+. .++.++||||||+++|+|++|++||...+..........+..
T Consensus 166 ~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 166 ARAFSLSKNSKP----NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cccccCCcccCC----CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 987654322111 111234578899999988765 478999999999999999999999976543221111000000
Q ss_pred ccC----C-------------CC--------CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 LLD----P-------------LA--------GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~~d----~-------------~~--------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.+. + .. .-.+...+..+.+||.+||..||.+||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 000 0 00 000112345678999999999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.32 Aligned_cols=234 Identities=26% Similarity=0.327 Sum_probs=191.1
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL 361 (641)
||.|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++.+ ....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999996 789999998764332 235688999999999999999999987 3468999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++.. ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------ 148 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------ 148 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------
Confidence 999953 3458999999999999999999999 8999999999999999999999999999986654310
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH--HHHHHHhhcccccccCCCCCCCChhhH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--EVQYALDTGKLKNLLDPLAGDWPFVQA 519 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~ 519 (641)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......... ......+|...+
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 220 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-----GNGKLEFPNYID 220 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-----cCCCCCCCcccC
Confidence 122357889999999988889999999999999999999999997655 2221111110 011223444457
Q ss_pred HHHHHHHHHHhhhccCCCCChHH
Q 006545 520 EQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 520 ~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+.+++.+||..+|.+||++.+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~ 243 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLK 243 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcc
Confidence 88999999999999999999533
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.10 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=194.3
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc------CceE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWT 350 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~------~~~~ 350 (641)
.+|.+.+.||.|+||.||+|... +..||+|++..... .....+.+|+.+|+.++||||+++++++. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57899999999999999999874 78899999876432 23456778999999999999999998763 3478
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||+. |+|.+++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988884 33459999999999999999999999 89999999999999999999999999999765
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHH---hh------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL---DT------ 500 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~---~~------ 500 (641)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+...... ..
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 158 SSSPTEHK----YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred cccCcCCC----cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 44321110 11123468999999999866 468899999999999999999999996543321110 00
Q ss_pred --------cccccccC--CCCCC-----CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 --------GKLKNLLD--PLAGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 --------~~~~~~~d--~~~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
........ +.... .....+..+.++|.+||+.+|.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00000000 00000 1123467899999999999999999999844
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.24 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=193.7
Q ss_pred hhcCCCCccceeeccCceEEEEEEECC-eEEEEEEecCCCC--CCchhHHHHHHHHhcCC-CCceeeEeccc--cCceEE
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSL--QGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~l 351 (641)
.....|+++++||+||.+.||++...+ ..||+|.+..... ....-|.+|+..|.+|+ |.+||+||++- ++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345679999999999999999998864 5678776654332 23467999999999994 99999999985 668999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||- ..+|..+|.+.... ++...+..+..||+.|+.++|. +||||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99986 46999999654332 3323788999999999999999 8999999999999995 5699999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----------ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~ 500 (641)
.+.++- .....+||+.||+||.+... ..++++||||||||||+|+.|++||+.......
T Consensus 511 ~DTTsI------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---- 580 (677)
T KOG0596|consen 511 PDTTSI------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---- 580 (677)
T ss_pred ccccce------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH----
Confidence 664332 23456799999999998532 256789999999999999999999975443322
Q ss_pred cccccccCCC-CCCCChhhHH-HHHHHHHHHhhhccCCCCChHHH
Q 006545 501 GKLKNLLDPL-AGDWPFVQAE-QLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 501 ~~~~~~~d~~-~~~~~~~~~~-~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
++..+.+|. .-+||..... ++.+++..||..||++||++.+.
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eL 624 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPEL 624 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHH
Confidence 234444442 2233333222 39999999999999999999983
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.87 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=190.6
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
++|.....||.|+||.||+|.+. +..||+|.+...... ....+.+|+.+++.++||||+++++++ .+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999874 678999998654322 235688999999999999999999998 356899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCcccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~~~~~~ 433 (641)
|++ ++|.+++.... ...+++..+..++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 57877774332 2346788899999999999999999 89999999999999985 567999999999755332
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-----ccccc
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK-----LKNLL 507 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~-----~~~~~ 507 (641)
.. ......+++.|+|||.+.+. .++.++|||||||++|+|+||.+||.............. .....
T Consensus 157 ~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 157 VR--------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred cc--------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 11 01223578999999998764 578999999999999999999999976544322221100 00000
Q ss_pred -------C--CCCCC--------CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 508 -------D--PLAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 -------d--~~~~~--------~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+ ..... .....+..+.+++.+||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 00000 1123456789999999999999999999854
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.25 Aligned_cols=247 Identities=27% Similarity=0.394 Sum_probs=199.3
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC---CchhHHHHHHHHhcCC-CCceeeEecccc--CceEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~lV 352 (641)
++|.+.+.||.|+||.||+|.. .+..||+|++...... ....+..|+.++++++ ||||+++++++. +..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688889999999999999988 4788999998764321 2356889999999998 999999999883 468899
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++++|.+++.. ...+++..+..|+.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999953 3469999999999999999999999 8999999999999999999999999999987654
Q ss_pred ccccCCC------------ccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh
Q 006545 433 NEISSNN------------TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 433 ~~~~~~~------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~ 500 (641)
....... ..........|+..|+|||.+....++.++||||||++++++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 3321000 0011223345789999999998888999999999999999999999999866543322111
Q ss_pred cccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
. .....++...+..+.+++.+||+.+|.+||++
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 1 11122344557889999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=341.52 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=201.5
Q ss_pred hhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
..+-++.....||.|.||.||.|.. +|...|+|-++..... ....+.+|+.+|..++|||+|++||+- .+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 4556788889999999999999987 5777899987754332 345688999999999999999999975 567899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
.||||.||+|.+.+. .+...++.....+..|++.||.|||+ +|||||||||+||||+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999984 34446777778889999999999999 899999999999999999999999999998876
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcHH-HHHHHhhccccccc
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLL 507 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~~sDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~ 507 (641)
....... ..-...+||+.|||||++.+. +..-++||||||||+.||+||+.||...+. ....+..+.
T Consensus 1386 ~~~~~~~----~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~----- 1456 (1509)
T KOG4645|consen 1386 NNAQTMP----GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA----- 1456 (1509)
T ss_pred CchhcCC----HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-----
Confidence 5521111 223456799999999999763 466799999999999999999999964432 222222211
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
...+.+|...+.+-.++|.+||..||+.|.++.+
T Consensus 1457 -gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1457 -GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred -cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 1224557778899999999999999999988776
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=293.95 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=192.3
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEecccc----CceEEEEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYE 354 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV~E 354 (641)
|.+.+.||.|+||.||+|... +..+|+|++.... ......+.+|+.+++.++|||++++++++. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999885 5889999998764 222356889999999999999999999883 45899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++ ++|.+++... ...+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 4888887533 2468999999999999999999999 899999999999999999999999999998665432
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc---------c
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------K 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~---------~ 504 (641)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||++||...+........... .
T Consensus 155 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 155 SA-------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred cc-------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 10 0122346889999998765 46889999999999999999999999765443221111000 0
Q ss_pred cc--------cCCC-------CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NL--------LDPL-------AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~--------~d~~-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ..+. ...+....+..+.+++.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 0000 0000111267899999999999999999998844
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=293.55 Aligned_cols=240 Identities=20% Similarity=0.277 Sum_probs=184.4
Q ss_pred hhhcCCCCcccee--eccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccc--cCce
Q 006545 277 EGATHNFDPSLKI--GEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVW 349 (641)
Q Consensus 277 ~~~~~~y~~~~~L--G~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~ 349 (641)
..-.++|.+.+.+ |.|+||.||++... +..+|+|++....... .|+.+...+ +||||+++++.+ .+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334566666666 99999999999874 6789999987543221 123233222 799999999987 4578
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-ccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISR 428 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-~vKL~DFGla~ 428 (641)
++||||+++|+|.+++... .++++..+..++.|++.||.|||+ .|++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998533 379999999999999999999999 8999999999999999988 99999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccC
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d 508 (641)
..... ....|+..|+|||++.+..++.++|||||||++|+|++|..||............ +....
T Consensus 159 ~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~- 223 (267)
T PHA03390 159 IIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES--LLKRQ- 223 (267)
T ss_pred ecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH--HHHhh-
Confidence 65422 1224789999999999989999999999999999999999999744321110000 00000
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCCh-HH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL-GK 542 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-~e 542 (641)
......+...+..+.++|.+||+.+|.+||+. .+
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 258 (267)
T PHA03390 224 QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE 258 (267)
T ss_pred cccCCcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence 01112233567889999999999999999964 55
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=296.64 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=194.0
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEeccccC-------
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACPE------- 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 347 (641)
...+|++.+.||.|+||.||+|... +..||||+++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3567899999999999999999984 68899999876432 223467789999999999999999998732
Q ss_pred -----ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccc
Q 006545 348 -----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422 (641)
Q Consensus 348 -----~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~ 422 (641)
..++|+||+++ +|...+... ...+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 57899999976 676766432 3468999999999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc
Q 006545 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 501 (641)
Q Consensus 423 DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~ 501 (641)
|||++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.........
T Consensus 159 dfg~~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 159 DFGLARLYNSEESRP-------YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccccccCCcccc-------cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999998665432110 1122367889999988654 57899999999999999999999997655433221111
Q ss_pred cc-----c----ccc--------CC------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 KL-----K----NLL--------DP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ~~-----~----~~~--------d~------~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. . .+. +. .........+..+.+++.+||..+|.+||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 00 0 000 00 00001113467899999999999999999998844
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=291.52 Aligned_cols=235 Identities=23% Similarity=0.274 Sum_probs=183.6
Q ss_pred ceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHH-hcCCCCceeeEecccc--CceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDIL-SKIRHPNLVTLVGACP--EVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL-~~l~HpnIv~l~g~~~--~~~~lV~Ey~~g 358 (641)
+.||.|+||.||+|.. .+..||||++....... ...+..|..++ ...+||||+++++++. +..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999988 46899999987543221 12344555544 4458999999999984 468999999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
++|.+++.. ..++++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 999999853 3468899999999999999999999 89999999999999999999999999988754321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 518 (641)
....|+..|+|||.+.+..++.++||||||+++|+|++|.+||...+............ .. .........
T Consensus 151 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~ 220 (260)
T cd05611 151 -------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR--IN-WPEEVKEFC 220 (260)
T ss_pred -------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc--cC-CCCcccccC
Confidence 22347889999999988889999999999999999999999997654432211111000 00 011112245
Q ss_pred HHHHHHHHHHHhhhccCCCCChHH
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 519 ~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+..+.+++.+||..+|.+||++.+
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~ 244 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANG 244 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCc
Confidence 678999999999999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=293.69 Aligned_cols=248 Identities=26% Similarity=0.330 Sum_probs=194.4
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
|.+.+.||.|++|.||+|... +..+++|.+...... ....+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999874 688999998765432 345788999999999999999999987 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++ +|.+++... ...+++..+..++.+++.||.|||. .+|+|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 888887543 2568999999999999999999999 8999999999999999999999999999877654320
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---------cccc
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---------LKNL 506 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~---------~~~~ 506 (641)
......++..|+|||.+.+. .++.++||||||+++|+|+||++||...+.......... +...
T Consensus 154 -------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 154 -------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred -------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 01223478899999999876 789999999999999999999999976554332211100 0000
Q ss_pred cC--------------CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 507 LD--------------PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ~d--------------~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ..........+..+.++|.+||..||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 00 000011123567899999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.04 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=192.8
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEeccccC-------c
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------V 348 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~ 348 (641)
..+|.+.+.||+|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999999874 6889999987542 2223467789999999999999999998732 3
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 68888874 33569999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh-------
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT------- 500 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~------- 500 (641)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||...+........
T Consensus 157 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 157 TTSEKGD--------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ccCCCcc--------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 6543311 0122347889999998865 46889999999999999999999999754322110000
Q ss_pred ----------ccccccc-------CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 ----------GKLKNLL-------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 ----------~~~~~~~-------d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+ .+.........+..+.+|+.+||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 0000000 0000111224567899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.89 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=205.7
Q ss_pred hhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCceEE
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~l 351 (641)
...+.|.+.+.||+|.|+.|.+|.+ ++..||||++.+..... ...+.+|+++|+.|+|||||+++.+. ...+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 4467899999999999999999987 57899999998865543 34588999999999999999999987 567999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+.+|.+.++|.+. ..+.+..+..++.|+..|++|||+ ++|+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999543 446668899999999999999999 899999999999999999999999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcHHHH--HHHhhcccccccC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGRPALGITKEVQ--YALDTGKLKNLLD 508 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~~sDVwSlGviL~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~d 508 (641)
.... ....+|++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++.+-.. .....+++
T Consensus 207 ~~~~---------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~----- 272 (596)
T KOG0586|consen 207 YGLM---------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY----- 272 (596)
T ss_pred cccc---------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-----
Confidence 5432 2344599999999999998765 89999999999999999999998654322 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 546 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~ 546 (641)
..|...+.+..+||+++|-.+|.+|+++.++.+.
T Consensus 273 ----rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 ----RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ----cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2355567789999999999999999999986543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.45 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=187.1
Q ss_pred CCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC-CchhHHHHHHHHhcCC-CCceeeEecccc----CceEEEEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLVYE 354 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~----~~~~lV~E 354 (641)
|.+.+.||+|+||.||+|.. .+..||+|++...... ......+|+.++.++. ||||+++++++. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778899999999999987 4688999998764322 2234457899999985 999999999873 56899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++ |+|.+.+... ...+++..++.++.|++.||.|||+ .|++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5787777432 2468999999999999999999999 89999999999999999 999999999998654322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc----------
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---------- 503 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~---------- 503 (641)
.. ....++..|+|||.+.. ..++.++|||||||++|+|++|.+||...+...........
T Consensus 154 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 154 PY---------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred Cc---------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 11 12347889999997754 55788999999999999999999999765433211111000
Q ss_pred ----ccccC----CCCC----CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ----KNLLD----PLAG----DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ----~~~~d----~~~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... .... ......+..+.+||.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 00000 0000 01123568899999999999999999998843
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.38 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=192.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEecccc---------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------- 346 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------- 346 (641)
.++|.+.++||.|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999984 6889999986543322 345789999999999999999998762
Q ss_pred -CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccc
Q 006545 347 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 347 -~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFG 425 (641)
...++||+|+.+ +|...+.. ....+++..+..++.|++.||.|||+ +||+|+||||+|||++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence 236899999964 67666642 23469999999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccCCCc---cccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc
Q 006545 426 ISRFLSQNEISSNNT---TLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 501 (641)
Q Consensus 426 la~~~~~~~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~ 501 (641)
++............. .....+...|++.|+|||.+.+. .++.++|||||||++|+|++|++||...+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998665432211110 11112334578899999988654 58899999999999999999999997654432211100
Q ss_pred cc---------------ccccC-CCCCCCC-------hhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 KL---------------KNLLD-PLAGDWP-------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 ~~---------------~~~~d-~~~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.. ....+ ......+ ......+.++|.+||..+|.+||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 00 00000 0000001 12235788999999999999999998843
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.36 Aligned_cols=231 Identities=27% Similarity=0.341 Sum_probs=178.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhc---CCCCceeeEeccc--cCceEEEEEecC
Q 006545 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSK---IRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~---l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.||+|+||.||++... +..||+|.+....... ...+.+|..++.. .+||||+.+++++ .+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 6889999987643221 1234455444433 4799999999887 456889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998853 3469999999999999999999999 899999999999999999999999999987543221
Q ss_pred CCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH-HHHHhhcccccccCCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~d~~~~~~~ 515 (641)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ......... ......+
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~ 219 (279)
T cd05633 152 -------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELP 219 (279)
T ss_pred -------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCc
Confidence 112358999999999864 56899999999999999999999999643211 111111110 1112234
Q ss_pred hhhHHHHHHHHHHHhhhccCCCCC
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
...+..+.++|.+||..||.+||+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcC
Confidence 456788999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.70 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=197.0
Q ss_pred CCCCChhhHhhhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEec
Q 006545 268 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343 (641)
Q Consensus 268 ~~~~~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g 343 (641)
++.....++...+++|...+.||+|+||.||+|.. .+..||+|++..... .....+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 34444556666788999999999999999999986 468899999875322 12356788999999999999999998
Q ss_pred ccc--------CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc
Q 006545 344 ACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415 (641)
Q Consensus 344 ~~~--------~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~ 415 (641)
++. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 762 2367788876 7899888742 358999999999999999999999 89999999999999999
Q ss_pred CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH
Q 006545 416 NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEV 494 (641)
Q Consensus 416 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~ 494 (641)
++.+||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred CCCEEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999998754321 122357899999999876 56889999999999999999999999654332
Q ss_pred HHHHhh----cc--------------------cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 495 QYALDT----GK--------------------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 495 ~~~~~~----~~--------------------~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...... +. +...............+..+.+||.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 211100 00 000000000011112456789999999999999999998844
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.98 Aligned_cols=240 Identities=28% Similarity=0.372 Sum_probs=189.7
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.|...+.||+|+||.||+|.+ .+..||+|++....... ...+.+|+.+++.++|||++++++++ .+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 377888999999999999987 46889999987543322 24688899999999999999999987 346889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++ |+|.+.+.. ...++++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 477777643 23468999999999999999999999 89999999999999999999999999988654321
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
....|++.|+|||++. .+.++.++|||||||++|+|++|.+||................. .
T Consensus 179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----~ 242 (317)
T cd06635 179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----P 242 (317)
T ss_pred -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-----C
Confidence 1234788999999974 45688999999999999999999999865443222111110000 0
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+|+.+||..+|.+||++.+++
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 011223466799999999999999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=317.14 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=195.1
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEeccccC--------ce
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACPE--------VW 349 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 349 (641)
..+.....||+||||.||+|++ .|..||||.++.... ...+...+|+++|++|+|||||+++++-++ ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3455667899999999999997 488999999987543 345678899999999999999999987532 35
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc--CC--cccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA--NF--VSKLSDFG 425 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~--~~--~vKL~DFG 425 (641)
.+|||||.||||+..|..-.+...|++...+.++.+++.||.|||. +||+||||||.||++-. +| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 7999999999999999887777889999999999999999999999 89999999999999942 23 56999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcH------HHHHHH
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITK------EVQYAL 498 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~------~~~~~~ 498 (641)
.|+-+.++. ..+..+||..|.+||++.. +.|+..+|.|||||++|+++||..||-... .+....
T Consensus 170 ~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~ 240 (732)
T KOG4250|consen 170 AARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI 240 (732)
T ss_pred ccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh
Confidence 999887663 2355679999999999984 789999999999999999999999994221 122222
Q ss_pred hhccccccc--------CCC--------CCCCChhhHHHHHHHHHHHhhhccCCCC--ChHH
Q 006545 499 DTGKLKNLL--------DPL--------AGDWPFVQAEQLANLAMRCCEMSRKSRP--ELGK 542 (641)
Q Consensus 499 ~~~~~~~~~--------d~~--------~~~~~~~~~~~l~~Li~~cL~~dP~~RP--s~~e 542 (641)
...+-.... .|. ...........+..++..+|..+|.+|. ...+
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~ 302 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDR 302 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcch
Confidence 111110000 000 1111122344678889999999999998 5544
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.85 Aligned_cols=244 Identities=30% Similarity=0.408 Sum_probs=198.5
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|++.+.||.|+||.||++... +..+|+|.+...... ....+.+|+.+++.++||||+++++++ ....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999874 678999998764322 234678899999999999999999887 4568899999
Q ss_pred cCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 356 ~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
+++++|.+++... .....+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988542 223568999999999999999999999 899999999999999999999999999998765431
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|++||...+......... . ......
T Consensus 158 ----------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~----~~~~~~ 221 (256)
T cd08530 158 ----------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--R----GKYPPI 221 (256)
T ss_pred ----------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--c----CCCCCC
Confidence 112347889999999999899999999999999999999999997665432221111 1 111222
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+..+.+++.+||..+|.+||++.+++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 345667899999999999999999999843
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.79 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=187.6
Q ss_pred eeecc--CceEEEEEEE--CCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 288 KIGEG--GYGSIYKGLL--RHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 288 ~LG~G--~fG~Vy~g~~--~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
.||+| +||+||++.+ .++.||+|++....... .+.+.+|+.+++.++||||++++++| .+..++||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 57999999987543222 35688999999999999999999998 45688999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCC
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~- 159 (328)
T cd08226 85 SANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK- 159 (328)
T ss_pred CHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc-
Confidence 9999886432 2358899999999999999999999 8999999999999999999999999987654332211110
Q ss_pred ccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccc-------------
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK------------- 504 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~------------- 504 (641)
..........++..|+|||++.+. .++.++|||||||++|+|++|.+||................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 000001112356789999999764 57899999999999999999999997543322221110000
Q ss_pred --------------------------ccc-CCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 --------------------------NLL-DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 --------------------------~~~-d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
... .......+...+..+.+|+.+||..||.+||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 0000111234567899999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=303.18 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=192.1
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccccC----------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE---------- 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---------- 347 (641)
.++|.+.+.||.|+||.||+|... +..||+|.+..........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999884 68899999876655555678899999999999999999987632
Q ss_pred ------ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec-cCCccc
Q 006545 348 ------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSK 420 (641)
Q Consensus 348 ------~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld-~~~~vK 420 (641)
..++||||++ ++|.+++. ...+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 3689999996 58888773 2358899999999999999999999 8999999999999997 556889
Q ss_pred ccccccccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh
Q 006545 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD 499 (641)
Q Consensus 421 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~ 499 (641)
|+|||++........... ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.......
T Consensus 156 l~dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 230 (342)
T cd07854 156 IGDFGLARIVDPHYSHKG-----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230 (342)
T ss_pred ECCcccceecCCcccccc-----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999876543211110 0122357889999998754 5688899999999999999999999975543322211
Q ss_pred hccccc---------------------ccCCC--CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 500 TGKLKN---------------------LLDPL--AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 500 ~~~~~~---------------------~~d~~--~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...... ..... ........+..+.+|+.+||..||.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 100000 00000 0001123456789999999999999999999844
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=302.50 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=188.1
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccccC--------c
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE--------V 348 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~ 348 (641)
.+|.....||+|+||.||+|.+ ++..||||++...... ....+.+|+.+++.++||||+++++++.. .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5789999999999999999987 4788999998753221 23457899999999999999999998732 3
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
+++|+||+. ++|..++ ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 589999995 4776654 2358899999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc----
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL---- 503 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~---- 503 (641)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...........
T Consensus 166 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 166 HADAE-----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCCCC-----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 54321 122347889999999876 46889999999999999999999999765432221110000
Q ss_pred -------------ccccC--CC--C---CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -------------KNLLD--PL--A---GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -------------~~~~d--~~--~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... +. . .......+..+.+||.+||+.||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00000 00 0 000112456789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.63 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=192.1
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccccC-------
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACPE------- 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------- 347 (641)
..++|++.+.||+|+||.||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3567999999999999999999874 688999998653222 23457899999999999999999998732
Q ss_pred -ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 348 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 348 -~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
.+++||+|+ +++|.+++. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 789988873 2468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc--
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL-- 503 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~-- 503 (641)
+....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+...........
T Consensus 165 ~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 165 ARQTDSEM-----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccCc-----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 87553221 22347889999999876 45889999999999999999999999765433221111000
Q ss_pred ---------------ccccC---C----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ---------------KNLLD---P----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ---------------~~~~d---~----~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
..... . .........+..+.++|.+||..||.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000 0 00011123456789999999999999999999844
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.33 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=192.9
Q ss_pred CCCccceeeccCceEEEEEEECC--eEEEEEEecCCCC-----CCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL-----QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLV 352 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV 352 (641)
+|.+.+.||+|+||.||++.+.. ..+++|+++.... .....+..|+.+++.++||||+++++++ .+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788899999999999998753 4466666554221 1223567899999999999999999988 3468899
Q ss_pred EEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
|||+++++|.+++... .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 234569999999999999999999999 89999999999999975 569999999987654
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
..... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||............. ....
T Consensus 157 ~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~------~~~~ 222 (260)
T cd08222 157 GSCDL--------ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV------EGPT 222 (260)
T ss_pred CCccc--------ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------cCCC
Confidence 32211 122347889999999988889999999999999999999999997654433222211 1111
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.++|.+||..+|.+||++.+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 223455678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=300.66 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=195.6
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEeccccC-------ceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 350 (641)
+|.+.+.||.|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++.. ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999974 6889999987653 2334678999999999999999999998732 478
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||+|++ ++|.+++.. ..++++..+..++.+++.||.|||+ +||+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 588888842 3379999999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL------ 503 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~------ 503 (641)
....... .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||...+...........
T Consensus 154 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 154 DPDEDEK-----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ccccccc-----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 5442110 011234578999999999887 7899999999999999999999999765433211110000
Q ss_pred -----------ccccC---C----CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -----------KNLLD---P----LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -----------~~~~d---~----~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+. . .........+..+.+++.+||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 00000 0 00001122467899999999999999999999844
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=296.11 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=189.3
Q ss_pred CCCccceeeccCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHhcC-CCCceeeEecccc--Cce
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 349 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~-----~~~~vAvK~~~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 349 (641)
+|++.+.||.|+||.||++.. ++..||+|++..... .....+.+|+.++..+ +||||+++++++. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999886 468899999875432 1235678899999999 5999999998874 457
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++++|.+++.. ..++++..+..++.|++.||.|||+ .|++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 899999999999999853 3468899999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccccc
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 507 (641)
........ .....|+..|+|||.+... .++.++||||||+++|+|++|..||............ ...+
T Consensus 155 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~ 224 (290)
T cd05613 155 FHEDEVER-------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI---SRRI 224 (290)
T ss_pred cccccccc-------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH---HHHh
Confidence 54332111 1223588999999998753 4778999999999999999999999643211000000 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 508 d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
......++...+..+.+++.+||..+|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 011122345567789999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.92 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=189.1
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~ 353 (641)
.++|.+.+.||.|+||.||+|.+. +..||||.+...... ....+..|+.++.++ .||||++++++| ....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356888999999999999999986 789999999754322 234566788777776 499999999998 34688999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+. ++|.+++... ..++++..+..++.+++.||.|||+. .||+||||+|+||+++.++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 5777766432 23789999999999999999999972 48999999999999999999999999998765432
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGE----LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||............. +... .+
T Consensus 169 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~-~~ 237 (296)
T cd06618 169 KA---------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI-LQEE-PP 237 (296)
T ss_pred Cc---------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH-hcCC-CC
Confidence 11 12234788999999987553 7889999999999999999999997533221111110 0000 00
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. .......+..+.+|+.+||..+|.+||++.+++
T Consensus 238 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 238 S-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred C-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0 011123567899999999999999999998854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.22 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=193.4
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHhcC-CCCceeeEecccc--C--ceE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--E--VWT 350 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~--~~~ 350 (641)
..+|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++++ +||||++++++|. + ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999884 6889999886432 22334577899999999 9999999999873 2 478
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||++ ++|..++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 589888742 268899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh---------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------- 500 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~--------- 500 (641)
......... .......|+..|+|||.+.+ ..++.++|||||||++|+|+||++||............
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPEN---PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccC---cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 543221100 11223458999999998765 46788999999999999999999999654332211100
Q ss_pred --------cccccccC----C---CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHH
Q 006545 501 --------GKLKNLLD----P---LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 545 (641)
Q Consensus 501 --------~~~~~~~d----~---~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~ 545 (641)
......++ . .........+..+.++|.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000000 0 001111225678999999999999999999999553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.74 Aligned_cols=234 Identities=26% Similarity=0.339 Sum_probs=181.4
Q ss_pred eeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHH---HHhcCCCCceeeEeccc--cCceEEEEEecC
Q 006545 288 KIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEID---ILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~---iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.||+|+||.||+|.. .++.||+|.+....... ...+..|.. .++...||||+.+++++ .+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999987 46789999987643221 122444444 34445799999999987 356889999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
||+|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999884 33569999999999999999999999 899999999999999999999999999987553221
Q ss_pred CCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHH-HHhhcccccccCCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~d~~~~~~~ 515 (641)
.....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........ ..... .......++
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 219 (278)
T cd05606 152 -------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELP 219 (278)
T ss_pred -------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----hhccCCCCC
Confidence 1223589999999999754 689999999999999999999999975421110 00000 001112334
Q ss_pred hhhHHHHHHHHHHHhhhccCCCC-----ChHH
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRP-----ELGK 542 (641)
Q Consensus 516 ~~~~~~l~~Li~~cL~~dP~~RP-----s~~e 542 (641)
...+..+.+++.+||..+|.+|| ++.+
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ 251 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHH
Confidence 45578999999999999999999 7776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.27 Aligned_cols=248 Identities=29% Similarity=0.387 Sum_probs=190.0
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--chhHHHHHHHHhcC---CCCceeeEecccc--Cc-----
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI---RHPNLVTLVGACP--EV----- 348 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l---~HpnIv~l~g~~~--~~----- 348 (641)
|++.+.||.|+||.||+|.+. +..||+|++....... ...+.+|+.+++++ +||||+++++++. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999985 6889999997543221 34566788877666 5999999999873 33
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.+++|||++ ++|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 789999997 48888875432 2358999999999999999999999 899999999999999999999999999987
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc---c--
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK---L-- 503 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~---~-- 503 (641)
........ ....++..|+|||.+.+..++.++|||||||++|+|++|.+||.............. .
T Consensus 156 ~~~~~~~~---------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 156 IYSFEMAL---------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226 (287)
T ss_pred eccCCccc---------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCC
Confidence 76433211 122478899999999998999999999999999999999999976544322111100 0
Q ss_pred -----------ccccCCCC----CCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 -----------KNLLDPLA----GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 -----------~~~~d~~~----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+.... .......+..+.++|.+||..||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 00000000 011123456789999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.41 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=190.7
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCC-CCceeeEeccc--cCceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
|.+.+.||.|+||+||+|... +..|+||.+...... ......+|+..+++++ ||||+++++++ .+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999984 678999998754322 2234567999999999 99999999988 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998885433 2468999999999999999999999 8999999999999999999999999999876543221
Q ss_pred CCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhc--------------
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG-------------- 501 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~-------------- 501 (641)
.....++..|+|||++.. ..++.++||||||+++|+|++|++||.............
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 155 --------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred --------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 122347889999998854 457899999999999999999999997554332221110
Q ss_pred -----ccccccCCC----CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 502 -----KLKNLLDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 502 -----~~~~~~d~~----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.....+... ........+..+.++|.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred hhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 000000000 0011112256799999999999999999998844
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.66 Aligned_cols=248 Identities=28% Similarity=0.384 Sum_probs=193.5
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~ 356 (641)
|+....||+|+||.||+|... +..||+|++.... ......+..|+.+++.++||||+++++++. +..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556678999999999999885 6889999998754 223456889999999999999999999874 4689999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+ ++|.+++.... ..+++..+..++.+++.||.|||. .||+||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999985432 468999999999999999999999 89999999999999999999999999998866433211
Q ss_pred CCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-------------
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------------- 502 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~------------- 502 (641)
.....++..|+|||.+.+. .++.++|||||||++|+|++|.+||..............
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 155 --------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred --------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 1223357889999999776 789999999999999999999999976654332211100
Q ss_pred -----cccccCCC----CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 -----LKNLLDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 -----~~~~~d~~----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+... ........+..+.++|.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 00000000 0000112356899999999999999999999844
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.53 Aligned_cols=254 Identities=18% Similarity=0.222 Sum_probs=178.9
Q ss_pred cCCCCccceeeccCceEEEEEEECC---eEEEEEEec--------------C---CCCCCchhHHHHHHHHhcCCCCcee
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLH--------------P---HSLQGPSEFQQEIDILSKIRHPNLV 339 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~---~~vAvK~~~--------------~---~~~~~~~~~~~Ei~iL~~l~HpnIv 339 (641)
..+|.+.+.||+|+||+||++..+. ..+++|.+. + ........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 112222110 0 0111124578999999999999999
Q ss_pred eEeccc--cCceEEEEEecCCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc
Q 006545 340 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKD--NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415 (641)
Q Consensus 340 ~l~g~~--~~~~~lV~Ey~~ggsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~ 415 (641)
++++++ .+..|+|++++. ++|.+++.... .........+..|+.||+.||.|||+ +||+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 999988 456889999985 57777664321 11223456778899999999999999 89999999999999999
Q ss_pred CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCc--H
Q 006545 416 NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP-ALGIT--K 492 (641)
Q Consensus 416 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~-Pf~~~--~ 492 (641)
++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||+|++|.. ||... .
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCEEEEeCCCceecCccccc-------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 999999999999876533211 1123468999999999999999999999999999999999874 44322 1
Q ss_pred HHHHHHhhcc--------c-------ccccCC-----CCCCC-----ChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 493 EVQYALDTGK--------L-------KNLLDP-----LAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 493 ~~~~~~~~~~--------~-------~~~~d~-----~~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
.......... + ...+.. ..... ....+..+.++|.+||..||.+||++.+++
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 1111110000 0 000000 00000 011234678889999999999999999944
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=294.33 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=192.7
Q ss_pred CCCccceeeccCceEEEEEEE-----CCeEEEEEEecCCCC----CCchhHHHHHHHHhcC-CCCceeeEecccc--Cce
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSL----QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVW 349 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~-----~~~~vAvK~~~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~ 349 (641)
+|.+.+.||+|+||.||++.. .+..||||++..... .....+.+|+.++.++ +||||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477788999999999999875 357799999875321 2235678999999999 5999999998873 468
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|.||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 899999999999998843 3458899999999999999999999 8999999999999999999999999999876
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcHHH--HHHHhhccccc
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGKLKN 505 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~~sDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~~~~~~~ 505 (641)
+...... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ...+......
T Consensus 155 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~- 226 (288)
T cd05583 155 FLAEEEE-------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK- 226 (288)
T ss_pred ccccccc-------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-
Confidence 5433211 112235889999999987654 788999999999999999999999643211 0111111001
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVL 548 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~L 548 (641)
.....+...+..+.+++.+||..+|++||++.+ +...|
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~-~~~~l 264 (288)
T cd05583 227 ----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG-ADEIK 264 (288)
T ss_pred ----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcch-HHHHh
Confidence 112234445678999999999999999999877 43333
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.70 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=192.3
Q ss_pred hhhcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc---Cce
Q 006545 277 EGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVW 349 (641)
Q Consensus 277 ~~~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~---~~~ 349 (641)
-..+++|++.+.||.|+||.||+|... +..||||.+..... .....+.+|+.+++.++||||++++++|. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345778999999999999999999874 68899998865322 22456889999999999999999999872 358
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 350 ~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
++||||+ +++|..++. ..++++..+..++.|++.||.|||+ .+|+||||+|+|||++.++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 578988873 2357888899999999999999999 8999999999999999999999999999875
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh--------
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT-------- 500 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~-------- 500 (641)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|+||++||............
T Consensus 158 ~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 158 QDPQM-----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cCCCc-----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 43211 22347889999998866 56899999999999999999999999754432111000
Q ss_pred ---------cccccccCCC--CCC-----CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 ---------GKLKNLLDPL--AGD-----WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 ---------~~~~~~~d~~--~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+... ... .....+..+.++|.+||..+|.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000 001 1123457899999999999999999998843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.39 Aligned_cols=240 Identities=22% Similarity=0.299 Sum_probs=196.8
Q ss_pred cCCCCccceeeccCceEEEEEEECC--eEEEEEEecCCCCC---CchhHHHHHHHHhcC-CCCceeeEeccc--cCceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ---GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~l 351 (641)
..+|.++.+||+|+||.|.+|..+| ..+|||++++.... +.+--..|-.+|.-. +-|.+++++.+| .+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3478999999999999999998876 45999999876432 233345677777766 578899999888 468999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+.||+|.-++. .-+.+.+..+..++.+|+-||-|||+ +|||+||||.+|||||.+|++||+|||+++---
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999884 34568888999999999999999999 999999999999999999999999999997432
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 511 (641)
-.. ......+|||.|+|||++...+|+.++|+|||||+||||+.|++||++.++......... ..
T Consensus 502 ~~~--------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e-------hn 566 (683)
T KOG0696|consen 502 FDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME-------HN 566 (683)
T ss_pred cCC--------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-------cc
Confidence 221 112345699999999999999999999999999999999999999998766543222211 11
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
-.+|...+.+...++...|...|.+|...
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 24678889999999999999999999543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.18 Aligned_cols=238 Identities=28% Similarity=0.368 Sum_probs=188.9
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~E 354 (641)
.|+..+.||.|+||.||+|... +..||+|.+...... ....+.+|+.+++.++|||++++++++ .+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777788999999999999884 678999988653222 234577899999999999999999987 456889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+. |+|.+.+... ..++++..+..++.+++.||.|||+ .+++||||+|+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 5787776432 3458999999999999999999999 89999999999999999999999999998764322
Q ss_pred ccCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHH--hhcccccccCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL--DTGKLKNLLDP 509 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~--~~~~~~~~~d~ 509 (641)
....|++.|+|||.+. ...++.++|||||||++|+|++|..||...+...... ..+...
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 232 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----- 232 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC-----
Confidence 1234788999999985 3567889999999999999999999986544332221 111110
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
...+...+..+.+||.+||..+|.+||++.+++
T Consensus 233 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred --CcCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 011234567899999999999999999998844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.98 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=191.0
Q ss_pred CCCC-ccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC--------------chhHHHHHHHHhcCCCCceeeEec
Q 006545 281 HNFD-PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--------------PSEFQQEIDILSKIRHPNLVTLVG 343 (641)
Q Consensus 281 ~~y~-~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~--------------~~~~~~Ei~iL~~l~HpnIv~l~g 343 (641)
.+|. +.+.||.|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 3467999999999999874 6889999986543221 124778999999999999999999
Q ss_pred cc--cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccc
Q 006545 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 344 ~~--~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL 421 (641)
++ .+..++||||+. |+|.+++. ....+++..+..++.|++.||.|||+ .||+||||+|+|||++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEE
Confidence 87 456889999996 68988884 33458999999999999999999999 89999999999999999999999
Q ss_pred cccccccccccccccCC-----C-ccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHH
Q 006545 422 SDFGISRFLSQNEISSN-----N-TTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEV 494 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~-----~-~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~ 494 (641)
+|||++........... . ..........+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986652211000 0 000111223468899999998764 4789999999999999999999999766543
Q ss_pred HHHHhhcc---------ccccc-----CC-------CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 495 QYALDTGK---------LKNLL-----DP-------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 495 ~~~~~~~~---------~~~~~-----d~-------~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
........ +.... .+ .........+..+.++|.+||..+|.+||++.+++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 32211100 00000 00 00001123356789999999999999999999844
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.30 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=189.4
Q ss_pred CCCccceeeccCceEEEEEEEC----CeEEEEEEecCCCCC--CchhHHHHHHHHhcC-CCCceeeEeccc------cCc
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKI-RHPNLVTLVGAC------PEV 348 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~----~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l-~HpnIv~l~g~~------~~~ 348 (641)
+|.+.+.||+|+||.||++... +..||||.+...... ....+.+|+.+++++ +||||+++++.+ ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999985 458999998753222 234678899999999 599999999864 134
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.+++++|+. ++|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889885 68988884 34568999999999999999999999 899999999999999999999999999998
Q ss_pred ccccccccCCCccccccCCCCCCcccCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHh--------
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD-------- 499 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~-------- 499 (641)
.+........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......
T Consensus 154 ~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 154 GFSENPGENA----GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred eccccccccc----ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 6654321111 11123468999999998765 4689999999999999999999999975432211100
Q ss_pred ---------hcc-------cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 500 ---------TGK-------LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 500 ---------~~~-------~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
... ................+..+.+++.+||..+|.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 000000000011112356899999999999999999999843
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.61 Aligned_cols=200 Identities=28% Similarity=0.413 Sum_probs=165.8
Q ss_pred CCCccceeeccCceEEEEEEEC------CeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc---cCceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~---~~~~~ 350 (641)
.|+....||+|.||.||+|.-+ ...+|||.++...... .....+|+.+++.++||||+.|..+| +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 6888899999999999999653 2369999998764322 34578999999999999999998887 44688
Q ss_pred EEEEecCCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC----Cccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCK--DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN----FVSKLSDF 424 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~----~~vKL~DF 424 (641)
++++|.+. +|..++... .....++...+..|+.||+.|+.|||+ +-|+||||||.||||..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 788777533 233568899999999999999999999 889999999999999876 99999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGI 490 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~ 490 (641)
|+++.+...-.. .......+-|++|.|||.+.+. .||++.||||+|||+.||+|-.|.|.+
T Consensus 181 GlaR~~~~plkp-----l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKP-----LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccc-----cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999988654321 1122344579999999999885 699999999999999999999988854
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=291.15 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=188.2
Q ss_pred CCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEe
Q 006545 283 FDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEY 355 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 355 (641)
|.....||+|+||.||+|.. .+..|++|++....... ...+.+|+.+++.++|||++++++++. +..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56667899999999999987 46889999987543322 245788999999999999999999873 468899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+. |+|.+++... ..++++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5777777432 3468999999999999999999999 8999999999999999999999999998753221
Q ss_pred cCCCccccccCCCCCCcccCChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLA---SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
.....|+..|+|||++. ...++.++|||||||++|+|++|.+||...+............ . + .
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~--~--~ 239 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S--P--T 239 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C--C--C
Confidence 12235889999999984 4568899999999999999999999997654433222211110 0 0 0
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+..+.+|+.+||+.+|.+||++.+++
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11123346799999999999999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=336.48 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=194.4
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
..|.....||+|+||.||+|.. .+..||||.+..... ....|+.++++++|||||+++|+| .+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 3567778999999999999986 478899999864332 224568999999999999999998 34688999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++. .++|..+..|+.+++.||.|||..+..+|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999983 38899999999999999999996444799999999999999998887775 6654332111
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH--------HHHHHHhhcccccccC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK--------EVQYALDTGKLKNLLD 508 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~--------~~~~~~~~~~~~~~~d 508 (641)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... +.............++
T Consensus 836 ---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 836 ---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 12257899999999999999999999999999999999999985321 1111111222223333
Q ss_pred CCC---CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 509 PLA---GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 509 ~~~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
+.. ...+......+.+++.+||+.+|.+||++.+ +++.|+.+...
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e-vl~~L~~~~~~ 954 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND-VLKTLESASRS 954 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH-HHHHHHHhhcc
Confidence 322 1223345567889999999999999999999 67778877653
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.10 Aligned_cols=238 Identities=21% Similarity=0.368 Sum_probs=186.9
Q ss_pred CccceeeccCceEEEEEEEC--CeEEEE---EEecCC-CCCCchhHHHHHHHHhcCCCCceeeEeccccC----ceEEEE
Q 006545 284 DPSLKIGEGGYGSIYKGLLR--HMQVAI---KMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGACPE----VWTLVY 353 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~--~~~vAv---K~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~lV~ 353 (641)
....+||+|+|-+||+|.+. |..||- |.-... .....+.|..|+.+|+.|+||||+++|+++.+ ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34457999999999999985 444542 221111 11224679999999999999999999998732 467999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~~~~~ 432 (641)
|.+..|+|..++.+ ...++...+..|+.||+.||.|||+.+| +|||||||.+||||+. -|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999954 3457888999999999999999999775 9999999999999975 58999999999998765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-HHHHHH--HhhcccccccCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGIT-KEVQYA--LDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~-~~~~~~--~~~~~~~~~~d~ 509 (641)
... ....|||.|||||++. ..|+..+||||||++++||+|+..||.-- +..+.. +..|.....
T Consensus 199 s~a----------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s--- 264 (632)
T KOG0584|consen 199 SHA----------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA--- 264 (632)
T ss_pred ccc----------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH---
Confidence 531 3356999999999997 88999999999999999999999999532 322221 122211111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+.....+++.++|.+||.. ..+||++.+.|
T Consensus 265 ----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 265 ----LSKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred ----hhccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 1222356899999999999 99999999944
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.35 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=192.0
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC--CCchhHHHHHHHHhcCCCCceeeEecccc--C-----
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--E----- 347 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~----- 347 (641)
..++|.....||.|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999984 67899999865321 22355778999999999999999988763 2
Q ss_pred -ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 348 -VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 348 -~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence 278999998 6799998842 468999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccccc
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
+...... .....++..|+|||.+.+. .++.++|||||||++|+|++|++||.................
T Consensus 165 ~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 165 ARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred ccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 8765432 1223478899999998653 678999999999999999999999975544322111100000
Q ss_pred c--------------------cCCC-CC---CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 506 L--------------------LDPL-AG---DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 506 ~--------------------~d~~-~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. +... .. ......+..+.++|.+||..+|.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 0 0000 00 00112367899999999999999999999843
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.50 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=189.7
Q ss_pred CCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCC-CCCchhHHHHHHHHhcCCCCceeeEeccc------------
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGAC------------ 345 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~------------ 345 (641)
.+|+....||+||||.||+++. .|..||||++.... ......+.+|+.+|++|+|||||++|.++
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678889999999999999987 59999999998664 22245688999999999999999986321
Q ss_pred ---------------------------------------------c----------------------------------
Q 006545 346 ---------------------------------------------P---------------------------------- 346 (641)
Q Consensus 346 ---------------------------------------------~---------------------------------- 346 (641)
.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ------------------------------CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 006545 347 ------------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396 (641)
Q Consensus 347 ------------------------------~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 396 (641)
-..||=||||+..+|.+++..+.... .....++++.+|++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~- 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD- 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh-
Confidence 01356788888877777774332111 356789999999999999999
Q ss_pred CCCceeeccCCCCceEeccCCccccccccccccccc---c---c----ccCCCccccccCCCCCCcccCChhhhccC---
Q 006545 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ---N---E----ISSNNTTLCCRTDPKGTFAYMDPEFLASG--- 463 (641)
Q Consensus 397 ~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~---~---~----~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--- 463 (641)
+|||||||||.|||||.++.|||+|||+|..... . . ...........+..+||.-|+|||++.+.
T Consensus 716 --~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 --QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred --CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8999999999999999999999999999987220 0 0 00111111234667899999999999765
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 464 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 464 ~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.|+.|+|+|||||||+||+. ||+..-+....+.. +....-|....+.....+.-..+|.+|++.||.+|||+.+.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~--LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN--LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh--cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 49999999999999999985 57654443333322 22211122234455566678899999999999999999994
Q ss_pred H
Q 006545 544 V 544 (641)
Q Consensus 544 v 544 (641)
+
T Consensus 869 L 869 (1351)
T KOG1035|consen 869 L 869 (1351)
T ss_pred h
Confidence 4
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=279.67 Aligned_cols=233 Identities=30% Similarity=0.370 Sum_probs=191.1
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCCh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSL 361 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL 361 (641)
||.|+||.||++... +..||+|++...... ....+..|+.+++.++||||+++++.+. +..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999885 688999998765433 2357889999999999999999999874 467999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~ 441 (641)
.+++.. ...+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 999853 3368999999999999999999999 8999999999999999999999999999876644310
Q ss_pred ccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHH
Q 006545 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521 (641)
Q Consensus 442 ~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 521 (641)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ....++...+..
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 219 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------DPLRFPEFLSPE 219 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------CCCCCCCCCCHH
Confidence 11234578899999999888899999999999999999999999976553221111100 112334455788
Q ss_pred HHHHHHHHhhhccCCCCChHH
Q 006545 522 LANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 522 l~~Li~~cL~~dP~~RPs~~e 542 (641)
+.+++.+||..||.+||++.+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 999999999999999999953
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=279.44 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=188.2
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
...+..||.|..|.||++.++ |...|||.+...... ..+++...++++.+. ++|+||+.+|+| +...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999986 488999998865433 245677778877666 489999999998 44677889987
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+..+..+|.. ...++++..+-++...++.||.||... ++|+|||+||+|||+|..|++||+|||++..+......
T Consensus 174 -s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 -STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred -HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4456666642 345699999999999999999999986 68999999999999999999999999999887665422
Q ss_pred CCCccccccCCCCCCcccCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcHH-HHHHHhhcccccccCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG---ELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~~sDVwSlGviL~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~d~~~~ 512 (641)
+...|.+.|||||.+... .|+.++||||||+.|+||.||+.||.+.+. +...... +.. ..|...
T Consensus 249 ---------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv--ln~-ePP~L~ 316 (391)
T KOG0983|consen 249 ---------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV--LNE-EPPLLP 316 (391)
T ss_pred ---------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH--Hhc-CCCCCC
Confidence 334589999999999654 688999999999999999999999976432 2221111 111 112211
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
. ....++.+.+++..||..|+.+||...+
T Consensus 317 ~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~ 345 (391)
T KOG0983|consen 317 G-HMGFSPDFQSFVKDCLTKDHRKRPKYNK 345 (391)
T ss_pred c-ccCcCHHHHHHHHHHhhcCcccCcchHH
Confidence 1 1226789999999999999999999988
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=281.14 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=192.9
Q ss_pred hcCCCCcc-ceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccccC------c
Q 006545 279 ATHNFDPS-LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE------V 348 (641)
Q Consensus 279 ~~~~y~~~-~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~ 348 (641)
.+.+|.+. .+||-|-.|.|-.+..+ +..+|+|++.. ....++|++..-.. .|||||.+++++.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35566654 47999999999988774 67899999863 34678899887665 59999999998843 4
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec---cCCcccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFG 425 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld---~~~~vKL~DFG 425 (641)
+.+|||.++||.|...+..+ ....|++.++..|+.||+.|+.|||+ .+|.||||||+|+|.. .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 66899999999999999654 34579999999999999999999999 8999999999999996 45689999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHH------HHHHHh
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE------VQYALD 499 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~------~~~~~~ 499 (641)
+|+...... . .....-|+.|.|||++....|+..+|+||+||++|-||+|.|||-.... ....+.
T Consensus 210 FAK~t~~~~---~------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 210 FAKETQEPG---D------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred cccccCCCc---c------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 998655322 1 2334579999999999999999999999999999999999999953322 222222
Q ss_pred hcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 500 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 500 ~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.+ .+.....+| ...++...++|+.+|..+|.+|.++.++
T Consensus 281 ~g----qy~FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 281 TG----QYEFPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred cc----CccCCChhH-hHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 22 111122334 3578899999999999999999999983
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=277.95 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=194.5
Q ss_pred ceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEecccc--CceEEEEEecCCCCh
Q 006545 287 LKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLVYEYLPNGSL 361 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL 361 (641)
..||+|+|+.|-.++. ++..+|||++.+........+.+|++++... .|+||++|+.+|+ +.+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4699999999987754 6889999999988777788899999999998 5999999999995 479999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC---CcccccccccccccccccccCC
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~---~~vKL~DFGla~~~~~~~~~~~ 438 (641)
..++. ....|++..+.++..+|+.||.|||. +||.||||||+|||.... .-+||+||.+...+.....-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s- 236 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS- 236 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC-
Confidence 99985 34569999999999999999999999 999999999999999644 357999999987654443222
Q ss_pred CccccccCCCCCCcccCChhhhc---c--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH-----------------HH
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLA---S--GELTPKSDVYSFGIILLRLLTGRPALGITKEV-----------------QY 496 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~---~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~-----------------~~ 496 (641)
.........++|+..|||||+.. + ..|+.++|.||||||||-||.|.+||.+.-.. ..
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 12223345678999999999773 2 35899999999999999999999999542111 11
Q ss_pred HHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 497 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 497 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.+..|+.. ....+| ...+.+..+||..+|..++.+|-++.++
T Consensus 317 sIQEGkYe----FPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 317 SIQEGKYE----FPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred HHhccCCc----CChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 11222111 111222 3567789999999999999999999883
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.92 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=203.0
Q ss_pred CCCccceeeccCceEEEEEEECCeE--EEEEEecCCCCC---CchhHHHHHHHHhcCCCCceeeEeccccC--ceEEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQ---GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYE 354 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~~~--vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~E 354 (641)
++..+..||-||||.|=++..++.. +|+|++++.... ..+++..|-+||...++|.||++|-.|.+ ..|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4456677999999999998887655 899988875433 34668899999999999999999999954 5789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
-|-||.|...|. ..+.|+..+...++..+.+|+.|||+ +|||+|||||+|+++|.+|-+||.|||+|+.+....
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999994 44568889999999999999999999 999999999999999999999999999999876553
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 514 (641)
. ....+|||.|.|||++.+..++.++|.||||+++|||+||.|||.+.+++......-+..+. -.|
T Consensus 575 ---K------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----i~~ 640 (732)
T KOG0614|consen 575 ---K------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----IEF 640 (732)
T ss_pred ---c------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----hhc
Confidence 1 23456999999999999999999999999999999999999999988877654333222222 246
Q ss_pred ChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 515 ~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
|........+||++++..+|.+|..
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 7888899999999999999999987
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=316.30 Aligned_cols=143 Identities=29% Similarity=0.435 Sum_probs=126.7
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEE
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~ 353 (641)
.+|.+.++||+|+||.||+|.+. +..||||++....... ...+..|+.++..++||||+++++++ .+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999986 7899999997644322 25688999999999999999999887 45789999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
||+.|++|.+++.. ...+++..++.|+.||+.||.|||. ++|+||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999853 3458899999999999999999999 8999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.25 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=206.3
Q ss_pred CCccceeeccCceEEEEEEEC------CeEEEEEEecCCCC-CCchhHHHHHHHHhcCCCCceeeEecccc-CceEEEEE
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYE 354 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~~~~lV~E 354 (641)
....++||.|+||+||+|.+- +-+||||++..... ....++..|+-+|.+++|||+++|+|+|. ....||++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 345678999999999999882 35799999876543 33568999999999999999999999994 45779999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+|+|+|.+++.. .+.++..+..+.|..||++|+.|||. ++++||||-..||||..-.++||.|||+++.+....
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999964 44568888999999999999999999 899999999999999999999999999999887664
Q ss_pred ccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcH--HHHHHHhhcccccccCCCC
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK--EVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~ 511 (641)
..-. .....-.+.|||=|.+....|+.++|||||||++||++| |..|+.+.. ++...+..+..
T Consensus 853 ~ey~------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------- 918 (1177)
T KOG1025|consen 853 KEYS------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------- 918 (1177)
T ss_pred cccc------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------
Confidence 3211 122234678999999999999999999999999999998 989987543 33333333321
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
-..|..++-++.-++.+||..|+..||.+.+ +...+..+..
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fke-l~~~fs~~ar 959 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKE-LAEEFSRMAR 959 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHH-HHHHHHHHhc
Confidence 2347788889999999999999999999998 6666665554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.42 Aligned_cols=218 Identities=24% Similarity=0.203 Sum_probs=176.4
Q ss_pred cCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCCChhhhhhc
Q 006545 292 GGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSC 367 (641)
Q Consensus 292 G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL~~~L~~ 367 (641)
|.||.||++.+ ++..||+|++.... .+..|...+....||||+++++++ .+..++||||++||+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999988 46889999987643 344566666667899999999987 3468999999999999999853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCC
Q 006545 368 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447 (641)
Q Consensus 368 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 447 (641)
. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||.+....... ..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----------~~ 141 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----------DG 141 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------cc
Confidence 2 358999999999999999999999 899999999999999999999999999876554321 12
Q ss_pred CCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHH
Q 006545 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 527 (641)
Q Consensus 448 ~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~ 527 (641)
..++..|+|||.+.+..++.++||||+||++|+|++|..||....... ........|...+..+.+++.
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccCCcccCCHHHHHHHH
Confidence 235778999999988889999999999999999999998885332110 000011234456778999999
Q ss_pred HHhhhccCCCCChHH
Q 006545 528 RCCEMSRKSRPELGK 542 (641)
Q Consensus 528 ~cL~~dP~~RPs~~e 542 (641)
+||+.||.+||++.+
T Consensus 211 ~~l~~dp~~R~~~~~ 225 (237)
T cd05576 211 QLLQFNPTERLGAGV 225 (237)
T ss_pred HHccCCHHHhcCCCc
Confidence 999999999999855
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.56 Aligned_cols=243 Identities=26% Similarity=0.318 Sum_probs=191.3
Q ss_pred ccceeeccCceEEEEEEEC--CeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEEEecCC
Q 006545 285 PSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 285 ~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
-+..||.|+||+|++-.++ |+..|||.++.... ....++..|.++..+- +.||||++||++ +...+|.||.| .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 3457999999999998775 78899999987654 3456788888876555 789999999986 45678999999 4
Q ss_pred CChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 359 GSLEDRLSC--KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 359 gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
.||..+... ......+++..+-.|......||.||... ..||||||||+|||++..|.+||+|||++..+..+-
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-- 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-- 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--
Confidence 577655422 12345688888899999999999999985 679999999999999999999999999998765442
Q ss_pred CCCccccccCCCCCCcccCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh---cccccccCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLAS--GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT---GKLKNLLDPLA 511 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~---~~~~~~~d~~~ 511 (641)
..+...|...|||||.+.. ..|+-+|||||||++|||+.||..|+...+.+...+.. +....+. .
T Consensus 223 -------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~---~ 292 (361)
T KOG1006|consen 223 -------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL---F 292 (361)
T ss_pred -------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec---C
Confidence 1244568999999999965 35999999999999999999999999877665444332 2111111 1
Q ss_pred CCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 512 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..-..+.+..+..+|.-||.+|.++||...+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 1112346789999999999999999999988
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=255.32 Aligned_cols=246 Identities=28% Similarity=0.382 Sum_probs=193.7
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
+|+...+||+|.||+||+|... +..||+|.++..... -+....+|+.+|+.++|.|||+++++. +....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666778999999999999875 577999998865433 367789999999999999999999986 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
|. .+|..+.... ++.++...+..++.|++.||.|+|+ ++++|||+||.|+||+.||.+||+|||+++.+.-..
T Consensus 83 cd-qdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 95 5787777533 4568899999999999999999999 899999999999999999999999999999775432
Q ss_pred cCCCccccccCCCCCCcccCChhhhccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.+....+-|.+|.+|.++.+.. |+...|+||-|||+.|+.. |+|.|.+.+..+.....-+.. -.+....
T Consensus 156 -------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l--g~p~ed~ 226 (292)
T KOG0662|consen 156 -------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL--GTPTEDQ 226 (292)
T ss_pred -------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh--CCCcccc
Confidence 3445556799999999998864 8899999999999999986 888887765544433221111 1111111
Q ss_pred CC---------------h---------hhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 514 WP---------------F---------VQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 514 ~~---------------~---------~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
|| . .....-.+|+.+.|.-+|..|.++..+
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 11 1 112235789999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=275.72 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=198.8
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCC--CCCCchhHHHHHHHHhcCCCCceeeEecccc---------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------- 346 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--------- 346 (641)
.+.|....+||+|.||.||+|... ++.||+|++... ...-+....+|+++|..|.|+|++.++..|.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 356777889999999999999874 577999876543 2233566789999999999999999999882
Q ss_pred -CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccc
Q 006545 347 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 347 -~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFG 425 (641)
..+|+||.+|+ .+|..+|. +....++...+.+++.++..||.|+|. ..|+|||+||+|+||+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence 13899999996 48888884 334679999999999999999999999 789999999999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhccc-
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL- 503 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~- 503 (641)
+++.+......... ..+..+-|.+|.+||.+.+. .|+++.|||..|||+.+|+||.|.|.+..+.+.......+
T Consensus 170 lar~fs~~~n~~kp----rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 170 LARAFSTSKNVVKP----RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred cccceecccccCCC----CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99988765433322 24566779999999999875 7999999999999999999999999876654433211110
Q ss_pred ---c-------------ccc--CCCC-CC--------CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 504 ---K-------------NLL--DPLA-GD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 504 ---~-------------~~~--d~~~-~~--------~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. ..+ .|.. +. -|..-.+...+|+..+|..||.+||++.+++
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 0 000 0000 00 0112234788999999999999999999854
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=292.85 Aligned_cols=239 Identities=27% Similarity=0.422 Sum_probs=198.3
Q ss_pred cceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--CchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCCC
Q 006545 286 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNG 359 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~gg 359 (641)
.++||.|.||+||-|+++ |+.||||++.+.... ....+.+|+.||+.+.||.||.+--.| .+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 467999999999999884 799999999876443 346789999999999999999998877 56899999999655
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc---CCccccccccccccccccccc
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~---~~~vKL~DFGla~~~~~~~~~ 436 (641)
=|.-+|. ...+.|++.....++.||+.||.|||. ++|+|+||||+|||+.. -.++||+|||+|+.+....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 4555553 234569999999999999999999999 89999999999999954 3589999999999987653
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCCh
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 516 (641)
.+...+||+.|+|||++....|+..-|+||.|||+|--|+|.-||....++...+....+.... ..| .
T Consensus 722 -------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp----~PW-~ 789 (888)
T KOG4236|consen 722 -------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPP----NPW-S 789 (888)
T ss_pred -------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCC----Cch-h
Confidence 2355679999999999999999999999999999999999999998777665555443332211 122 3
Q ss_pred hhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 517 ~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
..+....+||...|+..-.+|.+..+.
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 567789999999999999999998763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=301.35 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=211.4
Q ss_pred ChhhHhhhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccc---
Q 006545 272 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC--- 345 (641)
Q Consensus 272 ~~~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--- 345 (641)
.++.+...+..|.+...||.|.+|.||++.. .++.+|+|+...... ..+++..|.+||+.+ +|||++.+||++
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444555677899999999999999998876 578899999887553 346788999999988 699999999987
Q ss_pred ----cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccc
Q 006545 346 ----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 346 ----~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL 421 (641)
++.++||||||.|||..|++.... ...+.|..+..|+..++.||.+||. +.++|||||-.|||++.++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEE
Confidence 567999999999999999997655 6679999999999999999999999 78999999999999999999999
Q ss_pred cccccccccccccccCCCccccccCCCCCCcccCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHH
Q 006545 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY 496 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~ 496 (641)
+|||++..+.... ..+...+|||.|||||++.- ..|+..+|+||||++..||.-|.||+........
T Consensus 165 vDFGvSaQldsT~--------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra 236 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA 236 (953)
T ss_pred eeeeeeeeeeccc--------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence 9999998765442 23345679999999999964 3477899999999999999999999988777766
Q ss_pred HHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 497 ALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 497 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.+...+-. |....-|...+.++.++|..||..|...||++.+.
T Consensus 237 LF~IpRNP----PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 237 LFLIPRNP----PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred hccCCCCC----CccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 54432111 11112245668899999999999999999998873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=283.36 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=196.7
Q ss_pred CCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcC--CCCceeeEecccc------CceEEEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI--RHPNLVTLVGACP------EVWTLVY 353 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~g~~~------~~~~lV~ 353 (641)
......+||+|.||.||+|.+.++.||||++... ....|.+|-+|.+-. .|+||++++++-. ..+.||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3455667999999999999999999999998753 345788888888765 7999999999752 2578999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC------CceeeccCCCCceEeccCCcccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP------HSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
+|.+.|+|.++|. ...++|....+|+..+++||+|||.-.+ .+|+|||||+.||||.+++..-|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999994 3458999999999999999999998443 47999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCC------------C
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELT-----PKSDVYSFGIILLRLLTGRPAL------------G 489 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s-----~~sDVwSlGviL~eLltG~~Pf------------~ 489 (641)
..+........ .-..+||.+|||||++.+. .+. .+.||||+|.|||||++...-+ .
T Consensus 364 l~~~p~~~~~d------~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 364 LRLEPGKPQGD------THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred EEecCCCCCcc------hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 98875432211 1236799999999999764 222 3689999999999999865332 1
Q ss_pred -------CcHHHHHHHhhcccccccCCCCCCCCh-hhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 490 -------ITKEVQYALDTGKLKNLLDPLAGDWPF-VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 490 -------~~~~~~~~~~~~~~~~~~d~~~~~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
..+.++..+...+....+.. .|.. .....+.+.+..||+.||.-|.|+.= +.+.+..+...
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~---~W~~h~~~~~l~et~EeCWDhDaeARLTA~C-v~eR~~~l~~~ 506 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPD---AWRKHAGMAVLCETIEECWDHDAEARLTAGC-VEERMAELMML 506 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChh---hhhcCccHHHHHHHHHHHcCCchhhhhhhHH-HHHHHHHHhcc
Confidence 11223333333333222211 1111 23567899999999999999999988 66666666544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=281.80 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=196.2
Q ss_pred cCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhc--CCCCceeeEecccc------CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK--IRHPNLVTLVGACP------EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~------~~~~l 351 (641)
.....+.+.||+|.||+||+|.++|..||||++.... ...+.+|.+|.+. |+|+||+.++++-. ..++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 3456778899999999999999999999999997543 3467788888876 49999999998751 25789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCceeeccCCCCceEeccCCccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----CKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
|.+|-+.|||.|+|.. ..++....++++..+|.||++||. .....|.|||||+.||||.++|..-|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999943 468899999999999999999996 1224699999999999999999999999999
Q ss_pred ccccccccccCCCccccccCCCCCCcccCChhhhccC----CCC--chhhHHHHHHHHHHHHhC----------CCCCCC
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----ELT--PKSDVYSFGIILLRLLTG----------RPALGI 490 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s--~~sDVwSlGviL~eLltG----------~~Pf~~ 490 (641)
|-........ .....+..+||..|||||++... .+. ..+||||||.|+||+... ++||..
T Consensus 363 Av~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 363 AVRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eEEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9876654311 11223556899999999999653 222 358999999999998763 367742
Q ss_pred cHH----HHHH---HhhcccccccCCCCCCCC-hhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHh
Q 006545 491 TKE----VQYA---LDTGKLKNLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 491 ~~~----~~~~---~~~~~~~~~~d~~~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~ 553 (641)
.-+ .... +-..++...+ ...|. ......+.+|++.||..||.-|-++-. +.+.|..+..
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALr-iKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALR-IKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHH-HHHHHHHHhc
Confidence 211 1111 1122222222 22232 234568999999999999999999987 7777766653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=304.86 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=203.7
Q ss_pred cCCCCccceeeccCceEEEEEEEC---------CeEEEEEEecCCCCC-CchhHHHHHHHHhcC-CCCceeeEecccc--
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 346 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~---------~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-- 346 (641)
..+..+.+.||.|.||.|++|... ...||||.++..... ....+..|+++|+.+ .||||+.++|+|.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 334456669999999999999753 356999999865443 356799999999999 5999999999994
Q ss_pred CceEEEEEecCCCChhhhhhcCC------C-----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKD------N-----S--PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~------~-----~--~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl 413 (641)
...++|+||+..|+|.++|.... . . ..++....+.++.|||.|+.||++ .++|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 46889999999999999997554 0 0 238899999999999999999999 889999999999999
Q ss_pred ccCCcccccccccccccccccccCCCccccccCCCCC--CcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 006545 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG--TFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGI 490 (641)
Q Consensus 414 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G--t~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~ 490 (641)
..+..+||+|||+|+.......... ....| ...|||||.+....|+.++|||||||+||||+| |..||.+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~-------~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT-------KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-------cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999996554432211 11112 345999999999999999999999999999998 8999976
Q ss_pred c---HHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 491 T---KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 491 ~---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
. ..+...+..|. ....|..++.++.+++..||+.+|.+||++.+ +.+.++.+
T Consensus 525 ~~~~~~l~~~l~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~-~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE-CVEFFEKH 579 (609)
T ss_pred CCcHHHHHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHHHHH
Confidence 3 22222222322 23347778899999999999999999999999 66777664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=277.84 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=192.5
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCC--CCc----eeeEeccc--cCc
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR--HPN----LVTLVGAC--PEV 348 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~--Hpn----Iv~l~g~~--~~~ 348 (641)
.+.+|.+...+|+|.||.|-.+.++ +..||||+++.-.. -.+...-|+++|.++. -|+ +|.+.++| ..+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999998885 57899999875432 2345677999999994 233 77888887 457
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-------------
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA------------- 415 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~------------- 415 (641)
.|||+|.+ |-|+.++|.. ++..+++...+..|+.|++.+++|||+ .+++|-||||+|||+..
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence 89999998 6799999954 345679999999999999999999999 89999999999999921
Q ss_pred -------CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 006545 416 -------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL 488 (641)
Q Consensus 416 -------~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf 488 (641)
+..++|+|||.|......+ ...+.|..|.|||++.+-+++..+||||+||||+|+.||...|
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3468999999998766553 3345799999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHhhcccccccC--------------CCCCCC-------------------------ChhhHHHHHHHHHHH
Q 006545 489 GITKEVQYALDTGKLKNLLD--------------PLAGDW-------------------------PFVQAEQLANLAMRC 529 (641)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~d--------------~~~~~~-------------------------~~~~~~~l~~Li~~c 529 (641)
...+..+.......+...++ ...-+| .......|.+|+.+|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 75543221110000000000 000011 123445799999999
Q ss_pred hhhccCCCCChHHHHH
Q 006545 530 CEMSRKSRPELGKDVW 545 (641)
Q Consensus 530 L~~dP~~RPs~~evv~ 545 (641)
|.+||.+|+|+.+++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=289.29 Aligned_cols=235 Identities=26% Similarity=0.359 Sum_probs=188.6
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccccC--ceEEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYE 354 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~--~~~lV~E 354 (641)
+..|.+...+|.|+|+.|-.+.. +++..++|++.... ....+|+.++... +||||+++.+.+.+ ..|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 55788888899999999998877 46789999997652 2345677666665 79999999999955 6889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe-ccCCcccccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL-DANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl-d~~~~vKL~DFGla~~~~~~ 433 (641)
++.|+-|.+.+... . .....+..|+.+|+.|+.|||. +|+|||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~---~-~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK---P-EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc---c-hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999888877432 2 2236777899999999999999 899999999999999 58899999999999876554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
. ...+-|..|.|||++....|+.+|||||||++||+||+|+.||.....-...... + ..+.
T Consensus 470 ~-----------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~-----i---~~~~ 530 (612)
T KOG0603|consen 470 C-----------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR-----I---QMPK 530 (612)
T ss_pred h-----------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh-----h---cCCc
Confidence 1 1233588999999999999999999999999999999999999644322111111 0 0122
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+....+..+.+|+.+||+.||.+||++.++.
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 2356788999999999999999999999843
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=265.47 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=192.3
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCC---CCchhHHHHHHHHhcC-CCCceeeEecccc--CceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~l 351 (641)
..+|+.+++||+|+|+.|..+.+. .+.+|+|++++.-. .+..-+..|-.+.... +||.+|-+..+|. ..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357899999999999999998875 46799999987533 3345567788887766 7999999999984 46899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
|.||++||+|.-++. ....+++..+..+..+|+.||.|||+ .|||+||||.+|+|+|..|++||+|+|+++---
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999988884 45679999999999999999999999 999999999999999999999999999998543
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH-------HHHHHHhhcccc
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-------EVQYALDTGKLK 504 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~-------~~~~~~~~~~~~ 504 (641)
..+. .....+|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+... ..++.+.
T Consensus 403 ~~gd--------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq----- 469 (593)
T KOG0695|consen 403 GPGD--------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ----- 469 (593)
T ss_pred CCCc--------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH-----
Confidence 3221 1234569999999999999999999999999999999999999996321 1111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCC
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 539 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs 539 (641)
++-...-.+|...+-....++...|++||.+|..
T Consensus 470 -vilekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 470 -VILEKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -HHhhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1111112235555667888999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=257.48 Aligned_cols=234 Identities=30% Similarity=0.397 Sum_probs=187.8
Q ss_pred CceEEEEEEEC--CeEEEEEEecCCCCCC-chhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCChhhhhhc
Q 006545 293 GYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSC 367 (641)
Q Consensus 293 ~fG~Vy~g~~~--~~~vAvK~~~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~~~L~~ 367 (641)
+||.||+|... +..+|+|++....... ...+.+|+.++++++|+||+++++.+. ...+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999985 5889999998765544 578999999999999999999999884 568899999999999999853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCC
Q 006545 368 KDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447 (641)
Q Consensus 368 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~ 447 (641)
. ..+++..++.++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------~~~~ 145 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------LLTT 145 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------cccc
Confidence 2 238899999999999999999999 899999999999999999999999999998765432 1123
Q ss_pred CCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHH
Q 006545 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAM 527 (641)
Q Consensus 448 ~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~ 527 (641)
..++..|++||.+.+..++.++||||||+++|+|++|..||............... .... ........+..+.+++.
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-PKPP--FPPPEWKISPEAKDLIR 222 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-cCCC--CccccccCCHHHHHHHH
Confidence 34788999999999888999999999999999999999999763222211111000 0000 00000015678999999
Q ss_pred HHhhhccCCCCChHHHH
Q 006545 528 RCCEMSRKSRPELGKDV 544 (641)
Q Consensus 528 ~cL~~dP~~RPs~~evv 544 (641)
+||..+|.+||++.+++
T Consensus 223 ~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 223 KLLVKDPEKRLTAEEAL 239 (244)
T ss_pred HHccCCchhccCHHHHh
Confidence 99999999999999844
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=291.72 Aligned_cols=252 Identities=20% Similarity=0.211 Sum_probs=164.7
Q ss_pred hcCCCCccceeeccCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecc--------
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA-------- 344 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~-------- 344 (641)
..++|.+.++||+|+||.||+|.+. +..||||++..... .+.+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999884 56899998764321 1111111 1222223333333222
Q ss_pred ccCceEEEEEecCCCChhhhhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCC
Q 006545 345 CPEVWTLVYEYLPNGSLEDRLSCKDNS-----------------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 407 (641)
Q Consensus 345 ~~~~~~lV~Ey~~ggsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIk 407 (641)
..+..++||||+++++|.+++...... .......+..|+.|++.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 134688999999999999988533210 011234466899999999999999 899999999
Q ss_pred CCceEecc-CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccC----------------------C
Q 006545 408 PANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG----------------------E 464 (641)
Q Consensus 408 p~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~ 464 (641)
|+|||++. ++.+||+|||+|+.+...... ......|++.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-------CCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999985 689999999999865432211 11334589999999976432 2
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCcHHH-HHHHhhc-----ccccccCCCC-C------CCChhhHHHHHHHHHHHhh
Q 006545 465 LTPKSDVYSFGIILLRLLTGRPALGITKEV-QYALDTG-----KLKNLLDPLA-G------DWPFVQAEQLANLAMRCCE 531 (641)
Q Consensus 465 ~s~~sDVwSlGviL~eLltG~~Pf~~~~~~-~~~~~~~-----~~~~~~d~~~-~------~~~~~~~~~l~~Li~~cL~ 531 (641)
++.++|||||||+||||+++..|++..... ...+... .+...+.+.. . ...........+||.+||.
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 344679999999999999977665432111 1111110 0011111100 0 0001122345689999999
Q ss_pred hccCCCCChHHHH
Q 006545 532 MSRKSRPELGKDV 544 (641)
Q Consensus 532 ~dP~~RPs~~evv 544 (641)
.||.+||++.+++
T Consensus 436 ~dP~kR~ta~e~L 448 (566)
T PLN03225 436 FKGRQRISAKAAL 448 (566)
T ss_pred CCcccCCCHHHHh
Confidence 9999999999844
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=279.74 Aligned_cols=255 Identities=19% Similarity=0.223 Sum_probs=178.6
Q ss_pred hcCCCCccceeeccCceEEEEEEE------------------CCeEEEEEEecCCCCCCch--------------hHHHH
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLL------------------RHMQVAIKMLHPHSLQGPS--------------EFQQE 326 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~------------------~~~~vAvK~~~~~~~~~~~--------------~~~~E 326 (641)
..++|.+.++||+|+||.||+|.+ .++.||||.+......... .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999964 2357999998754322222 23457
Q ss_pred HHHHhcCCCCce-----eeEecccc----------CceEEEEEecCCCChhhhhhcCCC---------------------
Q 006545 327 IDILSKIRHPNL-----VTLVGACP----------EVWTLVYEYLPNGSLEDRLSCKDN--------------------- 370 (641)
Q Consensus 327 i~iL~~l~HpnI-----v~l~g~~~----------~~~~lV~Ey~~ggsL~~~L~~~~~--------------------- 370 (641)
+.++.+++|.++ ++++++|. ...+|||||+++|+|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 66777662 347899999999999998863211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCC
Q 006545 371 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450 (641)
Q Consensus 371 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~G 450 (641)
...+++..+..++.+++.||.|||. .+|+||||||+|||++.++.+||+|||++.......... .....+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-------PLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------ccccCC
Confidence 1235677889999999999999999 899999999999999999999999999997554321110 112235
Q ss_pred CcccCChhhhccCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCcHHHHHHHhh-----cc
Q 006545 451 TFAYMDPEFLASGE--------------------LT--PKSDVYSFGIILLRLLTGRP-ALGITKEVQYALDT-----GK 502 (641)
Q Consensus 451 t~~Y~APE~l~~~~--------------------~s--~~sDVwSlGviL~eLltG~~-Pf~~~~~~~~~~~~-----~~ 502 (641)
|+.|+|||.+.... |+ .+.||||+|||+|+|++|.. ||............ ..
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 88999999885432 11 24799999999999999875 77533222111110 00
Q ss_pred cccccCCCCCC--CChhhHHHHHHHHHHHhhhcc---CCCCChHHHH
Q 006545 503 LKNLLDPLAGD--WPFVQAEQLANLAMRCCEMSR---KSRPELGKDV 544 (641)
Q Consensus 503 ~~~~~d~~~~~--~~~~~~~~l~~Li~~cL~~dP---~~RPs~~evv 544 (641)
+.. ....... .....+....+|+.+||..+| .+|+|+.+++
T Consensus 453 ~r~-~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 453 WRM-YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HHh-hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 000 0000001 122356789999999999866 6899999954
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=291.38 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=190.3
Q ss_pred CCCccceeeccCceE-EEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEeccccC--ceEEEEEecC
Q 006545 282 NFDPSLKIGEGGYGS-IYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACPE--VWTLVYEYLP 357 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~-Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~--~~~lV~Ey~~ 357 (641)
-|...+++|.|+-|+ ||+|.+.++.||||.+-... .....+|+..|+.- +|||||++|+.-.+ ..||..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 355667799999875 69999999999999886533 23568999999988 59999999987643 5889999994
Q ss_pred CCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc---C--Ccccccccccccccc
Q 006545 358 NGSLEDRLSCKDNS-PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---N--FVSKLSDFGISRFLS 431 (641)
Q Consensus 358 ggsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~---~--~~vKL~DFGla~~~~ 431 (641)
.+|.+++...... ........+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+|+.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6999999653111 111113457889999999999999 78999999999999975 2 578999999999887
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCcHHHHHHHhhcccccccCCC
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~d~~ 510 (641)
....+... .....||-+|+|||++....-+.++|||||||++|+.++| .+||+..-..+..+..+...... +
T Consensus 663 ~~~sS~~r-----~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~--L 735 (903)
T KOG1027|consen 663 GGKSSFSR-----LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH--L 735 (903)
T ss_pred CCcchhhc-----ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee--e
Confidence 76543322 3456799999999999998888899999999999999985 99998776655444443221111 0
Q ss_pred CCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 511 ~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
. +.. .....+||.+|++++|..||++.+++
T Consensus 736 ~---~~~-d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 E---PLP-DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred c---cCc-hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 111 11889999999999999999999965
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=247.97 Aligned_cols=262 Identities=21% Similarity=0.368 Sum_probs=199.7
Q ss_pred CCCCCcCCCCChhhHh-hhcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCC-CCc
Q 006545 262 SHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPN 337 (641)
Q Consensus 262 ~~~~~~~~~~~~~ei~-~~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn 337 (641)
...+..+++|.--.+. +...+|++.+++|+|.|+.||.|.. ++..++||++++-. ...+.+|+.||..|. |||
T Consensus 18 ~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~N 94 (338)
T KOG0668|consen 18 EERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPN 94 (338)
T ss_pred ccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCC
Confidence 3445566666543333 4567899999999999999999985 57889999998643 357899999999997 999
Q ss_pred eeeEeccccC----ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe
Q 006545 338 LVTLVGACPE----VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 338 Iv~l~g~~~~----~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl 413 (641)
|++++++..+ ...||+||+.+.+...+. +.|+...+..++.+++.||.|+|+ .||+|||+||.|++|
T Consensus 95 Ii~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 95 IIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMI 165 (338)
T ss_pred eeehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeee
Confidence 9999998854 367999999998887765 457778899999999999999999 999999999999999
Q ss_pred cc-CCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC-C
Q 006545 414 DA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALG-I 490 (641)
Q Consensus 414 d~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~-~ 490 (641)
|. .-.++|+|+|+|.++...... ...+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||- +
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eY---------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred chhhceeeeeecchHhhcCCCcee---------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 85 468999999999988765422 223467789999999764 58889999999999999999998873 2
Q ss_pred cHHHHHHHhh-------------cccccccCCC---------C--------CCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 491 TKEVQYALDT-------------GKLKNLLDPL---------A--------GDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 491 ~~~~~~~~~~-------------~~~~~~~d~~---------~--------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
.+..+..+.. .+..-.+++. . .+-....++++.+|+.+.|.+|..+|||+
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa 316 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA 316 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch
Confidence 2221111110 0011111111 0 11112235789999999999999999999
Q ss_pred HHHH
Q 006545 541 GKDV 544 (641)
Q Consensus 541 ~evv 544 (641)
.++.
T Consensus 317 kEam 320 (338)
T KOG0668|consen 317 KEAM 320 (338)
T ss_pred HHHh
Confidence 9843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=277.15 Aligned_cols=248 Identities=28% Similarity=0.358 Sum_probs=207.8
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEe
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey 355 (641)
..+|.....+|.|.||.||++++. +...|+|+++.....+..-+..|+-+++..+|||||.++|.+ .+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457889999999999999999884 788999999988877788889999999999999999999988 5689999999
Q ss_pred cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccc
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
|.||+|.+.. ....++++.++..++++.+.||+|||+ .|-+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCccccee---eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--
Confidence 9999999987 456789999999999999999999999 89999999999999999999999999998765433
Q ss_pred cCCCccccccCCCCCCcccCChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFL---ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l---~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
...+....||+.|||||+. ..+.|...+|||++|+...|+---++|.......+...... ...+++...
T Consensus 166 ------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~l 237 (829)
T KOG0576|consen 166 ------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTL 237 (829)
T ss_pred ------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCcc
Confidence 2344567799999999987 35789999999999999999998888865554444333221 122233222
Q ss_pred CCChhhHHHHHHHHHHHhhhccCCCCChHHH
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 513 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev 543 (641)
.-+...+..+.+|++.||..+|++||++...
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaekl 268 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKL 268 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence 3344557789999999999999999999873
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=239.37 Aligned_cols=200 Identities=27% Similarity=0.351 Sum_probs=161.5
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCC-CCchhHHHHHHHHhcC-CCCceeeEeccc--cCceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~lV~ 353 (641)
.+....+..||+|+||.|-+-.+ .|...|+|.+...-. +...+..+|+++..+. .+|.+|.+||.. ....+|.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455567799999998865544 689999999986543 2345677888877665 799999999976 44688999
Q ss_pred EecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|.|. .||..+...- ..+..+++..+-+|+..+..||.|||+. ..+||||+||+|||++.+|++|+||||++..+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 6777665332 4556789999999999999999999995 6899999999999999999999999999987765
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLAS----GELTPKSDVYSFGIILLRLLTGRPALGIT 491 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~~sDVwSlGviL~eLltG~~Pf~~~ 491 (641)
+.. .+...|...|||||.+.. ..|+-++||||||+.++||.+++.||+..
T Consensus 202 SiA---------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIA---------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhH---------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 431 122358889999999864 36899999999999999999999999644
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=253.70 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=209.1
Q ss_pred hhHhhhcCCCCccceeeccCceEEEEEEECC-------eEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccc
Q 006545 274 SEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC 345 (641)
Q Consensus 274 ~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~~~-------~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 345 (641)
.++.....+++...++-+|.||.||.|+++. +.|-+|.++..... ....+..|.-.+..+.|||++.+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4444455567778889999999999998753 34777877654322 245688899999999999999999987
Q ss_pred ---cCceEEEEEecCCCChhhhhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC
Q 006545 346 ---PEVWTLVYEYLPNGSLEDRLS-----CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 346 ---~~~~~lV~Ey~~ggsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~ 417 (641)
.+..+.++.++.-|+|..+|. .......++..+...++.|++.|+.|||. +||||.||-..|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 345788999999999999997 23344567788889999999999999999 8999999999999999999
Q ss_pred cccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHH
Q 006545 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQY 496 (641)
Q Consensus 418 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~ 496 (641)
++||+|=.+++.+-..... |.....-....||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.
T Consensus 434 qVkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred eEEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999999876554322 22233335778999999999999999999999999999998 9999976665543
Q ss_pred H--HhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 497 A--LDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 497 ~--~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
. +..| ..-..|.++++++..++.-||...|++||++.+ +..-|..+.
T Consensus 508 ~~ylkdG--------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q-lv~cLseF~ 556 (563)
T KOG1024|consen 508 EHYLKDG--------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQ-LVICLSEFH 556 (563)
T ss_pred HHHHhcc--------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH-HHHHHHHHH
Confidence 2 2332 222347889999999999999999999999999 656665544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=253.74 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=189.0
Q ss_pred CCCccceeeccCceEEEEEEE--CCeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEeccccC-------ceE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------VWT 350 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 350 (641)
+.+..+.||-|+||.||.+++ .|+.||+|++..-. ....+.+.+|+.+|..++|.|++..++.... ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456778999999999999888 47899999886432 2234678899999999999999998887532 357
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
+|+|.+. .+|..++ ....+++...+.-+++||++||+|||+ .+|+||||||.|+|++.|..+||+|||+++..
T Consensus 134 V~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 7888884 5888877 345678889999999999999999999 89999999999999999999999999999976
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh---------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--------- 500 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~--------- 500 (641)
....... ++..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|...+.++.....
T Consensus 207 e~d~~~h-------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 207 DQRDRLN-------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred chhhhhh-------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 6543221 1223468899999999986 6999999999999999999999888655544322110
Q ss_pred --------cccccccC-C-CCCC--------CChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 501 --------GKLKNLLD-P-LAGD--------WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 501 --------~~~~~~~d-~-~~~~--------~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
|...-++. + ..+. .+.........++..++..||++|.+..+.+
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~ 341 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEAL 341 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhc
Confidence 10000000 0 0011 1122334677888999999999999988743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=231.64 Aligned_cols=204 Identities=38% Similarity=0.585 Sum_probs=176.9
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccccC--ceEEEEEecCCCChhh
Q 006545 289 IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLED 363 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~ggsL~~ 363 (641)
||.|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++|+++++++.. ..+++|||++|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 789999998865432 23579999999999999999999999854 7899999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCcccccccccccccccccccCCCccc
Q 006545 364 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 442 (641)
Q Consensus 364 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~~~~~~~~~~~~~~~ 442 (641)
++.... ..+++..+..++.+++.+|.+||. .|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------- 148 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------- 148 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------
Confidence 985332 468899999999999999999999 89999999999999999 89999999999986654321
Q ss_pred cccCCCCCCcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHH
Q 006545 443 CCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521 (641)
Q Consensus 443 ~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 521 (641)
......+...|++||.+... .++.+.|+|++|+++++| ..
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~ 189 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PE 189 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HH
Confidence 11223478899999999887 888999999999999999 56
Q ss_pred HHHHHHHHhhhccCCCCChHHH
Q 006545 522 LANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 522 l~~Li~~cL~~dP~~RPs~~ev 543 (641)
+.+++..|+..+|.+||++.++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l 211 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEI 211 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHH
Confidence 8999999999999999999883
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=264.36 Aligned_cols=199 Identities=25% Similarity=0.331 Sum_probs=169.6
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCC------CCceeeEeccc--cCc
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR------HPNLVTLVGAC--PEV 348 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~g~~--~~~ 348 (641)
....|.+....|+|-||+|..|.+. +..||||+|.+.... ...=..|+.||++|+ --|+++|+-.| ..+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4567888888999999999999884 679999999865322 234568999999995 34789998877 568
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-Ccccccccccc
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 427 (641)
Q Consensus 349 ~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFGla 427 (641)
+|||+|-+ ..+|.++|.+...+..|....+..++.|+..||..|.. .||+|.||||+|||++++ ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence 99999998 57999999888888889999999999999999999999 699999999999999864 68899999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK 492 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~ 492 (641)
.....+...+. .-+..|.|||++.|.+|+...|+||+||+||||.||+..|.+..
T Consensus 585 ~~~~eneitPY----------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEITPY----------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccHH----------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 88877653322 13568999999999999999999999999999999999997543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=250.90 Aligned_cols=129 Identities=23% Similarity=0.353 Sum_probs=108.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCC-----C---CceeeEeccc----
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----H---PNLVTLVGAC---- 345 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~l~g~~---- 345 (641)
.++|-+.++||.|.|++||++.++ .+.||+|+.+... .-.+....||.+|++++ | .+||+|++.|
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 467899999999999999999985 5789999987533 22456789999999983 3 3599999998
Q ss_pred --cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEe
Q 006545 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 346 --~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILl 413 (641)
..++|+|+|++ |.+|..++..... ..++...+..|+.||+.||.|||.. .||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 23689999999 7789888865543 4589999999999999999999995 589999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=260.21 Aligned_cols=193 Identities=24% Similarity=0.397 Sum_probs=164.7
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--------CchhHHHHHHHHhcCC---CCceeeEecccc-
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------GPSEFQQEIDILSKIR---HPNLVTLVGACP- 346 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--------~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~- 346 (641)
.+|...+.+|.|+||.|++++++ ...|+||.+.+...- ....+-.|+.||..|+ |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999996 467999999875321 1234668999999997 999999999995
Q ss_pred -CceEEEEEec-CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccc
Q 006545 347 -EVWTLVYEYL-PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 347 -~~~~lV~Ey~-~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DF 424 (641)
+.+||+||-- +|.+|.+++ ...+.+++..+..|+.|++.|+++||+ .||||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeec
Confidence 4688999864 456889998 455679999999999999999999999 89999999999999999999999999
Q ss_pred ccccccccccccCCCccccccCCCCCCcccCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALG 489 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~~sDVwSlGviL~eLltG~~Pf~ 489 (641)
|.|....... ....+||..|.|||++.+.+| +..-|||++|++||.++....||-
T Consensus 715 gsaa~~ksgp----------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987655432 234569999999999999887 467899999999999999998883
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=231.50 Aligned_cols=196 Identities=37% Similarity=0.553 Sum_probs=167.6
Q ss_pred CCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecC
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLP 357 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 357 (641)
|.+...||.|++|.||+|... +..+|+|.+...... ....+.+|+..+..++|+|++++++++. +..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556788999999999999985 588999999876544 5668899999999999999999999874 57899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+++|.+++..... .+++..+..++.+++.+|.+||. .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999853321 17899999999999999999999 79999999999999999999999999999876544200
Q ss_pred CCccccccCCCCCCcccCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRPALGI 490 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~~sDVwSlGviL~eLltG~~Pf~~ 490 (641)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11223478899999999 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=240.94 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=189.3
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCC--CCCchhHHHHHHHHhcCCCCceeeEeccccC--------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS--LQGPSEFQQEIDILSKIRHPNLVTLVGACPE-------- 347 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 347 (641)
..+|.-+..+|.|.- .|-.+.+ .+.+||+|.+.... ........+|..++..++|+||++++.+|..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888999998 5555555 47899999876542 2234567899999999999999999999832
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..|+||||+ .++|...+. -.++-.++..|+.|+++|+.|||+ .||+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 478999999 568888774 336677899999999999999999 89999999999999999999999999999
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcc-----
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 502 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~----- 502 (641)
+..... ...+..+.|..|.|||++.+..|...+||||+||++.||++|.-.|.+.+..+.......
T Consensus 166 r~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 166 RTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred cccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 865433 123455689999999999998899999999999999999999998875443322111000
Q ss_pred --------------------------cccccC----CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 503 --------------------------LKNLLD----PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 --------------------------~~~~~d----~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
+...+. +...+.+...+..+.+|+.+||-.||++|.++.+++
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 000000 001111223456789999999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=243.75 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=191.5
Q ss_pred hcCCCCccceeeccCceEEEEEEEC-----CeEEEEEEecCCCCCCchhHHHHHHHHhcCC-CCceeeEeccc--cCceE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWT 350 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~-----~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~ 350 (641)
....|....+||.|.|++||++++. ...||+|.+...+ .+..+.+|+++|..+. +.||+++.+++ .+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3456888999999999999999763 4679999987644 4568999999999994 89999999998 67899
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-CCcccccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRF 429 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~~ 429 (641)
+||||++.....+++. .++...+..+++.++.||.++|. +|||||||||.|+|.+. -+.-.|.|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999988873 36678999999999999999999 99999999999999974 46789999999983
Q ss_pred ccccc------------ccC----------------CCcc--------ccccCCCCCCcccCChhhhccC-CCCchhhHH
Q 006545 430 LSQNE------------ISS----------------NNTT--------LCCRTDPKGTFAYMDPEFLASG-ELTPKSDVY 472 (641)
Q Consensus 430 ~~~~~------------~~~----------------~~~~--------~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVw 472 (641)
..... ... .... ........||++|.|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 22111 000 0000 0112234699999999999775 578999999
Q ss_pred HHHHHHHHHHhCCCCCCCcH----------------HH-HHHHhhcc--ccc----------------c----cCC----
Q 006545 473 SFGIILLRLLTGRPALGITK----------------EV-QYALDTGK--LKN----------------L----LDP---- 509 (641)
Q Consensus 473 SlGviL~eLltG~~Pf~~~~----------------~~-~~~~~~~~--~~~----------------~----~d~---- 509 (641)
|.|||++.+++++.||-... .+ ..+...+. +.. + +.+
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999983211 00 11111121 000 0 000
Q ss_pred --CCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 510 --LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 510 --~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
....+....+..+.+|+.+|++.||.+|.+++++|
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 01123334456899999999999999999999955
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-27 Score=228.57 Aligned_cols=244 Identities=21% Similarity=0.317 Sum_probs=180.9
Q ss_pred cCCCCccceeeccCceEEEEEEECC--eEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceeeEecc-c--cCceEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA-C--PEVWTLVY 353 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~-~--~~~~~lV~ 353 (641)
...|.+.+.||+|.||.+-++.+++ +.+++|-+.... ....+|.+|..---.| .|.||+.-|++ | .+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3469999999999999999999974 679999887543 3467899998876666 48999988875 3 45678999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec--cCCcccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLS 431 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld--~~~~vKL~DFGla~~~~ 431 (641)
||+|.|+|..-+. ...+.+....+++.|++.||.|+|+ +++||||||.+||||- +...+||+|||+++..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998873 3457888899999999999999999 8999999999999993 44699999999987554
Q ss_pred cccccCCCccccccCCCCCCcccCChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH-HHHhhccccc
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-YALDTGKLKN 505 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~-~~~~~~~~~~ 505 (641)
.... ...-+..|.+||..... ...+.+|||.||+|+|.++||.+||......+ ..+.-..+..
T Consensus 175 ~tV~-----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 175 TTVK-----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK 243 (378)
T ss_pred ceeh-----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence 3211 11246789999987532 35688999999999999999999996321110 0000001111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
...+..+......++.+..+.++-|..+|++|=-+.+
T Consensus 244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 1112222223345678889999999999999944333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=268.55 Aligned_cols=199 Identities=16% Similarity=0.194 Sum_probs=140.7
Q ss_pred cCCC-CceeeEeccc---------cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 006545 332 KIRH-PNLVTLVGAC---------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401 (641)
Q Consensus 332 ~l~H-pnIv~l~g~~---------~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gI 401 (641)
.++| +||++++++| .+.++++|||+ +++|.++|.. ....+++..+..|+.||+.||.|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4556 5788888876 12466788887 6799999953 23569999999999999999999999 899
Q ss_pred eeccCCCCceEecc-------------------CCccccccccccccccccccc------C--CCccccccCCCCCCccc
Q 006545 402 VHGDLKPANILLDA-------------------NFVSKLSDFGISRFLSQNEIS------S--NNTTLCCRTDPKGTFAY 454 (641)
Q Consensus 402 iHrDIkp~NILld~-------------------~~~vKL~DFGla~~~~~~~~~------~--~~~~~~~~~~~~Gt~~Y 454 (641)
+||||||+||||+. ++.+||+|||+++........ . ............||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 445666777766543211000 0 00000011224689999
Q ss_pred CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhcc
Q 006545 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 534 (641)
Q Consensus 455 ~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP 534 (641)
+|||++.+..|+.++|||||||+||||++|.+|+.........+... .+.+ . ..........++.+||.++|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~---~-~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPP---Q-ILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcCh---h-hhhcCHHHHHHHHHhCCCCh
Confidence 99999999999999999999999999999999986433222211111 1111 0 11123456788999999999
Q ss_pred CCCCChHHHH
Q 006545 535 KSRPELGKDV 544 (641)
Q Consensus 535 ~~RPs~~evv 544 (641)
.+||++.+++
T Consensus 254 ~~Rps~~eil 263 (793)
T PLN00181 254 SCRPSMSELL 263 (793)
T ss_pred hhCcChHHHh
Confidence 9999999964
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=207.91 Aligned_cols=164 Identities=23% Similarity=0.257 Sum_probs=123.6
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCC
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~ 438 (641)
|+|.+++... ..++++..++.|+.|++.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899998532 3469999999999999999999999 55 999999999999999 99987654321
Q ss_pred CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh--cccccccCCCCCCCCh
Q 006545 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT--GKLKNLLDPLAGDWPF 516 (641)
Q Consensus 439 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~--~~~~~~~d~~~~~~~~ 516 (641)
..||+.|+|||++.+..++.++|||||||++|+|+||++||............ ..... ..+.....+.
T Consensus 64 ---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 133 (176)
T smart00750 64 ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-DDPRDRSNLE 133 (176)
T ss_pred ---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-CCccccccHH
Confidence 14889999999999999999999999999999999999999654332211111 00111 1111111122
Q ss_pred hhHH--HHHHHHHHHhhhccCCCCChHHHHHHHHHH
Q 006545 517 VQAE--QLANLAMRCCEMSRKSRPELGKDVWRVLEP 550 (641)
Q Consensus 517 ~~~~--~l~~Li~~cL~~dP~~RPs~~evv~~~Le~ 550 (641)
.... .+.+++.+||..+|.+||++.+ ++..+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~-ll~~~~~ 168 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANH-YLAHCRA 168 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHH-HHHHHHH
Confidence 3333 6999999999999999999999 4444443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=223.68 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=198.0
Q ss_pred CCCccceeeccCceEEEEEEECC---eEEEEEEecCCCCCCchhHHHHHHHHhcCCC----CceeeEeccc---cCceEE
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRH---MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTLVGAC---PEVWTL 351 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~---~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~g~~---~~~~~l 351 (641)
+|.+.++||+|+||.||.+.... ..+|+|+...........+..|+.++..+.. +++..+++.. ....++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999854 4699998876544444478899999999973 5788887766 335789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-----Cccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGI 426 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-----~~vKL~DFGl 426 (641)
||+.+ |.+|.++..... ...++..+++.|+.|++.+|.+||+ .|++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99998 889999875444 5679999999999999999999999 899999999999999755 4689999999
Q ss_pred ccccc--cccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHH--HHHHhhcc
Q 006545 427 SRFLS--QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEV--QYALDTGK 502 (641)
Q Consensus 427 a~~~~--~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~--~~~~~~~~ 502 (641)
++.+. ..................||..|+++..+.+...+.+.|+||++.++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99333 222111011101123456999999999999999999999999999999999999999654321 11111111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhhc
Q 006545 503 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 503 ~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~~ 555 (641)
....... .....+..+..+...+-..+...+|.... +...|.......
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~-~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEK-LAELLKDVFDSE 301 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHH-HHHHHHHHHHhc
Confidence 1111111 22334567777777777799999999998 777776665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=226.57 Aligned_cols=173 Identities=16% Similarity=0.133 Sum_probs=131.4
Q ss_pred HhhhcCCCCccceeeccCceEEEEEEEC---CeEEEEEEecCCCC---C--CchhHHHHHHHHhcCCCCceee-Eecccc
Q 006545 276 IEGATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL---Q--GPSEFQQEIDILSKIRHPNLVT-LVGACP 346 (641)
Q Consensus 276 i~~~~~~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~---~--~~~~~~~Ei~iL~~l~HpnIv~-l~g~~~ 346 (641)
+.....+|.+.+.||+|+||+||+|.+. +..||||++..... . ....|.+|+.+|+.++|+|+++ +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445668999999999999999999873 56789998764311 1 1345899999999999999985 5443
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC-CCCceEeccCCcccccccc
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFG 425 (641)
Q Consensus 347 ~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDI-kp~NILld~~~~vKL~DFG 425 (641)
...+|||||++|++|.... . .. ...++.+++.||.|||+ +||+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4579999999999996321 1 11 14678899999999999 89999999 9999999999999999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccC
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 463 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 463 (641)
+|+.+..............-+...+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99987654322111111111345688999999999654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-22 Score=202.98 Aligned_cols=258 Identities=33% Similarity=0.468 Sum_probs=195.0
Q ss_pred CCccceeeccCceEEEEEEECCeEEEEEEecCCCCCC---chhHHHHHHHHhcCCCC-ceeeEeccccC--ceEEEEEec
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHP-NLVTLVGACPE--VWTLVYEYL 356 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~--~~~lV~Ey~ 356 (641)
|.....||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+.. ..+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 567788999999999999988 789999988765433 56799999999999988 79999998843 358999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC-cccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~-~vKL~DFGla~~~~~~~~ 435 (641)
.++++.+++........++......++.+++.++.|+|. .+++||||||+||+++..+ .++++|||++..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999766422111368899999999999999999999 8999999999999999988 799999999985554332
Q ss_pred cCCCccccccCCCCCCcccCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcHH---HHHH---Hhhcccccc
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKE---VQYA---LDTGKLKNL 506 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~---~~~~---~~~~~~~~~ 506 (641)
..... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||..... .... +........
T Consensus 158 ~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 158 TSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 11100 12245569999999999987 5788999999999999999999999876542 1111 111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 546 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~ 546 (641)
........+......+.+++..|+..+|..|.+.......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000111111223578999999999999999999885544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=202.14 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=195.2
Q ss_pred CCccceeeccCceEEEEEEECCeEEEEEEecCCCCCC--chhHHHHHHHHhcCCCCceeeEeccc--cCceEEEEEecCC
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPN 358 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~lV~Ey~~g 358 (641)
..+..+|.....|..|+|.+.|..+++|+++...... ...|..|.-.|+-+.||||+.++|+| +....+|..||+.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4456678999999999999999999999987654332 45799999999999999999999999 4568899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccc--cccccccccccccc
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS--DFGISRFLSQNEIS 436 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~--DFGla~~~~~~~~~ 436 (641)
|||...|+... ....+..++.+++.+++.|+.|||+..+ -|.---|++..+++|++.+++|+ |--++- .
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--q----- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q----- 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee--e-----
Confidence 99999996442 3346777999999999999999999864 24455689999999999887764 322211 0
Q ss_pred CCCccccccCCCCCCcccCChhhhccCCCC---chhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCC
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s---~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 513 (641)
.....-.|.||+||.+...+-+ .++|+|||++++|||.|...||.......... .-.+..+...
T Consensus 343 --------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----kialeglrv~ 409 (448)
T KOG0195|consen 343 --------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----KIALEGLRVH 409 (448)
T ss_pred --------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----hhhhcccccc
Confidence 1122347899999999876533 57899999999999999999998766655432 2234445566
Q ss_pred CChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHH
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 514 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l 551 (641)
+|+..+..+..|+.-|+..||.+||.+.. +.-+|+.+
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdm-ivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDM-IVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcce-ehhhHHHh
Confidence 78888999999999999999999999988 66777765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=198.49 Aligned_cols=261 Identities=19% Similarity=0.245 Sum_probs=200.2
Q ss_pred cCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCC-CCceeeEecc--ccCceEEEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA--CPEVWTLVYE 354 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~--~~~~~~lV~E 354 (641)
.-+|.++++||+|+||.++.|.. ++.+||||.-...+ ..-++..|....+.|. .++|...|.+ |.-+..|||+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 44899999999999999999975 78999999754433 2347888999998885 6888777654 4446679999
Q ss_pred ecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-----Ccccccccccccc
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-----FVSKLSDFGISRF 429 (641)
Q Consensus 355 y~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-----~~vKL~DFGla~~ 429 (641)
.+ |.||+|++.-.. ..|+..++..|+.|++.-+.|+|+ +.+|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 889999886443 459999999999999999999999 899999999999999643 4688999999998
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH---HHHhhc--ccc
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ---YALDTG--KLK 504 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~---~~~~~~--~~~ 504 (641)
+.+..+..... ........||..||+--.+.+...+...|+-|||-++++.|-|..||.+..... ..-..+ +..
T Consensus 179 YrDp~TkqHIP-YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIP-YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCc-cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 87766543322 344566789999999999999999999999999999999999999997543211 111111 111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHHhh
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~~~ 554 (641)
..+..+. ...+.++...+.-.-..+..+-|+..- +..++..+...
T Consensus 258 T~i~~Lc----~g~P~efa~Yl~yvR~L~F~E~PDYdy-lr~Lf~dvldr 302 (449)
T KOG1165|consen 258 TPIEVLC----EGFPEEFATYLRYVRRLDFFETPDYDY-LRKLFDDVLDR 302 (449)
T ss_pred CCHHHHH----hcCHHHHHHHHHHHHhcCcccCCCHHH-HHHHHHHHHHh
Confidence 1111111 224667888888888889999999876 66666666543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.8e-22 Score=192.07 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=195.8
Q ss_pred hcCCCCccceeeccCceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCC-CceeeEeccc--cCceEEEE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVY 353 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~--~~~~~lV~ 353 (641)
..++|.++++||.|+||.+|.|.. .|..||||+-..... ..++..|..+...|++ ..|..+.-+. .+...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356899999999999999999987 578999998665432 2467889999999975 4455554444 44677999
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC---Cccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFL 430 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~---~~vKL~DFGla~~~ 430 (641)
+.+ |.||.+++.-.. ..++..+++-++-|++.-++|+|. +++|||||||+|+|..-+ ..+.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 889999885433 358889999999999999999999 899999999999999643 57899999999988
Q ss_pred ccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHH-----HHHhhccccc
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-----YALDTGKLKN 505 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~-----~~~~~~~~~~ 505 (641)
.+..+...- .........||..|.+--.+.+...+...|+-|+|.+|.++.-|..||.+..... ..+...++..
T Consensus 165 ~d~~t~~HI-pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHI-PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccC-ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 766543322 2233456679999999988888888999999999999999999999997654322 1122223333
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 506 ~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
.+..+... .+.++.-.+.-|-..-..+-|+..- +.+++.-+.
T Consensus 244 ~ie~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLf 285 (341)
T KOG1163|consen 244 PIEVLCKG----FPAEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILF 285 (341)
T ss_pred CHHHHhCC----CcHHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHH
Confidence 33222333 3456777888888888888888765 544444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=227.15 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=182.8
Q ss_pred CCCccceeeccCceEEEEEEECCeEEEEEEecCCCC-CCchhHHHHHHH--HhcCCCCceeeEeccc--cCceEEEEEec
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-QGPSEFQQEIDI--LSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~i--L~~l~HpnIv~l~g~~--~~~~~lV~Ey~ 356 (641)
+|...+.||.+.|=.|.+|.++...|+||++-+... .....|.+.+.- ...++|||++++.-+- ....|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 577778899999999999999887799999977653 334445444433 4445899999987654 44577888998
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
. -+|.|.|. .++-+..-+...|+.|++.||.-+|. .||+|||||.+||||+.-.-+.|+||..-+...-....
T Consensus 104 k-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 58999983 45567778889999999999999999 89999999999999999999999999877644333333
Q ss_pred CCCccccccCCCCCCcccCChhhhccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccc
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG----------E-LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------~-~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 504 (641)
+..-.+.. .....-.+|+|||.+... . .++++||||+||+++||++ |+|||....-..+.-.. .
T Consensus 177 Padf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~---~ 252 (1431)
T KOG1240|consen 177 PADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN---A 252 (1431)
T ss_pred cccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC---c
Confidence 33222222 333345689999988542 2 6789999999999999988 89999755443332111 0
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......... .....+.+||..|++.||.+|.++.+.+
T Consensus 253 ~~~e~~Le~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 253 DDPEQLLEK---IEDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred cCHHHHHHh---CcCccHHHHHHHHHccCchhccCHHHHH
Confidence 000000011 1234789999999999999999999844
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-22 Score=224.69 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=179.9
Q ss_pred CccceeeccCceEEEEEEEC--CeEEEEEEecCC--CCCCc----hhHHHHHHHHhcCCCCceeeEeccccC--ceEEEE
Q 006545 284 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH--SLQGP----SEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVY 353 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~--~~~~~----~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~ 353 (641)
....++|.|++|.|+..... ...++.|.+... ..... ..+..|+.+-..+.|||++..+..+.+ ...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999987766542 233444433211 11111 125667778888899999887766532 233449
Q ss_pred EecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
|||++ +|..++... ..++...+..++.|++.||.|||. .||.||||||+|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998432 457888999999999999999999 89999999999999999999999999999877654
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTP-KSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~-~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 512 (641)
... ........+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+................+
T Consensus 474 ~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 474 WEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred cch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 322 123345678999999999999999986 479999999999999999999654332221100000000000111
Q ss_pred --CCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 513 --DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 --~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
......+.....+|.+||+.+|.+|.++.+++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 11233466789999999999999999999954
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=193.33 Aligned_cols=169 Identities=16% Similarity=0.175 Sum_probs=133.4
Q ss_pred hcCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHhcCCCCceeeEecccc---
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRHPNLVTLVGACP--- 346 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~---------~~~Ei~iL~~l~HpnIv~l~g~~~--- 346 (641)
..++|...++||.|+||.||+....+..+|||++.+........ +.+|+..+.++.||+|..+.+++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46789999999999999999987777889999998765443322 679999999999999998877642
Q ss_pred -------CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 347 -------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 347 -------~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
...+|||||++|.+|.++.. ++. ....+++.+|..||. .|++||||+|+||+++++| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 24789999999999988741 222 345689999999999 8999999999999999988 9
Q ss_pred cccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHH
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLL 482 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLl 482 (641)
+|+|||.......... ..-++....|+.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9999998765432210 011344556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.4e-21 Score=185.95 Aligned_cols=138 Identities=18% Similarity=0.187 Sum_probs=106.8
Q ss_pred cceeeccCceEEEEEEE-CCeEEEEEEecCCCCCC---------chhH-----------------HHHHHHHhcCCCCce
Q 006545 286 SLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG---------PSEF-----------------QQEIDILSKIRHPNL 338 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~~---------~~~~-----------------~~Ei~iL~~l~HpnI 338 (641)
...||+|+||.||+|.. .|..||||+++...... ...| ..|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 48899999997653211 1122 349999999987766
Q ss_pred eeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeccCCCCceEeccCC
Q 006545 339 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 339 v~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~gIiHrDIkp~NILld~~~ 417 (641)
...........+|||||++|+++...+. ...+++...+..++.|++.+|.+| |+ .||+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence 4332222233489999999887765432 234688999999999999999999 67 7999999999999998 47
Q ss_pred ccccccccccccc
Q 006545 418 VSKLSDFGISRFL 430 (641)
Q Consensus 418 ~vKL~DFGla~~~ 430 (641)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-21 Score=209.07 Aligned_cols=223 Identities=27% Similarity=0.331 Sum_probs=181.5
Q ss_pred eeeccCceEEEEE-----EECCeEEEEEEecCCCCCC--chhHHHHHHHHhcCC-CCceeeEeccc--cCceEEEEEecC
Q 006545 288 KIGEGGYGSIYKG-----LLRHMQVAIKMLHPHSLQG--PSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLP 357 (641)
Q Consensus 288 ~LG~G~fG~Vy~g-----~~~~~~vAvK~~~~~~~~~--~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~lV~Ey~~ 357 (641)
.+|.|+||.|+++ .+.+..+|+|++++..... ......|..++..++ ||.+|++...+ +...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999864 3456779999887754322 225667888999997 99999999887 456899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccC
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
||.|...+. ....+++.....+...++-++.++|. .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999998884 34457788888899999999999999 8999999999999999999999999999987654431
Q ss_pred CCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChh
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 517 (641)
.+||..|||||+++ .+..++|+||||+++++|+||..||.. ..... +.......|..
T Consensus 153 ----------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~----------Il~~~~~~p~~ 209 (612)
T KOG0603|consen 153 ----------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKR----------ILKAELEMPRE 209 (612)
T ss_pred ----------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHH----------HhhhccCCchh
Confidence 15899999999998 677899999999999999999999977 11111 11112345677
Q ss_pred hHHHHHHHHHHHhhhccCCCCChH
Q 006545 518 QAEQLANLAMRCCEMSRKSRPELG 541 (641)
Q Consensus 518 ~~~~l~~Li~~cL~~dP~~RPs~~ 541 (641)
.+..+.+++..++..+|.+|--..
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccC
Confidence 788999999999999999997664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-20 Score=179.91 Aligned_cols=192 Identities=15% Similarity=0.060 Sum_probs=141.8
Q ss_pred CccceeeccCceEEEEEEECCeEEEEEEecCCCCCCc----hhHHHHHHHHhcCC-CCceeeEeccccCceEEEEEecCC
Q 006545 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP----SEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYLPN 358 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~----~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lV~Ey~~g 358 (641)
.+...|++|+||+||.+...+.+++.+.+.....-.. ..+.+|+++|++|. |++|++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 4567899999999998877788888887765443111 24789999999995 5889999886 456899999999
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccC-CCCceEeccCCccccccccccccccccccc-
Q 006545 359 GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANFVSKLSDFGISRFLSQNEIS- 436 (641)
Q Consensus 359 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDI-kp~NILld~~~~vKL~DFGla~~~~~~~~~- 436 (641)
.+|...+. . ....++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPP---R-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhh---h-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99875431 0 123577899999999999 89999999 799999999999999999999855432210
Q ss_pred ---CCCcc-ccccCCCCCCcccCChhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 006545 437 ---SNNTT-LCCRTDPKGTFAYMDPEFLASG-ELT-PKSDVYSFGIILLRLLTGRPALGI 490 (641)
Q Consensus 437 ---~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s-~~sDVwSlGviL~eLltG~~Pf~~ 490 (641)
..... .........++.|++|+...-- ..+ ...++++.|+.+|.++||+.|+-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00000 0000112367888888865432 333 678999999999999999988743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=176.91 Aligned_cols=141 Identities=17% Similarity=0.152 Sum_probs=109.5
Q ss_pred cceeeccCceEEEEEEEC-CeEEEEEEecCCCCCC--------------------------chhHHHHHHHHhcCCCCce
Q 006545 286 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQG--------------------------PSEFQQEIDILSKIRHPNL 338 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~--------------------------~~~~~~Ei~iL~~l~HpnI 338 (641)
...||+|+||.||+|.+. |..||||+++...... ...+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999885 8999999998753210 0123578999999999887
Q ss_pred eeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 339 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 339 v~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
.....+.....+|||||++|+++..... ....++......++.+++.+|.+||+. .||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCC
Confidence 4433322234589999999886543321 124577889999999999999999983 5899999999999999 889
Q ss_pred cccccccccccccc
Q 006545 419 SKLSDFGISRFLSQ 432 (641)
Q Consensus 419 vKL~DFGla~~~~~ 432 (641)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.6e-19 Score=179.68 Aligned_cols=230 Identities=21% Similarity=0.303 Sum_probs=148.4
Q ss_pred CCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC---CchhHHHHHHHHhcCCC---C-------c------eee
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ---GPSEFQQEIDILSKIRH---P-------N------LVT 340 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~---~~~~~~~Ei~iL~~l~H---p-------n------Iv~ 340 (641)
.+.....||.|+|+.||.+++. +..+|||++...... ..+.+.+|.-....+.+ | . +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4456778999999999999995 599999998765422 13456666654444322 1 1 222
Q ss_pred Eecc---c---c--C-----ceEEEEEecCCCChhhhhhc---CC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 006545 341 LVGA---C---P--E-----VWTLVYEYLPNGSLEDRLSC---KD-NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403 (641)
Q Consensus 341 l~g~---~---~--~-----~~~lV~Ey~~ggsL~~~L~~---~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiH 403 (641)
+-+- + . . +.+++|+-+ .++|.+++.. .. ....+....+..+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 2210 0 1 0 236778877 4688777532 11 12234455567778999999999999 89999
Q ss_pred ccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccC--------CCCchhhHHHHH
Q 006545 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--------ELTPKSDVYSFG 475 (641)
Q Consensus 404 rDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--------~~s~~sDVwSlG 475 (641)
+||+|+|+|++.+|.++|+||+........... ...+..|.|||..... .++.+.|.|+||
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 999999999999999999999987665443211 1245789999977442 478899999999
Q ss_pred HHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCC
Q 006545 476 IILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 537 (641)
Q Consensus 476 viL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~R 537 (641)
+++|.|++|..||+........ +.....+. ..+..+..||..+|+.||.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~----------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADP----------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTS----------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCccccc----------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999755321100 00122344 678899999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=198.72 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=179.8
Q ss_pred hhHhhhcCCCCccceeeccCceEEEEEEE-CCeEEEEEEecCCCCCCchhHHHHHHHHhcCC---CCceeeEecc--ccC
Q 006545 274 SEIEGATHNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR---HPNLVTLVGA--CPE 347 (641)
Q Consensus 274 ~ei~~~~~~y~~~~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~--~~~ 347 (641)
.+++.....|.+.+.||+|+||.||+|.. +++.||||+-++...- +|.--..++.+|+ -+.|..+..+ |.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44555566899999999999999999987 4788999998765432 3333445566666 1223333332 367
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEec-------cCCccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD-------ANFVSK 420 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld-------~~~~vK 420 (641)
..+||++|.+.|+|.+++. ....+++..+..++.|++..+..||. .+||||||||+|+||. .+.-++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 7889999999999999994 66779999999999999999999999 8999999999999993 245689
Q ss_pred ccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhh
Q 006545 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 421 L~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~ 500 (641)
|+|||.+-.+.--... ......++|-.+-.+|+..|.+++...|.|.|+.+++-||.|+.- + ...
T Consensus 842 lIDfG~siDm~lfp~~------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q--~~~ 906 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDG------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E--VKN 906 (974)
T ss_pred EEecccceeeeEcCCC------cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H--hcC
Confidence 9999998654332111 112445688999999999999999999999999999999999731 1 111
Q ss_pred cccccccCCCCCCCChh-hHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 501 GKLKNLLDPLAGDWPFV-QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 501 ~~~~~~~d~~~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
+..... +. .++.. .-.-+.+++..+|..|-..=|.+.+ +...++...
T Consensus 907 g~~~~~-~~---~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~-lr~~~~~~~ 954 (974)
T KOG1166|consen 907 GSSWMV-KT---NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQE-LRTELEEVL 954 (974)
T ss_pred Ccceec-cc---cchhhhhHHHHHHHHHHHhCcCcccchhHHH-HHHHHHHHH
Confidence 111111 11 01111 1234667788888866666677666 555555443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=170.39 Aligned_cols=133 Identities=17% Similarity=0.203 Sum_probs=103.4
Q ss_pred CccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcC-----CCCceeeEeccccCc-----eE-EE
Q 006545 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-----RHPNLVTLVGACPEV-----WT-LV 352 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~g~~~~~-----~~-lV 352 (641)
.....||+|+||.||.....+. .+||++..........+.+|+.+++.+ +||||++++|++.+. .+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 3456899999999996222233 479998775544567899999999999 679999999998443 23 78
Q ss_pred EEe--cCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceeeccCCCCceEecc----CCcccccccc
Q 006545 353 YEY--LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL-IFLHSCKPHSIVHGDLKPANILLDA----NFVSKLSDFG 425 (641)
Q Consensus 353 ~Ey--~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~gIiHrDIkp~NILld~----~~~vKL~DFG 425 (641)
+|| +++|+|.+++.. ..+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 567999999943 235555 35677888777 89999 89999999999999974 3489999955
Q ss_pred c
Q 006545 426 I 426 (641)
Q Consensus 426 l 426 (641)
.
T Consensus 155 G 155 (210)
T PRK10345 155 G 155 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=195.84 Aligned_cols=218 Identities=24% Similarity=0.291 Sum_probs=149.4
Q ss_pred hcCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccccCceEEEEEec
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYL 356 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~ 356 (641)
...+|+.++.|..|+||-||...++ .+++|+|+ ++... .+++ |+.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee-----------------
Confidence 3468999999999999999999876 67899854 32221 0111 22222333333
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
|+-...+ .+-++++.. ++.+++|||+ .||+|||+||+|++|+.-|++|++|||+++........
T Consensus 136 --gDc~tll---k~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLL---KNIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhc---ccCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444 222334433 3779999999 89999999999999999999999999999754322111
Q ss_pred CC-------CccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHH-hhcccccccC
Q 006545 437 SN-------NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL-DTGKLKNLLD 508 (641)
Q Consensus 437 ~~-------~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~d 508 (641)
.. ..........+||+.|+|||++....|+..+|+|++|+|+|+.+.|..||.+.......- .......+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-
Confidence 00 000112234579999999999999999999999999999999999999998764432211 111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 509 ~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
+-....+.++.++|.++|+.+|..|--...
T Consensus 279 ----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 279 ----EEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred ----ccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 112234678999999999999999965443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=186.01 Aligned_cols=209 Identities=28% Similarity=0.460 Sum_probs=154.5
Q ss_pred HhcCCCCceeeEeccc--cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce-eeccC
Q 006545 330 LSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI-VHGDL 406 (641)
Q Consensus 330 L~~l~HpnIv~l~g~~--~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gI-iHrDI 406 (641)
|+.+.|.|+.+++|.+ ....++|.+||..|+|.|.+.. ....+++.....++.+++.||.|||.. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4678999999999988 4568899999999999999964 455689999999999999999999994 34 99999
Q ss_pred CCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccC---C----CCchhhHHHHHHHHH
Q 006545 407 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG---E----LTPKSDVYSFGIILL 479 (641)
Q Consensus 407 kp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~----~s~~sDVwSlGviL~ 479 (641)
++.|.++|..+.+||+|||+............ .....-...|.|||.+.+. . .+.+.||||||++++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~------~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEA------HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccc------cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 99999999999999999999887653110000 0111245689999999763 1 467899999999999
Q ss_pred HHHhCCCCCCCcH------HHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHHHHHHHH
Q 006545 480 RLLTGRPALGITK------EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 480 eLltG~~Pf~~~~------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~~Le~l~ 552 (641)
|+++...||+... +....+.. .....+-|...... ...+.+..++..||..+|.+||++.+ +...++.+.
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~-i~~~~~~~~ 225 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ-IRSKLLTIN 225 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHH-HHhhhhhhc
Confidence 9999999996421 11122222 01111111111111 33447999999999999999999998 555555444
|
|
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-19 Score=144.88 Aligned_cols=71 Identities=44% Similarity=0.843 Sum_probs=63.1
Q ss_pred CCCCcCCCccccccCCCcccccCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHHhhC
Q 006545 571 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641 (641)
Q Consensus 571 ~p~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~~ 641 (641)
+|++|+|||+.++|.|||++++|+|||+.+|..|+..++.+||+|+.++...+|+||++||++|++|+.+|
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~~ 71 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAEN 71 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHHC
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHHc
Confidence 59999999999999999999999999999999999998999999999999999999999999999999876
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=171.99 Aligned_cols=200 Identities=22% Similarity=0.247 Sum_probs=141.6
Q ss_pred CCCceeeEecccc-----------------------------CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 006545 334 RHPNLVTLVGACP-----------------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 384 (641)
Q Consensus 334 ~HpnIv~l~g~~~-----------------------------~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~ 384 (641)
+|||||+++++|. ...|+||...+ .+|..++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 5999999988761 12578888774 5898888432 355567788999
Q ss_pred HHHHHHHHHHhcCCCceeeccCCCCceEe--ccC--CcccccccccccccccccccCCCccccccCCCCCCcccCChhhh
Q 006545 385 ELCSVLIFLHSCKPHSIVHGDLKPANILL--DAN--FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460 (641)
Q Consensus 385 qia~aL~~LH~~~~~gIiHrDIkp~NILl--d~~--~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l 460 (641)
|+++|+.|||. +||.|||+|++|||| |++ ..+.|+|||++---...+...... .......|....||||+.
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~--S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE--SDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc--cccccCCCcceecchhhh
Confidence 99999999999 899999999999999 344 367899999875433222111111 112334588899999998
Q ss_pred ccCC-----C-CchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhcc
Q 006545 461 ASGE-----L-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 534 (641)
Q Consensus 461 ~~~~-----~-s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP 534 (641)
...+ . -.++|.|+.|.+.||+++...||-...+....... ......+..|..+++.+.+|+...|+.||
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----Yqe~qLPalp~~vpp~~rqlV~~lL~r~p 498 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----YQESQLPALPSRVPPVARQLVFDLLKRDP 498 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----hhhhhCCCCcccCChHHHHHHHHHhcCCc
Confidence 6532 1 24899999999999999999999653322111111 11112344566778899999999999999
Q ss_pred CCCCChHHHHHHHHH
Q 006545 535 KSRPELGKDVWRVLE 549 (641)
Q Consensus 535 ~~RPs~~evv~~~Le 549 (641)
++|++..= ...+|.
T Consensus 499 skRvsp~i-AANvl~ 512 (598)
T KOG4158|consen 499 SKRVSPNI-AANVLN 512 (598)
T ss_pred cccCCccH-HHhHHH
Confidence 99998753 444444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=169.58 Aligned_cols=141 Identities=18% Similarity=0.168 Sum_probs=110.6
Q ss_pred CCCccceeeccCceEEEEEE-E--CCeEEEEEEecCCCCC-------------------C-----chhHHHHHHHHhcCC
Q 006545 282 NFDPSLKIGEGGYGSIYKGL-L--RHMQVAIKMLHPHSLQ-------------------G-----PSEFQQEIDILSKIR 334 (641)
Q Consensus 282 ~y~~~~~LG~G~fG~Vy~g~-~--~~~~vAvK~~~~~~~~-------------------~-----~~~~~~Ei~iL~~l~ 334 (641)
.|.+...||+|+||.||+|. . .|..||||+++..... . ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788899999999999998 3 5799999998764311 0 012568999999997
Q ss_pred C--CceeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeeccCCCCce
Q 006545 335 H--PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANI 411 (641)
Q Consensus 335 H--pnIv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g-IiHrDIkp~NI 411 (641)
+ ..+.++++. ...++||||++|++|...+. ....+.......++.+++.+|.+||. .| |+||||||+||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 5 334455543 24589999999988876542 22345666778999999999999999 88 99999999999
Q ss_pred EeccCCcccccccccccccc
Q 006545 412 LLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 412 Lld~~~~vKL~DFGla~~~~ 431 (641)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999887543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=163.20 Aligned_cols=129 Identities=27% Similarity=0.390 Sum_probs=106.0
Q ss_pred eeeccCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHhcCCCCc--eeeEeccccCceEEEEEecC
Q 006545 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPN--LVTLVGACPEVWTLVYEYLP 357 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~lV~Ey~~ 357 (641)
.||+|+||.||+|.+.+..|++|+........ ...+.+|+.++..+.|++ +..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999999999999976543221 145678999999998775 44555555667899999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccc
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~ 430 (641)
|++|.+++... . ..++.+++.+|.+||+ .|++|||++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG---N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc---H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887321 1 1789999999999999 8999999999999999 889999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=164.41 Aligned_cols=132 Identities=27% Similarity=0.417 Sum_probs=109.9
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHhcCCCCceeeEecc--ccCceEEEEEec
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYL 356 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV~Ey~ 356 (641)
+.||+|++|.||+|.+.+..|++|+........ ...+.+|+.++..+.|++|+....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 569999999999999999999999876543322 1347789999999999887654444 456788999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
+|++|.+++... .. .+..++.+++.+|.+||. .+++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988421 12 788999999999999999 8999999999999999 78899999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=157.40 Aligned_cols=137 Identities=20% Similarity=0.174 Sum_probs=108.8
Q ss_pred CCCCccceeeccCceEEEEEEE-CCeEEEEEEecCCCCC----------------------CchhHHHHHHHHhcCCCC-
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP- 336 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~----------------------~~~~~~~Ei~iL~~l~Hp- 336 (641)
..|.+.+.||.|+||.||+|.. .+..||||++...... ....+..|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3477788999999999999988 4789999997654310 011256789999999877
Q ss_pred -ceeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc
Q 006545 337 -NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415 (641)
Q Consensus 337 -nIv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~ 415 (641)
+++..++. ...++||||++|++|...... .....++.+++.++.++|. .||+||||+|+||+++.
T Consensus 95 i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 45555543 345899999999999776420 2456788999999999999 89999999999999999
Q ss_pred CCcccccccccccccc
Q 006545 416 NFVSKLSDFGISRFLS 431 (641)
Q Consensus 416 ~~~vKL~DFGla~~~~ 431 (641)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=178.59 Aligned_cols=175 Identities=23% Similarity=0.341 Sum_probs=134.3
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
.+||.|++|.-.+|.++|.........++.....++.|++.|+.| ++.+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999766666677888999999999999999 48999999999999999999999999998
Q ss_pred cccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcHHHHHHHhhcccccc
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
......... .......+..+||..||+||.+.+..|+.++||||||+||+||++ =..+|..... +..+
T Consensus 404 ts~~~~~~~--~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---------~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETV--APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---------LTDI 472 (516)
T ss_pred eecccCCcc--cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------hhhh
Confidence 876655411 111223456789999999999999999999999999999999998 2223311111 1111
Q ss_pred cCCCCCCCCh---hhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 507 LDPLAGDWPF---VQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 507 ~d~~~~~~~~---~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
..+.+|. ...+.-..|+.+++.+.|.+||++.+
T Consensus 473 ---r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 ---RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1122331 12234568999999999999995544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=181.00 Aligned_cols=138 Identities=28% Similarity=0.364 Sum_probs=112.2
Q ss_pred hhcCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHhcCCCCceeeEeccc--cC
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPNLVTLVGAC--PE 347 (641)
Q Consensus 278 ~~~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~ 347 (641)
.....|...+.||+|+||+||+|.+.+..+++|+........ ...+.+|+.++..++|++++..+.++ .+
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 334556778999999999999999987777776543321111 24578999999999999987765444 45
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
..++||||++|++|.+++. ....++.+++.+|.+||+ .+|+||||||+|||+ .++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 7889999999999999873 457889999999999999 899999999999999 6789999999998
Q ss_pred ccc
Q 006545 428 RFL 430 (641)
Q Consensus 428 ~~~ 430 (641)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=139.89 Aligned_cols=132 Identities=20% Similarity=0.276 Sum_probs=112.0
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCC--CceeeEecccc--CceEEEEEecCCCCh
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGACP--EVWTLVYEYLPNGSL 361 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~--~~~~lV~Ey~~ggsL 361 (641)
.+.||.|.++.||++...+..+++|....... ...+.+|+.++..+.| ++++++++++. +..+++|||++|+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46799999999999999888999999865443 4578999999999976 58888888764 368999999998877
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
..+ +......++.+++.+|.+||..+..+++|+|++|.||+++..+.++++|||.+..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 653 4456778899999999999996556899999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.9e-15 Score=143.47 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=97.3
Q ss_pred cceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCc--hh----------------------HHHHHHHHhcCCCC--ce
Q 006545 286 SLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP--SE----------------------FQQEIDILSKIRHP--NL 338 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~--~~----------------------~~~Ei~iL~~l~Hp--nI 338 (641)
.+.||+|+||.||+|.+. +..||||++........ .. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999886 88999999876432111 11 13456666666433 24
Q ss_pred eeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc
Q 006545 339 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418 (641)
Q Consensus 339 v~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~ 418 (641)
.+.++. ...++||||++|+++........ ... .....++.+++.++.++|.. .+|+||||||+||+++ ++.
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCc
Confidence 444443 24689999999965432111000 011 56788999999999999983 5899999999999999 899
Q ss_pred ccccccccccccc
Q 006545 419 SKLSDFGISRFLS 431 (641)
Q Consensus 419 vKL~DFGla~~~~ 431 (641)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=147.00 Aligned_cols=132 Identities=20% Similarity=0.221 Sum_probs=103.5
Q ss_pred ceee-ccCceEEEEEEECCeEEEEEEecCCCC-------------CCchhHHHHHHHHhcCCCCce--eeEecccc---C
Q 006545 287 LKIG-EGGYGSIYKGLLRHMQVAIKMLHPHSL-------------QGPSEFQQEIDILSKIRHPNL--VTLVGACP---E 347 (641)
Q Consensus 287 ~~LG-~G~fG~Vy~g~~~~~~vAvK~~~~~~~-------------~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~---~ 347 (641)
..|| .||.|+||.+...+..++||.+..... .....+.+|+.++.+|.|++| +..+++.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 899999999988889999998853211 123457889999999998775 56666531 1
Q ss_pred ---ceEEEEEecCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccc
Q 006545 348 ---VWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 423 (641)
Q Consensus 348 ---~~~lV~Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~D 423 (641)
..++||||++| .+|.+++.. .+++.. .+.+++.+|.+||. .||+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999997 689888742 235543 35689999999999 8999999999999999999999999
Q ss_pred cccccc
Q 006545 424 FGISRF 429 (641)
Q Consensus 424 FGla~~ 429 (641)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.6e-16 Score=175.32 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=183.9
Q ss_pred cCCCCccceeeccCceEEEEEEEC---CeEEEEEEecCCC--CCCchhHHHHHHHHhcCC-CCceeeEeccc--cCceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHS--LQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~l 351 (641)
...|.+.+.||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++.. .+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346778888999999999876553 3456777665443 222344556888888887 99999999987 456789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCceeeccCCCCceEeccCC-cccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH-SCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRF 429 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~gIiHrDIkp~NILld~~~-~vKL~DFGla~~ 429 (641)
+++|..||++.+.+.. ......+....-.++.|+..+|.|+| . .++.|+||||+|.+++.++ .++++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999888731 11114555677889999999999999 6 7999999999999999999 999999999988
Q ss_pred ccc-ccccCCCccccccCCCCC-CcccCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccc
Q 006545 430 LSQ-NEISSNNTTLCCRTDPKG-TFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL 506 (641)
Q Consensus 430 ~~~-~~~~~~~~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 506 (641)
+.. .+... ......| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+............ +...
T Consensus 175 ~~~~~g~~~------~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~--~~~~ 246 (601)
T KOG0590|consen 175 YRNKNGAER------SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS--WKSN 246 (601)
T ss_pred ccccCCcce------eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee--eccc
Confidence 766 32211 1233457 9999999999885 4567899999999999999999999654432211000 0000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 507 ~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
-................+++.+++..+|..|.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 011011112344567889999999999999999988
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.1e-13 Score=145.99 Aligned_cols=137 Identities=23% Similarity=0.288 Sum_probs=97.6
Q ss_pred ceeeccCceEEEEEEE-CCeEEEEEEecCCCCCC--------------------------c--------------hhHHH
Q 006545 287 LKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQG--------------------------P--------------SEFQQ 325 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~~--------------------------~--------------~~~~~ 325 (641)
+.||.|++|.||+|+. .|+.||||+.++..... . -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 58999999987652110 0 02445
Q ss_pred HHHHHhcCC-----CCc--eeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 006545 326 EIDILSKIR-----HPN--LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS-VLIFLHSCK 397 (641)
Q Consensus 326 Ei~iL~~l~-----Hpn--Iv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 397 (641)
|+..+.++. +++ |.+++..+....+|||||++|++|.++...... .+ ....++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence 666555552 333 233443334567899999999999887642211 12 23456666655 4677887
Q ss_pred CCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 398 ~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
.|++|+|++|.||+++.++.++|+|||++..+.
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.9e-13 Score=107.20 Aligned_cols=63 Identities=57% Similarity=0.993 Sum_probs=60.7
Q ss_pred CcCCCccccccCCCcccccCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHH
Q 006545 574 YFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEW 637 (641)
Q Consensus 574 ~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~ 637 (641)
+|.||++.++|.||+++++|++|++.+|..|+.. +.+||+|+.++...+++||.+||++|++|
T Consensus 1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 4889999999999999999999999999999988 78999999999999999999999999998
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.4e-12 Score=122.82 Aligned_cols=129 Identities=18% Similarity=0.144 Sum_probs=99.2
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCce-eeEeccccCceEEEEEecCCCChhhhh
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDRL 365 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~ggsL~~~L 365 (641)
+.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.++ .++++...+..++||||++|.++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 5689999999999999999999999765432 23357899999999865443 456666555678999999998876431
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeeccCCCCceEeccCCccccccccccc
Q 006545 366 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 366 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
. ....++.+++.+|..||... +.+++|||++|.||+++ ++.++++|||.+.
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1 12345678999999999943 23469999999999999 6689999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-12 Score=132.22 Aligned_cols=205 Identities=23% Similarity=0.324 Sum_probs=139.7
Q ss_pred HHHHhcCCCCceeeEeccccC-------ceEEEEEecCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006545 327 IDILSKIRHPNLVTLVGACPE-------VWTLVYEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCKP 398 (641)
Q Consensus 327 i~iL~~l~HpnIv~l~g~~~~-------~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 398 (641)
..-|-.+.|.|||+++.++.+ ...++.||+..|+|..+|.+. .....+......+|+.||+.||.|||++.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344556679999999988743 356899999999999999654 334457778888999999999999999875
Q ss_pred CceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHH
Q 006545 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478 (641)
Q Consensus 399 ~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL 478 (641)
+|+|+++..+-|++..+|-+|++--.-... ................+-++|.+||.=.....+.++|||+||+..
T Consensus 198 -piihgnlTc~tifiq~ngLIkig~~ap~s~----h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 198 -PIIHGNLTCDTIFIQHNGLIKIGSVAPDST----HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred -ccccCCcchhheeecCCceEEecccCcccc----chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 899999999999999999888753221110 000011111112234578899999987777778899999999999
Q ss_pred HHHHhCCCCCC-CcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHHHH
Q 006545 479 LRLLTGRPALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWR 546 (641)
Q Consensus 479 ~eLltG~~Pf~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv~~ 546 (641)
++|..|..--. ....+..... ....+-.+ ....-..++.+|++..|..||++...++.
T Consensus 273 lemailEiq~tnseS~~~~ee~---ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVEVEEN---IANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHheeccCCCcceeehhhh---hhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 99988763321 1111100000 00000000 01123467889999999999999986543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.9e-12 Score=137.23 Aligned_cols=244 Identities=25% Similarity=0.274 Sum_probs=174.8
Q ss_pred CCCccceeec--cCceEEEEEEE----CCeEEEEEEecCC--CCCCchhHHHHHHHHhcCC-CCceeeEecccc--CceE
Q 006545 282 NFDPSLKIGE--GGYGSIYKGLL----RHMQVAIKMLHPH--SLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWT 350 (641)
Q Consensus 282 ~y~~~~~LG~--G~fG~Vy~g~~----~~~~vAvK~~~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~ 350 (641)
.|.+...+|. |.+|.||.+.. .+..+|+|.-+.. .......=.+|+....+++ |+|.++.+..+. +..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4666778999 99999999877 2467898874332 2223333456777777774 999999777763 4567
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceeeccCCCCceEeccC-Ccccccccc
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS----VLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFG 425 (641)
Q Consensus 351 lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFG 425 (641)
+-+|+| +.+|..+.... ..-++....+.++.+... ||.++|. .+++|-|+||+||+...+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 778888 57887776432 333677788888888888 9999999 899999999999999988 889999999
Q ss_pred cccccccccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcH-HHHHHHhhcccc
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-EVQYALDTGKLK 504 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~-~~~~~~~~~~~~ 504 (641)
+...+.......... ......|...|++||... +-++...|||++|.++.+-.+|..++.... ..+..+..+
T Consensus 269 ~v~~i~~~~~~~~~~---~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--- 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFK---VSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--- 341 (524)
T ss_pred eeEEccCCcccccee---eeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---
Confidence 999887765333221 123346888999999874 567889999999999999999877664321 111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 505 ~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
. ...++-...+..+...+..|++.+|..|++...
T Consensus 342 --~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~ 375 (524)
T KOG0601|consen 342 --Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI 375 (524)
T ss_pred --c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHH
Confidence 1 111222233456666999999999999998865
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-11 Score=135.71 Aligned_cols=142 Identities=19% Similarity=0.246 Sum_probs=92.9
Q ss_pred CCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCCCC--------------------------Cc------------
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--------------------------GP------------ 320 (641)
Q Consensus 281 ~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~~~--------------------------~~------------ 320 (641)
..|+. +.||.|++|.||+|..+ |+.||||++++.... +.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 68999999999999984 799999999865210 00
Q ss_pred --hhHHHHHHHHhcCC----CCc---eeeEeccccCceEEEEEecCCCChhhhhhcCCCC---CCCCHHHHHHHHHHHHH
Q 006545 321 --SEFQQEIDILSKIR----HPN---LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS---PPLSWQTRIRIATELCS 388 (641)
Q Consensus 321 --~~~~~Ei~iL~~l~----Hpn---Iv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~---~~l~~~~~~~i~~qia~ 388 (641)
-.|.+|+..+.++. +.+ |.++|.-+....+|||||+.|+++.++-.-...+ ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12444555555542 332 2333433344678999999999998742111111 112222233333333
Q ss_pred HHHHHHhcCCCceeeccCCCCceEeccCC----cccccccccccccccc
Q 006545 389 VLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFGISRFLSQN 433 (641)
Q Consensus 389 aL~~LH~~~~~gIiHrDIkp~NILld~~~----~vKL~DFGla~~~~~~ 433 (641)
.. .|++|+|++|.||+++.+| .+++.|||++..++..
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23 7999999999999999887 9999999999877553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=142.18 Aligned_cols=253 Identities=23% Similarity=0.227 Sum_probs=173.7
Q ss_pred cCCCCccceeeccCceEEEEEEEC--CeEEEEEEecCCC---CCCchhHHHHHHHHhcCCCCceeeEecc--ccCceEEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS---LQGPSEFQQEIDILSKIRHPNLVTLVGA--CPEVWTLV 352 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV 352 (641)
...|.+.+.+-+|.+|.++.+.-. +...++|+..... .........+-.++-...||-++..... |....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666778899999999876553 2233444332211 1122333444444444556777776665 45678999
Q ss_pred EEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|+.|++|...|+.. +..+..-....+..+..++++||. ..+.|+|++|.|+|+..+|+.+++|||.......
T Consensus 883 ~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999888533 345555666777888999999999 5699999999999999999999999985433221
Q ss_pred c----cc----c----------CCCccc-----cccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 006545 433 N----EI----S----------SNNTTL-----CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 489 (641)
Q Consensus 433 ~----~~----~----------~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~ 489 (641)
. .. . ...... .......||+.|.+||.+.+......+|+|++|+++++.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 1 00 0 000000 11345679999999999999999999999999999999999999997
Q ss_pred CcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 490 ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.....+..-.. ... +.....-+...+....+++...+..+|.+|-.+.-
T Consensus 1037 a~tpq~~f~ni--~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1037 AETPQQIFENI--LNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred Ccchhhhhhcc--ccC--CCCCCCCccccChhhhhhhhhhhccCchhccCccc
Confidence 66544322111 100 11122234455678899999999999999987763
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-10 Score=113.68 Aligned_cols=134 Identities=16% Similarity=0.139 Sum_probs=97.7
Q ss_pred ceeeccCceEEEEEEEC--------CeEEEEEEecCCCCC----------C------------chhH----HHHHHHHhc
Q 006545 287 LKIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSLQ----------G------------PSEF----QQEIDILSK 332 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--------~~~vAvK~~~~~~~~----------~------------~~~~----~~Ei~iL~~ 332 (641)
..||.|-=+.||.|... +..+|||+.+..... + ...+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46999999999999764 368999998643110 0 0112 379999999
Q ss_pred CC--CCceeeEeccccCceEEEEEecCCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeeccCCC
Q 006545 333 IR--HPNLVTLVGACPEVWTLVYEYLPNGSLED-RLSCKDNSPPLSWQTRIRIATELCSVLIFL-HSCKPHSIVHGDLKP 408 (641)
Q Consensus 333 l~--HpnIv~l~g~~~~~~~lV~Ey~~ggsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~gIiHrDIkp 408 (641)
+. .-++..++++ ...+|||||+.++.+.. .+ ....++......+..+++.+|..| |. .||+||||++
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 84 3456666654 56789999997654422 22 112355556778889999999998 78 7999999999
Q ss_pred CceEeccCCccccccccccccc
Q 006545 409 ANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 409 ~NILld~~~~vKL~DFGla~~~ 430 (641)
.|||++ ++.++|+|||.+-..
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeC
Confidence 999997 467999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-10 Score=110.70 Aligned_cols=129 Identities=28% Similarity=0.379 Sum_probs=102.8
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCc--------hhHHHHHHHHhcCC--CCceeeEeccccCceEEEEEec
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGP--------SEFQQEIDILSKIR--HPNLVTLVGACPEVWTLVYEYL 356 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~--------~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~lV~Ey~ 356 (641)
..+++|+=+.+|.+.+.+.++++|.-.+.....+ ..-.+|+.++.++. --+...++++.++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3588999999999988888888887555433322 34568999998885 3455667777788888999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 357 ~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
+|..|.+.+... ...++..+-.-+.-||. .||+||||.++||++..++ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888422 25677788888899999 8999999999999997765 89999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=112.91 Aligned_cols=138 Identities=22% Similarity=0.321 Sum_probs=108.6
Q ss_pred ceeeccCceEEEEEEECC-eEEEEEEecCCCC-CCchhHHHHHHHHhcCCC--CceeeEeccccC-----ceEEEEEecC
Q 006545 287 LKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRH--PNLVTLVGACPE-----VWTLVYEYLP 357 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~-~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~-----~~~lV~Ey~~ 357 (641)
+.||.|.++.||++...+ ..+++|+...... .....+..|+.+++.+.+ .++.+++++... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998875 8899999765432 235678999999999975 445667776643 5689999999
Q ss_pred CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------------- 397 (641)
Q Consensus 358 ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 397 (641)
|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876521 34677788888899999999998521
Q ss_pred -------------CCceeeccCCCCceEecc--CCccccccccccc
Q 006545 398 -------------PHSIVHGDLKPANILLDA--NFVSKLSDFGISR 428 (641)
Q Consensus 398 -------------~~gIiHrDIkp~NILld~--~~~vKL~DFGla~ 428 (641)
+..++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 6778999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.9e-10 Score=125.73 Aligned_cols=162 Identities=19% Similarity=0.223 Sum_probs=121.7
Q ss_pred CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc--CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHH
Q 006545 303 RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 380 (641)
Q Consensus 303 ~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~ 380 (641)
.+.+|.|...............+-+..|+.++||||++++..+. +..|||+|-+. .|..++.. ++...+.
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHHH
Confidence 46778888777655433455788899999999999999999884 46799999984 57777742 2345667
Q ss_pred HHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCcccCChhhh
Q 006545 381 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460 (641)
Q Consensus 381 ~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l 460 (641)
..+.||+.||.|||.- .+++|++|.-+.|+|+..|..||++|.++.......... ....--..|..|+.+
T Consensus 108 ~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--------~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--------KSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--------ccchhhhcccChhhc
Confidence 7789999999999863 579999999999999999999999999886554332100 011123346667655
Q ss_pred ccCCCCchhhHHHHHHHHHHHHhC
Q 006545 461 ASGELTPKSDVYSFGIILLRLLTG 484 (641)
Q Consensus 461 ~~~~~s~~sDVwSlGviL~eLltG 484 (641)
.... -..|.|-|||++++++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4333 346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3e-09 Score=111.83 Aligned_cols=254 Identities=20% Similarity=0.284 Sum_probs=166.6
Q ss_pred CccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcC-CCCceee--------EeccccC-ceEEEE
Q 006545 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVT--------LVGACPE-VWTLVY 353 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~g~~~~-~~~lV~ 353 (641)
...+.||+|+-+.+|-.---+. .+.|+++...... -..-+..|... .||-+-. ++|.-.. ...+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAA---QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhheeecCCCchH---HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567799999999995322222 3457776543321 12233344444 4664433 2332222 256788
Q ss_pred EecCCC-Chhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccc
Q 006545 354 EYLPNG-SLEDRLS---CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 354 Ey~~gg-sL~~~L~---~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
..+.|. .+..++. +....+...|...++++..++.+.+.||. .|.+-||++++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 887765 2333332 23445668899999999999999999999 8999999999999999999999987543221
Q ss_pred cccccccCCCccccccCCCCCCcccCChhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCc-------HHHHH
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTG-RPALGIT-------KEVQY 496 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~eLltG-~~Pf~~~-------~~~~~ 496 (641)
- .++ ......+|...|.+||... +..-+...|.|.||++++++|.| ++||.+. +..+.
T Consensus 167 ~-~ng--------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 167 N-ANG--------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred c-cCC--------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 1 111 1123457999999999765 33456789999999999999886 9999642 22333
Q ss_pred HHhhcccccccC------CCCCCCChh-hHHHHHHHHHHHhhh--ccCCCCChHHHHHHHHHHHHhh
Q 006545 497 ALDTGKLKNLLD------PLAGDWPFV-QAEQLANLAMRCCEM--SRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 497 ~~~~~~~~~~~d------~~~~~~~~~-~~~~l~~Li~~cL~~--dP~~RPs~~evv~~~Le~l~~~ 554 (641)
.+..+.+....+ +....||.. .++.+..|..+|+.. ++.-||+... .+..|..+...
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a-W~aAl~al~~~ 303 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA-WVAALDALRQQ 303 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH-HHHHHHHHHHh
Confidence 333333332222 222334433 456889999999985 3678999987 77777777654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.6e-11 Score=128.36 Aligned_cols=237 Identities=24% Similarity=0.242 Sum_probs=167.2
Q ss_pred cCCCCccceeeccCceEEEEEEEC---CeEEEEEEecCCCCCCchh--HHHHHHHHhcC-CCCceeeEeccc--cCceEE
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSE--FQQEIDILSKI-RHPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 280 ~~~y~~~~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~~~~~~--~~~Ei~iL~~l-~HpnIv~l~g~~--~~~~~l 351 (641)
..+|..+..||.|.|+.|+....+ +..|++|.+.........+ -..|+-+...+ .|.+++.++..+ .+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999987653 5778988877654433222 23456566555 488888876655 346778
Q ss_pred EEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccC-Cccccccccccccc
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFL 430 (641)
Q Consensus 352 V~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~-~~vKL~DFGla~~~ 430 (641)
=.|||.++++...+ .....+.+..++++..+++.++.++|+ +.++|+|++|+||++..+ +..+++|||+...+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence 89999999887665 223346777889999999999999999 899999999999999876 78899999988643
Q ss_pred ccccccCCCccccccCCCCCCccc-CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCC
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAY-MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 509 (641)
.-... ....++..| .+|.......+..+.|+||||.-+.+.++|.+.-...... ..+...
T Consensus 418 ~~~~~----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------~~i~~~ 478 (524)
T KOG0601|consen 418 AFSSG----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------LTIRSG 478 (524)
T ss_pred ceecc----------cccccccccccchhhccccccccccccccccccccccccCcccCcccccc---------eeeecc
Confidence 22110 011123334 3555666678889999999999999999987543211111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhccCCCCChHH
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 510 ~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e 542 (641)
.....+. ....+..+...+...++..||.+.+
T Consensus 479 ~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~ 510 (524)
T KOG0601|consen 479 DTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVE 510 (524)
T ss_pred cccCCCc-hHHhhhhhhhhhcCCccccchhhhh
Confidence 1111222 2377888999999999999999877
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=101.88 Aligned_cols=141 Identities=21% Similarity=0.252 Sum_probs=102.5
Q ss_pred ccceeeccCceEEEEEEECCeEEEEEEecCCCCCC--------chhHHHHHHHHhcCCCCc--eeeEeccccCceEEEEE
Q 006545 285 PSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQG--------PSEFQQEIDILSKIRHPN--LVTLVGACPEVWTLVYE 354 (641)
Q Consensus 285 ~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~--------~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~lV~E 354 (641)
....|-+|+-+.|+++.+.|+.+.||.-....... .....+|+.+|.++.--. ...++-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45678999999999999999999998654433222 235678999999885322 23333333445689999
Q ss_pred ecCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC---cccccccccccc
Q 006545 355 YLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF 429 (641)
Q Consensus 355 y~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~---~vKL~DFGla~~ 429 (641)
|++| .++.+++........ .......++..+-..+.-||. ++||||||..+||+|..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 367777754433332 223337788899999999999 8999999999999996543 447999999764
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.6e-10 Score=109.57 Aligned_cols=73 Identities=32% Similarity=0.587 Sum_probs=70.4
Q ss_pred CCCCCCcCCCccccccCCCcccccCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHHhhC
Q 006545 569 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641 (641)
Q Consensus 569 ~~~p~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~~ 641 (641)
..+|++++|.|..++|.+||++++|.||++..|.+++.+.+..+|+|+.+|...+++||++|+.+|..|+..|
T Consensus 206 rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~n 278 (284)
T KOG4642|consen 206 REVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKEN 278 (284)
T ss_pred ccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHhc
Confidence 5789999999999999999999999999999999999998999999999999999999999999999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.3e-08 Score=103.99 Aligned_cols=165 Identities=22% Similarity=0.290 Sum_probs=129.1
Q ss_pred ceEEEEEEE--CCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEecccc------CceEEEEEecCC-CChhhh
Q 006545 294 YGSIYKGLL--RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVYEYLPN-GSLEDR 364 (641)
Q Consensus 294 fG~Vy~g~~--~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~------~~~~lV~Ey~~g-gsL~~~ 364 (641)
-.+.|++.. +|..|++|+++............-+++++++.|+|||++..+|. ...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457788876 58889999997766666666677789999999999999988762 357899999886 467766
Q ss_pred hhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccccccccc
Q 006545 365 LSCK------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 365 L~~~------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
.... ..+...++..+|.++.|+..||.++|+ .|+.-+-|.|.+||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5322 123457789999999999999999999 8999999999999999999999999998766554
Q ss_pred ccccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~ 486 (641)
+.. +-+. --.+-|.=.||.+++.|.||..
T Consensus 446 d~~----------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 320 0011 1135688899999999999964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.3e-08 Score=99.28 Aligned_cols=124 Identities=23% Similarity=0.250 Sum_probs=80.4
Q ss_pred EEEEEEE-CCeEEEEEEecCCCCCC--------------------------chhHHHHHHHHhcCCCC--ceeeEecccc
Q 006545 296 SIYKGLL-RHMQVAIKMLHPHSLQG--------------------------PSEFQQEIDILSKIRHP--NLVTLVGACP 346 (641)
Q Consensus 296 ~Vy~g~~-~~~~vAvK~~~~~~~~~--------------------------~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~ 346 (641)
.||.|.. .+..+|||+.+.....- .....+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 57899999987532110 01256899999999754 566666553
Q ss_pred CceEEEEEecC--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceeeccCCCCceEeccCCcccccc
Q 006545 347 EVWTLVYEYLP--NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIF-LHSCKPHSIVHGDLKPANILLDANFVSKLSD 423 (641)
Q Consensus 347 ~~~~lV~Ey~~--ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~gIiHrDIkp~NILld~~~~vKL~D 423 (641)
..+|||||++ |..+..+.... ++......++.+++..+.. +|. .||+||||.+.|||++.+ .+.|+|
T Consensus 80 -~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 -RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp -TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred -CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 4579999998 65554433211 1123456777788885555 567 899999999999999887 899999
Q ss_pred ccccccc
Q 006545 424 FGISRFL 430 (641)
Q Consensus 424 FGla~~~ 430 (641)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.4e-08 Score=100.37 Aligned_cols=137 Identities=15% Similarity=0.063 Sum_probs=97.8
Q ss_pred eeeccCceEEEEEEECCeEEEEEEecCCCCC-----------CchhHHHHHHHHhcCCCCc--eeeEeccc-------cC
Q 006545 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ-----------GPSEFQQEIDILSKIRHPN--LVTLVGAC-------PE 347 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~-------~~ 347 (641)
.+-......|+++.+.|+.|.||........ ....+.+|...+.+|..-+ .+.++++. ..
T Consensus 29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3444444457778888899999977543311 1124789999988884222 22332222 12
Q ss_pred ceEEEEEecCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc-------CCcc
Q 006545 348 VWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-------NFVS 419 (641)
Q Consensus 348 ~~~lV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~-------~~~v 419 (641)
..+||||++++. +|.+++.... ..+.+......++.+++..+.-||. .||+|+|+++.|||++. ++.+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 467999999886 8988874321 2345566778999999999999999 89999999999999975 4688
Q ss_pred ccccccccc
Q 006545 420 KLSDFGISR 428 (641)
Q Consensus 420 KL~DFGla~ 428 (641)
.|+||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.7e-09 Score=115.08 Aligned_cols=153 Identities=22% Similarity=0.322 Sum_probs=105.6
Q ss_pred HHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccccccCCCcc-ccccCCCCCCcccCChhhhcc
Q 006545 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT-LCCRTDPKGTFAYMDPEFLAS 462 (641)
Q Consensus 384 ~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~ 462 (641)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+++.............. ............|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999985 6899999999999999999999999999875544211110000 000011235678999999999
Q ss_pred CCCCchhhHHHHHHHHHHHH-hCCCCCCCcHHHH-HHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCCh
Q 006545 463 GELTPKSDVYSFGIILLRLL-TGRPALGITKEVQ-YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 463 ~~~s~~sDVwSlGviL~eLl-tG~~Pf~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~ 540 (641)
...++++|+||+||++|.+. .|++.+...+... +....+ ..+...-.++...+.++.+=+.+++..++.-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 88899999999999999999 5666664332211 111111 11111222345667889999999999999999966
Q ss_pred HH
Q 006545 541 GK 542 (641)
Q Consensus 541 ~e 542 (641)
..
T Consensus 260 ~~ 261 (700)
T KOG2137|consen 260 DL 261 (700)
T ss_pred hh
Confidence 54
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-07 Score=95.71 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=95.8
Q ss_pred CCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCC----------------------CchhHHHHHHHHhcCCCC--c
Q 006545 283 FDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ----------------------GPSEFQQEIDILSKIRHP--N 337 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~----------------------~~~~~~~Ei~iL~~l~Hp--n 337 (641)
+.++.+||-|-=|.||.|... +.++|||.-+..... ......+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 466788999999999999985 899999976432110 012256899999998654 6
Q ss_pred eeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCC
Q 006545 338 LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF 417 (641)
Q Consensus 338 Iv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~ 417 (641)
|.+.+++ +...+||||+.|-.|...- ++....-.|+..|+.-+.-+-. .||||||+++-|||++++|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 6666664 4567999999987665432 1222333444445444444434 6999999999999999999
Q ss_pred cccccccccccc
Q 006545 418 VSKLSDFGISRF 429 (641)
Q Consensus 418 ~vKL~DFGla~~ 429 (641)
.++++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999986543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.3e-07 Score=92.13 Aligned_cols=104 Identities=30% Similarity=0.338 Sum_probs=79.5
Q ss_pred chhHHHHHHHHhcCCCC--ceeeEecccc------CceEEEEEecCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 006545 320 PSEFQQEIDILSKIRHP--NLVTLVGACP------EVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390 (641)
Q Consensus 320 ~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~------~~~~lV~Ey~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 390 (641)
.....+|...+..|..- .+...+++.. ...+||+|++++. +|.+++.... .++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34678899888887422 2333333331 2357999999885 7999885322 155667889999999999
Q ss_pred HHHHhcCCCceeeccCCCCceEeccCC---cccccccccccc
Q 006545 391 IFLHSCKPHSIVHGDLKPANILLDANF---VSKLSDFGISRF 429 (641)
Q Consensus 391 ~~LH~~~~~gIiHrDIkp~NILld~~~---~vKL~DFGla~~ 429 (641)
.-||. .||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 8999999999999998876 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=7e-07 Score=88.04 Aligned_cols=136 Identities=16% Similarity=0.119 Sum_probs=103.0
Q ss_pred eeccCceEEEEEEECCeEEEEEEecCCC------CCCchhHHHHHHHHhcCCC--CceeeEecccc-------CceEEEE
Q 006545 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHS------LQGPSEFQQEIDILSKIRH--PNLVTLVGACP-------EVWTLVY 353 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~~~~vAvK~~~~~~------~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~-------~~~~lV~ 353 (641)
-|+||.+.|+...+.|..+-+|.-.... ......|.+|+..|.+|.. -.+.+.+ ++. -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4779999999988888889999865321 1234679999999999853 2244444 221 1367999
Q ss_pred EecCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCc--ccccccccccc
Q 006545 354 EYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV--SKLSDFGISRF 429 (641)
Q Consensus 354 Ey~~g-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~--vKL~DFGla~~ 429 (641)
|-++| -+|.+++.... ..+.+......++.+++..|.-||. .|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 47888874322 2356777888999999999999999 89999999999999986666 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.7e-07 Score=98.52 Aligned_cols=139 Identities=21% Similarity=0.297 Sum_probs=92.4
Q ss_pred ceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCc------------------------------h----------hHHH
Q 006545 287 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP------------------------------S----------EFQQ 325 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~------------------------------~----------~~~~ 325 (641)
..|+.++-|.||+|++. |+.||||+.++.-.... + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999997 89999999987532110 0 1344
Q ss_pred HHHHHhcCC-----CCc--eeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 006545 326 EIDILSKIR-----HPN--LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV-LIFLHSCK 397 (641)
Q Consensus 326 Ei~iL~~l~-----Hpn--Iv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~~ 397 (641)
|..-+.+++ .|+ |.++|--+.....|+|||++|..+.+...... ..++.. .++..++.+ +.-+=.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHh--
Confidence 555555542 333 23344333456679999999999988853222 223322 233333332 111112
Q ss_pred CCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 398 ~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
.|++|.|..|.||+++.+|.+.+.|||+...++..
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 58999999999999999999999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.3e-06 Score=86.49 Aligned_cols=135 Identities=19% Similarity=0.213 Sum_probs=93.3
Q ss_pred hcCCCCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchh---------HHHHHHHHhcCCC---CceeeEeccc-
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE---------FQQEIDILSKIRH---PNLVTLVGAC- 345 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~---------~~~Ei~iL~~l~H---pnIv~l~g~~- 345 (641)
..++|...+++-......|.+-...+..+++|............ ..+.+..+.++.. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45678888888888888888888889999999887654322221 2344444444432 2222222221
Q ss_pred ------cCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 346 ------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 346 ------~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
....++||||++|..|.+... ++. .++..+..++.-||. .|++|||..|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 234568999999988877641 222 245567788999999 8999999999999998665 8
Q ss_pred ccccccccc
Q 006545 420 KLSDFGISR 428 (641)
Q Consensus 420 KL~DFGla~ 428 (641)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.3e-06 Score=84.24 Aligned_cols=130 Identities=18% Similarity=0.249 Sum_probs=80.9
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCc--eeeEeccc--cCceEEEEEecCCCC-h
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGAC--PEVWTLVYEYLPNGS-L 361 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~--~~~~~lV~Ey~~ggs-L 361 (641)
..||.|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++. .+...+||++++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56999999999984 35567889876532 3456789999998885332 34555553 345678999999863 2
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHhc-CCCce
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSV---------------------------------------LIFLHSC-KPHSI 401 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~a---------------------------------------L~~LH~~-~~~gI 401 (641)
...+. .+......++..++.. ..+|... ....+
T Consensus 83 ~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 83 SRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 21110 0001111111112222 2222211 12357
Q ss_pred eeccCCCCceEeccCCccccccccccc
Q 006545 402 VHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 402 iHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
+|+|+.|.||++++++ +.|+||+.+.
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcC
Confidence 8999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.8e-06 Score=84.59 Aligned_cols=140 Identities=21% Similarity=0.299 Sum_probs=84.2
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCC--ceeeEeccc-----cCceEEEEEecCCC
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC-----PEVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~-----~~~~~lV~Ey~~gg 359 (641)
+.|+.|..+.||+....+..+++|..... .....+..|..+++.+... .+.+++..+ ....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 57899999999999998889999997654 2345788999999888532 345566532 22368999999998
Q ss_pred Chhh----------------hhh---cC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHhc-
Q 006545 360 SLED----------------RLS---CK-DNSPPLSWQT---------RIRI------------ATELCS-VLIFLHSC- 396 (641)
Q Consensus 360 sL~~----------------~L~---~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~~LH~~- 396 (641)
++.. .+. .. ....++.... .... ...+.. .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 11 0111111111 0000 111222 33444431
Q ss_pred ---CCCceeeccCCCCceEec-cCCccccccccccc
Q 006545 397 ---KPHSIVHGDLKPANILLD-ANFVSKLSDFGISR 428 (641)
Q Consensus 397 ---~~~gIiHrDIkp~NILld-~~~~vKL~DFGla~ 428 (641)
.+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 346799999999999999 66666899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.9e-06 Score=79.80 Aligned_cols=131 Identities=20% Similarity=0.195 Sum_probs=92.9
Q ss_pred CCccceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCceeeEeccccCceEEEEEecCCCChh
Q 006545 283 FDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLE 362 (641)
Q Consensus 283 y~~~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~~ggsL~ 362 (641)
-...+.||+|.+|.||+|.+++..+|+|+-+.++ ....+..|+++|..+..-++.+=+..+.. .++.|||+.|-+|.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~-~~i~me~i~G~~L~ 100 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE-DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech-hhhhhhhhcCcchh
Confidence 3456779999999999999999999999976544 34578999999999987666543322222 23559999998887
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCC-CCceEeccCCcccccccccccc
Q 006545 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK-PANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 363 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIk-p~NILld~~~~vKL~DFGla~~ 429 (641)
+.-... + .+-+..+++.-.-|.. .||-|+.|. |..++|..++.+.|+||..|+.
T Consensus 101 ~~~~~~------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 765211 1 2233345555445555 799999997 5545554555999999998863
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=80.33 Aligned_cols=135 Identities=19% Similarity=0.209 Sum_probs=89.0
Q ss_pred eeeccCceEEEEEEE-CCeEEEEEEecCCCCCCc-------------------h-----hHHHHHHHHhcCC--CCceee
Q 006545 288 KIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQGP-------------------S-----EFQQEIDILSKIR--HPNLVT 340 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~~~~-------------------~-----~~~~Ei~iL~~l~--HpnIv~ 340 (641)
.|..|--+.||+|.. .+..+|||+++....... . -..+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 466777789999886 478999999976432211 0 1345777777763 344445
Q ss_pred EeccccCceEEEEEecCCCCh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 341 LVGACPEVWTLVYEYLPNGSL-EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 341 l~g~~~~~~~lV~Ey~~ggsL-~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
-+++.. ..|||||+....+ .-.| ...++.......+..++++.+.-|-.. .++||+||+.=|||+. ++.+
T Consensus 135 Pi~~~~--nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFRN--NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeecC--CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 554433 4699999954311 1111 112233335666777777777766542 5899999999999999 8899
Q ss_pred cccccccccccc
Q 006545 420 KLSDFGISRFLS 431 (641)
Q Consensus 420 KL~DFGla~~~~ 431 (641)
.|+|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-05 Score=80.72 Aligned_cols=137 Identities=16% Similarity=0.157 Sum_probs=83.0
Q ss_pred eeccCc-eEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCC-CCceeeEecccc--CceEEEEEecCCCChhhh
Q 006545 289 IGEGGY-GSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP--EVWTLVYEYLPNGSLEDR 364 (641)
Q Consensus 289 LG~G~f-G~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~lV~Ey~~ggsL~~~ 364 (641)
|-.|.+ +.||+....+..+.||+..... ...+.+|+.++..+. +--+.+++++.. +..++||++++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 455555 7899987777788889876443 346788999998884 334556666653 357899999999877643
Q ss_pred h-------------------hcCCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----cCC
Q 006545 365 L-------------------SCKDN-SPPLSWQ--TRIRIAT--------------------ELCSVLIFLHS----CKP 398 (641)
Q Consensus 365 L-------------------~~~~~-~~~l~~~--~~~~i~~--------------------qia~aL~~LH~----~~~ 398 (641)
. +.... ..++... ....... .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 10000 0111100 0000000 01111222211 112
Q ss_pred CceeeccCCCCceEeccCCccccccccccc
Q 006545 399 HSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 399 ~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998888899999664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR00599 rad18 DNA repair protein rad18 | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.6e-06 Score=89.38 Aligned_cols=69 Identities=12% Similarity=0.250 Sum_probs=63.6
Q ss_pred CCCCCcCCCccccccCCCcccccCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHHh
Q 006545 570 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 639 (641)
Q Consensus 570 ~~p~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~ 639 (641)
.....|.|+|+.+++.+|++++|||+||..||..|+.. ...||+|+.+.....|.+|.+|.++|+.|..
T Consensus 22 ~Le~~l~C~IC~d~~~~PvitpCgH~FCs~CI~~~l~~-~~~CP~Cr~~~~~~~Lr~N~~L~~iVe~~~~ 90 (397)
T TIGR00599 22 PLDTSLRCHICKDFFDVPVLTSCSHTFCSLCIRRCLSN-QPKCPLCRAEDQESKLRSNWLVSEIVESFKN 90 (397)
T ss_pred ccccccCCCcCchhhhCccCCCCCCchhHHHHHHHHhC-CCCCCCCCCccccccCccchHHHHHHHHHHH
Confidence 35577999999999999999999999999999999987 5689999999998899999999999999975
|
This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University). |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.2e-05 Score=78.62 Aligned_cols=107 Identities=22% Similarity=0.231 Sum_probs=85.1
Q ss_pred HHHHHHHhcCCC-CceeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 006545 324 QQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402 (641)
Q Consensus 324 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIi 402 (641)
..|.-+|+.+.+ +++++++|+|.+ ++|.||...+++.............+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 458888999976 699999999975 67999998776643210001112468999999999999999999986666688
Q ss_pred eccCCCCceEeccCCccccccccccccccc
Q 006545 403 HGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 403 HrDIkp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
-.|++|+|+-++++|.+|++|...+.....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 899999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.4e-05 Score=89.11 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=92.4
Q ss_pred ceeeccCceEEEEEEEC-CeEEEEEEecCCCCCCc-------------------------------------hhHHHHHH
Q 006545 287 LKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGP-------------------------------------SEFQQEID 328 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~~~-------------------------------------~~~~~Ei~ 328 (641)
..||.-+.|.||+|+.+ |..||||+-++.-.... -.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 35899999999999985 68899999886532210 01444555
Q ss_pred HHhcC----CCCc------eeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006545 329 ILSKI----RHPN------LVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398 (641)
Q Consensus 329 iL~~l----~Hpn------Iv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 398 (641)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-.. ..++... |+..+.++. ++..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---ILNKLVEAY--LEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---HHHHHHHHH--HHHHHh
Confidence 44333 3444 56666666667889999999998877643222 2244443 333333332 222112
Q ss_pred CceeeccCCCCceEecc----CCccccccccccccccc
Q 006545 399 HSIVHGDLKPANILLDA----NFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 399 ~gIiHrDIkp~NILld~----~~~vKL~DFGla~~~~~ 432 (641)
.|++|+|-.|.||++.. ++.+.+.|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 58999999999999983 67899999999876654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.1e-05 Score=78.35 Aligned_cols=71 Identities=11% Similarity=0.165 Sum_probs=46.0
Q ss_pred ceeeccCce-EEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCC---ceeeEeccccC-----ceEEEEEecC
Q 006545 287 LKIGEGGYG-SIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP---NLVTLVGACPE-----VWTLVYEYLP 357 (641)
Q Consensus 287 ~~LG~G~fG-~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~~-----~~~lV~Ey~~ 357 (641)
..|+.||.. .||+. +..+++|+.... .....+.+|..+|..+... .+..+++.... ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 48874 345777875432 2345788999999887531 23444444321 3478999999
Q ss_pred CCChh
Q 006545 358 NGSLE 362 (641)
Q Consensus 358 ggsL~ 362 (641)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.5e-05 Score=90.39 Aligned_cols=146 Identities=19% Similarity=0.304 Sum_probs=91.0
Q ss_pred cceeeccCceEEEEEEECC----eEEEEEEecCCCC-CCchhHHHHHHHHhcCC-CCce--eeEeccccC-----ceEEE
Q 006545 286 SLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIR-HPNL--VTLVGACPE-----VWTLV 352 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~----~~vAvK~~~~~~~-~~~~~~~~Ei~iL~~l~-HpnI--v~l~g~~~~-----~~~lV 352 (641)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |++| .+++++|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999877654 4678887654322 23356889999999995 6654 777877743 47899
Q ss_pred EEecCCCChhhh--------------------h---hcCCCC--------CCCC--HHHHHHHHH---------------
Q 006545 353 YEYLPNGSLEDR--------------------L---SCKDNS--------PPLS--WQTRIRIAT--------------- 384 (641)
Q Consensus 353 ~Ey~~ggsL~~~--------------------L---~~~~~~--------~~l~--~~~~~~i~~--------------- 384 (641)
|||++|..+.+. | +..... .+.. ..++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998654321 1 110000 0111 112211111
Q ss_pred HHHHHHHHHHhcCC--------CceeeccCCCCceEeccC-C-cccccccccccccc
Q 006545 385 ELCSVLIFLHSCKP--------HSIVHGDLKPANILLDAN-F-VSKLSDFGISRFLS 431 (641)
Q Consensus 385 qia~aL~~LH~~~~--------~gIiHrDIkp~NILld~~-~-~vKL~DFGla~~~~ 431 (641)
.+...+.+|....| ..+||+|+++.|||++.+ + .+-|.||+++..-.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12334566654333 249999999999999853 3 35689999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.8e-06 Score=95.62 Aligned_cols=187 Identities=19% Similarity=0.148 Sum_probs=132.7
Q ss_pred hcCCCCccceeeccCceEEEEEEECCe-EEEEEEecCCCCCCchhHHHHHHHHhcCCCCc-eeeEeccc--cCceEEEEE
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRHM-QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 279 ~~~~y~~~~~LG~G~fG~Vy~g~~~~~-~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~--~~~~~lV~E 354 (641)
.+..+....-+++|+++.++|.+.... ....+.+... ....-++++|.+++||| .+..++.+ ++...++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 344455566789999999998776532 2334444322 45667899999999999 66666665 446779999
Q ss_pred ecCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcccccccccccccccc
Q 006545 355 YLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 355 y~~gg-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
++.++ +-..... .....+...+...+...-..+|++||+ -.-+|+| ||+..+ +..+.+||+....+...
T Consensus 315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 3222211 111123344555667778889999998 3358888 777765 67899999988766554
Q ss_pred cccCCCccccccCCCCCCcccCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 489 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~ 489 (641)
. ......+++.++|||+.....+....|+|++|+-..+|--|-+|-.
T Consensus 385 ~---------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M---------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c---------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2 1234458999999999999999999999999998888888877764
|
|
| >KOG2042 consensus Ubiquitin fusion degradation protein-2 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.1e-05 Score=93.52 Aligned_cols=71 Identities=27% Similarity=0.485 Sum_probs=67.8
Q ss_pred CCCCCCcCCCccccccCCCcccc-cCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHHhh
Q 006545 569 CEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640 (641)
Q Consensus 569 ~~~p~~~~cPi~~evm~dPvv~~-~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~ 640 (641)
..+|++|..|+...+|.|||+.+ +|.+.+|+.|..++.+ ..++|++|.+|..++++||-.||.-|+.|..+
T Consensus 865 ~dvpdef~DPlm~Tlm~dPV~LP~Srv~vDRsti~rhlLs-~~tdPFNR~pLt~d~v~pn~eLK~kI~~~~~e 936 (943)
T KOG2042|consen 865 GDVPDEFLDPLMSTLMSDPVVLPSSRVTVDRSTIERHLLS-DCTDPFNREPLTEDMVSPNEELKAKIRCWIKE 936 (943)
T ss_pred ccCchhhhCccccccCCCCccCCcccccccHHHHHHHHhc-CCCCccccccCchhhcCCCHHHHHHHHHHHHH
Confidence 45999999999999999999999 9999999999999988 77999999999999999999999999999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.6e-05 Score=78.08 Aligned_cols=137 Identities=16% Similarity=0.130 Sum_probs=80.8
Q ss_pred eeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCce-eeEeccccCceEEEEEecCCCChhhh---
Q 006545 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSLEDR--- 364 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~ggsL~~~--- 364 (641)
+..|-.+.+|+....+..+++|+.........-...+|..+++.+....+ .++++.+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 55677889999887788899997654322211246789999999864322 34444443 4689999998766421
Q ss_pred --------------hhcCC-CCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCceeeccCCCCceEec
Q 006545 365 --------------LSCKD-NSPPLSWQT-RIRIATEL---------CSVLIFLHSC-----KPHSIVHGDLKPANILLD 414 (641)
Q Consensus 365 --------------L~~~~-~~~~l~~~~-~~~i~~qi---------a~aL~~LH~~-----~~~gIiHrDIkp~NILld 414 (641)
|+... ...+++... +..+..++ ...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 11111 111222211 11111111 1112222111 123589999999999999
Q ss_pred cCCccccccccccc
Q 006545 415 ANFVSKLSDFGISR 428 (641)
Q Consensus 415 ~~~~vKL~DFGla~ 428 (641)
+++ +.|+||+.+.
T Consensus 162 ~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 162 PQG-LKLIDWEYAS 174 (256)
T ss_pred CCC-CEEEeccccC
Confidence 877 7899999765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=76.73 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=78.0
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCC-----CCceeeE-----eccccCceEEEEEec
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----HPNLVTL-----VGACPEVWTLVYEYL 356 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l-----~g~~~~~~~lV~Ey~ 356 (641)
+.|+.|....+|+....+..+++|++. . .....+..|+.++..|. .|.++.- +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 456778778999987766689999876 2 22344555666666653 2333321 111244578999999
Q ss_pred CCCChhh-----------hh---hcCCC--------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhc----
Q 006545 357 PNGSLED-----------RL---SCKDN--------SPPLSW-QTRIR------------IA-TELCSVLIFLHSC---- 396 (641)
Q Consensus 357 ~ggsL~~-----------~L---~~~~~--------~~~l~~-~~~~~------------i~-~qia~aL~~LH~~---- 396 (641)
+|..+.. .| +.... ...+.+ ..... .+ ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9875421 11 10000 001111 11111 11 1111122333211
Q ss_pred CCCceeeccCCCCceEeccCCccccccccccc
Q 006545 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 397 ~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24689999999999999977666899999764
|
|
| >PLN03208 E3 ubiquitin-protein ligase RMA2; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.4e-05 Score=76.80 Aligned_cols=59 Identities=20% Similarity=0.372 Sum_probs=52.0
Q ss_pred CCCCcCCCccccccCCCcccccCccchHHHHHHHHhc---------------CCCCCCCCCCCCCCCCCChhHH
Q 006545 571 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS---------------GHETSPMTNLPLAHKNLVPNLA 629 (641)
Q Consensus 571 ~p~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~---------------~~~~~P~t~~~l~~~~l~pN~~ 629 (641)
....|.|||+.+.+.||+++.+||.|+..||..|+.. +..+||+|+.++...+++|.+.
T Consensus 15 ~~~~~~CpICld~~~dPVvT~CGH~FC~~CI~~wl~~s~~s~~~~~~~~~~k~~~~CPvCR~~Is~~~LvPiyg 88 (193)
T PLN03208 15 SGGDFDCNICLDQVRDPVVTLCGHLFCWPCIHKWTYASNNSRQRVDQYDHKREPPKCPVCKSDVSEATLVPIYG 88 (193)
T ss_pred CCCccCCccCCCcCCCcEEcCCCchhHHHHHHHHHHhccccccccccccccCCCCcCCCCCCcCChhcEEEeec
Confidence 4467999999999999999999999999999999852 2458999999999999998763
|
|
| >COG5113 UFD2 Ubiquitin fusion degradation protein 2 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.7e-05 Score=84.07 Aligned_cols=73 Identities=26% Similarity=0.468 Sum_probs=67.0
Q ss_pred CCCCCCCCcCCCccccccCCCcccc-cCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHHhh
Q 006545 567 ERCEPPPYFTCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQ 640 (641)
Q Consensus 567 ~r~~~p~~~~cPi~~evm~dPvv~~-~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~ 640 (641)
+...+|++|+.|.+..+|+|||+.+ ++.+.+|+.|..++.+ ..++|..|.||...+.+||-.||+-|-.|+..
T Consensus 847 D~GDvPDeFlDPLmftimkdPV~Lp~S~i~IDRSTikahlls-d~tDPFNRmPLtlddVtpn~eLrekIn~f~k~ 920 (929)
T COG5113 847 DMGDVPDEFLDPLMFTIMKDPVKLPTSRITIDRSTIKAHLLS-DGTDPFNRMPLTLDDVTPNAELREKINRFYKC 920 (929)
T ss_pred hccCCchhhhCchhhhcccCCeecccccccccHHHHHHHHhc-CCCCccccCCCchhhcCCCHHHHHHHHHHHhc
Confidence 3467999999999999999999996 7789999999999998 66999999999999999999999999988753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=72.78 Aligned_cols=139 Identities=18% Similarity=0.260 Sum_probs=81.9
Q ss_pred ceeeccCceEEEEEEEC---CeEEEEEEecCCCCCCchhHHHHHHHHhcCCC-CceeeEeccccCceEEEEEecCCCChh
Q 006545 287 LKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGACPEVWTLVYEYLPNGSLE 362 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~---~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~~lV~Ey~~ggsL~ 362 (641)
+.|..|-...+|+.... +..|++|+...... ..-...+|+.++..+.. .-.+++++.+.+ .+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~--~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQN--GLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC--cEEEEeeCCCcCC
Confidence 45777888899998765 46899997764322 12234579999998853 334455554443 4899999987763
Q ss_pred hh-------h----------hcCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHHH-
Q 006545 363 DR-------L----------SCKDNS--------PPLS-WQTRIRIAT----------------------ELCSVLIFL- 393 (641)
Q Consensus 363 ~~-------L----------~~~~~~--------~~l~-~~~~~~i~~----------------------qia~aL~~L- 393 (641)
.. + +..... .... +..+..+.. .+...+..|
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 0 111111 0111 222222211 111111122
Q ss_pred ---Hhc-CCCceeeccCCCCceEecc-CCccccccccccc
Q 006545 394 ---HSC-KPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 428 (641)
Q Consensus 394 ---H~~-~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~ 428 (641)
... .+..++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 111 2357999999999999997 5789999999764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00025 Score=74.52 Aligned_cols=73 Identities=22% Similarity=0.132 Sum_probs=55.2
Q ss_pred ceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCC---CceeeEecccc-----CceEEEEEecCC
Q 006545 287 LKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PNLVTLVGACP-----EVWTLVYEYLPN 358 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~g~~~-----~~~~lV~Ey~~g 358 (641)
..||.|..+.||.....+..+.+|..+. ......+..|...|+.|.- ..+.+++++|. +..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 4599999999999876655677887543 1234589999999998842 35777887663 457999999998
Q ss_pred CCh
Q 006545 359 GSL 361 (641)
Q Consensus 359 gsL 361 (641)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00021 Score=74.76 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=86.3
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCC--ceeeEeccc--------cCceEEEEEe
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY 355 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~--------~~~~~lV~Ey 355 (641)
...|..|....+|+....+..+++|+... .....+..|+.++..+.+. .+.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 44577788889999877777899998764 2345677888888888432 244544422 3356799999
Q ss_pred cCCCChhh----hh----------hcC----CCC----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCCC
Q 006545 356 LPNGSLED----RL----------SCK----DNS----PPLSWQTRI----------RIATELCSVLIFLHS----CKPH 399 (641)
Q Consensus 356 ~~ggsL~~----~L----------~~~----~~~----~~l~~~~~~----------~i~~qia~aL~~LH~----~~~~ 399 (641)
++|..+.. .+ +.. ... ....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99877532 00 000 000 011111110 011112334444443 2235
Q ss_pred ceeeccCCCCceEeccCCccccccccccc
Q 006545 400 SIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 400 gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998778899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF11789 zf-Nse: Zinc-finger of the MIZ type in Nse subunit; PDB: 2YU4_A 3HTK_C | Back alignment and domain information |
|---|
Probab=97.67 E-value=1.5e-05 Score=61.81 Aligned_cols=43 Identities=28% Similarity=0.597 Sum_probs=31.7
Q ss_pred CcCCCccccccCCCccc-ccCccchHHHHHHHH-hcCCCCCCCCC
Q 006545 574 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWL-DSGHETSPMTN 616 (641)
Q Consensus 574 ~~~cPi~~evm~dPvv~-~~g~t~e~~~i~~w~-~~~~~~~P~t~ 616 (641)
.++|||+...+.|||++ .+||+|++++|..|+ ..+...||+++
T Consensus 11 ~~~CPiT~~~~~~PV~s~~C~H~fek~aI~~~i~~~~~~~CPv~G 55 (57)
T PF11789_consen 11 SLKCPITLQPFEDPVKSKKCGHTFEKEAILQYIQRNGSKRCPVAG 55 (57)
T ss_dssp -SB-TTTSSB-SSEEEESSS--EEEHHHHHHHCTTTS-EE-SCCC
T ss_pred ccCCCCcCChhhCCcCcCCCCCeecHHHHHHHHHhcCCCCCCCCC
Confidence 48999999999999998 789999999999999 33466899864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00038 Score=73.37 Aligned_cols=141 Identities=18% Similarity=0.211 Sum_probs=84.0
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCCC--ceeeEeccc--------cCceEEEEEe
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHP--NLVTLVGAC--------PEVWTLVYEY 355 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~--------~~~~~lV~Ey 355 (641)
...++.|....+|+....+..+++|+..... ....+..|+.++..|... .+.+++... .+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4557777778999887666678899876532 234566778888777422 244444332 3456799999
Q ss_pred cCCCChhhh--------------hhcCCCC--C------C-CCHHHHH------------HHHHHHHHHHHHHHh----c
Q 006545 356 LPNGSLEDR--------------LSCKDNS--P------P-LSWQTRI------------RIATELCSVLIFLHS----C 396 (641)
Q Consensus 356 ~~ggsL~~~--------------L~~~~~~--~------~-l~~~~~~------------~i~~qia~aL~~LH~----~ 396 (641)
++|..+... ++..... . . -.|.... .....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 998654211 1110000 0 0 0111100 001123334555532 2
Q ss_pred CCCceeeccCCCCceEeccCCccccccccccc
Q 006545 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 397 ~~~gIiHrDIkp~NILld~~~~vKL~DFGla~ 428 (641)
.+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999998877899999753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00035 Score=76.05 Aligned_cols=74 Identities=16% Similarity=0.096 Sum_probs=56.0
Q ss_pred ceeeccCceEEEEEEECC--eEEEEEEecCCC-------CCCchhHHHHHHHHhcCC---CCceeeEeccccCceEEEEE
Q 006545 287 LKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS-------LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYE 354 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~~-------~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~E 354 (641)
+.||.|.++.||++...+ +.|+||.-.+.. ....+.+..|...|..+. ..++++++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 469999999999998864 489999854321 123456788999888873 35678888887777899999
Q ss_pred ecCCCC
Q 006545 355 YLPNGS 360 (641)
Q Consensus 355 y~~ggs 360 (641)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0005 Score=67.49 Aligned_cols=123 Identities=24% Similarity=0.357 Sum_probs=89.2
Q ss_pred CCCCccceeeccCc-eEEEEEEECCeEEEEEEecC---CCC------------------CCchhHHHHHHHHhcCC---C
Q 006545 281 HNFDPSLKIGEGGY-GSIYKGLLRHMQVAIKMLHP---HSL------------------QGPSEFQQEIDILSKIR---H 335 (641)
Q Consensus 281 ~~y~~~~~LG~G~f-G~Vy~g~~~~~~vAvK~~~~---~~~------------------~~~~~~~~Ei~iL~~l~---H 335 (641)
.+++.+..||.|.- |.||++...|..+|||++.. ... .....|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68889999999999 99999999999999999332 111 01134788988888774 4
Q ss_pred Cce--eeEeccc--c------------------CceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006545 336 PNL--VTLVGAC--P------------------EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393 (641)
Q Consensus 336 pnI--v~l~g~~--~------------------~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L 393 (641)
.++ |+.+|+. . ..+.||.||++... .++. .-+.+|..-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence 455 8888875 1 02457888876543 1222 2344566777888
Q ss_pred HhcCCCceeeccCCCCceEeccCCcccccccccc
Q 006545 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 394 H~~~~~gIiHrDIkp~NILld~~~~vKL~DFGla 427 (641)
|. .||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 98 89999999999987 3389999954
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=3.8e-05 Score=92.13 Aligned_cols=175 Identities=14% Similarity=0.022 Sum_probs=124.5
Q ss_pred EEEEEecCCCCCCc-----hhHHHHHHHHhcCCCCceeeEecccc----CceEEEEEecCCCChhhhhhcC-CCCCCCCH
Q 006545 307 VAIKMLHPHSLQGP-----SEFQQEIDILSKIRHPNLVTLVGACP----EVWTLVYEYLPNGSLEDRLSCK-DNSPPLSW 376 (641)
Q Consensus 307 vAvK~~~~~~~~~~-----~~~~~Ei~iL~~l~HpnIv~l~g~~~----~~~~lV~Ey~~ggsL~~~L~~~-~~~~~l~~ 376 (641)
+.+|+.+....+.. +....|.+.++...|+++...+.-.+ ..-+.+++|+.+|.+.+.+.+. ...+++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 55666554433332 22445555666678999887765442 3467899999999999998654 33444554
Q ss_pred HHHHHHHHHHHHHHHHHHhcCC--CceeeccCCCCceEeccCCcccccccccccccccccccCCCccccccCCCCCCccc
Q 006545 377 QTRIRIATELCSVLIFLHSCKP--HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454 (641)
Q Consensus 377 ~~~~~i~~qia~aL~~LH~~~~--~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 454 (641)
..+...-.+......-+|+... +--+|+++|+-|.+|..+..+|++++|+.+...... ...+...+++.|
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--------sf~Gl~l~sp~~ 1406 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--------SFFGLELCSPIY 1406 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--------hhhhhhhCCHHH
Confidence 4444444444556666665432 237899999999999999999999999998332221 223445678899
Q ss_pred CChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 006545 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALG 489 (641)
Q Consensus 455 ~APE~l~~~~~s~~sDVwSlGviL~eLltG~~Pf~ 489 (641)
+.|++.+.-.++.++|+|..|+-+|....|.++|-
T Consensus 1407 v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1407 VLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 99999998899999999999999999999998883
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0018 Score=63.87 Aligned_cols=126 Identities=24% Similarity=0.284 Sum_probs=84.3
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCC----------------CCCchhHHHHHHHHhcCC------CCceeeEec
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHS----------------LQGPSEFQQEIDILSKIR------HPNLVTLVG 343 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~----------------~~~~~~~~~Ei~iL~~l~------HpnIv~l~g 343 (641)
...||+|+.-.||.- -......||+..+.. .....++.+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEEC-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 457999999999952 234557889988765 112356777877766665 788999999
Q ss_pred cccC--ceEEEEEecCC------CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEecc
Q 006545 344 ACPE--VWTLVYEYLPN------GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415 (641)
Q Consensus 344 ~~~~--~~~lV~Ey~~g------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~ 415 (641)
+.+. ...+|+|.+.+ .+|.+++. ...++. .... .+-.-..||-. ++|+.+||+|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence 9854 46788887543 25777773 223444 3333 33344456666 68999999999999953
Q ss_pred C---C-cccccc
Q 006545 416 N---F-VSKLSD 423 (641)
Q Consensus 416 ~---~-~vKL~D 423 (641)
. . .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00082 Score=70.53 Aligned_cols=139 Identities=22% Similarity=0.269 Sum_probs=82.7
Q ss_pred ceeeccCceEEEEEEEC--------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCc-eeeEeccccCceEEEEEecC
Q 006545 287 LKIGEGGYGSIYKGLLR--------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN-LVTLVGACPEVWTLVYEYLP 357 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~Ey~~ 357 (641)
+.|..|-...||+.... +..+++|+..... .......+|..++..+.... ..++++++.+ .+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeC
Confidence 34566667788987764 3689999976543 23345678998988885322 3455665543 36899999
Q ss_pred CCChhhhh-----------------hcCCCCC------CCC--HHHHHH--------------------------HHHHH
Q 006545 358 NGSLEDRL-----------------SCKDNSP------PLS--WQTRIR--------------------------IATEL 386 (641)
Q Consensus 358 ggsL~~~L-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~qi 386 (641)
|.++.... +...... ..+ +..+.. +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 87764311 1111110 111 111111 11122
Q ss_pred HHHHHHHHh------cCCCceeeccCCCCceEeccC----Cccccccccccc
Q 006545 387 CSVLIFLHS------CKPHSIVHGDLKPANILLDAN----FVSKLSDFGISR 428 (641)
Q Consensus 387 a~aL~~LH~------~~~~gIiHrDIkp~NILld~~----~~vKL~DFGla~ 428 (641)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222334432 134579999999999999874 889999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0012 Score=78.38 Aligned_cols=191 Identities=23% Similarity=0.219 Sum_probs=130.2
Q ss_pred HHHHHHHHhcCCCCceeeEeccccC------ceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 006545 323 FQQEIDILSKIRHPNLVTLVGACPE------VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396 (641)
Q Consensus 323 ~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 396 (641)
...|...+.++.|+|++.++.+.-. ...+..++|..-++...+. .-..++....+.+..++.+||.|+|.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH-
Confidence 3457778888899999999887522 1224567888888888874 44567888899999999999999999
Q ss_pred CCCceeeccCCCC---ceEeccCCccccc--ccccccccccccccCCCccccccCCCCCCcccCChhhhccCCCCch--h
Q 006545 397 KPHSIVHGDLKPA---NILLDANFVSKLS--DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPK--S 469 (641)
Q Consensus 397 ~~~gIiHrDIkp~---NILld~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~--s 469 (641)
....|.-+..+ +...+..+.+.++ ||+.+..+........ ..-+..|.+||......+..+ .
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---------~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---------DLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---------hcCccccccccccccccchhhhhh
Confidence 44444444444 4444556666666 8888876655432221 123556778887766655544 7
Q ss_pred hHHHHHHHHHHHHhCCCCCCCcHHHHHHHhhcccccccCCCCCCCChhhHHHHHHHHHHHhhhccCCCCChHHHH
Q 006545 470 DVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 470 DVwSlGviL~eLltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evv 544 (641)
|+|.+|..+..+..|..+-......... + +........+...+|+.-++++|++..+++
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~~~~~~~---------l-------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKSAVPVSL---------L-------DVLSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccccchhhh---------h-------ccccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999999999987654222111110 0 111112578888999999999999998844
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0046 Score=67.25 Aligned_cols=73 Identities=14% Similarity=0.068 Sum_probs=54.8
Q ss_pred cceeeccCceEEEEEEECCeEEEEEEecCCCC-------CCchhHHHHHHHHhcCC---CCceeeEeccccCceEEEEEe
Q 006545 286 SLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL-------QGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVYEY 355 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~-------~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~Ey 355 (641)
.+.||.|....||+....+..|+||.-.+... .....-..|...|+.+. ..++.+++.++.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 45689999999999887777799997653211 13344556677776664 357888999999889999999
Q ss_pred cCC
Q 006545 356 LPN 358 (641)
Q Consensus 356 ~~g 358 (641)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 977
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00035 Score=72.55 Aligned_cols=147 Identities=14% Similarity=0.157 Sum_probs=97.6
Q ss_pred CCCChhhHhhhcC---CCCccceeeccCceEEEEEEEC-CeEEEEEEecCCCCC--C--------------------chh
Q 006545 269 SDFSFSEIEGATH---NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQ--G--------------------PSE 322 (641)
Q Consensus 269 ~~~~~~ei~~~~~---~y~~~~~LG~G~fG~Vy~g~~~-~~~vAvK~~~~~~~~--~--------------------~~~ 322 (641)
.-|.+--|+...+ -+.+++.||-|--+.||.+-+. |.+.++|.-+..... + .-.
T Consensus 77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla 156 (465)
T KOG2268|consen 77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA 156 (465)
T ss_pred ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence 3444444444333 4678899999999999999885 888888864322110 0 012
Q ss_pred HHHHHHHHhcCC-C-CceeeEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 006545 323 FQQEIDILSKIR-H-PNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400 (641)
Q Consensus 323 ~~~Ei~iL~~l~-H-pnIv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g 400 (641)
..+|...|+.|. | =-+.+.+++ +..++|||++.|..|...-.- .+. ..+...+..-+--|-. +|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~---~G 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLAN---HG 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHH---cC
Confidence 457888888874 2 224445554 356899999999888664311 112 2333444444455555 89
Q ss_pred eeeccCCCCceEeccCCcccccccccccc
Q 006545 401 IVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 401 IiHrDIkp~NILld~~~~vKL~DFGla~~ 429 (641)
+||||.+-=||++++++.++++||--+..
T Consensus 223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999986543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0053 Score=64.76 Aligned_cols=131 Identities=19% Similarity=0.311 Sum_probs=81.6
Q ss_pred cCceEEEEEEECCeEEEEEEecC--CCCCCchhHHHHHHHHhcCCC--CceeeEeccccCce----EEEEEecCCCChhh
Q 006545 292 GGYGSIYKGLLRHMQVAIKMLHP--HSLQGPSEFQQEIDILSKIRH--PNLVTLVGACPEVW----TLVYEYLPNGSLED 363 (641)
Q Consensus 292 G~fG~Vy~g~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~~~----~lV~Ey~~ggsL~~ 363 (641)
|....+|.....++.+++. ... ..........+|..+|+.+.- .-+...++.|.+.. +.||+|+.|..+.+
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 3334556555567778887 332 122234556788888888743 33455677786555 89999999854443
Q ss_pred hhhcCCCCCCCCHHHHHHHH-HHHHHHHHHHHhcC---------------------------------------------
Q 006545 364 RLSCKDNSPPLSWQTRIRIA-TELCSVLIFLHSCK--------------------------------------------- 397 (641)
Q Consensus 364 ~L~~~~~~~~l~~~~~~~i~-~qia~aL~~LH~~~--------------------------------------------- 397 (641)
.+.. .+.. ..++ ..++..|.-||+..
T Consensus 115 ~~~~------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 115 ALPP------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred cCCc------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 3311 0000 1122 24445555555421
Q ss_pred ----------CCceeeccCCCCceEeccCCcccccccccccccc
Q 006545 398 ----------PHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 398 ----------~~gIiHrDIkp~NILld~~~~vKL~DFGla~~~~ 431 (641)
+..++|||+.+.||+++.++-+=|.||+++..-.
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2358999999999999998889999999887544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0039 Score=66.97 Aligned_cols=138 Identities=15% Similarity=0.178 Sum_probs=81.4
Q ss_pred eeeccCceEEEEEEEC------CeEEEEEEecCCCCCCchhHHHHHHHHhcCCCCce-eeEeccccCceEEEEEecCCCC
Q 006545 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGS 360 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~------~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~ggs 360 (641)
.|-.|-...+|+.... +..|++|+......... .-.+|..+++.+..-++ .++++.+.+. .|++|+++.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~~ 119 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHART 119 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCCC
Confidence 4545777889988652 25789998765432222 23689999988854333 3556666543 6899998877
Q ss_pred hhhh-----------------hhcCCC-C-C-CCCHHHHHHHHHHH-----------------HHHHHHHH----h-cCC
Q 006545 361 LEDR-----------------LSCKDN-S-P-PLSWQTRIRIATEL-----------------CSVLIFLH----S-CKP 398 (641)
Q Consensus 361 L~~~-----------------L~~~~~-~-~-~l~~~~~~~i~~qi-----------------a~aL~~LH----~-~~~ 398 (641)
|... ++.... . . +..+..+..+..++ ...+..|. . ..+
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 111110 0 0 11233333332211 11122222 1 223
Q ss_pred CceeeccCCCCceEecc-CCccccccccccc
Q 006545 399 HSIVHGDLKPANILLDA-NFVSKLSDFGISR 428 (641)
Q Consensus 399 ~gIiHrDIkp~NILld~-~~~vKL~DFGla~ 428 (641)
..++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 46899999999999986 4789999999765
|
|
| >PF15227 zf-C3HC4_4: zinc finger of C3HC4-type, RING; PDB: 2EGP_A 2ECV_A 2ECJ_A 2YSL_A 2YSJ_A | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.00073 Score=49.07 Aligned_cols=38 Identities=21% Similarity=0.455 Sum_probs=29.7
Q ss_pred CCccccccCCCcccccCccchHHHHHHHHhcCCC---CCCC
Q 006545 577 CPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHE---TSPM 614 (641)
Q Consensus 577 cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~---~~P~ 614 (641)
|||..+++.|||+.+.||+|++.+|..|....+. .||.
T Consensus 1 CpiC~~~~~~Pv~l~CGH~FC~~Cl~~~~~~~~~~~~~CP~ 41 (42)
T PF15227_consen 1 CPICLDLFKDPVSLPCGHSFCRSCLERLWKEPSGSGFSCPE 41 (42)
T ss_dssp ETTTTSB-SSEEE-SSSSEEEHHHHHHHHCCSSSST---SS
T ss_pred CCccchhhCCccccCCcCHHHHHHHHHHHHccCCcCCCCcC
Confidence 8999999999999999999999999998766433 3554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0091 Score=63.92 Aligned_cols=72 Identities=17% Similarity=0.145 Sum_probs=51.3
Q ss_pred eeeccCceEEEEEEECC--eEEEEEEecCC------C-CCCchhHHHHHHHHhcCC--CC-ceeeEeccccCceEEEEEe
Q 006545 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH------S-LQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYEY 355 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~--~~vAvK~~~~~------~-~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~g~~~~~~~lV~Ey 355 (641)
.||-|....||++...+ +.|+||.-.+. + .....+..-|...|+... .| .+.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47999999999998764 57999965431 1 223456677888887763 34 4666777667777899999
Q ss_pred cCCC
Q 006545 356 LPNG 359 (641)
Q Consensus 356 ~~gg 359 (641)
++..
T Consensus 82 L~~~ 85 (370)
T TIGR01767 82 LSHH 85 (370)
T ss_pred Cccc
Confidence 9653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG0823 consensus Predicted E3 ubiquitin ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.001 Score=65.25 Aligned_cols=58 Identities=22% Similarity=0.469 Sum_probs=51.1
Q ss_pred CCCCcCCCccccccCCCcccccCccchHHHHHHHHhc--CCCCCCCCCCCCCCCCCChhH
Q 006545 571 PPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMTNLPLAHKNLVPNL 628 (641)
Q Consensus 571 ~p~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~--~~~~~P~t~~~l~~~~l~pN~ 628 (641)
+=..|-|.|+.+.-+||||+-+||-||=.||-+|+.. +...||+|+-....+.++|=|
T Consensus 44 ~~~~FdCNICLd~akdPVvTlCGHLFCWpClyqWl~~~~~~~~cPVCK~~Vs~~~vvPlY 103 (230)
T KOG0823|consen 44 DGGFFDCNICLDLAKDPVVTLCGHLFCWPCLYQWLQTRPNSKECPVCKAEVSIDTVVPLY 103 (230)
T ss_pred CCCceeeeeeccccCCCEEeecccceehHHHHHHHhhcCCCeeCCccccccccceEEeee
Confidence 3467999999999999999999999999999999855 566789999999988888854
|
|
| >KOG0287 consensus Postreplication repair protein RAD18 [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0013 Score=67.37 Aligned_cols=65 Identities=15% Similarity=0.268 Sum_probs=60.6
Q ss_pred CCcCCCccccccCCCcccccCccchHHHHHHHHhcCCCCCCCCCCCCCCCCCChhHHHHHHHHHHH
Q 006545 573 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 638 (641)
Q Consensus 573 ~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~ 638 (641)
+-+.|-|+.+.++-|++++||||||--||+.++.. +..||.|..+.....|.-|..|-.+|+.|.
T Consensus 22 ~lLRC~IC~eyf~ip~itpCsHtfCSlCIR~~L~~-~p~CP~C~~~~~Es~Lr~n~il~Eiv~S~~ 86 (442)
T KOG0287|consen 22 DLLRCGICFEYFNIPMITPCSHTFCSLCIRKFLSY-KPQCPTCCVTVTESDLRNNRILDEIVKSLN 86 (442)
T ss_pred HHHHHhHHHHHhcCceeccccchHHHHHHHHHhcc-CCCCCceecccchhhhhhhhHHHHHHHHHH
Confidence 34679999999999999999999999999999987 999999999999999999999999998774
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.01 Score=62.96 Aligned_cols=137 Identities=19% Similarity=0.180 Sum_probs=90.4
Q ss_pred ceeeccCceEEEEEEE-CCeEEEEEEecCCCC--C-------------------Cchh-----HHHHHHHHhcCCCCcee
Q 006545 287 LKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSL--Q-------------------GPSE-----FQQEIDILSKIRHPNLV 339 (641)
Q Consensus 287 ~~LG~G~fG~Vy~g~~-~~~~vAvK~~~~~~~--~-------------------~~~~-----~~~Ei~iL~~l~HpnIv 339 (641)
..|..|--+.||.+.- .|..+|||+++..-. . ++.. ...|+.-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3588899999999887 478899999864311 0 1111 34677777777644432
Q ss_pred eEeccccCceEEEEEecCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCcc
Q 006545 340 TLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 340 ~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~v 419 (641)
-.--+.-....|||+|+.... +-.-.-....++...+..+-.+++.-+.-|-.. .++||.||+--|+|+. +|.+
T Consensus 230 ~PePIlLk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 230 CPEPILLKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCceeeecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-CCEE
Confidence 111111123569999994321 111112334577778888888888888877664 4799999999999995 5688
Q ss_pred cccccccccc
Q 006545 420 KLSDFGISRF 429 (641)
Q Consensus 420 KL~DFGla~~ 429 (641)
+|+|.+-+--
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999886643
|
|
| >PF13923 zf-C3HC4_2: Zinc finger, C3HC4 type (RING finger); PDB: 3HCU_A 2ECI_A 2JMD_A 3HCS_B 3HCT_A 3ZTG_A 2YUR_A 3L11_A | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0019 Score=45.96 Aligned_cols=38 Identities=26% Similarity=0.653 Sum_probs=33.0
Q ss_pred CCccccccCCC-cccccCccchHHHHHHHHhcCCCCCCCC
Q 006545 577 CPIFQEVMQDP-HVAADGFTYEAEALKGWLDSGHETSPMT 615 (641)
Q Consensus 577 cPi~~evm~dP-vv~~~g~t~e~~~i~~w~~~~~~~~P~t 615 (641)
|||..+.+.+| ++.+.||+|.+.+|.+|+.. +.+||++
T Consensus 1 C~iC~~~~~~~~~~~~CGH~fC~~C~~~~~~~-~~~CP~C 39 (39)
T PF13923_consen 1 CPICLDELRDPVVVTPCGHSFCKECIEKYLEK-NPKCPVC 39 (39)
T ss_dssp ETTTTSB-SSEEEECTTSEEEEHHHHHHHHHC-TSB-TTT
T ss_pred CCCCCCcccCcCEECCCCCchhHHHHHHHHHC-cCCCcCC
Confidence 78999999999 68999999999999999998 7899874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.015 Score=57.75 Aligned_cols=115 Identities=17% Similarity=0.159 Sum_probs=73.5
Q ss_pred CceEEEEEEECCeEEEEEEecCCCCC-CchhHHHHHHHHhcCCCCceeeEeccccCceEEEEEecCCCChhhhhhcCCCC
Q 006545 293 GYGSIYKGLLRHMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNS 371 (641)
Q Consensus 293 ~fG~Vy~g~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~~ggsL~~~L~~~~~~ 371 (641)
+-++.-.|..+=.+..+|++...... ...-|.++..++.++.- |+++..--...+.+|+|+|-....
T Consensus 74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~NDn~~~yGvIlE~Cy~~~i---------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKNDNNYKYGVILERCYKIKI---------- 141 (308)
T ss_pred CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecCCCceeEEEEeeccCccc----------
Confidence 33444333333244566666654443 44567888888887753 666664322346689999843211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeeccCCCCceEeccCCccccccccc
Q 006545 372 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 372 ~~l~~~~~~~i~~qia~aL~~LH~~~~~gIiHrDIkp~NILld~~~~vKL~DFGl 426 (641)
. . ..++..=+.+|.-.|+.+ .+.+|||-.|+||+-|..|.+||.|-+.
T Consensus 142 --~---~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 --N---F-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred --c---h-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 1 0 112222256778888755 5899999999999999999999999875
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.031 Score=59.45 Aligned_cols=137 Identities=26% Similarity=0.353 Sum_probs=83.1
Q ss_pred eeccCceEEEEEEECCeEEEEEEecCCCCCCchhHHHHHHHHhcCCC---Cc---eeeEec----cccC--ceEEEEEec
Q 006545 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH---PN---LVTLVG----ACPE--VWTLVYEYL 356 (641)
Q Consensus 289 LG~G~fG~Vy~g~~~~~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~H---pn---Iv~l~g----~~~~--~~~lV~Ey~ 356 (641)
|.. .-..||+....+..+++|+.++. ....++.-|...|..|.- += +..+=| .... ..+-|++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 45678888877777799998875 455677888888888831 11 222222 2344 677899999
Q ss_pred CCCChhh-hh--------------h----cCC--C---CCCCCHHH-------------HHHHHHHHHHHHHHHHh----
Q 006545 357 PNGSLED-RL--------------S----CKD--N---SPPLSWQT-------------RIRIATELCSVLIFLHS---- 395 (641)
Q Consensus 357 ~ggsL~~-~L--------------~----~~~--~---~~~l~~~~-------------~~~i~~qia~aL~~LH~---- 395 (641)
+|..+.. .- + ... . .....|.. -.....++...+..+..
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 11 0 000 0 01122320 01122333344444443
Q ss_pred cCCCc---eeeccCCCCceEeccCCc-cccccccccc
Q 006545 396 CKPHS---IVHGDLKPANILLDANFV-SKLSDFGISR 428 (641)
Q Consensus 396 ~~~~g---IiHrDIkp~NILld~~~~-vKL~DFGla~ 428 (641)
.-+.+ +||+|+.|.|||++.+.. +-+.|||-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22344 999999999999998874 8899999664
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.026 Score=60.26 Aligned_cols=138 Identities=15% Similarity=0.275 Sum_probs=79.0
Q ss_pred eeeccCceEEEEEEECC-----eEEEEEEecCCCCCCchhHHHHHHHHhcCCCCce-eeEeccccCceEEEEEecCCCCh
Q 006545 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL-VTLVGACPEVWTLVYEYLPNGSL 361 (641)
Q Consensus 288 ~LG~G~fG~Vy~g~~~~-----~~vAvK~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~ggsL 361 (641)
.|..|-...+|+....+ ..|++|+...... ..-.-.+|..+++.+..-++ .++++++... +|.+|++|.+|
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--~i~~fi~g~~l 97 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--MIQSFINARTL 97 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc--EeehhhcCCCC
Confidence 45446677889886543 2789998765432 22234689999988864444 3556655433 58999987765
Q ss_pred hhh-------h----------hcCC-C-CC-CCCHHHHHHHHHHH----------------------HHHHHHHHh----
Q 006545 362 EDR-------L----------SCKD-N-SP-PLSWQTRIRIATEL----------------------CSVLIFLHS---- 395 (641)
Q Consensus 362 ~~~-------L----------~~~~-~-~~-~l~~~~~~~i~~qi----------------------a~aL~~LH~---- 395 (641)
... + +... . .. +-.+..+..+..++ ..-+..+..
T Consensus 98 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~ 177 (330)
T PLN02421 98 TPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDS 177 (330)
T ss_pred ChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhcc
Confidence 321 1 1111 0 01 11233332322221 111222211
Q ss_pred -cCCCceeeccCCCCceEecc-CCccccccccccc
Q 006545 396 -CKPHSIVHGDLKPANILLDA-NFVSKLSDFGISR 428 (641)
Q Consensus 396 -~~~~gIiHrDIkp~NILld~-~~~vKL~DFGla~ 428 (641)
..+.-++|.|+.+.|||+++ ++.++++||..|.
T Consensus 178 ~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 178 LKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred CCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11224799999999999974 5789999999764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.012 Score=63.75 Aligned_cols=73 Identities=16% Similarity=0.178 Sum_probs=52.4
Q ss_pred cceeeccCceEEEEEEEC--CeEEEEEEecCCC------CCCchhHHHHHHHHhcCC--CC-ceeeEeccccCceEEEEE
Q 006545 286 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHS------LQGPSEFQQEIDILSKIR--HP-NLVTLVGACPEVWTLVYE 354 (641)
Q Consensus 286 ~~~LG~G~fG~Vy~g~~~--~~~vAvK~~~~~~------~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~g~~~~~~~lV~E 354 (641)
...||-|.-..||++.+. +..|+||.-.+.. .-..++..-|..+|+.+. .| ++.++|.+-++...+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 456899999999999875 5679999644321 223456778888888773 34 466677666677788999
Q ss_pred ecCC
Q 006545 355 YLPN 358 (641)
Q Consensus 355 y~~g 358 (641)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 9864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 641 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-49 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-49 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-48 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2oxq_C | 80 | Structure Of The Ubch5 :chip U-Box Complex Length = | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-05 | ||
| 2f42_A | 179 | Dimerization And U-Box Domains Of Zebrafish C-Termi | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 7e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 7e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OXQ|C Chain C, Structure Of The Ubch5 :chip U-Box Complex Length = 80 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2F42|A Chain A, Dimerization And U-Box Domains Of Zebrafish C-Terminal Of Hsp70 Interacting Protein Length = 179 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-102
Identities = 118/314 (37%), Positives = 176/314 (56%), Gaps = 31/314 (9%)
Query: 254 SRKEASSSSHMPQFFS-DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKM 311
S +A SSS++ F S ++E AT+NFD IG G +G +YKG+LR +VA+K
Sbjct: 11 SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 312 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKD 369
P S QG EF+ EI+ LS RHP+LV+L+G C E L+Y+Y+ NG+L+ L D
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 370 N-SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428
+ +SW+ R+ I L +LH+ +I+H D+K NILLD NFV K++DFGIS+
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187
Query: 429 FLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
++ + +S T KGT Y+DPE+ G LT KSDVYSFG++L +L R
Sbjct: 188 KGTELDQTHLS---------TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 486 PALGITKE------VQYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRK 535
A+ + ++A + G+L+ ++DP LA + + A++C +S +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 536 SRPELGKDVWRVLE 549
RP +G DV LE
Sbjct: 299 DRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-100
Identities = 114/304 (37%), Positives = 171/304 (56%), Gaps = 31/304 (10%)
Query: 271 FSFSEIEGATHNFDPSL------KIGEGGYGSIYKGLLRHMQVAIKMLHPH----SLQGP 320
FSF E++ T+NFD K+GEGG+G +YKG + + VA+K L + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 321 SEFQQEIDILSKIRHPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQT 378
+F QEI +++K +H NLV L+G + LVY Y+PNGSL DRLSC D +PPLSW
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 379 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438
R +IA + + FLH + +H D+K ANILLD F +K+SDFG++R + +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 439 NTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 498
+ + GT AYM PE L GE+TPKSD+YSFG++LL ++TG PA+ +E Q L
Sbjct: 192 TSRI------VGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 499 --------DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEP 550
+ +++ +D D E + ++A +C + RP++ V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQE 303
Query: 551 MRAS 554
M AS
Sbjct: 304 MTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 4e-88
Identities = 101/299 (33%), Positives = 161/299 (53%), Gaps = 31/299 (10%)
Query: 271 FSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGP-SEFQQEID 328
FS E++ A+ NF +G GG+G +YKG L VA+K L QG +FQ E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 329 ILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATE 385
++S H NL+ L G C LVY Y+ NGS+ L ++ PPL W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 386 LCSVLIFLH-SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTL 442
L +LH C P I+H D+K ANILLD F + + DFG+++ + + ++
Sbjct: 140 SARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------ 192
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKE--------V 494
T +GT ++ PE+L++G+ + K+DV+ +G++LL L+TG+ A + + +
Sbjct: 193 ---TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 495 QYA---LDTGKLKNLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549
+ L KL+ L+D L G++ + EQL +A+ C + S RP++ +V R+LE
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-69
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 21/273 (7%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPE 347
+G G +G + K R VAIK + S + F E+ LS++ HPN+V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 407
LV EY GSL + L + P + + + + +LHS +P +++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 408 PANILLDANF-VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT 466
P N+LL A V K+ DFG + + + T+ KG+ A+M PE +
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTH-----------MTNNKGSAAWMAPEVFEGSNYS 181
Query: 467 PKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 525
K DV+S+GIIL ++T R P I + PL + P + + +L
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP----KPIESL 236
Query: 526 AMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 558
RC RP + +++ +++ + G+
Sbjct: 237 MTRCWSKDPSQRPSM-EEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-68
Identities = 83/315 (26%), Positives = 134/315 (42%), Gaps = 21/315 (6%)
Query: 245 VKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH 304
+K ++ F +++ + + KIG G +G++++
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 305 MQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGS 360
VA+K+L EF +E+ I+ ++RHPN+V +GA P ++V EYL GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
L L L + R+ +A ++ + +LH+ P IVH +LK N+L+D + K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVK 179
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
+ DFG+SR + +SS GT +M PE L KSDVYSFG+IL
Sbjct: 180 VCDFGLSRLKASTFLSS--------KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 481 LLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPE 539
L T + P + Q G K + + Q+A + C RP
Sbjct: 232 LATLQQPWGNLN-PAQVVAAVGF-KCKRLEIPRNLN----PQVAAIIEGCWTNEPWKRPS 285
Query: 540 LGKDVWRVLEPMRAS 554
+ +L P+ S
Sbjct: 286 F-ATIMDLLRPLIKS 299
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 8e-65
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 53/319 (16%)
Query: 254 SRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLH 313
SS D + + G +G ++K L + VA+K+
Sbjct: 3 HHHHHHSSG------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP 56
Query: 314 PHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWT---LVYEYLPNGSLEDRLSC 367
Q + + E+ L ++H N++ +GA V L+ + GSL D L
Sbjct: 57 IQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113
Query: 368 KDNSPPLSWQTRIRIATELCSVLIFLHS--------CKPHSIVHGDLKPANILLDANFVS 419
+ +SW IA + L +LH KP I H D+K N+LL N +
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA-ISHRDIKSKNVLLKNNLTA 170
Query: 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-----ELTPKSDVYSF 474
++DFG++ + + + GT YM PE L + + D+Y+
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQV------GTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 475 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSR 534
G++L L + A + +Y L + + M+ + +
Sbjct: 225 GLVLWELASRCTAADGPVD-EYML------PFEEEIGQHPSLED--------MQEVVVHK 269
Query: 535 KSRPELGKDVWRVLEPMRA 553
K RP L +D W+ M
Sbjct: 270 KKRPVL-RDYWQKHAGMAM 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-63
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTLVG 343
IG GG+G +Y+ +VA+K + S +QE + + ++HPN++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
C LV E+ G L LS K + + A ++ + +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 402 VHGDLKPANILLD--------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
+H DLK +NIL+ +N + K++DFG++R + S G +A
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----------AGAYA 179
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 512
+M PE + + + SDV+S+G++L LLTG P GI + A L P+
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAM-NKLALPIPS 237
Query: 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
P E A L C SRP ++ L +
Sbjct: 238 TCP----EPFAKLMEDCWNPDPHSRPSF-TNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-62
Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 26/273 (9%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 345
+IG G +G++YKG H VA+KML+ + F+ E+ +L K RH N++ +G
Sbjct: 31 RIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 346 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+V ++ SL L + + I IA + + +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DLK NI L + K+ DFG++ S+ S G+ +M PE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ------LSGSILWMAPEVIRMQD 198
Query: 465 LTP---KSDVYSFGIILLRLLTGR-PALGIT--KEVQYALDTGKLKNLLDPLAGDWPFVQ 518
P +SDVY+FGI+L L+TG+ P I ++ + G L L + + P
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP--- 255
Query: 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
+++ L C + R RP + +E +
Sbjct: 256 -KRMKRLMAECLKKKRDERPSF-PRILAEIEEL 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-61
Identities = 80/282 (28%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS-------EFQQEIDILSKIRHPNL 338
+IG+GG+G ++KG + VAIK L +G + EFQ+E+ I+S + HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 339 VTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
V L G +V E++P G L RL D + P+ W ++R+ ++ + ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 399 HSIVHGDLKPANILLD-----ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
IVH DL+ NI L A +K++DFG+S+ S ++ + G F
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVHSV----SGLLGNFQ 191
Query: 454 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR-PALGIT-KEVQYALDTGKLKNLLDP 509
+M PE + + E T K+D YSF +IL +LTG P + ++++ + + L
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRPT 250
Query: 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
+ D P +L N+ C K RP + + L +
Sbjct: 251 IPEDCP----PRLRNVIELCWSGDPKKRPHF-SYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-61
Identities = 62/281 (22%), Positives = 109/281 (38%), Gaps = 20/281 (7%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+G+G +G K R + +K L + F +E+ ++ + HPN++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ + EY+ G+L + K W R+ A ++ S + +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIH 131
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK------GTFAYMDP 457
DL N L+ N ++DFG++R + + + D K G +M P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
E + K DV+SFGI+L ++ A L + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP-- 249
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGS 558
+ +RCC++ + RP + LE +R G
Sbjct: 250 --PSFFPITVRCCDLDPEKRPSF-VKLEHWLETLRMHLAGH 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-60
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 345
IG+G +G +Y G H +VAI+++ F++E+ + RH N+V +GAC
Sbjct: 40 LIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
P ++ +L + +D L +IA E+ + +LH+ I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILH 153
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
DLK N+ D V ++DFG+ + L G ++ PE +
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKL---RIQNGWLCHLAPEIIRQL 209
Query: 464 EL---------TPKSDVYSFGIILLRLLTGR-PALGITKE-VQYALDTGKLKNLLDPLAG 512
+ SDV++ G I L P E + + + TG +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM---KPNLSQI 266
Query: 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
++++++ + C ++ RP + +LE +
Sbjct: 267 GMG----KEISDILLFCWAFEQEERPTF-TKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-59
Identities = 51/275 (18%), Positives = 108/275 (39%), Gaps = 32/275 (11%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNLVTLVGAC 345
K+ E G ++KG + + +K+L +F +E L HPN++ ++GAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 346 --PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
P + ++P GSL + L + + + ++ A ++ + FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL- 460
L ++++D + +++S + A++ PE L
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS-------------PGRMYAPAWVAPEALQ 181
Query: 461 --ASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
+D++SF ++L L+T P ++ ++ + L+ L +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVA-LEGLRPTIPPGIS-- 237
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552
++ L C RP+ + +LE M+
Sbjct: 238 --PHVSKLMKICMNEDPAKRPKF-DMIVPILEKMQ 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-55
Identities = 65/248 (26%), Positives = 96/248 (38%), Gaps = 31/248 (12%)
Query: 270 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI 329
+ + SE N IG G YG++YKG L VA+K+ + Q F E +I
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 330 --LSKIRHPNLVTLVGAC--------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTR 379
+ + H N+ + E LV EY PNGSL L + W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYL-LVMEYYPNGSLXKYL----SLHTSDWVSS 113
Query: 380 IRIATELCSVLIFLHSCKPHS------IVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433
R+A + L +LH+ P I H DL N+L+ + +SDFG+S L+ N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 434 EISSNNTTLCCRTDPKGTFAYMDPEFL-------ASGELTPKSDVYSFGIILLRLLTGRP 486
+ GT YM PE L + D+Y+ G+I +
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 487 ALGITKEV 494
L + V
Sbjct: 234 DLFPGESV 241
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 345
+G+G YG +++G + VA+K+ + + +E ++ +RH N++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 346 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 395
++W L+ Y GSL D L L + +RI + S L LH
Sbjct: 72 MTSRHSSTQLW-LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 396 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
KP +I H DLK NIL+ N ++D G++ SQ+ N GT
Sbjct: 127 GTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST----NQLDVGNNPRVGTK 181
Query: 453 AYMDPEFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495
YM PE L + + D+++FG++L + + GI ++ +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 1e-50
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC 345
+IG+G YG ++ G R +VA+K+ + +E +I +RH N++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 346 -------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS--- 395
+++ L+ +Y NGSL D L S L ++ +++A S L LH+
Sbjct: 101 IKGTGSWTQLY-LITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 396 ---CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
KP +I H DLK NIL+ N ++D G++ + N GT
Sbjct: 156 STQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRVGTK 210
Query: 453 AYMDPEFLA------SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495
YM PE L + +D+YSFG+IL + + GI +E Q
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-49
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 41/284 (14%)
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG 292
E L ++L + S S +P I IG+G
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQE-------SIGKG 53
Query: 293 GYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDI--LSKIRHPNLVTLVGAC----- 345
+G +++G R +VA+K+ + + +E +I +RH N++ + A
Sbjct: 54 RFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS------CK 397
++W LV +Y +GSL D L N ++ + I++A S L LH K
Sbjct: 111 TWTQLW-LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
P +I H DLK NIL+ N ++D G++ +T GT YM P
Sbjct: 166 P-AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA----TDTIDIAPNHRVGTKRYMAP 220
Query: 458 EFL------ASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ 495
E L E ++D+Y+ G++ + GI ++ Q
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 342
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 343 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 454 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 486
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 40/285 (14%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 341
K+G GG ++Y + +++VAIK + + F++E+ S++ H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 342 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
V + + LV EY+ +L + + ++ PLS T I ++ + H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
IVH D+KP NIL+D+N K+ DFGI++ LS+ ++ N L GT Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-------GTVQYFSPEQA 184
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP------ALGI-TKEVQYALDTGKLKNLLDPLAGD 513
+D+YS GI+L +L G P A+ I K +Q + + D
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPNVTTDVRK---D 239
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRAS 554
P + L+N+ +R E + +R E+ D+ VL RA+
Sbjct: 240 IP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 33/262 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
+IG G +G ++ G LR + VA+K ++F QE IL + HPN+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 345 CPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
C + ++ +V E + G L + L +T +++ + + + +L S
Sbjct: 181 CTQKQPIY-IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEF 459
+H DL N L+ V K+SDFG+SR + + + PE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA--------ASGGLRQVPVKWTAPEA 286
Query: 460 LASGELTPKSDVYSFGIILLRLLT-GR-PALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 516
L G + +SDV+SFGI+L + G P ++ ++ + ++ G L P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG---GRLPC-----PE 338
Query: 517 VQAEQLANLAMRCCEMSRKSRP 538
+ + + L +C RP
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRP 360
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 342
+G+G ++++G RH AIK+ + S P + +E ++L K+ H N+V L
Sbjct: 16 ILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 343 GACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
A E T L+ E+ P GSL L N+ L + + ++ + L
Sbjct: 74 -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
+ IVH ++KP NI+ D V KL+DFG +R L +E +L GT
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLY------GTEE 180
Query: 454 YMDPEFLASGEL--------TPKSDVYSFGIILLRLLTGRP 486
Y+ P+ L D++S G+ TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 31/72 (43%), Positives = 44/72 (61%)
Query: 570 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 629
E P YF CPI E+M+DP + + G TYE +++ WLD+GH+T P + L H L PN
Sbjct: 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63
Query: 630 LRSAIQEWLQQH 641
L+S I W + +
Sbjct: 64 LKSLIALWCESN 75
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-37
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL- 341
+G GG G +Y+ +R VA+K++ P Q+E +++ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 342 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G + + L L PL+ + I ++ S L H+
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
H D+KP NIL+ A+ + L DFGI+ + +++ T+ GT YM PE
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-------GTLYYMAPERF 207
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
+ T ++D+Y+ +L LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSP 233
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 340
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 456
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 342
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 343 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+ +V E N L L K + R + + +H H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 147
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 200
Query: 461 -----------ASGELTPKSDVYSFGIILLRLLTGRP 486
+ +++PKSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVT 340
IG G YG K R + K L S+ +E Q E+++L +++HPN+V
Sbjct: 13 TIGTGSYGRCQKI--RRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVR 69
Query: 341 LVGACPEVWT----LVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+ +V EY G L + L + +R+ T+L L H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 396 CK--PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H+++H DLKPAN+ LD KL DFG++R L+ + +S T GT
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV------GTPY 181
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487
YM PE + KSD++S G +L L P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 22/252 (8%)
Query: 251 LRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIY--KGLLRHMQVA 308
+ S SS + F + ++ K+GEGG+ + +GL A
Sbjct: 1 MGSSHHHHHHSS--GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58
Query: 309 IKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-------PEVWTLVYEYLPNGSL 361
+K + H Q E Q+E D+ HPN++ LV C E W L+ + G+L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW-LLLPFFKRGTL 117
Query: 362 EDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
+ + KD L+ + + +C L +H+ H DLKP NILL
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPV 174
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPK--GTFAYMDPEFLAS---GELTPKSDVYSFG 475
L D G + + L + T +Y PE + + ++DV+S G
Sbjct: 175 LMDLGSMNQAC-IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 476 IILLRLLTGRPA 487
+L ++ G
Sbjct: 234 CVLYAMMFGEGP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 342
KIG G + +Y+ + VA+K + L +EID+L ++ HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 343 GACPEVWTL--VYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ E L V E G L + K + +T + +LCS L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
++H D+KPAN+ + A V KL D G+ RF ++ GT YM PE
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF--------SSKTTAAHSLVGTPYYMSPER 207
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRPA 487
+ KSD++S G +L + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPS--EFQQEIDILSKIRHPNL--VTLV 342
+IG GG +++ L Q AIK ++ + ++ EI L+K++ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 343 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+ +V E N L L K + R + + +H H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ---HG 128
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
IVH DLKPAN L+ + KL DFGI+ + + S + GT YM PE +
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GTVNYMPPEAI 181
Query: 461 -----------ASGELTPKSDVYSFGIILLRLLTGRP 486
+ +++PKSDV+S G IL + G+
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKML-HPHSLQGPSEFQQEIDILSKIRHPNL 338
+F+P +G GG+G +++ + AIK + P+ + +E+ L+K+ HP +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 339 VTLVGACPEVWT--------------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 384
V A E T + + +L+D ++ + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE----ISSNNT 440
++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+E + +
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 441 TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483
T GT YM PE + + K D++S G+IL LL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVT 340
+GEG +G + QVA+K L P S ++ ++EI+IL + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 341 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
G C L+ E+LP+GSL++ L N ++ + +++ A ++C + +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
VH DL N+L+++ K+ DFG+++ + ++ + D +
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-----EYYTVKDDRDSPVFWYA 197
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT 483
PE L + SDV+SFG+ L LLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 260 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL 317
SS + + F +E + KIGEG +G Q IK + S
Sbjct: 7 HSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISR 61
Query: 318 QGPSEFQ---QEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSP 372
E + +E+ +L+ ++HPN+V + E +L V +Y G L R++
Sbjct: 62 MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGV 120
Query: 373 PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432
+ ++C L +H K I+H D+K NI L + +L DFGI+R L+
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177
Query: 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA 487
GT Y+ PE + KSD+++ G +L L T + A
Sbjct: 178 T--VELARACI------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 342 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EFFKVKEPGESPIFWYAP 186
Query: 458 EFLASGELTPKSDVYSFGIILLRLLT 483
E L + + SDV+SFG++L L T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 64/281 (22%), Positives = 103/281 (36%), Gaps = 41/281 (14%)
Query: 230 YKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHN---FDPS 286
+ + R +KE + R+ S S S E + +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 287 LKIGEGGYGSIYKGLLRHMQ-VAIKM-----LHPHSLQGPSEFQQEIDILSKIRHPNL-- 338
+IG GG +++ L Q AIK +L ++ EI L+K++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
+ L + +V E N L L K + R + + +H
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQ- 173
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
H IVH DLKPAN L+ + KL DFGI+ + + S + G YM
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV------GAVNYMP 224
Query: 457 PEFL-----------ASGELTPKSDVYSFGIILLRLLTGRP 486
PE + + +++PKSDV+S G IL + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
++G+G +GS+ VA+K L + + +F++EI+IL ++H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 342 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G C L+ EYLP GSL D L + + + ++ +++C + +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+H DL NIL++ K+ DFG+++ L Q++ + + + P
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-----EYYKVKEPGESPIFWYAP 217
Query: 458 EFLASGELTPKSDVYSFGIILLRLLT 483
E L + + SDV+SFG++L L T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL 341
++G+G +GS+ VA+K L +FQ+EI IL + +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 342 VGACPEVWT----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
G LV EYLP+G L D L + + L + ++++C + +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
VH DL NIL+++ K++DFG+++ L ++ R + + P
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-----DYYVVREPGQSPIFWYAP 199
Query: 458 EFLASGELTPKSDVYSFGIILLRLLT 483
E L+ + +SDV+SFG++L L T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
+IG G +G ++ G +VAIK + ++ +F +E +++ K+ HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 347 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
E + LV E++ +G L D L + + +T + + ++C + +L ++H
Sbjct: 74 EQAPIC-LVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 127
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
DL N L+ N V K+SDFG++RF+ ++ SS T + + PE +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WASPEVFSF 179
Query: 463 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ KSDV+SFG+++ + + P + EV + TG
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-35
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 347 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 357
Query: 465 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-35
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLV 342
++G GG+G + + H QVAIK E + EI I+ K+ HPN+V+
Sbjct: 21 RLGTGGFGYVLRW--IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 343 GACPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
P+ L EY G L L+ +N L + +++ S L +L
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 394 HSCKPHSIVHGDLKPANILLDAN---FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
H + I+H DLKP NI+L + K+ D G ++ L Q E+ T G
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV------G 185
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T Y+ PE L + T D +SFG + +TG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 8e-35
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 23/222 (10%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
++G G +G + G + VA+KM+ S+ EF QE + K+ HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 347 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ ++ +V EY+ NG L + L + + L + + ++C + FL S H +H
Sbjct: 74 KEYPIY-IVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
DL N L+D + K+SDFG++R++ ++ +SS T + + PE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK--------WSAPEVFHY 179
Query: 463 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + KSDV++FGI++ + + P T EV + G
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-35
Identities = 65/286 (22%), Positives = 99/286 (34%), Gaps = 52/286 (18%)
Query: 288 KIGEGGYGSIYKGL---LRHMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL-- 341
I GG G IY L + V +K L E L+++ HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 342 VGACPEVWT-----LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
+ +V EY+ SL+ L I E+ L +LHS
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS- 200
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+V+ DLKP NI+L + KL D G I+S GT +
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVS-----RINSFGYLY-------GTPGFQA 245
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516
PE + T +D+Y+ G L L P G+ +D L D P
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPT-----------RNGR---YVDGLPEDDPV 290
Query: 517 VQA-EQLANLAMRCCEMSRKSRP----ELGKDVWRVLEPMRASCGG 557
++ + L R + + R E+ + VL + A G
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-35
Identities = 63/222 (28%), Positives = 116/222 (52%), Gaps = 21/222 (9%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 346 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 286 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H +L N L+ N + K++DFG+SR ++ + ++ K + PE LA
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-------HAGAKFPIKWTAPESLAY 393
Query: 463 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + KSDV++FG++L + T P GI +V L+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIK--MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVG 343
+IG G + ++YKGL ++VA + F++E ++L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 344 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+ LV E + +G+L+ L + + ++ L FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 398 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
P I+H DLK NI + K+ D G++ + + GT +M
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----------IGTPEFMA 198
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE DVY+FG+ +L + T
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEY 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 345
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 258 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 461
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 359
Query: 462 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 280 THNFDPSLKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH 335
+F+ +G+G +G + K R+ AIK + H+ + S E+ +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA--RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61
Query: 336 PNLVTLVGA------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRI 380
+V A + + ++ EY NG+L D + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119
Query: 381 RIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT 440
R+ ++ L ++HS I+H DLKP NI +D + K+ DFG+++ + ++
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 441 TLCCRTDPK------GTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTG 484
+ GT Y+ E L +G K D+YS GII ++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN 337
+F IG GG+G ++K +H IK + ++ + + ++E+ L+K+ H N
Sbjct: 12 DFKEIELIGSGGFGQVFKA--KHRIDGKTYVIKRV-KYNNE---KAEREVKALAKLDHVN 65
Query: 338 LVTLVGA---------------CPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTR 379
+V G ++ E+ G+LE + K L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLA 124
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
+ + ++ + ++HS K +++ DLKP+NI L K+ DFG+ L +
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKR 178
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T GT YM PE ++S + + D+Y+ G+IL LL
Sbjct: 179 TRSK------GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 25/227 (11%)
Query: 287 LKIGEGGYGSIYKGLLRH----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
+++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G C + LV E G L L + + ++ + +L
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDP 457
+ VH DL N+LL +K+SDFG+S+ L ++ G + + P
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-------SYYTARSAGKWPLKWYAP 182
Query: 458 EFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
E + + + +SDV+S+G+ + L+ +P + EV ++ G
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
++G G +G ++ G H +VA+K L S+ P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 347 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+ ++ ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H
Sbjct: 79 QEPIY-IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ K++DFG++R + NE ++ R K + PE + G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTAPEAINYGT 186
Query: 465 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
T KSDV+SFGI+L ++T P G+T EV L+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G G +G ++ H +VA+K + P S+ F E +++ ++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 347 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+ ++ ++ E++ GSL D L D I + ++ + F+ + +H
Sbjct: 254 KEPIY-IITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
DL+ ANIL+ A+ V K++DFG++R + NE + + + PE + G
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINFG 360
Query: 464 ELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
T KSDV+SFGI+L+ ++T P G++ EV AL+ G
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
K+G+G +G ++ G +VAIK L P ++ P F QE ++ K+RH LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 347 E--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
E ++ +V EY+ GSL D L + L + +A ++ S + ++ + VH
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGR 440
Query: 465 LTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
T KSDV+SFGI+L L T P G+ +EV ++ G
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 340
+G G +G++YKGL + VAIK L S + E E +++ + +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G C V L+ + +P G L D + +++ + Q + ++ + +L
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMD 456
+VH DL N+L+ K++DFG+++ L E G +M
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--------EYHAEGGKVPIKWMA 187
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
E + T +SDV+S+G+ + L+T +P GI E+ L+ G
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 345
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
++ +V EY+ GSL D L L ++ + ++C + +L ++ VH
Sbjct: 86 EKGGLY-IVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFLA 461
DL N+L+ + V+K+SDFG+++ S T G PE L
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------------STQDTGKLPVKWTAPEALR 187
Query: 462 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + KSDV+SFGI+L + + P I K+V ++ G
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 23/222 (10%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP 346
++G G +G + G R VAIKM+ S+ EF +E ++ + H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 347 E---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ ++ ++ EY+ NG L + L ++ Q + + ++C + +L S +H
Sbjct: 90 KQRPIF-IITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNE-ISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
DL N L++ V K+SDFG+SR++ +E SS + R + PE L
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------WSPPEVLMY 195
Query: 463 GELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + KSD+++FG+++ + + P T E + G
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 64/224 (28%), Positives = 116/224 (51%), Gaps = 25/224 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
K+G G YG +Y+G+ + + VA+K L +++ EF +E ++ +I+HPNLV L+G C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 346 PE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ ++ E++ G+L D L + N +S + +AT++ S + +L + +
Sbjct: 79 TREPPFY-IITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MDPEFL 460
H DL N L+ N + K++DFG+SR ++ + +++ F PE L
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA---------GAKFPIKWTAPESL 184
Query: 461 ASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
A + + KSDV++FG++L + T P GI +V L+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 50/229 (21%), Positives = 90/229 (39%), Gaps = 46/229 (20%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEF-----------------QQEIDIL 330
+ +G + I + A+K L+ +F + E+ I+
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 331 SKIRHPNLVTLVGACPEVWT------LVYEYLPNGSLEDRLSC-----KDNSPPLSWQTR 379
+ I++ +T + T ++YEY+ N S+ K+ + + Q
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
I + + ++H+ K +I H D+KP+NIL+D N KLSDFG S+ +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG----ESEYMVDKKI 207
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGELT--PKSDVYSFGIILLRLLTGRP 486
GT+ +M PEF ++ K D++S GI L +
Sbjct: 208 KGSR------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 339
K+G+G +G + +G + VA+K L P L P +F +E++ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 340 TLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
L G + +V E P GSL DRL + + T R A ++ + +L S
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+H DL N+LL + K+ DFG+ R L QN+ + K FA+ P
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPFAWCAP 193
Query: 458 EFLASGELTPKSDVYSFGIIL 478
E L + + SD + FG+ L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTL 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G +G++Y L R Q +A+K+L L+ Q E++I S +RHPN++ L
Sbjct: 17 LGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 342 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
G L+ EY P G++ L Q TEL + L + HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS---K 128
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
++H D+KP N+LL + K++DFG S + SS T LC GT Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLC------GTLDYLPPEM 178
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
+ K D++S G++ L G+P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 32/308 (10%)
Query: 259 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLH 313
S+ P+ I ++ + IG G +G +Y G L + A+K L+
Sbjct: 3 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62
Query: 314 P-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRLSCKD 369
+ S+F E I+ HPN+++L+G C Y+ +G L + + ++
Sbjct: 63 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RN 120
Query: 370 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429
+ + + I ++ + +L S VH DL N +LD F K++DFG++R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
Query: 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPA 487
+ E S + + K +M E L + + T KSDV+SFG++L L+T P
Sbjct: 178 MYDKEYYSVHNKTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 488 LGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP---ELGKD 543
+ ++ L G L P + L + ++C + RP EL
Sbjct: 234 PDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 544 VWRVLEPM 551
+ +
Sbjct: 286 ISAIFSTF 293
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 22/77 (28%), Positives = 40/77 (51%)
Query: 565 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 624
++ E P Y I E+M++P + G TY+ + ++ L P+T PL L
Sbjct: 97 KRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQL 156
Query: 625 VPNLALRSAIQEWLQQH 641
+PNLA++ I ++Q++
Sbjct: 157 IPNLAMKEVIDAFIQEN 173
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 27/229 (11%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
IG+G +G +Y G +Q AIK L +Q F +E ++ + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 342 VGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+G ++ Y+ +G L + + + + I ++ + +L
Sbjct: 88 IGIMLPPEGLPH-VLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAE-- 142
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYM 455
VH DL N +LD +F K++DFG++R + E S + +
Sbjct: 143 -QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS------VQQHRHARLPVKWT 195
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
E L + T KSDV+SFG++L LLT P I ++ + L G
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 340
+GEG +G + VA+K L Q S ++QEIDIL + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 341 LVGAC----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
G C LV EY+P GSL D L +S L+ + A ++C + +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL--LLFAQQICEGMAYLHAQ 153
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+H DL N+LLD + + K+ DFG+++ + + R D +
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-----EYYRVREDGDSPVFWYA 205
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT 483
PE L + SDV+SFG+ L LLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVT 340
+G G +G+++KG+ + V IK++ Q + + + H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 341 LVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+G CP + LV +YLP GSL D + + + L Q + ++ + +L
Sbjct: 80 LLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
H +VH +L N+LL + +++DFG++ L ++ ++ K +M E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------YSEAKTPIKWMALE 187
Query: 459 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ G+ T +SDV+S+G+ + L+T P G+ EV L+ G
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
+GEG +G +Y+G+ + + VA+K +L +F E I+ + HP++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G E W ++ E P G L L + N L T + + ++C + +L S
Sbjct: 79 IGIIEEEPTW-IIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+ VH D+ NIL+ + KL DFG+SR++ + + T + +M PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-------RLPIKWMSPES 185
Query: 460 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ T SDV+ F + + +L+ +P + K+V L+ G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
IGEG +G +++G+ + VAIK S +F QE + + HP++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 82 IGVITENPVW-IIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLES---K 135
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 188
Query: 460 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ T SDV+ FG+ + +L +P G+ +V ++ G
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 42/238 (17%)
Query: 288 KIGEGGYGSIYKGLLR---------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNL 338
+G+G + I+KG+ R +V +K+L F + ++SK+ H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 339 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
V G C E LV E++ GSL+ L K N ++ ++ +A +L + + FL
Sbjct: 75 VLNYGVCVCGDENI-LVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 396 CKPHSIVHGDLKPANILLDA--------NFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
++++HG++ NILL KLSD GIS + +I
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL----------- 177
Query: 448 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTG 501
+ ++ PE L +D +SFG L + +G +P + + +
Sbjct: 178 -QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVTL 341
IG G G + G LR + VAIK L + + +F E I+ + HPN++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 342 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G +V EY+ NGSL+ L + + + + + + + + +L
Sbjct: 116 EGVVTRGRLAM-IVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 456
VH DL N+L+D+N V K+SDFG+SR L + ++ TT G
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-------GGKIPIRWTA 222
Query: 457 PEFLASGELTPKSDVYSFGIIL 478
PE +A + SDV+SFG+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVM 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 46/262 (17%), Positives = 87/262 (33%), Gaps = 35/262 (13%)
Query: 251 LRKSRKEASSSSHMPQFFSDFS----FSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 304
L K SS + ++ +E + + +GEG + +Y+
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 305 -----MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLP 357
+ +K+ P + Q ++ L + A LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 358 NGSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415
G+L + ++ N+P + I A + ++ +H C+ I+HGD+KP N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGN 207
Query: 416 NFVS-----------KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
F+ L D G S + + T C T + E L++
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNKP 261
Query: 465 LTPKSDVYSFGIILLRLLTGRP 486
+ D + + +L G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTY 283
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 288 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 340
+G GG ++ R VA+K+L + PS F++E + + HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 341 L------VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
+ + +V EY+ +L D + P++ + I + + C L F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTF 452
+ I+H D+KPANI++ A K+ DFGI+R ++ + ++ + GT
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-------GTA 183
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
Y+ PE + +SDVYS G +L +LTG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 288 KIGEGGYGSIYKGLL-----RHMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
+G G +G + G L + + VAIK L ++ + +F E I+ + HPN++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 342 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G + V +V EY+ NGSL+ L + + + + + + S + +L
Sbjct: 112 EGVVTKSKPVM-IVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSD--- 165
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--MD 456
VH DL NIL+++N V K+SDFG+ R L + ++ T G
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-------GGKIPIRWTS 218
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
PE +A + T SDV+S+GI+L +++ RP ++ ++V A+D G
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 288 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 344
+ EGG+ +Y + + + A+K L + + QE+ + K+ HPN+V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 345 CPEVWT---------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
L+ L G L + L ++ PLS T ++I + C + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK----GT 451
KP I+H DLK N+LL KL DFG + +S S + + + T
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 452 FAYMDPE---FLASGELTPKSDVYSFGIILLRLLTGRPA 487
Y PE ++ + K D+++ G IL L +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 33/301 (10%)
Query: 252 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-----MQ 306
+ S+ P+ I ++ + IG G +G +Y G L +
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 307 VAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLE 362
A+K L+ + S+F E I+ HPN+++L+G C Y+ +G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 363 DRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLS 422
+ + ++ + + + I ++ + FL S VH DL N +LD F K++
Sbjct: 180 NFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234
Query: 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLR 480
DFG++R + E S +M E L + + T KSDV+SFG++L
Sbjct: 235 DFGLARDMYDKEFDS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288
Query: 481 LLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSR 537
L+T P + ++ L G L P + L + ++C + R
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLLQG---RRLLQ-----PEYCPDPLYEVMLKCWHPKAEMR 340
Query: 538 P 538
P
Sbjct: 341 P 341
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 288 KIGEGGYGSIYKGLLR------HMQVAIKMLHPH-SLQGPSEFQQEIDILSKIRHPNLVT 340
IG G +G +YKG+L+ + VAIK L + + +F E I+ + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 341 LVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
L G + + ++ EY+ NG+L+ L ++ S + + + + + +L +
Sbjct: 111 LEGVISKYKPMM-IITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY--M 455
+ VH DL NIL+++N V K+SDFG+SR L + ++ T+ G
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------GGKIPIRWT 217
Query: 456 DPEFLASGELTPKSDVYSFGIIL 478
PE ++ + T SDV+SFGI++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVM 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 32/262 (12%)
Query: 288 KIGEGGYGSIYKGLLR-----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTL 341
IGEG +G +++G+ M VAIK S +F QE + + HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+G E VW ++ E G L L + L + I A +L + L +L S
Sbjct: 457 IGVITENPVW-IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLES---K 510
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPES 563
Query: 460 LASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKNLLDPLAGDWPF 516
+ T SDV+ FG+ + +L +P G+ +V ++ G L P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM-----PP 615
Query: 517 VQAEQLANLAMRCCEMSRKSRP 538
L +L +C RP
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRP 637
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 18/234 (7%)
Query: 260 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSL 317
S + + E + + +G+G YG +Y G Q +AIK +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 318 QGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPPLS 375
+ +EI + ++H N+V +G+ E + E +P GSL L K +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 376 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNE 434
QT ++ L +LH + IVH D+K N+L++ + V K+SDFG S+ L+
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--G 175
Query: 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 486
I+ T GT YM PE + G +D++S G ++ + TG+P
Sbjct: 176 INPCTETF------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 3e-32
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G + +Y + VAIKM+ ++ Q+ E+ I +++HP+++ L
Sbjct: 19 LGKGSFAGVY--RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 342 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+ LV E NG + L K+ P S ++ + +++LHS
Sbjct: 77 Y----NYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H I+H DL +N+LL N K++DFG++ L + TLC GT Y+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLC------GTPNYI 179
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE +SDV+S G + LL GRP
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 19/224 (8%)
Query: 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLVTLV 342
++G G +GS+ +G+ R + VAIK+L E +E I+ ++ +P +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 343 GAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
G C E LV E G L L + + ++ + +L +
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
VH +L N+LL +K+SDFG+S+ L ++ + R+ K + PE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECIN 512
Query: 462 SGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGK 502
+ + +SDV+S+G+ + L+ +P + EV ++ GK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 288 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
++GEG +G ++ M VA+K L +L +FQ+E ++L+ ++H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 341 LVGACPEV--WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATE 385
G C + +V+EY+ +G L L + L + IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCR 445
+ S +++L S VH DL N L+ AN + K+ DFG+SR + + R
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--------YR 190
Query: 446 TDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 478
+M PE + + T +SDV+SFG+IL
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G+G +G++Y L R Q +A+K+L L+ Q EI+I S +RHPN++ +
Sbjct: 22 LGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 342 VG--ACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ L+ E+ P G L L Q EL L + H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
++H D+KP N+L+ K++DFG S + S T+C GT Y+ PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRTMC------GTLDYLPPEM 183
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
+ K D++ G++ L G P
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 64/277 (23%), Positives = 117/277 (42%), Gaps = 45/277 (16%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
++GEG +G ++ + M VA+K L S +FQ+E ++L+ ++H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 341 LVGACPEV--WTLVYEYLPNGSLEDRL------------SCKDNSPPLSWQTRIRIATEL 386
G C E +V+EY+ +G L L PL + +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
+ +++L VH DL N L+ V K+ DFG+SR +I S + R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYY---RV 216
Query: 447 DPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ +M PE + + T +SDV+SFG++L + T +P ++ E + G
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
L+ P ++ + C + + R
Sbjct: 277 ---RELER-----PRACPPEVYAIMRGCWQREPQQRH 305
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 282 NFDPSLKIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLV 339
+F P +G G G+I Y+G+ + VA+K + P +E+ +L + HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+ + E +L++ + KD + I + + S L LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHS-- 136
Query: 398 PHSIVHGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
+IVH DLKP NIL+ + +SDFG+ + L+ S + + GT
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-----GTE 190
Query: 453 AYMDPEFL---ASGELTPKSDVYSFGIILLRLLT-GRP 486
++ PE L T D++S G + +++ G
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 33/236 (13%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 340
+GEG +GS+ +G L+ ++VA+K + S + EF E + HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 341 LVGAC----PEVWTLVY---EYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSVL 390
L+G C + ++ G L L + + QT ++ ++ +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L + + +H DL N +L + ++DFG+S+ + +
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR--------IA 209
Query: 451 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
++ E LA T KSDV++FG+ + + T P G+ E+ L G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/252 (20%), Positives = 95/252 (37%), Gaps = 24/252 (9%)
Query: 241 RDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKG 300
+ K ++ D+ + E H ++G G +G +++
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRM 77
Query: 301 LLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 355
+ Q A+K + + +E+ + + P +V L GA P V + E
Sbjct: 78 KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN-IFMEL 131
Query: 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA 415
L GSL + L + + L +LH+ + I+HGD+K N+LL +
Sbjct: 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSS 185
Query: 416 NFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 474
+ L DFG + L + + +L GT +M PE + K D++S
Sbjct: 186 DGSRAALCDFGHALCLQPDGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 475 GIILLRLLTGRP 486
++L +L G
Sbjct: 243 CCMMLHMLNGCH 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTL 341
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 342 VGACP-EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SN 137
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF--AYMDPE 458
VH DL N+LL +K+SDFG+S+ L +E + G + + PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-------NYYKAQTHGKWPVKWYAPE 190
Query: 459 FLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+ + + KSDV+SFG+++ + +P G+ EV L+ G
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 59/264 (22%), Positives = 89/264 (33%), Gaps = 43/264 (16%)
Query: 235 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGY 294
+ + + V E ++ + P+ F SF + ++G G Y
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS----------RLGHGSY 70
Query: 295 GSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTLVGACPEV 348
G ++K + A+K +GP + E+ K+ +HP V L A
Sbjct: 71 GEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---- 125
Query: 349 WT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
W L E SL+ C+ L + L LHS +V
Sbjct: 126 WEEGGILYLQTELC-GPSLQQH--CEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLV 179
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+KPANI L KL DFG+ L G YM PE L
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQE------GDPRYMAPELLQG 230
Query: 463 GELTPKSDVYSFGIILLRLLTGRP 486
+DV+S G+ +L +
Sbjct: 231 S-YGTAADVFSLGLTILEVACNME 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 70/310 (22%), Positives = 133/310 (42%), Gaps = 42/310 (13%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
++G+G +G +Y+G+ + +VAIK ++ S++ EF E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 340 TLVGACPEV--WTLVYEYLPNGSLED-------RLSCKDNSPPLSWQTRIRIATELCSVL 390
L+G + ++ E + G L+ ++ P S I++A E+ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L++ + VH DL N ++ +F K+ DFG++R + + + R KG
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--------YRKGGKG 200
Query: 451 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 505
+M PE L G T SDV+SFG++L + T +P G++ ++V + G
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG---G 257
Query: 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGS 565
LLD P + L L C + + K RP ++ ++ S+
Sbjct: 258 LLDK-----PDNCPDMLFELMRMCWQYNPKMRPSF-LEIISSIKEEMEPGFREVSFYYSE 311
Query: 566 EERCEPPPYF 575
E + P
Sbjct: 312 ENKLPEPEEL 321
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHP--HSLQGPSEFQQEIDILSKIRHPNLVT 340
+G+G +GS+ + L+ ++VA+KML + EF +E + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 341 LVGAC----PEVWT----LVYEYLPNGSLEDRL---SCKDNSPPLSWQTRIRIATELCSV 389
LVG + ++ ++ +G L L +N L QT +R ++
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
+ +L S + +H DL N +L + ++DFG+SR + + R
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY--------YRQGCA 198
Query: 450 GTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
++ E LA T SDV++FG+ + ++T P GI E+ L G
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTL 341
+G+GG+ + + A K++ L P + EI I + H ++V
Sbjct: 23 LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 342 VGACPEVWTLVY---EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G E V+ E SL + + L+ ++ +LH
Sbjct: 81 HG-FFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHR--- 133
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ ++H DLK N+ L+ + K+ DFG++ + + LC GT Y+ PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLC------GTPNYIAPE 185
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L+ + + DV+S G I+ LL G+P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 41/273 (15%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 340 TLVGACPEV--WTLVYEYLPNGSLED----RLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
+G + ++ E + G L+ L+ + +A ++ +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 394 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------YYRKGGCA 205
Query: 451 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 505
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 262
Query: 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+DP P + + +C + + RP
Sbjct: 263 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 43/345 (12%), Positives = 87/345 (25%), Gaps = 60/345 (17%)
Query: 237 LQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGS 296
+ +EA + + EA +++ PQ S + + G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 297 IYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGACPEVWT- 350
++ A+K+ + SE + +++ + +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 351 ---------------------------LVYEYLPNGSLEDRLSCKDNSP----PLSWQTR 379
L+ + LE S D
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 380 IRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
+ +L + L S +VHG P N+ + + L D ++ +
Sbjct: 197 HILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRG 248
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRPALGITKEVQYA 497
Y EFL + T + + G+ + R+ G+
Sbjct: 249 PASS------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-- 300
Query: 498 LDTGKLKNLLDPLAGDWPFVQA----EQLANLAMRCCEMSRKSRP 538
+ K +L P F + + L R R+ R
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 35/246 (14%)
Query: 252 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----V 307
+ A + +P+ D + + +G+GG+ + +
Sbjct: 18 PGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFAKCF--EISDADTKEVF 69
Query: 308 AIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSL 361
A K++ L P + EI I + H ++V G E V+ E SL
Sbjct: 70 AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSL 128
Query: 362 EDRLSCKDNSPPLS-WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
+ + L+ + R ++ +LH + ++H DLK N+ L+ + K
Sbjct: 129 LELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVK 181
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
+ DFG++ + + LC GT Y+ PE L+ + + DV+S G I+
Sbjct: 182 IGDFGLATKVEYD--GERKKVLC------GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 481 LLTGRP 486
LL G+P
Sbjct: 234 LLVGKP 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 338
+G G +G + + M VA+KML P L E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSLEDRL---------------SCKDNSPPLSWQTRIR 381
V L+GAC ++ EY G L + L +D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+ ++ + FL S +H DL NILL ++K+ DFG++R + +
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG- 205
Query: 442 LCCRTDPKGTFAY--MDPEFLASGELTPKSDVYSFGIIL 478
M PE + + T +SDV+S+GI L
Sbjct: 206 -------NARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 71/321 (22%), Positives = 125/321 (38%), Gaps = 43/321 (13%)
Query: 243 KAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLL 302
K ++E E + RK + Q + + E + ++G G G ++K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKIS-------ELGAGNGGVVFKVSH 54
Query: 303 RHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTLVGAC---PEVWTLVYE 354
+ +A K++H P+ Q E+ +L + P +V GA E+ + E
Sbjct: 55 KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-ICME 111
Query: 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD 414
++ GSL+ L + + Q +++ + L +L H I+H D+KP+NIL++
Sbjct: 112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 415 ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 474
+ KL DFG+S L S N+ + GT +YM PE L + +SD++S
Sbjct: 167 SRGEIKLCDFGVSGQLID---SMANSFV-------GTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 475 GIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMS- 533
G+ L+ + GR + + L G P L M
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
Query: 534 ---------RKSRPELGKDVW 545
+ P+L V+
Sbjct: 277 IFELLDYIVNEPPPKLPSGVF 297
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 41/273 (15%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
+G G +G +Y+G + +QVA+K L S Q +F E I+SK H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 340 TLVGACPEV--WTLVYEYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSVLIFL 393
+G + ++ E + G L+ L L+ + +A ++ +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 394 HSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+ +H D+ N LL V+K+ DFG++R + + R
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------YYRKGGCA 246
Query: 451 TFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTGKLKN 505
+M PE G T K+D +SFG++L + + P + +EV + +G
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---G 303
Query: 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+DP P + + +C + + RP
Sbjct: 304 RMDP-----PKNCPGPVYRIMTQCWQHQPEDRP 331
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
++GE +G +YKG L VAIK L EF+ E + ++++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 340 TLVGAC----PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 382
L+G P ++++ Y +G L + L + L + +
Sbjct: 76 CLLGVVTKDQP--LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
++ + + +L S H +VH DL N+L+ K+SD G+ R + +
Sbjct: 134 VAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183
Query: 443 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 478
+ +M PE + G+ + SD++S+G++L
Sbjct: 184 -YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
E+W +V EYL GSL D ++ + + E L FLHS + ++
Sbjct: 87 LVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+K NILL + KL+DFG ++ E S +T + GT +M PE +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRSTMV-------GTPYWMAPEVVTR 190
Query: 463 GELTPKSDVYSFGIILLRLLTGRP 486
PK D++S GI+ + ++ G P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 288 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 336
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 381
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+L + +L S K +H DL N+L+ N V K++DFG++R ++ + T
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT- 217
Query: 442 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 478
G +M PE L T +SDV+SFG+++
Sbjct: 218 -------NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
KIGEG G + +H QVA+KM+ Q E+ I+ +H N+V + +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
E+W ++ E+L G+L D +S L+ + + + L +LH+ ++
Sbjct: 112 LVGEELW-VLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+K +ILL + KLSDFG +S ++ + + GT +M PE ++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLV-------GTPYWMAPEVISR 215
Query: 463 GELTPKSDVYSFGIILLRLLTGRP 486
+ D++S GI+++ ++ G P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 36/238 (15%)
Query: 288 KIGEGGYGSIYKGLLR----HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNLVTL 341
IGEG +G + K ++ M AIK + S +F E+++L K+ HPN++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 342 VGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRIATEL 386
+GAC L EY P+G+L D L + LS Q + A ++
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
+ +L +H DL NIL+ N+V+K++DFG+SR + + L R
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRLPVR- 206
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT--GRPALGIT-KEVQYALDTG 501
+M E L T SDV+S+G++L +++ G P G+T E+ L G
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 58/262 (22%), Positives = 98/262 (37%), Gaps = 41/262 (15%)
Query: 288 KIGEGGYGSI-YKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 345
+G G G++ ++G + VA+K + EI +L++ HPN++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATEL----CSVLIFLHSCKPH 399
+ E N +L+D + K+ S + L S + LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 400 SIVHGDLKPANILLD-------------ANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
I+H DLKP NIL+ N +SDFG+ + L + S
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL----N 190
Query: 447 DPKGTFAYMDPEFLASGE-------LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYAL 498
+P GT + PE L LT D++S G + +L+ G+ G + +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 499 DTGKLKNLLDPLAGDWPFVQAE 520
G +L + + AE
Sbjct: 251 IRGIF-SLDEMKCLHDRSLIAE 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 42/245 (17%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 338
+G G +G + + VA+KML + E+ IL I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 339 VTLVGACPEV---WTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIRI 382
V L+GAC + ++ E+ G+L L L+ + I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
+ ++ + FL S K +H DL NILL V K+ DFG++R + ++
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG-- 208
Query: 443 CCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIILLRLLT-GR---PALGITKEVQY 496
+M PE + T +SDV+SFG++L + + G P + I +E
Sbjct: 209 ------DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 497 ALDTG 501
L G
Sbjct: 263 RLKEG 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 32/295 (10%), Positives = 78/295 (26%), Gaps = 53/295 (17%)
Query: 235 DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSF-SEIEGATHNFDPSLKIGEGG 293
+ V+ E +S ++ S+ + F SE+ +G+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 294 YGSIYKG--LLRHMQVAIKML----------------------------HPHSLQGPSEF 323
+ + + + + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 324 QQEIDILSKIRHPNLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSW 376
D++ + ++ + ++W L +L+ S L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
R+++ ++ +L LH + +VH L+P +I+LD L+ F
Sbjct: 211 HARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------R 260
Query: 437 SNNTTLCCRTDPKGTFAYMDPEFLAS-----GELTPKSDVYSFGIILLRLLTGRP 486
+ + L +T D ++ G+ + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVGA 344
K+G G +G ++ R ++ IK ++ Q P E + EI++L + HPN++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+V E G L +R+ LS + ++ + L + HS +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DLKP NIL + K+ DFG++ +E S T GT YM PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAA------GTALYMAPE 196
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
++T K D++S G+++ LLTG
Sbjct: 197 VF-KRDVTFKCDIWSAGVVMYFLLTGCL 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 32/230 (13%)
Query: 274 SEIEGATHNFDPSL------KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ 325
E E + DP+ ++G+G +G +YK + A K++ S + ++
Sbjct: 6 REYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV 65
Query: 326 EIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIR- 381
EI+IL+ HP +V L+GA ++W ++ E+ P G+++ + + L+ + +I+
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLT-EPQIQV 121
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+ ++ L FLHS I+H DLK N+L+ +L+DFG+S + ++
Sbjct: 122 VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQKRDSF 177
Query: 442 LCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLRLLTGRP 486
+ GT +M PE + + K+D++S GI L+ + P
Sbjct: 178 I-------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 33/288 (11%), Positives = 79/288 (27%), Gaps = 63/288 (21%)
Query: 247 EAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH-- 304
+E ++ + S+S SE+ +G+ + + +
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 305 MQVAIKML----------------------------HPHSLQGPSEFQQEIDILSKIRHP 336
+ + + + F D++ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 337 NLVTLVGACPEVWTLVY---EYLPNGSLEDRL----SCKDNSPPLSWQTRIRIATELCSV 389
++ + ++W L +L+ S L R+++ ++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L LH + +VH L+P +I+LD L+ F R
Sbjct: 219 LASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------RVVSS 263
Query: 450 GTFAYMDPEFLAS-----------GELTPKSDVYSFGIILLRLLTGRP 486
+ + PE A +T D ++ G+++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 288 KIGEGGYGSIYKGLLR---------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 336
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 381
N++ L+GAC ++ EY G+L + L + LS + +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
A ++ + +L S K +H DL N+L+ + V K++DFG++R + +
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------ 246
Query: 442 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 478
+ G +M PE L T +SDV+SFG++L
Sbjct: 247 --YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA- 344
+G G + ++ R A+K + S + EI +L KI+H N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 345 -CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ LV + + G L DR+ + + + + ++ S + +LH + IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 404 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
DLKP N+L + N ++DFG+S+ + +T C GT Y+ PE L
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC------GTPGYVAPEVL 179
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
A + D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 288 KIGEGGYGSIYKGLLR-------HMQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 338
+G G +G + + ++VA+KML E+ I+S + +H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 385
V L+GAC ++ EY G L E + + S + + +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE--ISSNNTTLC 443
+ + FL S + +H D+ N+LL V+K+ DFG++R + + I N L
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478
+ +M PE + T +SDV+S+GI+L
Sbjct: 230 VK--------WMAPESIFDCVYTVQSDVWSYGILL 256
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 56/262 (21%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 290
K + + K E++ K + + E ++G
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILE------------ELG 60
Query: 291 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 346
G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406
L+ E+L G L DR++ +D +S I + C L +H HSIVH D+
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSIVHLDI 175
Query: 407 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
KP NI+ + S K+ DFG++ L+ +EI T + PE +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTT------ATAEFAAPEIVDREP 226
Query: 465 LTPKSDVYSFGIILLRLLTGRP 486
+ +D+++ G++ LL+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLS 248
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLV 342
+G+G +G + + + A+K++ ++ ++ +E+ +L ++ HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 343 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+ LV E G L D + + S RI ++ S + ++H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK---NK 146
Query: 401 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
IVH DLKP N+LL + ++ DFG+S ++ D GT Y+ P
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---------MKDKIGTAYYIAP 197
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L G K DV+S G+IL LL+G P
Sbjct: 198 EVL-HGTYDEKCDVWSTGVILYILLSGCP 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 344
IG G + + +VAIK ++ Q E +EI +S+ HPN+V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 345 ---CPEVWTLVYEYLPNGSLED--RLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 396
E+W LV + L GS+ D + IAT E+ L +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+ +H D+K NILL + +++DFG+S FL+ + T R GT +M
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT---GGDITRNKVRKTFVGTPCWMA 194
Query: 457 PEFLASGEL-TPKSDVYSFGIILLRLLTGRP 486
PE + K+D++SFGI + L TG
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
+GEG +G + K H VA+KML S + E ++L ++ HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 376
L GAC L+ EY GSL L + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
I A ++ + +L K +VH DL NIL+ K+SDFG+SR + + +
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 437 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 478
+ +G +M E L T +SDV+SFG++L
Sbjct: 207 VKRS--------QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 274 SEIEGATHNFDPSL------KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ 325
+++ + P K+GEG YGS+YK + + VAIK + E +
Sbjct: 16 KKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIK 73
Query: 326 EIDILSKIRHPNLVTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI 382
EI I+ + P++V G+ ++W +V EY GS+ D + + + L T I
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLW-IVMEYCGAGSVSDII--RLRNKTL---TEDEI 127
Query: 383 AT---ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
AT L +LH +H D+K NILL+ +KL+DFG++ L+ + ++ N
Sbjct: 128 ATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DTMAKRN 183
Query: 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T + GT +M PE + +D++S GI + + G+P
Sbjct: 184 TVI-------GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF---- 283
Q+ + +E + A KS++ ++ + +P + F +
Sbjct: 30 QDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY 89
Query: 284 --DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLV 339
+ +G G +G ++K +++A K++ ++ E + EI +++++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
L A LV EY+ G L DR+ + + L+ I ++C + +H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ-- 205
Query: 398 PHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
I+H DLKP NIL K+ DFG++R E GT ++
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNF------GTPEFL 255
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE + ++ +D++S G+I LL+G
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGP-SEFQQEIDILSKIRHPNLVTLVGA 344
KIG+G +G ++KG+ Q VAIK++ + + QQEI +LS+ P + G+
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 345 ---CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSCKP 398
++W ++ EYL GS D L PL +IAT E+ L +LHS
Sbjct: 89 YLKDTKLW-IIMEYLGGGSALDLLEPG----PL---DETQIATILREILKGLDYLHS--- 137
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+H D+K AN+LL + KL+DFG++ L+ NT + GT +M PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFV-------GTPFWMAPE 189
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ K+D++S GI + L G P
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
K+G G YG + + H++ AIK++ S+ S +E+ +L + HPN++ L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ LV E G L D + + + I ++ S + +LH H+I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK---HNI 157
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DLKP N+LL + + + K+ DFG+S + + GT Y+ PE
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---------MKERLGTAYYIAPE 208
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L + K DV+S G+IL LL G P
Sbjct: 209 VL-RKKYDEKCDVWSIGVILFILLAGYP 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 38/241 (15%)
Query: 268 FSDFSFSEIEGATHNF----DPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS 321
F D + + S +G G G + R +VAI+++ S
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 322 E--------FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 371
+ EI+IL K+ HP ++ + + + +V E + G L D++
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR- 235
Query: 372 PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISR 428
L T ++ + +LH + I+H DLKP N+LL + + + K++DFG S+
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGR 485
L + + TLC GT Y+ PE L S D +S G+IL L+G
Sbjct: 291 ILGETSLM---RTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 486 P 486
P
Sbjct: 342 P 342
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 338
+G G +G + +QVA+KML E+ +++++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSL--------------------EDRLSCKDNSPPLSW 376
V L+GAC L++EY G L + RL +++ L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
+ + A ++ + FL VH DL N+L+ V K+ DFG++R + +
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 437 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 478
+M PE L G T KSDV+S+GI+L
Sbjct: 229 VVRG--------NARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTL- 341
IG+G + + RH+ +VAIK++ L S +E+ I+ + HPN+V L
Sbjct: 23 IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 342 -VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
V + L+ EY G + D L + + ++ S + + H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---KR 134
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
IVH DLK N+LLDA+ K++DFG S + C G Y PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFC------GAPPYAAPELF 185
Query: 461 ASGEL--TPKSDVYSFGIILLRLLTGR 485
G+ P+ DV+S G+IL L++G
Sbjct: 186 -QGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 46/243 (18%), Positives = 80/243 (32%), Gaps = 23/243 (9%)
Query: 258 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEG--GYGSIYKGLLRHMQ--VAIKM-- 311
A H + S ++ IG+G ++ + V ++
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 312 LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA---CPEVWTLVYEYLPNGSLEDRLSCK 368
L S + + Q E+ + HPN+V E+W +V ++ GS +D +
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW-VVTSFMAYGSAKDLICTH 120
Query: 369 DNSPPLSWQTRIRIATELCSVLI---FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425
+ IA L VL ++H VH +K ++IL+ + LS
Sbjct: 121 FMDG----MNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLR 173
Query: 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLT 483
+ + + ++ PE L KSD+YS GI L
Sbjct: 174 SNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 484 GRP 486
G
Sbjct: 233 GHV 235
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 20/262 (7%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 290
+K + ++ + + S + Q++ + + ++D ++G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 291 EGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--P 346
G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406
++YE++ G L ++++ + N +S + ++C L +H ++ VH DL
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 281
Query: 407 KPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
KP NI+ + KL DFG++ L + GT + PE
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTT------GTAEFAAPEVAEGKP 332
Query: 465 LTPKSDVYSFGIILLRLLTGRP 486
+ +D++S G++ LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLS 354
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 288 KIGEGGYGSIYKGLLRH---------MQVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHP 336
+GEG +G + + VA+KML + + S+ E++++ I +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------SCKDNSPPLSWQTRIR 381
N++ L+GAC ++ EY G+L + L + ++++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+L + +L S K +H DL N+L+ N V K++DFG++R ++ +
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258
Query: 442 LCCRTDPKGTFA--YMDPEFLASGELTPKSDVYSFGIIL 478
+ G +M PE L T +SDV+SFG+++
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
IG G +G + + + ++ A K + + ++ F+QEI+I+ + HPN++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
LV E G L +R+ K RI ++ S + + H ++ H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 404 GDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
DLKP N L + KL DFG++ ++ T GT Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKV------GTPYYVSPQVL 180
Query: 461 ASGELTPKSDVYSFGIILLRLLTGRP 486
G P+ D +S G+++ LL G P
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYP 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 66/240 (27%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEF--------------------- 323
IG+G YG + + A+K+L L + F
Sbjct: 21 IGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 324 -----QQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCKDN 370
QEI IL K+ HPN+V LV EV +V+E + G + + + K
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLK-- 132
Query: 371 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430
PLS +L + +LH I+H D+KP+N+L+ + K++DFG+S
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS--- 184
Query: 431 SQNEISSNNTTL--CCRTDPKGTFAYMDPEFLASGELT---PKSDVYSFGIILLRLLTGR 485
NE ++ L GT A+M PE L+ DV++ G+ L + G+
Sbjct: 185 --NEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRHPNLVTLVG 343
+G+G +G + K R + A+K+++ S + S +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 41/218 (18%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ----EIDILSKIRHPNLVT 340
+GEG YG + + + A+K+L L+ + EI +L ++RH N++
Sbjct: 13 LGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 341 LVGACPEVWT--------LVYEYLPNGSLE--DRLSCKDNSPPLS-WQTRIRIATELCSV 389
LV +V +V EY G E D + K Q +L
Sbjct: 71 LV----DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAH-GYFCQLIDG 121
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
L +LHS IVH D+KP N+LL K+S G++ L T
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------ 172
Query: 450 GTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 485
G+ A+ PE + K D++S G+ L + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS-------------EFQQEIDILSK 332
K+G G YG + + H + AIK++ E EI +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 333 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
+ HPN++ L + + LV E+ G L +++ + I ++ S +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGI 159
Query: 391 IFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+LH H+IVH D+KP NILL ++ K+ DFG+S F S++
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRL---- 209
Query: 448 PKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L + K DV+S G+I+ LL G P
Sbjct: 210 --GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 34/217 (15%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--------FQQEIDILSKIRHPN 337
+G G G + R +VAIK++ S + EI+IL K+ HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 338 LVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
++ + + + +V E + G L D++ L T ++ + +LH
Sbjct: 77 IIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHE 132
Query: 396 CKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
+ I+H DLKP N+LL + + + K++DFG S+ L + + TLC GT
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLC------GTP 180
Query: 453 AYMDPEFLASGEL---TPKSDVYSFGIILLRLLTGRP 486
Y+ PE L S D +S G+IL L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNLV 339
IGEG +G +++ VA+KML S ++FQ+E ++++ +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 340 TLVGACPEV--WTLVYEYLPNGSLEDRL---------------------SCKDNSPPLSW 376
L+G C L++EY+ G L + L PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
++ IA ++ + + +L VH DL N L+ N V K++DFG+SR + +
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY- 229
Query: 437 SNNTTLCCRTDPKGTF--AYMDPEFLASGELTPKSDVYSFGIIL 478
+ D +M PE + T +SDV+++G++L
Sbjct: 230 -------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G G +G + G H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 19 LGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V + P + +V EY+ G L D + + R+ ++ S + + H H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---H 130
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYAAPEV 181
Query: 460 LASGEL--TPKSDVYSFGIILLRLLTGR 485
+ SG L P+ D++S G+IL LL G
Sbjct: 182 I-SGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
+G+G +G + K R + A+K+++ S + +E+++L K+ HPN++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ +V E G L D + + S RI ++ S + ++H H+I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DLKP NILL + + K+ DFG+S QN GT Y+ PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRI------GTAYYIAPE 193
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L G K DV+S G+IL LL+G P
Sbjct: 194 VL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 70/246 (28%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 260 SSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPH 315
+S + + S + F+ +G G YG +YKG RH++ AIK++
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVT 60
Query: 316 SLQGPSEFQQEIDILSKI-RHPNLVTLVGA---------CPEVWTLVYEYLPNGSLEDRL 365
E +QEI++L K H N+ T GA ++W LV E+ GS+ D +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLI 118
Query: 366 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425
+ I E+ L LH H ++H D+K N+LL N KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELT-----PKSDVYSFGIILLR 480
+S L + NT + GT +M PE +A E KSD++S GI +
Sbjct: 175 VSAQLD-RTVGRRNTFI-------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 481 LLTGRP 486
+ G P
Sbjct: 227 MAEGAP 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 339
++G G + + K + ++ A K + + E ++E+ IL ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 339
++G G + + K + + A K + L E ++E++IL +IRHPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
TL L+ E + G L D L+ K++ L+ + ++ + +LHS
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHS-- 126
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I H DLKP NI+L N KL DFGI+ + + GT
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF------GTPE 176
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
++ PE + L ++D++S G+I LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 343
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 344 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 458 EFLASGEL--TPKSDVYSFGIILLRLLTGR 485
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/214 (26%), Positives = 85/214 (39%), Gaps = 30/214 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 341
+IG G YGS+ K H +A+K + + + ++D+ + P +V
Sbjct: 29 EIGRGAYGSVNKM--VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 342 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI--RIATELCSVLIFLHSC 396
GA + W + E + + S + + I +I L L
Sbjct: 87 YGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
I+H D+KP+NILLD + KL DFGIS L + I+ G YM
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDA--------GCRPYMA 193
Query: 457 PEFLASGELTP----KSDVYSFGIILLRLLTGRP 486
PE + +SDV+S GI L L TGR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 9/175 (5%)
Query: 316 SLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTL--VYEYLPNGSLEDRLSCKDNSPP 373
S +I + N V + L + +L+D ++ + +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 374 LSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433
+ I ++ + FLHS ++H DLKP+NI + V K+ DFG+ + Q+
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 434 E----ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 484
E + + T GT YM PE + + K D++S G+IL LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHP-HSLQGPSEFQQEIDI-LSKIRHPNLVTL 341
++G G YG + K RH+ +A+K + + Q ++DI + + P VT
Sbjct: 14 ELGRGAYGVVEKM--RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 342 VGAC---PEVWTLVYEYLPNGSLEDRL-SCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
GA +VW + E + + SL+ D + +IA + L LHS
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
S++H D+KP+N+L++A K+ DFGIS +L + D G YM P
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--------DDVAKDID-AGCKPYMAP 178
Query: 458 EFLASGELTP----KSDVYSFGIILLRLLTGRP 486
E + KSD++S GI ++ L R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 126
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFA------GTPGYLSPE 177
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L + D+++ G+IL LL G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYP 205
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-26
Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 1/76 (1%)
Query: 566 EERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 625
+ + P F P+ +M DP G + + L + T P L L
Sbjct: 6 IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64
Query: 626 PNLALRSAIQEWLQQH 641
P L+ IQ W+++
Sbjct: 65 PVPELKEQIQAWMREK 80
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 64/283 (22%)
Query: 256 KEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLH 313
SS +F S E+ + IG+G YG + + AIK+++
Sbjct: 4 HHHHSSGRENLYFQGGSLLEL---QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 314 PHSLQGPSE-----FQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLS 366
+ ++ + + E+ ++ K+ HPN+ L + LV E G L D+L+
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 367 CKDNSPPLSWQTRI-------------------------------------RIATELCSV 389
+ + I ++ S
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 390 LIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNN--TTLCCR 445
L +LH+ I H D+KP N L + +F KL DFG+S+ + TT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-- 235
Query: 446 TDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 486
GT ++ PE L + PK D +S G++L LL G
Sbjct: 236 ----GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 57/210 (27%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTLVG 343
+GEG YG + L + VA+K++ E ++EI I + H N+V
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY- 71
Query: 344 ACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
L EY G L DR+ + R +L + +++LH
Sbjct: 72 ---GHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 123
Query: 398 PHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
I H D+KP N+LLD K+SDFG++ N +C GT Y+ P
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVAP 176
Query: 458 EFLASGEL--TPKSDVYSFGIILLRLLTGR 485
E L DV+S GI+L +L G
Sbjct: 177 ELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 339
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
TL L+ E + G L D L+ K++ L+ + ++ + + +LHS
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS-- 132
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I H DLKP NI+L K+ DFG++ + + GT
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF------GTPE 182
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
++ PE + L ++D++S G+I LL+G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 25/207 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
E +++E++ + +R++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 404 GDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
D++P NI+ + K+ +FG +R L + L Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF---RLLF------TAPEYYAPEV 174
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
++ +D++S G ++ LL+G
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQ---EIDILSK-IRHPNLVTL 341
++G G G ++K R +A+K + E ++ ++D++ K P +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 342 VGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
G +V+ + E + E K P+ + ++ + L +L
Sbjct: 90 FGTFITNTDVF-IAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKE--K 143
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
H ++H D+KP+NILLD KL DFGIS L ++ + + + G AYM PE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSA--------GCAAYMAPE 194
Query: 459 FLASGEL-----TPKSDVYSFGIILLRLLTGRP 486
+ + ++DV+S GI L+ L TG+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 45/229 (19%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQ---QEIDILSKI-RHPNLVTL 341
KIG G +GS++K + R AIK L G + Q +E+ + + +H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 342 VGACPEVWTL--VYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
A E + EY GSL D +S + ++ L ++HS
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 399 HSIVHGDLKPANILLDAN-------------------FVSKLSDFGISRFLSQNEISSNN 439
+VH D+KP+NI + + K+ D G ISS
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----RISSPQ 188
Query: 440 TTLCCRTDPKGTFAYMDPEFLA-SGELTPKSDVYSFGIILLRLLTGRPA 487
+G ++ E L + PK+D+++ + ++ P
Sbjct: 189 VE-------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS------EFQQEIDILSKIRHPNLV 339
++G G + + K + ++ A K + + E ++E+ IL ++ HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 340 TLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
TL L+ E + G L D L+ K++ LS + ++ + +LH+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHT-- 133
Query: 398 PHSIVHGDLKPANILL----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I H DLKP NI+L KL DFG++ + + GT
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF------GTPE 183
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
++ PE + L ++D++S G+I LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-26
Identities = 17/82 (20%), Positives = 28/82 (34%), Gaps = 1/82 (1%)
Query: 560 SYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPL 619
+ + P F P+ +M DP G + + L + T P L
Sbjct: 15 KNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP-TDPFNRQTL 73
Query: 620 AHKNLVPNLALRSAIQEWLQQH 641
L P L+ IQ W+++
Sbjct: 74 TESMLEPVPELKEQIQAWMREK 95
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
++G+G + + + + + ++ A K+++ L ++E I K++HPN+V L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ LV++ + G L + + ++ S ++ + + HS + I
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHS---NGI 149
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH +LKP N+LL KL+DFG++ ++ +E GT Y+ PE
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA------GTPGYLSPE 200
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L + D+++ G+IL LL G P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYP 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDILSKI-RH 335
+G G + + + + + A+K++ S +E+DIL K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 336 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
PN++ L + LV++ + G L D L+ K LS + +I L V+ L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 140
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H +IVH DLKP NILLD + KL+DFG S L E +C GT +
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC------GTPS 188
Query: 454 YMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRP 486
Y+ PE + + D++S G+I+ LL G P
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 278 GATHNFDPSLK---------IGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQE 326
G+T +F + +GEG + + + + A+K++ S +E
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 327 IDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 383
+++L + + H N++ L+ + + LV+E + GS+ + + + + +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVV 117
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNT 440
++ S L FLH+ I H DLKP NIL + K+ DF + + N S +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 441 TLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLTGRP 486
T T P G+ YM PE + + D++S G+IL LL+G P
Sbjct: 175 TPELLT-PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 23/209 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGP--SEFQQEIDILSKIRH-PNLVTLV 342
++G G + + + + + + A K L +E EI +L + P ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 343 GA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
L+ EY G + + + +S IR+ ++ + +LH ++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQ---NN 151
Query: 401 IVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
IVH DLKP NILL K+ DFG+SR + + GT Y+ P
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIM------GTPEYLAP 202
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L +T +D+++ GII LLT
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 34/309 (11%)
Query: 197 DQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRK 256
+ + + + + L ++ K+ + +
Sbjct: 10 GVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGT 69
Query: 257 EASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP 314
E M ++ + +DP IG G + + + R + A+K++
Sbjct: 70 ENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 315 HSLQGPSE--------FQQEIDILSKIR-HPNLVTLVGAC--PEVWTLVYEYLPNGSLED 363
+ + E ++E IL ++ HP+++TL+ + LV++ + G L D
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189
Query: 364 RLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSD 423
L+ K LS + I L + FLH+ ++IVH DLKP NILLD N +LSD
Sbjct: 190 YLTEKVA---LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243
Query: 424 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL------TPKSDVYSFGII 477
FG S L E LC GT Y+ PE L + D+++ G+I
Sbjct: 244 FGFSCHLEPGEKL---RELC------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 478 LLRLLTGRP 486
L LL G P
Sbjct: 295 LFTLLAGSP 303
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 23/208 (11%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE--FQQEIDILSKIRHPNLVTLVG 343
++G+G + + + + + A +++ L ++E I ++HPN+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
+ L+++ + G L + + ++ S ++ ++ H +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQ---MGV 131
Query: 402 VHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH +LKP N+LL KL+DFG++ + + GT Y+ PE
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFA------GTPGYLSPE 183
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
L D+++ G+IL LL G P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 35/214 (16%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIRH--P 336
+G GG+GS+Y G + VAIK + L + E+ +L K+
Sbjct: 51 LGSGGFGSVYSG--IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 337 NLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
++ L P+ + L+ E P L D ++ + L + ++ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 165
Query: 394 HSCKPHSIVHGDLKPANILLDANFVS-KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
H+ ++H D+K NIL+D N KL DFG L T GT
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFD------GTR 212
Query: 453 AYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 485
Y PE++ + V+S GI+L ++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 30/247 (12%)
Query: 253 KSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIK 310
+ D F ++ ++ IG+G + + + + R Q A+K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDV------YELCEVIGKGPFSVVRRCINRETGQQFAVK 55
Query: 311 M-----LHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLED 363
+ + ++E I ++HP++V L+ + +V+E++ L
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 364 RLSCKDNSP-PLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL---DANFVS 419
+ + ++ S ++ L + H ++I+H D+KP +LL + +
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPV 172
Query: 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILL 479
KL FG++ L ++ GT +M PE + DV+ G+IL
Sbjct: 173 KLGGFGVAIQLGES--GLVAGGRV------GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 480 RLLTGRP 486
LL+G
Sbjct: 225 ILLSGCL 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/267 (22%), Positives = 112/267 (41%), Gaps = 26/267 (9%)
Query: 227 LQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPS 286
+ ++ + + + ++ + ++S +P ++ D S + + F+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVE 58
Query: 287 LKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA 344
++G G +Y+ + A+K+L + EI +L ++ HPN++ L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
P +LV E + G L DR+ K S + ++ + +LH + IV
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 403 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
H DLKP N+L + K++DFG+S+ + + T+C GT Y PE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVC------GTPGYCAPEI 221
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
L P+ D++S GII LL G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFE 248
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 37/212 (17%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+G G +G + G +H +VA+K+L+ ++ + EI L RHP+++ L
Sbjct: 24 LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 342 VGACPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+V + +V EY+ G L D + L + R+ ++ S + + H
Sbjct: 82 Y----QVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHR 134
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H +VH DLKP N+LLDA+ +K++DFG+S +S E T C G+ Y
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSC------GSPNYA 182
Query: 456 DPEFLASGEL--TPKSDVYSFGIILLRLLTGR 485
PE + SG L P+ D++S G+IL LL G
Sbjct: 183 APEVI-SGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+GEG +G + H +VA+K + L+ + EI L +RHP+++ L
Sbjct: 17 LGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V P +V EY G L D + K ++ R ++ + + H H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHR---H 127
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
IVH DLKP N+LLD N K++DFG+S ++ T C G+ Y PE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TSC------GSPNYAAPEV 178
Query: 460 LASGEL--TPKSDVYSFGIILLRLLTGR 485
+ +G+L P+ DV+S GI+L +L GR
Sbjct: 179 I-NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 344
+G G G + + R + A+K+L+ +QE+D + P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDV 90
Query: 345 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
+ ++ E + G L R+ + + + + I ++ + + FLHS
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHS--- 146
Query: 399 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H+I H D+KP N+L + + V KL+DFG ++ +QN + T C T Y+
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC------YTPYYV 196
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE L + D++S G+I+ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKML---HPHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
+IG G +G++Y VAIK + S + + +E+ L K+RHPN +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 343 GAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT---ELCSVLIFLHSC 396
G W LV EY GS D L + + PL + IA L +LHS
Sbjct: 121 GCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPL---QEVEIAAVTHGALQGLAYLHS- 172
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
H+++H D+K NILL + KL DFG + + ++ N+ + GT +M
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFV-------GTPYWMA 218
Query: 457 PEFLAS---GELTPKSDVYSFGIILLRLLTGRP 486
PE + + G+ K DV+S GI + L +P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKM-----LHPHSLQGPSEFQQ---EIDILSKIRHP 336
+G G +G ++ +V +K + + + EI ILS++ H
Sbjct: 32 LGSGAFGFVWTA--VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 337 NLVTL--VGACPEVWTLVYEYLPNGS-LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
N++ + + + LV E +G L + L I +L S + +L
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYL 146
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I+H D+K NI++ +F KL DFG + +L + ++ T C GT
Sbjct: 147 RL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---TFC------GTIE 194
Query: 454 YMDPEFLASGEL--TPKSDVYSFGIILLRLLTGR 485
Y PE L G P+ +++S G+ L L+
Sbjct: 195 YCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-24
Identities = 22/77 (28%), Positives = 29/77 (37%), Gaps = 2/77 (2%)
Query: 566 EERCEPPPYFTCPIFQEVMQDPHVAADG-FTYEAEALKGWLDSGHETSPMTNLPLAHKNL 624
E + F PI +M DP V T + + L S T P PL +
Sbjct: 14 ETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQ-TDPFNRSPLTMDQI 72
Query: 625 VPNLALRSAIQEWLQQH 641
PN L+ IQ WL +
Sbjct: 73 RPNTELKEKIQRWLAER 89
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHPNLVTL 341
+GEG + ++ L R + AIK+L + ++ E D++S++ HP V L
Sbjct: 38 LGEGSFSTVV--LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 342 VGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
E Y NG L + K S + TR A E+ S L +LH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET-CTRFYTA-EIVSALEYLHG---K 149
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y+ PE
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQYVSPEL 203
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
L SD+++ G I+ +L+ G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKML------HPHSLQGPSEFQQEIDILSKIR---- 334
+G+GG+G+++ G + QVAIK++ L E+ +L K+
Sbjct: 39 LGKGGFGTVFAG--HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 335 HPNLVTL--VGACPEVWTLVYEY-LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 391
HP ++ L E + LV E LP L D ++ K L ++ + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQ 153
Query: 392 FLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
HS +VH D+K NIL+D +KL DFG L T G
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFD------G 200
Query: 451 TFAYMDPEFLASGELT-PKSDVYSFGIILLRLLTGR 485
T Y PE+++ + + V+S GI+L ++ G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGA 344
+GEG + K + + + A+K++ Q+EI L HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEITALKLCEGHPNIVKLHEV 74
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
LV E L G L +R+ K + S I +L S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 403 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
H DLKP N+L + N K+ DFG +R +N L P T Y PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL-----KPPDNQPL---KTPCFTLHYAAPEL 180
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRP 486
L D++S G+IL +L+G+
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 34/208 (16%), Positives = 56/208 (26%), Gaps = 54/208 (25%)
Query: 288 KIGEGGYGSIYKG----LLRHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVT 340
G ++ L R QVA+ + P + E LS+I P +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 341 L--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
+ V +V E++ GSL++ + P IR L + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGA-IRAMQSLAAAADAAHR--- 147
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+ P+ + + + L A M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVL----------------------------AYPATMPDA 179
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
P+ D+ G L LL R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRW 200
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSK-IRHPNLVTLVGA 344
IG G Y + + + +M+ A+K++ +EI+IL + +HPN++TL
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ +V E + G L D++ + S + + + + +LH+ +V
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA---QGVV 138
Query: 403 HGDLKPANILL-----DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
H DLKP+NIL + + ++ DFG ++ L T C T ++ P
Sbjct: 139 HRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAEN--GLLMTPC------YTANFVAP 189
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L D++S G++L +LTG
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 344
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123
Query: 345 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 179
Query: 399 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
+I H D+KP N+L N + KL+DFG ++ + + TT C T Y+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC------YTPYYV 230
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE L + D++S G+I+ LL G P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 57/207 (27%), Positives = 83/207 (40%), Gaps = 29/207 (14%)
Query: 289 IGEGGYGSIYKGLLRHM----QVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL--V 342
IG G +G L+R VA+K + + Q+EI +RHPN+V V
Sbjct: 28 IGSGNFGVAR--LMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
P ++ EY G L +R+ S +L S + + HS I
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHS---MQIC 138
Query: 403 HGDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
H DLK N LLD + K+ DFG S+ + + GT AY+ PE L
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STV------GTPAYIAPEVL 189
Query: 461 ASGEL--TPKSDVYSFGIILLRLLTGR 485
+ +DV+S G+ L +L G
Sbjct: 190 -LRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 341
+GEG YG + K R+ VAIK +EI +L ++RH NLV L
Sbjct: 32 LVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ C + W LV+E++ + ++ D L + L +Q + ++ + + F HS H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS---H 143
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+I+H D+KP NIL+ + V KL DFG +R +++ D T Y PE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVY---DDEVATRWYRAPEL 195
Query: 460 L-ASGELTPKSDVYSFGIILLRLLTGRP 486
L + DV++ G ++ + G P
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 63/280 (22%), Positives = 103/280 (36%), Gaps = 46/280 (16%)
Query: 224 VELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNF 283
++LL +E ++ +DK V A+ L+ + + DF
Sbjct: 18 LDLLLGVHQELGASELAQDKYV--ADFLQWAEPIVVRLKEVRLQRDDFEI---------- 65
Query: 284 DPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRH 335
LK IG G + + +++ Q A+K+++ + E F++E D+L
Sbjct: 66 ---LKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 336 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
+ L A LV EY G L LS P R +A E+ + +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSV 178
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H VH D+KP NILLD +L+DFG L + + GT
Sbjct: 179 HR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-VAV------GTPD 228
Query: 454 YMDPEFLASGELTPKSDVY-------SFGIILLRLLTGRP 486
Y+ PE L + P + Y + G+ + G+
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 20/77 (25%), Positives = 41/77 (53%)
Query: 565 SEERCEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNL 624
++ + P Y I E+M++P + G TY+ + ++ L +P+T PL + L
Sbjct: 199 KRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQL 258
Query: 625 VPNLALRSAIQEWLQQH 641
+PNLA++ I ++ ++
Sbjct: 259 IPNLAMKEVIDAFISEN 275
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 46/303 (15%)
Query: 200 SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 259
LE I + + + +++L E + + R+K + E L ++ S
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNI--LEYLEWAKPFTS 64
Query: 260 SSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQ----VAIKMLHP 314
M DF LK IG G +G + +++ A+K+L+
Sbjct: 65 KVKQMRLHREDFEI-------------LKVIGRGAFGEVA--VVKLKNADKVFAMKILNK 109
Query: 315 HSLQGPSE---FQQEIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKD 369
+ +E F++E D+L + TL A LV +Y G L LS +
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 370 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS-R 428
+ P R +A E+ + +H VH D+KP NIL+D N +L+DFG +
Sbjct: 170 DRLPEEM-ARFYLA-EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKS-----DVYSFGIILLRLLT 483
+ + S+ GT Y+ PE L + E D +S G+ + +L
Sbjct: 225 LMEDGTVQSS--VAV------GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 484 GRP 486
G
Sbjct: 277 GET 279
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL- 341
K+G G Y ++YKG + VA+K + S +G PS +EI ++ +++H N+V L
Sbjct: 12 KLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 342 -VGACPEVWTLVYEYLPN--GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
V TLV+E++ N D + + L +L L F H
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--- 126
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA----- 453
+ I+H DLKP N+L++ KL DFG++R P TF+
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG---------------IPVNTFSSEVVT 171
Query: 454 --YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
Y P+ + S + D++S G IL ++TG+P
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 50/229 (21%)
Query: 287 LKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV 342
K+G G YG +YK + + A+K + + +EI +L +++HPN+++L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 84
Query: 343 GACPE-----VWTLVYEYLPN---GSLEDRLSCKDNSP--PLSWQTRIRIATELCSVLIF 392
VW L+++Y + ++ + K N L + ++ + +
Sbjct: 85 KVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDP 448
LH+ + ++H DLKPANIL+ K++D G +R + P
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---------------SP 185
Query: 449 KGTFAYMDPE-----------FLASGELTPKSDVYSFGIILLRLLTGRP 486
A +DP L + T D+++ G I LLT P
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 6e-20
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 341
KIGEG YG ++K R+ VAIK +EI +L +++HPNLV L
Sbjct: 10 KIGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 342 VGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
+ LV+EY + ++ L + I + + F H H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK---H 121
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
+ +H D+KP NIL+ + V KL DFG +R ++ + D T Y PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYY---DDEVATRWYRSPEL 173
Query: 460 L-ASGELTPKSDVYSFGIILLRLLTGRP 486
L + P DV++ G + LL+G P
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 342
KIGEG YG +YK + + A+K + G PS +EI IL +++H N+V L V
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ LV+E+L L+ L L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 455
H DLKP N+L++ K++DFG++R P + Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFG---------------IPVRKYTHEIVTLWYR 167
Query: 456 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
P+ + S + + D++S G I ++ G P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNL 338
+ K+GEG Y ++YKG + VA+K + +G P +E+ +L ++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 339 VTL--VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
VTL + + TLV+EYL L+ L D ++ +L L + H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR- 118
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA--- 453
++H DLKP N+L++ KL+DFG++R S P T+
Sbjct: 119 --QKVLHRDLKPQNLLINERGELKLADFGLARAKS---------------IPTKTYDNEV 161
Query: 454 ----YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
Y P+ L S + + + D++ G I + TGRP
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 2e-19
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 8/123 (6%)
Query: 520 EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPI 579
+ ++ R ++ E + E R + E + P F P+
Sbjct: 843 VRAVDILGRKTGLASPEFIEKLLNFANKAEEQRKAD------EEEDLEYGDVPDEFLDPL 896
Query: 580 FQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWL 638
+M+DP + A + +K L S T P +PL +++ PN LR I +
Sbjct: 897 MYTIMKDPVILPASKMNIDRSTIKAHLLS-DSTDPFNRMPLKLEDVTPNEELRQKILCFK 955
Query: 639 QQH 641
+Q
Sbjct: 956 KQK 958
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL--V 342
K+GEG YG +YK + VA+K + + G PS +EI +L ++ HPN+V+L V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 343 GACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
TLV+E++ L+ L +N L +L + H H I+
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRIL 141
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA-------YM 455
H DLKP N+L++++ KL+DFG++R P ++ Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFG---------------IPVRSYTHEVVTLWYR 186
Query: 456 DPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
P+ + S + + D++S G I ++TG+P
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-IGE 291
+ D + ++K + L + + + + D+ +K IG
Sbjct: 35 DLDFPALRKNKNI--DNFLSRYKDTINKIRDLRMKAEDYEV-------------VKVIGR 79
Query: 292 GGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGA 344
G +G + L+RH A+K+L + S+ F +E DI++ P +V L A
Sbjct: 80 GAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 345 --CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+V EY+P G L + +S D R A E+ L +HS +
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA-EVVLALDAIHS---MGFI 190
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H D+KP N+LLD + KL+DFG +++ + + T GT Y+ PE L S
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD-TAV------GTPDYISPEVLKS 243
Query: 463 ----GELTPKSDVYSFGIILLRLLTGRP 486
G + D +S G+ L +L G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 289 IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 341
IG+G +G + +++ A+K ++ +E + +E+ I+ + HP LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 342 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 388
+ E +V + L G L E+ ++ I EL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------------VKLFIC-ELVM 126
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDP 448
L +L + I+H D+KP NILLD + ++DF I+ L + TT+
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA----- 175
Query: 449 KGTFAYMDPEFLASGELTPKS---DVYSFGIILLRLLTGRP 486
GT YM PE +S + S D +S G+ LL GR
Sbjct: 176 -GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 341
K+GEG YG +YK VAIK + + G P +E+ +L +++H N++ L
Sbjct: 41 KLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V L++EY N D D +P +S + +L + + F HS
Sbjct: 99 KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---R 151
Query: 400 SIVHGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA- 453
+H DLKP N+LL + S K+ DFG++R P F
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG---------------IPIRQFTH 196
Query: 454 ------YMDPEFL-ASGELTPKSDVYSFGIILLRLLTGRP 486
Y PE L S + D++S I +L P
Sbjct: 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-19
Identities = 78/344 (22%), Positives = 131/344 (38%), Gaps = 47/344 (13%)
Query: 159 EELKRRKEFEEALAN-GKLEL-ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKEL 216
EE K EF E + KLE E E+ + + + + L
Sbjct: 77 EEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHL 136
Query: 217 EQKIISAVELLQNYKKEQ-DELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE 275
+K + +L Q Y +E L+ + + E+++ + + + ++ +DFS
Sbjct: 137 VKKQVPP-DLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSV-- 193
Query: 276 IEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQ---QEIDI 329
+ IG GG+G +Y A+K L ++ E +
Sbjct: 194 -----------HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 330 LSKI---RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-A 383
LS + P +V + A P+ + + + + G L LS + +R A
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYA 298
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443
E+ L +H+ +V+ DLKPANILLD + ++SD G++ + S
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHAS 350
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKS-DVYSFGIILLRLLTGRP 486
GT YM PE L G S D +S G +L +LL G
Sbjct: 351 V-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 39/217 (17%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ-G-PSEFQQEIDILSKIRHPNLVTL 341
KIGEG YG+++K ++ + VA+K + G PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 342 --VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
V + TLV+E+ L+ + L + +L L F HS
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 400 SIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA------ 453
+++H DLKP N+L++ N KL++FG++R P ++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFG---------------IPVRCYSAEVVTL 165
Query: 454 -YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRPAL 488
Y P+ + + D++S G I L L
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 45/289 (15%)
Query: 211 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSD 270
+T +E ++ +A++ + + K+Q +M+ + + + + ++
Sbjct: 91 ETPEE-REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 271 FSFSEIEGATHNFDPSLK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQQ 325
F + LK +G+G +G + L++ A+K+L + E
Sbjct: 150 FEY-------------LKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAH 194
Query: 326 ---EIDILSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRI 380
E +L RHP L L + + V EY G L LS + + R
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRA 250
Query: 381 RI-ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439
R E+ S L +LHS ++V+ DLK N++LD + K++DFG L + I
Sbjct: 251 RFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG----LCKEGIKDGA 304
Query: 440 T--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T T C GT Y+ PE L + D + G+++ ++ GR
Sbjct: 305 TMKTFC------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 48/221 (21%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQQ--------EIDILSKIRH 335
+GEG + ++YK R VAIK + L SE + EI +L ++ H
Sbjct: 17 FLGEGQFATVYKA--RDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQELSH 71
Query: 336 PNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
PN++ L+ A +LV++++ LE + KDNS L+ L +L
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H H I+H DLKP N+LLD N V KL+DFG+++ P +
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------SPNRAYT 170
Query: 454 -------YMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
Y PE + D+++ G IL LL P
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 43/218 (19%)
Query: 288 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL----- 341
IG G +G +++ L +VAIK + LQ +E+ I+ ++HPN+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 342 --VGACPEVW-TLVYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVL 390
EV+ LV EY+P + K P L +Q L L
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ--------LLRSL 154
Query: 391 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
++HS I H D+KP N+LLD V KL DFG ++ L E N + C
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYIC----- 203
Query: 450 GTFAYMDPEF-LASGELTPKSDVYSFGIILLRLLTGRP 486
+ Y PE + T D++S G ++ L+ G+P
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 282 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQ--QEIDILS 331
F+ LK +G+G +G ++ L++ + A+K+L +L+ + E DIL
Sbjct: 25 QFEL-LKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 332 KIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQT 378
++ HP +V L A L+ ++L G L E+
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-------------V 128
Query: 379 RIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSN 438
+ +A EL L LHS I++ DLKP NILLD KL+DFG LS+ I
Sbjct: 129 KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHE 180
Query: 439 NT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ C GT YM PE + T +D +SFG+++ +LTG
Sbjct: 181 KKAYSFC------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 71/335 (21%), Positives = 120/335 (35%), Gaps = 27/335 (8%)
Query: 164 RKEFEEALANGKLELERMKKQHDEVME-ELQIALDQKSLLESQIAESDQTAKELEQKIIS 222
R F E A + EL R D V E E+ +K+ + +
Sbjct: 64 RLLFREFCAT-RPELSRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVP 122
Query: 223 --AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGAT 280
V ++ + ++ E L + S F + + E + T
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182
Query: 281 -HNFDPSLKIGEGGYGSIYKGLLRHMQV--AIKMLHPHSLQGPSEFQQ---EIDILSKIR 334
+ F +G+GG+G + +R A K L ++ E IL K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 335 HPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLI 391
+V+L A + LV + G L+ + + R A E+C L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-EARAVFYAAEICCGLE 300
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
LH IV+ DLKP NILLD + ++SD G++ + + + GT
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV------GT 348
Query: 452 FAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
YM PE + + T D ++ G +L ++ G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 48/249 (19%)
Query: 264 MPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQ- 318
M + + + + ++ KIG+G +G ++K RH + VA+K + + +
Sbjct: 1 MAKQYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKA--RHRKTGQKVALKKVLMENEKE 57
Query: 319 G-PSEFQQEIDILSKIRHPNLVTLVGACPEVWT----------LVYEYLPN---GSLEDR 364
G P +EI IL ++H N+V L+ C + LV+++ + G L +
Sbjct: 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117
Query: 365 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424
+ R+ L + L ++H + I+H D+K AN+L+ + V KL+DF
Sbjct: 118 ------LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168
Query: 425 GISRFLSQNEISSNNT------TLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGII 477
G++R S + S N TL Y PE L + P D++ G I
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVVTLW----------YRPPELLLGERDYGPPIDLWGAGCI 218
Query: 478 LLRLLTGRP 486
+ + T P
Sbjct: 219 MAEMWTRSP 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 64/340 (18%), Positives = 120/340 (35%), Gaps = 42/340 (12%)
Query: 158 AEELKRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELE 217
E+ + + + + +D + L+ Q ++ L+
Sbjct: 79 HEQHGPALQLWKDIED-----------YDTADDALRPQKAQALRAAYLEPQAQLFCSFLD 127
Query: 218 QKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIE 277
+ ++ D L +AV L ++ + S F + + E +
Sbjct: 128 AETVARAR-----AGAGDGLFQPLLRAVLA--HLGQAPFQEFLDSLYFLRFLQWKWLEAQ 180
Query: 278 GAT-HNFDPSLKIGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEFQ---QEIDI 329
F +G GG+G ++ + A K L+ L+ +Q E I
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF--ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 330 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATEL 386
L+K+ +V+L A LV + G + + D P + R ++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
S L LH +I++ DLKP N+LLD + ++SD G++ L + +
Sbjct: 299 VSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA--- 350
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT +M PE L E D ++ G+ L ++ R
Sbjct: 351 ---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 54/265 (20%)
Query: 242 DKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL 301
V ++ K ++ P + S+++ + IG G +G +Y+
Sbjct: 25 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAK 74
Query: 302 LRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------L 351
L VAIK + LQ +E+ I+ K+ H N+V L L
Sbjct: 75 LCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 352 VYEYLP---NGSLEDRLSCKDNSPPL-----SWQTRIRIATELCSVLIFLHSCKPHSIVH 403
V +Y+P K P + +Q L L ++HS I H
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICH 179
Query: 404 GDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLA 461
D+KP N+LLD + V KL DFG ++ L + E N + C + Y PE
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYIC------SRYYRAPELIFG 230
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP 486
+ + T DV+S G +L LL G+P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 43/222 (19%)
Query: 288 KIGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQG-----PSEFQQEIDIL---SKIRH 335
+IG G YG++YK R VA+K + + G P +E+ +L H
Sbjct: 16 EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 336 PNLVTLV-------GACPEVWTLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATE 385
PN+V L+ TLV+E++ L+ P L +T + +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKDLMRQ 128
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCC 444
L FLH+ + IVH DLKP NIL+ + KL+DFG++R + Q ++ TL
Sbjct: 129 FLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW- 184
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
Y PE L D++S G I + +P
Sbjct: 185 ---------YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 2e-17
Identities = 50/265 (18%), Positives = 79/265 (29%), Gaps = 59/265 (22%)
Query: 261 SSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--- 317
S P FS T KIGEG +G +++ + H VAIK++
Sbjct: 6 SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 318 -----QGPSEFQQEIDILSKI---------RHPNLVTLV------GACPEVWTLVYEYLP 357
+ E EI I ++ R + L G+ P + +++
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 358 --NGSLEDRLS--------------------CKDNSPPLSWQTRIRIATELCSVLIFLHS 395
GS DR + + S T I +L + L
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE- 178
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISR---FLSQNEISSNNTTLCCRTDPKGTF 452
H DL N+LL + KL + S S R + G
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIV 237
Query: 453 AYMDPEF---LASGELTPKSDVYSF 474
+ D L +G+ + D+Y
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 50/268 (18%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 290
KK ++ ++ A + + L+K + +++ + F + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKT------------LG 50
Query: 291 EGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTLVG 343
G +G + L++H + A+K+L + + + E IL + P LV L
Sbjct: 51 TGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 344 AC--PEVWTLVYEYLPNGSLEDRLSCK---DNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
+ +V EY+ G + L R A ++ +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-----HARFYAA-QIVLTFEYLHS--- 159
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+++ DLKP N+L+D +++DFG ++ + TLC GT + PE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLC------GTPEALAPE 208
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ S D ++ G+++ + G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 253 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 309
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 7 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 66
Query: 310 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTL--VGACPEVWTLVY--EYLPNGSLEDR 364
K+L P + + ++EI IL +R PN++TL + P T E++ N
Sbjct: 67 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--- 120
Query: 365 LSCKDNSPPLSWQTRIR-IATELCSVLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLS 422
K L+ IR E+ L + HS I+H D+KP N+++D + +L
Sbjct: 121 ---KQLYQTLT-DYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLI 173
Query: 423 DFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRL 481
D+G++ F + + + PE L ++ D++S G +L +
Sbjct: 174 DWGLAEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
Query: 482 LTGRPAL 488
+ +
Sbjct: 225 IFRKEPF 231
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 282 NFDPSLK-IGEGGYGSIYKGLLRHMQV-------AIKMLH-PHSLQGPSEFQQ---EIDI 329
F+ L+ +G+GGYG ++ +R + A+K+L ++ + E +I
Sbjct: 18 CFEL-LRVLGKGGYGKVF--QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 330 LSKIRHPNLVTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSW 376
L +++HP +V L+ A L+ EYL G L ED
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------------ 122
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
+A E+ L LH I++ DLKP NI+L+ KL+DFG L + I
Sbjct: 123 -ACFYLA-EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG----LCKESIH 173
Query: 437 SNNT--TLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T C GT YM PE L D +S G ++ +LTG P
Sbjct: 174 DGTVTHTFC------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSLQG--PSEFQQEIDIL---SKIRHPN 337
+IGEG YG ++K R ++ VA+K + + + P +E+ +L HPN
Sbjct: 18 EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 338 LVTLVGACPEVW-------TLVYEYLPN---GSLEDRLSCKDNSPPLSWQTRIRIATELC 387
+V L C TLV+E++ L+ P + +T + +L
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLL 130
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR-FLSQNEISSNNTTLCCRT 446
L FLHS H +VH DLKP NIL+ ++ KL+DFG++R + Q ++S TL
Sbjct: 131 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW--- 184
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
Y PE L D++S G I + +P
Sbjct: 185 -------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 289 IGEGGYGSIYKGLLRHMQ----VAIKMLHPHSLQGPSEFQ---QEIDILSKIRHPNLVTL 341
+G G +G ++ L+R A+K+L + + + E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVH--LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 342 VGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 392
G + ++ +Y+ G L R + A E+C L +
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----------NPVAKFYAAEVCLALEY 121
Query: 393 LHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTF 452
LHS I++ DLKP NILLD N K++DFG ++ + TLC GT
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLC------GTP 167
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
Y+ PE +++ D +SFGI++ +L G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 53/221 (23%)
Query: 289 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKIRHP 336
+G+G +G + + V A+K+L + E E +L RHP
Sbjct: 13 LGKGTFGKV-------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 337 NLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 387
L L A + V EY G L E + + R R E+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------EERARFYGAEIV 115
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 445
S L +LHS +V+ D+K N++LD + K++DFG L + IS T T C
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFC-- 166
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L + D + G+++ ++ GR
Sbjct: 167 ----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 51/211 (24%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGA 344
+G G G + + + + A+KML ++E+++ + + P++V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79
Query: 345 CPEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
++ +V E L G L R+ + + + + I + + +LHS
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS--- 135
Query: 399 HSIVHGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
+I H D+KP N+L N + KL+DFG +
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------------- 167
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
E D++S G+I+ LL G P
Sbjct: 168 -KETTGEK-YDKSCDMWSLGVIMYILLCGYP 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 40/246 (16%)
Query: 258 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 315
S S F+S + IG G G + VAIK L
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SR 60
Query: 316 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 360
Q + ++ E+ ++ + H N++ L + +V+ +V E +
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQV 119
Query: 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
++ L + L +Q LC + LHS I+H DLKP+NI++ ++ K
Sbjct: 120 IQMELD-HERMSYLLYQM-------LCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLK 167
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
+ DFG++R + + T T Y PE + D++S G I+
Sbjct: 168 ILDFGLARTAGTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 481 LLTGRP 486
++ G
Sbjct: 219 MIKGGV 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 49/242 (20%), Positives = 81/242 (33%), Gaps = 39/242 (16%)
Query: 269 SDFSFSEIEGATHN----FDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSE- 322
+ + ++ H + I G YG++ G+ + VAIK + G +
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 323 -FQQ---------EIDILSKIRHPNLVTLVGA-CPEVWT------LVYEYLPNGSLEDRL 365
EI +L+ HPN++ L LV E + L +
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI 124
Query: 366 SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425
D +S Q + L LH +VH DL P NILL N + DF
Sbjct: 125 --HDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179
Query: 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTG 484
++R + + T Y PE + T D++S G ++ +
Sbjct: 180 LAREDTADANK---------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 485 RP 486
+
Sbjct: 231 KA 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 74/286 (25%)
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPSLK-IG 290
+ ++ ++ + A+ + H + +F LK +G
Sbjct: 17 GAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFEL-------------LKVLG 63
Query: 291 EGGYGSIYKGLLRHMQV-------AIKMLHPHSLQGPSEFQQ----EIDILSKIRH-PNL 338
G YG ++ L+R + A+K+L ++ ++ + E +L IR P L
Sbjct: 64 TGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 339 VTLVGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATE 385
VTL A L+ +Y+ G L E +I + E
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-------------VQIYVG-E 167
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT---TL 442
+ L LH I++ D+K NILLD+N L+DFG LS+ ++
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFVADETERAYDF 220
Query: 443 CCRTDPKGTFAYMDPEFLASGEL--TPKSDVYSFGIILLRLLTGRP 486
C GT YM P+ + G+ D +S G+++ LLTG
Sbjct: 221 C------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 46/255 (18%)
Query: 252 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGL--LRHMQVAI 309
A++++ P+ F ++ + IGEG YG + L ++VAI
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVF-DV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57
Query: 310 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 352
K + P F+ EI IL + RH N++ + +V+ +V
Sbjct: 58 KKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY-IV 108
Query: 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 412
+ + E L + LS ++ L ++HS +++H DLKP+N+L
Sbjct: 109 QDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLL 160
Query: 413 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDV 471
L+ K+ DFG++R + + T+ T Y PE L S T D+
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFL-----TEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 472 YSFGIILLRLLTGRP 486
+S G IL +L+ RP
Sbjct: 216 WSVGCILAEMLSNRP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS----EFQQEIDILSKIRHPNLVTL 341
G+G +G++ G + M VAIK + +Q P E Q + L+ + HPN+V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQ-IMQDLAVLHHPNIVQL 84
Query: 342 --------VGACPEVW-TLVYEYLPNGSLED--RL--SCKDNSPPLSWQTRIRIATELCS 388
+++ +V EY+P + R + +L
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLD-ANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
+ LH ++ H D+KP N+L++ A+ KL DFG ++ LS +E N C
Sbjct: 141 SIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC--- 193
Query: 448 PKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ Y PE + T D++S G I ++ G P
Sbjct: 194 ---SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 60/320 (18%), Positives = 108/320 (33%), Gaps = 78/320 (24%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 290
++ + ++ + RK + ++ MP+ SD+ + ++ IG
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RYEIRHLIG 62
Query: 291 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLV 339
G YG + + + VAIK + F+ EI IL+++ H ++V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 340 TLVGACP--------EVWTLVYEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRI 382
++ E++ +V E L + L +
Sbjct: 116 KVLDIVIPKDVEKFDELY-VVLEIADSDFKKLFRTPVYLTELHIKT-----LLYNL---- 165
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
L + ++HS I+H DLKPAN L++ + K+ DFG++R + E ++ +
Sbjct: 166 ---LVG-VKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 443 CCRTDPKGTFAYMD-------------------PE-FLASGELTPKSDVYSFGIILLRLL 482
R D + PE L T DV+S G I LL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 483 TGRPALGITKEVQYALDTGK 502
+ L G
Sbjct: 279 NMIKENVAYHADRGPLFPGS 298
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 60/243 (24%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTL---- 341
+G G +G + + + A+K + P +E+DI+ + H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 342 -----VGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATE----------- 385
P + L + K S + + E
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 386 --------------------LCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDF 424
L + F+HS I H D+KP N+L+++ KL DF
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 483
G ++ L +E + C + Y PE L + E TP D++S G + L+
Sbjct: 187 GSAKKLIPSE---PSVAYIC------SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 484 GRP 486
G+P
Sbjct: 238 GKP 240
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 61/281 (21%)
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQF-FSDFSFSEIEGATHNFDPS 286
+Y E + EE +++ S DF
Sbjct: 10 HDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDL------------- 56
Query: 287 LK-IGEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSKI-RHPN 337
L+ IG G Y + L+R + A++++ + + Q E + + HP
Sbjct: 57 LRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 338 LVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATELC 387
LV L +C V EY+ G L + +L + R + E+
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAEIS 163
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCR 445
L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC-- 214
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 215 ----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 22/236 (9%)
Query: 259 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 316
S S QF+S + IG G G + VAIK L
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRP 98
Query: 317 LQGPSEFQQ---EIDILSKIRHPNLVTL---VGACPEVWTLVYEYLPNGSLEDRLSCKDN 370
Q + ++ E+ ++ + H N+++L + YL ++ L
Sbjct: 99 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 371 SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430
+ + LC + LHS I+H DLKP+NI++ ++ K+ DFG++R
Sbjct: 159 MELDHERMSYLLYQMLCG-IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ + T T Y PE + D++S G I+ ++ +
Sbjct: 215 GTSFMM---------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 55/234 (23%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EIDILS 331
F +GEG YG + + VAIK + P F + EI IL
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILK 64
Query: 332 KIRHPNLVTLVGACP--------EVWTLVYEYLPNGSLEDRLSCKDNSPPLS-------- 375
+H N++T+ EV+ ++ E + L +S + LS
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVY-IIQELMQT-DLHRVIS----TQMLSDDHIQYFI 118
Query: 376 WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435
+QT L + + LH +++H DLKP+N+L+++N K+ DFG++R + ++
Sbjct: 119 YQT-------LRA-VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 436 SSNNTTLCCR--TDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
++ T + T Y PE L S + + DV+S G IL L RP
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 78/280 (27%), Positives = 112/280 (40%), Gaps = 69/280 (24%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLK-I 289
+ Q+ M + A A + + +S+ P SDF F LK I
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKP---SDFHF-------------LKVI 46
Query: 290 GEGGYGSIYKGLLRHMQV----AIKMLHPHSLQGPSEF---QQEIDILSK-IRHPNLVTL 341
G+G +G + L RH A+K+L ++ E E ++L K ++HP LV L
Sbjct: 47 GKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 342 VGA--CPEVWTLVYEYLPNGSL-----------EDRLSCKDNSPPLSWQTRIRIATELCS 388
+ + V +Y+ G L E R R A E+ S
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-------------ARFYAA-EIAS 150
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCCRT 446
L +LHS +IV+ DLKP NILLD+ L+DFG L + I N+T T C
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFG----LCKENIEHNSTTSTFC--- 200
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L D + G +L +L G P
Sbjct: 201 ---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-14
Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 9/76 (11%)
Query: 575 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-----PMT---NLPLAHKNLV 625
FTCPI +E M+ P G TYE +A+ ++S + P + + +L+
Sbjct: 8 FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67
Query: 626 PNLALRSAIQEWLQQH 641
+ ALR AI+ ++
Sbjct: 68 QDEALRRAIENHNKKR 83
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 57/217 (26%), Positives = 84/217 (38%), Gaps = 44/217 (20%)
Query: 289 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSK-IRH 335
+G+G +G + AIK L + + E +LS H
Sbjct: 25 LGKGSFGKV-------FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 336 PNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-ATELCSVLIF 392
P L + E V EYL G L + +R A E+ L F
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQF 133
Query: 393 LHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNT--TLCCRTDPK 449
LHS IV+ DLK NILLD + + K++DFG + + + + T C
Sbjct: 134 LHS---KGIVYRDLKLDNILLDKDGHI-KIADFG----MCKENMLGDAKTNTFC------ 179
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L + D +SFG++L +L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 56/223 (25%)
Query: 289 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 335
IG G Y + + V A+K++ + + Q E + + H
Sbjct: 17 IGRGSYAKV-------LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 336 PNLVTLVGAC---PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATE 385
P LV L +C V EY+ G L + +L + R + E
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP----------EEHARFYSAE 118
Query: 386 LCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLC 443
+ L +LH I++ DLK N+LLD+ KL+D+G + + + +T T C
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFC 171
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L + D ++ G+++ ++ GR
Sbjct: 172 ------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)
Query: 289 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 335
+G+G +G + M A+K+L + + E +L+ +
Sbjct: 28 LGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 336 PNLVTLVGA--CPEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 386
P L L + V EY+ G L R + A E+
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------EPHAVFYAAEI 130
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 444
L FL S I++ DLK N++LD+ K++DFG + + I T T C
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFC- 182
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE +A D ++FG++L +L G+
Sbjct: 183 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 59/222 (26%), Positives = 86/222 (38%), Gaps = 54/222 (24%)
Query: 289 IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEF---QQEIDILSKI-RH 335
+G+G +G + M A+K+L + + E ILS H
Sbjct: 31 LGKGSFGKV-------MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 336 PNLVTLVGAC--PEVWTLVYEYLPNGSL------EDRLSCKDNSPPLSWQTRIRI-ATEL 386
P L L P+ V E++ G L R + R R A E+
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------EARARFYAAEI 133
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TLCC 444
S L+FLH I++ DLK N+LLD KL+DFG + + I + T T C
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGICNGVTTATFC- 185
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
GT Y+ PE L P D ++ G++L +L G
Sbjct: 186 -----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 73/290 (25%)
Query: 252 RKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM--QVAI 309
+ + Q + + N+ IG G YG +Y ++ VAI
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPD------NYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56
Query: 310 KMLHPHSLQGPSEFQQ---------EIDILSKIRHPNLVTLVGACP--------EVWTLV 352
K ++ F+ EI IL++++ ++ L E++ +V
Sbjct: 57 KKVN-------RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY-IV 108
Query: 353 YEYLP---------NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
E L + ++ + + L F+H I+H
Sbjct: 109 LEIADSDLKKLFKTPIFLTE-----EHIKTILYNL-------LLG-ENFIHES---GIIH 152
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD------- 456
DLKPAN LL+ + K+ DFG++R ++ + ++ L +P +
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 457 -------PE-FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYAL 498
PE L T D++S G I LL + ++ L
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 9e-14
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 56/284 (19%)
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATH 281
E + +++ + ++ + E + K ++ + +DF+F
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF-------- 345
Query: 282 NFDPSLK-IGEGGYGSIYKGLLRHMQV---------AIKMLHPHSLQGPSEFQQ---EID 328
L +G+G +G + M A+K+L + + + E
Sbjct: 346 -----LMVLGKGSFGKV-------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 329 ILSKI-RHPNLVTLVGA--CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRI-AT 384
+L+ + P L L + V EY+ G L + + A
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAA 449
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNT--TL 442
E+ L FL S I++ DLK N++LD+ K++DFG + + I T T
Sbjct: 450 EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTF 502
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
C GT Y+ PE +A D ++FG++L +L G+
Sbjct: 503 C------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 280 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---EIDILSKIR 334
+ +G GG G ++ + +VAIK + L P + EI I+ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 335 HPNLVTLVGA-CPEVWTLVYEYLPNGSLED-----RLSCKD-----NSPPLSWQTRIRIA 383
H N+V + P L + L D PL +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTL 442
+L L ++HS +++H DLKPAN+ ++ + V K+ DFG++R + + S+ L
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--SHKGHL 181
Query: 443 CCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
++ T Y P L+ T D+++ G I +LTG+
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 52/247 (21%), Positives = 96/247 (38%), Gaps = 43/247 (17%)
Query: 258 ASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPH 315
+ S F+ + +G G YGS+ + + +VAIK L
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SR 59
Query: 316 SLQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLP---NGS 360
Q ++ E+ +L ++H N++ L + + + LV ++
Sbjct: 60 PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY-LVMPFMQTDLQKI 118
Query: 361 LEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK 420
+ + S ++ L +Q L L ++HS +VH DLKP N+ ++ + K
Sbjct: 119 MGLKFS-EEKIQYLVYQM-------LKG-LKYIHSA---GVVHRDLKPGNLAVNEDCELK 166
Query: 421 LSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILL 479
+ DFG++R + + T T Y PE L+ D++S G I+
Sbjct: 167 ILDFGLAR--------HADAEM---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 480 RLLTGRP 486
+LTG+
Sbjct: 216 EMLTGKT 222
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 62/221 (28%), Positives = 88/221 (39%), Gaps = 51/221 (23%)
Query: 289 IGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRH------PN 337
IG+G +G + K H VA+KM+ +Q EI IL +R N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 338 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
++ ++ C + +E L + +L + L K+ S + A + L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVS--KLSDFGISRFLSQN---EISSNNTTLCCR 445
LH + I+H DLKP NILL S K+ DFG S + Q I S R
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS-------R 263
Query: 446 TDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
F Y PE + D++S G IL LLTG P
Sbjct: 264 ------F-YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)
Query: 265 PQFFSDFSFSEIEGA----THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQ 318
P S F E+ + +G G YG++ + +VAIK L Q
Sbjct: 5 PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQ 63
Query: 319 GPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDRLS 366
++ E+ +L +RH N++ L + + + LV ++ L
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-----GTDLG 117
Query: 367 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426
L + ++ L ++H+ I+H DLKP N+ ++ + K+ DFG+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGR 485
+R T T Y PE L T D++S G I+ ++TG+
Sbjct: 175 ARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 486 P 486
Sbjct: 224 T 224
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 36/243 (14%)
Query: 259 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 316
S P F+ I + +G G YGS+ ++VA+K L
Sbjct: 7 HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRP 65
Query: 317 LQGPSEFQQ---EIDILSKIRHPNLVTL---------VGACPEVWTLVYEYLPNGSLEDR 364
Q ++ E+ +L ++H N++ L + +V+ LV + L +
Sbjct: 66 FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-LVTHLMGA-DLNNI 123
Query: 365 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424
+ C+ L+ + ++ L ++HS I+H DLKP+N+ ++ + K+ DF
Sbjct: 124 VKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176
Query: 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLT 483
G++R + T T Y PE L D++S G I+ LLT
Sbjct: 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 484 GRP 486
GR
Sbjct: 226 GRT 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 63/246 (25%)
Query: 280 THNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQ---------EID 328
++ K+G+G YG ++K + R VA+K + FQ EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 329 ILSKIR-HPNLVTLVGACP-----EVWTLVYEYLPNGSLEDRLSCKDNSPPLS------- 375
IL+++ H N+V L+ +V+ LV++Y+ E L + L
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVY-LVFDYM-----ETDLHAVIRANILEPVHKQYV 114
Query: 376 -WQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434
+Q + + +LHS ++H D+KP+NILL+A K++DFG+SR
Sbjct: 115 VYQL-------IKV-IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 435 ISSNNTTLCCRTDPKGTFAYMD-------------PE-FLASGELTPKSDVYSFGIILLR 480
+NN L + + PE L S + T D++S G IL
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223
Query: 481 LLTGRP 486
+L G+P
Sbjct: 224 ILCGKP 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 41/239 (17%), Positives = 91/239 (38%), Gaps = 71/239 (29%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKML------HPHSLQGPSEFQQEIDILSKIR----- 334
K+G G + +++ ++ + VA+K++ + + EI +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA-------EDEIKLLQRVNDADNT 78
Query: 335 ------HPNLVTLVGA-----------CPEVWTLVYEYLPNGSLEDRLSCKDNSP-PLSW 376
+++ L+ +V+E L +L + ++ PL
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVV-----MVFEVL-GENLLALIKKYEHRGIPLI- 131
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS------KLSDFGISRFL 430
+ +I+ +L L ++H + I+H D+KP N+L++ K++D G + +
Sbjct: 132 YVK-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 431 SQ---NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ N I + Y PE L +D++S ++ L+TG
Sbjct: 189 DEHYTNSIQTR--------------EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 45/220 (20%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP------ 336
IG+G +G + K + VAIK++ + Q E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 337 NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIRIATELCS 388
+V L C LV+E L + +L D L ++ + +S + A ++C+
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYDLL--RNTNFRGVSLNLTRKFAQQMCT 168
Query: 389 VLIFLHSCKPHSIVHGDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRT 446
L+FL + + I+H DLKP NILL K+ DFG S L Q + R
Sbjct: 169 ALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR- 222
Query: 447 DPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
F Y PE L D++S G IL+ + TG P
Sbjct: 223 -----F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 32/268 (11%)
Query: 253 KSRKEASSSSHMPQFFSDFSF----------SEIEGA-THNFDPSLKIGE-GGYGSIYKG 300
K KE ++ S S+ + GA T P + I E +G++
Sbjct: 58 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117
Query: 301 LLRHMQVAIK-MLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWTLVYEYLPNG 359
L + + ++ I + K R ++ + + V E +
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS--GFVEEKSLSD 175
Query: 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419
E+ L+ + I + ++ + FL S K +H DL NILL V
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVV 232
Query: 420 KLSDFGISRFLSQNE--ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGII 477
K+ DFG++R + ++ + + L + +M PE + T +SDV+SFG++
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLK--------WMAPETIFDRVYTIQSDVWSFGVL 284
Query: 478 LLRLLT-GR---PALGITKEVQYALDTG 501
L + + G P + I +E L G
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 43/195 (22%), Positives = 65/195 (33%), Gaps = 32/195 (16%)
Query: 288 KIGEGGYGSIYKGLLRHM-------QVAIKMLHP-HSLQGPSEFQQEIDILSKI-RHPNL 338
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 339 VTLVGAC---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
V L+GAC ++ E+ G+L L K N R V
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV------ 142
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG---TF 452
+ DLK + ++ S S F + LS E L +
Sbjct: 143 ----GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 453 AY-----MDPEFLAS 462
++ M EFLAS
Sbjct: 199 SFQVAKGM--EFLAS 211
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 27/211 (12%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 342
KIG G +G IY G + +VAIK+ + + E I ++ + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 343 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
GA + +V E L G SLED + S +T + +A ++ S + ++HS +
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 402 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 454
+H D+KP N L+ N V + DFG++ ++ + + + R + GT Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRD----ARTHQHIPYRENKNLTGTARY 181
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
E + + D+ S G +L+ G
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 43/245 (17%), Positives = 90/245 (36%), Gaps = 47/245 (19%)
Query: 288 KIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQGPSEFQ-----QEIDILSKIRH 335
IG+GG+G IY + +K+ + +E + + + + K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 336 PNLVTLVGACPEVWT------------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRI 382
+ +G + ++ + G L+ + N+ S +T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAKRFSRKTVLQL 157
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNT 440
+ + +L ++H H VHGD+K +N+LL+ + L D+G++
Sbjct: 158 SLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY-----RYCPEGV 209
Query: 441 TLCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TK 492
DPK GT + + + + D+ G +++ LTG P K
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269
Query: 493 EVQYA 497
V+ +
Sbjct: 270 YVRDS 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 40/244 (16%), Positives = 78/244 (31%), Gaps = 45/244 (18%)
Query: 288 KIGEGGYGSIYKG----------LLRHMQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHP 336
G +Y+ + + ++K+ L F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 337 NLVTLVGAC--PEVWT----------LVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 383
+ P LV L G SL+ LS ++ +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 441
L L FLH + VHG++ NI +D S+ L+ +G + +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF-----RYCPSGKH 217
Query: 442 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGI---TKE 493
+ + G ++ + + +SD+ S G +L+ L G P T++
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277
Query: 494 VQYA 497
+
Sbjct: 278 IMKQ 281
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 44/228 (19%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
KIG GG+G IY + + A ++ + F E+ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 346 --------PEVW-------------TLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIA 383
P + +V E L G L+ + T +++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQ---NGTFKKSTVLQLG 157
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSK--LSDFGISRFLSQNEISSNNTT 441
+ VL ++H + VHGD+K AN+LL + L+D+G+S N
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY-----RYCPNGNH 209
Query: 442 LCCRTDPK----GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
+ +P+ GT + + L+ +SDV G +LR L G+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 342
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 343 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
G LV + L G SLED L S +T A ++ + + +H S+
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 402 VHGDLKPANILL------DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 452
V+ D+KP N L+ +AN + + DFG+ + + R GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRD----PVTKQHIPYREKKNLSGTA 182
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
YM E + + D+ + G + + L G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
+++ +A + E E R + E++ + ++ K +L+ + E EE A
Sbjct: 912 EEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLE-EEEAA 970
Query: 173 NGKLELERMKKQHDEVMEELQIALD-----------QKSLLESQIAESDQTAKELEQKII 221
KL+LE K D +++++ + ++ LLE ++++ E E+K
Sbjct: 971 RQKLQLE--KVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAK 1028
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKE 257
+ +L ++ EL++ K K +EL K +++
Sbjct: 1029 NLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRK 1064
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 25/148 (16%), Positives = 57/148 (38%), Gaps = 4/148 (2%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKAS----ESLYAEELKRRKEFEE 169
+ + E+ ++ + K K E + + E K + + E
Sbjct: 980 TADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHES 1039
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
++ ++ L++ +K E+ + + + S L QIAE EL+ ++ E LQ
Sbjct: 1040 MISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQA 1099
Query: 230 YKKEQDELQMERDKAVKEAEELRKSRKE 257
++ +++ A+K+ EL +
Sbjct: 1100 ALARLEDETSQKNNALKKIRELESHISD 1127
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 29/154 (18%), Positives = 62/154 (40%), Gaps = 11/154 (7%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
++ ++L + E E + E++ +++ + K EL+ R + E
Sbjct: 996 EDQNNKLTKERKLLE----ERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKE 1051
Query: 169 EA----LANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 224
E L K +LE E + ELQ Q + L++Q+A+ ++ + ++
Sbjct: 1052 EKSRQELEKIKRKLEGESSDLHEQIAELQ---AQIAELKAQLAKKEEELQAALARLEDET 1108
Query: 225 ELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
N K+ EL+ ++ E + +R +A
Sbjct: 1109 SQKNNALKKIRELESHISDLQEDLESEKAARNKA 1142
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 26/144 (18%), Positives = 56/144 (38%)
Query: 116 AQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGK 175
Q E + + E +AE+ + + + E + E R +E EE +
Sbjct: 888 TQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQ 947
Query: 176 LELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 235
E ++M++Q ++ E+L+ + L+ + +D K++E I+ + KE+
Sbjct: 948 AEKKKMQQQMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERK 1007
Query: 236 ELQMERDKAVKEAEELRKSRKEAS 259
L+ E + K +
Sbjct: 1008 LLEERVSDLTTNLAEEEEKAKNLT 1031
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 24/161 (14%), Positives = 63/161 (39%), Gaps = 7/161 (4%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
L ++++ +A + K E E R K E E K +++ E
Sbjct: 1007 KLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLE 1066
Query: 169 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQI-------AESDQTAKELEQKII 221
++ ++ ++ Q E+ +L ++ +++ + + +ELE I
Sbjct: 1067 GESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQKNNALKKIRELESHIS 1126
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSS 262
E L++ K +++ + ++ +E E L+ ++ ++
Sbjct: 1127 DLQEDLESEKAARNKAEKQKRDLSEELEALKTELEDTLDTT 1167
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 18/140 (12%)
Query: 121 EAENSRREAFEEALRRGKAE-KDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELE 179
+ E R+ E+ R+ + E D E I +A + +L + KE E A +LE E
Sbjct: 1049 KKEEKSRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAK-KEEELQAALARLEDE 1107
Query: 180 R------------MKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 227
++ ++ E+L+ ++ E Q + + + L+ ++ E
Sbjct: 1108 TSQKNNALKKIRELESHISDLQEDLESEKAARNKAEKQKRDLSEELEALKTEL----EDT 1163
Query: 228 QNYKKEQDELQMERDKAVKE 247
+ Q EL+ K +
Sbjct: 1164 LDTTATQQELRGSDYKDDDD 1183
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 20/127 (15%), Positives = 51/127 (40%)
Query: 132 EALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEE 191
L+ + E++ + ++ + KE E+ E ++++ E
Sbjct: 848 PLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKLQAETEL 907
Query: 192 LQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEEL 251
A + + L ++ E ++ E+E +I E Q + E+ ++Q + ++ EE
Sbjct: 908 YAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLEEQLEEE 967
Query: 252 RKSRKEA 258
+R++
Sbjct: 968 EAARQKL 974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH----PNLVTL 341
KIG G +G + G L + VAIK+ S + E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 342 VGACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G C + +V E L G SLED D + S +T + IA +L S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS---KN 125
Query: 401 IVHGDLKPANILLDANFVSK-----LSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTF 452
+++ D+KP N L+ + DF ++ ++ + R GT
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE----TKKHIPYREHKSLTGTA 181
Query: 453 AYMDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
YM E + + D+ + G + + L G
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLV--- 342
KIG G +G IY G + + +VAIK+ + + + E I ++ + V
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 343 GACPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
G + LV + L G SLED S LS +T + +A ++ + + F+HS S
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 402 VHGDLKPANILL----DANFVSKLSDFGIS-RFLSQNEISSNNTTLCCRTDPK--GTFAY 454
+H D+KP N L+ AN V + DFG++ ++ + + + R + GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTS----THQHIPYRENKNLTGTARY 179
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGR 485
E + + D+ S G +L+ L G
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 24/149 (16%), Positives = 61/149 (40%), Gaps = 1/149 (0%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR-KEFEEALA 172
L + RR + L++ K E ++E ++ +L+R+ E +
Sbjct: 886 TLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKLHIGLENKIMQLQRKIDEQNKEYK 945
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ ++ ++ + E+L+ +++ + E + + L+++I + L +
Sbjct: 946 SLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQT 1005
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSS 261
E+ ++ DK E E+L KE ++
Sbjct: 1006 EKKTIEEWADKYKHETEQLVSELKEQNTL 1034
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 26/158 (16%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
+ + E E +++ E ++ R+ Y L++ E +
Sbjct: 903 KRELKKLKIEARSVERYKKL--HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYST 960
Query: 174 GKLEL----ERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
+L ER++ EE + A ++ L+ +IA+ + + + + + E
Sbjct: 961 ETEKLRSDVERLRMS----EEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADK 1016
Query: 230 YKKEQDELQMERDKAV----KEAEELRKSRKEASSSSH 263
YK E ++L E + E EEL + + +
Sbjct: 1017 YKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEIT 1054
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 24/147 (16%), Positives = 58/147 (39%), Gaps = 3/147 (2%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIES-IRRAKASESLYAEELKRRKEFEEALA 172
+ +++ ++ R R ++ RR A L +++ R
Sbjct: 863 REHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSVERYKKL 922
Query: 173 NGKLE--LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNY 230
+ LE + +++++ DE +E + L++ + LE + + + +++ + E +N
Sbjct: 923 HIGLENKIMQLQRKIDEQNKEYKSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNA 982
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKE 257
LQ E K KE + + +K
Sbjct: 983 TNRVLSLQEEIAKLRKELHQTQTEKKT 1009
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 29/173 (16%), Positives = 59/173 (34%), Gaps = 14/173 (8%)
Query: 95 LQSSPPSVLDGSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASE 154
+Q + + D A + + R I+ R +
Sbjct: 822 IQKFQRMYVVRKRYQCMRDATIALQALLRGYLVRNKYQMMLREHKSI-IIQKHVRGWLAR 880
Query: 155 SLYAEELKRR----KEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESD 210
Y LK + +A K EL+++K + V ++ LE++I +
Sbjct: 881 VHYHRTLKAIVYLQCCYRRMMA--KRELKKLKIEARSVERYKKL----HIGLENKIMQLQ 934
Query: 211 QTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSH 263
+ E ++ LL+ + E +K + E LR S +EA ++++
Sbjct: 935 RKIDEQNKEY---KSLLEKMNNLEITYSTETEKLRSDVERLRMSEEEAKNATN 984
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 14/145 (9%), Positives = 50/145 (34%), Gaps = 7/145 (4%)
Query: 117 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 176
+ + ++ +R A +++ + Y + +R+ + + +
Sbjct: 857 KYQMMLREHKSIIIQKHVRGWLARVHYHRTLKAIVYLQCCYRRMMAKRELKKLKIEARSV 916
Query: 177 E-LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 235
E +++ + + +LQ +D+ + + LE + + + +
Sbjct: 917 ERYKKLHIGLENKIMQLQRKIDE---QNKEYKSLLEKMNNLEITY---STETEKLRSDVE 970
Query: 236 ELQMERDKAVKEAEELRKSRKEASS 260
L+M ++A + ++E +
Sbjct: 971 RLRMSEEEAKNATNRVLSLQEEIAK 995
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/134 (14%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 117 QAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKL 176
+ E + + E LR + E + + EE+ + ++ K
Sbjct: 955 EITYSTETEKLRSDVERLRMSEEEAKNATNRVLSLQ------EEIAKLRKELHQTQTEKK 1008
Query: 177 ELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQD 235
+E ++ E+L L Q +LL+++ E ++ + ++I +E + +E
Sbjct: 1009 TIEEWADKYKHETEQLVSELKEQNTLLKTEKEELNRRIHDQAKEITETME--KKLVEETK 1066
Query: 236 ELQMERDKAVKEAE 249
+L+++ + +
Sbjct: 1067 QLELDLNDERLRYQ 1080
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 25/145 (17%), Positives = 55/145 (37%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
++LA A+ + E + + A E E A + + + E E ++ +
Sbjct: 104 ERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYE 163
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+L ++ + E +++ + + LE +I K LE + + Y++
Sbjct: 164 EVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEE 223
Query: 233 EQDELQMERDKAVKEAEELRKSRKE 257
E L + +A AE +S +
Sbjct: 224 EIKVLSDKLKEAETRAEFAERSVTK 248
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 32/143 (22%), Positives = 66/143 (46%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
+ QL +A AE++ R+ E A + E D + RA+ SE AE + K
Sbjct: 142 EIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVT 201
Query: 169 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 228
L + + + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L
Sbjct: 202 NNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELY 261
Query: 229 NYKKEQDELQMERDKAVKEAEEL 251
K + + E D A+ + +
Sbjct: 262 AQKLKYKAISEELDHALNDMTSI 284
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 22/147 (14%), Positives = 62/147 (42%), Gaps = 2/147 (1%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
A+A +A R + E+ L + + A E + ++ + E+ +
Sbjct: 23 DEAEADKKAAEDRSKQLEDELVSLQKKLKATED--ELDKYSEALKDAQEKLELAEKKATD 80
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ ++ + ++ EEL A ++ + ++ E+++ A E E+ + Q +++
Sbjct: 81 AEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEK 140
Query: 234 QDELQMERDKAVKEAEELRKSRKEASS 260
+ +++ +A AE+ + +E +
Sbjct: 141 MEIQEIQLKEAKHIAEDADRKYEEVAR 167
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 22/146 (15%), Positives = 50/146 (34%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
+ + + E + E A++ E R+ ES +R + E A
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ E++ + + + + ++ E +I KE E + A + +K
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEK 251
Query: 233 EQDELQMERDKAVKEAEELRKSRKEA 258
D+L+ E + + + + A
Sbjct: 252 SIDDLEDELYAQKLKYKAISEELDHA 277
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 22/148 (14%), Positives = 54/148 (36%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
++ + EN+ A E + AE + + + + ++ EAL +
Sbjct: 7 KMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKYSEALKD 66
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ +LE +K+ + ++ + L E ++ + + QK+ A + ++
Sbjct: 67 AQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERG 126
Query: 234 QDELQMERDKAVKEAEELRKSRKEASSS 261
++ K ++ E KEA
Sbjct: 127 MKVIESRAQKDEEKMEIQEIQLKEAKHI 154
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 20/151 (13%), Positives = 55/151 (36%)
Query: 110 NLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEE 169
D+L + ++++ + + AE D RR + E +R +
Sbjct: 52 ATEDELDKYSEALKDAQEKLELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQ 111
Query: 170 ALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQN 229
L + + ++ + Q ++ + E Q+ E+ A++ ++K L
Sbjct: 112 KLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVI 171
Query: 230 YKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+ + + + + + + EL + K ++
Sbjct: 172 IESDLERAEERAELSEGKCAELEEEIKTVTN 202
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 2/146 (1%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
++ ++ A+ + + E E L+ K + + R+ + + EE
Sbjct: 128 KVIESRAQKDEEKMEIQEIQLKEAKHIAEDAD--RKYEEVARKLVIIESDLERAEERAEL 185
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ + ++++ V L+ Q + + ++ K L K+ A + ++
Sbjct: 186 SEGKCAELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERS 245
Query: 234 QDELQMERDKAVKEAEELRKSRKEAS 259
+L+ D E + K S
Sbjct: 246 VTKLEKSIDDLEDELYAQKLKYKAIS 271
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 22/148 (14%), Positives = 63/148 (42%), Gaps = 3/148 (2%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
L + + E+ + EAL+ + + + E ++A +E+ A +R + FEE L
Sbjct: 44 VSLQKKLKATEDELDKY-SEALKDAQEKLELAE--KKATDAEADVASLNRRIQLFEEELD 100
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ L ++ +E + + ++ES+ + ++ + E ++ A + ++ +
Sbjct: 101 RAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDADR 160
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASS 260
+ +E+ + + E + + +
Sbjct: 161 KYEEVARKLVIIESDLERAEERAELSEG 188
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 17/83 (20%), Positives = 41/83 (49%)
Query: 178 LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDEL 237
++ +KK+ + + + ALD+ E+ ++ +K+LE +++S + L+ + E D+
Sbjct: 1 MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDELDKY 60
Query: 238 QMERDKAVKEAEELRKSRKEASS 260
A ++ E K +A +
Sbjct: 61 SEALKDAQEKLELAEKKATDAEA 83
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 22/159 (13%), Positives = 60/159 (37%), Gaps = 7/159 (4%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
+ + A A+ + R +A++ ++++ + +E E + K E
Sbjct: 72 ELAEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIE 131
Query: 169 EALANGKLELERMKKQHDEV---MEELQIALD----QKSLLESQIAESDQTAKELEQKII 221
+ ++E + Q E E+ + + ++ES + +++ A+ E K
Sbjct: 132 SRAQKDEEKMEIQEIQLKEAKHIAEDADRKYEEVARKLVIIESDLERAEERAELSEGKCA 191
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
E ++ L+ + +K ++ ++ + K S
Sbjct: 192 ELEEEIKTVTNNLKSLEAQAEKYSQKEDKYEEEIKVLSD 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 55/390 (14%), Positives = 118/390 (30%), Gaps = 127/390 (32%)
Query: 7 VQDLFHRVRSMNFDRNVGNVMTSQD-SIGGLSSPASRSDAEVSSDECTTGRSTSQGSLSS 65
VQ+ + N + ++T++ + S A+ + +S D + + + S
Sbjct: 253 VQNAKA-WNAFNLSCKI--LLTTRFKQVTDFLSAATTT--HISLDHHSMTLTPDE-VKSL 306
Query: 66 CSSRGVIDVAMIPLIRTEGVSTLPPSKEDLQSSPPSVLDGSVDDNLYDQLAQAMAEAENS 125
+D LP E L ++P ++
Sbjct: 307 LLK--YLDCR---------PQDLPR--EVLTTNP---------------RRLSI------ 332
Query: 126 RREAFEEALRRGKA--------EKDAIESIRRAKAS-ESLYAEELKRRKEFEEALA---- 172
E++R G A D + +I ++S L E ++ F+ L+
Sbjct: 333 ----IAESIRDGLATWDNWKHVNCDKLTTII--ESSLNVLEPAEYRKM--FDR-LSVFPP 383
Query: 173 NGKLE---LERM--KKQHDEVMEELQIALDQKSLLESQIAES---------DQTAK---- 214
+ + L + +VM + L + SL+E Q ES + K
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVN-KLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 215 -ELEQKIISAVELLQNYKKEQDELQMERD-----------KAVKEAEELRKSRKEASSSS 262
L + I+ + + + + D + D K ++ E + +
Sbjct: 443 YALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHPERM----------T 491
Query: 263 HMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSE 322
F DF F +E KI G + + +K P+ +
Sbjct: 492 LFRMVFLDFRF--LEQ---------KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK 540
Query: 323 FQQEIDILSK---------IRHP--NLVTL 341
+++ ++ + I +L+ +
Sbjct: 541 YERLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 3e-08
Identities = 74/556 (13%), Positives = 149/556 (26%), Gaps = 162/556 (29%)
Query: 128 EAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDE 187
FE+A KD + + + E + + + K+ + + +E
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEI--DHIIMSKDAVSGT---LRLFWTLLSKQEE 77
Query: 188 VMEELQIALDQK--SLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAV 245
++++ + + L S I + + + I + L N + + + R +
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 246 KEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM 305
+LR++ E + ++ G G G K +
Sbjct: 138 L---KLRQALLELRPAKNV--------------LID--------GVLGSG---KTWV--- 166
Query: 306 QVAIKMLHPHSLQGPSEFQQEIDI----LSKIRHPNLVTLVGACPEVWTLVYEYLPNGSL 361
A+ + + +Q +F+ I L P V + + L+Y+ PN +
Sbjct: 167 --ALDVCLSYKVQCKMDFK----IFWLNLKNCNSPETVLEM-----LQKLLYQIDPNWTS 215
Query: 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS-IVHGDLKPANILLDANFVSK 420
S S Q +R + + +V +++ A +A F
Sbjct: 216 RSDHSSNIKLRIHSIQAELRR--------LLKSKPYENCLLVLLNVQNAKA-WNA-F--- 262
Query: 421 LSDFG-----ISRFLS-QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSF 474
+ +RF + +S+ TT T E L K
Sbjct: 263 --NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVK---SLLLK----YL 311
Query: 475 GIILLRL----LTGRP-ALG-ITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMR 528
L LT P L I + ++ L T N W V ++L +
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLAT--WDN--------WKHVNCDKLTTIIES 361
Query: 529 CCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPH 588
VLEP +E R + +F H
Sbjct: 362 SLN---------------VLEP--------------AEYR---KMFDRLSVFPP---SAH 386
Query: 589 VAA--------DGFTYEAE----------ALKGWLDSG----H-----ETSPMTNLPLAH 621
+ D + ++ + N H
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 622 KNLVPNLALRSAIQEW 637
+++V + +
Sbjct: 447 RSIVDHYNIPKTFDSD 462
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 57/246 (23%), Positives = 90/246 (36%), Gaps = 77/246 (31%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKML---HPHSLQGPSEFQQEIDILSKIRH-----PN 337
K+G+G +G + + A+K++ ++ + E DIL KI++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 338 LVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATELCS 388
+V G C L++E L SL + + N+ + I+ E+
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYEII--TRNNYNGFHIE-DIKLYCIEILK 148
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------------KLSD 423
L +L + H DLKP NILLD + KL D
Sbjct: 149 ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 424 FGISRFLSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLR 480
FG + F S I++ R Y PE + + SD++SFG +L
Sbjct: 206 FGCATFKSDYHGSIINT-------RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 481 LLTGRP 486
L TG
Sbjct: 252 LYTGSL 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 51/271 (18%), Positives = 86/271 (31%), Gaps = 95/271 (35%)
Query: 288 KIGEGGYGSIY--KGLLRHMQVAIKMLHPHSLQGPSEF-QQEIDILSKIR-----HPN-- 337
K+G G + +++ + VA+K++ S + +E EI +L +R PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 338 -LVTLVGA-----------CPEVWTLVYEYLPNG-SLEDRLSCKDNSPPLSWQTRIRIAT 384
+V L+ C +V+E L G L K N L +I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQ 153
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILL------------------------------- 413
++ L +LH+ I+H D+KP NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 414 ------------------DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
K++D G + ++ + T+ T Y
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----------HFTEDIQTRQYR 260
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
E L +D++S + L TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 57/240 (23%), Positives = 89/240 (37%), Gaps = 69/240 (28%)
Query: 288 KIGEGGYGSIYKGLLRHMQ---VAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 336
+GEG +G + + + VA+K++ + EI +L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNST 76
Query: 337 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNS-PPLSWQTRIR-IATEL 386
V ++ C +V+E L S D + K+N P IR +A ++
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYDFI--KENGFLPFRLD-HIRKMAYQI 127
Query: 387 CSVLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGIS 427
C + FLHS K + H DLKP NIL + + K+ DFG +
Sbjct: 128 CKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPE-FLASGELTPKSDVYSFGIILLRLLTGRP 486
+ ++ T + R Y PE LA G P DV+S G IL+ G
Sbjct: 185 TYDDEHHS----TLVSTR------H-YRAPEVILALGWSQP-CDVWSIGCILIEYYLGFT 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 50/240 (20%), Positives = 84/240 (35%), Gaps = 69/240 (28%)
Query: 288 KIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQGPSEFQQ---EIDILSKIRHP----- 336
+GEG +G + + L QVA+K++ + EI++L KI+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 337 -NLVTLVGA-------CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCS 388
V + C + +E L + + ++N P +A +LC
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 389 VLIFLHSCKPHSIVHGDLKPANILLDANFVS-------------------KLSDFGISRF 429
L FLH + + H DLKP NIL + +++DFG + F
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 430 LSQNE---ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
++ +++ R Y PE + DV+S G IL G
Sbjct: 192 DHEHHTTIVAT-------R------H-YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 6e-07
Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 4/77 (5%)
Query: 184 QHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS-AVELLQNYKKEQDELQMERD 242
Q D + +E + + ++ E D +K +EQ+ A + L+ + + Q E Q+E++
Sbjct: 76 QADRLTQEPESIRKWREEQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSE-QVEKN 134
Query: 243 KAV--KEAEELRKSRKE 257
K + +
Sbjct: 135 KINNRIADKAFYQQPDA 151
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 33/110 (30%)
Query: 114 QLAQAMAEAENSR--REAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEAL 171
Q + E E+ R RE + L E DA + +E + E+A
Sbjct: 76 QADRLTQEPESIRKWREEQRKRL----QELDAASKVME---------QEWR-----EKA- 116
Query: 172 ANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 221
K +LE ++ E +E K+ + ++IA+ ++ + II
Sbjct: 117 ---KKDLEEWNQRQSEQVE--------KNKINNRIAD-KAFYQQPDADII 154
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-07
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 574 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 626
+ C I +V + P ++ +E L+ ++ P+TN PL+ + +V
Sbjct: 3 HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 26/140 (18%), Positives = 54/140 (38%), Gaps = 8/140 (5%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
Q +EAE +R+E E +A A+ES AKA AE R E E ++
Sbjct: 691 QKILDQSEAEKARKELLEL-----EAMSMAVESTGNAKAEAESRAEA--ARIEGEGSVLQ 743
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQT-AKELEQKIISAVELLQNYKK 232
KL+ + + + + +E ++ + + + E + + A++L + +
Sbjct: 744 AKLKAQALAIETEAELERVKKVREMELIYARAQLELEVSKAQQLANVEAKKFKEMTEALG 803
Query: 233 EQDELQMERDKAVKEAEELR 252
+ + + L+
Sbjct: 804 PGTIRDLAVAGPEMQVKLLQ 823
|
| >1w1w_A Structural maintenance of chromosome 1; cohesin, chromosome segregation, cell adhesion, kleisin, MIT cell cycle; HET: ATG; 2.90A {Saccharomyces cerevisiae} SCOP: c.37.1.12 Length = 430 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/144 (12%), Positives = 50/144 (34%), Gaps = 9/144 (6%)
Query: 123 ENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANG---KLELE 179
+ + + L A + E + A+ E ++ K E E
Sbjct: 124 KTVSYKDYSIFLENENILIKAKNFLVFQGDVEQIAAQSPVELSRMFEEVSGSIQYKKEYE 183
Query: 180 RMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVEL------LQNYKKE 233
+K++ +++ + ++ + + ++ E+ + + E
Sbjct: 184 ELKEKIEKLSKSATESIKNRRRIHGELKTYKSPGLEVLFQGPRGSRYDEAEGRFEVINNE 243
Query: 234 QDELQMERDKAVKEAEELRKSRKE 257
++L+ E K + + +++K RKE
Sbjct: 244 TEQLKAEEKKILNQFLKIKKKRKE 267
|
| >2efr_A General control protein GCN4 and tropomyosin 1 Al; destabilizing cluster, hydrophobic core, contractIle protein; 1.80A {Saccharomyces cerevisiae} PDB: 2efs_A 2d3e_A Length = 155 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 26/145 (17%), Positives = 60/145 (41%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
++ Q + E + + + +K + RA+ SE AE + K L +
Sbjct: 1 RMKQLEDKVEELLSKNYHLENEVARLKKLLERAEERAELSEGKSAELEEELKTVTNNLKS 60
Query: 174 GKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKE 233
+ + E+ ++ D+ EE+++ D+ E++ ++++ +LE+ I + L K +
Sbjct: 61 LEAQAEKYSQKEDKYEEEIKVLSDKLKEAETRAEFAERSVTKLEKSIDDLEDELYAQKLK 120
Query: 234 QDELQMERDKAVKEAEELRKSRKEA 258
+ E + + EEL
Sbjct: 121 YKAISEEMKQLEDKVEELLSKNYHL 145
|
| >1cii_A Colicin IA; bacteriocin, ION channel formation, transmembrane protein; 3.00A {Escherichia coli} SCOP: f.1.1.1 h.4.3.1 Length = 602 | Back alignment and structure |
|---|
Score = 45.1 bits (105), Expect = 6e-05
Identities = 22/151 (14%), Positives = 48/151 (31%), Gaps = 1/151 (0%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKR-RKEF 167
+ L+ E EN R EA + A + +++ +A + A+ ++ +
Sbjct: 56 TAYKNTLSAQQKENENKRTEAGKRLSAAIAAREKDENTLKTLRAGNADAADITRQEFRLL 115
Query: 168 EEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELL 227
+ L E + E ++ L E+ ++ E++ A
Sbjct: 116 QAELREYGFRTEIAGYDALRLHTESRMLFADADSLRISPREARSLIEQAEKRQKDAQNAD 175
Query: 228 QNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
+ E + + EL K+ A
Sbjct: 176 KKAADMLAEYERRKGILDTRLSELEKNGGAA 206
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 8e-05
Identities = 8/71 (11%), Positives = 27/71 (38%), Gaps = 4/71 (5%)
Query: 575 FTCPIFQEVMQDPHVAAD-GFTYEAEALKGWLDSGHETS-PMT--NLPLAHKNLVPNLAL 630
TCPI + + P ++ ++ + ++ +L P + ++ ++ V + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 631 RSAIQEWLQQH 641
+ +
Sbjct: 242 ELRCKIAKMKE 252
|
| >1f5n_A Interferon-induced guanylate-binding protein 1; GBP, GTP hydrolysis, GDP, GMP, dynamin related, large GTPase family. GMPPNP, GPPNHP.; HET: GNP; 1.70A {Homo sapiens} SCOP: a.114.1.1 c.37.1.8 PDB: 1dg3_A* 2b8w_A* 2b92_A* 2bc9_A* 2d4h_A* Length = 592 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 1e-04
Identities = 21/164 (12%), Positives = 60/164 (36%), Gaps = 13/164 (7%)
Query: 109 DNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
Y Q + + + + +EE + +AE+ ++ ++ + + E E
Sbjct: 430 PGGYRLFVQKLQDLKK---KYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKE 486
Query: 169 EALANGKLELERMKKQHDEVMEELQ-----IALDQKSLLESQIAESDQTAKELEQKIISA 223
+ + +++ E + + E + + ++S E +++ + Q +
Sbjct: 487 KEIEVERVKAESAQASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQ 546
Query: 224 VELLQNYKKEQDEL-----QMERDKAVKEAEELRKSRKEASSSS 262
L +EQ++L Q E E ++L+ + + +
Sbjct: 547 ERTLALKLQEQEQLLKEGFQKESRIMKNEIQDLQTKMRRRKACT 590
|
| >2v71_A Nuclear distribution protein NUDE-like 1; developmental protein, nuclear protein, neurogenesis, cytosk LIS1 binding, differentiation; 2.24A {Rattus norvegicus} Length = 189 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 24/155 (15%), Positives = 62/155 (40%), Gaps = 7/155 (4%)
Query: 112 YDQLAQAMAEAENSRREAFEEAL-----RRGKAEKDAIESIRRAKA-SESLYAEELKRRK 165
+ + + E + RE E L + + +D +R K E+L + +
Sbjct: 26 FQEARDELVEFQEGSRE-LEAELEAQLVQAEQRNRDLQADNQRLKYEVEALKEKLEHQYA 84
Query: 166 EFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVE 225
+ + ++ + +L + + +++ + ++ LE + + ++ EQ++ A+E
Sbjct: 85 QSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIMSLEDFEQRLNQAIE 144
Query: 226 LLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
+ E DE + + +E R R+E +
Sbjct: 145 RNAFLESELDEKESLLVSVQRLKDEARDLRQELAV 179
|
| >3haj_A Human pacsin2 F-BAR; pacsin,syndapin,FAP52,F-BAR, alternative splicing, coiled coil, cytoplasmic vesicle, endocytosis, phosphoprotein, polymorphism; 2.78A {Homo sapiens} Length = 486 | Back alignment and structure |
|---|
Score = 44.0 bits (102), Expect = 1e-04
Identities = 28/166 (16%), Positives = 51/166 (30%), Gaps = 8/166 (4%)
Query: 108 DDNLYDQLAQAMAEAENSRREAFEEALR-RGKAEKDAIESIRRAKASESLYAEELKRRKE 166
+ Y + + + + + L R + EK + + E+ +
Sbjct: 20 EVGNYKRTVKRIDDGHRLCSD-LMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGT 78
Query: 167 FEEALANGKLELERMKKQHDEVMEELQ------IALDQKSLLESQIAESDQTAKELEQKI 220
E+A E ER+ + H EV L I QK Q+ + KE E
Sbjct: 79 VEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGF 138
Query: 221 ISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQ 266
A + KE + + A KE + + + +
Sbjct: 139 RKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNP 184
|
| >2xs1_A Programmed cell death 6-interacting protein; protein transport-viral protein complex, cell cycle; 2.30A {Homo sapiens} PDB: 2xs8_A 2oev_A 2r05_A 2r02_A 2r03_A 2oex_A 2ojq_A Length = 704 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 28/157 (17%), Positives = 55/157 (35%), Gaps = 12/157 (7%)
Query: 113 DQLAQAMAEAENSRREAFE---------EALRRGKAE-KDAIESIRRAKASESLYAEELK 162
+ +A + + E L + + E AI S AK + +E +
Sbjct: 499 TNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQG--SEVVN 556
Query: 163 RRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIIS 222
K L K E E ++ V ++ + I E + EL++
Sbjct: 557 VLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGG 616
Query: 223 AVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEAS 259
+Q K+Q+ L + +E ++++S EA+
Sbjct: 617 LTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEAN 653
|
| >3qwe_A GMIP, GEM-interacting protein; structural genomics consortium, SGC, protein binding; 2.40A {Homo sapiens} Length = 279 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 3e-04
Identities = 27/144 (18%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 111 LYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEA 170
Y LA E E R+E E+ ++ K +A++++RRA+ +E+L+ R +
Sbjct: 99 YYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQGSPE 158
Query: 171 LANGKLE------LERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAV 224
+ + ER ++ +E + Q A ++ + E++ ++LE V
Sbjct: 159 DSAPQASPGPSKQQERRRRSREEAQAKAQEAEAL---YQACVREANARQQDLEIAKQRIV 215
Query: 225 ELLQNYKKEQDELQMERDKAVKEA 248
++ +L + D+ ++
Sbjct: 216 SHVR-------KLVFQGDEVLRRV 232
|
| >3na7_A HP0958; flagellar biogenesis, flagellum export, C4 Zn-ribbon, coiled post-transcriptional, gene regulation, chaperone; HET: EPE; 2.20A {Helicobacter pylori} Length = 256 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 15/97 (15%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 162 KRRKEFEEALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKII 221
+E + L + E K + EE Q S E + +++ +++K+
Sbjct: 25 PLIREKRKDLDKALNDKEAKNKAILNLEEEKLALKLQVSKNEQTLQDTNAKIASIQKKMS 84
Query: 222 SAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEA 258
++E L +E D A + + + + +
Sbjct: 85 EIKS-----ERELRSLNIEEDIAKERSNQANREIENL 116
|
| >3auy_A DNA double-strand break repair RAD50 ATPase; DNA repair, ABC transporter ATPase domain-like; HET: DNA ADP; 2.70A {Methanocaldococcus jannaschii} PDB: 3aux_A* 3av0_B* Length = 371 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 21/143 (14%), Positives = 48/143 (33%), Gaps = 12/143 (8%)
Query: 119 MAEAENSRREAFEEAL----------RRGKAEKDAIESIRRAKASESLYAEELKRRKEFE 168
++ + + E + L + G+ K+ + + R + + E LK R +
Sbjct: 141 LSLKPSEKLETVAKLLGIDEFEKCYQKMGEIVKEYEKRLERIEGELNYKEESLKARLKEM 200
Query: 169 EALANGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQ 228
L K +L + + D+V Q L E + + E + ++
Sbjct: 201 SNLEKEKEKLTKFVEYLDKVRRIFGRNGFQAYLREKYVPLIQKYLNEAFSEFDLPYSFVE 260
Query: 229 NYKKEQDELQMERDKAVKEAEEL 251
+ E+++ V + L
Sbjct: 261 --LTKDFEVRVHAPNGVLTIDNL 281
|
| >2fxo_A Myosin heavy chain, cardiac muscle beta isoform; coiled coil (dimeric, parallel), familial hypertrophic cardiomyopathy, FHC-associated mutant E924K; 2.50A {Homo sapiens} SCOP: h.1.26.1 PDB: 2fxm_A Length = 129 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 5e-04
Identities = 22/121 (18%), Positives = 52/121 (42%), Gaps = 7/121 (5%)
Query: 134 LRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALANGKLELERMKKQHDEVMEELQ 193
L+ + EK+ + + RRKE EE ++ + ++ +++ ++Q
Sbjct: 6 LKSAEREKEMASMKEEFTRLKEALEKSEARRKELEE-------KMVSLLQEKNDLQLQVQ 58
Query: 194 IALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRK 253
D + E + + + +LE K+ + L++ ++ EL ++ K E EL++
Sbjct: 59 AEQDNLADAEERCDQLIKNKIQLEAKVKEMNKRLEDEEEMNAELTAKKRKLEDECSELKR 118
Query: 254 S 254
Sbjct: 119 D 119
|
| >4f61_I Stathmin-like domain R4; alpha-tubulin, beta-tubulin, GTPase, microtubule, RB3, stath tubulin, cell cycle; HET: GTP GDP; 4.17A {Artificial gene} Length = 240 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 5e-04
Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 5/146 (3%)
Query: 114 QLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALAN 173
+LAQ M + +R F L R + + E +R+ E + E+
Sbjct: 97 KLAQKMESNKENREAHFAAMLERLQEKDKHAEEVRQRAIEE----NNNWIKMAKEKLAQK 152
Query: 174 GKLELERMKKQHDEVMEELQIALD-QKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
+ E K Q E+++ L + ++ +++ I E++ K ++K+ +E + ++
Sbjct: 153 MESNKENRKYQEAELLKHLAEKREHEREVIQRAIEENNNWIKMAKEKLAQKMESNKENRE 212
Query: 233 EQDELQMERDKAVKEAEELRKSRKEA 258
+ER + + E + KE
Sbjct: 213 AHFAAMLERLQEKDKHAEEVRKNKEL 238
|
| >2v0o_A FCHO2, FCH domain only protein 2; lipid-binding protein, EFC domain, vesicle trafficking, membrane curvature, endocytosis, exocytosis, F-BAR domain; 2.30A {Homo sapiens} Length = 276 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 29/229 (12%), Positives = 77/229 (33%), Gaps = 28/229 (12%)
Query: 128 EAFEEALRRGKAEKDAIESIR-----RAKASESLYAEELKR----------RKEFEEALA 172
F+ K + + + + RA E Y+ + + F
Sbjct: 18 SGFDVLYHNMKHGQISTKELADFVRERATI-EEAYSRSMTKLAKSASNYSQLGTFAPVWD 76
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
K E++ H +++ +LQ + + ++ E ++ K+ ++++ +E +Q +
Sbjct: 77 VFKTSTEKLANCHLDLVRKLQELIKE---VQKYGEEQVKSHKKTKEEVAGTLEAVQTIQS 133
Query: 233 EQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSE---------IEGATHNF 283
LQ ++ + E + +KE ++ + + + A +F
Sbjct: 134 ITQALQKSKENYNAKCVEQERLKKEGATQREIEKAAVKSKKATDTYKLYVEKYALAKADF 193
Query: 284 DPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSK 332
+ + + I + L H++ I L + + Q +
Sbjct: 194 EQKMTETAQKFQDIEETHLIHIKEIIGSLSNAIKEIHLQIGQVHEEFIN 242
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 641 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-26 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 5e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-19 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 6e-15 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 6e-12 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 1e-07 | |
| d1f5na1 | 300 | a.114.1.1 (A:284-583) Interferon-induced guanylate | 1e-05 | |
| d1eq1a_ | 166 | a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [Ta | 2e-04 | |
| d2baya1 | 56 | g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 { | 2e-04 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.001 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-66
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 26/276 (9%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+IG G +G++YKG VA+KML+ + Q F+ E+ +L K RH N++ +G
Sbjct: 15 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 346 PEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+V ++ SL L I IA + + +LH SI+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL---A 461
DLK NI L + K+ DFG++ S+ S L G+ +M PE +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS------GSILWMAPEVIRMQD 182
Query: 462 SGELTPKSDVYSFGIILLRLLTGRP---ALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
+ +SDVY+FGI+L L+TG+ + ++ + + G L L + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP--- 239
Query: 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
+ + L C + R RP + +E + S
Sbjct: 240 -KAMKRLMAECLKKKRDERPLF-PQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-58
Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 345
++G G +G ++ G H +VA+K L S P F E +++ +++H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 346 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 405
E ++ EY+ NGSL D L + L+ + +A ++ + F+ + +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 406 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 465
L+ ANIL+ K++DFG++R + NE R K + PE + G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGTF 187
Query: 466 TPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 524
T KSDV+SFGI+L ++T GR + ++NL P E+L
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCPEELYQ 241
Query: 525 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
L C + + RP + VLE +
Sbjct: 242 LMRLCWKERPEDRPTF-DYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-56
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 345
IG+G +G + G R +VA+K + + F E +++++RH NLV L+G
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 346 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
+V EY+ GSL D L + S L ++ + ++C + +L ++ VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL N+L+ + V+K+SDFG+++ S + K + PE L +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKLPVKWTAPEALREKK 176
Query: 465 LTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 523
+ KSDV+SFGI+L + + GR + + D P +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCPPAVY 230
Query: 524 NLAMRCCEMSRKSRPELGKDVWRVLEPMR 552
+ C + RP + LE ++
Sbjct: 231 EVMKNCWHLDAAMRPSF-LQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 5e-56
Identities = 72/304 (23%), Positives = 129/304 (42%), Gaps = 35/304 (11%)
Query: 267 FFSDFSFSEIEGATHNFDPSL---------KIGEGGYGSIYKGLLR-----HMQVAIKML 312
F F+F + A F + IG G +G + G L+ + VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 313 HP-HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKD 369
++ + +F E I+ + HPN++ L G ++ E++ NGSL+ +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF--LRQ 120
Query: 370 NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRF 429
N + + + + + + +L + VH DL NIL+++N V K+SDFG+SRF
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPA 487
L + +++ T K + PE + + T SDV+S+GI++ +++ RP
Sbjct: 178 LEDD---TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 488 LGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRV 547
+T + + + P L L + C + R RP+ +
Sbjct: 235 WDMTNQDV-------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF-GQIVNT 286
Query: 548 LEPM 551
L+ M
Sbjct: 287 LDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-56
Identities = 60/270 (22%), Positives = 119/270 (44%), Gaps = 22/270 (8%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 345
+IG G +G ++ G + VAIK + + +F +E +++ K+ HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 346 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHG 404
LV+E++ +G L D + + +T + + ++C + + ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHR 125
Query: 405 DLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE 464
DL N L+ N V K+SDFG++RF+ ++ +S+ T K + PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-------KFPVKWASPEVFSFSR 178
Query: 465 LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLAN 524
+ KSDV+SFG+++ + + + ++++ P + + +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQ 233
Query: 525 LAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
+ C + + RP + R L + S
Sbjct: 234 IMNHCWKERPEDRPAF-SRLLRQLAEIAES 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-56
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 276 IEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSK 332
+E +F+ ++G G G ++K + + +A K++H ++ +E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 333 IRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
P +V GA ++ E++ GSL+ L + + Q +++ + L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 391 IFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
+L H I+H D+KP+NIL+++ KL DFG+S L + G
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----------ANSFVG 165
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T +YM PE L + +SD++S G+ L+ + GR
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 78/269 (28%), Positives = 119/269 (44%), Gaps = 20/269 (7%)
Query: 288 KIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC- 345
K+G+G +G ++ G +VAIK L P + P F QE ++ K+RH LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 346 PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGD 405
E +V EY+ GSL + L + +A ++ S + ++ + VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 406 LKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL 465
L+ ANIL+ N V K++DFG++R + NE ++ R K + PE G
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRF 191
Query: 466 TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANL 525
T KSDV+SFGI+L L T + LD + P + P E L +L
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECP----ESLHDL 246
Query: 526 AMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
+C + RP + + LE S
Sbjct: 247 MCQCWRKEPEERPTF-EYLQAFLEDYFTS 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-55
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 42/297 (14%)
Query: 288 KIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC-- 345
IG+G +G +++G R +VA+K+ + + EI +RH N++ + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 346 ----PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS-----C 396
LV +Y +GSL D L N ++ + I++A S L LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+I H DLK NIL+ N ++D G++ S+ +T GT YM
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD----SATDTIDIAPNHRVGTKRYMA 180
Query: 457 PEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-------------A 497
PE L E ++D+Y+ G++ + GI ++ Q
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 498 LDTGKLKNLLDP-LAGDWPFVQA-EQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552
+ + L P + W +A +A + C + +R + + L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA-LRIKKTLSQLS 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-54
Identities = 56/262 (21%), Positives = 105/262 (40%), Gaps = 30/262 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343
+IG G + ++YKGL ++VA L L F++E ++L ++HPN+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 344 AC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
+ + LV E + +G+L+ L + + ++ L FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 398 PHSIVHGDLKPANILLDA-NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
P I+H DLK NI + K+ D G++ +S + GT +M
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVI------GTPEFMA 181
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516
PE + + DVY+FG+ +L + T + ++ + + P +
Sbjct: 182 PE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPA--SFDK 236
Query: 517 VQAEQLANLAMRCCEMSRKSRP 538
V ++ + C ++ R
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERY 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 1e-54
Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 24/288 (8%)
Query: 269 SDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQE 326
S ++ + E + K+G G YG +Y+G+ + + VA+K L +++ EF +E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 327 IDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 384
++ +I+HPNLV L+G C + ++ E++ G+L D L + N +S + +AT
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 444
++ S + +L + +H DL N L+ N + K++DFG+SR ++ + +++
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--- 176
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504
K + PE LA + + KSDV++FG++L + T + +D ++
Sbjct: 177 ----KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVY 226
Query: 505 NLLDP-LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
LL+ + P E++ L C + + RP ++ + E M
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF-AEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-54
Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 28/272 (10%)
Query: 287 LKIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
+++G G +GS+ +G+ R + VAIK+L + + E +E I+ ++ +P +V L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 342 VGACPEV-WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C LV E G L L + + ++ + +L +
Sbjct: 75 IGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE---EKN 129
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
VH DL N+LL +K+SDFG+S+ L ++ + + PE +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-----WPLKWYAPECI 184
Query: 461 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 517
+ + +SDV+S+G+ + L+ +P + EV ++ GK + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----RMECPPECP-- 238
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549
+L L C + RP+ V + +
Sbjct: 239 --PELYALMSDCWIYKWEDRPDF-LTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-54
Identities = 61/272 (22%), Positives = 115/272 (42%), Gaps = 23/272 (8%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVT 340
+ ++G G +G + G R VAIKM+ S EF +E ++ + H LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L G C ++ EY+ NG L + L + Q + + ++C + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+H DL N L++ V K+SDFG+SR++ +E +S K + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKFPVRWSPPE 171
Query: 459 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
L + + KSD+++FG+++ + + G+ + +++ L P +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQGLRLYRPHL 225
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549
+E++ + C RP + +L+
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-54
Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 288 KIGEGGYGSIYKGLLRH----MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTL 341
++G G +G++ KG + VA+K+L + E E +++ ++ +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 342 VGAC-PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G C E W LV E G L L + + + I + ++ + +L +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
VH DL N+LL +K+SDFG+S+ L ++ +T K + PE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR-----ADENYYKAQTHGKWPVKWYAPECI 182
Query: 461 ASGELTPKSDVYSFGIILLRLLTG--RPALGIT-KEVQYALDTGKLKNLLDPLAGDWPFV 517
+ + KSDV+SFG+++ + +P G+ EV L+ G+ P
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----RMGCPAGCP-- 236
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
++ +L C ++RP V L
Sbjct: 237 --REMYDLMNLCWTYDVENRPGF-AAVELRLRNY 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 25/268 (9%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 337
+++ IG G YG K + + K L S+ E+++L +++HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 338 LVTLVGAC----PEVWTLVYEYLPNGSLEDRLS-CKDNSPPLSWQTRIRIATELCSVLIF 392
+V +V EY G L ++ L + +R+ T+L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 393 LH--SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKG 450
H S H+++H DLKPAN+ LD KL DFG++R L+ + +S
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVG------ 176
Query: 451 TFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510
T YM PE + KSD++S G +L L P + + + +
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGK 230
Query: 511 AGDWPFVQAEQLANLAMRCCEMSRKSRP 538
P+ +++L + R + RP
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRP 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-53
Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRHPNL 338
++D +GEG YG + + R VA+K++ ++ P ++EI I + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
V G + L EY G L DR+ + R +L + +++LH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
I H D+KP N+LLD K+SDFG++ N +C GT Y+
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLPYVA 173
Query: 457 PEFLASGEL-TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDW 514
PE L E DV+S GI+L +L G + Q D + K L+P W
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W 229
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP---ELGKDVW 545
+ + L + + +R ++ KD W
Sbjct: 230 KKIDSA-PLALLHKILVENPSARITIPDIKKDRW 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-52
Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 26/260 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQ--VAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
++G+G +G +YK + A K++ S + ++ EIDIL+ HPN+V L+ A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
++ E+ G+++ + + PL+ + + L +LH + I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVM--LELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS- 462
DLK NIL + KL+DFG+S ++ + GT +M PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFI------GTPYWMAPEVVMCE 185
Query: 463 ----GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
K+DV+S GI L+ + P ++ L K + W
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS--- 242
Query: 519 AEQLANLAMRCCEMSRKSRP 538
+ +C E + +R
Sbjct: 243 -SNFKDFLKKCLEKNVDARW 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTL 341
IG G +G +Y G L + A+K L+ + G S+F E I+ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 342 VGACPE---VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
+G C +V Y+ +G L + ++ + + + I ++ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
VH DL N +LD F K++DFG++R + E ++ +T K +M E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----DSVHNKTGAKLPVKWMALE 204
Query: 459 FLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
L + + T KSDV+SFG++L L+T G P + + + LL P P
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--EYCP-- 260
Query: 518 QAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
+ L + ++C + RP ++ + + ++
Sbjct: 261 --DPLYEVMLKCWHPKAEMRPSF-SELVSRISAIFST 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-52
Identities = 66/260 (25%), Positives = 107/260 (41%), Gaps = 23/260 (8%)
Query: 288 KIGEGGYGSIYKGLL-----RHMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLV 339
K+G+G +G + +G + + VA+K L P L P +F +E++ + + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 340 TLVGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L G +V E P GSL DR + + T R A ++ + +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
+H DL N+LL + K+ DFG+ R L QN+ FA+ PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-----VPFAWCAPE 184
Query: 459 FLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
L + + SD + FG+ L + T I L + P D P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP--- 241
Query: 519 AEQLANLAMRCCEMSRKSRP 538
+ + N+ ++C + RP
Sbjct: 242 -QDIYNVMVQCWAHKPEDRP 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-52
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 27/290 (9%)
Query: 274 SEIEGATHNFDPSLKIGEGGYGSIYKGLLR------HMQVAIKMLHPHSLQG-PSEFQQE 326
+EI IG G +G +YKG+L+ + VAIK L + +F E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 327 IDILSKIRHPNLVTLVGACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIAT 384
I+ + H N++ L G + ++ EY+ NG+L+ ++ S + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGMLR 117
Query: 385 ELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCC 444
+ + + +L + VH DL NIL+++N V K+SDFG+SR L + ++ T+
Sbjct: 118 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 445 RTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504
+ PE ++ + T SDV+SFGI++ ++T +K
Sbjct: 175 -----IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MK 224
Query: 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554
+ D P + L M+C + R RP+ D+ +L+ + +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF-ADIVSILDKLIRA 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 30/264 (11%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 336
+F+ +G+G +G++Y + +A+K+L L+ + ++E++I S +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
N++ L G L+ EY P G++ L Q TEL + L + H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH 123
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S ++H D+KP N+LL + K++DFG S SS TTLC GT Y
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC------GTLDY 170
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514
+ PE + K D++S G++ L G+P A + + + +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-------EANTYQETYKRISRVEFTF 223
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP 538
P E +L R + + RP
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRP 247
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 5e-51
Identities = 65/261 (24%), Positives = 100/261 (38%), Gaps = 33/261 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 342
+IG G +G++Y VAIK + Q + +E+ L K+RHPN +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 343 GAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
G LV EY + + + + PL + L +LHS H+
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDL---LEVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
++H D+K NILL + KL DFG + ++ GT +M PE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------------NSFVGTPYWMAPEVI 183
Query: 461 AS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
+ G+ K DV+S GI + L +P L + AL +G W
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWS-- 240
Query: 518 QAEQLANLAMRCCEMSRKSRP 538
E N C + + RP
Sbjct: 241 --EYFRNFVDSCLQKIPQDRP 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 7e-51
Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 50/315 (15%)
Query: 270 DFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQG-PS 321
+ +E +N + IGEG +G +++ + VA+KML + +
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 322 EFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------- 365
+FQ+E ++++ +PN+V L+G C + L++EY+ G L + L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 366 -------SCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFV 418
PPLS ++ IA ++ + + +L K VH DL N L+ N V
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 178
Query: 419 SKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIIL 478
K++DFG+SR + + + +M PE + T +SDV+++G++L
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDA------IPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 479 LRLLTGR--PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKS 536
+ + P G+ E + + D P +L NL C
Sbjct: 233 WEIFSYGLQPYYGMAHEEV-------IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 537 RPELGKDVWRVLEPM 551
RP + R+L+ M
Sbjct: 286 RPSF-CSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-49
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 48/284 (16%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 338
+G G +G + +QVA+KML + E+ +++++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK--------------------DNSPPLSW 376
V L+GAC L++EY G L + L K ++ L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 377 QTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436
+ + A ++ + FL S VH DL N+L+ V K+ DFG++R + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEV 494
+M PE L G T KSDV+S+GI+L + + P GI +
Sbjct: 221 VVRGNAR------LPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 495 QYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+ K + + D PF E++ + C + RP
Sbjct: 275 NF------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-49
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 23/255 (9%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
KIG+G G++Y + +VAI+ ++ EI ++ + ++PN+V + +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ +V EYL GSL D ++ + + E L FLHS + ++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
D+K NILL + KL+DFG ++ + R+ GT +M PE +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--------SKRSTMVGTPYWMAPEVVTRK 191
Query: 464 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 523
PK D++S GI+ + ++ G P ++ + P + + A
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAI-FR 247
Query: 524 NLAMRCCEMSRKSRP 538
+ RC +M + R
Sbjct: 248 DFLNRCLDMDVEKRG 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 7e-49
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 288 KIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQGPSE-FQQEIDILSKIRHPNLVTL 341
IGEG +G +++G+ + VAIK + E F QE + + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 342 VGACPEVWT-LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS 400
+G E ++ E G L + L + I A +L + L +L S +
Sbjct: 74 IGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLESKR--- 128
Query: 401 IVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFL 460
VH D+ N+L+ +N KL DFG+SR++ + + K +M PE +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------SKGKLPIKWMAPESI 181
Query: 461 ASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
T SDV+ FG+ + +L +P G+ P+ + P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCP--- 235
Query: 519 AEQLANLAMRCCEMSRKSRP---ELGKDVWRVLEPMRA 553
L +L +C RP EL + +LE +A
Sbjct: 236 -PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 9e-48
Identities = 74/308 (24%), Positives = 125/308 (40%), Gaps = 55/308 (17%)
Query: 268 FSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR----HMQVAIKMLHPH-SLQGPSE 322
++D F + IGEG +G + K ++ M AIK + + S +
Sbjct: 9 WNDIKFQD------------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 323 FQQEIDILSKI-RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRL-------------S 366
F E+++L K+ HPN++ L+GAC L EY P+G+L D L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 367 CKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426
+ LS Q + A ++ + +L +H DL NIL+ N+V+K++DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR- 485
SR +T + +M E L T SDV+S+G++L +++
Sbjct: 174 SRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 486 -PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544
P G+T Y + L + P +++ +L +C RP +
Sbjct: 225 TPYCGMTCAELY-------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF-AQI 276
Query: 545 WRVLEPMR 552
L M
Sbjct: 277 LVSLNRML 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 40/290 (13%)
Query: 288 KIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKI-RHPNL 338
+G G +G + + M VA+KML P + E+ +LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 339 VTLVGAC--PEVWTLVYEYLPNGSLEDRLSCK---------------DNSPPLSWQTRIR 381
V L+GAC ++ EY G L + L K D+ L + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
+ ++ + FL S + +H DL NILL ++K+ DFG++R + N++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI------KNDSN 200
Query: 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTG 501
+ + + +M PE + + T +SDV+S+GI L L + + V
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--- 257
Query: 502 KLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
K + + P ++ ++ C + RP K + +++E
Sbjct: 258 -YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF-KQIVQLIEKQ 305
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 4e-47
Identities = 65/276 (23%), Positives = 118/276 (42%), Gaps = 25/276 (9%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHPNLVTLV 342
+G GG ++ H VA+K+L + PS F++E + + HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 343 GAC------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
+ +V EY+ +L D + + P++ + I + + C L F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+ I+H D+KPANI++ A K+ DFGI+R ++ + S T GT Y+
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-----GTAQYLS 182
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516
PE + +SDVYS G +L +LTG P V A ++ P +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ--HVREDPIPPSARHEG 240
Query: 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552
+ + L + ++ + ++R + ++ L +
Sbjct: 241 L-SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 5e-47
Identities = 54/258 (20%), Positives = 98/258 (37%), Gaps = 25/258 (9%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
++G G +G +++ R A K + ++EI +S +RHP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
++YE++ G L ++++ + N +S + ++C L +H ++ VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 404 GDLKPANILL--DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
DLKP NI+ + KL DFG++ L GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---------QSVKVTTGTAEFAAPEVAE 198
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 520
+ +D++S G++ LL+G G + N+ D E
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS----E 254
Query: 521 QLANLAMRCCEMSRKSRP 538
+ + +R
Sbjct: 255 DGKDFIRKLLLADPNTRM 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 62/313 (19%), Positives = 121/313 (38%), Gaps = 29/313 (9%)
Query: 283 FDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHP-HSLQGPSEFQQEIDILSKIRH 335
F +G G +G++YKGL + VAIK L S + E E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 336 PNLVTLVGACPE-VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
P++ L+G C L+ + +P G L D +++ + Q + ++ + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
+VH DL N+L+ K++DFG+++ L E K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEYHAEGGKVPIKW 179
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGD 513
M E + T +SDV+S+G+ + L+T G + L
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP 233
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASCGGSTSYRLGSEERCEPPP 573
P + + + ++C + SRP+ +++ M + +ER P
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFSKMARDP--QRYLVIQGDERMHLPS 290
Query: 574 YFTCPIFQEVMQD 586
++ +M +
Sbjct: 291 PTDSNFYRALMDE 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 4e-46
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 23/257 (8%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
++G G +G +++ + + K ++ + EI I++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
L+ E+L G L DR+ +S I + C L +H HSIVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 404 GDLKPANILLDANFVS--KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
D+KP NI+ + S K+ DFG++ L+ +EI T T + PE +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---------ATAEFAAPEIVD 201
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521
+ +D+++ G++ LL+G +++ + + + + V E
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--KRCDWEFDEDAFSSVSPE- 258
Query: 522 LANLAMRCCEMSRKSRP 538
+ + + R
Sbjct: 259 AKDFIKNLLQKEPRKRL 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-46
Identities = 70/307 (22%), Positives = 133/307 (43%), Gaps = 39/307 (12%)
Query: 265 PQFFSDFSF---SEIEGATHNFDPSLKIGEGGYGSIYKGLLRHM-------QVAIKMLHP 314
P++FS E E A S ++G+G +G +Y+G+ + + +VAIK ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 315 -HSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNS 371
S++ EF E ++ + ++V L+G + ++ E + G L+ L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 372 -------PPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424
P S I++A E+ + +L++ + VH DL N ++ +F K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG 484
G++R + + + +M PE L G T SDV+SFG++L + T
Sbjct: 178 GMTRDIYETDYYRKGGKGL------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 485 R--PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGK 542
P G++ E L+ +++ D P + L L C + + K RP
Sbjct: 232 AEQPYQGLSNEQV-------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF-L 283
Query: 543 DVWRVLE 549
++ ++
Sbjct: 284 EIISSIK 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-45
Identities = 51/258 (19%), Positives = 101/258 (39%), Gaps = 26/258 (10%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+G G +G +++ + K + ++EI IL+ RH N++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 346 --PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
E +++E++ + +R+ ++ L+ + + ++C L FLHS H+I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 404 GDLKPANILLDA--NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
D++P NI+ + K+ +FG +R L + Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------NFRLLFTAPEYYAPEVHQ 176
Query: 462 SGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAE 520
++ +D++S G ++ LL+G P L T + + +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS----I 232
Query: 521 QLANLAMRCCEMSRKSRP 538
+ + R RKSR
Sbjct: 233 EAMDFVDRLLVKERKSRM 250
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-45
Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 26/264 (9%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPS---EFQQEIDILSKIRHP 336
+F +GEG + ++ + AIK+L + + +E D++S++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
V L E Y NG L + E+ S L +LH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
I+H DLKP NILL+ + +++DFG ++ LS + + GT Y
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQY 176
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514
+ PE L SD+++ G I+ +L+ G P E KL+ D+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-------YDF 229
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP 538
P + +L + + R
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRL 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 3e-44
Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 28/260 (10%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 344
+G G + + + VAIK + +L+G + EI +L KI+HPN+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
L+ + + G L DR+ K + + R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 403 HGDLKPANILL---DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
H DLKP N+L D + +SDFG+S+ + +T C GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC------GTPGYVAPEV 180
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
LA + D +S G+I LL G P + P D
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--- 237
Query: 519 AEQLANLAMRCCEMSRKSRP 538
+ + E + R
Sbjct: 238 -DSAKDFIRHLMEKDPEKRF 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 4e-44
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---------FQQEIDIL 330
N++P +G G + + + + + A+K++ S +E+DIL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 331 SKIR-HPNLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELC 387
K+ HPN++ L LV++ + G L D L+ LS + +I L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120
Query: 388 SVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTD 447
V+ LH +IVH DLKP NILLD + KL+DFG S L E +
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---------KLRE 168
Query: 448 PKGTFAYMDPEFLASGEL------TPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDT 500
GT +Y+ PE + + D++S G+I+ LL G P + + +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
Query: 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
P D+ + + +L R + + R
Sbjct: 229 SGNYQFGSPEWDDYS----DTVKDLVSRFLVVQPQKRY 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 5e-43
Identities = 49/261 (18%), Positives = 92/261 (35%), Gaps = 20/261 (7%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
KIG G +G IY G +VAIK+ + + E I ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
+ +V E L + S S +T + +A ++ S + ++HS + +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 403 HGDLKPANIL---LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEF 459
H D+KP N L + + DFG+++ + + + GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR-THQHIPYRENKNLTGTARYASINT 184
Query: 460 LASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDWPFV 517
E + + D+ S G +L+ G + + K + P+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 518 QAEQLANLAMRCCEMSRKSRP 538
+E A C + +P
Sbjct: 245 PSE-FATYLNFCRSLRFDDKP 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 2e-41
Identities = 49/266 (18%), Positives = 92/266 (34%), Gaps = 28/266 (10%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
+IGEG +G I++G LL + QVAIK S + + E + + V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 346 ---PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
LV + L + S +T A ++ + + +H S+V
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL---LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 403 HGDLKPANILLDANFVS-----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP 457
+ D+KP N L+ + DFG+ +F + ++ + + + GT YM
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPYREKKNLSGTARYMSI 182
Query: 458 EFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP-----LAG 512
E + + D+ + G + + L G K ++ L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 513 DWPFVQAEQLANLAMRCCEMSRKSRP 538
+P E+ ++ + P
Sbjct: 243 GFP----EEFYKYMHYARNLAFDATP 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 67/294 (22%), Positives = 120/294 (40%), Gaps = 45/294 (15%)
Query: 288 KIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHP 336
+GEG +G + +VA+KML + + S+ E++++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 337 NLVTLVGACPEVWT--LVYEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIR 381
N++ L+GAC + ++ EY G+L + L + + LS + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 382 IATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTT 441
A ++ + +L S +H DL N+L+ + V K++DFG++R + + T
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 442 LCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG--RPALGITKEVQYALD 499
+M PE L T +SDV+SFG++L + T P G+ E +
Sbjct: 197 GR------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF--- 247
Query: 500 TGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553
K L + D P +L + C RP K + L+ + A
Sbjct: 248 ----KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF-KQLVEDLDRIVA 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 9e-41
Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 31/264 (11%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 336
+F +G G +G ++ RH A+K+L + + E +LS + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
++ + G + ++ +Y+ G L L P A E+C L +LH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH 121
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S I++ DLKP NILLD N K++DFG ++++ GT Y
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----------TYTLCGTPDY 167
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514
+ PE +++ D +SFGI++ +L G Y +T K + +
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-------YDSNTMKTYEKILNAELRF 220
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP 538
P E + +L R R
Sbjct: 221 PPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 62/265 (23%), Positives = 102/265 (38%), Gaps = 29/265 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSK-IRH 335
+F +G+G +G ++ + AIK L + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 336 PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
P L + E V EYL G L + + A E+ L FL
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
HS IV+ DLK NILLD + K++DFG+ + + + T C GT
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFC------GTPD 168
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513
Y+ PE L + D +SFG++L +L G+ + D +L + +
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRMDNPF 221
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP 538
+P ++ +L ++ + R
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 39/289 (13%)
Query: 288 KIGEGGYGSIYKGLLRHM-------QVAIKMLHPHSLQGP-SEFQQEIDILSKIRH-PNL 338
+G G +G + + + VA+KML + E+ IL I H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 339 VTLVGACPE---VWTLVYEYLPNGSLEDRLSCKDNSP-------------PLSWQTRIRI 382
V L+GAC + ++ E+ G+L L K N L+ + I
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 383 ATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTL 442
+ ++ + FL S +H DL NILL V K+ DFG++R + ++
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 443 CCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK 502
+M PE + T +SDV+SFG++L + + + ++
Sbjct: 197 R------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246
Query: 503 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
+ L + P ++ + C RP ++ L +
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF-SELVEHLGNL 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 16/263 (6%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGA 344
IGEG YG + ++VAIK + P Q +EI IL + RH N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 345 C--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
P + + YL + L + LS ++ L ++HS +++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS 462
H DLKP+N+LL+ K+ DFG++R ++ T+ T Y PE + +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARV-----ADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 463 GEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQ 521
+ T D++S G IL +L+ RP + L L P D + +
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINLK 244
Query: 522 LANLAMRCCEMSRKSRPELGKDV 544
N + ++ L +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-39
Identities = 55/264 (20%), Positives = 105/264 (39%), Gaps = 33/264 (12%)
Query: 289 IGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGAC 345
+G G G + + + + A+KML + ++E+++ + + P++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVY 74
Query: 346 PEVWT------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPH 399
++ +V E L G L R+ + + I + + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 400 SIVHGDLKPANILLDA---NFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
+I H D+KP N+L + N + KL+DFG ++ + + T P T Y+
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTPYYVA 181
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL--GITKEVQYALDTGKLKNLLDPLAGDW 514
PE L + D++S G+I+ LL G P + + T + +W
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 515 PFVQAEQLANLAMRCCEMSRKSRP 538
V +E++ L + R
Sbjct: 242 SEV-SEEVKMLIRNLLKTEPTQRM 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 60/266 (22%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGP------SEFQQEIDILSKIRHPNLV 339
++G G + + K + +Q A K + + + ++E+ IL +I+HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 340 TLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK 397
TL L+ E + G L D L+ + ++ + + +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 398 PHSIVHGDLKPANILLDANFVS----KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
I H DLKP NI+L V K+ DFG++ + + GT
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---------EFKNIFGTPE 181
Query: 454 YMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDPLAG 512
++ PE + L ++D++S G+I LL+G P LG TK+ A + D
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 513 DWPFVQAEQLANLAMRCCEMSRKSRP 538
+ + R K R
Sbjct: 242 NTS----ALAKDFIRRLLVKDPKKRM 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 1e-38
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 33/269 (12%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKI 333
+F IG GG+G +Y A+K L + QG + E + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 334 RHPNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLI 391
P +V + A P+ + + + + G L LS S A E+ L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLE 121
Query: 392 FLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGT 451
+H+ +V+ DLKPANILLD + ++SD G++ S+ + GT
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------PHASVGT 168
Query: 452 FAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGR-PALGITKEVQYALDTGKLKNLLDP 509
YM PE L G +D +S G +L +LL G P + ++ +D L +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-- 226
Query: 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRP 538
+ P + +L +L + R
Sbjct: 227 ---ELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 36/239 (15%)
Query: 259 SSSSHMPQFFSDFSFSEIEGATHNFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHS 316
++ P + S+++ + IG G +G +Y+ L VAIK +
Sbjct: 8 ATPGQGPDRPQEVSYTDTK----------VIGNGSFGVVYQAKLCDSGELVAIKKV---- 53
Query: 317 LQGPSEFQQEIDILSKIRHPNLVTLVGACPEVWT--------LVYEYLPNGSLEDRLSCK 368
LQ +E+ I+ K+ H N+V L LV +Y+P
Sbjct: 54 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 369 DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGIS 427
L +L L ++HS I H D+KP N+LLD + V KL DFG +
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
+ L + E + + + + T DV+S G +L LL G+P
Sbjct: 171 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 1e-37
Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVG 343
KIG+G +G ++K R +VA+K + + + P +EI IL ++H N+V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 344 ACPEVWT----------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFL 393
C + LV+++ + + + R+ L + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LSNVLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 394 HSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFA 453
H K I+H D+K AN+L+ + V KL+DFG++R S + N+ T+ T
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK----NSQPNRYTNRVVTLW 186
Query: 454 YMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLA 511
Y PE L + P D++ G I+ + T P + G T++ Q AL +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSITP 243
Query: 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVW 545
WP V +L RK + L V
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 33/289 (11%)
Query: 279 ATHNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSLQG--PSEFQQEIDILSKI 333
A ++ +IGEG YG ++K VA+K + + + P +E+ +L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 334 ---RHPNLVTLVGACPEVWT-------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIA 383
HPN+V L C T LV+E++ K P + +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 384 TELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLC 443
+L L FLHS H +VH DLKP NIL+ ++ KL+DFG++R S
Sbjct: 123 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---------M 170
Query: 444 CRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGK 502
T T Y PE L D++S G I + +P G + Q
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---I 227
Query: 503 LKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551
L + P DWP A + + K ++ + +L
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 42/265 (15%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE------FQQEIDILSKIR--HPN 337
+G GG+GS+Y G+ ++ VAIK + + E E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 338 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
++ L+ P+ + L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 396 CKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
++H D+K NIL+D N KL DFG L TD GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------VYTDFDGTRVY 175
Query: 455 MDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513
PE++ + V+S GI+L ++ G +E+ G++
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----RGQV---------F 222
Query: 514 WPFVQAEQLANLAMRCCEMSRKSRP 538
+ + + +L C + RP
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRP 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-36
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE-----FQQEIDILSKIRHPNLVT 340
+GEG + ++YK ++ VAIK + + +EI +L ++ HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 341 LVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKP 398
L+ A +LV++++ KDNS L+ L +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVI---IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 399 HSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPE 458
H I+H DLKP N+LLD N V KL+DFG+++ T T Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPE 170
Query: 459 FLASGEL-TPKSDVYSFGIILLRLLTGRP 486
L + D+++ G IL LL P
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 28/269 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHP 336
+FD +G+G +G + + A+K+L + E E +L RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 337 NLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLH 394
L L A + V EY G L LS + + E+ S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH 122
Query: 395 SCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAY 454
S +V+ D+K N++LD + K++DFG+ + E S+ T+ GT Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFC---GTPEY 171
Query: 455 MDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514
+ PE L + D + G+++ ++ GR Y D +L L+ +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRF 224
Query: 515 PFVQAEQLANLAMRCCEMSRKSRPELGKD 543
P + + +L + K R G
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 9e-35
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 288 KIGEGGYGSIYKGLLRHMQ-VAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGA 344
KIGEG YG +YK + + A+K + PS +EI IL +++H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 345 CPEVWT--LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIV 402
LV+E+L + C+ L T +L + + + H ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 403 HGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA- 461
H DLKP N+L++ K++DFG++R + + Y P+ L
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--------LWYRAPDVLMG 174
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518
S + + D++S G I ++ G P G+++ Q + L P + +WP V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVT 229
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 20/212 (9%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPN 337
NF KIGEG YG +YK + VA+K + + PS +EI +L ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 338 LVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
+V L+ LV+E+L + + +L L F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H ++H DLKP N+L++ KL+DFG++R T Y
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTL------WYR 169
Query: 456 DPEFLA-SGELTPKSDVYSFGIILLRLLTGRP 486
PE L + D++S G I ++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 9e-34
Identities = 55/315 (17%), Positives = 111/315 (35%), Gaps = 47/315 (14%)
Query: 231 KKEQDELQMERDKAVKEAEELRKSRKEASSSSHMPQFFSDFSFSEIEGATHNFDPSLKIG 290
KK ++ ++ A + + L+K + +++ + QF + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQF-------DRIK---------TLG 50
Query: 291 EGGYGSIYKGLLRH--MQVAIKMLHPHSLQGPSE---FQQEIDILSKIRHPNLVTLVGAC 345
G +G + + A+K+L + + E IL + P LV L +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 346 PEVWTL--VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403
+ L V EY+ G + L S A ++ +LHS +++
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG 463
DLKP N+L+D +++DFG ++ GT + PE + S
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSK 213
Query: 464 ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLA 523
D ++ G+++ + G P +A ++ + +P + L
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 524 NLAMRCCEMSRKSRP 538
+L ++ R
Sbjct: 267 DLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-32
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 34/270 (12%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343
+G G YG++ + +VAIK L+ +E+ +L +RH N++ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 344 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
T LV ++ G+ +L L + ++ L ++H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
H DLKP N+ ++ + K+ DFG++R T T Y
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----------MTGYVVTRWYR 185
Query: 456 DPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514
PE + + T D++S G I+ ++TG+ + + +K P A
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 243
Query: 515 PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544
+Q+++ N E+ +K + +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNA 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 8e-32
Identities = 50/246 (20%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 253 KSRKEASSSSHMPQFFSDFSFSEIE-GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAI 309
++R ++H P+ + D+ +E G ++ K+G G Y +++ + + +V +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 310 KMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPE----VWTLVYEYLPNGSLEDR 364
K+L P + + ++EI IL +R PN++TL + LV+E++ N +
Sbjct: 66 KILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 365 LSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSD 423
L+ E+ L + HS I+H D+KP N+++D + +L D
Sbjct: 123 YQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID 173
Query: 424 FGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLL 482
+G++ F + + + PE L ++ D++S G +L ++
Sbjct: 174 WGLAEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 483 TGRPAL 488
+
Sbjct: 225 FRKEPF 230
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 20/236 (8%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343
KIGEG YG+++K R H VA+K + PS +EI +L +++H N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 344 ACPE--VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSI 401
TLV+E+ + SC + + +L L F H ++
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 402 VHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLA 461
+H DLKP N+L++ N KL++FG++R + T +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI---PVRCYSAEVVT----LWYRPPDVLFG 175
Query: 462 SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPFV 517
+ + D++S G I L L +V L + L P WP +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEEQWPSM 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 30/276 (10%)
Query: 282 NFDPSLKIGEGGYGSIYKGLLRHMQ-----VAIKMLHPHSL----QGPSEFQQEIDILSK 332
NF+ +G G YG ++ A+K+L ++ + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 333 IRH-PNLVTLVGAC--PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSV 389
IR P LVTL A L+ +Y+ G L LS ++ Q + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG------EI 138
Query: 390 LIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
++ L I++ D+K NILLD+N L+DFG+S+ +E D
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-------RAYDFC 191
Query: 450 GTFAYMDPEFLASGE--LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507
GT YM P+ + G+ D +S G+++ LLTG + E + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 508 DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543
+P +P + +L R K R G
Sbjct: 252 EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 32/269 (11%)
Query: 288 KIGEGGYGSIYKGLLRH--MQVAIKMLHPH--SLQGPSEFQQEIDILSKIRHPNLVTLVG 343
+G G YGS+ ++VA+K L S+ +E+ +L ++H N++ L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 344 ACPEVWTL-------VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
+L + +L L + + C+ L+ + ++ L ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMD 456
I+H DLKP+N+ ++ + K+ DFG++R +
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------EMTGYVATRWYRAP 187
Query: 457 PEFLASGELTPKSDVYSFGIILLRLLTGRPAL-GITKEVQYALDTGKLKNLLDPLAGDWP 515
L D++S G I+ LLTGR G Q L L+ + P A
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLK 244
Query: 516 FVQAEQLANLAMRCCEMSRKSRPELGKDV 544
+ +E N +M + + +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGA 273
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-27
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 30/211 (14%)
Query: 288 KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVG 343
IG G G + VAIK L +E+ ++ + H N+++L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 344 ACPEVWT--------LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHS 395
T LV E + + D + + ++ + LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 396 CKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYM 455
+H DLKP+NI++ ++ K+ DFG++R + T T Y
Sbjct: 138 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---------MMTPYVVTRYYR 185
Query: 456 DPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
PE + D++S G I+ ++ +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 7e-26
Identities = 37/217 (17%), Positives = 77/217 (35%), Gaps = 27/217 (12%)
Query: 288 KIGEGGYGSIYKG--LLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC 345
K+G G + +++ ++ + VA+K++ + + EI +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 346 ---------------PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVL 390
P +V + G L K + +I+ +L L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 391 IFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLSQNEISSNNTTLCCRTDPK 449
++ + I+H D+KP N+L++ L I+ + + T
Sbjct: 139 DYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI------ 190
Query: 450 GTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRP 486
T Y PE L +D++S ++ L+TG
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 85.1 bits (210), Expect = 5e-21
Identities = 31/72 (43%), Positives = 44/72 (61%)
Query: 570 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 629
E P YF CPI E+M+DP + + G TYE +++ WLD+GH+T P + L H L PN
Sbjct: 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYV 63
Query: 630 LRSAIQEWLQQH 641
L+S I W + +
Sbjct: 64 LKSLIALWCESN 75
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 6e-19
Identities = 24/158 (15%), Positives = 46/158 (29%), Gaps = 19/158 (12%)
Query: 288 KIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL----------QGPSEFQQEIDILSKIRHP 336
+GEG +++ + +K G F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 337 NLVTLVGACPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC 396
L L G Y + N L + L + + + + + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 397 KPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434
IVHGDL N+L+ + + DF S + +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 68.0 bits (165), Expect = 6e-15
Identities = 20/72 (27%), Positives = 39/72 (54%)
Query: 570 EPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLA 629
+ P Y I E+M++P + G TY+ + ++ L +P+T PL + L+PNLA
Sbjct: 3 DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLA 62
Query: 630 LRSAIQEWLQQH 641
++ I ++ ++
Sbjct: 63 MKEVIDAFISEN 74
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 6e-12
Identities = 25/90 (27%), Positives = 34/90 (37%), Gaps = 2/90 (2%)
Query: 553 ASCGGSTSYRLGSEERCEPPPYFTCPIFQEVMQDPHVAADGF-TYEAEALKGWLDSGHET 611
S G S + E + F PI +M DP V T + + L S +T
Sbjct: 1 GSSGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQT 59
Query: 612 SPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641
P PL + PN L+ IQ WL +
Sbjct: 60 DPFNRSPLTMDQIRPNTELKEKIQRWLAER 89
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.1 bits (114), Expect = 1e-07
Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 2/67 (2%)
Query: 575 FTCPIFQEVMQDPHVAADGFTYEAEALKGWLDS--GHETSPMTNLPLAHKNLVPNLALRS 632
CPI E++++P + + L+ G P+ + ++L +
Sbjct: 22 LECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQ 81
Query: 633 AIQEWLQ 639
++E L+
Sbjct: 82 LVEELLK 88
|
| >d1f5na1 a.114.1.1 (A:284-583) Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 300 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain superfamily: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain family: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain domain: Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (107), Expect = 1e-05
Identities = 22/141 (15%), Positives = 62/141 (43%)
Query: 113 DQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRRKEFEEALA 172
L + E +A E K+++ ++I + + + +E++ + E+
Sbjct: 158 QDLKKKYYEEPRKGIQAEEILQTYLKSKESMTDAILQTDQTLTEKEKEIEVERVKAESAQ 217
Query: 173 NGKLELERMKKQHDEVMEELQIALDQKSLLESQIAESDQTAKELEQKIISAVELLQNYKK 232
L M+++++++ME+ + + + ++ E+D+ EQ+ A++L + +
Sbjct: 218 ASAKMLHEMQRKNEQMMEQKERSYQEHLKQLTEKMENDRVQLLKEQERTLALKLQEQEQL 277
Query: 233 EQDELQMERDKAVKEAEELRK 253
++ Q E E ++L+
Sbjct: 278 LKEGFQKESRIMKNEIQDLQT 298
|
| >d1eq1a_ a.63.1.1 (A:) Apolipophorin-III {Manduca sexta [TaxId: 7130]} Length = 166 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Apolipophorin-III superfamily: Apolipophorin-III family: Apolipophorin-III domain: Apolipophorin-III species: Manduca sexta [TaxId: 7130]
Score = 40.3 bits (94), Expect = 2e-04
Identities = 32/173 (18%), Positives = 63/173 (36%), Gaps = 31/173 (17%)
Query: 105 GSVDDNLYDQLAQAMAEAENSRREAFEEALRRGKAEKDAIESIRRAKASESLYAEELKRR 164
G+ + + + F E K+ + + K ++L
Sbjct: 6 GNAFEEMEKHAKEFQKT--------FSEQFNSLVNSKNTQDFNKALKDGSDSVLQQLSAF 57
Query: 165 ------------KEFEEAL--ANGKLEL--ERMKKQHDEVMEEL-QIALDQKSLLESQIA 207
+ +EAL A +E E ++K H +V +E ++ +++ +
Sbjct: 58 SSSLQGAISDANGKAKEALEQARQNVEKTAEELRKAHPDVEKEANAFKDKLQAAVQTTVQ 117
Query: 208 ESDQTAKELEQKIISAVELLQNYKKEQDELQMERDKAVKEAEELRKSRKEASS 260
ES + AKE+ + + L K+ D VK AEE++K EA++
Sbjct: 118 ESQKLAKEVASNMEETNKKLAPKIKQA------YDDFVKHAEEVQKKLHEAAT 164
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 37.8 bits (87), Expect = 2e-04
Identities = 12/52 (23%), Positives = 24/52 (46%), Gaps = 2/52 (3%)
Query: 576 TCPIFQEVMQDPHVAA-DGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVP 626
C I +V + P ++ +E L+ ++ P+TN PL+ + +V
Sbjct: 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 52
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 641 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.67 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.64 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.64 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.96 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 98.81 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 98.76 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 98.69 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.34 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 98.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.61 | |
| d1g25a_ | 65 | TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9 | 97.49 | |
| d1chca_ | 68 | Immediate early protein, IEEHV {Equine herpesvirus | 97.13 | |
| d1bora_ | 56 | Acute promyelocytic leukaemia proto-oncoprotein PM | 96.96 | |
| d1v87a_ | 114 | Deltex protein 2 RING-H2 domain {Mouse (Mus muscul | 96.73 | |
| d1iyma_ | 55 | EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 45 | 96.34 | |
| d1ur6b_ | 52 | Not-4 N-terminal RING finger domain {Human (Homo s | 95.98 | |
| d3dplr1 | 88 | RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase | 95.87 | |
| d1vyxa_ | 60 | IE1B protein (ORF K3), N-terminal domain {Kaposi's | 94.89 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.71 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=211.2
Q ss_pred HCCCCCCCCEEECCCCEEEEEEEECCEEEEEEEECCCCCC--CCHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEEEEE
Q ss_conf 1079776520100184689999988928999995479999--9113999999985079996135704105-840899972
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEY 355 (641)
Q Consensus 279 ~~~~f~~~~~LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV~Ey 355 (641)
..++|.+.+.||+|+||.||+|.+++ .||||+++..... ..+.|.+|+.++++++|||||+++|++. +..++||||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred CCCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEEC
T ss_conf 54518998898307885899999999-89999997346998999999999999984799878645679715589999965
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58999233310279999999999999999989999998730999601056788846855698201124420001453434
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++|+|.+++... ..++++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 8998889998523--5789999999999999999888750---9995161478997981899788750022133355677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH---HHHHCCCCCCCCC
Q ss_conf 678864211379998756689000004---9999503688799999999919999998379999---9862411112588
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY---ALDTGKLKNLLDP 509 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~---~~~~~~~~~~ld~ 509 (641)
... .....||+.|||||++.+ ..|+.++|||||||++|||+||+.||...+.... ....+ ...+
T Consensus 160 ~~~------~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~----~~~p 229 (276)
T d1uwha_ 160 SHQ------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----YLSP 229 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT----SCCC
T ss_pred CCC------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC----CCCC
T ss_conf 631------256655743179999950568999953151635999999997889989989699999999658----8898
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 789998235999999999985113399999479999998987860
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 510 ~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.....+..+++.+.+|+.+||..+|.+||++.+ +...|+.+.+.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~-il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ-ILASIELLARS 273 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred CCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 600036555499999999975889768929999-99999999970
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.13 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=209.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC-----EEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEE
Q ss_conf 797765201001846899999889-----28999995479999-9113999999985079996135704105--840899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV 352 (641)
.+|...+.||+|+||+||+|.+.. ..||||.+...... ....|.+|+.+|++++|||||+++|+|. +..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730999601056788846855698201124420001453
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++|+|.+++.. ....+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 972279853002104--56799999999999999998898852---7983576150448988999199888443157567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 434678864211379998756689000004999950368879999999991-9999998379999986241111258878
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 511 (641)
....... .......||+.|+|||++.++.++.++|||||||++|||+| |++||.............. ...
T Consensus 181 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------~~~ 251 (299)
T d1jpaa_ 181 DTSDPTY---TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------DYR 251 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------TCC
T ss_pred CCCCCEE---EECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC------CCC
T ss_conf 7776536---5025666883003878883699786121445357899998679999999999999999973------788
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9998235999999999985113399999479999998987860
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
...|..++..+.+|+.+||+.+|.+||++.+ +.+.|+.+...
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e-i~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ-IVNTLDKMIRN 293 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHCC
T ss_conf 9997422699999999975879768929999-99999998418
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.73 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=206.0
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEEC
Q ss_conf 79776520100184689999988--928999995479999911399999998507999613570410--58408999725
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 356 (641)
.+|.....||+|+||.||+|... +..||||++........+.+.+|+.+++.++||||+++++++ .+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
+||+|.+++.. ..+++..+..|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 79808988641----599999999999999999999998---79722677688868878996864251564132136664
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 78864211379998756689000004999950368879999999991999999837999998624111125887899982
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 516 (641)
.....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+............. .....+.
T Consensus 173 --------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~ 240 (293)
T d1yhwa1 173 --------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPE 240 (293)
T ss_dssp --------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----CCCSSGG
T ss_pred --------CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC----CCCCCCC
T ss_conf --------4444447773682664479988012031372999998048899899799999999985799----9888855
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 359999999999851133999994799
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 517 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
..+..+.+|+.+||..+|.+||++.++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 379999999999866996689099999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.75 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=211.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC-CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEEC
Q ss_conf 079776520100184689999988-928999995479999911399999998507999613570410--58408999725
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 356 (641)
.++|...+.||+|+||.||+|.+. +..||||++.... ...+.|.+|+.++++++||||++++|+| .+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 69958888982088829999998899999999987886-76899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++.. ....+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 99918997520--13478899999999999998776531---64310443153266668877686553210023688733
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 78864211379998756689000004999950368879999999991-99999983799999862411112588789998
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 515 (641)
. .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||................ ....|
T Consensus 158 ~-------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------~~~~p 224 (263)
T d1sm2a_ 158 S-------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKP 224 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------CCCCC
T ss_pred E-------ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC------CCCCC
T ss_conf 5-------0430017666785786079998403321059999999878988877899999999998068------88995
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 235999999999985113399999479999998987860
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 516 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
..++..+.+|+.+||+.+|.+||++.+ +++.|+.+..+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~-il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSR-LLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 436799999999976579768919999-99999999857
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.03 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=209.6
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC-CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEEEEECC
Q ss_conf 079776520100184689999988-9289999954799999113999999985079996135704105-84089997258
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 357 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV~Ey~~ 357 (641)
..+|.+.+.||+|+||.||+|.++ +..||||++.... ...+.|.+|+.++++++|||||+++|+|. +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99923331027999999999999999998999999873099960105678884685569820112442000145343467
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.+++.... ..++++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC
T ss_conf 982888875147-8988788999999999999999974---895467564225156202440423410147735886442
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 8864211379998756689000004999950368879999999991-999999837999998624111125887899982
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 516 (641)
.....||+.|+|||++.++.++.++|||||||++|||+| |.+||............... .....|.
T Consensus 167 -------~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------~~~~~p~ 233 (272)
T d1qpca_ 167 -------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------YRMVRPD 233 (272)
T ss_dssp -------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------CCCCCCT
T ss_pred -------CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC------CCCCCCC
T ss_conf -------035677444458289837999824564525799999996898888888999999999706------8888965
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 35999999999985113399999479999998987860
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 517 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.++..+.+|+.+||+.+|.+||++.+ |.+.|+++-.+
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~e-i~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDY-LRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 57199999999975889768939999-99986113213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.31 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=206.7
Q ss_pred CCCCCCC-EEECCCCEEEEEEEEC----CEEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEEE
Q ss_conf 7977652-0100184689999988----928999995479999-9113999999985079996135704105-8408999
Q 006545 281 HNFDPSL-KIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVY 353 (641)
Q Consensus 281 ~~f~~~~-~LG~G~fG~Vykg~~~----~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV~ 353 (641)
.+|.... +||+|+||.||+|.++ +..||||++...... ..+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++.. ....+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 80789968997521--25699999999999999998789986---88105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991-99999983799999862411112588789
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 512 (641)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |++||......+....... ....
T Consensus 163 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~------~~~~ 231 (285)
T d1u59a_ 163 DSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------GKRM 231 (285)
T ss_dssp SCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT------TCCC
T ss_pred CCCC-----CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC------CCCC
T ss_conf 4321-----1356211374335868872799995412322017899999389999999799999999981------8999
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 99823599999999998511339999947999999898786
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 513 ~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~ 553 (641)
..|..++..+.+|+.+||..+|.+||++.+ |.+.|+.+..
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~-i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYY 271 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHH
T ss_conf 999767899999999975779768909999-9999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.73 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=207.9
Q ss_pred HHCCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEE
Q ss_conf 21079776520100184689999988--9289999954799999113999999985079996135704105--8408999
Q 006545 278 GATHNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 278 ~~~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~ 353 (641)
....+|...+.||+|+||+||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||+++|+|. +..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 45799398659820888089999999999699999977761-03999999999998679998826775274578547876
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++... ....+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 314676067775303-55415799999999999997888987---89305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 346788642113799987566890000049999503688799999999919999-9983799999862411112588789
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPA-LGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~P-f~~~~~~~~~~~~~~~~~~ld~~~~ 512 (641)
.... .....|++.|+|||++.+..|+.++|||||||++|||++|..| |...+.......... ....
T Consensus 169 ~~~~-------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~------~~~~ 235 (287)
T d1opja_ 169 TYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------DYRM 235 (287)
T ss_dssp SSEE-------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT------TCCC
T ss_pred CCEE-------ECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC------CCCC
T ss_conf 7221-------03556654666927872799981043021789999998679988774259999999855------8888
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9982359999999999851133999994799999989878
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 513 ~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~ 552 (641)
..|..++..+.+|+.+||+.+|.+||++.+ +.+.|+.+.
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~e-i~~~L~~~~ 274 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAE-IHQAFETMF 274 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHH
T ss_conf 887433099999999975779768939999-999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.16 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=205.7
Q ss_pred HCCCCCCCCEEECCCCEEEEEEEECC-------EEEEEEEECCCCC-CCCHHHHHHHHHHHCC-CCCCEEEEECCCC--C
Q ss_conf 10797765201001846899999889-------2899999547999-9911399999998507-9996135704105--8
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSL-QGPSEFQQEIDILSKI-RHPNLVTLVGACP--E 347 (641)
Q Consensus 279 ~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~vAiK~~~~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 347 (641)
...+|.+.+.||+|+||+||+|.+.+ ..||+|++..... .....|.+|+.++.++ +|||||+++|+|. +
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CEEEEEEECCCCCHHHHHHCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 40899972589992333102799--------------------9999999999999998999999873099960105678
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDN--------------------SPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLK 407 (641)
Q Consensus 348 ~~~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIK 407 (641)
..++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+ ++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCC
T ss_conf 58999972799959999986257775102210000122200125778999999999999999999973---990505270
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCC
Q ss_conf 8846855698201124420001453434678864211379998756689000004999950368879999999991-999
Q 006545 408 PANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRP 486 (641)
Q Consensus 408 p~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~ 486 (641)
|+|||++.++.+||+|||+|+......... ......||+.|+|||++.++.|+.++|||||||++|||+| |++
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEE------EECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCC
T ss_conf 321443459828985142222045778615------62343578765783887279999633030003999999838999
Q ss_pred CCCCCHHHH---HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
Q ss_conf 999837999---998624111125887899982359999999999851133999994799999989
Q 006545 487 ALGITKEVQ---YALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 487 Pf~~~~~~~---~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~ 549 (641)
||....... ..+..+ .....|..++..+.+|+.+||+.+|.+||++.+ |.+.|.
T Consensus 266 Pf~~~~~~~~~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e-i~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN-LTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHH
T ss_pred CCCCCCHHHHHHHHHHCC--------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHH
T ss_conf 999989899999998569--------989988767899999999975889668939999-999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.97 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=200.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCC-CCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEE
Q ss_conf 79776520100184689999988--92899999547999-9911399999998507999613570410--5840899972
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey 355 (641)
++|++.+.||+|+||+||+|... +..||||++..... ...+.+.+|+.++++++||||+++++++ .+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58999233310279999999999999999989999998730999601056788846855698201124420001453434
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+++|+|.+++. ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 58980899975---37999999999999999999999997---5983575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 678864211379998756689000004999-9503688799999999919999998379999986241111258878999
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 514 (641)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|+||++||.................. ....
T Consensus 159 ~~------~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~----~~~~ 228 (271)
T d1nvra_ 159 ER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----YLNP 228 (271)
T ss_dssp EC------CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----TSTT
T ss_pred CC------CCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC----CCCC
T ss_conf 53------1113255747428728618999997101617379999998299788889859999999863888----7886
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 82359999999999851133999994799
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 515 p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
....+..+.+|+.+||+.+|.+||++.++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 44699999999999767996689099999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=366.91 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=203.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEEC
Q ss_conf 79776520100184689999988--928999995479999911399999998507999613570410--58408999725
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 356 (641)
.+|++.+.||+|+||.||+|... |..||||++........+.+.+|+.+|++++|||||++++++ ....++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 57589889840768199999988999899999984524316999999999998679979992999999899999999857
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999233310279999999999999999989999998730999601056788846855--69820112442000145343
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld--~~~~vKL~DFGla~~~~~~~ 434 (641)
+||+|.+++.. ...++++..+..|+.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC
T ss_conf 99889999976--23789999999999999999999975---69760001546736416889869995452104425654
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 46788642113799987566890000049999503688799999999919999998379999986241111258878999
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 514 (641)
.. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..............+. ...
T Consensus 181 ~~---------~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 248 (350)
T d1koaa2 181 SV---------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---DSA 248 (350)
T ss_dssp CE---------EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---CGG
T ss_pred CC---------CEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---CCC
T ss_conf 32---------000686242188997589987267655465999999859899899799999999984788989---422
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 82359999999999851133999994799
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 515 p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
+...+..+.+|+.+||..||.+||++.++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 35899999999999756896679089998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.92 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=203.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEEC
Q ss_conf 79776520100184689999988--928999995479999911399999998507999613570410--58408999725
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEYL 356 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey~ 356 (641)
+.|++...||+|+||.||+|.+. +..||+|++........+.|.+|+.+|++++|||||++++++ .+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++... ..++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|........
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC-
T ss_conf 998188999862--8999999999999999999999998---8988714070031487899989971612303577864-
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 7886421137999875668900000-----49999503688799999999919999998379999986241111258878
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLA-----SGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 511 (641)
......||+.|+|||++. +..|+.++|||||||++|+|+||++||...+............ +..
T Consensus 166 -------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~----~~~ 234 (288)
T d2jfla1 166 -------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE----PPT 234 (288)
T ss_dssp -------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC----CCC
T ss_pred -------CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC----CCC
T ss_conf -------100102562647999983202578888806657878999999820889999989999999997079----987
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 99982359999999999851133999994799
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
...+...+..+.+|+.+||+.||.+||++.++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 77656699999999999766996689199999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.38 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=202.2
Q ss_pred CEEECCCCEEEEEEEEC----CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEEEEECCCC
Q ss_conf 20100184689999988----9289999954799999--113999999985079996135704105-8408999725899
Q 006545 287 LKIGEGGYGSIYKGLLR----HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLPNG 359 (641)
Q Consensus 287 ~~LG~G~fG~Vykg~~~----~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV~Ey~~~g 359 (641)
++||+|+||.||+|.+. +..||||++....... .+.|.+|+.+|++++|||||+++|+|. +..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 92333102799999999999999999899999987309996010567888468556982011244200014534346788
Q 006545 360 SLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISSNN 439 (641)
Q Consensus 360 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~ 439 (641)
+|.+++.. ..++++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 93 ~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred CHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC--
T ss_conf 68999752---2578999999999999999766874---795567776113102356751234134533134323443--
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf 64211379998756689000004999950368879999999991-99999983799999862411112588789998235
Q 006545 440 TTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPFVQ 518 (641)
Q Consensus 440 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~ 518 (641)
.......||+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....... ......|..+
T Consensus 165 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~------~~~~~~p~~~ 235 (277)
T d1xbba_ 165 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------GERMGCPAGC 235 (277)
T ss_dssp ---EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------TCCCCCCTTC
T ss_pred ---CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC------CCCCCCCCCC
T ss_conf ---2244567784203916653799984344303403132896589999999899999999982------8999998656
Q ss_pred HHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
Q ss_conf 999999999985113399999479999998987
Q 006545 519 AEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 519 ~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l 551 (641)
+..+.+|+.+||+.+|.+||++.+ |...|+.+
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~-i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAA-VELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHCH
T ss_conf 799999999975889768909899-99985288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=365.10 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=204.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEEEC
Q ss_conf 79776520100184689999988--9289999954799999113999999985079996135704105--8408999725
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~Ey~ 356 (641)
+.|++.+.||+|+||.||+|... +..||||++..........+.+|+.+|++++|||||++++++. ...++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 03599899931778299999998999799999988726467999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999233310279999999999999999989999998730999601056788846855--69820112442000145343
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD--ANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld--~~~~vKL~DFGla~~~~~~~ 434 (641)
+||+|.+.+.. ...++++..+..|+.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+|..+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC
T ss_conf 99808888986--38998999999999999999999997---79265131445531134678848995256303437887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 46788642113799987566890000049999503688799999999919999998379999986241111258878999
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGDW 514 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~ 514 (641)
.. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..............+ ....
T Consensus 184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 251 (352)
T d1koba_ 184 IV---------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---DEDA 251 (352)
T ss_dssp CE---------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---CSST
T ss_pred CE---------EECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---CCCC
T ss_conf 20---------10047645348999747998976333898999999996889989979999999998478898---9300
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 82359999999999851133999994799
Q 006545 515 PFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 515 p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
+...+..+.+|+.+||..+|.+||++.++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 24799999999999756996689189999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.01 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=202.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCC---CCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEE
Q ss_conf 79776520100184689999988--928999995479---9999113999999985079996135704105--8408999
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~ 353 (641)
++|++.+.||+|+||.||+|... +..||+|++... .......+.+|+.+++.++||||+++++++. +..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+++|+|.+++.. ..++++..+..|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|......
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 50479858988750---4899999999999999999999998---89465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991999999837999998624111125887899
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 513 (641)
.. ....||+.|+|||++.+..|+.++|||||||++|+|++|++||...+............ ..
T Consensus 160 ~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------~~ 222 (263)
T d2j4za1 160 RR----------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------FT 222 (263)
T ss_dssp CC----------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------CC
T ss_pred CC----------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-------CC
T ss_conf 52----------35578876349999758998931440467599999832999988899999999997189-------99
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 982359999999999851133999994799
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
+|...+..+.+|+.+||..+|.+||++.++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~ei 252 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREV 252 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 986689999999999764797689099999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.34 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=204.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCC----CCEEEE
Q ss_conf 79776520100184689999988--9289999954799999--113999999985079996135704105----840899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP----EVWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~LV 352 (641)
.+|++.+.||+|+||.||+|... +..||+|++....... ...+.+|+.++++++||||+++++++. ...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 9725899923331027-99999999999999999899999987309--99601056788846855698201124420001
Q 006545 353 YEYLPNGSLEDRLSCK-DNSPPLSWQTRIRIATELCSVLIFLHSCK--PHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~giiHrDIKp~NILld~~~~vKL~DFGla~~ 429 (641)
|||+++|+|.+++... .....+++..++.++.|++.||.|||+.. .++|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 45343467886421137999875668900000499995036887999999999199999983799999862411112588
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~ 509 (641)
+...... .....||+.|+|||++.+..|+.++|||||||++|||+||++||...+.......... .
T Consensus 164 ~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~------~ 229 (269)
T d2java1 164 LNHDTSF--------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------G 229 (269)
T ss_dssp C-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------T
T ss_pred CCCCCCC--------CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHC------C
T ss_conf 2457775--------5667788232799998399999389887527899998018899899899999999971------8
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 7899982359999999999851133999994799
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 510 ~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
.....|...+..+.+|+.+||+.||.+||++.++
T Consensus 230 ~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~el 263 (269)
T d2java1 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263 (269)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 9988974359999999999767995579189999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.48 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=207.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEECC------EEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEE
Q ss_conf 0797765201001846899999889------28999995479999-9113999999985079996135704105--8408
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWT 350 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~~------~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~ 350 (641)
.+.|+..+.||+|+||.||+|.+++ ..||||++...... ....|.+|+.++++++|||||+++|+|. +..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99972589992333102799999999999999999899999987309996010567888468556982011244200014
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||+.+|++.+.+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 999721357402221023--4542089999999999985412121---23425765644278889984998455103003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 534346788642113799987566890000049999503688799999999919-9999983799999862411112588
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDP 509 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG-~~Pf~~~~~~~~~~~~~~~~~~ld~ 509 (641)
........ ......||+.|+|||++.++.++.++|||||||++|||++| .+|+............ .+.
T Consensus 161 ~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i------~~~ 229 (283)
T d1mqba_ 161 EDDPEATY-----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------NDG 229 (283)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTT
T ss_pred CCCCCCCE-----EECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH------HCC
T ss_conf 57876526-----7426777734348888704999973556344898999996798865568999999998------635
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 789998235999999999985113399999479999998987860
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 510 ~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.....|..++..+.+|+.+||+.+|.+||++.+ |.+.|+.+...
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-il~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD-IVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH-HHHHHHHHHHS
T ss_pred CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 789985045799999999977679768939999-99999998669
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=364.78 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=202.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEE
Q ss_conf 079776520100184689999988--928999995479999-9113999999985079996135704105--84089997
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~E 354 (641)
.+.|++.+.||+|+||+||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++. ...++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCCCCCCCCCCCCC
Q ss_conf 258999233310279999999999999999989999998730999601056788846855---69820112442000145
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLS 431 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld---~~~~vKL~DFGla~~~~ 431 (641)
|++||+|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 2689848886530---3678878999999999999875241---305568704630011046888249983154358725
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34346788642113799987566890000049999503688799999999919999998379999986241111258878
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 511 (641)
.... ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||..................+ .
T Consensus 162 ~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~---~ 229 (307)
T d1a06a_ 162 PGSV---------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF---D 229 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC---C
T ss_pred CCCE---------EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC---C
T ss_conf 8970---------440032842259188737999807873451599999985979999989999999986168777---8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 99982359999999999851133999994799
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
...+...++.+.+|+.+||..+|.+||++.++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 76666789999999999760897579189998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.97 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=199.2
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC-CHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEE
Q ss_conf 079776520100184689999988--9289999954799999-113999999985079996135704105--84089997
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~E 354 (641)
.++|++.+.||+|+||+||+|.+. +..||+|+++...... ...+.+|+.+|+.++|||||+++++|. ...++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25899923331027999999999999999998999999873099960105678884685569820112442000145343
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|++||+|.+++... ..+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred CCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 67998689987424---9999999999999999999999985--999714457799468789989995487762567886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHH--H---CCCC-----
Q ss_conf 46788642113799987566890000049999503688799999999919999998379999986--2---4111-----
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALD--T---GKLK----- 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~--~---~~~~----- 504 (641)
. ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+....... . +...
T Consensus 160 ~----------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 160 A----------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp C-------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred C----------CCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 2----------111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred --------------------------CCCCCCCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf --------------------------12588789998-23599999999998511339999947999
Q 006545 505 --------------------------NLLDPLAGDWP-FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 --------------------------~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
..........+ ...+.++.+|+.+||..||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L 296 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 1233322111122235413477887665026876676444899999999998689946790899996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.90 Aligned_cols=262 Identities=26% Similarity=0.443 Sum_probs=212.9
Q ss_pred HHHHHCCCCCCCCEEECCCCEEEEEEEECC-------EEEEEEEECCCCCCC-CHHHHHHHHHHHCCCCCCEEEEECCCC
Q ss_conf 673210797765201001846899999889-------289999954799999-113999999985079996135704105
Q 006545 275 EIEGATHNFDPSLKIGEGGYGSIYKGLLRH-------MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP 346 (641)
Q Consensus 275 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~-------~~vAiK~~~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 346 (641)
+++...++|++.+.||+|+||+||+|.+.+ ..||||++....... ...|.+|+.+++.++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 11389889388679820788399999988876577882999999882108579999999999999668997655246660
Q ss_pred --CCEEEEEEECCCCCHHHHHHCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf --84089997258999233310279---------------------9999999999999999899999987309996010
Q 006545 347 --EVWTLVYEYLPNGSLEDRLSCKD---------------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVH 403 (641)
Q Consensus 347 --~~~~LV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiH 403 (641)
...++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+ ++++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEE
T ss_conf 598038999815899299999852755421000011100121034678898999999999999998554135---78685
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 56788846855698201124420001453434678864211379998756689000004999950368879999999991
Q 006545 404 GDLKPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT 483 (641)
Q Consensus 404 rDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt 483 (641)
|||||+|||++.++.+||+|||+|+.......... .+...|++.|+|||++.+..|+.++|||||||++|||++
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCEEECCCCCEEECCCHHHEECCCCCCCCC------CCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHC
T ss_conf 48840116898999289833144211367764111------577776767679899726889805630252362999980
Q ss_pred CC-CCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99-9999837999998624111125887899982359999999999851133999994799999989878
Q 006545 484 GR-PALGITKEVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 484 G~-~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~ 552 (641)
|. +||...+......... +......|..++..+.+|+.+||+.+|.+||++.+ |.+.|+.+.
T Consensus 238 ~~~~p~~~~~~~e~~~~v~------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e-v~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGMAHEEVIYYVR------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCS-IHRILQRMC 300 (301)
T ss_dssp TTCCTTTTSCHHHHHHHHH------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHTT
T ss_pred CCCCCCCCCCHHHHHHHHH------CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHC
T ss_conf 6899999989999999997------39978887325299999999974889657939999-999999842
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.90 Aligned_cols=239 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred CCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC---CHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEE
Q ss_conf 9776520100184689999988--9289999954799999---11399999998507999613570410--584089997
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 282 ~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~E 354 (641)
.|+..+.||+|+||.||+|... +..||||++....... ...+.+|+.+|++++|||||++++++ .+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25899923331027999999999999999998999999873099960105678884685569820112442000145343
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
||++|+|..++.. ..++++..+..|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 0699945789973---7999999999999999999999986---89766678842179879997898443653346778-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 4678864211379998756689000004---9999503688799999999919999998379999986241111258878
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLAS---GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 511 (641)
....||+.|+|||++.+ +.|+.++|||||||++|||++|++||................. .+
T Consensus 169 -----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~--~~-- 233 (309)
T d1u5ra_ 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA-- 233 (309)
T ss_dssp -----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC--
T ss_pred -----------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC--CC--
T ss_conf -----------731347663688998346788867214545589999999878899999799999999982899--98--
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 99982359999999999851133999994799
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
..+...+..+.+|+.+||..||.+||++.++
T Consensus 234 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 264 (309)
T d1u5ra_ 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (309)
T ss_dssp -CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf -8878889999999999773796579189999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.40 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=207.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--C----EEEEEEEECCCC-CCCCHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEE
Q ss_conf 79776520100184689999988--9----289999954799-999113999999985079996135704105-840899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--H----MQVAIKMLHPHS-LQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~----~~vAiK~~~~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV 352 (641)
.+|+..+.||+|+||+||+|.+. + ..||+|++.... ....+.|.+|+.++++++|||||+++|+|. +..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730999601056788846855698201124420001453
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
++|+.+|+|.+.+... ...+++..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 9842687401011133--4579999999999999999999987---6950476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHH--HHHHHHCCCCCCCCC
Q ss_conf 434678864211379998756689000004999950368879999999991-99999983799--999862411112588
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEV--QYALDTGKLKNLLDP 509 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ld~ 509 (641)
...... .....||+.|+|||++.++.|+.++|||||||++|||+| |.+||...+.. ...+..+.
T Consensus 164 ~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~------- 230 (317)
T d1xkka_ 164 EEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 230 (317)
T ss_dssp TCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-------
T ss_pred CCCCCC------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-------
T ss_conf 445322------3651058644670887469998356544079999999977999999999899999997599-------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 78999823599999999998511339999947999999898786
Q 006545 510 LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 510 ~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~ 553 (641)
....|..++..+.+|+.+||..+|.+||++.+ +...|..+..
T Consensus 231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e-il~~l~~~~~ 272 (317)
T d1xkka_ 231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMAR 272 (317)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHH
T ss_conf -89998556899999999847899346919999-9999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.20 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=204.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCC---CCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEE
Q ss_conf 79776520100184689999988--928999995479---9999113999999985079996135704105--8408999
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~ 353 (641)
.+|++.+.||+|+||.||+|... +..||||++... .......+.+|+.++++++||||+++++++. +..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 704898777765315---999999999999999999976216---50884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991999999837999998624111125887899
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 513 (641)
..... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+........... ...
T Consensus 162 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------~~~ 228 (288)
T d1uu3a_ 162 SKQAR------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------EYD 228 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------CCC
T ss_pred CCCCC------CCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-------CCC
T ss_conf 76433------35556775525844002689896662304569999980388998995999999999718-------999
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 98235999999999985113399999479
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGK 542 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e 542 (641)
+|...+..+.+|+.+||+.||.+||++.+
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 98547999999999985579768919789
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.79 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=201.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCC---CCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEE
Q ss_conf 079776520100184689999988--928999995479---9999113999999985079996135704105--840899
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV 352 (641)
-++|++.+.||+|+||.||+|... +..||+|++... .......+.+|+.+|+.++||||+++++++. +.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730999601056788846855698201124420001453
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 0035798605555325---677599999999999652113431---5962246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 43467886421137999875668900000499995036887999999999199999983799999862411112588789
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 512 (641)
.... ....+||+.|+|||++.+..|+.++||||+||++|||++|++||...+........... ..
T Consensus 158 ~~~~--------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------~~ 222 (337)
T d1o6la_ 158 DGAT--------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------EI 222 (337)
T ss_dssp TTCC--------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC
T ss_pred CCCC--------CCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-------CC
T ss_conf 7862--------05510088996666504898883331022306788998789999996999999998528-------99
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCH
Q ss_conf 9982359999999999851133999994
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 513 ~~p~~~~~~l~~Li~~Cl~~dP~~RPs~ 540 (641)
.+|...+..+.+|+.+||+.||.+||+.
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCCHHHCCC
T ss_conf 8986689999999986663893442256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.71 Aligned_cols=250 Identities=24% Similarity=0.441 Sum_probs=208.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC-CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEEEC
Q ss_conf 079776520100184689999988-9289999954799999113999999985079996135704105--8408999725
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~-~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~Ey~ 356 (641)
.++|+..++||+|+||+||+|.++ +..||||+++.... ..+.|.+|+.++++++||||++++|+|. ...++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 699799689820788399999988998999999874757-7899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|..++... ...+++..+++|+.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 899388864102--4677689999999999999998754---68434665413588769984798861442023578722
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 78864211379998756689000004999950368879999999991-99999983799999862411112588789998
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWP 515 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p 515 (641)
. .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+......... ....|
T Consensus 157 ~-------~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~------~~~~p 223 (258)
T d1k2pa_ 157 S-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRP 223 (258)
T ss_dssp C-------CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC------CCCCC
T ss_pred E-------ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC------CCCCC
T ss_conf 5-------2465788775780786379988521033643246739755999988999999999998079------78996
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
Q ss_conf 2359999999999851133999994799999989
Q 006545 516 FVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLE 549 (641)
Q Consensus 516 ~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~ 549 (641)
...+..+.+|+.+||+.+|.+||++.+ ++..|.
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~e-il~~L~ 256 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKI-LLSNIL 256 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHH
T ss_conf 546599999999976689768939999-998741
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.47 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=207.4
Q ss_pred CCCCCCCCEEECCCCEEEEEEEECC-EEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEEEEECC
Q ss_conf 0797765201001846899999889-289999954799999113999999985079996135704105-84089997258
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLVYEYLP 357 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~~-~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV~Ey~~ 357 (641)
..+|.+...||+|+||.||+|.+++ ..||||++.... ...+.|.+|+.++++++|||||+++|+|. +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECC
T ss_conf 79979846993079809999999999999999988044-88899999999998666678868999982397599999447
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99923331027999999999999999998999999873099960105678884685569820112442000145343467
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|..++.... ...+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEE
T ss_conf 994354200003-5530599999999999999998754---114335312307999899929984425554256887335
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 88642113799987566890000049999503688799999999919-99999837999998624111125887899982
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG-~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 516 (641)
.....||+.|+|||++..+.++.++|||||||++|||+|| ++|+............... .....+.
T Consensus 171 -------~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~------~~~~~~~ 237 (285)
T d1fmka3 171 -------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------YRMPCPP 237 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------CCCCCCT
T ss_pred -------ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC------CCCCCCC
T ss_conf -------245455665458089837998917741323589999986899999888899999999826------8999983
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 3599999999998511339999947999999898786
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 517 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~ 553 (641)
.++..+.+|+.+||+.+|.+||++.+ |...|+.+..
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~~~~ 273 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEY-LQAFLEDYFT 273 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHTTTS
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHC
T ss_conf 23799999999975669758919999-9998766623
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.20 Aligned_cols=239 Identities=22% Similarity=0.369 Sum_probs=191.4
Q ss_pred CCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCC--CCHHHHHHHHHHHCCCCCCEEEEECCCC------CCEEEEE
Q ss_conf 76520100184689999988--928999995479999--9113999999985079996135704105------8408999
Q 006545 284 DPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ--GPSEFQQEIDILSKIRHPNLVTLVGACP------EVWTLVY 353 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~------~~~~LV~ 353 (641)
....+||+|+||+||+|.+. +..||+|++...... ....|.+|+++|++++|||||++++++. ...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996--01056788846855-6982011244200014
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHS--IVHGDLKPANILLD-ANFVSKLSDFGISRFL 430 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~g--iiHrDIKp~NILld-~~~~vKL~DFGla~~~ 430 (641)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 57898948999751---3554699999999999999999997---89979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 53434678864211379998756689000004999950368879999999991999999837999998624111125887
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~ 510 (641)
..... ...+||+.|+|||++.+ .|+.++|||||||++|||++|++||............- .... .
T Consensus 166 ~~~~~----------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i--~~~~--~ 230 (270)
T d1t4ha_ 166 RASFA----------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGV--K 230 (270)
T ss_dssp CTTSB----------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--TTTC--C
T ss_pred CCCCC----------CCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH--HCCC--C
T ss_conf 68766----------77553813008988478-99986711007999999987889998765599999999--7389--9
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 899982359999999999851133999994799
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 511 ~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
...++...++.+.+|+.+||..+|.+||++.++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~el 263 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 865675578999999999763797589299999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=353.68 Aligned_cols=238 Identities=25% Similarity=0.360 Sum_probs=200.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCC---CCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEE
Q ss_conf 79776520100184689999988--928999995479---9999113999999985079996135704105--8408999
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~ 353 (641)
++|++.+.||+|+||+||+|... +..||||++... .....+.+.+|+.+++.++||||+++++++. +..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||++||+|..++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 50378632234322---2211100799999999876554124---76770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991999999837999998624111125887899
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 513 (641)
. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+............ ..
T Consensus 158 ~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-------~~ 219 (316)
T d1fota_ 158 T-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-------LR 219 (316)
T ss_dssp B-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------CC
T ss_pred C-----------CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-------CC
T ss_conf 6-----------43457634359999838999804304653336899975989999969999999997089-------88
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCC-----CHHH
Q ss_conf 9823599999999998511339999-----9479
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRP-----ELGK 542 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RP-----s~~e 542 (641)
+|...+..+.+++.+||..+|.+|| ++.+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~ 253 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 253 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHH
T ss_conf 9977899999999999544997666431021999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=354.69 Aligned_cols=238 Identities=21% Similarity=0.294 Sum_probs=200.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCC---CCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEE
Q ss_conf 79776520100184689999988--928999995479---9999113999999985079996135704105--8408999
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH---SLQGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVY 353 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~ 353 (641)
++|++.+.||+|+||.||+|.++ +..||||++... .......+.+|+.+|+.++||||+++++++. ...++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 72589992333102799999999999999999899999987309996010567888468556982011244200014534
Q 006545 354 EYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQN 433 (641)
Q Consensus 354 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~ 433 (641)
||+.+|+|..++... ..+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 233466226667515---898999999999999998999985---99861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991999999837999998624111125887899
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 513 (641)
. ....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+............ ..
T Consensus 195 ~-----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-------~~ 256 (350)
T d1rdqe_ 195 T-----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-------VR 256 (350)
T ss_dssp B-----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------CC
T ss_pred C-----------CCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-------CC
T ss_conf 6-----------43367635678899717998853311450078999975889989959999999986179-------88
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCC-----CHHH
Q ss_conf 9823599999999998511339999-----9479
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRP-----ELGK 542 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RP-----s~~e 542 (641)
.|...+..+.+|+.+||..||.+|+ ++.+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e 290 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHH
T ss_conf 9766899999999998340998606553454999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.63 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCC------CCHHHHHHHHHHHCCCCCCEEEEECCCC--CCE
Q ss_conf 079776520100184689999988--928999995479999------9113999999985079996135704105--840
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ------GPSEFQQEIDILSKIRHPNLVTLVGACP--EVW 349 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~------~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~ 349 (641)
.+.|++.+.||+|+||+||+|... |..||||++...... ..+.|.+|+.+|++++|||||++++++. ...
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CCCCCCCC
Q ss_conf 89997258999233310279999999999999999989999998730999601056788846855698----20112442
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF----VSKLSDFG 425 (641)
Q Consensus 350 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~----~vKL~DFG 425 (641)
++|||||++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 9999867786431001035---642155789999999999876662---5422113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 00014534346788642113799987566890000049999503688799999999919999998379999986241111
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN 505 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~ 505 (641)
+|........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.............
T Consensus 163 ~a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp TCEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred HHHHCCCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 4210577763---------1224777743099998189999766522140999999708899889999999999981688
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 25887899982359999999999851133999994799
Q 006545 506 LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 506 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
.+ ....+...+..+.+|+.+||..+|.+||++.++
T Consensus 234 ~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 268 (293)
T d1jksa_ 234 EF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268 (293)
T ss_dssp CC---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CC---CCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 88---701047889999999999863896689199999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.55 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=207.5
Q ss_pred CCCCCCCCEEECCCCEEEEEEEECC-----EEEEEEEECCCCCCC-CHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEEE
Q ss_conf 0797765201001846899999889-----289999954799999-113999999985079996135704105-840899
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG-PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTLV 352 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~~-----~~vAiK~~~~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~LV 352 (641)
..+|++.+.||+|+||.||+|.+.. ..||||++....... ...|.+|+.++++++||||++++|+|. +..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953747999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730999601056788846855698201124420001453
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++|+|.+++... ..++++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 9840698077654224--7899999999999999877523022---6744141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 434678864211379998756689000004999950368879999999991-9999998379999986241111258878
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~ 511 (641)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.......... ...
T Consensus 161 ~~~~~-------~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~------~~~ 227 (273)
T d1mp8a_ 161 STYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------GER 227 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------TCC
T ss_pred CCCEE-------CCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC------CCC
T ss_conf 76233-------05400583103266751699887452444247899998269999888999999999981------899
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 999823599999999998511339999947999999898786
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRA 553 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~ 553 (641)
...|..++..+.+|+.+||..+|.+||++.+ |...|..+..
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e-i~~~L~~i~~ 268 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE-LKAQLSTILE 268 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHH
T ss_conf 9898777999999999976879768929999-9999999977
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.44 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=208.4
Q ss_pred CHHHHHHHCCCCCCCCEEECCCCEEEEEEEEC-------CEEEEEEEECCCCCC-CCHHHHHHHHHHHCC-CCCCEEEEE
Q ss_conf 85667321079776520100184689999988-------928999995479999-911399999998507-999613570
Q 006545 272 SFSEIEGATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLV 342 (641)
Q Consensus 272 ~~~ei~~~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~ 342 (641)
..++++....+|.+.+.||+|+||.||+|.+. ++.||||++...... ....+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 98252616799798449841678399999986777555783999999860017178999999999988614998499741
Q ss_pred CCCC---CCEEEEEEECCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 4105---84089997258999233310279-------------9999999999999999899999987309996010567
Q 006545 343 GACP---EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL 406 (641)
Q Consensus 343 g~~~---~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDI 406 (641)
+++. ...++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCC
T ss_conf 154047975799998458992999998536666653222023321468999999999999999998873---79717867
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-C
Q ss_conf 888468556982011244200014534346788642113799987566890000049999503688799999999919-9
Q 006545 407 KPANILLDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-R 485 (641)
Q Consensus 407 Kp~NILld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG-~ 485 (641)
||+|||++.++.+||+|||+|+.......... .....||+.|+|||++.++.++.++|||||||++|||+|| .
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCC------TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCCCC------CCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCC
T ss_conf 73106577998289845752001135665222------475166721020368646889966322136789999986889
Q ss_pred CCCCCCHH---HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99998379---9999862411112588789998235999999999985113399999479999998987860
Q 006545 486 PALGITKE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 486 ~Pf~~~~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
+||..... +...+..+. ....|...++.+.+|+.+||+.+|.+||++.+ +++.|+.+...
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e-il~~L~~ilq~ 297 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKEGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE-LVEHLGNLLQA 297 (299)
T ss_dssp CSSTTCCCSHHHHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 99989998999999996389--------88888657899999999976779667919999-99999799867
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.33 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=202.0
Q ss_pred CCEEECCCCEEEEEEEECC-----EEEEEEEECCCCC-CCCHHHHHHHHHHHCCCCCCEEEEECCCC---CCEEEEEEEC
Q ss_conf 5201001846899999889-----2899999547999-99113999999985079996135704105---8408999725
Q 006545 286 SLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSL-QGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYL 356 (641)
Q Consensus 286 ~~~LG~G~fG~Vykg~~~~-----~~vAiK~~~~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~LV~Ey~ 356 (641)
..+||+|+||+||+|.+.. ..||||++..... .....|.+|+++|++++||||++++|+|. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
++|+|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 06741442101--34540489999999998876520033---67625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH-HHH--HHHHHCCCCCCCCCCCCC
Q ss_conf 78864211379998756689000004999950368879999999991999999837-999--998624111125887899
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK-EVQ--YALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~-~~~--~~~~~~~~~~~ld~~~~~ 513 (641)
.. .......||+.|+|||.+.++.++.++||||||+++|||+||..||.... ..+ ..+..+. ...
T Consensus 187 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~--------~~~ 254 (311)
T d1r0pa_ 187 SV----HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLL 254 (311)
T ss_dssp CT----TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC--------CCC
T ss_pred CC----EECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------CCC
T ss_conf 31----002565556455676887437999745746619999999978999988899999999998089--------889
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 98235999999999985113399999479999998987860
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.|..+++.+.+|+.+||..+|.+||++.+ |.+.|+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~e-i~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSE-LVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 96447599999999976889768939999-99999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.16 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=208.5
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC---CCEEEEEEECC
Q ss_conf 797765201001846899999889289999954799999113999999985079996135704105---84089997258
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP---EVWTLVYEYLP 357 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~---~~~~LV~Ey~~ 357 (641)
.+|++...||+|+||.||+|.+++..||||+++... ..+.|.+|+.++++++||||++++|+|. +.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 994885798207980899999999099999988577--799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99923331027999999999999999998999999873099960105678884685569820112442000145343467
Q 006545 358 NGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEISS 437 (641)
Q Consensus 358 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~~ 437 (641)
+|+|.++|.... ...+++..++.|+.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 998999987457-8888999999999999852321133---765536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf 8864211379998756689000004999950368879999999991-999999837999998624111125887899982
Q 006545 438 NNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPLAGDWPF 516 (641)
Q Consensus 438 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~~p~ 516 (641)
....++..|+|||++.++.+++++|||||||++|||+| |++||......+....... ......|.
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------~~~~~~~~ 223 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------GYKMDAPD 223 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------TCCCCCCT
T ss_pred --------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC------CCCCCCCC
T ss_conf --------6556664677817872798885887775799999999789999999999999999980------89999976
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 35999999999985113399999479999998987860
Q 006545 517 VQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 517 ~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
..+..+.+|+.+||..||.+||++.+ +.+.|+.++..
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~-l~~~L~~i~~~ 260 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQ-LREQLEHIKTH 260 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 57999999999975669768939999-99999999867
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=353.56 Aligned_cols=239 Identities=26% Similarity=0.347 Sum_probs=192.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCC---CCCHHHHHH---HHHHHCCCCCCEEEEECCCC--CCEE
Q ss_conf 79776520100184689999988--92899999547999---991139999---99985079996135704105--8408
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL---QGPSEFQQE---IDILSKIRHPNLVTLVGACP--EVWT 350 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~---~~~~~f~~E---i~iL~~l~HpnIv~l~g~~~--~~~~ 350 (641)
++|++.+.||+|+||.||+|... +..||||++..... .....+.+| +.+++.++|||||++++++. +..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99972589992333102799999999999999999899999987309996010567888468556982011244200014
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~ 430 (641)
+||||++||+|.+++... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 999914898389998732---553278999999999999999997---79622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH-HHHHCCCCCCCC
Q ss_conf 53434678864211379998756689000004-9999503688799999999919999998379999-986241111258
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQY-ALDTGKLKNLLD 508 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~-~~~~~~~~~~ld 508 (641)
..... ....||+.|+|||++.. ..|++++|||||||++|+|+||++||........ .+.. ...
T Consensus 158 ~~~~~----------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-----~~~ 222 (364)
T d1omwa3 158 SKKKP----------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----MTL 222 (364)
T ss_dssp SSSCC----------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-----HSS
T ss_pred CCCCC----------CCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----HCC
T ss_conf 78864----------331134554216876038999844104677899999985999888899899999998-----604
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCH
Q ss_conf 87899982359999999999851133999994
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 509 ~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~ 540 (641)
.....+|...++.+.+|+.+||..||.+||+.
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCC
T ss_conf 68887887789999999999856698880887
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.10 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=208.4
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CE--EEEEEEECCCC-CCCCHHHHHHHHHHHCC-CCCCEEEEECCCC--CCEEEE
Q ss_conf 79776520100184689999988--92--89999954799-99911399999998507-9996135704105--840899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HM--QVAIKMLHPHS-LQGPSEFQQEIDILSKI-RHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~--~vAiK~~~~~~-~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~LV 352 (641)
++|++.+.||+|+||.||+|.+. +. .||||++.... ......|.+|+.+|+++ +||||++++|+|. +..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf 9725899923331027-------------999999999999999998999999873099960105678884685569820
Q 006545 353 YEYLPNGSLEDRLSCK-------------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVS 419 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~v 419 (641)
|||+++|+|.++|... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCE
T ss_conf 98028986999986403555551231012345789999999999999999876630---895455505204898688763
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCHHHHHHH
Q ss_conf 112442000145343467886421137999875668900000499995036887999999999199-9999837999998
Q 006545 420 KLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGR-PALGITKEVQYAL 498 (641)
Q Consensus 420 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~-~Pf~~~~~~~~~~ 498 (641)
||+|||+|+........ ....||..|+|||.+.++.++.++|||||||++|||++|. +||...+......
T Consensus 167 kl~DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EECCTTCEESSCEECCC-------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EECCCCCCCCCCCCCCC---------CCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 87434432244422345---------530137755553875269999622153138899999836899999999999999
Q ss_pred HHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 62411112588789998235999999999985113399999479999998987860
Q 006545 499 DTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 499 ~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.... ......|..+++.+.+|+.+||..+|.+||++.+ ++..|+.+...
T Consensus 238 ~i~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e-il~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQ------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRMLEE 286 (309)
T ss_dssp HGGG------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHS
T ss_pred HHHH------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 9982------6888887667899999999976789668949999-99999999861
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=348.60 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=208.4
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC---CHHHHHHHHHHHCCCCCCEEEEECCCCC------C
Q ss_conf 079776520100184689999988--9289999954799999---1139999999850799961357041058------4
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACPE------V 348 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~ 348 (641)
.++|.+.+.||+|+||.||+|.+. +..||||++....... ...|.+|+.+++.++||||+++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 08999725899923331027999999999999999998999999873099960105678884685569820112442000
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~ 428 (641)
.|+||||++||+|.+++.. ..++++..+..|+.|++.||.|||+ +||+||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 9999977889871011203---5899999999999999999999985---795276346755665754320100344432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 14534346788642113799987566890000049999503688799999999919999998379999986241111258
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLD 508 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld 508 (641)
......... .......||+.|+|||++.+..+++++|||||||++|+|+||++||...+...............
T Consensus 160 ~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 160 AIADSGNSV-----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP- 233 (277)
T ss_dssp ECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-
T ss_pred HHCCCCCCC-----CCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-
T ss_conf 212354433-----33464257624369999839999966320265289999976979989969999999998469999-
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHH
Q ss_conf 87899982359999999999851133999994799999989878
Q 006545 509 PLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMR 552 (641)
Q Consensus 509 ~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~ 552 (641)
+ ...+...+..+.+|+.+||..||.+||+..+++...|..+.
T Consensus 234 ~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C--CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 7--10034789999999999866797677739999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.60 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=200.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEE--CCEEEEEEEECCCC---CCCCHHHHHHHHHHH-CCCCCCEEEEECCCC--CCEEEE
Q ss_conf 7977652010018468999998--89289999954799---999113999999985-079996135704105--840899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHS---LQGPSEFQQEIDILS-KIRHPNLVTLVGACP--EVWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~--~~~~vAiK~~~~~~---~~~~~~f~~Ei~iL~-~l~HpnIv~l~g~~~--~~~~LV 352 (641)
.+|.+.+.||+|+||+||+|.. ++..||||++.+.. ......+..|..++. .++||||+++++++. +..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730999601056788846855698201124420001453
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~ 432 (641)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640---4789999999999999999999986---8934034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 43467886421137999875668900000499995036887999999999199999983799999862411112588789
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAG 512 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~ 512 (641)
.... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+........... ..
T Consensus 156 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------~~ 220 (320)
T d1xjda_ 156 GDAK--------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------NP 220 (320)
T ss_dssp TTCC--------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC
T ss_pred CCCC--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC-------CC
T ss_conf 6533--------45457877768999982799883232011227898987388999998999999999718-------99
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf 99823599999999998511339999947999
Q 006545 513 DWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 513 ~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
.+|...+..+.+|+.+||..+|.+||++..++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 89756799999999996544898783889999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.58 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=211.7
Q ss_pred CCCCCCCCEEECCCCEEEEEEEECC---------EEEEEEEECCCCCC-CCHHHHHHHHHHHCC-CCCCEEEEECCCC--
Q ss_conf 0797765201001846899999889---------28999995479999-911399999998507-9996135704105--
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP-- 346 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~~---------~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 346 (641)
.++|.+.+.||+|+||.||+|...+ ..||||+++..... ....+.+|...+.++ +|||||+++|+|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCEEEEEEECCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 84089997258999233310279-------------99999999999999998999999873099960105678884685
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKD-------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILL 413 (641)
Q Consensus 347 ~~~~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILl 413 (641)
...++||||+.+|+|.+++.... ....+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCEEE
T ss_conf 86899997369990999998606776432223345743467999999999999999987663---797863022102245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCH
Q ss_conf 5698201124420001453434678864211379998756689000004999950368879999999991-999999837
Q 006545 414 DANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITK 492 (641)
Q Consensus 414 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~ 492 (641)
+.++.+||+|||+++.......... .....|++.|+|||++.++.|+.++|||||||++|||++ |.+||....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKK------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCC------CTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCC------CCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 4789767622111011355555431------4667888466326675179888255547758888874017989899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 99999862411112588789998235999999999985113399999479999998987860
Q 006545 493 EVQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 493 ~~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
......... .......|...+..+.+|+.+||+.+|.+||++.+ |.+.|+.+.+.
T Consensus 243 ~~~~~~~i~------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~e-il~~L~~i~a~ 297 (299)
T d1fgka_ 243 VEELFKLLK------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ-LVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHH------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred HHHHHHHHH------CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHC
T ss_conf 999999997------28888987435299999999976679767939999-99999888604
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.67 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=208.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEECC-----EEEEEEEECCCCCCC---CHHHHHHHHHHHCCCCCCEEEEECCCC-CCEEE
Q ss_conf 797765201001846899999889-----289999954799999---113999999985079996135704105-84089
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRH-----MQVAIKMLHPHSLQG---PSEFQQEIDILSKIRHPNLVTLVGACP-EVWTL 351 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~vAiK~~~~~~~~~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~L 351 (641)
.+|++.+.||+|+||.||+|.+.+ ..||||++....... .+.|.+|+.+|++++||||++++|+|. +..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99725899923331027999999999999999998999999873099960105678884685569820112442000145
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLS 431 (641)
Q Consensus 352 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~ 431 (641)
||||+++|+|.+++... ..++++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 46542386125444212--6899999999999999999987521---787520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 3434678864211379998756689000004999950368879999999991-999999837999998624111125887
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGITKEVQYALDTGKLKNLLDPL 510 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~~~~~~~~~~~~~~~~ld~~ 510 (641)
...... .......|+..|+|||++.+..++.++|||||||++|||+| |++||...+.........+...
T Consensus 163 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~----- 232 (273)
T d1u46a_ 163 QNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----- 232 (273)
T ss_dssp C-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-----
T ss_pred CCCCCC-----EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-----
T ss_conf 588752-----6547632573107999983799994215661489999999689999999699999999984799-----
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
Q ss_conf 89998235999999999985113399999479999998987
Q 006545 511 AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 511 ~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l 551 (641)
....+...+..+.+|+.+||..+|.+||++.+ |.+.|...
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-i~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA-LRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHC
T ss_conf 99985445399999999976889667929999-99999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.63 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=207.3
Q ss_pred HCCCCCCCCEEECCCCEEEEEEEEC-------CEEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCC--CCC
Q ss_conf 1079776520100184689999988-------928999995479999-911399999998507999613570410--584
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGAC--PEV 348 (641)
Q Consensus 279 ~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~ 348 (641)
...+|...+.||+|+||+||+|.++ +..||||+++..... ....|.+|+.++++++||||++++|+| .+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 68991883598207881899999878644778968999998701286899999999999997699988412547842881
Q ss_pred EEEEEEECCCCCHHHHHHCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCC
Q ss_conf 08999725899923331027-------99999999999999999899999987309996010567888468556982011
Q 006545 349 WTLVYEYLPNGSLEDRLSCK-------DNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKL 421 (641)
Q Consensus 349 ~~LV~Ey~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL 421 (641)
.++||||+++|+|.+++... .....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEEEE
T ss_conf 067776048998899987503321134446887999999999999999998764---79654328677540359964999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHH
Q ss_conf 244200014534346788642113799987566890000049999503688799999999919-9999983799999862
Q 006545 422 SDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTG-RPALGITKEVQYALDT 500 (641)
Q Consensus 422 ~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG-~~Pf~~~~~~~~~~~~ 500 (641)
+|||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+|| .+||...+........
T Consensus 175 ~DFGla~~~~~~~~~------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EECCCCEECCCCCCE------EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 424542023577630------31340231632378888736998833344437899999996899999998999999999
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
Q ss_conf 411112588789998235999999999985113399999479999998987
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPM 551 (641)
Q Consensus 501 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l 551 (641)
. +......|..++..+.+|+.+||+.+|.+||++.+ |++.|+..
T Consensus 249 ~------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~-il~~L~~~ 292 (308)
T d1p4oa_ 249 M------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSIKEE 292 (308)
T ss_dssp H------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHGGG
T ss_pred H------HCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHH
T ss_conf 8------08888886335399999999975779658939999-99997876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.51 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=208.3
Q ss_pred HCCCCCCCCEEECCCCEEEEEEEEC-------CEEEEEEEECCCCCC-CCHHHHHHHHHHHCC-CCCCEEEEECCCC--C
Q ss_conf 1079776520100184689999988-------928999995479999-911399999998507-9996135704105--8
Q 006545 279 ATHNFDPSLKIGEGGYGSIYKGLLR-------HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKI-RHPNLVTLVGACP--E 347 (641)
Q Consensus 279 ~~~~f~~~~~LG~G~fG~Vykg~~~-------~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~--~ 347 (641)
...+|++.+.||+|+||.||+|.+. +..||||+++..... ....|.+|+.+++++ +|||||+++|+|. +
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred CEEEEEEECCCCCHHHHHHCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 4089997258999233310279---------------9999999999999999899999987309996010567888468
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKD---------------NSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANIL 412 (641)
Q Consensus 348 ~~~LV~Ey~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NIL 412 (641)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCC
T ss_conf 789999737998799999853566544444533222334588999999999999999998875---79266624102100
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 55698201124420001453434678864211379998756689000004999950368879999999991-99999983
Q 006545 413 LDANFVSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLT-GRPALGIT 491 (641)
Q Consensus 413 ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~Ellt-G~~Pf~~~ 491 (641)
++.++.+||+|||+++........ .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCCCCCCCCCCCCHHEECCCCCCC------EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 002575210234010233678861------58620135968767788617999974001025899999985899887789
Q ss_pred HH---HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 79---9999862411112588789998235999999999985113399999479999998987860
Q 006545 492 KE---VQYALDTGKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 492 ~~---~~~~~~~~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
.. +...+..+ . ....|...+..+.+|+.+||+.+|.+||++.+ ++++|+.+...
T Consensus 252 ~~~~~~~~~i~~~-~-------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~-il~~L~~~i~~ 308 (311)
T d1t46a_ 252 PVDSKFYKMIKEG-F-------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ-IVQLIEKQISE 308 (311)
T ss_dssp CSSHHHHHHHHHT-C-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCC-C-------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHCC
T ss_conf 9899999998668-9-------88985436599999999975779657929999-99999876534
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.80 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=193.9
Q ss_pred CCCCCCCC-EEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCC-CCCCEEEEECCCC------CCE
Q ss_conf 07977652-0100184689999988--928999995479999911399999998507-9996135704105------840
Q 006545 280 THNFDPSL-KIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKI-RHPNLVTLVGACP------EVW 349 (641)
Q Consensus 280 ~~~f~~~~-~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~------~~~ 349 (641)
.++|.+.. .||+|+||.||+|.+. +..||||++.. ...+.+|+.++.++ +||||+++++++. ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCCCCCCCCC
Q ss_conf 899972589992333102799999999999999999899999987309996010567888468556---98201124420
Q 006545 350 TLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA---NFVSKLSDFGI 426 (641)
Q Consensus 350 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~---~~~vKL~DFGl 426 (641)
|+|||||+||+|.+++... ....+++..+..|+.|++.||.|||+ +||+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-78775799999999999999999997---6986444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH--HHHCCCC
Q ss_conf 00145343467886421137999875668900000499995036887999999999199999983799999--8624111
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYA--LDTGKLK 504 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~--~~~~~~~ 504 (641)
|+....... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||...+..... .......
T Consensus 161 a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~ 231 (335)
T d2ozaa1 161 AKETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231 (335)
T ss_dssp CEECCCCCC---------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred EEECCCCCC---------CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHC
T ss_conf 233368886---------43226775637927774898888888876451677886588998898877889999999853
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf 1258878999823599999999998511339999947999
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
..... ........+..+.+|+.+||..+|.+||++.+++
T Consensus 232 ~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 232 GQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp CSSSC-CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 88888-9854346999999999997569965790999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.85 Aligned_cols=247 Identities=20% Similarity=0.296 Sum_probs=200.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEE
Q ss_conf 079776520100184689999988--928999995479999911399999998507999613570410--5840899972
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey 355 (641)
.++|.+.+.||+|+||+||+|... +..||+|++.... .....+.+|+.+|+.++||||+++++++ ....|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCCCCCCCCCCCCCCCC
Q ss_conf 5899923331027999999999999999998999999873099960105678884685569--82011244200014534
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN--FVSKLSDFGISRFLSQN 433 (641)
Q Consensus 356 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~--~~vKL~DFGla~~~~~~ 433 (641)
|+||+|.+++.. ...++++..+..|+.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 899808899875--38999999999999999999999987---6997513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 34678864211379998756689000004999950368879999999991999999837999998624111125887899
Q 006545 434 EISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLLDPLAGD 513 (641)
Q Consensus 434 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~ld~~~~~ 513 (641)
... ....||+.|+|||.+.+..|+.++|||||||++|+|++|++||...+..............++ ..
T Consensus 158 ~~~---------~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~ 225 (321)
T d1tkia_ 158 DNF---------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD---EE 225 (321)
T ss_dssp CEE---------EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---HH
T ss_pred CCC---------CCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---HH
T ss_conf 753---------212233222340210487778401130279999999828999999899999999983899988---02
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf 9823599999999998511339999947999
Q 006545 514 WPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 514 ~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
.+...+..+.+|+.+||..||.+||++.+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 2367899999999998669966890999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.80 Aligned_cols=244 Identities=25% Similarity=0.269 Sum_probs=193.1
Q ss_pred CCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC-----CHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEEEC
Q ss_conf 520100184689999988--9289999954799999-----113999999985079996135704105--8408999725
Q 006545 286 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG-----PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYEYL 356 (641)
Q Consensus 286 ~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~-----~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~Ey~ 356 (641)
.++||+|+||+||+|.+. +..||||++....... ...+.+|+.+++.++|||||++++++. +..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89992333102799999999999999999899999987309996010567888468556982011244200014534346
Q 006545 357 PNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEIS 436 (641)
Q Consensus 357 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~~ 436 (641)
.++++..++ .....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred CCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 450776554---126677899999999999999988631---63550357762588537784114657610005787554
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCC------CCC
Q ss_conf 788642113799987566890000049-9995036887999999999199999983799999862411112------588
Q 006545 437 SNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL------LDP 509 (641)
Q Consensus 437 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~------ld~ 509 (641)
....+||+.|+|||++.+. .|+.++|||||||++|||+||.+||......+........... .+.
T Consensus 157 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 157 --------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp --------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred --------CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCH
T ss_conf --------330204733363999726778880564363042899998596999999999999999985189972545210
Q ss_pred ----------CCCCC-----CHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf ----------78999-----82359999999999851133999994799
Q 006545 510 ----------LAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 510 ----------~~~~~-----p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
..... ....+..+.+|+.+||+.||.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~ 277 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred HCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 0021344303478988678565689999999999763894569089999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=339.45 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=200.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEE--CCEEEEEEEECCCCCCCC---------HHHHHHHHHHHCCC-CCCEEEEECCCC--
Q ss_conf 7977652010018468999998--892899999547999991---------13999999985079-996135704105--
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL--RHMQVAIKMLHPHSLQGP---------SEFQQEIDILSKIR-HPNLVTLVGACP-- 346 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~--~~~~vAiK~~~~~~~~~~---------~~f~~Ei~iL~~l~-HpnIv~l~g~~~-- 346 (641)
.+|++.+.||+|+||+||+|.. .+..||||++........ +.+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 84089997258999233310279999999999999999989999998730999601056788846855698201124420
Q 006545 347 EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGI 426 (641)
Q Consensus 347 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGl 426 (641)
+..++||||+++|+|.+++.. ..++++..+..++.|++.||.|||. +||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 605999976898668999986---5999999999999999999999987---5994323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 001453434678864211379998756689000004------99995036887999999999199999983799999862
Q 006545 427 SRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS------GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDT 500 (641)
Q Consensus 427 a~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~ 500 (641)
|+.+..... .....||+.|+|||++.+ ..+++++||||+||++|+|+||++||...+........
T Consensus 157 a~~~~~~~~---------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEECCCCCC---------EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHH
T ss_conf 167268872---------13452467888988860534456788992331856560231032288898899999999999
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 4111125887899982359999999999851133999994799
Q 006545 501 GKLKNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 501 ~~~~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
...... . ....+...++++.+|+.+||+.+|.+||++.++
T Consensus 228 ~~~~~~--~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 228 MSGNYQ--F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HHTCCC--C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHCCCC--C-CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 818988--8-985434689999999999765896689199999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.28 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=198.1
Q ss_pred CCCCCCCEEECCCCEEEEEEEECCEEEEEEEECCCCCCCCHHHHHH--HHHHHCCCCCCEEEEECCCCC------CEEEE
Q ss_conf 7977652010018468999998892899999547999991139999--999850799961357041058------40899
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQE--IDILSKIRHPNLVTLVGACPE------VWTLV 352 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~~~~~f~~E--i~iL~~l~HpnIv~l~g~~~~------~~~LV 352 (641)
.+|...+.||+|+||.||+|+++|..||||++.... ...+..| +..+..++||||++++|+|.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 689998898207881999999999899999987200---46799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 97258999233310279999999999999999989999998730-----9996010567888468556982011244200
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSC-----KPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~giiHrDIKp~NILld~~~~vKL~DFGla 427 (641)
|||+++|+|.++|.. .++++..++.++.+++.||.|||+. +.+||+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 964669898999865----8999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCH---------
Q ss_conf 0145343467886421137999875668900000499------9950368879999999991999999837---------
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGE------LTPKSDVYSFGIILLRLLTGRPALGITK--------- 492 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~s~~sDVwSlGviL~ElltG~~Pf~~~~--------- 492 (641)
+.......... .......||+.|+|||++.+.. ++.++|||||||+||||+||.+||....
T Consensus 156 ~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 156 VRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp EEEETTTTEEC----C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCCCCCCEE----CCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHC
T ss_conf 23467776200----13552503547678221056545467776750122015999999962899887663112410122
Q ss_pred --------HHHHHHHHCCCCCCCCCCCC-CC-CHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf --------99999862411112588789-99-82359999999999851133999994799999989878606
Q 006545 493 --------EVQYALDTGKLKNLLDPLAG-DW-PFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 493 --------~~~~~~~~~~~~~~ld~~~~-~~-p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~~ 555 (641)
........ ..+.|... .+ +......+.+|+.+||+.+|.+||++.+ |.+.|+.+....
T Consensus 232 ~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-i~~~L~~i~~~~ 299 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR-IKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH-HHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHC----CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHHC
T ss_conf 5564309999998750----2468887765577689999999999976069858959999-999999888865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.51 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=197.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC---CEEEEEEEECCCCC--CCCHHHHHHHHHHHCC---CCCCEEEEECCCC-----
Q ss_conf 079776520100184689999988---92899999547999--9911399999998507---9996135704105-----
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR---HMQVAIKMLHPHSL--QGPSEFQQEIDILSKI---RHPNLVTLVGACP----- 346 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~---~~~vAiK~~~~~~~--~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~----- 346 (641)
.++|++...||+|+||+||+|.+. +..||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred --CCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCC
Q ss_conf --840899972589992333102799999999999999999899999987309996010567888468556982011244
Q 006545 347 --EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 347 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DF 424 (641)
...+++|||+.++++..... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCH
T ss_conf 6746999997405871444443--037899989999999999999999975---88983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC-
Q ss_conf 2000145343467886421137999875668900000499995036887999999999199999983799999862411-
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL- 503 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~- 503 (641)
|++........ .....||+.|+|||++.+..|+.++||||+||++|||+||++||...+...........
T Consensus 161 g~~~~~~~~~~---------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 161 GLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred HHHHHHCCCCC---------CCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 01011002345---------777654851148310017988811100032899999987879989989899999999840
Q ss_pred -------------------CCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf -------------------1125887899982359999999999851133999994799
Q 006545 504 -------------------KNLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 504 -------------------~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
..........++...+..+.+|+.+||..||.+||++.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 79961105321111033302234564544044589999999999874896679189999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.75 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=195.7
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCC--CCCHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEE
Q ss_conf 79776520100184689999988--92899999547999--99113999999985079996135704105--84089997
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~E 354 (641)
.+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++. ...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25899923331027999999999999999998999999873099960105678884685569820112442000145343
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
|+.++ +.+++... ....+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCC-HHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774-45554420-25688889999999999999998652---889921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC----CCC---
Q ss_conf 467886421137999875668900000499-995036887999999999199999983799999862411----112---
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----KNL--- 506 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~----~~~--- 506 (641)
.. .....||+.|+|||++.... ++.++|||||||++|+|++|+.||...+........... ...
T Consensus 157 ~~--------~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 157 RT--------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp BC--------TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CC--------CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCC
T ss_conf 41--------0010365215411221366577742210333313427966879989889999999999832898333144
Q ss_pred ----CCCCCCCC-----------CHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf ----58878999-----------82359999999999851133999994799
Q 006545 507 ----LDPLAGDW-----------PFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 507 ----ld~~~~~~-----------p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
.......+ ....+..+.+|+.+||..||.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 4222421243454322220444166789999999999763995579189999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.97 Aligned_cols=247 Identities=26% Similarity=0.320 Sum_probs=191.3
Q ss_pred CCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCCC--------CCEEE
Q ss_conf 9776520100184689999988--9289999954799999113999999985079996135704105--------84089
Q 006545 282 NFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGACP--------EVWTL 351 (641)
Q Consensus 282 ~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~~~~L 351 (641)
+|...++||+|+||+||+|.+. +..||||++..... .+.+|+.+|++++||||++++++|. ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCCCCCCCCCCCC
Q ss_conf 997258999233310279999999999999999989999998730999601056788846855698-2011244200014
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF-VSKLSDFGISRFL 430 (641)
Q Consensus 352 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~-~vKL~DFGla~~~ 430 (641)
||||++++.+..+.........+++..+..|+.|++.||.|||+ +||+||||||+|||++.++ .+||+|||++..+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 98416886078888631036899999999999999999999986---687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCC-------
Q ss_conf 53434678864211379998756689000004-9999503688799999999919999998379999986241-------
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK------- 502 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~------- 502 (641)
...... ....||..|+|||.+.+ ..|+.++||||+||++|||++|++||...+........-+
T Consensus 174 ~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 174 VRGEPN---------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTSCC---------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCCC---------CCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHH
T ss_conf 477653---------20025555568277640468882100024652778550287998987999999999997489817
Q ss_pred ---------CCCCCCC------CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf ---------1112588------78999823599999999998511339999947999
Q 006545 503 ---------LKNLLDP------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ---------~~~~ld~------~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
.....-+ .........++.+.+|+.+||..||.+||++.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 765430621011035544567444431568999999999997658955792999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.46 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=197.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCC--CCCHHHHHHHHHHHCCCCCCEEEEECCCC---------
Q ss_conf 079776520100184689999988--92899999547999--99113999999985079996135704105---------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGACP--------- 346 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------- 346 (641)
.++|++.++||+|+||+||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCC
Q ss_conf -8408999725899923331027999999999999999998999999873099960105678884685569820112442
Q 006545 347 -EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFG 425 (641)
Q Consensus 347 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFG 425 (641)
...++||||+.++.+.... .....++...+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---203443308999999999999988522---998856767222036689968763135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 00014534346788642113799987566890000049-99950368879999999991999999837999998624111
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
+++.+......... ......||+.|+|||++.+. .|++++|||||||++|+|++|++||...+............
T Consensus 163 ~~~~~~~~~~~~~~----~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 163 LARAFSLAKNSQPN----RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp TCEECCC-----CC----CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEECCCCCCCCCC----CCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHC
T ss_conf 00223554443211----35660249787428997079998917870067864661744879989989999999999841
Q ss_pred CCCCCC-----------------CC-CCC-------HHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf 125887-----------------89-998-------23599999999998511339999947999
Q 006545 505 NLLDPL-----------------AG-DWP-------FVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ~~ld~~-----------------~~-~~p-------~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
....+. .. ..+ ...+..+.+|+.+||+.||.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 89982553443203444332013344555033404445998999999998738965890999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=328.05 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=197.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC-CEEEEEEEECCCCC--CCCHHHHHHHHHHHCCCCCCEEEEECCC--CCCEEEEEEE
Q ss_conf 79776520100184689999988-92899999547999--9911399999998507999613570410--5840899972
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR-HMQVAIKMLHPHSL--QGPSEFQQEIDILSKIRHPNLVTLVGAC--PEVWTLVYEY 355 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~-~~~vAiK~~~~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~--~~~~~LV~Ey 355 (641)
.+|...++||+|+||+||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++ ....+++|+|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58999233310279999999999999999989999998730999601056788846855698201124420001453434
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNEI 435 (641)
Q Consensus 356 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~~ 435 (641)
+.++.+..+. .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998---604775144568999999999998605---7488267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCC-----------
Q ss_conf 6788642113799987566890000049-9995036887999999999199999983799999862411-----------
Q 006545 436 SSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKL----------- 503 (641)
Q Consensus 436 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~----------- 503 (641)
. .....|++.|+|||.+.+. .++.++|||||||++|||++|++||...+...........
T Consensus 156 ~--------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 156 K--------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred C--------CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 4--------10102431101378871788888410021117589999779799898898999999998638997110421
Q ss_pred -CCC------CCCC----CCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf -112------5887----899982359999999999851133999994799
Q 006545 504 -KNL------LDPL----AGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 504 -~~~------ld~~----~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
... .... ...++...+..+.+|+.+||+.||++||++.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el 278 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 233322143333356764666512589999999999866896689099998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.82 Aligned_cols=235 Identities=23% Similarity=0.358 Sum_probs=193.0
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC------CHHHHHHHHHHHCCC--CCCEEEEECCCC--C
Q ss_conf 079776520100184689999988--9289999954799999------113999999985079--996135704105--8
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG------PSEFQQEIDILSKIR--HPNLVTLVGACP--E 347 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~------~~~f~~Ei~iL~~l~--HpnIv~l~g~~~--~ 347 (641)
.++|.+.+.||+|+||.||+|... +..||||++....... ...+.+|+.++++++ ||||+++++++. +
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEEECCC-CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCCCCCCCC
Q ss_conf 40899972589-992333102799999999999999999899999987309996010567888468556-9820112442
Q 006545 348 VWTLVYEYLPN-GSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-NFVSKLSDFG 425 (641)
Q Consensus 348 ~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~-~~~vKL~DFG 425 (641)
..++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 689999833686228999861---5899999999999999999999987---7975566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 0001453434678864211379998756689000004999-950368879999999991999999837999998624111
Q 006545 426 ISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGEL-TPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK 504 (641)
Q Consensus 426 la~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~ 504 (641)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|+|+||++||........ +.
T Consensus 157 ~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~----~~-- 220 (273)
T d1xwsa_ 157 SGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQ-- 220 (273)
T ss_dssp TCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CC--
T ss_pred CCEECCCCC----------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHHHH----CC--
T ss_conf 535324445----------56656587747999984899788653325540345367568899887367761----54--
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf 125887899982359999999999851133999994799
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 505 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
..++...+..+.+|+.+||..||.+||++.++
T Consensus 221 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 252 (273)
T d1xwsa_ 221 -------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252 (273)
T ss_dssp -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf -------47787799999999999760897589399998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.20 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=195.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCC-CCHHHHHHHHHHHCCCCCCEEEEECCCCC------CEE
Q ss_conf 079776520100184689999988--928999995479999-91139999999850799961357041058------408
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQ-GPSEFQQEIDILSKIRHPNLVTLVGACPE------VWT 350 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~~ 350 (641)
+.+|....+||+|+||+||+|... +..||||++...... ....+.+|+.+|+.++||||+++++++.. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99972589992333102799999999999999999899999987309996010567888468556982011244200014
Q 006545 351 LVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFL 430 (641)
Q Consensus 351 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~ 430 (641)
++++|+.+|+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99996259865664405----899999999999999999999997---89867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCC---
Q ss_conf 53434678864211379998756689000004-99995036887999999999199999983799999862411112---
Q 006545 431 SQNEISSNNTTLCCRTDPKGTFAYMDPEFLAS-GELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNL--- 506 (641)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~--- 506 (641)
........ .....+||+.|+|||++.. ..++.++||||+||++|+|++|++||..................
T Consensus 160 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTG-----FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCC-----TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCCCCCCE-----EECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 47776410-----1011026520003878604788874101004670133776697997888889999987652069975
Q ss_pred ----------------CCCCCCCC-----CHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf ----------------58878999-----823599999999998511339999947999
Q 006545 507 ----------------LDPLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 507 ----------------ld~~~~~~-----p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
..+..... ....+..+.+|+.+||..||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 66423433222202446775577877783789999999999997648956790899986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.09 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=195.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCCC--------
Q ss_conf 079776520100184689999988--9289999954799999--1139999999850799961357041058--------
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACPE-------- 347 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 347 (641)
..+|...++||+|+||+||+|.+. +..||||++....... ...+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 40899972589992333102799999999999999999899999987309996010567888468556982011244200
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla 427 (641)
.+++||||+ +++|..++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-521899987----4022699999999999999999873---78764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCC--
Q ss_conf 014534346788642113799987566890000049-99950368879999999991999999837999998624111--
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLK-- 504 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~-- 504 (641)
+...... +...||+.|+|||++.+. .++.++||||+||++|+|++|++||...+............
T Consensus 169 ~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 169 RQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp EECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ECCCCCC-----------CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 2068763-----------10245533358899817878996501030038999999786998889768999999850378
Q ss_pred ----------------------CCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf ----------------------1258878999823599999999998511339999947999
Q 006545 505 ----------------------NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 505 ----------------------~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
..............++.+.+|+.+||..||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 84888865300034433115786665566775568999999999997729955792999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.76 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=200.2
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECCC---CCCEEEEEEE
Q ss_conf 79776520100184689999988--928999995479999911399999998507999613570410---5840899972
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGAC---PEVWTLVYEY 355 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~---~~~~~LV~Ey 355 (641)
++|++.+.||+|+||.||+|.+. +..||||++..... ...+..|+.+++.++|+|++..++.+ .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCCCCCCCCCCCCCC
Q ss_conf 58999233310279999999999999999989999998730999601056788846855---698201124420001453
Q 006545 356 LPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLD---ANFVSKLSDFGISRFLSQ 432 (641)
Q Consensus 356 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld---~~~~vKL~DFGla~~~~~ 432 (641)
+ +++|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-8713332443--06887689999999999999999997---9944266787660643357776156504675134255
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCC-CCCCCC
Q ss_conf 4346788642113799987566890000049999503688799999999919999998379999986241111-258878
Q 006545 433 NEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKN-LLDPLA 511 (641)
Q Consensus 433 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~-~ld~~~ 511 (641)
....... .........||+.|+|||++.+..++.++|||||||++|||+||++||................. ......
T Consensus 159 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred CCCCCCE-ECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
T ss_conf 4455410-001357767873532999991899898321886177899998498766553057799999985235678983
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 9998235999999999985113399999479999998987860
Q 006545 512 GDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRAS 554 (641)
Q Consensus 512 ~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~ 554 (641)
...+..++.++.+++.+||..+|.+||++.+ +.+.|+.+...
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~-i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHR 279 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH-HHHHHHHHHHH
T ss_pred HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 5753478899999999984399557919999-99999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=322.63 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=203.8
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCCC-CCEEEEECCC--CCCEEEEEE
Q ss_conf 079776520100184689999988--92899999547999991139999999850799-9613570410--584089997
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEVWTLVYE 354 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~--~~~~~LV~E 354 (641)
.++|.+.+.||+|+||+||+|.+. +..||||++.... ....+.+|+.++..+.| +|++.+++++ ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCCCCCCCCCCCC
Q ss_conf 2589992333102799999999999999999899999987309996010567888468556-----98201124420001
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDA-----NFVSKLSDFGISRF 429 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~-----~~~vKL~DFGla~~ 429 (641)
|+ +++|.+++... ...++...+..++.|++.||.|||+ +||+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-88879999752--0311068999999999999999997---796626677131523475434479568723660577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH---HHHHHHHHCCCCCC
Q ss_conf 453434678864211379998756689000004999950368879999999991999999837---99999862411112
Q 006545 430 LSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITK---EVQYALDTGKLKNL 506 (641)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~---~~~~~~~~~~~~~~ 506 (641)
+......... .........||+.|+|||++.+..+++++|||||||++|||+||+.||.... ..............
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCE-EECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 1467665411-102467627751026798964888886999898319999998698767885302199999999705679
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 5887899982359999999999851133999994799999989878606
Q 006545 507 LDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDVWRVLEPMRASC 555 (641)
Q Consensus 507 ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v~~~L~~l~~~~ 555 (641)
. + ....+..+++++.+++..|+..+|.+||++.. +...|..+....
T Consensus 235 ~-~-~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~-l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 T-P-LRELCAGFPEEFYKYMHYARNLAFDATPDYDY-LQGLFSKVLERL 280 (293)
T ss_dssp S-C-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH-HHHHHHHHHHHT
T ss_pred C-C-HHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHHHC
T ss_conf 9-9-58965799899999999984399300859999-999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.55 Aligned_cols=247 Identities=20% Similarity=0.249 Sum_probs=194.9
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCC--------C
Q ss_conf 079776520100184689999988--9289999954799999--113999999985079996135704105--------8
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--------E 347 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--------~ 347 (641)
..+|++.++||+|+||+||+|.+. +..||||++....... ...+.+|+.+++.++||||+++++++. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 40899972589992333102799999999999999999899999987309996010567888468556982011244200
Q 006545 348 VWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGIS 427 (641)
Q Consensus 348 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla 427 (641)
..|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHHH-HHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 26999841446778-7650-----389999999999999999988652---21124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCC-----
Q ss_conf 014534346788642113799987566890000049999503688799999999919999998379999986241-----
Q 006545 428 RFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGK----- 502 (641)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~----- 502 (641)
+....... .....||+.|+|||++.+..+++++||||+||++|+|++|++||.+.+..........
T Consensus 167 ~~~~~~~~---------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 167 RTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp -----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred HCCCCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 11466655---------332214655558133147777877433356625789865989988897788999999720589
Q ss_pred ---------------CCC---------------CCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf ---------------111---------------258878999823599999999998511339999947999
Q 006545 503 ---------------LKN---------------LLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 503 ---------------~~~---------------~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
... ...+.....+...+..+.+|+.+||..||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 879998765667777641754356664212643335432101333799999999998769945790899996
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=312.49 Aligned_cols=243 Identities=19% Similarity=0.328 Sum_probs=190.9
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCC-CCCEEEEECCCC----CCEEEE
Q ss_conf 079776520100184689999988--9289999954799999113999999985079-996135704105----840899
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACP----EVWTLV 352 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~----~~~~LV 352 (641)
.++|.+.++||+|+||+||+|.+. +..||||++... ....+.+|+.+|..+. ||||+++++++. ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 86718978983174819999998899979999998889---999999999999851579987679999981687712688
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCCCCCCCCCCCCCC
Q ss_conf 9725899923331027999999999999999998999999873099960105678884685569-820112442000145
Q 006545 353 YEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDAN-FVSKLSDFGISRFLS 431 (641)
Q Consensus 353 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~-~~vKL~DFGla~~~~ 431 (641)
|||+.+++|.... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|....
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 8631798589974------689999999999999999988764---3344345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHH-HHHHHH----------
Q ss_conf 34346788642113799987566890000049-999503688799999999919999998379-999986----------
Q 006545 432 QNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKE-VQYALD---------- 499 (641)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~-~~~~~~---------- 499 (641)
.... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||..... ......
T Consensus 182 ~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 182 PGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp TTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CCCC---------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHH
T ss_conf 8874---------4432248642476102688888845232335455587604889998876018999999998788415
Q ss_pred -----HC------CCCCCCCC---------CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf -----24------11112588---------7899982359999999999851133999994799
Q 006545 500 -----TG------KLKNLLDP---------LAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 500 -----~~------~~~~~ld~---------~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
.. .+...... .........+.++.+|+.+||..||.+||++.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~ 316 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 5555422544474300000333433112115521124489999999999866995689089999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.58 Aligned_cols=242 Identities=27% Similarity=0.372 Sum_probs=193.8
Q ss_pred CCCCCCCEEECCCCEEEEEEEE-----CCEEEEEEEECCCC----CCCCHHHHHHHHHHHCCCC-CCEEEEECCC--CCC
Q ss_conf 7977652010018468999998-----89289999954799----9991139999999850799-9613570410--584
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLL-----RHMQVAIKMLHPHS----LQGPSEFQQEIDILSKIRH-PNLVTLVGAC--PEV 348 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~vAiK~~~~~~----~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~--~~~ 348 (641)
++|++.+.||+|+||+||+|.. ++..||||++.... ......+.+|+.++++++| |||+++++++ ...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 08999725899923331027999999999999999998999999873099960105678884685569820112442000
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~ 428 (641)
.++||||+.+|+|.+++... ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 00123123411799998730---454378888889999999988514---998965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH--HHHHCCCC
Q ss_conf 14534346788642113799987566890000049--999503688799999999919999998379999--98624111
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG--ELTPKSDVYSFGIILLRLLTGRPALGITKEVQY--ALDTGKLK 504 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~--~~~~~~~~ 504 (641)
.+........ ....|++.|++||.+.+. .++.++|||||||+||+|+||+.||........ ........
T Consensus 178 ~~~~~~~~~~-------~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 178 EFVADETERA-------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp ECCGGGGGGG-------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred HHCCCCCCCC-------CCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 2034444322-------122233333106876057768871325177779999997689998888777799999983356
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCH
Q ss_conf 125887899982359999999999851133999994
Q 006545 505 NLLDPLAGDWPFVQAEQLANLAMRCCEMSRKSRPEL 540 (641)
Q Consensus 505 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~ 540 (641)
. ...+|...+..+.+|+.+||.++|.+||++
T Consensus 251 ~-----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 251 S-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred C-----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCC
T ss_conf 8-----998865479999999999744589881999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.54 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=195.3
Q ss_pred CCCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCC-------CC
Q ss_conf 079776520100184689999988--9289999954799999--113999999985079996135704105-------84
Q 006545 280 THNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP-------EV 348 (641)
Q Consensus 280 ~~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~-------~~ 348 (641)
..+|++.++||+|+||+||+|.+. +..||||++....... ...+.+|+.+|+.++|||++++++++. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 08999725899923331027999999999999999998999999873099960105678884685569820112442000
Q 006545 349 WTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 349 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~ 428 (641)
.+++++|+.+|+|.+++. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 499999625886232002----2453099999999999999999973---887651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 14534346788642113799987566890000049-99950368879999999991999999837999998624111125
Q 006545 429 FLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASG-ELTPKSDVYSFGIILLRLLTGRPALGITKEVQYALDTGKLKNLL 507 (641)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~~~~~~~~~~~~l 507 (641)
...... ....|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+...............
T Consensus 170 ~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 170 HTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CCCCCC-----------CCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 257544-----------443454355583553377567855124320589999976889978898899999999730799
Q ss_pred C-------------------CCCCCC-----CHHHHHHHHHHHHHHHHHCCCCCCCHHHHH
Q ss_conf 8-------------------878999-----823599999999998511339999947999
Q 006545 508 D-------------------PLAGDW-----PFVQAEQLANLAMRCCEMSRKSRPELGKDV 544 (641)
Q Consensus 508 d-------------------~~~~~~-----p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~v 544 (641)
. +..... ....+..+.+|+.+||..||.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 7577320010244544430355787555662678999999999997758834593899985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.83 Aligned_cols=249 Identities=24% Similarity=0.257 Sum_probs=195.9
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCC--CHHHHHHHHHHHCCCCCCEEEEECCCC--CCEEEEEE
Q ss_conf 79776520100184689999988--9289999954799999--113999999985079996135704105--84089997
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQG--PSEFQQEIDILSKIRHPNLVTLVGACP--EVWTLVYE 354 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~LV~E 354 (641)
.+|+..+.||+|+||+||+|.+. +..||||+++...... ...+.+|+.+++.++||||+++++++. ...++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25899923331027999999999999999998999999873099960105678884685569820112442000145343
Q 006545 355 YLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDFGISRFLSQNE 434 (641)
Q Consensus 355 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DFGla~~~~~~~ 434 (641)
++.+++|..++. ....+++..+..++.|++.||.|||. ++|+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212---35654036789999999999877433---998600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCC-CCHHHHHHHHHCCCC--------
Q ss_conf 467886421137999875668900000499-9950368879999999991999999-837999998624111--------
Q 006545 435 ISSNNTTLCCRTDPKGTFAYMDPEFLASGE-LTPKSDVYSFGIILLRLLTGRPALG-ITKEVQYALDTGKLK-------- 504 (641)
Q Consensus 435 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~~sDVwSlGviL~ElltG~~Pf~-~~~~~~~~~~~~~~~-------- 504 (641)
... ....++..|+|||++.+.. ++.++|||||||++|||++|+.||. ..+............
T Consensus 156 ~~~--------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 156 RCY--------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC--------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred CCC--------EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 510--------010344310146675069888804440265418899851899998899999999999861189973551
Q ss_pred ----CCC----------CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCHHHH
Q ss_conf ----125----------887899982359999999999851133999994799
Q 006545 505 ----NLL----------DPLAGDWPFVQAEQLANLAMRCCEMSRKSRPELGKD 543 (641)
Q Consensus 505 ----~~l----------d~~~~~~p~~~~~~l~~Li~~Cl~~dP~~RPs~~e~ 543 (641)
... .......+...+..+.+|+.+||+.||.+||++.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 34432221133444544310433065689999999999864996689099999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-45 Score=292.40 Aligned_cols=249 Identities=17% Similarity=0.245 Sum_probs=187.6
Q ss_pred CCCCCCCEEECCCCEEEEEEEEC--CEEEEEEEECCCCCCCCHHHHHHHHHHHCCC-----------CCCEEEEECCCC-
Q ss_conf 79776520100184689999988--9289999954799999113999999985079-----------996135704105-
Q 006545 281 HNFDPSLKIGEGGYGSIYKGLLR--HMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-----------HPNLVTLVGACP- 346 (641)
Q Consensus 281 ~~f~~~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~l~g~~~- 346 (641)
++|.+.++||+|+||+||+|+.. +..||||++..... ..+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred ---CCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC------
Q ss_conf ---84089997258999233310279999999999999999989999998730999601056788846855698------
Q 006545 347 ---EVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANF------ 417 (641)
Q Consensus 347 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~------ 417 (641)
...+++|.++..+..............+++..+..++.+++.||.|||+. .||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 25652023432000354200000122346786899999999999998887640--5864656770570563057656443
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHH--
Q ss_conf 201124420001453434678864211379998756689000004999950368879999999991999999837999--
Q 006545 418 VSKLSDFGISRFLSQNEISSNNTTLCCRTDPKGTFAYMDPEFLASGELTPKSDVYSFGIILLRLLTGRPALGITKEVQ-- 495 (641)
Q Consensus 418 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~~sDVwSlGviL~ElltG~~Pf~~~~~~~-- 495 (641)
.+|++|||.|....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||.......
T Consensus 170 ~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp EEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred EEEEEECCCCCCCCCCC-----------CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 05675314421234454-----------2236652105713214667776432012378999998788998987554321
Q ss_pred ----HHH----HHCC----------C-CCCCC---------C-----------CCCCCCHHHHHHHHHHHHHHHHHCCCC
Q ss_conf ----998----6241----------1-11258---------8-----------789998235999999999985113399
Q 006545 496 ----YAL----DTGK----------L-KNLLD---------P-----------LAGDWPFVQAEQLANLAMRCCEMSRKS 536 (641)
Q Consensus 496 ----~~~----~~~~----------~-~~~ld---------~-----------~~~~~p~~~~~~l~~Li~~Cl~~dP~~ 536 (641)
... ..+. . ....+ . .....+...+..+.+|+.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred CHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 02689999999837998788624532200013201220243235776444210001567435899999999987799457
Q ss_pred CCCHHHH
Q ss_conf 9994799
Q 006545 537 RPELGKD 543 (641)
Q Consensus 537 RPs~~e~ 543 (641)
||++.++
T Consensus 319 Rpta~e~ 325 (362)
T d1q8ya_ 319 RADAGGL 325 (362)
T ss_dssp CBCHHHH
T ss_pred CCCHHHH
T ss_conf 9089999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7.9e-25 Score=168.95 Aligned_cols=163 Identities=15% Similarity=0.133 Sum_probs=118.2
Q ss_pred CCCCEEECCCCEEEEEEEE-CCEEEEEEEECCCCCC-----C-------------CHHHHHHHHHHHCCCCCCEEEEECC
Q ss_conf 7652010018468999998-8928999995479999-----9-------------1139999999850799961357041
Q 006545 284 DPSLKIGEGGYGSIYKGLL-RHMQVAIKMLHPHSLQ-----G-------------PSEFQQEIDILSKIRHPNLVTLVGA 344 (641)
Q Consensus 284 ~~~~~LG~G~fG~Vykg~~-~~~~vAiK~~~~~~~~-----~-------------~~~f~~Ei~iL~~l~HpnIv~l~g~ 344 (641)
.+.++||+|+||.||+|.. +|..||||+++..... . ...+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred CCCCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCCCCCC
Q ss_conf 05840899972589992333102799999999999999999899999987309996010567888468556982011244
Q 006545 345 CPEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDLKPANILLDANFVSKLSDF 424 (641)
Q Consensus 345 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDIKp~NILld~~~~vKL~DF 424 (641)
.. .+++|||++++.+..+ +......++.+++.+|.|||. +||+||||||+|||+++++ ++|+||
T Consensus 83 ~~--~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 EG--NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp ET--TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEECCC
T ss_pred CC--CEEEEEEECCCCCCCH----------HHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEECCC-EEEEEC
T ss_conf 28--8899995045654200----------157899999999999999826---8889836890361142898-999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHCCCCCCCHHHHHHHHHHHH
Q ss_conf 200014534346788642113799987566890------0000499995036887999999
Q 006545 425 GISRFLSQNEISSNNTTLCCRTDPKGTFAYMDP------EFLASGELTPKSDVYSFGIILL 479 (641)
Q Consensus 425 Gla~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~AP------E~l~~~~~s~~sDVwSlGviL~ 479 (641)
|+|....... ...|... +.+ ...|+.++|+||..--++
T Consensus 147 G~a~~~~~~~----------------~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEG----------------WREILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTT----------------HHHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCC----------------CHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 8843089987----------------0999987799999997-578998446899999874
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=5.9e-17 Score=120.15 Aligned_cols=74 Identities=28% Similarity=0.461 Sum_probs=68.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 7789999867774100027981134686-32189999888329999998788887799880199999999998619
Q 006545 567 ERCEPPPYFTCPIFQEVMQDPHVAADGF-TYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641 (641)
Q Consensus 567 ~~~~~P~~~~cPi~~evm~dPvv~~~g~-t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~~ 641 (641)
....+|++|+|||+.++|.|||++++|+ |||+.+|..|+.. +.+||+|+.++...+|+||.+||++|++|+.++
T Consensus 15 ~~~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~~ 89 (98)
T d1wgma_ 15 TYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CCCSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred HHCCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHCCHHHHHHHHHHHHHHH
T ss_conf 515990774886734688777762355320149999999870-687665556664011201399999999999999
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.64 E-value=6.1e-17 Score=120.06 Aligned_cols=73 Identities=27% Similarity=0.583 Sum_probs=69.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 8999986777410002798113468632189999888329999998788887799880199999999998619
Q 006545 569 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641 (641)
Q Consensus 569 ~~~P~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~~ 641 (641)
.++|++|+|||+.++|.|||++++||||++.+|.+|+..++.+||.|+.++...+++||++||++|++|+.+|
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~~ 74 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 74 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 9897001185837323403305886856388999998637765787566654235551999999999999987
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.64 E-value=7.9e-17 Score=119.39 Aligned_cols=73 Identities=42% Similarity=0.820 Sum_probs=69.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 8999986777410002798113468632189999888329999998788887799880199999999998619
Q 006545 569 CEPPPYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQQH 641 (641)
Q Consensus 569 ~~~P~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~~~ 641 (641)
+++|++|+|||+.++|.|||++.+||+|++++|..|+..++.+||.|+.++...+++||++||++|++|+.+|
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9899627991718121083372677743399999999988887886556377565624699999999999995
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.96 E-value=2.7e-09 Score=72.73 Aligned_cols=147 Identities=15% Similarity=0.132 Sum_probs=97.6
Q ss_pred HHHHHCCCCCCCCEEECCCCEEEEEEEECCEEEEEEEECCCCCCCCHHHHHHHHHHHCCC-CCCEEEEECCC--CCCEEE
Q ss_conf 673210797765201001846899999889289999954799999113999999985079-99613570410--584089
Q 006545 275 EIEGATHNFDPSLKIGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGAC--PEVWTL 351 (641)
Q Consensus 275 ei~~~~~~f~~~~~LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~--~~~~~L 351 (641)
+++..-..|...+..+.++.+.||+....+..+.+|+...........+.+|...+..+. +-.+.+++..+ .+..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf 99975135279976789987718999908986999984887653255699999999987606998728999750896499
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q ss_conf 9972589992333102799999999999999999899999987309----------------------------------
Q 006545 352 VYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK---------------------------------- 397 (641)
Q Consensus 352 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------- 397 (641)
||++++|.++.+..... . ....++.+++..+..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEECCCCCCCCCCCCC-----C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 99860433435433440-----2---699999989999999855684214357644656555778998776555543033
Q ss_pred ----------------------CCCEEECCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf ----------------------99601056788846855698201124420001
Q 006545 398 ----------------------PHSIVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 398 ----------------------~~giiHrDIKp~NILld~~~~vKL~DFGla~~ 429 (641)
+..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 232005799999999844986781789860047642364996599960231441
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=4e-09 Score=71.62 Aligned_cols=63 Identities=16% Similarity=0.264 Sum_probs=56.9
Q ss_pred CCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 86777410002798113-4686321899998883299999987888877998801999999999986
Q 006545 574 YFTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 639 (641)
Q Consensus 574 ~~~cPi~~evm~dPvv~-~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~ 639 (641)
.+.|||+.++|.+|++. .+||+|++.+|..|+.. .||+|+.++...++.||.+|+.+|+.+..
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQDLKINRQLDSMIQLCSK 85 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCHHHHHHHHHHHH
T ss_conf 28992587221127465889993029999999853---66622786765518605899999999999
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=2.4e-09 Score=73.02 Aligned_cols=65 Identities=15% Similarity=0.345 Sum_probs=59.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 6777410002798113468632189999888329--9999987888877998801999999999986
Q 006545 575 FTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSG--HETSPMTNLPLAHKNLVPNLALRSAIQEWLQ 639 (641)
Q Consensus 575 ~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~--~~~~P~t~~~l~~~~l~pN~~lr~~i~~~~~ 639 (641)
|.|||+.+++.+|+++++||+|++.+|..|+... ...||+++.++...++.||..++++|+.++.
T Consensus 22 l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~~ 88 (103)
T d1jm7a_ 22 LECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLK 88 (103)
T ss_dssp TSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHHH
T ss_pred CCCCCCCCHHCCEEECCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHCCCCHHHHHHHHHHHH
T ss_conf 4997218231891883799864167899999977999809698883875528757899999999999
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.69 E-value=2e-09 Score=73.59 Aligned_cols=52 Identities=23% Similarity=0.436 Sum_probs=48.5
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 6777410002798113-4686321899998883299999987888877998801
Q 006545 575 FTCPIFQEVMQDPHVA-ADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 627 (641)
Q Consensus 575 ~~cPi~~evm~dPvv~-~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN 627 (641)
++|||+.++|.|||++ .+||+|++++|.+|+.+ +.+||+|+.++...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEEC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHCEEC
T ss_conf 9993678568865745789984559999998760-3679854781887753647
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.68 E-value=8.5e-09 Score=69.62 Aligned_cols=63 Identities=14% Similarity=0.227 Sum_probs=55.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-HHHHHHHHHH
Q ss_conf 98677741000279811346863218999988832999999878888779988-0199999999
Q 006545 573 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV-PNLALRSAIQ 635 (641)
Q Consensus 573 ~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~-pN~~lr~~i~ 635 (641)
..+.|||+.+.|.+|+++++||+|++.+|..|+..++.+||+++.++...++. |..++.+++.
T Consensus 22 ~~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l~ 85 (86)
T d1rmda2 22 KSISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILN 85 (86)
T ss_dssp HHTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHH
T ss_pred CCCCCCCCCCCHHCCEECCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHCCCHHHHHHHHHC
T ss_conf 6759956784441555267887631999999996487907036997996663598999999861
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.38 E-value=1.5e-06 Score=55.72 Aligned_cols=76 Identities=17% Similarity=0.105 Sum_probs=52.5
Q ss_pred CCEEECCCCEEEEEEEEC--CEEEEEEEECCC------C-CCCCHHHHHHHHHHHCCC---CCCEEEEECCCCCCEEEEE
Q ss_conf 520100184689999988--928999995479------9-999113999999985079---9961357041058408999
Q 006545 286 SLKIGEGGYGSIYKGLLR--HMQVAIKMLHPH------S-LQGPSEFQQEIDILSKIR---HPNLVTLVGACPEVWTLVY 353 (641)
Q Consensus 286 ~~~LG~G~fG~Vykg~~~--~~~vAiK~~~~~------~-~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~LV~ 353 (641)
...||.|....||+.... +..+++|.-.+. . .........|...|..+. ...+++++++..+..++||
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm 110 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 110 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998598877987
Q ss_pred EECCCCCH
Q ss_conf 72589992
Q 006545 354 EYLPNGSL 361 (641)
Q Consensus 354 Ey~~~gsL 361 (641)
|++.+..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred ECCCCCCC
T ss_conf 13577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.34 E-value=2.2e-06 Score=54.72 Aligned_cols=127 Identities=17% Similarity=0.128 Sum_probs=80.2
Q ss_pred EEECCC-CEEEEEEEECC-EEEEEEEECCCCCCCCHHHHHHHHHHHCCCC--CCEEEEECCC--CCCEEEEEEECCCCCH
Q ss_conf 010018-46899999889-2899999547999991139999999850799--9613570410--5840899972589992
Q 006545 288 KIGEGG-YGSIYKGLLRH-MQVAIKMLHPHSLQGPSEFQQEIDILSKIRH--PNLVTLVGAC--PEVWTLVYEYLPNGSL 361 (641)
Q Consensus 288 ~LG~G~-fG~Vykg~~~~-~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~--~~~~~LV~Ey~~~gsL 361 (641)
.+..|. .+.||+....+ ..+.+|...... ...+..|+..++.+.. -.+.++++++ ....++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------
Q ss_conf 333102799999999999999999899999987309--------------------------------------------
Q 006545 362 EDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCK-------------------------------------------- 397 (641)
Q Consensus 362 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 397 (641)
.+.. +.. ..++.+++..|..||...
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------268---99999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----------CCCEEECCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf -----------9960105678884685569820112442000
Q 006545 398 -----------PHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 398 -----------~~giiHrDIKp~NILld~~~~vKL~DFGla~ 428 (641)
+..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 999871876579567867888763577379658999853326
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=8e-07 Score=57.39 Aligned_cols=53 Identities=17% Similarity=0.331 Sum_probs=46.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 98677741000279811346863218999988832999999878888779988
Q 006545 573 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 625 (641)
Q Consensus 573 ~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~ 625 (641)
+...|||+.+.+.+|+++++||+|++.+|..|+..++.+||++|..+...+.+
T Consensus 22 ~~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~i 74 (79)
T d1fbva4 22 TFQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPI 74 (79)
T ss_dssp CTTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCCS
T ss_pred CCCCCCCCCCCCCCEEEECCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCEE
T ss_conf 98999358976899699589993529999999997858189979586477666
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.08 E-value=7e-05 Score=45.38 Aligned_cols=155 Identities=14% Similarity=0.105 Sum_probs=80.9
Q ss_pred CHHHHHHHCCCCCCCCE-----EECCCCEEEEEEEECCEEEEEEEECCCCCCCCHHHHHHHHHHHCCCC-----CCEEEE
Q ss_conf 85667321079776520-----10018468999998892899999547999991139999999850799-----961357
Q 006545 272 SFSEIEGATHNFDPSLK-----IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRH-----PNLVTL 341 (641)
Q Consensus 272 ~~~ei~~~~~~f~~~~~-----LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~H-----pnIv~l 341 (641)
+..++.....+|..... |..|--.+.|+....+..+++|++... .....+..++.++..|.. |..+..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred CHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCCEE
T ss_conf 9999999998679998568523788852673899978972899980789--99889999999987543025554556410
Q ss_pred E-CC----CCCCEEEEEEECCCCCHHHHH--------------H----CCC--CCCCCCHH------------------H
Q ss_conf 0-41----058408999725899923331--------------0----279--99999999------------------9
Q 006545 342 V-GA----CPEVWTLVYEYLPNGSLEDRL--------------S----CKD--NSPPLSWQ------------------T 378 (641)
Q Consensus 342 ~-g~----~~~~~~LV~Ey~~~gsL~~~L--------------~----~~~--~~~~l~~~------------------~ 378 (641)
. |. .......++.++.+......- . ... ........ .
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHH
T ss_conf 48976213412550245311465533320467888889987645444320245310111012002456777765311412
Q ss_pred HHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 99999998999999873-099960105678884685569820112442000
Q 006545 379 RIRIATELCSVLIFLHS-CKPHSIVHGDLKPANILLDANFVSKLSDFGISR 428 (641)
Q Consensus 379 ~~~i~~qia~aL~~LH~-~~~~giiHrDIKp~NILld~~~~vKL~DFGla~ 428 (641)
....+......+..... .-+.|+||+|+.++||+++.+...-|+||+.|.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 799999998764204855454503337863656402045412674222123
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.75 E-value=9.7e-05 Score=44.50 Aligned_cols=72 Identities=18% Similarity=0.218 Sum_probs=47.8
Q ss_pred CEEECCCCEEEEEEEECC---------EEEEEEEECCCCCCCCHHHHHHHHHHHCCC-CCCEEEEECCCCCCEEEEEEEC
Q ss_conf 201001846899999889---------289999954799999113999999985079-9961357041058408999725
Q 006545 287 LKIGEGGYGSIYKGLLRH---------MQVAIKMLHPHSLQGPSEFQQEIDILSKIR-HPNLVTLVGACPEVWTLVYEYL 356 (641)
Q Consensus 287 ~~LG~G~fG~Vykg~~~~---------~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~LV~Ey~ 356 (641)
..|+.|--..+|+..... ..|.+++... . ...-...+|..+++.+. +.-..+++++|++ .+|++|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-C-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC--CEEEEEE
T ss_conf 9917853343489996887754457898179996599-6-1165899999999999757999808998189--5699973
Q ss_pred CCCCHH
Q ss_conf 899923
Q 006545 357 PNGSLE 362 (641)
Q Consensus 357 ~~gsL~ 362 (641)
+|.+|.
T Consensus 124 ~g~~l~ 129 (395)
T d1nw1a_ 124 PSRPLS 129 (395)
T ss_dssp CEEECC
T ss_pred CCCCCC
T ss_conf 455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.61 E-value=0.00058 Score=39.68 Aligned_cols=133 Identities=12% Similarity=0.163 Sum_probs=73.1
Q ss_pred CEEEEEEEE-CCEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCC--EEEEECC-------CCCCEEEEEEECCCCCHHH
Q ss_conf 468999998-89289999954799999113999999985079996--1357041-------0584089997258999233
Q 006545 294 YGSIYKGLL-RHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPN--LVTLVGA-------CPEVWTLVYEYLPNGSLED 363 (641)
Q Consensus 294 fG~Vykg~~-~~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~-------~~~~~~LV~Ey~~~gsL~~ 363 (641)
-..||++.. .|..+++|+..+.. .....+..|...+..|.... ++..+.. .....+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 202699983899979999847877-8899999999999999855998787520689805665347999986527768899
Q ss_pred ----HH--------------HCC--CCCCCCCHHH-------------------HHHHHHHHHHHHHHHH----HCCCCC
Q ss_conf ----31--------------027--9999999999-------------------9999999899999987----309996
Q 006545 364 ----RL--------------SCK--DNSPPLSWQT-------------------RIRIATELCSVLIFLH----SCKPHS 400 (641)
Q Consensus 364 ----~L--------------~~~--~~~~~l~~~~-------------------~~~i~~qia~aL~~LH----~~~~~g 400 (641)
.+ ... .....++... ...+...+...+..+. ...+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEECCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 01056788846855698201124420001
Q 006545 401 IVHGDLKPANILLDANFVSKLSDFGISRF 429 (641)
Q Consensus 401 iiHrDIKp~NILld~~~~vKL~DFGla~~ 429 (641)
+||+|+.+.|||++.+ ..++||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1g25a_ g.44.1.1 (A:) TFIIH Mat1 subunit {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: TFIIH Mat1 subunit species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=3.8e-05 Score=47.00 Aligned_cols=53 Identities=19% Similarity=0.198 Sum_probs=43.2
Q ss_pred CCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 98677741000279-----811346863218999988832999999878888779988
Q 006545 573 PYFTCPIFQEVMQD-----PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLV 625 (641)
Q Consensus 573 ~~~~cPi~~evm~d-----Pvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~ 625 (641)
++..|||..+.+.. .+++++||+|+..+|..|+..++.+||++|.++...++.
T Consensus 2 dd~~CpIC~~~~~~~~~~~~~~~~C~H~fc~~Ci~~~~~~~~~~CP~CR~~i~~~~~~ 59 (65)
T d1g25a_ 2 DDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNFR 59 (65)
T ss_dssp CTTCCSTTTTHHHHCSSCCEEECTTCCCEEHHHHHHHHHTTSSSCTTTCCCCSSCCCE
T ss_pred CCCCCCCCCCEEECCCCEEEEECCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 9899870882600399567984763727648899998570819799998681304541
|
| >d1chca_ g.44.1.1 (A:) Immediate early protein, IEEHV {Equine herpesvirus 1 [TaxId: 10326]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Immediate early protein, IEEHV species: Equine herpesvirus 1 [TaxId: 10326]
Probab=97.13 E-value=0.00012 Score=43.99 Aligned_cols=44 Identities=18% Similarity=0.410 Sum_probs=39.4
Q ss_pred CCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 77741000279811-3468632189999888329999998788887
Q 006545 576 TCPIFQEVMQDPHV-AADGFTYEAEALKGWLDSGHETSPMTNLPLA 620 (641)
Q Consensus 576 ~cPi~~evm~dPvv-~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~ 620 (641)
.|||+.+.+.+|++ .++||+|+..+|..|+.. +.+||++|.++.
T Consensus 7 ~C~IC~~~~~~~~~~~~C~H~Fc~~Ci~~w~~~-~~~CP~CR~~i~ 51 (68)
T d1chca_ 7 RCPICLEDPSNYSMALPCLHAFCYVCITRWIRQ-NPTCPLCKVPVE 51 (68)
T ss_dssp CCSSCCSCCCSCEEETTTTEEESTTHHHHHHHH-SCSTTTTCCCCC
T ss_pred CCCCCCCCCCCCCEEECCCCCCCHHHHHHHHHH-CCCCCCCCCCHH
T ss_conf 994499396688388289991768999999982-990888781637
|
| >d1bora_ g.44.1.1 (A:) Acute promyelocytic leukaemia proto-oncoprotein PML {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Acute promyelocytic leukaemia proto-oncoprotein PML species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.96 E-value=0.00011 Score=44.28 Aligned_cols=51 Identities=16% Similarity=0.203 Sum_probs=43.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 9867774100027981134686321899998883299999987888877998801
Q 006545 573 PYFTCPIFQEVMQDPHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAHKNLVPN 627 (641)
Q Consensus 573 ~~~~cPi~~evm~dPvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~~~l~pN 627 (641)
..+.|+|..+.+.+|++.++||+|+..+|.+| ..+||+++.++....-.|.
T Consensus 5 ~~l~C~IC~~~~~~p~~lpCgH~fC~~Ci~~~----~~~CP~Cr~~~~~~~~~~a 55 (56)
T d1bora_ 5 QFLRCQQCQAEAKCPKLLPCLHTLCSGCLEAS----GMQCPICQAPWPLGADTPA 55 (56)
T ss_dssp CCSSCSSSCSSCBCCSCSTTSCCSBTTTCSSS----SSSCSSCCSSSSCCSSCCC
T ss_pred CCCCCCCCCCCCCCCEEECCCCHHHHHHHHCC----CCCCCCCCCCCCCCCCCCC
T ss_conf 78898402941589789017777859988729----7968497996669989888
|
| >d1v87a_ g.44.1.1 (A:) Deltex protein 2 RING-H2 domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Deltex protein 2 RING-H2 domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.73 E-value=0.00076 Score=38.95 Aligned_cols=50 Identities=14% Similarity=0.155 Sum_probs=39.2
Q ss_pred CCCCCCCCCCCCCCCC------------------CCCCCCCCCHHHHHHHHHHC----CCCCCCCCCCCCCC
Q ss_conf 9986777410002798------------------11346863218999988832----99999987888877
Q 006545 572 PPYFTCPIFQEVMQDP------------------HVAADGFTYEAEALKGWLDS----GHETSPMTNLPLAH 621 (641)
Q Consensus 572 P~~~~cPi~~evm~dP------------------vv~~~g~t~e~~~i~~w~~~----~~~~~P~t~~~l~~ 621 (641)
++...|+|+.+.|.++ .+..+||.|...||..|+.. ++.+||+||..+..
T Consensus 23 ~~~~~C~IC~e~l~~~~~~~~~~~~~~~~~~~~~~~~~CgH~FH~~Ci~~Wl~~~~~~~~~~CP~CR~~~~~ 94 (114)
T d1v87a_ 23 APEEDCIICMEKLAVASGYSDMTDSKALGPMVVGRLTKCSHAFHLLCLLAMYCNGNKDGSLQCPSCKTIYGE 94 (114)
T ss_dssp CCSCEETTTTEETTSCCSTTTTCCCSSSCSSCCEEESSSCCEECHHHHHHHHHHTCCSSCCBCTTTCCBSSS
T ss_pred CCCCCCCCHHHEECCCCCCCCCCCCCCCCCCCCEEECCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHCC
T ss_conf 656534530100013444335433345455434687999990569999999996675789766550122066
|
| >d1iyma_ g.44.1.1 (A:) EL5 RING-H2 domain {Rice (Oryza sativa) [TaxId: 4530]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: EL5 RING-H2 domain species: Rice (Oryza sativa) [TaxId: 4530]
Probab=96.34 E-value=0.0014 Score=37.39 Aligned_cols=47 Identities=26% Similarity=0.516 Sum_probs=38.6
Q ss_pred CCCCCCCCCCCCCCC--C--CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 986777410002798--1--13468632189999888329999998788887
Q 006545 573 PYFTCPIFQEVMQDP--H--VAADGFTYEAEALKGWLDSGHETSPMTNLPLA 620 (641)
Q Consensus 573 ~~~~cPi~~evm~dP--v--v~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~ 620 (641)
+...|+|..+-+.+. + +..+||.|...+|..|+.. +.+||++|.++.
T Consensus 4 d~~~C~ICl~~~~~~~~~~~l~~C~H~Fh~~Ci~~Wl~~-~~~CP~CR~~i~ 54 (55)
T d1iyma_ 4 DGVECAVCLAELEDGEEARFLPRCGHGFHAECVDMWLGS-HSTCPLCRLTVV 54 (55)
T ss_dssp CSCCCTTTCCCCCTTSCCEECSSSCCEECTTHHHHTTTT-CCSCSSSCCCSC
T ss_pred CCCCCEEECCCCCCCCEEEEECCCCCCCCHHHHHHHHHH-CCCCCCCCCEEE
T ss_conf 999984979001079889990898981059999999984-993878897848
|
| >d1ur6b_ g.44.1.1 (B:) Not-4 N-terminal RING finger domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: Not-4 N-terminal RING finger domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.98 E-value=0.0029 Score=35.31 Aligned_cols=46 Identities=13% Similarity=0.186 Sum_probs=37.3
Q ss_pred CCCCCCCCCCC----CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 77741000279----81134686321899998883299999987888877
Q 006545 576 TCPIFQEVMQD----PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 621 (641)
Q Consensus 576 ~cPi~~evm~d----Pvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~ 621 (641)
-|||..+.+.+ +.+.++||.|.+.++..|+..++.+||++|.++..
T Consensus 2 eCpICl~~~~~~~~~~~~~~CgH~~c~~C~~~w~~~~~~~CP~CR~~~~~ 51 (52)
T d1ur6b_ 2 ECPLCMEPLEIDDINFFPCTCGYQICRFCWHRIRTDENGLCPACRKPYPE 51 (52)
T ss_dssp EETTTTEECCGGGTTCCSSSSSCCCCHHHHHHHTTTSCCBCTTTCCBCSC
T ss_pred CCCCCCHHHHCCCCEEEECCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 99587823518982598669977045589999996648989865794889
|
| >d3dplr1 g.44.1.1 (R:19-106) RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: RIGG-box protein 1 (RBX1) of SCF ubiquitin ligase complex species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.87 E-value=0.0028 Score=35.47 Aligned_cols=34 Identities=12% Similarity=0.319 Sum_probs=29.3
Q ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 81134686321899998883299999987888877
Q 006545 587 PHVAADGFTYEAEALKGWLDSGHETSPMTNLPLAH 621 (641)
Q Consensus 587 Pvv~~~g~t~e~~~i~~w~~~~~~~~P~t~~~l~~ 621 (641)
+++..+||.|...+|..|+.. +.+||++|.+...
T Consensus 52 ~~~~~C~H~FH~~Ci~~Wl~~-~~~CP~CR~~~~~ 85 (88)
T d3dplr1 52 VAWGVCNHAFHFHCISRWLKT-RQVCPLDNREWEF 85 (88)
T ss_dssp EEEETTSCEEEHHHHHHHHTT-CSBCSSSCSBCCE
T ss_pred EEECCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCC
T ss_conf 287265474657999999987-9968788972312
|
| >d1vyxa_ g.44.1.3 (A:) IE1B protein (ORF K3), N-terminal domain {Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: Variant RING domain domain: IE1B protein (ORF K3), N-terminal domain species: Kaposi's sarcoma-associated herpesvirus, KSHV, HHV8 [TaxId: 37296]
Probab=94.89 E-value=0.013 Score=31.33 Aligned_cols=49 Identities=18% Similarity=0.258 Sum_probs=40.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-----CCCHHHHHHHHHH-CCCCCCCCCCCCCCC
Q ss_conf 986777410002798113468-----6321899998883-299999987888877
Q 006545 573 PYFTCPIFQEVMQDPHVAADG-----FTYEAEALKGWLD-SGHETSPMTNLPLAH 621 (641)
Q Consensus 573 ~~~~cPi~~evm~dPvv~~~g-----~t~e~~~i~~w~~-~~~~~~P~t~~~l~~ 621 (641)
+..+|+|..+.+.++.+.+.+ +.|...+|..|+. +++.+||+++.++..
T Consensus 5 d~~~C~IC~~~~~~~~~~~c~c~~c~h~~H~~Cl~~W~~~~~~~~CP~Cr~~~~~ 59 (60)
T d1vyxa_ 5 DVPVCWICNEELGNERFRACGCTGELENVHRSCLSTWLTISRNTACQICGVVYNT 59 (60)
T ss_dssp SCCEETTTTEECSCCCCCSCCCSSGGGSCCHHHHHHHHHHHTCSBCTTTCCBCCC
T ss_pred CCCCCCCCCCCCCCCEEEECCCCCCCCEECHHHHHHHHHHCCCCCCCCCCCEEEC
T ss_conf 8999923886277751673145897788738999999710789889166971242
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.82 E-value=1 Score=19.63 Aligned_cols=133 Identities=12% Similarity=0.072 Sum_probs=73.1
Q ss_pred EECCCCEEEEEEEECCEEEEEEEECCCCCCCCHHHHHHHHHHHCCCCCCEEEEECC---------------------C--
Q ss_conf 10018468999998892899999547999991139999999850799961357041---------------------0--
Q 006545 289 IGEGGYGSIYKGLLRHMQVAIKMLHPHSLQGPSEFQQEIDILSKIRHPNLVTLVGA---------------------C-- 345 (641)
Q Consensus 289 LG~G~fG~Vykg~~~~~~vAiK~~~~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~---------------------~-- 345 (641)
+..+|.+-|+-+...+..+++|.-. ....+.|..+....-.+..|...-+--. +
T Consensus 76 ~s~~Gs~Gv~FV~~e~gaiVlK~s~---tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~~e~d~~I~se 152 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVITTL 152 (342)
T ss_dssp ECCSTTSCEEEEEESSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHHHHH
T ss_pred EEECCCCEEEEEECCCCEEEEECCC---CHHHHHHHHHHHHHHCCCCCCEEEECCCCHHHHHHHHHHHCCCCHHHHHHHH
T ss_conf 7546984589998378669995588---4299999999999959999856885277789999877774378804788888
Q ss_pred -CCCEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC-CCCCEEECCCC-CCCCC
Q ss_conf -5840899972589992333102799999999999999999899999987309996010567-88846855698-20112
Q 006545 346 -PEVWTLVYEYLPNGSLEDRLSCKDNSPPLSWQTRIRIATELCSVLIFLHSCKPHSIVHGDL-KPANILLDANF-VSKLS 422 (641)
Q Consensus 346 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~giiHrDI-Kp~NILld~~~-~vKL~ 422 (641)
...++++|||.+|.+|.+.-.... ...+.. .++.=+..++-.=.+++.....++++++- .++||+++.++ .+..+
T Consensus 153 l~~A~~liMeYvpG~~l~e~~~~~a-~~~fs~-~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~I 230 (342)
T d1cjaa_ 153 ANQANILLMELVRGITLNKLTTTSA-PEVLTK-STMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPI 230 (342)
T ss_dssp TTCSEEEEEECCCEEESTTCCSSSH-HHHSCH-HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEEC
T ss_pred HHCCCCEEEECCCCCCCCCCCCCCC-HHHHCH-HHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCEEEECCCCEEEEE
T ss_conf 7514401000327842012433123-011057-99998656998999971776665211578870015770598589996
Q ss_pred CCCC
Q ss_conf 4420
Q 006545 423 DFGI 426 (641)
Q Consensus 423 DFGl 426 (641)
|=|.
T Consensus 231 Ds~i 234 (342)
T d1cjaa_ 231 DSKI 234 (342)
T ss_dssp SCCC
T ss_pred CCCC
T ss_conf 6886
|